Citrus Sinensis ID: 018682
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | 2.2.26 [Sep-21-2011] | |||||||
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.514 | 0.109 | 0.378 | 5e-33 | |
| Q54H46 | 642 | Probable serine/threonine | yes | no | 0.545 | 0.299 | 0.389 | 1e-32 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.545 | 0.278 | 0.399 | 2e-32 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.565 | 0.213 | 0.403 | 4e-32 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.517 | 0.221 | 0.421 | 4e-31 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.474 | 0.101 | 0.406 | 7e-31 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.556 | 0.081 | 0.403 | 8e-31 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.568 | 0.306 | 0.364 | 1e-30 | |
| Q86HG9 | 1024 | Probable serine/threonine | no | no | 0.5 | 0.171 | 0.402 | 3e-30 | |
| Q54R58 | 918 | Probable tyrosine-protein | no | no | 0.573 | 0.220 | 0.408 | 4e-30 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function desciption |
|---|
Score = 142 bits (357), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 72/190 (37%), Positives = 124/190 (65%), Gaps = 9/190 (4%)
Query: 162 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
+I G++ + + W+ + VA+KK ++ I D++ + R+E+A L+K+ HPN++ +GA
Sbjct: 1404 QIGLGSYGVVYRGKWKNVDVAIKKFIKQKI-DENHLLGIREEIAFLKKLHHPNIITMVGA 1462
Query: 219 VTQSSPMMIVTEYLPKGDLR-AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
+ + IVTEY+ KG+LR A L+ ++ ++IA+G++YLH P PIIHR
Sbjct: 1463 SLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDP-PIIHR 1521
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
D++PSNIL D++ N+K+ADFG ++ +KE+ + + + + APE+ +N+ YD KVDV
Sbjct: 1522 DIKPSNILIDENWNVKIADFGFAR---IKEENAIMTRCGTPCWTAPEIIRNDIYDEKVDV 1578
Query: 338 FSFALILQEV 347
FSF +++ EV
Sbjct: 1579 FSFGIVMWEV 1588
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (353), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 79/203 (38%), Positives = 124/203 (61%), Gaps = 11/203 (5%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID H++ V I KG + L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 424
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
V +++ Y K DV+SF +IL E
Sbjct: 541 VLRSQRYTEKADVYSFGIILWEC 563
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 139 bits (351), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 81/203 (39%), Positives = 122/203 (60%), Gaps = 11/203 (5%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID ++ V I KG F L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 385 DIDTQQIKI--GVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ S + I TEY+P+G L + L K + S R +D A+G+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 502 YLHGSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 557
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
V +++ Y K DV+SF +IL E
Sbjct: 558 VLRSQRYTEKADVYSFGIILWEC 580
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 139 bits (349), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 84/208 (40%), Positives = 128/208 (61%), Gaps = 9/208 (4%)
Query: 144 EVPEYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
+V E EI ++L + + + G A W G +VAVKK ++ S + FR E+
Sbjct: 658 DVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGA-ALAEFRSEVR 716
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIAR 261
+++++RHPNVV FLGAVT+ + IVTE+LP+G L L R K + ++ ALD+A
Sbjct: 717 IMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAM 776
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 319
GMN LH + P I+HRDL+ N+L D++ N+KV DFG+S+L K + L+ + T+
Sbjct: 777 GMNCLHTSTPT-IVHRDLKTPNLLVDNNWNVKVGDFGLSRL---KHNTFLSSKSTAGTPE 832
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEV 347
++APEV +NE + K DV+SF +IL E+
Sbjct: 833 WMAPEVLRNEPSNEKCDVYSFGVILWEL 860
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (341), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 81/192 (42%), Positives = 114/192 (59%), Gaps = 10/192 (5%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
GT A W G VAVK L E+ + RV F E+A+++++RHPN+V F+GAVTQ +
Sbjct: 563 GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 621
Query: 226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
IVTEYL +G L L + GA L + A D+A+GMNYLH P PI+HRDL+
Sbjct: 622 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 680
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSF 340
N+L D +KV DFG+S+L K L+ + + ++APEV ++E + K DV+SF
Sbjct: 681 NLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 737
Query: 341 ALILQEVKFYNQ 352
+IL E+ Q
Sbjct: 738 GVILWELATLQQ 749
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 7e-31, Method: Composition-based stats.
Identities = 72/177 (40%), Positives = 113/177 (63%), Gaps = 10/177 (5%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
W+ I VAVKK ++ I D+ ++ FR E+A L ++RHP+++ +GA + + IVTE++
Sbjct: 1413 WKNINVAVKKFVKQKI-DEKQMLEFRAEIAFLSQLRHPHIILMIGACLKRPNICIVTEFM 1471
Query: 233 PKGDLRAFLKRKGALKPSTAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G LR +K KP ++ + A G+ YLH + P+ IIHRD++PSNIL DDS
Sbjct: 1472 GNGSLRNVIK---TTKPEWKLKIKMLYQTALGIGYLHNSDPI-IIHRDIKPSNILVDDSM 1527
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
N+K+ADFG +++ +E+ +T T C + APE+ + E+Y KVDVFSF +++ EV
Sbjct: 1528 NVKIADFGFARI--KEENSVMTRCGTPC-WTAPEIIRGEKYTEKVDVFSFGIVMWEV 1581
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 8e-31, Method: Composition-based stats.
Identities = 90/223 (40%), Positives = 120/223 (53%), Gaps = 27/223 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
EYEID +EL+F + I KG F +WR VA+K + + + F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164
Query: 204 LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 258
L K+RHPNVVQFLGA T IVTE++ G LR FL L P ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRD---DSGN----------LKVADFGVSKLLTV 305
IA+GMNYLH P PI+HRDL NIL D D N K++DFG+S+L
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM- 2282
Query: 306 KEDRPLTCQDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
E Q C Y+APEVFK + K DV+S+ ++L E+
Sbjct: 2283 -EQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFEL 2324
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (336), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 77/211 (36%), Positives = 126/211 (59%), Gaps = 11/211 (5%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E+ +EID +E+ + ++ G F + RG +VA+KKL + V +++ + F+ E
Sbjct: 161 EIIRWEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVF-EENTMNEFKKE 219
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
++L+ K+R+P+++ F+GA T + IVTE +PKG + + L+ K + A+ IA
Sbjct: 220 VSLMAKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIA 279
Query: 261 R----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
R GM +LH + I+H DL+P+N+L D + +KVADFG+SK + L Q
Sbjct: 280 RDTVLGMTWLHASN---ILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAG 336
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
S Y+APE+ N+ YD KVDVFSF+++L E+
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWEL 367
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum GN=DDB_G0271682 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 132 bits (333), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 74/184 (40%), Positives = 112/184 (60%), Gaps = 8/184 (4%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
W+G VAVK + + ++ D + E+++L+ +RHPNVV F+G + + I+TEYL
Sbjct: 379 WKGTPVAVKTIFKSLLRKDKKEEF-EKEVSILKCLRHPNVVLFMGTCLLNGNLAIITEYL 437
Query: 233 PKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
+G LR L K L S V+ +D+A+GMNYLH P PIIHRDL+ N+L D++
Sbjct: 438 NRGSLRDVLTTMNKSELSLSVKVKMLIDVAQGMNYLHTYSP-PIIHRDLKSLNLLVDNNF 496
Query: 291 NLKVADFGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVK 348
N+KV+DFG+S+ ++ + C S ++APEVF Y TKVDV+SF ++L E+
Sbjct: 497 NVKVSDFGLSRFISGGIGSSAKTFCGTLS--WIAPEVFNGSGYTTKVDVYSFGIVLWEIL 554
Query: 349 FYNQ 352
+ Q
Sbjct: 555 THKQ 558
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 132 bits (332), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 91/223 (40%), Positives = 120/223 (53%), Gaps = 21/223 (9%)
Query: 139 VKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVR 195
VK + ++EI EL T EI +G F A WRG VA+KK+ D
Sbjct: 161 VKLKSTLKKHEIPSREL--TVEKEIGQGFFGKVYKARWRGKSVALKKITLIKFRDLTETE 218
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPM---MIVTEYLPKGDLRAFLKRKGA--LKPS 250
F E++++ K+ HP V F+GA + P I+ EY+ G LR L K + L PS
Sbjct: 219 IFDKEVSIMSKLCHPTCVMFIGACSLDGPSNDRSIIMEYMEGGSLRRLLDEKSSYHLPPS 278
Query: 251 TAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKED 308
+ A DIA GMNYLH N K PI+HRDL SNIL + S + K+ DFG+SK E
Sbjct: 279 LQLSIARDIAEGMNYLHTNFKEGPIVHRDLTSSNILLNSSYTVAKINDFGLSK-----EM 333
Query: 309 RP----LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+P +T S ++APE FK E Y KVDV+SFA+IL E+
Sbjct: 334 KPGPTEMTAAMGSLAWMAPECFKAENYTEKVDVYSFAIILWEI 376
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | ||||||
| 255562560 | 466 | protein kinase, putative [Ricinus commun | 0.982 | 0.742 | 0.810 | 1e-163 | |
| 356555470 | 456 | PREDICTED: probable serine/threonine-pro | 0.977 | 0.754 | 0.806 | 1e-162 | |
| 449459316 | 458 | PREDICTED: serine/threonine-protein kina | 0.960 | 0.737 | 0.824 | 1e-160 | |
| 225443668 | 462 | PREDICTED: dual specificity protein kina | 0.985 | 0.751 | 0.789 | 1e-157 | |
| 356549162 | 455 | PREDICTED: probable serine/threonine-pro | 0.974 | 0.753 | 0.795 | 1e-157 | |
| 224076914 | 423 | predicted protein [Populus trichocarpa] | 0.951 | 0.791 | 0.805 | 1e-157 | |
| 356499380 | 454 | PREDICTED: dual specificity protein kina | 0.957 | 0.742 | 0.765 | 1e-148 | |
| 255558750 | 401 | Serine/threonine-protein kinase HT1, put | 0.963 | 0.845 | 0.775 | 1e-148 | |
| 356553484 | 453 | PREDICTED: serine/threonine-protein kina | 0.965 | 0.750 | 0.744 | 1e-145 | |
| 449433589 | 460 | PREDICTED: probable serine/threonine-pro | 0.971 | 0.743 | 0.759 | 1e-145 |
| >gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-163, Method: Compositional matrix adjust.
Identities = 290/358 (81%), Positives = 316/358 (88%), Gaps = 12/358 (3%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNG-------LDDDGEE----IKPEFRLMFLAN 49
ME K VR TL KQSSLAP+R R+E N + +D EE I P RLM+ +
Sbjct: 1 MEGKSSVRFTLGKQSSLAPERSREEDVSNDQEEGSEDMSNDPEEELEDIHPGVRLMYSCH 60
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
E D++GI+ELLDSGIDVNFRDIDNRTALH+AACQG+T+VV+LLL GA+ DPKDRWGSTP
Sbjct: 61 EGDLDGIRELLDSGIDVNFRDIDNRTALHLAACQGYTDVVALLLNNGAETDPKDRWGSTP 120
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFI 169
L DAIYYKNH+VIKLLEK GAKPLMAPMHV HAREVPEYEI+PHELDFTNSVEITKGTF
Sbjct: 121 LADAIYYKNHDVIKLLEKRGAKPLMAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFH 180
Query: 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
LA WRGIQVAVKKLGE+VISD+D+VRAF DELALLQKIRHPNVVQFLGAVTQSSPMMIVT
Sbjct: 181 LASWRGIQVAVKKLGEDVISDEDKVRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 240
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
EYL KGDLRAFLK+KGAL+P TAVRF LDIARG+NYLHENKP PIIHRDLEPSNILRDDS
Sbjct: 241 EYLHKGDLRAFLKKKGALRPGTAVRFGLDIARGLNYLHENKP-PIIHRDLEPSNILRDDS 299
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G+LKVADFGVSKLLTVKED+PLTCQDTSCRYVAPEVFK+EEYDTKVDVFSFALILQE+
Sbjct: 300 GHLKVADFGVSKLLTVKEDKPLTCQDTSCRYVAPEVFKHEEYDTKVDVFSFALILQEM 357
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1487), Expect = e-162, Method: Compositional matrix adjust.
Identities = 280/347 (80%), Positives = 311/347 (89%), Gaps = 3/347 (0%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL DGE + RLM+ A E DV+GI+E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---KDGEAVDQGVRLMYSAFEGDVDGIREAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+SG+ VN++DIDNRTALHVAAC+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 ESGVSVNYKDIDNRTALHVAACEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAKPLMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF A WRG +VAV
Sbjct: 118 VIKLLEKHGAKPLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+KRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 MKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
KLL VKED+PLTCQDTSCRYVAPEVF+ EEYDTKVDVFSFALILQE+
Sbjct: 298 KLLAVKEDKPLTCQDTSCRYVAPEVFRQEEYDTKVDVFSFALILQEM 344
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459316|ref|XP_004147392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1472), Expect = e-160, Method: Compositional matrix adjust.
Identities = 281/341 (82%), Positives = 304/341 (89%), Gaps = 3/341 (0%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV 66
VR L KQSS+APDR+ +EAEL +DGEEI P RLM+LANE D+EGIKELLDSGIDV
Sbjct: 11 VRFLLGKQSSMAPDRQPEEAELA---EDGEEIDPGVRLMYLANEGDLEGIKELLDSGIDV 67
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
NF DIDNRTALH+AACQG E+V LLL RGA++DPKDRWGSTPL DAI+YKNHEVIKLLE
Sbjct: 68 NFHDIDNRTALHIAACQGCNEIVDLLLRRGAEIDPKDRWGSTPLADAIFYKNHEVIKLLE 127
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEE 186
K GAK LMAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+
Sbjct: 128 KRGAKHLMAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPED 187
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
VIS++D+V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL L +KG
Sbjct: 188 VISEEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGP 247
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
LKP AV+FALDIARGMNYLHENKP PIIHRDLEPSNILRDD+GNLKVADFGVSKLLTVK
Sbjct: 248 LKPIVAVKFALDIARGMNYLHENKPAPIIHRDLEPSNILRDDTGNLKVADFGVSKLLTVK 307
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
ED+PLTCQDT+CRYVAPEVFKN YDTKVDVFSFALILQE+
Sbjct: 308 EDKPLTCQDTACRYVAPEVFKNNGYDTKVDVFSFALILQEM 348
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 277/351 (78%), Positives = 311/351 (88%), Gaps = 4/351 (1%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
+E+K VR TL KQSSLAP+R R EA G D E I P RLM+LANE D+EG++ELL
Sbjct: 3 VESKTAVRFTLGKQSSLAPERARDEALTEGEQGDVEGIDPRVRLMYLANEGDLEGLRELL 62
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
DSG+DVNFRDIDNRTALHVAACQGF++VV LL+ GA++D +DRWGSTPL DAI+YKNH+
Sbjct: 63 DSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLEDRWGSTPLADAIHYKNHD 122
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGA+ LMAPMHV +AREVPEYEIDP ELDFTNSV+ITKGT+ +A WRGIQVAV
Sbjct: 123 VIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVAV 182
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
K+LG+EVI D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL AF
Sbjct: 183 KRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHAF 242
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
LKRKGALK +TAV+FALDIARGMNYLHE++P IIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 243 LKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPSNILRDDSGHLKVADFGVS 302
Query: 301 KLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
KLL TVKED PL CQ+TSCRY+APEVFKNE YDTKVDVFSFALILQE+
Sbjct: 303 KLLKVANTVKEDYPLICQETSCRYLAPEVFKNEAYDTKVDVFSFALILQEM 353
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 276/347 (79%), Positives = 308/347 (88%), Gaps = 4/347 (1%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL +DGE + RLM+ A E DV+GI E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---NDGEVVDQGVRLMYSAFEGDVDGICEAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ G+ VN++DIDNRTALHVA C+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 EFGVSVNYKDIDNRTALHVAVCEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAK LMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF +A WRG +VAV
Sbjct: 118 VIKLLEKHGAKLLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
LKRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 LKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
KLL VKED+PLTC DTSCRYVAPEVF+ +EYDTKVDVFSFALILQE+
Sbjct: 298 KLLAVKEDKPLTCHDTSCRYVAPEVFR-QEYDTKVDVFSFALILQEM 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1443), Expect = e-157, Method: Compositional matrix adjust.
Identities = 274/340 (80%), Positives = 308/340 (90%), Gaps = 5/340 (1%)
Query: 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN 67
R TL KQSSLAP+R+R+E+++ D DG + P RLM+LANE ++EGIKEL++S +DVN
Sbjct: 1 RFTLGKQSSLAPERDREESDV---DMDG--VDPGVRLMYLANEGNLEGIKELVNSDVDVN 55
Query: 68 FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
FRDID RTALH+A+CQG T+VV LLL+ GA++DPKDRWGSTPL DAI+YKNH+VIKLLEK
Sbjct: 56 FRDIDGRTALHIASCQGLTQVVDLLLDHGAEIDPKDRWGSTPLADAIFYKNHDVIKLLEK 115
Query: 128 HGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEV 187
GAKPLMAPMHVKHAREVPEYEI+P ELDFTNSVE+TKGTF +A WRGIQVAVKKLGEEV
Sbjct: 116 RGAKPLMAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEV 175
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+SD+D+VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE+LPKGD AFLKRKGAL
Sbjct: 176 LSDEDKVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGAL 235
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
KP AVR ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG+LKVADFG+SKLLTVKE
Sbjct: 236 KPIAAVRLALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGHLKVADFGISKLLTVKE 295
Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++PL D S RYVAPEVFKNEEYDTKVD+FSFALILQE+
Sbjct: 296 EKPLISLDNSWRYVAPEVFKNEEYDTKVDIFSFALILQEM 335
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1370), Expect = e-148, Method: Compositional matrix adjust.
Identities = 267/349 (76%), Positives = 299/349 (85%), Gaps = 12/349 (3%)
Query: 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDS 62
K+ R +L +QSSLAP+R G D E + P RLM+LANE D +GIKELLD+
Sbjct: 5 KLQPRFSLGRQSSLAPER-------GGCGGDASEALDPAVRLMYLANEGDSDGIKELLDA 57
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVNF DID RTALHVAACQG T+VV LLL RGADVDP+DRWGSTPL DA+YYKNH+V+
Sbjct: 58 GSDVNFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQDRWGSTPLVDAMYYKNHDVV 117
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRG QVAVK
Sbjct: 118 KLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKT 177
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
LGEE+ +DDD+V+AF DEL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDLRA+LK
Sbjct: 178 LGEELFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLK 237
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
RKGALKP TAV+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGVSKL
Sbjct: 238 RKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKL 297
Query: 303 L----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
L TVKED+P+T DTS RYVAPEV+KNEEYDTKVDVFSFALILQE+
Sbjct: 298 LKVAKTVKEDKPVTSLDTSWRYVAPEVYKNEEYDTKVDVFSFALILQEM 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558750|ref|XP_002520399.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis] gi|223540446|gb|EEF42015.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1368), Expect = e-148, Method: Compositional matrix adjust.
Identities = 270/348 (77%), Positives = 302/348 (86%), Gaps = 9/348 (2%)
Query: 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-LLDSG 63
P R TL KQSSL P+R+R E E + G I P RLM+LA+E D++GI E LL+SG
Sbjct: 18 TPARFTLGKQSSLKPERDRHEEEEEEEEVAG--IDPRVRLMYLASEGDIDGINEVLLESG 75
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
DVNF+DID RTALHVAACQG T+V+ LLL+RGA++DPKDRWGSTPL DAIYYKNH+VIK
Sbjct: 76 TDVNFKDIDGRTALHVAACQGLTDVLQLLLDRGAEIDPKDRWGSTPLADAIYYKNHDVIK 135
Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKL 183
LLE HGAKP +APMHV++AREVPEYEIDP+ELDF+NSV+ITKGTF A WRGIQVAVK L
Sbjct: 136 LLEIHGAKPPIAPMHVQNAREVPEYEIDPNELDFSNSVDITKGTFRSASWRGIQVAVKTL 195
Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
GEEV +D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL A+LK
Sbjct: 196 GEEVFTDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCAYLKL 255
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
KGALKP AV+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGVSKLL
Sbjct: 256 KGALKPRVAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKLL 315
Query: 304 ----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
TVKEDRP CQDTS RYVAPEV++NEEYDTKVDVFSFALILQE+
Sbjct: 316 KVTKTVKEDRP--CQDTSWRYVAPEVYRNEEYDTKVDVFSFALILQEM 361
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553484|ref|XP_003545086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1341), Expect = e-145, Method: Compositional matrix adjust.
Identities = 262/352 (74%), Positives = 297/352 (84%), Gaps = 12/352 (3%)
Query: 1 METK-VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKEL 59
METK + R +L +QSSLAP+R G D E + P RLM+LANE D +GIKEL
Sbjct: 1 METKKLHPRFSLGRQSSLAPERA-------GAGDSSEALDPAVRLMYLANEGDSDGIKEL 53
Query: 60 LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
LD+G +VNF DID RT+LHVAACQG T+VV LLL RGA VDP+DRWGSTPL DA+YYKNH
Sbjct: 54 LDAGSNVNFTDIDGRTSLHVAACQGRTDVVDLLLRRGAHVDPQDRWGSTPLVDAMYYKNH 113
Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
+V+KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRGIQVA
Sbjct: 114 QVVKLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGIQVA 173
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
VK LGEE+ +DDD+V+AF EL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDL A
Sbjct: 174 VKTLGEELFTDDDKVKAFHYELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLGA 233
Query: 240 FLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
+LKRKGALKP TAV+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGV
Sbjct: 234 YLKRKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGV 293
Query: 300 SKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
SKLL VKED+P+ DTS RYVAPEV++NEEYDT VDVFSFALILQE+
Sbjct: 294 SKLLKVAKMVKEDKPVASLDTSWRYVAPEVYRNEEYDTNVDVFSFALILQEM 345
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433589|ref|XP_004134580.1| PREDICTED: probable serine/threonine-protein kinase drkD-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-145, Method: Compositional matrix adjust.
Identities = 262/345 (75%), Positives = 293/345 (84%), Gaps = 3/345 (0%)
Query: 6 PVRTTLLKQSSLAPDRERKEAELNGL---DDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
PV+ L KQSSLAPD + +L L E I RLM+LANE D+EGI E+LDS
Sbjct: 4 PVKFKLGKQSSLAPDGDVHLEDLEELVKQHQTEEGIDSRVRLMYLANEGDLEGINEVLDS 63
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G+DVNFRDIDNRTALH+AACQGF +VV+LLLERGA+VD KDRWGSTPL DAI+YKNH+VI
Sbjct: 64 GVDVNFRDIDNRTALHIAACQGFADVVALLLERGAEVDSKDRWGSTPLRDAIHYKNHDVI 123
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
KLLEKHGAKP +APM VK+AREVP+YEIDP ELDFTNSV ITKGTF A WRG +VAVK+
Sbjct: 124 KLLEKHGAKPPVAPMLVKNAREVPDYEIDPKELDFTNSVNITKGTFRRASWRGTEVAVKE 183
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
LGE++ +D+++VRAFRDELALLQKIRHPNVVQFLGAVTQS PMMIVTEYLPKGDL A L
Sbjct: 184 LGEDLFTDEEKVRAFRDELALLQKIRHPNVVQFLGAVTQSWPMMIVTEYLPKGDLGALLS 243
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
RK +K + VR ALDIARGMNYLHENKP PIIHR+LEPSNILRDDSG+LKVADFGVSKL
Sbjct: 244 RKREIKTMSVVRLALDIARGMNYLHENKPAPIIHRNLEPSNILRDDSGHLKVADFGVSKL 303
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
LTVKED+ TC +TS RY APEVFKNEEYDTKVDVFSFALILQE+
Sbjct: 304 LTVKEDKFSTCSETSRRYQAPEVFKNEEYDTKVDVFSFALILQEM 348
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | ||||||
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.965 | 0.740 | 0.745 | 2.6e-134 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.985 | 0.736 | 0.696 | 1.6e-125 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.963 | 0.707 | 0.508 | 1.4e-85 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.965 | 0.714 | 0.485 | 7.4e-82 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.968 | 0.714 | 0.497 | 6.6e-81 | |
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 0.852 | 0.684 | 0.489 | 3.8e-69 | |
| WB|WBGene00016030 | 850 | C24A1.3 [Caenorhabditis elegan | 0.545 | 0.225 | 0.399 | 7.8e-36 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.681 | 0.439 | 0.374 | 1.5e-34 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.553 | 0.342 | 0.399 | 4.2e-34 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.556 | 0.256 | 0.411 | 9.7e-33 |
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1316 (468.3 bits), Expect = 2.6e-134, P = 2.6e-134
Identities = 255/342 (74%), Positives = 294/342 (85%)
Query: 8 RTTLLKQSSLAPDR--ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
R T+ +QSS+AP++ E + +DGEEI RLM+LANE D+EGIKEL+DSGID
Sbjct: 9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
N+RDID+RTALHVAACQG +VV LLL+R A+VDPKDRWGSTP DAI+YKN +VIK+L
Sbjct: 69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128
Query: 126 EKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGE 185
E HGAK MAPMHVK AREVPEYEI+P ELDFT S EITKGT+ +A WRGIQVAVKKL +
Sbjct: 129 EIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKKLDD 188
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
EV+SDDD+VR F DELALLQ++RHPN+VQFLGAVTQS+PMMIVTEYLP+GDLR LKRKG
Sbjct: 189 EVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKG 248
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
LKP+TAVR+ALDIARGM+YLHE K PIIHRDLEPSNILRDDSG+LKVADFGVSKL+TV
Sbjct: 249 QLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGVSKLVTV 308
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
KED+P TCQD SCRY+APEVF +EEYDTK DVFSFALI+QE+
Sbjct: 309 KEDKPFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEM 350
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 1.6e-125, P = 1.6e-125
Identities = 250/359 (69%), Positives = 289/359 (80%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------PEFRLMFLANERDV 53
++ K P R L +QSSLAP+ L +DD P RLM+LANE D+
Sbjct: 3 IKPKSPARFKLGRQSSLAPESRTPIDTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDI 62
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+GI ++LDSG +V++RDID RTALHVAACQG T+VV LLL RGA VD KDRWGSTPL DA
Sbjct: 63 DGINKMLDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADA 122
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW 173
+YYKNH+VIKLLEKHGAKP +APMHV +EVPEYEI P ELDF+NSV+I+KGTF A W
Sbjct: 123 VYYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASW 182
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
RGI VAVK GEE+ +D+D+V AFRDELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLP
Sbjct: 183 RGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 242
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
KGDLR +L RKG L P+ AV+FAL+IARGMNYLHE+KP IIH DLEP NILRDDSG+LK
Sbjct: 243 KGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLK 302
Query: 294 VADFGVSKLL----TVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
VADFGVSKLL TVK+DRP+ TC D+S RY+APEV++NEEYDTKVDVFSFALILQE+
Sbjct: 303 VADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEM 361
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 180/354 (50%), Positives = 238/354 (67%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPE-----FRLMFLANERDVEGIKELLD 61
+R + +QSSL P R ++ + DD+ PE +L+F+A++ DV GI+ELLD
Sbjct: 42 MRFSFGRQSSLDPIRRSPDSSKS--DDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLD 99
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
GIDVN D+D RTALH+AAC+G VV LL R A++D +DRWGST DA YY N +V
Sbjct: 100 EGIDVNSIDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDV 159
Query: 122 IKLLEKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQV 178
LL+ GAK P PM V + REVPEYE++P E+ S I+KG + +A W G +V
Sbjct: 160 YNLLKARGAKVPKTRKTPMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRV 219
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
+VK L ++ SD +R+ AFR EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL
Sbjct: 220 SVKILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLS 279
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+L++KG L PS A+RFALDIARGMNYLHE KP PIIH DL+P NIL D G LK++ FG
Sbjct: 280 VYLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFG 339
Query: 299 VSKLLTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ +L + +D+ D S Y+APEV+K+E +D +VD SF +IL E+
Sbjct: 340 MIRLSKISQDKAKVANHKAHIDLSNYYIAPEVYKDEIFDLRVDAHSFGVILYEI 393
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
Identities = 170/350 (48%), Positives = 232/350 (66%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R + NG + + +L+F+A DVEG+++LLD GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPDGS-NGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGID 100
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+AAC+G +VV LLL R A++D +DRWGST DA YY N +V +L
Sbjct: 101 VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNIL 160
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + REVPEYE++P EL + I+KG + +A W G +V+VK
Sbjct: 161 KARGAKVPKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKI 220
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
L +++ D D + AF+ EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL ++L+
Sbjct: 221 LDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQ 280
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
+KG L P+ +RFALDIARGMNYLHE KP P+IH DL+P NI+ D G+LKVA FG+
Sbjct: 281 KKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISF 340
Query: 303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ D+ D S +APEV+K+E +D VD +SF ++L E+
Sbjct: 341 AKLSSDKSKILNHGAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYEM 390
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 6.6e-81, P = 6.6e-81
Identities = 174/350 (49%), Positives = 230/350 (65%)
Query: 7 VRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R E+ E + +L+F+A++ DV G++ELL+ GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPESLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGID 101
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+A+C+G +VV +LL R A++D +DRWGST DA YY N EV LL
Sbjct: 102 VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLL 161
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + +EVPEYE++P EL I+KGT+ +A W G +V+VK
Sbjct: 162 KARGAKAPKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKI 221
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
++ SD +RV AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E PKGDL +L+
Sbjct: 222 FDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQ 281
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
+KG L PS A+RFALDIARGMNYLHE KP PIIH +L P NIL D G LK++ FG+ KL
Sbjct: 282 KKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKL 341
Query: 303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ ED D S Y+APE++K+E +D + DV SF +IL E+
Sbjct: 342 SKIGEDSAKVVNHEAQIDKSNYYIAPEIYKDEVFDKRADVHSFGVILYEL 391
|
|
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 701 (251.8 bits), Expect = 3.8e-69, P = 3.8e-69
Identities = 158/323 (48%), Positives = 216/323 (66%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+++ A++ D +++LL+ V+ RD D RT LHVA+ G+ +VV LLE GADV+ +
Sbjct: 41 ILWHAHQNDAAAVRKLLEEDPTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQ 100
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH--AREVP-------EYEIDPH 153
DRW +TPL DA + ++I+LL+ HG L + H + VP ++EI+P
Sbjct: 101 DRWKNTPLADAEGARKQKMIELLKSHGG--LSYGQNGSHFEPKPVPPPIPKKCDWEIEPA 158
Query: 154 ELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRV-RAFRDELALLQKIRH 209
ELDF+N+ I KG+F + A+WRG VAVK++ +SDD V + FR E+ LL K+RH
Sbjct: 159 ELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPS-LSDDRLVIQDFRHEVDLLVKLRH 217
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+VQFLGAVT+ P+M++TEYL GDL +LK KG L P+TAV FALDIARGM YLH N
Sbjct: 218 PNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLH-N 276
Query: 270 KPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDRP---LTCQDTSCRYVAPE 324
+P IIHRDL+P N+L +S +LKV DFG+SKL+ V+ +T + S RY+APE
Sbjct: 277 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 336
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
VFK+ YD KVDVFSFA+IL E+
Sbjct: 337 VFKHRRYDKKVDVFSFAMILYEM 359
|
|
| WB|WBGene00016030 C24A1.3 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 7.8e-36, Sum P(2) = 7.8e-36
Identities = 81/203 (39%), Positives = 116/203 (57%)
Query: 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
E++F S I G+F + +RG VAVK+ E+++L ++ HP
Sbjct: 515 EIEFQES--IGSGSFGKVYKGTYRGKLVAVKRYRAMAFGCKSETDMLCREVSILSRLAHP 572
Query: 211 NVVQFLG-AVTQSSPMMIVTEYLPKGDL--RAFLKRKG--ALKPSTAVRFALDIARGMNY 265
NVV F+G ++ S I+TE++ G L R +RK + P+ +R +LD+ARGM Y
Sbjct: 573 NVVAFVGTSLDDPSQFAIITEFVENGSLFRRENGERKNYRVMDPAFRLRISLDVARGMRY 632
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LHE+ P+IHRDL NIL G VADFG S+ + +ED LT Q + R++APEV
Sbjct: 633 LHESAAKPVIHRDLNSHNILIHADGRSVVADFGESRFVCQREDENLTKQPGNLRWMAPEV 692
Query: 326 FKNE-EYDTKVDVFSFALILQEV 347
F +YD KVDVFSFAL++ E+
Sbjct: 693 FSQSGKYDRKVDVFSFALVIWEI 715
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 375 (137.1 bits), Expect = 1.5e-34, P = 1.5e-34
Identities = 101/270 (37%), Positives = 162/270 (60%)
Query: 98 DVDPKDRWGSTP---LGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHARE-VPE-YEI 150
DV D W L DA+ + E++KL ++ G+K H K + E +P EI
Sbjct: 215 DVFVVDGWSQEETDGLRDAL---SKEILKLKDQPGSKQKSISFFEHDKSSNELIPACIEI 271
Query: 151 -----DPHELDFTN-SVE--ITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFR 198
D E+D T +E + G++ RG +VA+K L + ++++ +R F
Sbjct: 272 PTDGTDEWEIDVTQLKIEKKVASGSYG-DLHRGTYCSQEVAIKFLKPDRVNNE-MLREFS 329
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E+ +++K+RH NVVQFLGA T+S + IVTE++ +G + FL K+K A K T ++ AL
Sbjct: 330 QEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVAL 389
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
D+A+GM+YLH+N IIHRDL+ +N+L D+ G +KVADFGV+++ E +T + +
Sbjct: 390 DVAKGMSYLHQNN---IIHRDLKTANLLMDEHGLVKVADFGVARVQI--ESGVMTAETGT 444
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
R++APEV +++ Y+ K DVFS+A++L E+
Sbjct: 445 YRWMAPEVIEHKPYNHKADVFSYAIVLWEL 474
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 373 (136.4 bits), Expect = 4.2e-34, P = 4.2e-34
Identities = 81/203 (39%), Positives = 131/203 (64%)
Query: 147 EYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
E+EID +L V + G + +VA+K L E ++ + +R F E+ +++
Sbjct: 284 EWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAE-MLREFSQEVYIMR 342
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
K+RH NVVQF+GA T+S + IVTE++ +G + FL K KG K + ++ ALD+++GMN
Sbjct: 343 KVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMN 402
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH+N IIHRDL+ +N+L D+ +KVADFGV+++ T E +T + + R++APE
Sbjct: 403 YLHQNN---IIHRDLKTANLLMDEHEVVKVADFGVARVQT--ESGVMTAETGTYRWMAPE 457
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
V +++ YD + DVFS+A++L E+
Sbjct: 458 VIEHKPYDHRADVFSYAIVLWEL 480
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 366 (133.9 bits), Expect = 9.7e-33, P = 9.7e-33
Identities = 84/204 (41%), Positives = 125/204 (61%)
Query: 147 EYEIDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+YEI +L + + + GT W G VAVK ++ S++ + +F+ E++L++
Sbjct: 479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEI-ITSFKQEVSLMK 537
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMN 264
++RHPNV+ F+GAV + IVTE+LP+G L L+R K L + A DIARGMN
Sbjct: 538 RLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMN 597
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-RYVAP 323
YLH P PIIHRDL+ SN+L D + +KVADFG+S+ +K + LT +++AP
Sbjct: 598 YLHHCSP-PIIHRDLKSSNLLVDRNWTVKVADFGLSR---IKHETYLTTNGRGTPQWMAP 653
Query: 324 EVFKNEEYDTKVDVFSFALILQEV 347
EV +NE D K DV+SF ++L E+
Sbjct: 654 EVLRNEAADEKSDVYSFGVVLWEL 677
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.2537.1 | hypothetical protein (423 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 352 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-43 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-36 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-34 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-33 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-23 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 7e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-15 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 4e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 6e-09 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 7e-09 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 9e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 1e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 4e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 4e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 3e-07 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 4e-07 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 9e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 2e-06 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 2e-06 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 3e-06 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 4e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 5e-05 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 6e-05 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-05 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 6e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 0.001 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 0.001 | |
| PHA02946 | 446 | PHA02946, PHA02946, ankyin-like protein; Provision | 0.001 | |
| TIGR00870 | 743 | TIGR00870, trp, transient-receptor-potential calci | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| PHA02736 | 154 | PHA02736, PHA02736, Viral ankyrin protein; Provisi | 0.001 | |
| PHA02716 | 764 | PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provi | 0.002 | |
| PHA02798 | 489 | PHA02798, PHA02798, ankyrin-like protein; Provisio | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 7e-51
Identities = 65/183 (35%), Positives = 103/183 (56%), Gaps = 20/183 (10%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ ++VAVK L E+ + + ++ F E +++K+ HPNVV+ LG T+ P+ IV EY+
Sbjct: 26 KKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYM 83
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
GDL ++L K + L S + FAL IARGM YL IHRDL N L ++
Sbjct: 84 EGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV 140
Query: 292 LKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K++DFG+S+ L + P+ R++APE K ++ +K DV+SF ++L
Sbjct: 141 VKISDFGLSRDLYDDDYYRKRGGKLPI-------RWMAPESLKEGKFTSKSDVWSFGVLL 193
Query: 345 QEV 347
E+
Sbjct: 194 WEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 3e-50
Identities = 64/200 (32%), Positives = 109/200 (54%), Gaps = 22/200 (11%)
Query: 162 EITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
++ +G F +G +VAVK L E + ++ F +E ++++K+ HPN+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNI 63
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKP 271
V+ LG TQ P+ IVTEY+P GDL FL++ G L ++ AL IA+GM YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFK 327
+HRDL N L ++ +K++DFG+S+ + + + +++APE K
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY---YRKRGGGKLPIKWMAPESLK 177
Query: 328 NEEYDTKVDVFSFALILQEV 347
+ ++ +K DV+SF ++L E+
Sbjct: 178 DGKFTSKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-50
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 27/197 (13%)
Query: 166 GTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
G +G ++VAVK L E+ + + ++ F E +++K+ HPN+V+ LG
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVC 70
Query: 220 TQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
T+ P+MIV EY+P GDL +L+ R L S + FAL IARGM YL IHR
Sbjct: 71 TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHR 127
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEE 330
DL N L ++ +K++DFG+S+ L + P+ R++APE K +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-------RWMAPESLKEGK 180
Query: 331 YDTKVDVFSFALILQEV 347
+ +K DV+SF ++L E+
Sbjct: 181 FTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-48
Identities = 67/190 (35%), Positives = 98/190 (51%), Gaps = 14/190 (7%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ +G F LA + G +VA+K + + + E+ +L+K+ HPN+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EY G L+ LK L +R L I G+ YLH N IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 277 RDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTK 334
RDL+P NIL D+G +K+ADFG+SKLLT + T T Y+APEV + Y K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-AYMAPEVLLGKGYYSEK 174
Query: 335 VDVFSFALIL 344
D++S +IL
Sbjct: 175 SDIWSLGVIL 184
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 74/197 (37%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 157 FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
+ ++ G+F A + G VAVK L + A R E+ +L+++ HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP 271
+V+ + A + +V EY GDL +L R G L A + AL I RG+ YLH N
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEE 330
IIHRDL+P NIL D++G +K+ADFG++K L K LT + Y+APEV
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 331 YDTKVDVFSFALILQEV 347
Y KVDV+S +IL E+
Sbjct: 176 YGPKVDVWSLGVILYEL 192
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 21/199 (10%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ KG + +VAVK L E+ + ++ + F E +++K+ HPNVV+ LG T+
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 222 SSPMMIVTEYLPKGDLRAFLKR---------KGALKPSTAVRFALDIARGMNYLHENKPV 272
P+ +V EY+ GDL +L++ K L + FA+ IA+GM YL K
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKN 328
+HRDL N L + +K++DFG+S+ + + + T R++APE K+
Sbjct: 126 -FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWMAPESLKD 181
Query: 329 EEYDTKVDVFSFALILQEV 347
+ +K DV+SF ++L E+
Sbjct: 182 GIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-47
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 18/193 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G+F LA + G VA+K + ++ I D E+ +L+K++HPN+V+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLY 63
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +V EY GDL LK++G L A + I + YLH I+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+P NIL D+ G++K+ADFG+++ L E T Y+APEV + Y
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL-----TTFVGTPEYMAPEVLLGKGYGK 175
Query: 334 KVDVFSFALILQE 346
VD++S +IL E
Sbjct: 176 AVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 9e-43
Identities = 53/167 (31%), Positives = 87/167 (52%), Gaps = 9/167 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM--IVTEYLPKG 235
+AVK + E ++ + A E+ +L ++HPN+V++ G+ I EY+ G
Sbjct: 28 MAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
L + LK+ G L ++ I G+ YLH N I+HRD++ +NIL D G +K+A
Sbjct: 87 SLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLA 143
Query: 296 DFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
DFG +K L + + + T ++APEV + EEY D++S
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTP-YWMAPEVIRGEEYGRAADIWSL 189
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 73/208 (35%), Positives = 116/208 (55%), Gaps = 24/208 (11%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ I+ EL + I KG F +L +RG +VAVK L ++ + +AF E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARG 262
+RHPN+VQ LG V Q +P+ IVTEY+ KG L +L+ +G + + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CR 319
M YL E +HRDL N+L + KV+DFG++K + QD+ +
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-------QDSGKLPVK 164
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ APE + +++ TK DV+SF ++L E+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 76/205 (37%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F E+ G F L WRG I VA+K + E +S+DD F +E ++
Sbjct: 1 IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HPN+VQ G T+ P+ IVTEY+ G L +L+ RKG L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS--CRYVA 322
YL N IHRDL N L + +KV+DFG+++ V +D+ + Q T ++
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP 169
Query: 323 PEVFKNEEYDTKVDVFSFALILQEV 347
PEVF + +K DV+SF +++ EV
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F +I KG F A + G +VA+K + E +++ E+ +L+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHEN 269
N+V++ G+ + + IV E+ G L+ LK L S ++ +G+ YLH N
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
IIHRD++ +NIL G +K+ DFG+S L+ + R +T ++APEV
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-----NTMVGTPYWMAPEVI 169
Query: 327 KNEEYDTKVDVFSFALILQE 346
+ YD K D++S + E
Sbjct: 170 NGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
I+P EL F E+ G F L WR I+VA+K + E +S++D F +E ++
Sbjct: 1 INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HP +VQ G TQ P+ IVTE++ G L +L+ R+G L + D+ GM
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL N IHRDL N L +G +KV+DFG+++ + E + ++ PE
Sbjct: 115 YLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
VF +Y +K DV+SF +++ EV
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI-----QVAVKKLGEEVISDDDRVRAFRDELALL 204
I P EL EI G F L W G +VA+K + E +S++D F +E ++
Sbjct: 1 IHPSELTL--VQEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +VQ G T+ SP+ +V E++ G L +L+ ++G T + LD+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
YL + +IHRDL N L ++ +KV+DFG+++ + + T ++ +P
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 324 EVFKNEEYDTKVDVFSFALILQEV 347
EVF +Y +K DV+SF +++ EV
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 59/182 (32%), Positives = 97/182 (53%), Gaps = 17/182 (9%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G ++AVK++ + S + + V A E+ LL+ ++H +VQ+ G + + I EY+
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
P G ++ LK GAL + ++ I G+ YLH N I+HRD++ +NILRD +GN+
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQ 345
K+ DFG SK L + + T + +++PEV E Y K DV+S +
Sbjct: 144 KLGDFGASKRL-----QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198
Query: 346 EV 347
E+
Sbjct: 199 EM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 53/176 (30%), Positives = 93/176 (52%), Gaps = 9/176 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +K++ +S+ +R A E+ +L+K+ HPN++++ + + + IV EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 235 GDLRAFLKRKGALKPSTAVRFALD----IARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
GDL +K++ LD + + YLH K I+HRD++P NI +G
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNG 140
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+K+ DFG+SK+L+ D T T Y++PE+ +N+ Y+ K D++S +L E
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVVGTPY-YLSPELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 16/178 (8%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK+ EE I A R E++LL++++HPN+V+ L + + +V E
Sbjct: 24 GEIVALKKIRLDNEEEGIP----STALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78
Query: 231 YLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
Y DL+ +L KR G L P+ + RG+ Y H ++ I+HRDL+P NIL +
Sbjct: 79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD 134
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
G LK+ADFG+++ + R T + + Y APE+ ++ Y T VD++S I E
Sbjct: 135 GVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 22/211 (10%)
Query: 152 PHELDFTNSVEITKGTFILAF---WRG-IQVAVKKLGEEVISDDDRVRA--FRDELALLQ 205
P E +FT ++ G F + W+ ++VA+K ++ DD ++ F+ E+ L+
Sbjct: 4 PRE-EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-----ILKSDDLLKQQDFQKEVQALK 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGM 263
++RH +++ + P+ I+TE + KG L AFL+ L ++ + A +A GM
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYV 321
YL E IHRDL NIL + KVADFG+++L+ KED L+ D ++
Sbjct: 118 AYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLS-SDKKIPYKWT 171
Query: 322 APEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352
APE + + TK DV+SF ++L E+ Y Q
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 60/174 (34%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G A+KK+ V D++ + EL L+ P VV+ GA + + IV EY+
Sbjct: 24 PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
G L LK+ G + A I +G++YLH + IIHRD++PSN+L + G +
Sbjct: 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEV 139
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
K+ADFG+SK+L D+ T T Y++PE + E Y D++S L L E
Sbjct: 140 KIADFGISKVLENTLDQCNTFVGT-VTYMSPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 66/194 (34%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 162 EITKGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VAVK L +S AF E +++K+RH +VQ +
Sbjct: 21 EVWMGT-----WNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ P+ IVTEY+ KG L FLK L+ V A IA GM YL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L NIL ++ K+ADFG+++L+ E ++ APE + K DV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 339 SFALILQEVKFYNQ 352
SF ++L E+ Y +
Sbjct: 189 SFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 57/171 (33%), Positives = 88/171 (51%), Gaps = 10/171 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ I V E +L +I HP +V+ A + +V EY P G+L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L ++G A +A +I + YLH II+RDL+P NIL D G++K+ DFG
Sbjct: 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFG 138
Query: 299 VSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALILQE 346
++K L+ + R +T C Y+APEV + Y VD +S ++L E
Sbjct: 139 LAKELSSEGSRT----NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 59/187 (31%), Positives = 97/187 (51%), Gaps = 17/187 (9%)
Query: 171 AFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
W+ + VAVK L E+ + V F E A++++I+HPN+VQ LG T+ P I+
Sbjct: 25 GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80
Query: 229 TEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
TE++ G+L +L+ + + + A I+ M YL + IHRDL N L
Sbjct: 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLV 137
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALI 343
++ +KVADFG+S+L+T T + ++ APE ++ K DV++F ++
Sbjct: 138 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194
Query: 344 LQEVKFY 350
L E+ Y
Sbjct: 195 LWEIATY 201
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WRG VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
K+ H +VQ G T+ P+ IVTEY+ G L +L+ G +PS + D+ GM
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL + IHRDL N L DD G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
V ++ +K DV++F +++ EV
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 60/178 (33%), Positives = 91/178 (51%), Gaps = 13/178 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VAVK + D R F E +L++ HPN+V+ +G Q P+ IV E +P
Sbjct: 19 NTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L FL++K L ++ +LD A GM YL E+K IHRDL N L ++ LK
Sbjct: 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNC--IHRDLAARNCLVGENNVLK 133
Query: 294 VADFGVSKLLTVKEDRPLTCQD----TSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++DFG+S+ +E T D ++ APE Y ++ DV+S+ ++L E
Sbjct: 134 ISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 67/186 (36%), Positives = 102/186 (54%), Gaps = 18/186 (9%)
Query: 175 GIQVAVKK--LGEEVISDDDRVRAFRD----ELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
G +AVK+ L S DR R+ D E+ALL++++H N+VQ+LG+ + + I
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
EY+P G + A L GA + + F I +G+NYLH IIHRD++ +NIL D+
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141
Query: 289 SGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
G +K++DFG+SK L RP + Q S ++APEV K Y K D++S
Sbjct: 142 KGGIKISDFGISKKLEANSLSTKTNGARP-SLQG-SVFWMAPEVVKQTSYTRKADIWSLG 199
Query: 342 LILQEV 347
++ E+
Sbjct: 200 CLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 67/193 (34%), Positives = 98/193 (50%), Gaps = 7/193 (3%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L + I VA+K L + SD R F E +++ + HPN+++ G VT+
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQR-LDFLTEASIMGQFDHPNIIRLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TEY+ G L FL+ G V IA GM YL E V HRDL
Sbjct: 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL + + KV+DFG+S+ L E T R+ APE ++ + DV+S
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193
Query: 340 FALILQEVKFYNQ 352
F +++ EV Y +
Sbjct: 194 FGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 24/194 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA- 218
I KG F +L +RG +VAVK I +D +AF E +++ ++RH N+VQ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
V + + IVTEY+ KG L +L+ +G L ++F+LD+ M YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
RDL N+L + KV+DFG++K + + QDT ++ APE + +++ T
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFST 178
Query: 334 KVDVFSFALILQEV 347
K DV+SF ++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 55/190 (28%), Positives = 100/190 (52%), Gaps = 12/190 (6%)
Query: 156 DFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
++ I +G F ++G+ VA+K++ E I ++ +++ E+ LL+ ++H
Sbjct: 1 NYQLGDLIGRGAFG-VVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKH 58
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V+++G++ S + I+ EY G LR +K+ G S + + +G+ YLHE
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
+IHRD++ +NIL G +K+ADFGV+ L + T ++APEV +
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTP-YWMAPEVIEMS 174
Query: 330 EYDTKVDVFS 339
T D++S
Sbjct: 175 GASTASDIWS 184
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-28
Identities = 61/182 (33%), Positives = 102/182 (56%), Gaps = 15/182 (8%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ G +VAVK I D +AF +E A++ K+ H N+V+ LG + + + IV E +
Sbjct: 27 YTGQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80
Query: 233 PKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
KG+L FL+ +G S ++F+LD+A GM YL K ++HRDL NIL + G
Sbjct: 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350
KV+DFG++++ + ++ APE K++++ +K DV+S+ ++L EV Y
Sbjct: 138 VAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193
Query: 351 NQ 352
+
Sbjct: 194 GR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 58/186 (31%), Positives = 95/186 (51%), Gaps = 28/186 (15%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIV 228
G QVAVK L E+ SD F E+ +L+ + H N+V++ G + + ++
Sbjct: 33 GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
EYLP G LR +L+R + + + F+ I +GM+YL + IHRDL NIL +
Sbjct: 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE 143
Query: 288 DSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
+K++DFG++K+L VKE ++ + APE + ++ + DV+SF
Sbjct: 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPG-----ESPIFWYAPECLRTSKFSSASDVWSF 198
Query: 341 ALILQE 346
+ L E
Sbjct: 199 GVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 8/164 (4%)
Query: 179 AVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK L ++ + + V+ E+ALL K++HPN+VQ+LG + + I E +P G
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L LK+ G+ + I G+ YLH+ +HRD++ +NIL D +G +K+AD
Sbjct: 89 LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD 145
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFS 339
FG++K V E S ++APEV + Y D++S
Sbjct: 146 FGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 156 DFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NV 212
+ ++ +G+F + VA+K L +++ S V F E+ +L + HP N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFALDIARGMNYLHEN 269
V+ + +V EY+ G L LK RKG L S A+ I + YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 270 KPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT-----VKEDRPLTCQDTSCRYVAP 323
IIHRD++P NIL D G +K+ DFG++KLL + + Y+AP
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 324 EVFK---NEEYDTKVDVFSFALILQE 346
EV + D++S + L E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYE 203
|
Length = 384 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 51/161 (31%), Positives = 91/161 (56%), Gaps = 7/161 (4%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
++ V A R E+ L+ ++ HP++++ LGA + S + E++ G + L + GA K +
Sbjct: 44 EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA 103
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDR 309
+ + + RG++YLHEN+ IIHRD++ +N+L D +G L++ADFG + L K
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 310 PLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
Q + ++APEV + E+Y DV+S ++ E+
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 57/176 (32%), Positives = 89/176 (50%), Gaps = 10/176 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + + + ++V E +L + + P VV+ + + +V EYLP GDL
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L+ G+L A + +I + YLH N IIHRDL+P NIL D +G+LK+ DF
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDF 137
Query: 298 GVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQE 346
G+SK+ V+ L + + Y+APEV + + VD +S IL E
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 56/185 (30%), Positives = 97/185 (52%), Gaps = 16/185 (8%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K + E S +R F +E +++++ +VV+ LG V+ P ++V E +
Sbjct: 35 PETRVAIKTVNENA-SMRER-IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92
Query: 234 KGDLRAFLKRK-------GALKPSTAVRF---ALDIARGMNYLHENKPVPIIHRDLEPSN 283
KGDL+++L+ + L P T +F A +IA GM YL K +HRDL N
Sbjct: 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149
Query: 284 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+ + +K+ DFG+++ + + R R++APE K+ + TK DV+SF +
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209
Query: 343 ILQEV 347
+L E+
Sbjct: 210 VLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 54/172 (31%), Positives = 90/172 (52%), Gaps = 11/172 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K++ +S +R A +E+ +L + HPN++ + A + + IV EY P GDL
Sbjct: 29 ALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS 87
Query: 239 AFLKRKGALK---PSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ ++ + P + R + + RG+ LHE K I+HRDL+ +NIL + +K+
Sbjct: 88 KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKI 144
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
D G+SK+L Q + Y+APEV+K Y K D++S +L E
Sbjct: 145 GDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 153 HELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
EL N + KG +++ + ++VAVK L +E I+ + F E +++ ++ HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
V+ +G V + P+M+V E P G L +LK++ + S A +A GM YL V
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEE 330
HRDL N+L + K++DFG+S+ L D R T ++ APE +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 331 YDTKVDVFSFALILQEVKFYNQ 352
+ +K DV+S+ + L E Y
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGA 196
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 67/193 (34%), Positives = 102/193 (52%), Gaps = 18/193 (9%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
N E+ KGT VAVK E+ + + +++ F E +L++ HPN+V+ +G
Sbjct: 7 NFGEVFKGTL----KDKTPVAVKTCKED-LPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 219 VTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
TQ P+ IV E +P GD +FL K+K LK V+FALD A GM YL IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDT 333
DL N L ++ LK++DFG+S+ +ED + + ++ APE Y +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 334 KVDVFSFALILQE 346
+ DV+S+ ++L E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 14/187 (7%)
Query: 173 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
W G+ VAVK L + D F E +++K+RHP ++Q T P+ I
Sbjct: 23 WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78
Query: 228 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
VTE + G L +L+ ALK + A +A GM YL IHRDL N+L
Sbjct: 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVL 135
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
++ KVADFG+++++ ++ APE + K DV+SF ++L
Sbjct: 136 VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLT 195
Query: 346 EVKFYNQ 352
E+ Y +
Sbjct: 196 EIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MIVTEY+ G L AFL++ G V IA GM YL + + +HRDL
Sbjct: 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
NIL + + KV+DFG+S++L ED P T R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 336 DVFSFALILQEVKFYNQ 352
DV+S+ +++ EV Y +
Sbjct: 191 DVWSYGIVMWEVMSYGE 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 57/175 (32%), Positives = 93/175 (53%), Gaps = 7/175 (4%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G VA+KK+ + +A R E+ LQ +HP VV+ L S ++V EY+P
Sbjct: 24 TGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 234 KGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL L+ + L + + + +G+ Y+H N I+HRDL+P+N+L G L
Sbjct: 83 -SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVL 138
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
K+ADFG+++L + +E R + Q + Y APE+ + +YD VD+++ I E
Sbjct: 139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 5/168 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + VR +E +LQ++ HP +V + M +V + L GDLR
Sbjct: 29 AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K + +I + YLH IIHRD++P NIL D+ G++ + DF
Sbjct: 89 YHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
++ +T D T + Y+APEV + Y VD +S + E
Sbjct: 146 IATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYE 191
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 51/171 (29%), Positives = 90/171 (52%), Gaps = 8/171 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK+ S+ A R E+ LL+++ HPN+++ L + +V E++ DL
Sbjct: 27 VAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDL 84
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+K + P + ++ + + +G+ + H + I+HRDL+P N+L + G LK+AD
Sbjct: 85 YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
FG+++ RP T + Y APE+ ++ Y T VD++S I E
Sbjct: 142 FGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-24
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 16/199 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TE++ G L +FL++ G V IA GM YL E + +HRDL
Sbjct: 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-------RYVAPEVFKNEEYDT 333
NIL + + KV+DFG+S+ L ED TS R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190
Query: 334 KVDVFSFALILQEVKFYNQ 352
DV+S+ +++ EV Y +
Sbjct: 191 ASDVWSYGIVMWEVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 64/178 (35%), Positives = 95/178 (53%), Gaps = 13/178 (7%)
Query: 175 GIQVAVKK--LGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK LGE + D + A R E+ LLQ+++HPN++ L S + +V E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82
Query: 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
++ DL +K K L P+ + L RG+ YLH N I+HRDL+P+N+L
Sbjct: 83 FME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD 138
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
G LK+ADFG+++ +R +T Q + Y APE+ F Y VD++S I E
Sbjct: 139 GVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 53/150 (35%), Positives = 76/150 (50%), Gaps = 8/150 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
EL +L K P +V F GA + + I EY+ G L LK +G + + A+
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ +G+ YLHE IIHRD++PSNIL + G +K+ DFGVS L T
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKT--FVGT 162
Query: 319 R-YVAPEVFKNEEYDTKVDVFSFALILQEV 347
Y+APE + +Y K D++S L L E+
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-24
Identities = 54/154 (35%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
EL + + + P +V++ GA SS + I EY G L + K+ +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 258 DIA----RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
IA +G++YLH K IIHRD++PSNIL G +K+ DFGVS L T
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
TS Y+APE + + Y DV+S L L EV
Sbjct: 165 -GTS-FYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 9e-24
Identities = 57/163 (34%), Positives = 87/163 (53%), Gaps = 17/163 (10%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ ++H +VQ+ G + + + I EY+P G ++ LK GAL S
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
++ I GM+YLH N I+HRD++ +NILRD +GN+K+ DFG SK L + +
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTI 159
Query: 312 TCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEV 347
T R +++PEV E Y K DV+S + E+
Sbjct: 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-24
Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 179 AVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK E I D+D ++ DE+ +L+ ++HPN+V++ G + I EY G
Sbjct: 29 AVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L L+ L + L + G+ YLH + I+HRD++P+NI D +G +K+ D
Sbjct: 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTK---VDVFS 339
FG + L + + Y+APEV + D++S
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 52/174 (29%), Positives = 93/174 (53%), Gaps = 8/174 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L EE + + DE ++ + HP+VV+ LG + SS + ++T+ +P G
Sbjct: 37 IPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GM+YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKI 150
Query: 295 ADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG++KLL V E +++A E + Y K DV+S+ + + E+
Sbjct: 151 TDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-23
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 162 EITKGT-FILAFWRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
++ K T F L G VAVK L E + +R E LL+++ HP+V++ GA
Sbjct: 15 KVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPS------------------------TAVRF 255
+Q P++++ EY G LR+FL+ + PS + F
Sbjct: 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
A I+RGM YL E K ++HRDL N+L + +K++DFG+S+ + ++ +
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 316 -TSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++A E + Y T+ DV+SF ++L E+
Sbjct: 190 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 36/199 (18%)
Query: 176 IQVAVKKLGE--EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VA+K L E E + FR E L+ ++HPN+V LG T+ P ++ EYL
Sbjct: 36 TSVAIKTLKENAEPKVQQE----FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91
Query: 234 KGDLRAFLKR----------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
GDL FL R K +L S + A+ IA GM YL + +HR
Sbjct: 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
DL N L + +K++DFG+S+ + V+ L R++ PE ++
Sbjct: 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-----PVRWMPPEAILYGKF 203
Query: 332 DTKVDVFSFALILQEVKFY 350
T+ D++SF ++L E+ Y
Sbjct: 204 TTESDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 5/170 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E +D + A R E+ +L+++RH N+V A + + +V EY+ + L
Sbjct: 29 VAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
G L P + + + + Y H + IIHRD++P NIL +SG LK+ DF
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQE 346
G ++ L + PLT + Y APE+ + Y VDV++ I+ E
Sbjct: 145 GFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 32/198 (16%)
Query: 157 FTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
FT I KG+F + + I VA+K + E +D + + E+ L + R P
Sbjct: 3 FTLLECIGKGSFGEVY-KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSP 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ ++ G+ + S + I+ EY G LK G L + ++ G+ YLHE
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------YV 321
IHRD++ +NIL + G++K+ADFGVS LT T + ++
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT----------STMSKRNTFVGTPFWM 165
Query: 322 APEVFKNEEYDTKVDVFS 339
APEV K YD K D++S
Sbjct: 166 APEVIKQSGYDEKADIWS 183
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 28/190 (14%)
Query: 176 IQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
I VAVK L + +SD DD F E A++ + H N+++ G V P+M+VTE P
Sbjct: 24 IPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78
Query: 234 KGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G L L+ G ST +A+ IA GM YL + IHRDL NIL
Sbjct: 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDK 135
Query: 292 LKVADFGVSKLLTVKEDR---------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG+ + L ED P + APE + + DV+ F +
Sbjct: 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFA-------WCAPESLRTRTFSHASDVWMFGV 188
Query: 343 ILQEVKFYNQ 352
L E+ Y +
Sbjct: 189 TLWEMFTYGE 198
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-23
Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 17/177 (9%)
Query: 178 VAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEY 231
VA+KK + ++++ + A R E+ LLQK+RHPN+V+ VT + +V EY
Sbjct: 27 VALKK----IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
+ DL L S + + G+ YLH N I+HRD++ SNIL ++ G
Sbjct: 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDG 137
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
LK+ADFG+++ T + T + + Y PE+ Y +VD++S IL E
Sbjct: 138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 27/188 (14%)
Query: 177 QVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L + D R F E+ +L ++ PN+ + LG T P+ ++ EY+ G
Sbjct: 48 LVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 236 DLRAFLKR-----------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
DL FL++ +L ST + A IA GM YL V HRDL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNC 161
Query: 285 LRDDSGNLKVADFGVSKLLTVK-----EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
L + +K+ADFG+S+ L + R R++A E ++ TK DV++
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP----LPIRWMAWESVLLGKFTTKSDVWA 217
Query: 340 FALILQEV 347
F + L E+
Sbjct: 218 FGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-23
Identities = 59/179 (32%), Positives = 96/179 (53%), Gaps = 16/179 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K L + +S + AF E L+++++HP +V+ VTQ P+ I+TEY+ G
Sbjct: 32 KVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGS 86
Query: 237 LRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK L + + A IA GM ++ IHRDL +NIL ++ K+
Sbjct: 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350
ADFG+++L+ ED T ++ + ++ APE + K DV+SF ++L E+ Y
Sbjct: 144 ADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTY 199
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-23
Identities = 55/158 (34%), Positives = 87/158 (55%), Gaps = 7/158 (4%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ +RH +VQ+ G + + + I EY+P G ++ LK GAL +
Sbjct: 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV--KEDR 309
R+ I +G++YLH N I+HRD++ +NILRD +GN+K+ DFG SK +
Sbjct: 108 TRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ + +++PEV E Y K DV+S A + E+
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-23
Identities = 48/104 (46%), Positives = 64/104 (61%), Gaps = 5/104 (4%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
N D+DG L A+ +E +K LL++G DVN +D D RT LH+AA G E+
Sbjct: 1 NARDEDGRTP-----LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEI 55
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLE+GADV+ +D+ G+TPL A N +V+KLL KHGA
Sbjct: 56 VKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADV 99
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 60/181 (33%), Positives = 98/181 (54%), Gaps = 15/181 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK L +S V+AF +E L++ ++H +V+ VT+ P+ I+TEY+ KG
Sbjct: 32 KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87
Query: 237 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK G + + F+ IA GM Y+ IHRDL +N+L +S K+
Sbjct: 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 144
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E+ Y
Sbjct: 145 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG 201
Query: 352 Q 352
+
Sbjct: 202 K 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-22
Identities = 42/89 (47%), Positives = 54/89 (60%), Gaps = 2/89 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN D TALH+AA G E+V LLLE GADV+ KD
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G+T L A N E++KLL +HGA
Sbjct: 59 KDGNTALHLAARNGNLEIVKLLLEHGADI 87
|
Length = 91 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 39/198 (19%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VAVK L ++ D + E+ +++ I +H N++ LG TQ P+ +V EY
Sbjct: 43 STVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 235 GDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
G+LR FL+ + L V FA +ARGM +L K IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TSCR----YVAPEVFKNE 329
L N+L + +K+ADFG++ R + D T+ R ++APE +
Sbjct: 158 LAARNVLVTEDHVMKIADFGLA--------RDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209
Query: 330 EYDTKVDVFSFALILQEV 347
Y + DV+SF ++L E+
Sbjct: 210 VYTHQSDVWSFGVLLWEI 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 60/179 (33%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V VK L + D++ FR EL + +K+ H NVV+ LG ++ P ++ EY GDL
Sbjct: 38 VLVKALQK--TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 238 RAFL----KRKGALKP---STAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+ FL + LKP ST + AL IA GM++L + +HRDL N L
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSS 152
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+KV+ +SK + E L R++APE + +++ TK DV+SF +++ EV
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-22
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G + + + VA+K L + ++ R F E +++ + H N+++ G VT+
Sbjct: 20 EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
P MI+TEY+ G L +L+ G V IA GM YL + + +HRDL
Sbjct: 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
NIL + + KV+DFG+S++L ED P TS R+ APE ++ +
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191
Query: 336 DVFSFALILQEVKFYNQ 352
DV+SF +++ EV + +
Sbjct: 192 DVWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 12/162 (7%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D V+A R E+ L+ + H N+VQ+LG T + I EY+P G + + L+ G +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
F + G+ YLH I+HRDL+ N+L D G K++DFG+SK +D
Sbjct: 110 VRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYD 163
Query: 312 TCQDTSCR----YVAPEVFKNEE--YDTKVDVFSFALILQEV 347
Q+ S + ++APEV + Y KVD++S ++ E+
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 45/187 (24%), Positives = 93/187 (49%), Gaps = 7/187 (3%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
++ +G ++ I VAVK + F E ++++ HP++V+ +G +T+
Sbjct: 21 DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 222 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ P+ IV E P G+LR++L K +L ++ + ++ ++ + YL + V HRD+
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
N+L +K+ DFG+S+ L + + +++APE + + DV+ F
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 194
Query: 341 ALILQEV 347
+ + E+
Sbjct: 195 GVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 46/173 (26%), Positives = 87/173 (50%), Gaps = 9/173 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+KK + +E+ +++ +HPN+V + + + +V EY+
Sbjct: 44 GKEVAIKK----MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99
Query: 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L + + + ++ +G+ YLH +IHRD++ NIL G++K
Sbjct: 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+ADFG + LT ++ + + T ++APEV K ++Y KVD++S ++ E
Sbjct: 157 LADFGFAAQLTKEKSKRNSVVGTP-YWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-22
Identities = 56/179 (31%), Positives = 91/179 (50%), Gaps = 9/179 (5%)
Query: 175 GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTE 230
G ++AVK++ E V A E+ LL+ + H +VQ+ G + + I E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
++P G ++ LK GAL + ++ I G++YLH N I+HRD++ +NILRD G
Sbjct: 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143
Query: 291 NLKVADFGVSKLLTV--KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
N+K+ DFG SK L + + +++PEV E Y K D++S + E+
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-21
Identities = 57/193 (29%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 163 ITKGTFILAFWRGIQVAVKK-LGEEVI---SDDDRVRAFRDELALLQKIRH---PNVVQF 215
I +G + A +RG V + + ++I + DD V + E+ALL ++R PN+ ++
Sbjct: 9 IGRGAY-GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
G+ + + I+ EY G +R L + G + ++ + Y+H+ V +I
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VGVI 123
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTK 334
HRD++ +NIL ++GN+K+ DFGV+ LL + T T ++APEV + YDTK
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP-YWMAPEVITEGKYYDTK 182
Query: 335 VDVFSFALILQEV 347
D++S + + E+
Sbjct: 183 ADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 68/192 (35%), Positives = 101/192 (52%), Gaps = 22/192 (11%)
Query: 162 EITKGTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VA+K L +S + AF E +++K+RH +VQ L AV
Sbjct: 21 EVWMGT-----WNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVV 70
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
P+ IVTEY+ KG L FLK + L+ V A IA GM Y+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKV 335
L +NIL ++ KVADFG+++L+ ED T + + ++ APE + K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 336 DVFSFALILQEV 347
DV+SF ++L E+
Sbjct: 185 DVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 59/174 (33%), Positives = 92/174 (52%), Gaps = 10/174 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPK 234
VA+KK+ + D + + R E+ LL +RHPN+V+ V + +V EY +
Sbjct: 34 IVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92
Query: 235 GDLRAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL + L + V+ L + RG+ YLHEN IIHRDL+ SN+L D G LK
Sbjct: 93 -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
+ADFG+++ + +P+T + + Y APE+ Y T +D+++ IL E
Sbjct: 149 IADFGLARTYGLP-AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 68/188 (36%), Positives = 99/188 (52%), Gaps = 17/188 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VAVK L +S + +F +E +++K+RH +VQ L AV P
Sbjct: 20 GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTEY+ KG L FLK ALK V A +A GM Y+ + IHRDL +
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
NIL D K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 340 FALILQEV 347
F ++L E+
Sbjct: 189 FGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 52/173 (30%), Positives = 100/173 (57%), Gaps = 9/173 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V +K++ E ++ D+R+ A ++E +L+ + HPN++++ + +MIV EY P G L
Sbjct: 28 VIIKQIPVEQMTKDERLAA-QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 238 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKV 294
+++++ L T + F + I ++++H I+HRDL+ NIL D +K+
Sbjct: 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG+SK+L+ K + T T C Y++PE+ + + Y+ K D+++ +L E+
Sbjct: 144 GDFGISKILSSKS-KAYTVVGTPC-YISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 57/181 (31%), Positives = 95/181 (52%), Gaps = 21/181 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAF--RDELALLQKIR---HPNVVQFLG-----AVTQSSPMMI 227
VA+KK+ V ++ + R E+ALL+++ HPN+V+ L + + +
Sbjct: 27 VALKKV--RVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83
Query: 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
V E++ + DL +L + K L P T + RG+++LH ++ I+HRDL+P NIL
Sbjct: 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNIL 139
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
G +K+ADFG++++ + + LT + Y APEV Y T VD++S I
Sbjct: 140 VTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197
Query: 346 E 346
E
Sbjct: 198 E 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 3e-21
Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 7/169 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L + I +V +E +LQ IRHP +V G+ S + +V EY+P G+L
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L++ G A +A + + YLH I++RDL+P N+L D G +K+ DF
Sbjct: 89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
G +K + + R T T Y+APE+ ++ Y VD ++ +++ E
Sbjct: 146 GFAKRV---KGRTYTLCGT-PEYLAPEIILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 199 DELALLQKIRHPNVVQFLG--AVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTA 252
E+ +L++++HPN+V++ + + IV EY GDL +++ + ++
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 253 VRFALDIARGMNYLH---ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
R + + H + ++HRDL+P+NI D + N+K+ DFG++K+L
Sbjct: 108 WRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
T T Y++PE + YD K D++S ++ E
Sbjct: 167 AKTYVGTP-YYMSPEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 56/171 (32%), Positives = 88/171 (51%), Gaps = 21/171 (12%)
Query: 178 VAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K VI D + E+++L++ RHPN+V + G+ + + IV EY G
Sbjct: 31 VAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85
Query: 236 DLRAFLKR-KGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L+ + +G L + R L +G+ YLHE IHRD++ +NIL + G+
Sbjct: 86 SLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG---KIHRDIKGANILLTEDGD 139
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFS 339
+K+ADFGVS LT + + T ++APEV E YD K D+++
Sbjct: 140 VKLADFGVSAQLTATIAKRKSFIGTP-YWMAPEVAAVERKGGYDGKCDIWA 189
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-21
Identities = 50/175 (28%), Positives = 97/175 (55%), Gaps = 7/175 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 25 GKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 235 GDLRAFL-KRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL + ++G L P + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTI 140
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
K+ DFG++++L + TC T Y++PE+ +N Y+ K D+++ +L E+
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGTP-YYLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-21
Identities = 61/195 (31%), Positives = 88/195 (45%), Gaps = 30/195 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L E + +D + F E LL +H N+V+F G T+ P ++V EY+ G
Sbjct: 36 ELVAVKTLKE--TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 236 DLRAFLKR--------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
DL FL+ G L S ++ A+ IA GM YL V HRDL
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLAT 150
Query: 282 SNILRDDSGNLKVADFGVSK------LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
N L +K+ DFG+S+ V L R++ PE ++ T+
Sbjct: 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-----PIRWMPPESIMYRKFTTES 205
Query: 336 DVFSFALILQEVKFY 350
DV+SF ++L E+ Y
Sbjct: 206 DVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 9e-21
Identities = 63/186 (33%), Positives = 93/186 (50%), Gaps = 23/186 (12%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K+ +E S++D R F EL +L K+ HPN++ LGA + I EY P G+L
Sbjct: 32 AAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A ++FA D+A GM YL E + IHRDL
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N+L ++ K+ADFG+S+ V + T R++A E Y TK DV+SF
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205
Query: 342 LILQEV 347
++L E+
Sbjct: 206 VLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 23/210 (10%)
Query: 153 HELDFTNS---VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+E ++ + V + KGT+ + + +++A+K++ E D V+ +E+AL
Sbjct: 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALH 59
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKP--STAVRFALDIAR 261
++H N+VQ+LG+ +++ I E +P G L A L+ K G LK T + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDT-SCR 319
G+ YLH+N+ I+HRD++ N+L + SG +K++DFG SK L P T T + +
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQ 174
Query: 320 YVAPEVFKN--EEYDTKVDVFSFALILQEV 347
Y+APEV Y D++S + E+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 58/186 (31%), Positives = 91/186 (48%), Gaps = 17/186 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
+VAVK L ++ S D + F E A +++ HPNV++ +G +S M++
Sbjct: 27 FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 229 TEYLPKGDLRAFL--KRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL FL R G L T VRF +DIA GM YL IHRDL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142
Query: 283 NILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N + +++ + VADFG+S K+ + R +++A E + Y T DV++F
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202
Query: 342 LILQEV 347
+ + E+
Sbjct: 203 VTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF +I KG+F + F A+K++ ++ +R A DE +L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
++++ + + IV EY GDL LK R L RF + I G+ +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
K I+HRD++ N+ D N+K+ D GV+KLL+ + T T Y++PE+ ++
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP-YYLSPELCED 175
Query: 329 EEYDTKVDVFSFALILQE 346
+ Y+ K DV++ ++L E
Sbjct: 176 KPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 60/175 (34%), Positives = 91/175 (52%), Gaps = 15/175 (8%)
Query: 178 VAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK E + D ++A F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 23 VAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79
Query: 237 LRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
FL+ +G LK ++ + A GM YL E+K IHRDL N L + LK++
Sbjct: 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYL-ESKHC--IHRDLAARNCLVTEKNVLKIS 136
Query: 296 DFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
DFG+S+ +ED + ++ APE Y ++ DV+SF ++L E
Sbjct: 137 DFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 14/168 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+K + V D + E+++L++ P +V++ G+ +++ + IV EY
Sbjct: 28 GQVVAIKVV--PVEEDLQEII---KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82
Query: 235 GDLRAFLKRKGALKPSTAVRFAL---DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G + +K K T A +G+ YLH NK IHRD++ NIL ++ G
Sbjct: 83 GSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQ 137
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
K+ADFGVS LT + T T ++APEV + Y+ K D++S
Sbjct: 138 AKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYNNKADIWS 184
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 6/152 (3%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPS-TAVRF 255
R E LL K++HPN+V F + + IV EY GDL +K ++G L P T +++
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
+ + G+ ++HE + ++HRD++ NI +G +K+ DFG ++LLT T
Sbjct: 106 FVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
T YV PE+++N Y+ K D++S IL E+
Sbjct: 163 TP-YYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 42/196 (21%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+QVAVK L E S+ D F E ++ K H N+V+ +G + P I+ E + G
Sbjct: 37 LQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
DL++FL+ R +PS+ + A D+A+G YL EN IHRD+ N L
Sbjct: 95 DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151
Query: 289 SGN---LKVADFGVSK--------------LLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
G K+ADFG+++ +L +K ++ PE F + +
Sbjct: 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-------------WMPPEAFLDGIF 198
Query: 332 DTKVDVFSFALILQEV 347
+K DV+SF ++L E+
Sbjct: 199 TSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 13/182 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL-GAVTQSSPMMIVTEYLP 233
G +VA+K L + ++ + FR E AL ++ HPN+V L + V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
LR L GAL R L + + H I+HRDL+P NI+
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119
Query: 291 NLKVADFGVSKLLT-VKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ KV DFG+ LL V++ T T + Y APE + E D++++ LI
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 345 QE 346
E
Sbjct: 180 LE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 64/189 (33%), Positives = 101/189 (53%), Gaps = 14/189 (7%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSS 223
GT I + + I AVK L I+D + V F E +++ HPNV+ LG ++ S
Sbjct: 14 GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEP 281
P+ +V Y+ GDLR F+ R P+ + F L +A+GM YL K +HRDL
Sbjct: 72 PL-VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
N + D+S +KVADFG+++ + KE T +++A E + +++ TK DV+
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186
Query: 339 SFALILQEV 347
SF ++L E+
Sbjct: 187 SFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 28/196 (14%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L EE + D F+ E AL+ + HPN+V+ LG PM ++ EY+ GDL
Sbjct: 38 VAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95
Query: 238 RAFLKRKGALKPSTAVR----------------------FALDIARGMNYLHENKPVPII 275
FL+ + + A +A GM YL E K +
Sbjct: 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTK 334
HRDL N L ++ +K+ADFG+S+ + + + D R++ PE Y T+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 335 VDVFSFALILQEVKFY 350
DV+++ ++L E+ Y
Sbjct: 213 SDVWAYGVVLWEIFSY 228
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-20
Identities = 39/82 (47%), Positives = 50/82 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A +E +K LL+ G DVN RD D T LH+AA G +VV LLL+ GADV+ +D
Sbjct: 44 LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLL 125
+ G TPL A + EV+KLL
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 60/186 (32%), Positives = 96/186 (51%), Gaps = 27/186 (14%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---PMMIVTEYLPK 234
VAVKKL S + +R F E+ +L+ ++H N+V++ G V S+ + +V EYLP
Sbjct: 36 VAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEYLPY 91
Query: 235 GDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G LR +L K + L + +A I +GM YL + +HRDL NIL + +K
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148
Query: 294 VADFGVSKLL-------TVKE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ DFG++K+L V+E + P+ + APE ++ DV+SF ++L
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIF-------WYAPESLTESKFSVASDVWSFGVVL 201
Query: 345 QEVKFY 350
E+ Y
Sbjct: 202 YELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-20
Identities = 56/186 (30%), Positives = 98/186 (52%), Gaps = 20/186 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYL 232
G QVAVK L E S + + + E+ +L+ + H N+V++ G T+ + + ++ E+L
Sbjct: 33 GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 233 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
P G L+ +L R K + +++A+ I +GM+YL + +HRDL N+L +
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG++K + TVK+D D+ + APE ++ DV+SF + L
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDL-----DSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 345 QEVKFY 350
E+ Y
Sbjct: 203 YELLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-20
Identities = 62/186 (33%), Positives = 91/186 (48%), Gaps = 23/186 (12%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K +E S DD R F EL +L K+ HPN++ LGA + + EY P G+L
Sbjct: 25 AAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A + FA D+ARGM+YL + + IHRDL
Sbjct: 84 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
NIL ++ K+ADFG+S+ V + T R++A E Y T DV+S+
Sbjct: 141 RNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198
Query: 342 LILQEV 347
++L E+
Sbjct: 199 VLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 7/169 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K++ + ++ + VR E +L + +V+ L A + + EY+P GD
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
R L G L A + ++ ++ LHE + IHRDL+P N L D SG++K+ DF
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDF 145
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
G+SK + + + D Y+APEV + + YD VD +S +L E
Sbjct: 146 GLSKGIVTYANSVVGSPD----YMAPEVLRGKGYDFTVDYWSLGCMLYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 57/174 (32%), Positives = 97/174 (55%), Gaps = 13/174 (7%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK+ E ++D+ V A R E++LL+++ HPN+V+ L V + + +V E+L
Sbjct: 27 VALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL- 82
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL+ ++ L P + + +G+ Y H ++ ++HRDL+P N+L D G LK
Sbjct: 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALK 139
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
+ADFG+++ V R T + + Y APE+ + +Y T VD++S I E
Sbjct: 140 LADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-20
Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT I KG+F ++GI K++ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLERIGKGSF-GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P + ++ G+ + + + I+ EYL G LK G L+ + +I +G++YL
Sbjct: 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
H + IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 327 KNEEYDTKVDVFSFALILQEV 347
K YD K D++S + E+
Sbjct: 174 KQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 9e-20
Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 14/175 (8%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K++ E V R E+ + + HPNVV++ + + +V YL
Sbjct: 25 NNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 234 KGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G L +K G L + ++ +G+ YLH N IHRD++ NIL + G
Sbjct: 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDG 139
Query: 291 NLKVADFGVSKLLTVKEDRPL----TCQDTSCRYVAPEVFKNEE-YDTKVDVFSF 340
++K+ADFGVS L DR T T C ++APEV + YD K D++SF
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPC-WMAPEVMEQVHGYDFKADIWSF 193
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 55/169 (32%), Positives = 83/169 (49%), Gaps = 5/169 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L +HP + Q + V EY+ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R G A +A +I G+ +LHE II+RDL+ N+L D G++K+ADF
Sbjct: 84 MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
G+ K + T T Y+APE+ + Y VD ++ ++L E
Sbjct: 141 GMCKEGILGGVTTSTFCGTP-DYIAPEILSYQPYGPAVDWWALGVLLYE 188
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 49/155 (31%), Positives = 87/155 (56%), Gaps = 7/155 (4%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL-KPSTAV 253
A + E+ LL K++HPN+V F + ++ + IV EY GDL + R +G L +
Sbjct: 45 ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLT 312
+ + I+ G+ ++H+ K I+HRD++ NI +G + K+ DFG+++ L + T
Sbjct: 105 SWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
C T Y++PE+ +N Y+ K D++S +L E+
Sbjct: 162 CVGTP-YYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-19
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALL 204
DP EL FT I KG+F F +GI VA+K + E +D + + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVL 56
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
+ P V ++ G+ + + + I+ EYL G L R G +I +G++
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLD 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH K IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APE
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
V + YD+K D++S + E+
Sbjct: 172 VIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 24/189 (12%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ A+K++ E DD R F EL +L K+ HPN++ LGA + + EY P
Sbjct: 35 MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
G+L FL++ L+ P+ A+ FA D+ARGM+YL + + IHRD
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L NIL ++ K+ADFG+S+ V + T R++A E Y T DV+
Sbjct: 150 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 339 SFALILQEV 347
S+ ++L E+
Sbjct: 208 SYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 4e-19
Identities = 61/186 (32%), Positives = 88/186 (47%), Gaps = 25/186 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
G +VA+KK+ D R R E+ LL+ +RH N++ L + SP IVT
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E + DL +K L F I RG+ YLH +IHRDL+PSNIL + +
Sbjct: 84 ELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSN 139
Query: 290 GNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEVFKN-EEYDTKVDVFSF 340
+LK+ DFG+++ + ED LT YV APE+ + Y +D++S
Sbjct: 140 CDLKICDFGLARGVDPDEDEKGFLT------EYVVTRWYRAPELLLSSSRYTKAIDIWSV 193
Query: 341 ALILQE 346
I E
Sbjct: 194 GCIFAE 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-19
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT +I KG+F F +GI +K+ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P V ++ G+ + + + I+ EYL G L+ G L + +I +G++YL
Sbjct: 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
H K IHRD++ +N+L + G +K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 327 KNEEYDTKVDVFSFALILQEV 347
K YD+K D++S + E+
Sbjct: 174 KQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 20/194 (10%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++V+ +DD V R LAL + HP +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHLF 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EYL GDL ++ G + A +A +I G+ +LH+ II+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+ N+L D G++K+ADFG+ K E + T C Y+APE+ K ++Y+
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK----ASTFCGTPDYIAPEILKGQKYNE 175
Query: 334 KVDVFSFALILQEV 347
VD +SF ++L E+
Sbjct: 176 SVDWWSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 59/181 (32%), Positives = 99/181 (54%), Gaps = 16/181 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK + +S V AF E +++ ++H +V+ L AV P+ I+TE++ KG
Sbjct: 32 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 86
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK +G+ +P + F+ IA GM ++ + IHRDL +NIL S K+
Sbjct: 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E+ Y
Sbjct: 144 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200
Query: 352 Q 352
+
Sbjct: 201 R 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 46/149 (30%), Positives = 86/149 (57%), Gaps = 7/149 (4%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+E +L+++ HP +++ + ++ EY+P G+L ++L+ G ST + +A +
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I + YLH + I++RDL+P NIL D G++K+ DFG +K L DR T T
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLCGTP- 162
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
Y+APEV +++ ++ VD ++ +++ E+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-19
Identities = 65/188 (34%), Positives = 96/188 (51%), Gaps = 17/188 (9%)
Query: 166 GTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VA+K L + + AF E +++K+RH +V L AV P
Sbjct: 20 GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTE++ KG L FLK LK V A IA GM Y+ + IHRDL +
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
NIL D+ K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 340 FALILQEV 347
F ++L E+
Sbjct: 189 FGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 46/152 (30%), Positives = 91/152 (59%), Gaps = 9/152 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFA 256
E++L+++++H N+V+ + + +M+V EY+ K DL+ ++ +GAL P+T F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ +G+ + HEN+ ++HRDL+P N+L + G LK+ADFG+++ + + + +
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV 162
Query: 317 SCRYVAPEVF-KNEEYDTKVDVFSFALILQEV 347
+ Y AP+V + Y T +D++S I+ E+
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEM 194
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-19
Identities = 47/174 (27%), Positives = 88/174 (50%), Gaps = 11/174 (6%)
Query: 174 RGIQVAVKKLG---EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
+G +AVK++ V++ + ++E+ LL+ ++H N+VQ+LG + + I E
Sbjct: 23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
++P G + + L R G L ++ I G+ YLH N ++HRD++ +N++ +G
Sbjct: 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNG 139
Query: 291 NLKVADFGVSKLL-----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
+K+ DFG ++ L L + ++APEV Y K D++S
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWS 193
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-19
Identities = 64/203 (31%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIR 208
D+T +I +GT+ + + G VA+KK+ E S+++ V A R E++LL++++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIR-EISLLKELQ 57
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFAL-DIARGMNY 265
HPN+V + Q S + ++ E+L DL+ +L KG + V+ L I +G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
H + ++HRDL+P N+L D+ G +K+ADFG+++ + R T + + Y APEV
Sbjct: 117 CHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEV 172
Query: 326 F-KNEEYDTKVDVFSFALILQEV 347
+ Y T VD++S I E+
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 44/190 (23%), Positives = 82/190 (43%), Gaps = 23/190 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ A+K L + + + +V+ ++ L + HP +++ + V EY P
Sbjct: 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++++ G+L +A +I + YLH IIHRDL+P NIL D ++K
Sbjct: 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142
Query: 294 VADFGVSKLL---------------TVKEDRPLTCQDTS----CRYVAPEVFKNEEYDTK 334
+ DFG +K+L + + S YV+PE+ +
Sbjct: 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202
Query: 335 VDVFSFALIL 344
D+++ I+
Sbjct: 203 SDLWALGCII 212
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 12/176 (6%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-VTQSSPMMIVTEYL 232
G VA+KK+ + + R +R EL LL+ +RH N++ ++ + VTE L
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL L L+ F I RG+ Y+H ++HRDL+PSNIL +++ +L
Sbjct: 93 GT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDL 147
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEV 347
K+ DFG++++ +D +T ++ Y APE+ ++YD +VD++S I E+
Sbjct: 148 KICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 54/188 (28%), Positives = 94/188 (50%), Gaps = 23/188 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L + I++ + F+ E +L+ ++ HPN+V LG VTQ P+ ++ EYL +GDL
Sbjct: 37 VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 238 RAFL-----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
FL K +L + A+ IA GM YL + +H+DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151
Query: 281 PSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL + ++K++D G+S+ + + R R++ PE ++ + D++S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 340 FALILQEV 347
F ++L E+
Sbjct: 212 FGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + A EL ++ + H N+V LGA T P++++TEY
Sbjct: 66 MKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 235 GDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL FL+RK L + F+ +A+GM +L IHRDL N+L +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
K+ DFG+++ + D + + +++APE N Y + DV+S+ ++L E+
Sbjct: 181 KICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 23/192 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 43 KPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L+ + L V A +ARGM YL K IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217
Query: 336 DVFSFALILQEV 347
DV+SF ++L E+
Sbjct: 218 DVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 54/186 (29%), Positives = 93/186 (50%), Gaps = 19/186 (10%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVT 229
++VAVK + ++ + + + F E A ++ HPNV++ +G ++S + M++
Sbjct: 28 LKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86
Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
++ GDL +FL R G L T ++F +DIA GM YL IHRDL N
Sbjct: 87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARN 143
Query: 284 ILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
+ + + VADFG+SK + D R +++A E + Y +K DV++F
Sbjct: 144 CMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202
Query: 342 LILQEV 347
+ + E+
Sbjct: 203 VTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 51/201 (25%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRH 209
+F +I KG F + + G VA+KK+ E++ R + E+ LL+++ H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAV-RFALDIARGMNY 265
PNV+++L + +++ + IV E GDL +K ++ L P + ++ + + + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
+H + I+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE
Sbjct: 122 MHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPER 177
Query: 326 FKNEEYDTKVDVFSFALILQE 346
Y+ K D++S +L E
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 57/176 (32%), Positives = 93/176 (52%), Gaps = 8/176 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-IVTEYLP 233
G Q +KKL S +R +A E LL +++HPN+V + + ++ IV +
Sbjct: 25 GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 234 KGDLRAFLK-RKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
GDL LK +KG L P + V + + IA + YLHE I+HRDL+ N+ +
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNI 140
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+KV D G++++L + D T T Y++PE+F N+ Y+ K DV++ + E+
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTP-YYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 5/168 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + I + + E +L++ HP +V+ + ++ EY G+L
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L+ +G TA + + YLH II+RDL+P N+L D +G +K+ DFG
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFG 138
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+K L + + T T YVAPE+ N+ YD VD +S ++L E
Sbjct: 139 FAKKLKSGQ-KTWTFCGTP-EYVAPEIILNKGYDFSVDYWSLGILLYE 184
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 23/190 (12%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY K
Sbjct: 48 VTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 235 GDLRAFLKRKGALK----------PSTAVRF------ALDIARGMNYLHENKPVPIIHRD 278
G+LR +L+ + P + F +ARGM YL K IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRD 162
Query: 279 LEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
L N+L ++ +K+ADFG+++ + + + T +++APE + Y + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 338 FSFALILQEV 347
+SF +++ E+
Sbjct: 223 WSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 50/177 (28%), Positives = 94/177 (53%), Gaps = 18/177 (10%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V EY +
Sbjct: 28 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ + G + P F + +G+ + H + ++HRDL+P N+L + +G LK+
Sbjct: 84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140
Query: 295 ADFGVSKLLTVKEDRPLTC---QDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEV 347
ADFG+++ + P+ C + + Y P+V F + Y T +D++S I E+
Sbjct: 141 ADFGLARAFGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-18
Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E LL K+ HP +V+F + + I+TEY DL L + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
+ + G++Y+H+ + I+HRDL+ NI L+++ LK+ DFGVS+LL D T
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFT 166
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
T Y++PE K++ YD+K D++S IL E+
Sbjct: 167 GTP-YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-18
Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 16/168 (9%)
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KG 245
I ++ + F E+ +L + +HPN+V A + + I+ E+ G L + + +G
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99
Query: 246 ALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
+P R L+ +N+LH +K +IHRDL+ NIL G++K+ADFGVS
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
Query: 304 TVKEDRPLTCQDTSCRYVAPEV-----FKNEEYDTKVDVFSFALILQE 346
+ T T ++APEV FK+ YD K D++S + L E
Sbjct: 154 KSTLQKRDTFIGTP-YWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 23/192 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
R +VAVK L + D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 49 RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 233 PKGDLRAFL--KRKGALK----PSTA----------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L +R ++ P+ V A +ARGM YL K IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 336 DVFSFALILQEV 347
DV+SF ++L E+
Sbjct: 224 DVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 47/149 (31%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ + R P +V F GA + + + E++ G L K+ G + + A+ +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSC 318
G+ YL+ I+HRD++PSNIL + G +K+ DFGVS +L+ D T TS
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---TFVGTST 167
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
Y++PE + +Y K DV+S + + E+
Sbjct: 168 -YMSPERIQGGKYTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++VI DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
II+RDL+ N++ D G++K+ADFG+ K T T Y+APE+
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP-DYIAPEIIA 174
Query: 328 NEEYDTKVDVFSFALILQEV 347
+ Y VD ++F ++L E+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R + VA+ L SD R R F E L + H N+V+ G +T+
Sbjct: 20 ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITR 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ MMIVTEY+ G L +FL++ +G L + +A GM YL E + +H+ L
Sbjct: 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKV 335
+L + K++ F ++ED+ T + APE + + +
Sbjct: 135 AHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 336 DVFSFALILQEVKFYNQ 352
DV+SF +++ EV Y +
Sbjct: 190 DVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 47/173 (27%), Positives = 91/173 (52%), Gaps = 7/173 (4%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
V K++ +S+ +R R +E+ +L ++HPN++ + + ++I EY G
Sbjct: 27 LVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85
Query: 237 L-RAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++KG L V + L I ++Y+H+ I+HRD++ NI +G +K+
Sbjct: 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG+SK+L + T T Y++PE+ + +Y+ K D+++ +L E+
Sbjct: 143 GDFGISKILGSEYSMAETVVGTP-YYMSPELCQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 57/194 (29%), Positives = 105/194 (54%), Gaps = 22/194 (11%)
Query: 164 TKGTFILAFWR--GIQVAVKKLGEEVISDDD--RVRAFRDELALLQKI-RHPNVVQFLGA 218
T G+ LA + G VA+KK+ ++ S ++ +R E+ L+K+ HPN+V+
Sbjct: 11 TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKLKEV 66
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIH 276
++ + V EY+ +G+L +K RKG + +R + I +G+ ++H++ H
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCR-YVAPEVF-KNEEYDT 333
RDL+P N+L +K+ADFG+++ ++ P T D S R Y APE+ ++ Y +
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYT--DYVSTRWYRAPEILLRSTSYSS 178
Query: 334 KVDVFSFALILQEV 347
VD+++ I+ E+
Sbjct: 179 PVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 24/178 (13%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP------MMIVTE 230
VA+K + +D ++E +L+K HPN+ F GA + +P + +V E
Sbjct: 34 VAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89
Query: 231 YLPKG---DL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
G DL + K+ LK + RG+ YLHENK +IHRD++ NIL
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVFS 339
+ +K+ DFGVS L R T T ++APEV +E YD + DV+S
Sbjct: 147 TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWS 203
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 16/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEY-- 231
G +AVK++ D+ + +L ++ + P +V+F GA+ + I E
Sbjct: 29 GTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86
Query: 232 --LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L K + K + + A+ + +NYL E + IIHRD++PSNIL D +
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRN 144
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE---VFKNEEYDTKVDVFSFALILQ 345
GN+K+ DFG+S L D +D CR Y+APE + YD + DV+S + L
Sbjct: 145 GNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201
Query: 346 EV 347
EV
Sbjct: 202 EV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 45/203 (22%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + +++ R E +L P +V+ + + +V EY+P GDL
Sbjct: 30 AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89
Query: 239 AFLKRKGALKPSTAVRF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L RK TA RF ALD + + IHRD++P NIL D G+
Sbjct: 90 NLLIRKDVFPEETA-RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGH 139
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT----------------------------SCRYVAP 323
+K+ADFG+ K + +DR D+ + Y+AP
Sbjct: 140 IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199
Query: 324 EVFKNEEYDTKVDVFSFALILQE 346
EV + Y + D +S +IL E
Sbjct: 200 EVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------SPMMIV 228
++VAVK + + I + F E +++ HPNV++ +G Q+ SP++I+
Sbjct: 27 LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85
Query: 229 TEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL +FL R G L V+F DIA GM YL IHRDL
Sbjct: 86 P-FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR 141
Query: 283 NILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N + +++ N+ VADFG+SK + + R +++A E + Y TK DV+SF
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201
Query: 342 LILQEVKFYNQ 352
+ + E+ Q
Sbjct: 202 VTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-17
Identities = 50/187 (26%), Positives = 92/187 (49%), Gaps = 18/187 (9%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ + VAVK L +V F E+ ++ ++++PN+++ LG P+ ++TEY+
Sbjct: 43 QPVLVAVKMLRADVTKTARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100
Query: 234 KGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
GDL FL ++ ++ + + A+ IA GM YL + +HRDL
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
N L + +K+ADFG+S+ L + + + R++A E ++ T DV++F
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217
Query: 341 ALILQEV 347
+ L E+
Sbjct: 218 GVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 5/147 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + + ++ +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 163
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE 346
Y++PE + Y + D++S L L E
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 60/180 (33%), Positives = 90/180 (50%), Gaps = 19/180 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S R +R EL LL+ + H NV+ L T +S + +V
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 287
T L DL +K + L ++F + I RG+ Y+H IIHRDL+PSNI +
Sbjct: 99 TH-LMGADLNNIVKCQ-KLSDDH-IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVN 152
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQE 346
+ LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E
Sbjct: 153 EDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 49/173 (28%), Positives = 88/173 (50%), Gaps = 7/173 (4%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G A+K L + I +V+ E ++L ++ HP +V + + + + + E++
Sbjct: 42 TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L L++ G A + ++ YLH II+RDL+P N+L D+ G++K
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
V DFG +K + DR T T Y+APEV +++ + VD ++ ++L E
Sbjct: 159 VTDFGFAKKVP---DRTFTLCGTP-EYLAPEVIQSKGHGKAVDWWTMGVLLYE 207
|
Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 14/194 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215
I+KG F LA R G A+K L + + ++V + E A++ P V +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ + +V EYL GD + +K G L A ++ ++ G+ LH+ II
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
HRD++P N+L D +G+LK+ DFG+S+ + T Y+APE D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPETILGVGDDKMS 174
Query: 336 DVFSFALILQEVKF 349
D +S ++ E F
Sbjct: 175 DWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 23/192 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L + + D + E+ L++ I +H N++ LG TQ P+ ++ EY
Sbjct: 43 QTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 233 PKGDLRAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR FL+ + P V A +ARGM YL + IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + + +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 336 DVFSFALILQEV 347
DV+SF +++ E+
Sbjct: 218 DVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++V+ DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +I+ G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPE 324
II+RDL+ N++ D G++K+ADFG+ K V T C Y+APE
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
+ + Y VD +++ ++L E+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 9/174 (5%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++ I + + + A R+ LL+ ++HP +V + + + V +Y+ G
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+R+ A +A ++A + YLH + II+RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLT 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349
DFG+ K E+ T T Y+APEV + E YD VD + +L E+ +
Sbjct: 139 DFGLCKEGVEPEETTSTFCGTP-EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 52/185 (28%), Positives = 99/185 (53%), Gaps = 22/185 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + E S +R+ F +E +++++ +VV+ LG V+Q P +++ E + +GD
Sbjct: 38 RVAIKTVNEAA-SMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95
Query: 237 LRAFLKRKGALKPSTA-------------VRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
L+++L+ +L+P ++ A +IA GM YL+ NK +HRDL N
Sbjct: 96 LKSYLR---SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARN 149
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+ + +K+ DFG+++ + R R+++PE K+ + T DV+SF +
Sbjct: 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209
Query: 343 ILQEV 347
+L E+
Sbjct: 210 VLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 5/172 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+ + A +A +IA + YLH II+RDL+P NIL D G++ + DF
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349
G+ K T T Y+APEV + + YD VD + +L E+ +
Sbjct: 141 GLCKEGIEHSKTTSTFCGTP-EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 20/191 (10%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VAVK L + + D+ + F E LL ++H ++V+F G + P+++V EY+ G
Sbjct: 36 ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 236 DLRAFLKRKGA-------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
DL FL+ G L S + A IA GM YL +HRDL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 149
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N L ++ +K+ DFG+S+ + + R R++ PE ++ T+ DV+S
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209
Query: 342 LILQEVKFYNQ 352
++L E+ Y +
Sbjct: 210 VVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +AVK++ V S + + R D ++ + P V F GA+ + + I E +
Sbjct: 26 GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VMD 83
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
L F K+ KG P + + A+ I + + YLH V IHRD++PSN+L + +G
Sbjct: 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNG 141
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVF----KNEEYDTKVDVFSFALILQ 345
+K+ DFG+S L D D C+ Y+APE + YD K DV+S + +
Sbjct: 142 QVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 346 EV 347
E+
Sbjct: 199 EL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 52/173 (30%), Positives = 92/173 (53%), Gaps = 11/173 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + Q HP +V S + V EY+ GDL
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ E+
Sbjct: 141 GMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 25/192 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G VA+KK+ D + A R E+ +L+K++HPNVV + + +
Sbjct: 33 GRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91
Query: 227 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+VT Y+ DL L+ L S + L + G+NYLHEN I+HRD++ +NIL
Sbjct: 92 MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRP------LTCQDTSC---R-YVAPEVFKNE-EYDTK 334
D+ G LK+ADFG+++ P T + T+ R Y PE+ E Y T
Sbjct: 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207
Query: 335 VDVFSFALILQE 346
VD++ + E
Sbjct: 208 VDIWGIGCVFAE 219
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 7/150 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL DL+ +L G L V+ F
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG++Y H+ K I+HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTL 167
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEV 347
Y P+V + EY T +D++ IL E+
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+V VK+L + D F E+ +++ HPNV+Q LG +S P ++V E+ P
Sbjct: 21 SKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78
Query: 234 KGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
GDL+ +L+ + R A ++A G+ +LH+ IH DL N
Sbjct: 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTA 135
Query: 289 SGNLKVADFGVSKLLTVKEDRPLT--CQDTSCRYVAPEVFKNEEYDTKV-------DVFS 339
++K+ D+G++ L ED +T C R++APE+ + D +++S
Sbjct: 136 DLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194
Query: 340 FALILQEV 347
+ + E+
Sbjct: 195 LGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 9/177 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + ++ A R E++LL+++ HPN+V+ L + + + +V E+L +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83
Query: 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL+ F+ + + + +G+ + H ++ ++HRDL+P N+L + G +
Sbjct: 84 -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAI 139
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEVK 348
K+ADFG+++ V R T + + Y APE+ + Y T VD++S I E+
Sbjct: 140 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 54/175 (30%), Positives = 87/175 (49%), Gaps = 5/175 (2%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+G AVK L ++V+ DD V E +L +P + + V E+L
Sbjct: 19 KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL ++ KG A +A +I G+ +LH II+RDL+ N++ D G++
Sbjct: 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHI 135
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
K+ADFG+ K ++R T T Y+APE+ + +Y VD +SF ++L E+
Sbjct: 136 KIADFGMCKENVFGDNRASTFCGTP-DYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 162 EITKGTF--ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ +GT IL G I+VAVK L + D + F E L+ HPN+V+ LG
Sbjct: 10 EVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------VRFALDIARGMNYLHENKP 271
+ P I+ E + GDL ++L+ + + LD+A+G YL +
Sbjct: 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126
Query: 272 VPIIHRDLEPSNILRDDSGN-----LKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPE 324
IHRDL N L + G +K+ DFG+++ + K D R R++APE
Sbjct: 127 --FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPVRWMAPE 183
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
+ ++ T+ DV+SF +++ E+
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEI 206
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 15/181 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK ++ +D+ A +DEL ++Q++ +P +V+ +G + ++ M+V E
Sbjct: 25 VAVK-----ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAE 78
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L FL++ + ++ GM YL E +HRDL N+L K
Sbjct: 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135
Query: 294 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351
++DFG+SK L E+ + T ++ APE ++ +K DV+SF +++ E Y
Sbjct: 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195
Query: 352 Q 352
Q
Sbjct: 196 Q 196
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L + ++ + F+ E LL ++H ++V+F G P+++V EY+ GDL
Sbjct: 38 VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL+ KG L S + A IA GM YL +HRDL
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 151
Query: 282 SNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
N L + +K+ DFG+S+ + + R R++ PE ++ T+ DV+SF
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 341 ALILQEVKFYNQ 352
+IL E+ Y +
Sbjct: 212 GVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-16
Identities = 46/170 (27%), Positives = 85/170 (50%), Gaps = 9/170 (5%)
Query: 183 LGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYL---PKGDLR 238
G++ D + E+ ++ +++RHPN+V++ ++ + IV + + P G+
Sbjct: 41 FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100
Query: 239 AFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
LK K + + + + YLH+ K I+HRDL P+NI+ + + + DF
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G++K + + LT + Y PE+ KNE Y K DV++F IL ++
Sbjct: 159 GLAK--QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 10/189 (5%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGA 218
KG+F LA +G A+K L ++V+ DD V E +L HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ V EYL GDL ++ A +A +I G+ +LH I++RD
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRD 121
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L+ NIL D G++K+ADFG+ K + + + T T Y+APE+ ++Y+T VD +
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP-DYIAPEILLGQKYNTSVDWW 180
Query: 339 SFALILQEV 347
SF ++L E+
Sbjct: 181 SFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-16
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYL 232
G VAVK L E ++ E+ +L+ + H N+V++ G ++ + ++ EY+
Sbjct: 33 GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
P G LR +L + L + + FA I GM YLH IHRDL N+L D+ +
Sbjct: 91 PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146
Query: 293 KVADFGVSKLLT-------VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
K+ DFG++K + V+ED D+ + A E K ++ DV+SF + L
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 346 EV 347
E+
Sbjct: 202 EL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-16
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 27/164 (16%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVR-- 254
E LL + H N++ L + P ++ Y+ G+L+ FL+ R G A+
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 255 ----FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK--------L 302
A+ IA GM+YLH+ +IH+D+ N + D+ +K+ D +S+
Sbjct: 118 QLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
L E+RP+ +++A E N+EY + DV+SF ++L E
Sbjct: 175 LGDNENRPV-------KWMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 22/190 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L ++ + F+ E + +++HPN+V LG VT+ P+ ++ Y DL
Sbjct: 38 VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 238 RAFL----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL K L+P+ V IA GM +L + ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
N+L D N+K++D G+ + + + L R+++PE ++ D++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 341 ALILQEVKFY 350
++L EV Y
Sbjct: 213 GVVLWEVFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E++ DD+ + + E + Q +P +V +S + +V EY+ GDL
Sbjct: 24 AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A +A +I +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G+ K + P T C Y+APE+ + EEY VD ++ +++ E+
Sbjct: 141 GMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 49/173 (28%), Positives = 91/173 (52%), Gaps = 11/173 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + HP +V S + V E++ GDL
Sbjct: 24 AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ E+
Sbjct: 141 GMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 47/171 (27%), Positives = 88/171 (51%), Gaps = 7/171 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + + +E +L+K+ +V A + +V + GDL+
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+ G + A+ +A I G+ +LH+ + I++RDL+P N+L DD GN++++D
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISD 138
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G++ + +K + + + + Y+APEV + E YD VD F+ L E+
Sbjct: 139 LGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 11/179 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI---VTEY 231
G +VA+KK+ R R EL +L+ +H N++ + V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + DL + L F + RG+ Y+H +IHRDL+PSN+L ++
Sbjct: 89 LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCE 145
Query: 292 LKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
L++ DFG+++ L+ + +T + Y APE+ EY T +D++S I E
Sbjct: 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 8/171 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L + I D V + E + + RHP +V + V EY G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL + +P AV +A + G+ YLHENK I++RDL+ N+L D G +K+A
Sbjct: 88 DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIA 143
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
DFG+ K DR T T ++APEV Y VD + +++ E
Sbjct: 144 DFGLCKEGMGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYE 193
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
I VA+K I D + F+ D + + + H +V+ LG +S + +VT+
Sbjct: 37 IPVAIK-----TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLS 90
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
P G L + + + +L P + + + IA+GM YL E++ ++HR+L NIL
Sbjct: 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350
+++ADFGV+ LL + + + T +++A E Y + DV+S+ + + E+ Y
Sbjct: 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 163 ITKGTF---ILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFL 216
I KG+F +LA + + AVK L ++ I + E LL+ ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + + V +Y+ G+L L+R+ A +A +IA + YLH + I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+P NIL D G++ + DFG+ K + T C Y+APEV + YD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 334 KVDVFSFALILQEVKF 349
VD + +L E+ +
Sbjct: 176 TVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-15
Identities = 30/60 (50%), Positives = 39/60 (65%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN +D D TALH+AA G E+V LLLE GAD++ KD
Sbjct: 32 LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91
|
Length = 91 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 47/150 (31%), Positives = 83/150 (55%), Gaps = 7/150 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V V + +V EYL K DL+ ++ G + V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I RG+ Y H K ++HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTL 168
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEV 347
Y P+V + EY T++D++ I E+
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 165 KGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
KGTF IL + G A+K L +EVI D V E +LQ RHP + A
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ V EY G+L L R+ A + +I + YLH +++RD+
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
+ N++ D G++K+ DFG+ K T T Y+APEV ++ +Y VD +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 180
Query: 340 FALILQE-----VKFYNQ 352
+++ E + FYNQ
Sbjct: 181 LGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 8/179 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I ++YLH K V ++RDL+ N++ D G++K+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG 141
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-----VKFYNQ 352
+ K +K+ + + Y+APEV ++ +Y VD + +++ E + FYNQ
Sbjct: 142 LCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 15/181 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKG 235
VA+KKL E + + + R E+ +L K++HPN+V V S+ + +V EY+ +
Sbjct: 33 VALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EH 90
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL++ ++ K S L + G+ +LH+N I+HRDL+ SN+L ++ G LK+
Sbjct: 91 DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKI 147
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFS----FA-LILQEVK 348
DFG+++ +P T + Y APE+ EY T +D++S FA L+ ++
Sbjct: 148 CDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL 206
Query: 349 F 349
F
Sbjct: 207 F 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 22/191 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL
Sbjct: 38 VAVKALKE--ASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
FL+ G L + A IA GM YL + +HRDL
Sbjct: 95 NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATR 151
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N L +K+ DFG+S+ + + R R++ PE ++ T+ D++SF
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211
Query: 342 LILQEVKFYNQ 352
++L E+ Y +
Sbjct: 212 VVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 5/148 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+G+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEV 347
Y++PE + Y + D++S L L E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 23/170 (13%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
+D R E+ +L+ + HPNVV+ + + ++ E++ G L A +
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQ 168
Query: 250 STAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
A D+AR G+ YLH I+HRD++PSN+L + + N+K+ADFGVS++L
Sbjct: 169 FLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNE----EYDTKV-DVFSFALILQEVKFY 350
D P + Y++PE + YD D++S + + E FY
Sbjct: 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE--FY 267
|
Length = 353 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 9/174 (5%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++++ + + A R+ LL+ ++HP +V + + + V +++ G
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+R+ + A +A +IA + YLH + I++RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLT 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349
DFG+ K + D T T Y+APEV + + YD VD + +L E+ +
Sbjct: 139 DFGLCKEGIAQSDTTTTFCGTP-EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 54/166 (32%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKP 249
++ + + E+ +L HPN+V+ L A + + I+ E+ G + A L+ + L
Sbjct: 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
+NYLHENK IIHRDL+ NIL G++K+ADFGVS K R
Sbjct: 103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTR 155
Query: 310 PLTCQDT---SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEV 347
+ +D+ + ++APEV K+ YD K DV+S + L E+
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 44/150 (29%), Positives = 83/150 (55%), Gaps = 7/150 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL K DL+ +L G V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG+NY H K ++HRDL+P N+L ++ G LK+ADFG+++ ++ + + + +
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTL 168
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEV 347
Y P++ + +Y T++D++ I E+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 39/196 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + + + A R E+ +L+++ H N+V IVT+ K
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL---------KEIVTD---K 78
Query: 235 GDLRAFLKRKGA--------------LKPSTAVRFALD--------IARGMNYLHENKPV 272
D F K KGA L S V F+ D + G+NY H+
Sbjct: 79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-Y 331
+HRD++ SNIL ++ G +K+ADFG+++L +E RP T + + Y PE+ EE Y
Sbjct: 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195
Query: 332 DTKVDVFSFALILQEV 347
+DV+S IL E+
Sbjct: 196 GPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 50/193 (25%), Positives = 99/193 (51%), Gaps = 17/193 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGA 218
E+ + T +L G+ VA+KK+ I D +A D E+ LL+++ HPNV+++ +
Sbjct: 17 EVYRATCLL---DGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70
Query: 219 VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
+ + + IV E GDL + F K+K + T ++ + + + ++H + +
Sbjct: 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 334
+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPERIHENGYNFK 186
Query: 335 VDVFSFALILQEV 347
D++S +L E+
Sbjct: 187 SDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 9/183 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A+K L +EVI D V E +L+ RHP + + + V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L L R+ + +I ++YLH K I++RDL+ N++ D G++K+
Sbjct: 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKI 136
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-----VKF 349
DFG+ K + + + + Y+APEV ++ +Y VD + +++ E + F
Sbjct: 137 TDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
Query: 350 YNQ 352
YNQ
Sbjct: 196 YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 41/150 (27%), Positives = 80/150 (53%), Gaps = 7/150 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFAL 257
E +L+K+ P +V A + + +V + GDL+ + G L+ + ++
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
I G+ +LH + I++RD++P N+L DD GN +++D G++ + +K+ + +T + +
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
Y+APE+ K E Y VD F+ + E+
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ +I+H N++ + + + +V + + DL+ + RK L S L I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------SKLLTVK 306
G+N LH+ +HRDL P+NI + G K+ADFG+ SK T++
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 307 EDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFSFALILQE 346
+T + + Y APE + E+Y VD++S I E
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226
|
Length = 335 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
L+ HPNVV+ T S + + +V E++ + DL +L + + + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 116
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ RG+++LH ++ ++HRDL+P NIL SG +K+ADFG++++ + + LT
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV 171
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ Y APEV Y T VD++S I E+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 16/137 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E+ ++ + F E+ ++ +++ PN+++ L S P+ ++TEY+ GDL
Sbjct: 49 VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 238 RAFLKRKGALKP-----------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
FL R + ST + A IA GM YL + +HRDL N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 287 DDSGNLKVADFGVSKLL 303
+ +K+ADFG+S+ L
Sbjct: 164 GKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 5/149 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +LL+ ++H N+V + + +V EY+ + K G L P F +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG++Y+H+ I+HRDL+P N+L D+G LK+ADFG+++ +V + + +
Sbjct: 113 LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLW 168
Query: 320 YVAPEV-FKNEEYDTKVDVFSFALILQEV 347
Y P+V + EY T +D++ I E+
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 43/123 (34%), Positives = 71/123 (57%), Gaps = 9/123 (7%)
Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252
+V+A RD LAL + P +V ++ ++ + +V EYL GD+++ L G A
Sbjct: 50 QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
V++ ++A ++YLH + IIHRDL+P N+L + G++K+ DFG+SK V +R L
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK---VTLNRELN 160
Query: 313 CQD 315
D
Sbjct: 161 MMD 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + + KG+F +LA +G A+K L ++V+ DD V E +L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
+ L + Q+ + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-----LTVKEDRPLTCQDTSC---RYV 321
II+RDL+ N++ D G++K+ADFG+ K +T K T C Y+
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK---------TFCGTPDYI 168
Query: 322 APEVFKNEEYDTKVDVFSFALILQEV 347
APE+ + Y VD ++F ++L E+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 18/182 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + V+ + V F +E +L P + Q A + +V EY P GDL
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L R +F L ++ ++ +H+ + +HRD++P N+L D +G++K+ADF
Sbjct: 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADF 146
Query: 298 GVSKLLT----VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEV 347
G + LT V P+ D Y+APEV Y + D +S +I E+
Sbjct: 147 GSAARLTANKMVNSKLPVGTPD----YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 348 KF 349
+
Sbjct: 203 IY 204
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 52/183 (28%), Positives = 94/183 (51%), Gaps = 16/183 (8%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + E S +R+ F +E ++++ +VV+ LG V++ P ++V E + G
Sbjct: 37 TRVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 236 DLRAFLK--------RKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
DL+++L+ G P+ ++ A +IA GM YL+ K +HRDL N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151
Query: 286 RDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+++ + R R++APE K+ + T D++SF ++L
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211
Query: 345 QEV 347
E+
Sbjct: 212 WEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
EL N + KG + + + I VA+K K E D+ +R E ++ ++ +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPY 56
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENK 270
+V+ +G V ++ +M+V E G L FL +K + S V ++ GM YL
Sbjct: 57 IVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN 328
+HRDL N+L + K++DFG+SK L + + + ++ APE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 329 EEYDTKVDVFSFALILQEVKFYNQ 352
++ ++ DV+S+ + + E Y Q
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQ 196
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 53/170 (31%), Positives = 91/170 (53%), Gaps = 7/170 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 28 AMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 86
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L K + V+F L ++A +++LH + II+RDL+P NIL D+ G++K+ DF
Sbjct: 87 TRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDF 142
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G+SK E + + T Y+APEV + D +SF +++ E+
Sbjct: 143 GLSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEM 191
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G +VA+KK+ + R FR EL +L +H NV L A+ P +
Sbjct: 25 GKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
+VTE L + DL + L F I RG+ YLH I+HRD++P N+L
Sbjct: 81 VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLV 136
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQ 345
+ + LK+ DFG++++ E + +T + + Y APE+ + Y + VD++S I
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 346 E 346
E
Sbjct: 197 E 197
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 144 EVPEYEID-PHEL---DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
EV E+ P +L F +V KG R + VAVK L + ++ + F
Sbjct: 20 EVHLCEVVNPQDLPTLQFPFNVR--KG-------RPLLVAVKILRPD--ANKNARNDFLK 68
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------- 245
E+ +L +++ PN+++ LG P+ ++TEY+ GDL FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
A+ S+ + AL IA GM YL + +HRDL N L ++ +K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 301 KLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ L + + + R++A E ++ T DV++F + L E+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEV 347
Y++PE + Y + D++S L L E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 14/174 (8%)
Query: 178 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK E DD V+ A R E+ +L+++RH N+V + + + +V E++
Sbjct: 29 VAIKKFLES--EDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
L K L S ++ I RG+ + H + IIHRD++P NIL SG +K+
Sbjct: 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142
Query: 296 DFGVSKLLTVKEDRPLTCQD-TSCR-YVAPE-VFKNEEYDTKVDVFSFALILQE 346
DFG ++ L + D + R Y APE + + +Y VD+++ ++ E
Sbjct: 143 DFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 9/179 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I + YLH +++RDL+ N++ D G++K+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG 140
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-----VKFYNQ 352
+ K T T Y+APEV ++ +Y VD + +++ E + FYNQ
Sbjct: 141 LCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++VI DD V E LAL K HP +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EY+ GDL ++R + +A ++ + +LH + +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+ NIL D G+ K+ADFG+ K + T T Y+APE+ + EY VD
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP-DYIAPEILQELEYGPSVD 178
Query: 337 VFSFALILQEV 347
++ +++ E+
Sbjct: 179 WWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH + +IHRD++ NIL + G +K+ DFG + ++ P + ++APEV
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEV 182
Query: 326 ---FKNEEYDTKVDVFSFALILQEV 347
+YD KVDV+S + E+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 51/175 (29%), Positives = 88/175 (50%), Gaps = 7/175 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G + AV +A +I G+ LH+ + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++D G++ + V E + + + + Y+APEV KNE Y D ++ +L E+
Sbjct: 142 RISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
QV VK+L + F +E + ++H N++Q LG T+ +P ++V E+ P GD
Sbjct: 24 QVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81
Query: 237 LRAFLK--RKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L+ +L+ RK L P+T R A +IA G+ +LH+N IH DL N L
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLT 138
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEV 325
+K+ D+G+S KED +T R++APE+
Sbjct: 139 VKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPEL 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 39/152 (25%), Positives = 81/152 (53%), Gaps = 8/152 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E+ LL+++ HPNV+++L + + + + IV E GDL + F K+K + T ++
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
+ + + ++H + ++HRD++P+N+ +G +K+ D G+ + + K +
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
T Y++PE Y+ K D++S +L E+
Sbjct: 169 TP-YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 16/158 (10%)
Query: 200 ELALLQKIR---HPNVVQFLGAVT-----QSSPMMIVTEYLPKGDLRAFLKRKGA--LKP 249
E+ALL+++ HPN+V+ + + + + +V E++ + DLR +L + L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA 107
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
T RG+++LH N I+HRDL+P NIL G +K+ADFG++++ + +
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--M 162
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
LT + Y APEV Y T VD++S I E+
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 6e-14
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+
Sbjct: 19 FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+I+HPN +++ G + +V EY K L+ +G
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + + P + ++A
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEV 347
PEV +YD KVDV+S + E+
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 44/173 (25%), Positives = 88/173 (50%), Gaps = 8/173 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ +HPN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG +T ++ + T T ++APEV + Y KVD++S ++ E+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 151 DPHELDFTNSVEI---TKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP N V+I + G +A + G QVAVKK+ + R +E+ +++
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+HPN+V+ + + +V E+L G L + + A L + + +++
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH +IHRD++ +IL G +K++DFG ++ + R + T ++APEV
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP-YWMAPEV 186
Query: 326 FKNEEYDTKVDVFSFALILQE 346
Y T+VD++S +++ E
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 8/173 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + E +L K+ +V A + + +V + GDLR
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81
Query: 239 AFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ + A + I G+ +LH+ + II+RDL+P N+L D+ GN+++
Sbjct: 82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRI 138
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+D G++ L + + T ++APE+ + EEYD VD F+ + L E+
Sbjct: 139 SDLGLAVELKDGQSKTKGYAGTP-GFMAPELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 10/185 (5%)
Query: 166 GTFILAFWRGIQ---VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
G ILA ++ VA+K+ + I +V E +L I HP V G+
Sbjct: 44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
S + +V E++ G+ FL+R +A I YL + + I++RDL+P
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPE 160
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
N+L D G +K+ DFG +K++ + R T T Y+APE+ N + D ++ +
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTP-EYIAPEILLNVGHGKAADWWTLGI 216
Query: 343 ILQEV 347
+ E+
Sbjct: 217 FIYEI 221
|
Length = 340 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 18/168 (10%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGAL 247
++ + + E+ +L HP +V+ LGA + I+ E+ P G + A + +G
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
+P V + + YLH K IIHRDL+ N+L G++K+ADFGVS K
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS----AKN 160
Query: 308 DRPLTCQDT---SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEV 347
+ L +D+ + ++APEV K+ YD K D++S + L E+
Sbjct: 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 29/188 (15%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRH-PNVVQFLGA--VTQSSP---MMIVT 229
VA+KK E D++ + A R E++LLQ + +V+ L V + + + +V
Sbjct: 29 VALKKTRLE--MDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85
Query: 230 EYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
EYL DL+ F+ G L T F + +G+ + H++ ++HRDL+P N+
Sbjct: 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNL 141
Query: 285 LRDDSGN-LKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEV-FKNEEYDTKVDVFS 339
L D LK+AD G+ + ++ P+ T + + Y APEV + Y T VD++S
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSI----PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197
Query: 340 FALILQEV 347
I E+
Sbjct: 198 VGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 10/153 (6%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
+ EL +L K P ++ F GA + + I TE++ G L + + R
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
A+ + +G+ YL K I+HRD++PSN+L + G +K+ DFGVS L +
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ Y+APE E+Y DV+S + E+
Sbjct: 157 NA---YMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 31 LDDDGEEIKPE---FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHV---AACQG 84
+D+ +I E + + A+ VE ++ LL +G DVNFR +T LH+ + +
Sbjct: 2 EEDESVDIIMEAALYDYLLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEK 61
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE-VIKLLEKHGA 130
++V LLLE GADV+ +R G TPL +Y VIKLL K GA
Sbjct: 62 VKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGA 108
|
Length = 471 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A+K++ E+ D+ + EL +L K P +V F GA + + EY+
Sbjct: 26 GVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83
Query: 235 GDLRAFLKRKGAL--KPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G L A P +R + +G+ +L E IIHRD++P+N+L + +G
Sbjct: 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQ 141
Query: 292 LKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALIL 344
+K+ DFGVS L+ + CQ Y+APE K+ Y + DV+S L +
Sbjct: 142 VKLCDFGVSGNLVASLAKTNIGCQS----YMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197
Query: 345 QE 346
E
Sbjct: 198 LE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 11/173 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L R HP + Q + V E++ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 84 MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G+ K + T C Y+APE+ + Y VD ++ ++L E+
Sbjct: 141 GMCK----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 7/175 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G AV +A +I G+ LH + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++D G++ + + E + + + Y+APEV KNE Y D + ++ E+
Sbjct: 142 RISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFL-KRKGALKPSTAVRFA 256
E LLQ + HP+V++ + + +V LP DL +L KR L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
I G+ YLH + IIHRD++ NI +D + + D G ++ V L T
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGT 219
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350
APEV ++Y++K D++S ++L E+ Y
Sbjct: 220 -VETNAPEVLARDKYNSKADIWSAGIVLFEMLAY 252
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 57/180 (31%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
G++VAVKKL S R +R EL LL+ ++H NV+ L T + + + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+L DL +K + V+F + I RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 THLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEV 347
LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E+
Sbjct: 156 DCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 12/177 (6%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-----QSSPMMIVTEY 231
+VA+KK+ + D R R E+ LL+ + H NV+ + + + IV E
Sbjct: 32 KVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE- 89
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L DL ++ L F + RG+ Y+H ++HRDL+PSN+L + + +
Sbjct: 90 LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEV 347
LK+ DFG+++ + K D +T + Y APE+ N EY T +DV+S I E+
Sbjct: 147 LKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +LL+ ++H N+V + + +V EYL DL+ ++ G L F
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
+ RG+ Y H+ + ++HRDL+P N+L + G LK+ADFG+++
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 4e-13
Identities = 43/173 (24%), Positives = 89/173 (51%), Gaps = 8/173 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ +++++++PN+V FL + + +V EYL
Sbjct: 44 GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + + +LH N+ +IHRD++ N+L G++K+
Sbjct: 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG +T ++ + T T ++APEV + Y KVD++S ++ E+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E +L+ ++HP +V + A + ++ EYL G+L L+R+G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+I+ + +LH+ II+RDL+P NIL D G++K+ DFG+ K ++ E T T
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEG---TVTHTF 160
Query: 318 C---RYVAPEVFKNEEYDTKVDVFS 339
C Y+APE+ + VD +S
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWS 185
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 47/174 (27%), Positives = 92/174 (52%), Gaps = 8/174 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K+L E ++ DE ++ + +P+V + LG + +S + ++T+ +P G
Sbjct: 37 IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GMNYL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG++KLL E + +++A E + Y + DV+S+ + + E+
Sbjct: 151 TDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 56/176 (31%), Positives = 93/176 (52%), Gaps = 14/176 (7%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+A+KK+ E +D+ V A R E++LL++++H N+V+ V + +V EYL
Sbjct: 30 IALKKIRLE--QEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-L 292
DL+ + A P + I RG+ Y H ++ ++HRDL+P N+L D N L
Sbjct: 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNAL 142
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEV 347
K+ADFG+++ + R T + + Y APE+ + Y T VD++S I E+
Sbjct: 143 KLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 9e-13
Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I V E +L + P +V + S + +VT+Y+ G
Sbjct: 22 AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+++G A + ++ + +LH+ I++RDL+P NIL D +G++ +
Sbjct: 82 ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALC 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEV 347
DFG+SK T T+ Y+APEV +E+ Y VD +S +++ E+
Sbjct: 139 DFGLSKANLTDNKTTNTFCGTT-EYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 27/205 (13%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYL--PKGDLRAFLKRKGALKPSTAVRFA---LDIA 260
++RHPN +++ G + +V EY D+ K KP V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
+G+ YLH ++ IHRD++ NIL + G +K+ADFG + L++ P + +
Sbjct: 126 QGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYW 177
Query: 321 VAPEV---FKNEEYDTKVDVFSFAL 342
+APEV +YD KVDV+S +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 23/185 (12%)
Query: 174 RGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVTQSS-----P 224
G++VA+KK IS + R R E+ +L++ +H N++ L + S
Sbjct: 29 TGVKVAIKK-----ISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSFESFND 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+ IV E + DL +K + L F I RG+ Y+H ++HRDL+PSN+
Sbjct: 83 VYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFA 341
L + + +LK+ DFG++++ + D LT + Y APE+ N + Y +D++S
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG 197
Query: 342 LILQE 346
IL E
Sbjct: 198 CILAE 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAFRDELA 202
Y+ DP E+ F EI G+F ++ VAVKK+ +++ + E+
Sbjct: 15 YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+++HPN +++ G + +V EY K L+ +G
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + P + ++A
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEV 347
PEV +YD KVDV+S + E+
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 4/170 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK + +++ + R EL +L+ ++ N+V+ A + + +V EY+ K L
Sbjct: 29 VAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ + P + + + +++ H+N I+HRD++P N+L + LK+ DF
Sbjct: 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
G ++ L+ + T + Y +PE+ Y VD++S IL E+
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-12
Identities = 43/173 (24%), Positives = 88/173 (50%), Gaps = 8/173 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + +++LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG +T ++ + T T ++APEV + Y KVD++S ++ E+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 60/189 (31%), Positives = 88/189 (46%), Gaps = 25/189 (13%)
Query: 175 GIQVAVKKLGEEVISD-DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-----PMMI 227
G AVK L + ISD D+ + A E +LQ + HPNVV+F G ++ + +
Sbjct: 47 GSLAAVKIL--DPISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101
Query: 228 VTEYLPKGD----LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
V E G ++ L L + G+ +LH N+ IIHRD++ +N
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVF 338
IL G +K+ DFGVS LT R T T ++APEV E+ YD + DV+
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVW 217
Query: 339 SFALILQEV 347
S + E+
Sbjct: 218 SLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 46/198 (23%), Positives = 88/198 (44%), Gaps = 33/198 (16%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V+ E +L + HP + + + + +V +Y P G+L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 239 AFL-KRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L ++ G RF A ++ + YLH I++RDL+P NIL +SG++ ++D
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSD 146
Query: 297 FGVSKLLTVK--------------------EDRPLTCQDT----SC----RYVAPEVFKN 328
F +SK V+ + + + S Y+APEV
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 329 EEYDTKVDVFSFALILQE 346
+ + + VD ++ ++L E
Sbjct: 207 DGHGSAVDWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 17/155 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E +LL+ ++H N+V + + V EY+ DL ++ + G L P F
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG+ Y+H I+HRDL+P N+L G LK+ADFG+++ + + Q S
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSS 162
Query: 319 R-----YVAPEVF-KNEEYDTKVDVFSFALILQEV 347
Y P+V +Y + +D++ I E+
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 37/82 (45%), Positives = 45/82 (54%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
LA D G + LL G D N RD D RT LH+A G +VV +LLE GAD D+ G
Sbjct: 89 LAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148
Query: 107 STPLGDAIYYKNHEVIKLLEKH 128
TPL A EV++LL +H
Sbjct: 149 KTPLELAEENGFREVVQLLSRH 170
|
Length = 664 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 49/142 (34%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE 268
P +V+ G S + I E L L LKR +G + + + I + ++YL E
Sbjct: 74 PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-- 326
V IHRD++PSNIL D SGN+K+ DFG+S L + + T Y+APE
Sbjct: 133 KHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYMAPERIDP 188
Query: 327 --KNEEYDTKVDVFSFALILQE 346
N +YD + DV+S + L E
Sbjct: 189 PDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 48/174 (27%), Positives = 90/174 (51%), Gaps = 8/174 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E + F DE ++ + HP++V+ LG V S + +VT+ +P G
Sbjct: 37 IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 93
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L ++ + K + + + + IA+GM YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG+++LL E + +++A E ++ + DV+S+ + + E+
Sbjct: 151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+KK+ ++ + ++++ E +L +P VV + + +V EY+ GD
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
LK GAL A + + + YLH I+HRDL+P N+L G++K+ DFG
Sbjct: 90 TLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG 146
Query: 299 VSKL----LTV--------KEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+SK+ LT K+ R + + Y+APEV + Y VD ++ +IL
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206
Query: 345 QE 346
E
Sbjct: 207 YE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E+ +++ +H N+V + G+ + + I E+ G L+ G L S +
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGVS +T + + T
Sbjct: 114 ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 318 CRYVAPEVFKNEE---YDTKVDVFSFALILQEV 347
++APEV E Y+ D+++ + E+
Sbjct: 171 -YWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K+L ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G + A+ +A +I G+ LH ++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++D G++ + + E + + + Y+APEV N+ Y D + ++ E+
Sbjct: 142 RISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 163 ITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
I KGT+ +L G + AVK L + + D+ + A + L L HPNVV+F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSD--HPNVVKFYG 82
Query: 218 A-----VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
V + +V E G + + FLKR ++ + G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
NK IHRD++ +NIL G +K+ DFGVS LT R T T ++APEV
Sbjct: 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIAC 198
Query: 329 EE-----YDTKVDVFSFALILQEV 347
E+ YD + DV+S + E+
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 15/177 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY----- 231
+VAVKKL S R +R EL LL+ ++H NV+ L T ++ + E
Sbjct: 42 KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L DL +K + L + RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 156
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEV 347
L++ DFG+++ + D +T + Y APE+ N Y+ VD++S I+ E+
Sbjct: 157 LRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 34/190 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM---------IV 228
VA+KK+ E + + A R E+ +LQ ++H NVV L + ++ +V
Sbjct: 40 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLV 97
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIAR-------GMNYLHENKPVPIIHRDLE 280
E+ DL L K V+F L +I + G+ Y+H NK I+HRD++
Sbjct: 98 FEFCEH-DLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNE-EYDTKVD 336
+NIL G LK+ADFG+++ ++ ++ + Y PE+ E +Y +D
Sbjct: 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPID 206
Query: 337 VFSFALILQE 346
++ I+ E
Sbjct: 207 MWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 15/179 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + ++
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+P DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 99 MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNED 154
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEV 347
LK+ DFG+++ + D +T + Y APEV N Y VD++S I+ E+
Sbjct: 155 CELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 23/183 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
GI VAVKKL + RA+R EL LL+ + H N++ L T P + E+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKSLEEF--- 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
D+ ++ A + LD R G+ +LH IIHRDL+PSNI
Sbjct: 99 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ LK+ DFG+++ T + +T + Y APEV Y VD++S I+
Sbjct: 155 VVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212
Query: 345 QEV 347
E+
Sbjct: 213 GEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----MMIVT 229
G +VA+KK+ + D R R E+ LL+ +RHP++V+ + S + +V
Sbjct: 25 GEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E L + DL +K L P F + R + Y+H + HRDL+P NIL +
Sbjct: 84 E-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--------YDTKVDVFSFA 341
LK+ DFG++++ D P T YVA ++ E Y +D++S
Sbjct: 140 CKLKICDFGLARVAF--NDTPTAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIG 195
Query: 342 LILQEV 347
I EV
Sbjct: 196 CIFAEV 201
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 22/240 (9%)
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELD-------FTNSVEITKGTFILAFWRG 175
+ EK+ A + P K ++PE E P + T V T RG
Sbjct: 32 EAFEKYCAD--LDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRG 89
Query: 176 IQVAVKKLGEEVISDDDRVRAF-RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + V+ +D+R A+ R EL L H +V+ ++++ EY
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
GDL + LK + I ++ +H K ++HRDL+ +NI +G
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTG 206
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+K+ DFG SK + + L + C Y+APE+++ + Y K D++S +IL E+
Sbjct: 207 IIKLGDFGFSKQYS--DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264
|
Length = 478 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 34/191 (17%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229
VA+KK+ +++++ RA R EL LL+ R H N+ M IV
Sbjct: 27 EETVAIKKITNVFSKKILAK----RALR-ELKLLRHFRGHKNITCLYD-------MDIVF 74
Query: 230 ----------EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
E L + DL ++ L + F I G+ Y+H ++HRDL
Sbjct: 75 PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131
Query: 280 EPSNILRDDSGNLKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKV 335
+P N+L + LK+ DFG+++ + + +T + Y APE+ + Y +
Sbjct: 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI 191
Query: 336 DVFSFALILQE 346
DV+S IL E
Sbjct: 192 DVWSVGCILAE 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 60/185 (32%), Positives = 96/185 (51%), Gaps = 30/185 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM---IVTEYLP 233
VA+KK+ + + D R FR E+ LQ++ HPN+V+ L V ++ +V EY+
Sbjct: 35 VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM- 91
Query: 234 KGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
+ DL A + R L+ R+ + + + + Y+H +IHRDL+PSNIL + +
Sbjct: 92 ETDLHAVI-RANILED-VHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRV 146
Query: 293 KVADFGVSKLLTVKEDRP----LTCQDTSCRYVA------PEV-FKNEEYDTKVDVFSFA 341
K+ADFG+++ L+ E+ P LT YVA PE+ + Y VD++S
Sbjct: 147 KLADFGLARSLSELEENPENPVLT------DYVATRWYRAPEILLGSTRYTKGVDMWSVG 200
Query: 342 LILQE 346
IL E
Sbjct: 201 CILGE 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 33/77 (42%), Positives = 48/77 (62%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ IK +LD GIDVN +D + +T LH A +G E + +L E GADV+ +D G P+ A
Sbjct: 105 DMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIA 164
Query: 114 IYYKNHEVIKLLEKHGA 130
I + ++IKLL + GA
Sbjct: 165 IKHNFFDIIKLLLEKGA 181
|
Length = 434 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 46/174 (26%), Positives = 90/174 (51%), Gaps = 8/174 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E ++ DE ++ + P V + LG + +S + +VT+ +P G
Sbjct: 37 IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GM+YL E V ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG+++LL + E + +++A E + + + DV+S+ + + E+
Sbjct: 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +L ++ P +V + + +V ++ G+L L+R+G S A + ++
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
+ LH+ +I+RDL+P NIL D G++ + DFG+ KL +D+ +T C
Sbjct: 103 LCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----TNTFCG 155
Query: 319 --RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
Y+APE+ Y VD ++ ++L E+
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 26/194 (13%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D D + E+ +L+K H N+ + GA + +P
Sbjct: 23 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82
Query: 225 -MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K + LK +I RG+++LH++K +IHRD++
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKG 139
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 195
Query: 334 KVDVFSFALILQEV 347
K D++S + E+
Sbjct: 196 KSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 57/197 (28%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
VRA RD LA + +P VV+ + + + ++ EYLP GD+ L +K
Sbjct: 48 VRAERDILA---EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET- 103
Query: 254 RF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL--- 303
RF A+D + Y IHRD++P N+L D G++K++DFG+ L
Sbjct: 104 RFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 304 -------TVKEDRPLTCQDTSCR---------------------------YVAPEVFKNE 329
+ P D + Y+APEVF
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 330 EYDTKVDVFSFALILQE 346
Y+ + D +S +I+ E
Sbjct: 215 GYNKECDWWSLGVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
G+D + ++ + + L + + D+E IK L + G DVN D + +H+A F +++
Sbjct: 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDII 173
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA------KPLMAPMH--VKH 141
LLLE+GA + KD G +PL +A Y ++ IKLL HG K P+H + H
Sbjct: 174 KLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIH 233
Query: 142 AREVPEYEIDPHELDFTN 159
R E I+ ++ +
Sbjct: 234 NRSAIELLINNASINDQD 251
|
Length = 434 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 178 VAVKKLGEEVISDDD---RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK E S+DD + A R E+ +L++++HPN+V + + + +V EY
Sbjct: 29 VAIKKFVE---SEDDPVIKKIALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L K + + + +N+ H++ IHRD++P NIL G +K+
Sbjct: 85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQE 346
DFG +++LT D T Y APE+ + +Y VDV++ + E
Sbjct: 142 CDFGFARILTGPGDDYTDYVATRW-YRAPELLVGDTQYGPPVDVWAIGCVFAE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 42/173 (24%), Positives = 87/173 (50%), Gaps = 8/173 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA++++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 45 GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFG +T ++ + T T ++APEV + Y KVD++S ++ E+
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 26/194 (13%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D +D + E+ +L+K H N+ + GA + SP
Sbjct: 33 YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92
Query: 225 -MMIVTEYLPKGDLRAFLKR-KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K KG ALK +I RG+ +LH +K +IHRD++
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205
Query: 334 KVDVFSFALILQEV 347
+ D++S + E+
Sbjct: 206 RSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 255
F +E ++ P VVQ A + +V EY+P GDL + P +F
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFY 147
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
++ ++ +H + +IHRD++P N+L D G+LK+ADFG + + E + C D
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRC-D 201
Query: 316 TSC---RYVAPEVFKNEEYDT---------KVDVFSFALILQEVKFY 350
T+ Y++PEV K++ D V VF F +++ + FY
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G QVAVKK+ + R +E+ +++ H NVV + + +V E+L
Sbjct: 47 GKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + A L + R ++YLH +IHRD++ +IL G +K+
Sbjct: 104 GALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+DFG ++ + + + T ++APEV Y T+VD++S +++ E+
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTP-YWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 33/114 (28%), Positives = 62/114 (54%), Gaps = 15/114 (13%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKGDLRAFLK-----RKGALKPSTA 252
E+ALL++++H NVV + + + + + +Y + DL +K ++ ++ PS
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKL 302
I G++YLH N ++HRDL+P+NIL + G +K+ D G+++L
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G A+ +A ++ G+ L + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++D G++ + + E + + + Y+APEV NE+Y D + ++ E+
Sbjct: 142 RISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D + E+ ++++ +H N+V + G+ + I EY G L+ G L
Sbjct: 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGV+ +T +
Sbjct: 108 IAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164
Query: 312 TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEV 347
+ T ++APEV KN Y+ D+++ + E+
Sbjct: 165 SFIGTP-YWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 29/171 (16%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
F +E ++ P VVQ A + +V EY+P GDL + K A +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
V ALD M + IHRD++P N+L D SG+LK+ADFG + + ++ +
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 198
Query: 312 TCQDTSC---RYVAPEVFKNEEYDT---------KVDVFSFALILQEVKFY 350
C DT+ Y++PEV K++ D V VF + +++ + FY
Sbjct: 199 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 12/177 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYLP 233
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T S YL
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98
Query: 234 KGDLRAFLKRKGALKPST-AVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
++ L++ S V++ + + G+ Y+H IIHRDL+P N+ ++
Sbjct: 99 MPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCE 155
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEV 347
LK+ DFG+++ D +T + Y APEV N Y+ VD++S I+ E+
Sbjct: 156 LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 56/184 (30%), Positives = 80/184 (43%), Gaps = 25/184 (13%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232
G VA+KKL + RA+R EL L++ + H N++ L T Q S YL
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPS 282
+ A L ++ LD R G+ +LH IIHRDL+PS
Sbjct: 99 VMELMDANL--------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
NI+ LK+ DFG+++ T +T + Y APEV Y VD++S
Sbjct: 148 NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 343 ILQE 346
I+ E
Sbjct: 206 IMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G+L L ++ S +
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
+I +++LH+ II+RD++ NIL D G++ + DFG+SK L +E+R +
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 316 TSCRYVAPEVFKNEE--YDTKVDVFSFALILQEV 347
T Y+APEV + +D VD +S ++ E+
Sbjct: 169 T-IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFAL 257
E +L+ I HP+++Q G T + ++ LP K DL +L K + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-LTVKEDRPLTCQDT 316
+ R + YLHEN+ IIHRD++ NI + G++ + DFG + + + ++ T
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
APE+ + Y VD++S ++L E+
Sbjct: 247 IATN-APELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 40/129 (31%), Positives = 69/129 (53%), Gaps = 10/129 (7%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ +V +Y GDLR +K + + A + + ++++H +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170
Query: 281 PSNILRDDSGNLKVADFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
+NIL +G +K+ DFG SK+ TV +D T T YVAPE+++ + Y K D+F
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP-YYVAPEIWRRKPYSKKADMF 229
Query: 339 SFALILQEV 347
S ++L E+
Sbjct: 230 SLGVLLYEL 238
|
Length = 496 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 37/126 (29%), Positives = 69/126 (54%), Gaps = 12/126 (9%)
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV----RFALDIARG 262
++HPN++Q LG ++ P ++V EY GDL+++L ++ + ++ + R A +IA G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---R 319
+ ++H++ +H DL N +KV D+G+ KED + +D C R
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDY-IETEDDKCVPLR 166
Query: 320 YVAPEV 325
++APE+
Sbjct: 167 WLAPEL 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 29/160 (18%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMN 264
+VQ A + +V EY+P GDL + K A + V ALD M
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYV 321
+ IHRD++P N+L D SG+LK+ADFG + + + + C DT+ Y+
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRC-DTAVGTPDYI 210
Query: 322 APEVFKNE----EYDTKVD-----VFSFALILQEVKFYNQ 352
+PEV K++ Y + D VF + +++ + FY
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 40/142 (28%), Positives = 78/142 (54%), Gaps = 23/142 (16%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 222
+VAVKK+ V++D V+ E+ +++++ H N+V+ +G++T+
Sbjct: 32 RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + IV EY+ + DL L+ +G L A F + RG+ Y+H ++HRDL+P+
Sbjct: 89 NSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143
Query: 283 NIL-RDDSGNLKVADFGVSKLL 303
N+ + LK+ DFG+++++
Sbjct: 144 NVFINTEDLVLKIGDFGLARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE-VVSLLLERGADVDPK 102
+ ++E+ + ++ LL++G DVN + T LH+ T V+ LL++ GADV+ K
Sbjct: 54 YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113
Query: 103 DRWGSTPL-----GDAIYYKNHEVIKLLEKHGAKP------LMAPMHV 139
D+ G TPL G I K VI+LL + GA M P+ V
Sbjct: 114 DKVGRTPLHVYLSGFNINPK---VIRLLLRKGADVNALDLYGMTPLAV 158
|
Length = 471 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 23/180 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D+
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKSLEEF---QDV 97
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 98 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
LK+ DFG+++ T +T + Y APEV Y VD++S I+ E+
Sbjct: 154 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 37/111 (33%), Positives = 62/111 (55%), Gaps = 7/111 (6%)
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
GDL L + G + +A +I G+ ++H N+ V ++RDL+P+NIL D+ G++++
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFV--VYRDLKPANILLDEHGHVRI 138
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALIL 344
+D G++ + K +P T Y+APEV K YD+ D FS +L
Sbjct: 139 SDLGLACDFSKK--KPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 23/181 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QD 103
Query: 237 LRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILR 286
+ ++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 104 VYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 159
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
LK+ DFG+++ T +T + Y APEV Y VD++S I+ E
Sbjct: 160 KSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 347 V 347
+
Sbjct: 218 M 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
R L+L+ P +V A + + + + GDL L + G +A
Sbjct: 45 RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+I G+ ++H +++RDL+P+NIL D+ G+++++D G++ + K +P T
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTH 159
Query: 318 CRYVAPEVF-KNEEYDTKVDVFSFALIL 344
Y+APEV K YD+ D FS +L
Sbjct: 160 -GYMAPEVLQKGTAYDSSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 18/95 (18%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA--CQGFTEVVSLLLERGADVDPKDR--------- 104
++ LLD+G +VN ++ D LH+ + +++ LL+++G D++ K+R
Sbjct: 124 VEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYLLSYGV 183
Query: 105 -------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G TPL A+Y N E +K L GA P
Sbjct: 184 PINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANP 218
|
Length = 422 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + +D + LL G +VN D N + LH A +V +LLE GA D +D
Sbjct: 172 LHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231
Query: 104 RWGSTPLGDAI-YYKNHEVIKLLEKHG----AKPL---MAPMHVKHARE-----VPEYEI 150
+ G+TPL ++ Y K+++++KLL +HG AK + +H E + EY
Sbjct: 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLEYGA 291
Query: 151 DPHELDFTNSVEIT 164
D + L+ ++
Sbjct: 292 DINSLNSYKLTPLS 305
|
Length = 477 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 54.8 bits (131), Expect = 9e-09
Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 56 IKELLDSGI--DVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
K LL++G DVN D D T LH AA G ++V LLLE GAD + ++ +G T L
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186
Query: 113 AIYYKNHEVIKLLEKHG 129
A E++KLL G
Sbjct: 187 AAKNGRIELVKLLLDKG 203
|
Length = 235 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + + VV+ + + V +Y+P GD+ + L R G + A
Sbjct: 48 VKAERDILA---EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
+ ++ + +H+ + IHRD++P NIL D G++K+ DFG+
Sbjct: 105 FYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 151 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L N ++I +G T I+ R G QVAVK + + R +E+ +++
Sbjct: 18 DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCY 132
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY-VAPE 324
LH +IHRD++ +IL G +K++DFG + +D P Y +APE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPE 187
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
V Y T+VD++S +++ E+
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEM 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 17/155 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
E+ +L+ I H ++ + A S + M++ +Y K DL ++ R G L A+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL------T 312
+ + YLH IIHRD++ NI D+ N + DFG + L D P T
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ S PE+ + Y K D++S L+L E+
Sbjct: 251 LETNS-----PELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 3/70 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + + D A EL +L + +H N+V LGA T P++++TEY
Sbjct: 69 LRVAVKML--KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126
Query: 235 GDLRAFLKRK 244
GDL FL++K
Sbjct: 127 GDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 2/96 (2%)
Query: 32 DDDGEEIKP--EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
D+ GE P L+ +A+ + ++ELL + +D + D RT LH+AA +G+ + V
Sbjct: 515 DNGGEHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCV 574
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+LL+ +V +D G+T L +AI K+H++ ++L
Sbjct: 575 LVLLKHACNVHIRDANGNTALWNAISAKHHKIFRIL 610
|
Length = 823 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 27/75 (36%), Positives = 40/75 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G+ +N +D+ T LH A E V LL+ GA+ + +++G TPL AI
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234
Query: 116 YKNHEVIKLLEKHGA 130
N E+ KLL +G
Sbjct: 235 NNNKEIFKLLLNNGP 249
|
Length = 422 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 41/167 (24%), Positives = 76/167 (45%), Gaps = 22/167 (13%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
AF + +L+ ++ H ++V+ G V ++V EY+ G L FL R+ S +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKL 104
Query: 256 --ALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGN---LKVADFGVSKLLTVK 306
A +A ++YL + K ++H ++ NIL + G +K++D G+ + +
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEVKFYN 351
E+R ++APE +N + D +SF L E+ N
Sbjct: 162 EERVERIP-----WIAPECIRNGQASLTIAADKWSFGTTLLEI-CSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 39/153 (25%), Positives = 78/153 (50%), Gaps = 6/153 (3%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ IR P +V A + + ++ +Y+ G+L L ++ K ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+I + +LH+ + II+RD++ NIL D +G++ + DFG+SK E
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168
Query: 317 SCRYVAPEVFKNEE--YDTKVDVFSFALILQEV 347
+ Y+AP++ + + +D VD +S +++ E+
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG 146
Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
+ K T K++R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
VF Y+ D +S +I+ E+
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 38/174 (21%), Positives = 80/174 (45%), Gaps = 18/174 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVKK+ + + ++ + E+ ++++HPN++ ++ + S + +V+ + G
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 238 RAFLKR--KGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
LK L P A+ F L D+ ++Y+H IHR ++ S+IL G + +
Sbjct: 87 EDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRY-------VAPEVFKN--EEYDTKVDVFS 339
+ S + +K + + ++PEV + + Y+ K D++S
Sbjct: 143 SGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS 195
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-08
Identities = 25/50 (50%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +++ +K LL G DVN RD D RT LH+AA G EVV LLL
Sbjct: 77 LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFT-----EVVSLLLERGADVDPKDRWGSTPL 110
+K LLD+G D+N +N T LH + + E+V LLLE GA+V+ D G TPL
Sbjct: 51 VKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPL 110
Query: 111 GDAIYYK--NHEVIKLLEKHGAK 131
AI K ++ +++ L +GA
Sbjct: 111 LYAISKKSNSYSIVEYLLDNGAN 133
|
Length = 422 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 4e-08
Identities = 19/33 (57%), Positives = 23/33 (69%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104
D T LH+AA G EVV LLLE GADV+ +D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 33/97 (34%), Positives = 56/97 (57%), Gaps = 10/97 (10%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + +D P +
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR--DIYKD-PDYVR 232
Query: 315 DTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEV 347
S R ++APE ++ Y T+ DV+SF ++L E+
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 18/101 (17%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 178 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
PL +++APE ++ Y T+ DV+SF ++L E+
Sbjct: 235 ARLPL-------KWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 37/203 (18%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFG 146
Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
+ K T K +R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
VF Y+ D +S +I+ E+
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/173 (24%), Positives = 82/173 (47%), Gaps = 8/173 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVKK+ + R +E+ +++ +H NVV+ + + +V E+L
Sbjct: 45 GKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + A L + + ++ LH +IHRD++ +IL G +K+
Sbjct: 102 GALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+DFG ++ + R + T ++APE+ Y +VD++S +++ E+
Sbjct: 158 SDFGFCAQVSKEVPRRKSLVGTP-YWMAPELISRLPYGPEVDIWSLGIMVIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 9e-08
Identities = 34/129 (26%), Positives = 64/129 (49%), Gaps = 9/129 (6%)
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+PN ++ +VT +++ +Y+ GDL LK++G L + + + +N LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 269 NKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
+ IIH D++ N+L D + + + D+G+ K++ +C D + Y +PE K
Sbjct: 128 HN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIK 179
Query: 328 NEEYDTKVD 336
YD D
Sbjct: 180 GHNYDVSFD 188
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 24/167 (14%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ S + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
+ V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEV 347
+PL D + Y APE+ + TK +D+++ I E+
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 46/212 (21%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 150 IDPHELDFTNSVEITKGT--FILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELAL 203
I+ ++D SV I + I ++GI +V ++ + + +E+
Sbjct: 15 IESDDIDKYTSVLIKENDQNSI---YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKN 71
Query: 204 LQKIRHPNVVQFLG---AVTQSSP-MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
L++I N+++ G + P + ++ EY +G LR L ++ L T + A+D
Sbjct: 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDC 131
Query: 260 ARGMNYLHE--NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+G+ L++ NKP +++L + L ++ LK+ G+ K+L+ P
Sbjct: 132 CKGLYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNF 183
Query: 318 CRYVAPEVFKN--EEYDTKVDVFSFALILQEV 347
Y + ++ + EY K D++S ++L E+
Sbjct: 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + P VV + + + ++ E+LP GDL L +
Sbjct: 48 VKAERDVLA---ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+ + + +H+ + IHRD++P NIL D G++K++DFG+S
Sbjct: 105 FYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 38/153 (24%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G++ L ++ ++
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
+I + +LH+ + I++RD++ NIL D G++ + DFG+SK L+ +++R +
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEV 347
T Y+APE+ + + K VD +S +++ E+
Sbjct: 169 TI-EYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 16/176 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--MMIVTEYLPK 234
A+K + ++ ++V R E+ L+++ HPN+++ + + + +V E L
Sbjct: 27 YAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMD 83
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
+L +K RK L + + + ++++H N I HRD++P NIL D LK
Sbjct: 84 MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILK 139
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEV 347
+ADFG + + P T + S R Y APE + + Y K+D+++ + E+
Sbjct: 140 LADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-07
Identities = 26/53 (49%), Positives = 32/53 (60%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
RTALH AA G E+V LLE+G D++ D G+T L A N EV+KLL
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53
|
Length = 54 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 31/121 (25%), Positives = 62/121 (51%), Gaps = 3/121 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L R A + ++ + +H+ + IHRD++P NIL D G++K+ DFG
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG 146
Query: 299 V 299
+
Sbjct: 147 L 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 18/101 (17%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
++ +A+GM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
PL +++APE + Y + DV+SF ++L E+
Sbjct: 241 ARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 4/128 (3%)
Query: 8 RTTLLKQSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLA-NERDVEGIKELLDSGI 64
+ T L +S AP R +L G D + + IK E L +A N D E I+ L+ G
Sbjct: 273 KNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGA 332
Query: 65 DVNFRDIDNRTALHVAAC-QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
DVN D T LH A+ ++V LLE GA+V+ +D TP+ A N +I
Sbjct: 333 DVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIIN 392
Query: 124 LLEKHGAK 131
L +GA
Sbjct: 393 TLLDYGAD 400
|
Length = 682 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 32/121 (26%), Positives = 62/121 (51%), Gaps = 3/121 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L R G A + ++ + +H+ + IHRD++P NIL D G++K+ DFG
Sbjct: 90 SLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG 146
Query: 299 V 299
+
Sbjct: 147 L 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-07
Identities = 23/50 (46%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +E +K LL+ G+D+N D D TALH+AA G EV+ LLL
Sbjct: 5 LHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 49.8 bits (118), Expect = 4e-07
Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-----CQGFTEVVSLLLERGAD 98
L A++ D + +K LL SG DVN +D D T LH+AA +G EV LLLE GAD
Sbjct: 77 LHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGAD 136
Query: 99 VDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+D + G+TPL A + ++++LL + GA P
Sbjct: 137 LDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADP 173
|
Length = 235 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ + + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEV 347
+PL D + Y APE+ + TK +D+++ I E+
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-07
Identities = 20/47 (42%), Positives = 28/47 (59%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
ID+N D + T LH+AA G E+V LL+ G D++ +D G T L
Sbjct: 7 IDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 23/57 (40%), Positives = 32/57 (56%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L A D+ +KELL G++V+ D TAL VA + ++V LL+ GADVD
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD 682
|
Length = 823 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 17/163 (10%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
FR+E +L + + A + + +V +Y GDL L + P RF
Sbjct: 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 257 L-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
L ++ ++ +H+ + +HRD++P NIL D +G++++ADFG L + ED T Q
Sbjct: 108 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDG--TVQS 160
Query: 316 T----SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEVKF 349
+ + Y++PE+ + E Y + D +S + + E+ +
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 47.9 bits (113), Expect = 2e-06
Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
+ + L + + L + RD+D R LH AA +G ++V LLL GADV
Sbjct: 40 NLYLELALLPAASLSELLLKLIVDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADV 99
Query: 100 DPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKP 132
+ KD G TPL A N EV KLL + GA
Sbjct: 100 NAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADL 137
|
Length = 235 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 23/82 (28%), Positives = 42/82 (51%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ ++ +K L+ G D + + D + LH+A G + + LL++ A +D +D G TPL
Sbjct: 113 KKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPL 172
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A+ + + K+L GA
Sbjct: 173 IIAMAKGDIAICKMLLDSGANI 194
|
Length = 413 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 1/80 (1%)
Query: 52 DVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ E K LL G D+N +D TALH A + LLL GA+V+ D+ ++PL
Sbjct: 146 EAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPL 205
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
A+ + N ++ +L ++GA
Sbjct: 206 HHAVKHYNKPIVHILLENGA 225
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKE-LLDSGIDVNFRDIDNRTALHV 79
KEA ++G D ++I M L ER D I E LL+ G DVN +DI T +H
Sbjct: 126 KEA-ISGNDIHYDKINESIEYMKLIKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHY 184
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
AA +G ++V+LLL GADV+ + L A+ KN + IK
Sbjct: 185 AAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNIDTIK 228
|
Length = 682 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 28/179 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+Q VK+ I+D + + + E+A + K++HPN+V+ +G ++ EY+
Sbjct: 715 GMQFVVKE-----INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNL 292
+L L+ L + A+ IA+ + +LH ++ +L P I+ D D +L
Sbjct: 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++ G L C DT C YVAPE + ++ K D++ F LIL E+
Sbjct: 825 RLSLPG------------LLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871
|
Length = 968 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 45/180 (25%), Positives = 85/180 (47%), Gaps = 18/180 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G V V+ E +++ ++A ++E+ L RHPN++ T S + +++ ++
Sbjct: 25 GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 235 GDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
G + LK S A+ RG+NYLH+N IHR+++ S+IL G +
Sbjct: 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLV 140
Query: 293 KVADFGVSKL--LTVKEDRPLTCQD-----TSCR-YVAPEVFKNE--EYDTKVDVFSFAL 342
++ G+S L L + D TS +++PE+ + + Y+ K D++S +
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 34/139 (24%), Positives = 58/139 (41%), Gaps = 9/139 (6%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V + + +V ++ G L + + + + R+A ++ ++ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKN 328
I+ RDL P+NIL DD G++++ F E + Y APEV
Sbjct: 105 G---IVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGI 156
Query: 329 EEYDTKVDVFSFALILQEV 347
E D +S IL E+
Sbjct: 157 SEETEACDWWSLGAILFEL 175
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 35/179 (19%)
Query: 200 ELALLQKIRHPNVVQ----FLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPST 251
E+ ++++++H N+V+ FL Q + I+ E+ GDL + K G ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 252 AVRFALDIARGMNYLHENKPVP----IIHRDLEPSNI-----------LRDDSGNL---- 292
V + + Y H K P ++HRDL+P NI + + NL
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 293 --KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEV 347
K+ DFG+SK + + E +C T Y +PE+ +E YD K D+++ I+ E+
Sbjct: 180 IAKIGDFGLSKNIGI-ESMAHSCVGTP-YYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 13/138 (9%)
Query: 218 AVTQSSPMMI-VTEYLP----KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
A +SS +YLP + + AL V F+ +A GM +L V
Sbjct: 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNE 329
HRDL N+L + +K+ DFG+++ + D + ++ +++APE N
Sbjct: 262 ---HRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 330 EYDTKVDVFSFALILQEV 347
Y T DV+SF ++L E+
Sbjct: 317 LYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 29/186 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-----QFLGAVTQSSP---MMIV 228
+VA+KK V+ D + EL +++ + H N++ + ++ + +V
Sbjct: 93 KVAIKK----VLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 229 TEYLPKGDLRAFLK---RKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
E++P+ + ++K R P V+ ++ + R + Y+H I HRDL+P N+
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201
Query: 285 LRD-DSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 341
L D ++ LK+ DFG +K LL + C S Y APE+ Y T +D++S
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPELMLGATNYTTHIDLWSLG 258
Query: 342 LILQEV 347
I+ E+
Sbjct: 259 CIIAEM 264
|
Length = 440 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 150 IDPHELDFTNSVEITKGTFIL-------AFWR--------------GIQVAVKKLGEEVI 188
+DP +L + ++ E+ + +L AF R ++VAVK L
Sbjct: 21 VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80
Query: 189 SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
S + + A EL ++ + H N+V LGA T+ P+ I+TEY GDL +L R
Sbjct: 81 SSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR---- 134
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
T +++ LD R L P+ R S D G
Sbjct: 135 NKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 31/121 (25%), Positives = 57/121 (47%), Gaps = 10/121 (8%)
Query: 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+++ L G+ L + F +ARGM +L V HRDL N+L
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQG 273
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+K+ DFG+++ + D + ++ +++APE + Y T DV+S+ ++L E
Sbjct: 274 KIVKICDFGLAR--DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331
Query: 347 V 347
+
Sbjct: 332 I 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTE--VVSLLLERGADVDPKDRWGSTPLGDA 113
++EL+ +G D D+ T LH A + +V LL G ++ ++R+G TPL A
Sbjct: 205 VRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYA 264
Query: 114 IYYKNHEVIKLLEKHGAKP 132
+ N + L GA
Sbjct: 265 AVFNNPRACRRLIALGADI 283
|
Length = 471 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 22/139 (15%)
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V +Y GDL L + P RF L ++ ++ +H+ + +HRD++P N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVL 134
Query: 286 RDDSGNLKVADFGVS-KLL---TVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVD 336
D +G++++ADFG +LL TV+ + + D Y++PE+ + E Y + D
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD----YISPEILQAMEDGKGRYGPECD 190
Query: 337 -----VFSFALILQEVKFY 350
V + ++ E FY
Sbjct: 191 WWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 9/97 (9%)
Query: 44 LMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ--GFTEVVSLLLERG 96
L +L+N E +K LL+ G +VN D + T L A + +V LL+ G
Sbjct: 72 LHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNG 131
Query: 97 ADVDPKDRWGSTPLGDAIYYKNH--EVIKLLEKHGAK 131
A+V+ K+ G L + +++KLL G
Sbjct: 132 ANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVD 168
|
Length = 422 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 4/69 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKG 235
VAVK L E + + + A EL +L I H NVV LGA T+ P+M++ EY G
Sbjct: 40 VAVKMLKEGATASEYK--ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFG 97
Query: 236 DLRAFLKRK 244
+L +L+ K
Sbjct: 98 NLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 34/135 (25%), Positives = 68/135 (50%), Gaps = 17/135 (12%)
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSN 283
+ +V +Y GDL L + P RF + ++ ++ +H+ V HRD++P N
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV---HRDIKPDN 132
Query: 284 ILRDDSGNLKVADFG----VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTK 334
+L D +G++++ADFG +++ TV+ + D Y++PE+ + E Y +
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YISPEILQAMEDGMGKYGPE 188
Query: 335 VDVFSFALILQEVKF 349
D +S + + E+ +
Sbjct: 189 CDWWSLGVCMYEMLY 203
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 4e-05
Identities = 16/29 (55%), Positives = 20/29 (68%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D T LH+AA G E+V LLLE GAD++
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADIN 29
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 20/61 (32%), Positives = 29/61 (47%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL +GI +N R+ +T LH AA L+ GAD++ G+TPL + N
Sbjct: 243 LLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNN 302
Query: 119 H 119
Sbjct: 303 G 303
|
Length = 471 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 6e-05
Identities = 17/29 (58%), Positives = 22/29 (75%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D RT LH+AA G EVV LLL++GAD++
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADIN 29
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA---DVDPKDRWGS 107
RD E IK L+ G + + D + LH A +G + V LL+ G DV KD G
Sbjct: 46 RDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKD--GM 103
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL A K +++KLL GA P
Sbjct: 104 TPLHLATILKKLDIMKLLIARGADP 128
|
Length = 413 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 8/105 (7%)
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
AL + F+ +A+GM++L IHRDL NIL K+ DFG+++ +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR--DI 264
Query: 306 KEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ D + + +++APE N Y + DV+S+ ++L E+
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 3/68 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L + A EL +L + H N+V LGA T P +++TEY GD
Sbjct: 68 VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125
Query: 237 LRAFLKRK 244
L FL+RK
Sbjct: 126 LLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 18/160 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK--GDLRAFL-KRKGALKPSTAVRFA 256
E LL+++ HP V+ L +V LPK DL +L R L + A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT---- 312
+ ++Y+H IIHRD++ N+L + ++ + DFG + P
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 313 -CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351
DT+ APEV + Y VD++S L++ E +
Sbjct: 324 GTVDTN----APEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359
|
Length = 461 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WG 106
N R+VE K +L + N + ID + E+ LLL GAD++ KDR G
Sbjct: 110 NNRNVEIFKIILTNRYK-NIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKG 168
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKPLM------APMH--VKHARE 144
+T L A K+ + +LL +GA + +P+H VKH +
Sbjct: 169 NTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNK 214
|
Length = 477 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
VAVK L E + + + A EL +L I H NVV LGA T+ + P+M++ E+ G
Sbjct: 40 VAVKMLKEGATASEHK--ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97
Query: 236 DLRAFLKRK 244
+L FL+ K
Sbjct: 98 NLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 27/69 (39%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
VAVK L E + R A EL +L I H NVV LGA T+ P+M++ E+ G
Sbjct: 40 VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97
Query: 236 DLRAFLKRK 244
+L +L+ K
Sbjct: 98 NLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 50 ERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
E DV+ ++ELLD G DV ++D T LH+A +++ LL+ RGAD D +
Sbjct: 78 EGDVKAVEELLDLGKFADDVFYKD--GMTPLHLATILKKLDIMKLLIARGADPDIPNTDK 135
Query: 107 STPLGDAIYYKNHEVIKLLEKHGA 130
+PL A+ + + I+LL H A
Sbjct: 136 FSPLHLAVMMGDIKGIELLIDHKA 159
|
Length = 413 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 14/101 (13%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVK 306
+RF+ +A+GM++L IHRD+ N+L D K+ DFG+++ + VK
Sbjct: 215 LRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ L +++APE + Y + DV+S+ ++L E+
Sbjct: 272 GNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 28/73 (38%), Positives = 37/73 (50%), Gaps = 1/73 (1%)
Query: 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-CQGFTEVVSLLLERGA 97
K + L+ D+E L D+G VN D T LH A+ + +V LLERGA
Sbjct: 239 KNDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSRLVPKLLERGA 298
Query: 98 DVDPKDRWGSTPL 110
DV+ K+ G TPL
Sbjct: 299 DVNAKNIKGETPL 311
|
Length = 682 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 3/69 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L S + + A EL ++ + H N+V LGA T+S P+ I+TEY
Sbjct: 68 MKVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125
Query: 235 GDLRAFLKR 243
GDL +L +
Sbjct: 126 GDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 31/196 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+KK+ E++ + + F E + + HP +V + P+ Y+
Sbjct: 29 RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88
Query: 237 LRAFLKR-------KGALKPSTAVRFALDI----ARGMNYLHENKPVPIIHRDLEPSNIL 285
L++ LK L T+V L I + Y+H ++HRDL+P NIL
Sbjct: 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNIL 145
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTC---QDTSC--------------RYVAPEVFKN 328
G + + D+G + ++E+ L + C Y+APE
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
Query: 329 EEYDTKVDVFSFALIL 344
D+++ +IL
Sbjct: 206 VPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 17/170 (10%)
Query: 189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL 247
S D AF + +L+ ++ H ++ G + S ++V E++ G L L++ KG +
Sbjct: 55 SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV 114
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFGVS 300
+ + A +A ++YL E+K ++H ++ NIL G +K++D GVS
Sbjct: 115 PVAWKITVAQQLASALSYL-EDK--NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKF 349
+E+R ++APE T D +SF L E+ F
Sbjct: 172 FTALSREERV-----ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA---CQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+K L+D G +VN ++ D T LH A C+ +V+ +LL+ GADV+ + PL
Sbjct: 425 VKTLIDRGANVNSKNKDLSTPLHYACKKNCK--LDVIEMLLDNGADVNAINIQNQYPLLI 482
Query: 113 AIYYKNHEVIKLLEKHGAK 131
A+ Y H ++ +L +GA+
Sbjct: 483 ALEY--HGIVNILLHYGAE 499
|
Length = 682 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)
Query: 52 DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
D + +K LL+ G+DVN + I TALH + + LLLE GAD++ + + TPL
Sbjct: 247 DYDILKLLLEHGVDVNAKSYILGLTALHSSIKS--ERKLKLLLEYGADINSLNSYKLTPL 304
Query: 111 GDAIY-YKNHEVIKLLEKH 128
A+ Y + ++L +
Sbjct: 305 SSAVKQYLCINIGRILISN 323
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+R+ + + LL+ G +VN RD ++T +H AA + +++ LL+ GAD++ + T
Sbjct: 352 DRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTA 411
Query: 110 LGDAIYYKN-HEVIKLLEKHGA------KPLMAPMH 138
L A+ N + +K L GA K L P+H
Sbjct: 412 LHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLH 447
|
Length = 682 |
| >gnl|CDD|165256 PHA02946, PHA02946, ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
+ER VE ELL G N D D LH+A+ +V++LL GAD + D+ T
Sbjct: 51 DERFVE---ELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKT 107
Query: 109 PLGDAIYY---KNHEVIK---LLEKHGAK 131
PL YY + EVI+ LL ++GAK
Sbjct: 108 PL----YYLSGTDDEVIERINLLVQYGAK 132
|
Length = 446 |
| >gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 19/83 (22%)
Query: 68 FRDIDNRTALHVAA-CQGFTEVVSLLLERGADVDPK---DRWGSTPLGDAIYY------- 116
I TALH+AA Q + E+V LLLERGA V + D + + D+ Y+
Sbjct: 126 TPGI---TALHLAAHRQNY-EIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNA 181
Query: 117 ----KNHEVIKLLEKHGAKPLMA 135
+ ++ LL + A L A
Sbjct: 182 AACLGSPSIVALLSEDPADILTA 204
|
The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 165 KGTFILAFWRGIQVAVKKLGE----EVI------SDDDRVRAFRDELALLQKIRHPNVVQ 214
+GTF F +GI+ V GE EV+ S + +F + +++ ++ H ++V
Sbjct: 5 QGTFTKIF-KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL 63
Query: 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-AVRFALDIARGMNYLHENKPVP 273
G ++V EY+ G L +LK+ L + + A +A +++L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--- 120
Query: 274 IIHRDLEPSNIL-----RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
+ H ++ N+L +GN +K++D G+S +TV L +V PE
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILL---ERIPWVPPEC 175
Query: 326 FKN-EEYDTKVDVFSFALILQEV 347
+N + D +SF L E+
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165103 PHA02736, PHA02736, Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.001
Identities = 19/58 (32%), Positives = 34/58 (58%), Gaps = 4/58 (6%)
Query: 72 DNRTALHVAACQGFT---EVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLL 125
+ +H+ + E + LL+E GAD++ K+R +G+TPL A+Y +N+E+ L
Sbjct: 54 HGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWL 111
|
Length = 154 |
| >gnl|CDD|165089 PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 4/95 (4%)
Query: 20 DRERKEAELNGLDDDGEEIKPEFRLMF--LANERDVEGIKELLDSGIDVNFRDIDNRTAL 77
+ E + LD + + P + LA D+ + L G+ ++++D RT L
Sbjct: 262 NPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCL 321
Query: 78 HVAACQGF--TEVVSLLLERGADVDPKDRWGSTPL 110
H + T+++ LL E G D++ D G+T L
Sbjct: 322 HQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVL 356
|
Length = 764 |
| >gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 8/84 (9%)
Query: 56 IKELLDSGIDVNFRDIDNRTAL-----HVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+K ++ G +VN D + T L ++ + ++V +L+E GAD++ K+ G TPL
Sbjct: 54 VKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPL 113
Query: 111 GDAI---YYKNHEVIKLLEKHGAK 131
+ Y N E++ + ++GA
Sbjct: 114 YCLLSNGYINNLEILLFMIENGAD 137
|
Length = 489 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.82 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.79 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.79 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.79 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.78 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.78 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.77 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.76 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.76 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.75 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.75 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.75 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.75 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.74 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.74 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.74 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.74 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.73 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.73 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.73 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.73 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.73 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.72 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.72 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.71 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.71 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.7 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.7 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.7 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.69 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.68 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.66 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.66 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.66 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.66 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.66 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.66 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.65 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.64 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.64 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.63 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.63 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.62 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.62 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| cd00204 | 126 | ANK ankyrin repeats; ankyrin repeats mediate prote | 99.58 | |
| PTZ00322 | 664 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatas | 99.58 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.58 | |
| KOG0505 | 527 | consensus Myosin phosphatase, regulatory subunit [ | 99.58 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.58 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.58 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.57 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 99.57 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.55 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=331.02 Aligned_cols=193 Identities=34% Similarity=0.579 Sum_probs=175.5
Q ss_pred CCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
.-+|...++||+|+|+.|| .++..||||.+.+... ..+.++.+..|+.+|+.++|||||++++++..++.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3478888889999999998 3678999999987765 566778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC------CCEEEEccCCccc
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKL 302 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~------~~vkL~Dfg~a~~ 302 (352)
||||.||+|.+|+++.+.+++..+..++.||+.||++||+++ ||||||||+|||++.. ..+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999999999999999999999999999999999 9999999999999965 4589999999998
Q ss_pred ccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+... .......|++.|||||++....|+.|+|+||+|+|+|+|++|+.
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~ 212 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKP 212 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCC
Confidence 8743 33345779999999999999999999999999999999999973
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=322.99 Aligned_cols=194 Identities=32% Similarity=0.482 Sum_probs=179.5
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|+..+.||+|+||.|+ .+++-+|+|++++..+......+..+.|..+|..++||+||.++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 378899999999999887 468899999999988888778889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+.||.|...+++.+.+++..+..++.+|+.||.|||++| ||||||||+|||++.+|.++|+|||+++..-..+.
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~- 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD- 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999986544332
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|||||++.+.+|+..+|+||||+++|||++|.+
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 3344789999999999999999999999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=333.08 Aligned_cols=205 Identities=29% Similarity=0.473 Sum_probs=188.2
Q ss_pred cCCCcccCCCCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q 018682 144 EVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (352)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 218 (352)
.+|+.-.++....|...+.||+|+|..+| .+|..||+|++.+..+..+...+.+.+|+++-++|+|||||+++++
T Consensus 7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~ 86 (592)
T KOG0575|consen 7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF 86 (592)
T ss_pred CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence 34444455555789999999999999988 3689999999999888888888999999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
|++.+.+|+|+|+|..++|..++++.+++++.++..+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||
T Consensus 87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence 9999999999999999999999999999999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+|..+...+.+ .....|||.|.|||++....++..+||||+||+||-||+|.+
T Consensus 164 LAt~le~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P 216 (592)
T KOG0575|consen 164 LATQLEYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP 216 (592)
T ss_pred eeeeecCcccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence 99988765443 345789999999999999999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=305.86 Aligned_cols=194 Identities=27% Similarity=0.475 Sum_probs=168.4
Q ss_pred CCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeE-EEEeCCc-eE
Q 018682 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MM 226 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~ 226 (352)
..+|++.++||+|+||.|| ++|..+|.|.+.-... +....+.+..|+.+|++|+|||||++++ .|.+++. ++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3479999999999999887 6899999999984433 5556677888999999999999999998 5666666 99
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 227 IVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP-VPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
++||+|.+|+|...++. ...+++..+++++.|++.||..+|++=+ ..|+||||||.||+++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999998863 3459999999999999999999999211 139999999999999999999999999999
Q ss_pred cccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
.+.... ....+.+|||.||+||.+.+.+|+.++||||+||++|||..
T Consensus 177 ~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca 223 (375)
T KOG0591|consen 177 FLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA 223 (375)
T ss_pred Hhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh
Confidence 887543 33456889999999999999999999999999999999964
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=306.42 Aligned_cols=188 Identities=31% Similarity=0.484 Sum_probs=171.8
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc-eEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 229 (352)
+++....||+|..|.|+ ++++.+|+|.+... .++...+++.+|+++++.++||+||.+|+.|..++. ++++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 56667799999999887 47899999999543 356777889999999999999999999999999995 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||++|+|.++++..+.+++.....++.++++||.|||. ++ ||||||||+|||++..|.|||+|||.|..+.+.
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999988889999999999999999999996 77 999999999999999999999999999887654
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
...++.||..|||||.+.+..|+.++||||||+.++||.+|.
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~Gr 274 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGR 274 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCC
Confidence 445678999999999999999999999999999999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=310.63 Aligned_cols=192 Identities=27% Similarity=0.399 Sum_probs=167.8
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
.|...+.+|+|+||.|. .+|+.||||++++....... ....+++|+++|++++||+||+++++|...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 58888999999999886 47999999999987655422 2334679999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---CCEEEEccCCcccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLL 303 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~vkL~Dfg~a~~~ 303 (352)
+||||++||+|.+.+-.++.+.+...+.++.|++.|+.|||++| |+||||||+|||++.+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999888999999999999999999999999 9999999999999876 56999999999987
Q ss_pred cccCCCCcccCCCCCccccccccCCCCC---CCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEY---DTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~elltG~~ 352 (352)
.. ........|||.|.|||++.+..+ ..++|+|||||+||-+|+|-+
T Consensus 330 g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 330 GE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred cc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 63 333455789999999999976643 347899999999999999853
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=293.49 Aligned_cols=190 Identities=28% Similarity=0.499 Sum_probs=176.6
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+-||.|+||+|- .+|.-+|+|++.+..+-.-...+...+|..+|+.+.||+++++++.|.+.+.+|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 78889999999999885 4688999999998877677777888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|++||.|..++++.+++++..+..++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+.... .
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----r 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----R 197 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC----c
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999987543 2
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....|||.|+|||++...+++..+|+|||||++|||+.|-+
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 445789999999999999999999999999999999999853
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=310.82 Aligned_cols=202 Identities=45% Similarity=0.774 Sum_probs=176.5
Q ss_pred cCCCcccCCCCCcccCceeecccEEEEEE---EcCeE-EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q 018682 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (352)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~ig~G~~~~v~---~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 219 (352)
..+.+++++.++.+.. .||+|+||.|| |.|+. ||+|++......... .+.|.+|+.+|.+++|||||++++++
T Consensus 32 ~~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred cccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 3456677666555444 59999999887 88998 999999877655544 78899999999999999999999999
Q ss_pred EeCC-ceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEE
Q 018682 220 TQSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVA 295 (352)
Q Consensus 220 ~~~~-~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~ 295 (352)
.+.. .+++||||+++|+|.+++.. ...++...++.++.||++||+|||++++ ||||||||+|||++.++ .+||+
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEEC
Confidence 9887 79999999999999999987 5679999999999999999999999985 99999999999999997 99999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccC--CCCCCCchhHHHHHHHHHHhhccC
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~elltG~ 351 (352)
|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+
T Consensus 187 DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~ 243 (362)
T KOG0192|consen 187 DFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGE 243 (362)
T ss_pred CCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCC
Confidence 999998765422 2334467999999999999 569999999999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=295.44 Aligned_cols=192 Identities=22% Similarity=0.407 Sum_probs=168.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+...++|+|+||.|+ .+|+.||||++.... .++...+-..+|+++|++++|||+|.++++|.....+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 47777899999999997 479999999998653 345555666889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
||+..-|.++-.....++...+..++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||+|+.+.. ....
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 9977555554444456899999999999999999999999 99999999999999999999999999998875 3445
Q ss_pred cccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
++.++.|.+|+|||.+.+ .+|.+.+||||+||++.||++|.+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~p 200 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEP 200 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCc
Confidence 667788999999999887 689999999999999999999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=311.06 Aligned_cols=198 Identities=28% Similarity=0.461 Sum_probs=174.3
Q ss_pred cCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--
Q 018682 150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-- 222 (352)
Q Consensus 150 i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 222 (352)
.....-.|+..++||+|+||.||. +|+.||+|++......+ +......+|+.+|++|.||||+++.+...+.
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 334445799999999999999983 68899999998765433 3334557799999999999999999988776
Q ss_pred CceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
+.+|+|+|||+. +|.-++...+ .+++.+++.+++||+.||+|||++| |+|||||.+||||+.+|.+||+|||+|+
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence 689999999965 8888887654 4999999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
++........+..+-|.+|+|||++.+. .|++.+|+||+||||.||++|++
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 9887777778888899999999998775 89999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.90 Aligned_cols=196 Identities=28% Similarity=0.501 Sum_probs=178.4
Q ss_pred CCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEE
Q 018682 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 227 (352)
..+|...+.||.|+|..|+ ..++.||||++.+..+..+..++-+..|-..|.+| .||.|+++|..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3478888999999999887 36889999999988877777777788899999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|+||+++|+|.+++++.+.+++..+..++.||+.||+|||++| ||||||||+|||++.++.++|+|||.|+.+....
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999998875322
Q ss_pred CC----------C--cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DR----------P--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~----------~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. . ..+++||..|.+||++.....++.+|||+||||+|+|+.|.+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~P 285 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQP 285 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCC
Confidence 11 1 145889999999999999999999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.99 Aligned_cols=196 Identities=29% Similarity=0.404 Sum_probs=176.6
Q ss_pred CCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
..-+|+..+.||+|+||.|+ .+|..+|+|++++........+..++.|-.+|....+|+||++|.+|.+...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 34478999999999999997 4688999999999888788888999999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc--
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV-- 305 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~-- 305 (352)
||||++||++..++.+.+.+++..+..++.+++.|++.+|+.| +|||||||+|+|||..|.+||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999999999999999999999999999999999999999 99999999999999999999999999853311
Q ss_pred -------------------cCCCC-----c--------------------ccCCCCCccccccccCCCCCCCchhHHHHH
Q 018682 306 -------------------KEDRP-----L--------------------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341 (352)
Q Consensus 306 -------------------~~~~~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 341 (352)
..+.. . .+.+|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 00000 0 245699999999999999999999999999
Q ss_pred HHHHHhhccC
Q 018682 342 LILQEVKFYN 351 (352)
Q Consensus 342 ~il~elltG~ 351 (352)
||+||||.|=
T Consensus 376 ~ImyEmLvGy 385 (550)
T KOG0605|consen 376 CIMYEMLVGY 385 (550)
T ss_pred HHHHHHHhCC
Confidence 9999999984
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=305.67 Aligned_cols=191 Identities=30% Similarity=0.536 Sum_probs=173.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|-+.+.||+|+||.||. +.+.||+|.+.+... .++..+.+++|+++++.++||||+.++++|+....+|+|+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 577788999999999984 567899998876543 45567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+.| +|..++...+.++++.+..++.|++.||.|||+++ |+|||+||.|||+...+.+|++|||+++.+... ...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 9976 99999999999999999999999999999999999 999999999999999999999999999887642 334
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....|||.|||||++.+.+|+..+|+||||||+|||++|++
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 456789999999999999999999999999999999999975
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=294.38 Aligned_cols=192 Identities=28% Similarity=0.522 Sum_probs=178.1
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.|. ..|+.||||.+++..+.++...-.+++|+++|..|+||||+.+|++|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 378888999999999886 468999999999999988877788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||..+|.|++|+.+.+.+++.++..+++||++|+.|+|.++ ++|||||.+|||++.++++||+|||++..+.. .+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~--~k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KK 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--cc
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999987653 33
Q ss_pred CcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
....+.|++-|.+||++.+.+| .+.+|-||||++||.|+.|.
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGt 250 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGT 250 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcc
Confidence 4456789999999999999988 57899999999999999884
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=302.45 Aligned_cols=194 Identities=31% Similarity=0.517 Sum_probs=171.3
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH--HHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCce
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 225 (352)
.-.|...+.||+|+||.|+. ++..||+|++........ ...+.+.+|+.++++++ ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 44789999999999999873 578999998776533211 23456778999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-CCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~vkL~Dfg~a~~~~ 304 (352)
|+||||+.||+|.+++.+.+++++.++..+++|+++|++|||++| |+||||||+|||++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999889999999999999999999999999 9999999999999999 999999999998764
Q ss_pred ccCCCCcccCCCCCccccccccCCCC-CC-CchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~il~elltG~ 351 (352)
..........||+.|+|||++.+.. |+ .++||||+||+||.|++|.
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~ 220 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR 220 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 2334455678999999999999977 86 6899999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=274.88 Aligned_cols=191 Identities=29% Similarity=0.526 Sum_probs=167.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|...+.+|+|+||.|| .+|+.||||+++.....+.-... ..+|++.|+.++|+||+.+++.|...+.+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~t-alREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRT-ALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHH-HHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57888899999999998 46899999999987665444444 4569999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|++ .+|...++... .+++.+++.|+.++++|++|||++. |+||||||.|+|++.+|.+||+|||+++.+......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 995 59999998654 4899999999999999999999999 999999999999999999999999999988765443
Q ss_pred CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
. ...+.|..|+|||.+.+ ..|+..+||||.|||+.||+-|.+
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P 200 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP 200 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence 3 33367889999998865 578999999999999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=298.21 Aligned_cols=198 Identities=35% Similarity=0.611 Sum_probs=169.1
Q ss_pred CCcccCCCCCcccCceeecccEEEEEE---EcCe-EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAF---WRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~---~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 221 (352)
..|++++.. ++..+.||+|.||.|+ |++. +||+|.++...... +.|.+|+++|++|+|++||++++++..
T Consensus 199 d~wei~r~~--l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 199 DPWEIPREE--LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred CCeeecHHH--HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 345555543 4556799999999875 7777 99999998765443 567899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
++.+||||||++.|+|.+|++. ...+...+.+.++.||++|++||++++ +|||||.+.|||++++..+||+|||+
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccc
Confidence 9999999999999999999987 455899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
|+..............-...|.|||.+....++.+||||||||+||||+|-++
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~ 402 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR 402 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence 99543322222222334567999999999999999999999999999999654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=279.00 Aligned_cols=191 Identities=31% Similarity=0.491 Sum_probs=165.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 228 (352)
+|+...+|++|+||.||. ++..||+|+++.+.....-.+.. .+|+.+|.+++|||||.+-++... -+.+|+|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIts-LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITS-LREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchh-HHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 688899999999999983 56789999998876444333443 459999999999999999888764 3569999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||||+. +|..++..-+ +++..+++.++.|+++|++|||.+. |+||||||+|+|++..|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999965 9999998654 6999999999999999999999999 999999999999999999999999999988764
Q ss_pred CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
.++.+..+-|.+|+|||++.+. .|+...|+||+|||+.||+++++
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP 276 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence 4455667779999999988764 78999999999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=270.51 Aligned_cols=311 Identities=29% Similarity=0.448 Sum_probs=243.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
..-|.|.-|..|-.|||+||+.|+..++++|++.|+.+|..|.-..||||+||.+|+.++|+.|++..+|+|..|..|.|
T Consensus 23 tehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgnt 102 (448)
T KOG0195|consen 23 TEHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNT 102 (448)
T ss_pred cccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCC
Confidence 34566667777888899999999999999999999999999998999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCcc-----------------------cccccccCCCcccC--------------
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM-----------------------HVKHAREVPEYEID-------------- 151 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~-----------------------~~~~~~~~~~~~i~-------------- 151 (352)
|||||+.+|...+++-|+..|+.+..-.. ++.+...+|..+..
T Consensus 103 plhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatls 182 (448)
T KOG0195|consen 103 PLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLS 182 (448)
T ss_pred chhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccc
Confidence 99999999999999999998875422111 12222223321111
Q ss_pred ------CCCCcc-cCceeecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 152 ------PHELDF-TNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 152 ------~~~~~~-~~~~~ig~G~~~~v~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
...+++ +....-.+|..+.+.|.|..+++|++....... ...+.|..|+-.|+-+.||||+.+++.|.....
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 111111 111122456777888999999999987654432 233578899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceec-CCCCCCeEeCCCCCEEEE--ccCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHR-DLEPSNILRDDSGNLKVA--DFGV 299 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~-Dikp~Nill~~~~~vkL~--Dfg~ 299 (352)
+.++..|++.|+|+.++..... .+..++.+++.++++|+.|||+..| ++-| -|.+..++++++.+.+|. |--+
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheeccccee
Confidence 9999999999999999987654 6788999999999999999999884 4444 688999999998876653 4333
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCC---CchhHHHHHHHHHHhhcc
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEVKFY 350 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DiwslG~il~elltG 350 (352)
+.+- .. ...+|.||+||.+...+-+ ..+|+|||++++|||-|.
T Consensus 340 sfqe---~g-----r~y~pawmspealqrkped~n~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 340 SFQE---VG-----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTR 385 (448)
T ss_pred eeec---cc-----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence 3221 11 2235789999999877554 369999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.55 Aligned_cols=193 Identities=29% Similarity=0.509 Sum_probs=164.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC--ceE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 226 (352)
..++...+.||+|+||.|+. +|...|+|.+.... .. ..+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45688889999999999973 36899999887552 22 2677999999999999999999999754444 699
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEccCCccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Dfg~a~~~~ 304 (352)
++|||+++|+|.+++.+.+ .+++..+..+.+|+++||.|||++| |+||||||+|||++. ++.+||+|||++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999877 7999999999999999999999999 999999999999999 7999999999998765
Q ss_pred c--cCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 305 V--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 305 ~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
. ..........||+.|||||++..+ ...+++|||||||++.||+||++
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 3 222233457799999999999853 33459999999999999999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.74 Aligned_cols=203 Identities=36% Similarity=0.557 Sum_probs=173.8
Q ss_pred CCcccCCCCCcccCceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 221 (352)
+..++...+.+|.....||+|+||.|| .+|..||||++....... ..+|.+|+.++.+++|||+|+++|+|.+
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 334555566689999999999999998 356899999887654321 3459999999999999999999999999
Q ss_pred CCc-eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 222 SSP-MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 222 ~~~-~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
.+. .++|+||+++|+|.+++.... +++|..+.+|+.++++||+|||+..+.+|+||||||+|||+|.+.++||+|||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 884 999999999999999997654 78999999999999999999999876679999999999999999999999999
Q ss_pred CcccccccCCCCcccC-CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 299 VSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+|+..... ....... .||.+|+|||+...+..+.++||||||++|.||+||.+
T Consensus 223 La~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 223 LAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred CcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCc
Confidence 99665431 2222222 78999999999998899999999999999999999973
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=294.68 Aligned_cols=194 Identities=25% Similarity=0.407 Sum_probs=169.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.||. +++.||+|++.............++.|+.++++++||+|+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 578889999999999873 478999999976544444555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC--
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-- 308 (352)
|+++++|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999875432110
Q ss_pred --------------------------------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00123468999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=291.59 Aligned_cols=186 Identities=26% Similarity=0.454 Sum_probs=163.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCC-ceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv 228 (352)
+|+..++||.|+||.|+. .|..||||.++.+...-++. -. .+|++.|++++ ||||+++.+++.+.+ .+|+|
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~n-LREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HH-HHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 789999999999999983 57889999999876543322 22 45999999998 999999999999888 89999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||| ..+|+++++.+. .+++..+..|+.||++||+|+|.+| +.|||+||+|||++....+||+|||+|+....
T Consensus 89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc--
Confidence 9999 579999998654 4999999999999999999999999 99999999999999888999999999998654
Q ss_pred CCCcccCCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhc
Q 018682 308 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt 349 (352)
..+++.++.|.+|+|||++. ...|+.+.||||+|||++|+.+
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s 205 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS 205 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH
Confidence 34667788999999999875 5678999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=295.54 Aligned_cols=190 Identities=30% Similarity=0.465 Sum_probs=171.2
Q ss_pred ccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+-||.|+-|.|. .+|+.+|||++.+...........+.+|+-+|+.+.|||++++|++++...++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 4456789999999886 57999999999877544455556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+++|.|.+++-+++++++.++.+++.||+.|+.|||..+ |+|||+||+|+|++..+++||+|||+|..-. ..+..
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklL 168 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLL 168 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CCccc
Confidence 999999999999999999999999999999999999999 9999999999999999999999999997643 34445
Q ss_pred ccCCCCCccccccccCCCCCC-CchhHHHHHHHHHHhhccC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltG~ 351 (352)
...+|+|.|.|||++.+.+|+ .++||||+|||||.||||+
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~ 209 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK 209 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence 567899999999999999885 6899999999999999996
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.41 Aligned_cols=190 Identities=24% Similarity=0.442 Sum_probs=171.1
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
..|+.-++||+|..|.|| .+++.||+|.+...... ..+-+.+|+.+|+..+|+|||.+++.|...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 368888899999999887 46788999999765433 3456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||++||+|.+.+... .+++.++..+++++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999999999998765 4899999999999999999999999 99999999999999999999999999988876544
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....+||++|||||++....|++++||||||++++||+-|.+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 4456789999999999999999999999999999999999974
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=296.40 Aligned_cols=194 Identities=27% Similarity=0.413 Sum_probs=175.1
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceE
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 226 (352)
..-+|...+.||+|+||.|.. +++.+|||++++..+-..+.++..+.|..++.... ||+++.++..|....++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 344799999999999999873 57799999999999988889999999999999885 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+||||+.||++..+.+ .+.+++..+..|+..|+.||.|||++| ||+||||.+|||+|.+|.+||+|||+++.....
T Consensus 446 fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999554443 456999999999999999999999999 999999999999999999999999999875533
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ....+.|||.|+|||++.+..|+..+|+|||||+|||||.|.
T Consensus 522 g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq 565 (694)
T KOG0694|consen 522 GD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGE 565 (694)
T ss_pred CC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCC
Confidence 33 445688999999999999999999999999999999999996
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=276.77 Aligned_cols=191 Identities=30% Similarity=0.535 Sum_probs=164.1
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc-eeeeeEEEEeCC------
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------ 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~------ 223 (352)
.|+..++||+|+||.|| .+|+.||+|++......+ ..-....+|+.+++.++|+| |+++++++..++
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 57778889999999998 368899999998764321 12234567999999999999 999999998877
Q ss_pred ceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
.+++|+||+ .-+|..++...+ .++...++.++.||+.||.|||+++ |+||||||+|||+++.|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 799999999 459999998755 4777889999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
|+....+ .........|..|+|||++.+. .|++..||||+|||++||+++.+
T Consensus 167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 9876543 3335567789999999998876 78999999999999999999764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=293.16 Aligned_cols=193 Identities=23% Similarity=0.360 Sum_probs=168.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|+||.||. +++.||+|++.............+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999973 578999999976655455566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~- 309 (352)
|+++++|.+++.+...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999987543110000
Q ss_pred ---------------------------------------------CcccCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 018682 310 ---------------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (352)
Q Consensus 310 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 344 (352)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 01134689999999999988999999999999999
Q ss_pred HHhhccC
Q 018682 345 QEVKFYN 351 (352)
Q Consensus 345 ~elltG~ 351 (352)
|||+||.
T Consensus 239 ~elltG~ 245 (381)
T cd05626 239 FEMLVGQ 245 (381)
T ss_pred HHHHhCC
Confidence 9999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=283.08 Aligned_cols=189 Identities=25% Similarity=0.443 Sum_probs=167.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++...........+.+.+|+.+++.++||||+++++++.++..++++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 578889999999998873 478999999875443333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998765321
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~ 195 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 12345789999999999988999999999999999999986
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=293.36 Aligned_cols=193 Identities=26% Similarity=0.398 Sum_probs=167.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++...........+.+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 578889999999999983 678999999875443344456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~- 309 (352)
|+++++|.+++.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998632210000
Q ss_pred ---------------------------------------------CcccCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 018682 310 ---------------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (352)
Q Consensus 310 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 344 (352)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00124588999999999998999999999999999
Q ss_pred HHhhccC
Q 018682 345 QEVKFYN 351 (352)
Q Consensus 345 ~elltG~ 351 (352)
|||++|.
T Consensus 239 ~elltG~ 245 (377)
T cd05629 239 FECLIGW 245 (377)
T ss_pred hhhhcCC
Confidence 9999996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=291.63 Aligned_cols=193 Identities=26% Similarity=0.437 Sum_probs=168.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.||. +|+.||+|++.............+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 688889999999999873 578999999976544444555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~- 309 (352)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998654321100
Q ss_pred ------------------------------------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 ------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++....++.++|||||||++|||++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 001235899999999999989999999999999999999986
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=277.33 Aligned_cols=188 Identities=30% Similarity=0.486 Sum_probs=158.8
Q ss_pred CCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC---
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 223 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 223 (352)
...+.|...+.+|+|+||.||. .+.+||||++..+.- --.+|+.+|+.++|||||++..+|....
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 3556899999999999999984 578999998865432 1136999999999999999988886432
Q ss_pred --ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-CCEEEEc
Q 018682 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVAD 296 (352)
Q Consensus 224 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~vkL~D 296 (352)
...+||||++. +|.++++. +..++.-.++-++.||++||.|||+.| |+||||||+|+|+|.+ |.+||+|
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicD 169 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICD 169 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEecc
Confidence 35689999965 99888874 456888899999999999999999999 9999999999999966 8999999
Q ss_pred cCCcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 297 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
||.|+.+...+ +..+..+|..|+|||.+.+ ..|+.+.||||.||++.||+-|++
T Consensus 170 FGSAK~L~~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p 224 (364)
T KOG0658|consen 170 FGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP 224 (364)
T ss_pred CCcceeeccCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc
Confidence 99999876433 3355678899999998765 589999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=287.07 Aligned_cols=190 Identities=26% Similarity=0.418 Sum_probs=169.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|.+.+.||+|+||.||. +++.||+|++...........+.+.+|+.++++++||||+++++.+.+++.+|++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 3788899999999998873 57899999987654434445567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998765332
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 212 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCC
Confidence 12346889999999999989999999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=273.37 Aligned_cols=198 Identities=29% Similarity=0.457 Sum_probs=171.0
Q ss_pred ccCCCCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
+..+....|+....||.|.-+.|+ -.+..||||++..+..... .+.+++|+..|+.++||||++++..|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 334445578888899999887776 3578999999987765433 788999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
.+|+||.|+.+|++.++++.. ..+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence 999999999999999999864 33899999999999999999999999 9999999999999999999999999886
Q ss_pred cccccCCCCc---ccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDRPL---TCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~ 351 (352)
.+.....+.. ....+|+.|||||++.. ..|+.|+||||||++..||.+|.
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~ 229 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGH 229 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCC
Confidence 6554332221 44689999999999654 47899999999999999999995
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=285.16 Aligned_cols=187 Identities=27% Similarity=0.410 Sum_probs=164.4
Q ss_pred eeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCC
Q 018682 161 VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (352)
Q Consensus 161 ~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 235 (352)
+.||+|+||.|| .+|+.||+|++.............+.+|+.+++.++||||+++++.+..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999987 357899999997654444455567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCC
Q 018682 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (352)
Q Consensus 236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 315 (352)
+|.+++...+.+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 99999988888999999999999999999999999 9999999999999999999999999987532221 2223356
Q ss_pred CCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 192 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCC
Confidence 899999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=285.60 Aligned_cols=192 Identities=25% Similarity=0.393 Sum_probs=169.1
Q ss_pred CCcccCceeecccEEEEEEEc------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 154 ELDFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
..+|++.+.||+|+||.||.. +..||+|.+...........+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 347888999999999988731 25799999876544444456678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
+|||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....||+.|+|||++.+..++.++|+|||||++|||++|..
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~ 226 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCC
Confidence 223568899999999998889999999999999999999963
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=291.42 Aligned_cols=194 Identities=24% Similarity=0.367 Sum_probs=167.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|+||.||. +++.||+|++.............+.+|+.++++++||||+++++.+.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 478889999999999873 577899999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC--
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-- 308 (352)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988778899999999999999999999999 99999999999999999999999998753211000
Q ss_pred --------------------------------------------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 018682 309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (352)
Q Consensus 309 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 344 (352)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001124588999999999999999999999999999
Q ss_pred HHhhccCC
Q 018682 345 QEVKFYNQ 352 (352)
Q Consensus 345 ~elltG~~ 352 (352)
|||++|..
T Consensus 239 ~elltG~~ 246 (382)
T cd05625 239 YEMLVGQP 246 (382)
T ss_pred HHHHhCCC
Confidence 99999963
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=285.84 Aligned_cols=190 Identities=31% Similarity=0.467 Sum_probs=169.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++.............+.+|+.+++.++||||+++++++...+.+|++||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 588899999999998873 478999999976544444455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999876533 2
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....+++.|+|||++.+..++.++|||||||++|||++|..
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 233568899999999999899999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.92 Aligned_cols=191 Identities=27% Similarity=0.489 Sum_probs=171.5
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc-eEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 229 (352)
+|...+.+|+|+||.++ .++..+++|.+......+++.. ...+|+.++++++|||||.+.+.|..++. ++|+|
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 68888999999999775 4567999999998877666554 66779999999999999999999999988 99999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
+||+||++.+.+.+.+ .++++.+..|+.|++.|+.|||+++ |+|||||+.|||+++++.|+|.|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999997654 4899999999999999999999988 9999999999999999999999999999887654
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|++||++.+.+|+.|+|||||||++|||++-+
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcc
Confidence 2445678999999999999999999999999999999998743
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=292.04 Aligned_cols=193 Identities=24% Similarity=0.371 Sum_probs=166.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 588899999999999973 478999999875443333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC--
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-- 308 (352)
|+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999988888899999999999999999999999 99999999999999999999999998753211000
Q ss_pred ----------------------------------------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhh
Q 018682 309 ----------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVK 348 (352)
Q Consensus 309 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 348 (352)
.......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011246889999999999999999999999999999999
Q ss_pred ccC
Q 018682 349 FYN 351 (352)
Q Consensus 349 tG~ 351 (352)
+|.
T Consensus 239 ~G~ 241 (376)
T cd05598 239 VGQ 241 (376)
T ss_pred hCC
Confidence 986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=289.67 Aligned_cols=185 Identities=31% Similarity=0.394 Sum_probs=161.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-C-----CceeeeeEEEEeCCc
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H-----PNVVQFLGAVTQSSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~ 224 (352)
+|.+.+.||+|+||.|. .+++.||||+++.. ....++-..|+.+|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 78999999999999875 35889999999754 334455667999999996 4 389999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC--CEEEEccCCc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVS 300 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--~vkL~Dfg~a 300 (352)
+|||+|.+ ..+|+++++.+. .++...+..++.||+.||..||+.+ |||+||||+|||+...+ .||++|||+|
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999 569999998764 4889999999999999999999999 99999999999998543 6999999999
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+.... .......+..|+|||++.+.+|+.+.||||||||++||++|.+
T Consensus 339 c~~~q----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~P 386 (586)
T KOG0667|consen 339 CFESQ----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEP 386 (586)
T ss_pred cccCC----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcc
Confidence 87432 2335667889999999999999999999999999999999964
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.00 Aligned_cols=187 Identities=27% Similarity=0.421 Sum_probs=164.1
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 235 (352)
+.||+|+||.||. +|..||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999873 57899999997654444455567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCC
Q 018682 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (352)
Q Consensus 236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 315 (352)
+|..++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccccc
Confidence 99999988878999999999999999999999999 999999999999999999999999988653221 12223356
Q ss_pred CCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~ 192 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCC
Confidence 889999999999989999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=260.75 Aligned_cols=191 Identities=27% Similarity=0.442 Sum_probs=173.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|.+.+.||+|-||.||. ++-.||+|++.+..+.......++++|+++...|+||||+++|++|.++..+|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 788999999999999984 466899999988776666666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|..+|++...+. ...++++.....++.|++.|+.|+|.++ |+||||||+|+|++..+.+||+|||-+...+ .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999998 5566999999999999999999999999 9999999999999999999999999886543 3
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||..|.+||...+..++..+|+|++|++.||++.|.+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~p 220 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLP 220 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCC
Confidence 34455779999999999999999999999999999999999964
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=270.91 Aligned_cols=192 Identities=29% Similarity=0.466 Sum_probs=164.6
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-----CCce
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 225 (352)
.|...+.||+|+||.|. .+|..||+|++... +...-..+...+|+++|+.++|+||+.+++.+.. -+.+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45557899999999775 46899999999755 3445555667779999999999999999998865 3569
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|+|+|++ +.+|.+.++.+..++...+..++.|+++||.|+|+.+ |+||||||+|++++.+..+||+|||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 6799999999888999999999999999999999999 99999999999999999999999999988754
Q ss_pred cC-CCCcccCCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KE-DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ....+....|.+|+|||++. ...|+...||||+|||+.||++|++
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKP 226 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCC
Confidence 31 12225567799999999864 5689999999999999999999975
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=287.62 Aligned_cols=194 Identities=25% Similarity=0.363 Sum_probs=166.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|+||.||. +++.+|+|++.+...........+.+|+.+++.++||||+++++.+.++..+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788999999999999873 47789999987543333444556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999999764 5889999999999999999999999 999999999999999999999999999876433222
Q ss_pred CcccCCCCCccccccccCCC----CCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+. .++.++|+|||||++|+|++|..
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~ 245 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence 22345689999999998654 37789999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=281.25 Aligned_cols=187 Identities=27% Similarity=0.433 Sum_probs=164.5
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 235 (352)
+.||+|+||.||. +|+.||+|++.............+.+|+.+++.++||||+++++.+..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999873 57899999998665444555667888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCC
Q 018682 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (352)
Q Consensus 236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 315 (352)
+|..++.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccccc
Confidence 99999988778999999999999999999999999 999999999999999999999999998753221 12223356
Q ss_pred CCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 192 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCC
Confidence 889999999999889999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=287.71 Aligned_cols=193 Identities=25% Similarity=0.415 Sum_probs=168.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.|+. +++.||+|++........+....++.|+.++.+++||+|+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 578889999999999873 578999999975544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC--
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-- 308 (352)
|+++++|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999865421110
Q ss_pred --------------------------------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 0011346899999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.04 Aligned_cols=195 Identities=30% Similarity=0.476 Sum_probs=176.7
Q ss_pred CCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
+....|+..+.||+|+||.||. .++.||+|++..+.. .+.++.+++|+.+|.+++++||.++|+.+..+..+|
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 3445688889999999999983 578899999987643 445678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
++||||.||++.+.++....+.+..+..++++++.|+.|||+++ .+|||||+.|||+..+|.+||+|||.+.++...
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999999998877789999999999999999999999 999999999999999999999999999888765
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
..+. ..+.||+.|||||++....|+.++||||||++.+||.+|.+
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP 209 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP 209 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC
Confidence 5444 66889999999999999899999999999999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=272.52 Aligned_cols=190 Identities=25% Similarity=0.377 Sum_probs=164.2
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+.||+|+||.||. +|+.||+|.+.............+.+|+.++++++|++|+++++.+.+++.++++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999998863 5789999998765443333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999998887543 35889999999999999999999999 999999999999999999999999998765322 1
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 223356889999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=277.97 Aligned_cols=185 Identities=25% Similarity=0.372 Sum_probs=162.6
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||+|+||.||. ++..||+|++.............+.+|+.++++++||||+++++.+...+.+|++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999998873 4778999998765444445566788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCC
Q 018682 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (352)
Q Consensus 238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~ 317 (352)
.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 999988888999999999999999999999999 9999999999999999999999999987543222 122335688
Q ss_pred CccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCC
Confidence 9999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=279.92 Aligned_cols=193 Identities=22% Similarity=0.355 Sum_probs=165.9
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 225 (352)
+|++.+.||+|+||.||. ++..||+|++.+.... .....+.+..|+.+++.+ +||+|+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999873 4788999998754322 223345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+++|||+++++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999988788999999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
..........||+.|+|||++.+. .++.++|||||||++|||+||.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 333333345689999999998765 4788999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=275.16 Aligned_cols=192 Identities=28% Similarity=0.463 Sum_probs=158.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCC-----------HHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------DDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 219 (352)
+|++.+.||+|.||.|.. +++.||+|++.+..... ....+..++|+.+|+++.|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 799999999999998863 68899999997653221 11135788999999999999999999998
Q ss_pred Ee--CCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 220 TQ--SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 220 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
.+ ...+|+|+|||..|.+...- ..++ +++.++++|+++++.||+|||.+| |+||||||+|+|++.+|.+||+|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence 75 46799999999988775332 2334 899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCC----cccCCCCCccccccccCCC---C-CCCchhHHHHHHHHHHhhccC
Q 018682 297 FGVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNE---E-YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 297 fg~a~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---~-~~~~~DiwslG~il~elltG~ 351 (352)
||.+.......... .....|||.|+|||.+.++ . .+.+.||||+||+||-|++|.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99998663322111 1236799999999998763 2 356799999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=284.40 Aligned_cols=193 Identities=25% Similarity=0.366 Sum_probs=165.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. +++.||+|++.............+.+|+.+++.++||||+++++.+.++..+|++|
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4789999999999998872 57789999986543333344456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 999999999998764 4888999999999999999999999 999999999999999999999999999876533322
Q ss_pred CcccCCCCCccccccccCCC----CCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence 33345689999999998654 3788999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=285.46 Aligned_cols=193 Identities=28% Similarity=0.461 Sum_probs=170.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|.+.+.||+|+||.||. +|+.||+|++.............+..|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 588899999999998873 478999999976544444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC---
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~--- 307 (352)
|+++++|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999988878999999999999999999999999 9999999999999999999999999987654332
Q ss_pred -------------------------CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 -------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
........||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 11223356889999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=279.35 Aligned_cols=193 Identities=22% Similarity=0.364 Sum_probs=165.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.|+. +++.||+|++.+.........+.+.+|..+++.++|++|+++++++.+++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 588889999999998873 578999999875433344445668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.. ..++.++|||||||++|+|++|.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~ 205 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCC
Confidence 2233458999999999863 45788999999999999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=268.03 Aligned_cols=193 Identities=24% Similarity=0.407 Sum_probs=170.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|..|.||. .+..+|+|++.+......+...+...|.+||+.++||.++.+|..|+.++..|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 678889999999999984 347899999998877777777888899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc--
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK-- 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~-- 306 (352)
||+||+|...++++. .+++..+..++.+++.||+|||..| ||.|||||+|||+-++|.+-|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998754 4999999999999999999999999 999999999999999999999999987543210
Q ss_pred ------------------------------CCC-----------------------CcccCCCCCccccccccCCCCCCC
Q 018682 307 ------------------------------EDR-----------------------PLTCQDTSCRYVAPEVFKNEEYDT 333 (352)
Q Consensus 307 ------------------------------~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~ 333 (352)
..+ ...+++||-.|.|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 012456889999999999999999
Q ss_pred chhHHHHHHHHHHhhccC
Q 018682 334 KVDVFSFALILQEVKFYN 351 (352)
Q Consensus 334 ~~DiwslG~il~elltG~ 351 (352)
++|+|+||+++|||++|.
T Consensus 315 AVDWWtfGIflYEmLyG~ 332 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGT 332 (459)
T ss_pred hhhHHHHHHHHHHHHhCC
Confidence 999999999999999985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=280.03 Aligned_cols=187 Identities=27% Similarity=0.420 Sum_probs=163.4
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 235 (352)
+.||+|+||.||. +|..||+|++.............+..|+.+++.++||||+++++++..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999973 57899999998665444455567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
+|..++.....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccc
Confidence 999999887789999999999999999999997 68 9999999999999999999999999986533221 122334
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.+|+.|+|||++.+..++.++|||||||++|+|+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~ 193 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCC
Confidence 6889999999999889999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=283.80 Aligned_cols=194 Identities=25% Similarity=0.356 Sum_probs=165.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. ++..||+|.+.............+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 3788899999999999873 57899999986543333344456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999999998764 5888999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCccccccccCCC----CCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+. .++.++|+|||||++|||++|..
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 245 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCC
Confidence 22345689999999998653 47889999999999999999963
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=280.86 Aligned_cols=226 Identities=27% Similarity=0.481 Sum_probs=190.3
Q ss_pred HHHHHHHHHcCCCCCCCcccccccccCCCcccCCCCCcccCceeecccEEEEEEE------cC---eEEEEEEcCcccCC
Q 018682 119 HEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW------RG---IQVAVKKLGEEVIS 189 (352)
Q Consensus 119 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ig~G~~~~v~~------~~---~~vavK~~~~~~~~ 189 (352)
.+++.+................++...+.|++...++.+. +.||+|.||.|+. ++ ..||+|..+.....
T Consensus 123 ~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~ 200 (474)
T KOG0194|consen 123 SELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL 200 (474)
T ss_pred HHHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence 4556666665555545555567777888999999988888 7999999998872 12 23899998865556
Q ss_pred CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh
Q 018682 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHE 268 (352)
Q Consensus 190 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~ 268 (352)
..+.+..+.+|+++|++++|||||++||+...+.++++|||+|.||+|.+++++.+. ++..+...++.+.+.||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 788889999999999999999999999999999999999999999999999998774 9999999999999999999999
Q ss_pred CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhh
Q 018682 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVK 348 (352)
Q Consensus 269 ~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 348 (352)
++ ++||||-..|+|++.++.+||+|||+++.......... ...-...|+|||.+....|+.++||||+||++||++
T Consensus 281 k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 281 KN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred CC---CcchhHhHHHheecCCCeEEeCccccccCCcceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 99 99999999999999999999999999876531111111 112346899999999999999999999999999999
Q ss_pred cc
Q 018682 349 FY 350 (352)
Q Consensus 349 tG 350 (352)
+-
T Consensus 357 ~~ 358 (474)
T KOG0194|consen 357 EN 358 (474)
T ss_pred cc
Confidence 83
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=275.74 Aligned_cols=192 Identities=30% Similarity=0.433 Sum_probs=165.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-ceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 229 (352)
+|++.+.||+|+||.||. +++.||+|++...........+.+..|..+++.+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999873 4568999999765444445556778899999999764 6888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998643221 12
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++.+..++.++|+|||||++|+|+||.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 198 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCC
Confidence 223456889999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=279.69 Aligned_cols=193 Identities=21% Similarity=0.346 Sum_probs=165.9
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.|+ .+++.||+|++.............+.+|..+++.++|++|+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 58888999999999886 2567899999875433334445668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999987 456899999999999999999999999 999999999999999999999999998765443322
Q ss_pred CcccCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltG~ 351 (352)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~ 205 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCC
Confidence 2233568999999999865 46788999999999999999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=277.73 Aligned_cols=187 Identities=25% Similarity=0.437 Sum_probs=164.3
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +++.||+|+++..........+.+..|..+++.+ +||||+++++++...+.+|++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999998872 5789999999876555555667788999999988 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccc
Confidence 999999988888999999999999999999999999 999999999999999999999999998643221 1122335
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 193 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCC
Confidence 6889999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=276.44 Aligned_cols=187 Identities=27% Similarity=0.419 Sum_probs=161.7
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 161 ~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+.||+|+||.||. .++.||+|++...... .......+..|+.+++.++||||+++++.+..++.+|++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999998873 4678999998754322 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 999999999988888899999999999999999999999 9999999999999999999999999986533222 122
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....+++.|+|||++.+..++.++|||||||++|||++|.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 197 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCC
Confidence 3356889999999999888999999999999999999996
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.85 Aligned_cols=187 Identities=30% Similarity=0.471 Sum_probs=160.2
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +++.||+|.+...........+.+..|..++.. .+||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999873 467899999976544334444556667777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987543222 222345
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~ 193 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCC
Confidence 6899999999999989999999999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=280.99 Aligned_cols=193 Identities=26% Similarity=0.415 Sum_probs=168.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|.+.+.||+|+||.||. +|+.||+|++........+....+.+|+.+++.++||+|+++++.+.+.+.+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 578889999999999873 678999999986654445556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 56899999999999999999999999 999999999999999999999999999776543322
Q ss_pred CcccCCCCCccccccccC------CCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC
Confidence 223346889999999986 456788999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=280.34 Aligned_cols=185 Identities=25% Similarity=0.379 Sum_probs=162.2
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|++.+.||+|+||.||. +++.||+|.... ..+.+|+.++++++||||++++++|..+...+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 34799999999999999873 578999996532 3467899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
+|++ +++|..++.....++..+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 162 ~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 162 LPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999 4789999888778999999999999999999999999 99999999999999999999999999865432222
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~ 280 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 2333456899999999999989999999999999999999986
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=275.31 Aligned_cols=192 Identities=29% Similarity=0.423 Sum_probs=165.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|...+.||+|+||.||. ++..||+|++.............+..|..++..+ .||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999873 4678999998765443444455667788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-CC
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998754321 12
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~ 198 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCC
Confidence 223456889999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=281.47 Aligned_cols=199 Identities=30% Similarity=0.502 Sum_probs=168.3
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEEc--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
.+|+|.+. ++.....||+|+||+||.. .-.||||++..... .++..+.|++|+.++++-+|.||+.+.|++....
T Consensus 385 ~~WeIp~~--ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPE--EVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHH--HhhccceeccccccceeecccccceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35666655 4556679999999999822 24799999998765 4558899999999999999999999999998776
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
. .||+.+|+|-+|+.++... ..+.......|++|+++|+.|||.++ |||||||..||++.++++|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 6 9999999999999999743 34888999999999999999999999 99999999999999999999999999864
Q ss_pred cccc-CCCCcccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVK-EDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~ 351 (352)
-... .........+...|||||+++. .+|+..+||||||+++|||++|.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~ 590 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE 590 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence 3322 2233344567788999999864 48999999999999999999984
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=275.79 Aligned_cols=187 Identities=26% Similarity=0.444 Sum_probs=163.7
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +++.||+|++.............+..|..++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999998873 5778999999876555555667788899988876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987532221 122335
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCC
Confidence 6789999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=275.03 Aligned_cols=188 Identities=28% Similarity=0.423 Sum_probs=162.1
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +++.||+|++.............+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999873 4788999998765443444556677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|.+++.+...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... .......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccccc
Confidence 999999988888999999999999999999999999 999999999999999999999999998753221 1222335
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHA 194 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCC
Confidence 68899999999998899999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.08 Aligned_cols=194 Identities=22% Similarity=0.355 Sum_probs=165.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.|+. .++.+|+|++.+...........+..|+.++..++|++|+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 578889999999998873 467899999865433334445568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++. ...++.++|||||||++|||++|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence 223356899999999986 3467889999999999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=266.58 Aligned_cols=198 Identities=19% Similarity=0.297 Sum_probs=169.1
Q ss_pred cccCCCCCcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe---
Q 018682 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--- 221 (352)
Q Consensus 148 ~~i~~~~~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 221 (352)
..+++.+++......||+|+++.++ ++|+.||+|.+...........+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 3455566666666789999988775 7899999999987655555556788899999999999999999999876
Q ss_pred -CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 222 -SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 222 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
...++++|||+++|+|.+++.+...++......++.|++.||.|||+. + ++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccch
Confidence 356899999999999999998877899999999999999999999985 6 88999999999999999999999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~~ 352 (352)
+....... ....++..|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 170 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~ 220 (283)
T PHA02988 170 EKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220 (283)
T ss_pred Hhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence 87653321 22456788999999976 688999999999999999999863
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=275.12 Aligned_cols=188 Identities=26% Similarity=0.434 Sum_probs=164.6
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.|+. +++.||+|++........+..+.+..|..++.++ +||+|+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999998872 5688999999876555555667788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 999999988778999999999999999999999999 9999999999999999999999999987532211 222335
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~ 194 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCC
Confidence 68899999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.20 Aligned_cols=193 Identities=28% Similarity=0.426 Sum_probs=165.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|+..+.||+|+||.||. +|+.||+|++...........+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367788999999999973 57899999987654434444566778899988885 577888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999987543221 1
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCC
Confidence 2233458899999999999899999999999999999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=274.46 Aligned_cols=192 Identities=29% Similarity=0.473 Sum_probs=173.2
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 227 (352)
...|+..+.||+|.||.|+. +|+.+|+|.+.+...........+.+|+.+|+++. ||||+.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34688889999999999873 58999999998887766656678999999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC----CCEEEEccCCcccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 303 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~vkL~Dfg~a~~~ 303 (352)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+... +.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999876 4999999999999999999999999 9999999999999743 47999999999887
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ........||+.|+|||++...+|+..+||||+|+++|.|+.|.
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~ 235 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGV 235 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCC
Confidence 65 34455678999999999999999999999999999999999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=269.43 Aligned_cols=192 Identities=23% Similarity=0.393 Sum_probs=165.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 588899999999998873 477899999875432 23334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|++++.+..+......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9988777766555566899999999999999999999999 9999999999999999999999999998764433333
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+++.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~ 198 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC
Confidence 33456788999999998888999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=274.90 Aligned_cols=188 Identities=27% Similarity=0.397 Sum_probs=162.5
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +++.||+|++.............+..|..+++.+ +||+|+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999998873 4678999999765444445556677899998866 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence 999999988888999999999999999999999999 9999999999999999999999999987543222 222334
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~ 194 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP 194 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCC
Confidence 57899999999999899999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=274.57 Aligned_cols=188 Identities=29% Similarity=0.449 Sum_probs=159.0
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +|+.||+|++.............+..|.. +++.++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999998872 57899999987654333333344555544 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence 999999988888999999999999999999999999 999999999999999999999999998653222 1222334
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 194 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCC
Confidence 57899999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=280.45 Aligned_cols=188 Identities=37% Similarity=0.524 Sum_probs=165.7
Q ss_pred CcccCCCCCcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
.|+|.... ....+-||+|+-|.|| ..+..||||+++.- -..+++-|++|+||||+.|.++|....
T Consensus 118 ~WeiPFe~--IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEE--ISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHH--hhhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 45555432 3345678999998887 57889999988532 245889999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|||||||..|.|..+++....+++.....|..+|+.|+.|||.+. |||||||.-||||+.+..|||+|||-++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999998876
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... ....++.||..|||||+++..+++.|+|||||||+|||||||.
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~E 308 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGE 308 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcC
Confidence 543 2334578999999999999999999999999999999999985
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=273.32 Aligned_cols=190 Identities=28% Similarity=0.412 Sum_probs=161.5
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH---hcCCCCceeeeeEEEEeCCceEEE
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
|++.+.||+|+||.||. +++.||+|++...........+.+.+|..++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999873 5789999999765443444456677776665 456799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|..++.. +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 999999999988865 46899999999999999999999999 9999999999999999999999999886533221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence 1223456889999999999989999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=274.84 Aligned_cols=187 Identities=28% Similarity=0.452 Sum_probs=159.6
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +|+.||+|++.............+..|.. +++.++||||+++++.+..++.+|++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999873 57899999987654433334445555555 56778999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccc
Confidence 999999988888999999999999999999999999 999999999999999999999999998653221 1222345
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~ 193 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGL 193 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCC
Confidence 6889999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=273.30 Aligned_cols=188 Identities=30% Similarity=0.442 Sum_probs=158.8
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. ++..||+|++.............+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999873 57889999987554333333344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 999999988777999999999999999999999999 9999999999999999999999999987532221 222335
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+++.|+|||++.+..++.++|||||||++|||++|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCC
Confidence 67899999999998899999999999999999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=271.64 Aligned_cols=187 Identities=29% Similarity=0.450 Sum_probs=159.7
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +|..||+|.+.............+..|..++... +||+|+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999998872 5779999999765432233345566788887754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.....+++.++..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++...... .......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence 999999988778999999999999999999999999 999999999999999999999999998643221 1222345
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~ 193 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCC
Confidence 6889999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=272.12 Aligned_cols=191 Identities=31% Similarity=0.491 Sum_probs=158.0
Q ss_pred cccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC-C
Q 018682 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~ 223 (352)
+|++.+.||+|+||.||.. +..||+|++.... .......+.+|+.+++.+ +||||+++++++... +
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 6788899999999998742 3579999987442 334456788999999999 899999999988764 4
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------- 244 (352)
.++++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999998752
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCcc
Q 018682 245 ---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRY 320 (352)
Q Consensus 245 ---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y 320 (352)
.+++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23677888899999999999999999 999999999999999999999999998765322111 11223456789
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 321 VAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 321 ~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+|||++.+..++.++|||||||++|||++ |.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~ 274 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCC
Confidence 99999998899999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=273.10 Aligned_cols=188 Identities=28% Similarity=0.430 Sum_probs=157.5
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH-HHHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. +++.||+|++.............+..|. .+++.++||||+++++++...+.+|++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999998873 4678999998754332222233344444 456788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|.+++.....+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++...... .......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcccc
Confidence 999999988778899999999999999999999999 999999999999999999999999998754322 1222345
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCC
Confidence 68899999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=270.36 Aligned_cols=188 Identities=29% Similarity=0.442 Sum_probs=159.7
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. ++..||+|++.............+..|..+++. ++||||+++++++.+.+.++++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999998873 467899999876543223334556667788876 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence 999999988778999999999999999999999999 9999999999999999999999999986532211 122334
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+|+.|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~ 194 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 67899999999998899999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.74 Aligned_cols=192 Identities=27% Similarity=0.443 Sum_probs=160.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-----ce
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 225 (352)
+|++.+.||+|+||.||. +|..||+|.+..... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 478889999999998872 578999999875422 2233456788999999999999999999886432 48
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|++|||+ +++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999999 4699999988878999999999999999999999999 99999999999999999999999999875432
Q ss_pred cCC--CCcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KED--RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~~ 352 (352)
... .......+++.|+|||++.+ ..++.++|||||||++|+|+||++
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 211 11233568899999999865 578999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=252.66 Aligned_cols=192 Identities=26% Similarity=0.431 Sum_probs=166.3
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCc
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 224 (352)
.|...+.+|+|....+. .+|..+|+|++...... ..+..++-++|+.+|+++ .||+|+++.++|+.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 57777889999886553 57889999987543211 234456678899999998 59999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+++|+|.++.|.|.+++...-.+++.....|++|++.|++|||.++ ||||||||+|||++++.+++|+|||+|+.+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCCcccCCCCCccccccccCC------CCCCCchhHHHHHHHHHHhhccCC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. .......|||+|+|||.+.. ..|+..+|+||+|||+|.|+.|-+
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 43 34455789999999998853 478889999999999999999853
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=268.39 Aligned_cols=191 Identities=28% Similarity=0.429 Sum_probs=167.6
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|++.+.||+|+||.|+. +|..+|+|.+.... .+.....+.+|+.++++++||||+++++++..++.++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34788999999999998873 57789999987542 344556789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|.+++.....+++..+..++.|++.||.|||+++ .|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999999988778999999999999999999999863 2999999999999999999999999998765322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..++.++|||||||++|||+||.
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 199 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 223346789999999999989999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=270.06 Aligned_cols=188 Identities=30% Similarity=0.448 Sum_probs=162.5
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||+|+||.||. ++..||+|++.............+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999998873 4678999999865444444556677899999887 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|..++.+...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence 999999988878999999999999999999999999 9999999999999999999999999986532211 122234
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~ 194 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCC
Confidence 57889999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=264.13 Aligned_cols=185 Identities=26% Similarity=0.398 Sum_probs=159.4
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||+|+||.||. +++.||+|.+...........+.+..|+.+++.++||+|+++.+++..+..++++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999998873 5789999998765444444446678899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCccc
Q 018682 238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (352)
Q Consensus 238 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 313 (352)
..++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 887743 345899999999999999999999999 99999999999999999999999999876543222 2223
Q ss_pred CCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..+++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~ 194 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 46788999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=266.95 Aligned_cols=190 Identities=26% Similarity=0.485 Sum_probs=159.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. +++.||+|++...... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3688999999999998873 5789999998754321 12235678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+. ++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9995 6887777653 55889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 201 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 22233557889999998865 46788999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=267.39 Aligned_cols=190 Identities=25% Similarity=0.455 Sum_probs=166.7
Q ss_pred ccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|...+-||+|-|..|. ++|..||||++.+...+. -....+.+|+.+|+.++|||||++|++...+..+|+|+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 6677889999999875 789999999998876643 3446678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
=++|+|.+|+-+. ..+.+..+.+++.||+.|+.|+|+.. +|||||||+|+++- +-|-|||+|||++..+... +
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 9999999999764 44999999999999999999999998 99999999998754 6789999999999776543 3
Q ss_pred CcccCCCCCccccccccCCCCCC-CchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltG~~ 352 (352)
......|+..|-|||++.+..|+ +++||||||||||.|+.|.+
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~ 217 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP 217 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence 44557789999999999999997 57999999999999998863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=254.92 Aligned_cols=191 Identities=24% Similarity=0.417 Sum_probs=167.8
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|.|..|+ -+|+.+|+|++....+... ..+.+.+|+.+-+.++||||+++.+.+.+.+..|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 367888899999998775 5789999999987766544 5578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---CCEEEEccCCccccccc
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK 306 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~vkL~Dfg~a~~~~~~ 306 (352)
|+++|++|..-+-++..+++..+..+++||+++|.|+|.++ |||||+||+|+++-.. .-+||+|||++..+.
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999665555456889999999999999999999999 9999999999999643 349999999998876
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......-..|||.|||||++...+|+..+||||.|||||-|+.|-
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~ 209 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 209 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCC
Confidence 344455678999999999999999999999999999999999884
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=264.56 Aligned_cols=190 Identities=28% Similarity=0.495 Sum_probs=160.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||.|+||.||. ++..||+|.+...... .....+.+|+.++++++||||+++++++..++..+++||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 588899999999999873 5789999998654321 123456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++ +|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 9964 9999887654 4788999999999999999999999 9999999999999999999999999987643322 2
Q ss_pred CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||++.+ ..++.++|||||||++|+|+||.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 2233456889999998865 568999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=278.64 Aligned_cols=194 Identities=24% Similarity=0.360 Sum_probs=165.5
Q ss_pred CCCCcccCceeecccEEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+....|...+.||+|++|.||. + +..|++|.+... .......+++|+.+++.++||||+++++++..++.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 3344599999999999998873 2 567899976432 344456678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 226 MIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
|+||||+++++|.+++.. ..++++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 999999999999988753 345889999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~ 268 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH 268 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 7543221 1123355899999999999999999999999999999999986
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=272.32 Aligned_cols=186 Identities=26% Similarity=0.382 Sum_probs=161.7
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 161 ~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+.||+|+||.||. +|+.||+|++....... .....+..|+.++++++||||+++++++..++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999998872 57899999997643322 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcc
Q 018682 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (352)
Q Consensus 233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~ 312 (352)
++++|.+++.+...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999999988778999999999999999999999999 9999999999999999999999999987654321 2223
Q ss_pred cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
...+++.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCC
Confidence 456889999999999888999999999999999999986
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=263.37 Aligned_cols=190 Identities=29% Similarity=0.489 Sum_probs=159.8
Q ss_pred cccCceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceee
Q 018682 156 DFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---------------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (352)
+|...+.||+|+||.||. ++..||+|.+.... .......+.+|+.++++++||||++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 678888999999999873 23479999987542 3445567889999999999999999
Q ss_pred eeEEEEeCCceEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 018682 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (352)
Q Consensus 215 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~iv 275 (352)
+++++.+.+..+++|||+++++|.+++.... .++...+..++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986531 2567788899999999999999999 99
Q ss_pred ecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 276 H~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
||||||+|||++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|+++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 9999999999999999999999998765332211 11123346789999999888899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=262.14 Aligned_cols=192 Identities=27% Similarity=0.387 Sum_probs=164.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|+||.||. +++.||+|.+.............+.+|+.+++.++||+|+++++.+..++.++++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377889999999998863 578999999876544333344557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999887643 35889999999999999999999999 9999999999999999999999999987653221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||++.+..++.++|+||+||++|+|++|..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~ 199 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCC
Confidence 2223467889999999998889999999999999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=295.05 Aligned_cols=193 Identities=25% Similarity=0.378 Sum_probs=174.4
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|.+.+.||+|+||.|. .+++.||+|++++...........|+.|-.+|..-+.+-|+.++..|.++.++|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 78899999999999775 4688999999987544444445679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|++||+|..++.+..++++..+..|+..|+.||..||+.| +|||||||+|||++..|.+||+|||.+-.+...+.-.
T Consensus 156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence 9999999999999888999999999999999999999999 9999999999999999999999999998887666666
Q ss_pred cccCCCCCccccccccC----C-CCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFK----N-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~il~elltG~ 351 (352)
....+|||.|.+||++. + +.|++.+|+||+||++|||+.|.
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~ 278 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGE 278 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCC
Confidence 67789999999999984 2 57899999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=284.09 Aligned_cols=197 Identities=32% Similarity=0.556 Sum_probs=166.0
Q ss_pred cccCCCCCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeE
Q 018682 148 YEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (352)
Q Consensus 148 ~~i~~~~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 217 (352)
.+++..++.| .+.||+|.||.||. ..+.||||.++... +.....+|++|+.++..++|||||+++|
T Consensus 481 ~~i~r~~i~~--~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 481 LEIPRSDIVF--KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred eEechhheee--hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3444444444 45899999999983 35679999998653 4557789999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018682 218 AVTQSSPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (352)
Q Consensus 218 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N 283 (352)
+|..++.+|+|+||+..|+|.+|+... ++++..+.+.|+.||+.|+.||-++. +|||||-+.|
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRN 633 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRN 633 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhh
Confidence 999999999999999999999999642 23788999999999999999999999 9999999999
Q ss_pred eEeCCCCCEEEEccCCcccccccCCCCcc-cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 284 ill~~~~~vkL~Dfg~a~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+||.++..|||+|||+++..-..+-.... ...-..+|||||.+..+.|+.+|||||+||+|||+|+.+
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 99999999999999999876433221111 112256899999999999999999999999999999843
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=270.99 Aligned_cols=191 Identities=28% Similarity=0.450 Sum_probs=162.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-----ce
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 225 (352)
+|+..+.||+|+||.||. +|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 477889999999999873 57899999986542 23334467888999999999999999999998776 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|++|||+. ++|.+++.....++...+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999995 689888887778999999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
..........+++.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 202 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence 333333334578899999998764 5788999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=265.04 Aligned_cols=189 Identities=29% Similarity=0.467 Sum_probs=166.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||.|+||.||. ++..+|+|.+.... .......+.+|++++++++||||+++++++.+++.++++|
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4788899999999999873 57789999887542 3445567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++...+.++...+..++.|++.||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999998877889999999999999999999985 5 999999999999999999999999998755322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 199 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 122345788999999999888999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=280.09 Aligned_cols=194 Identities=22% Similarity=0.435 Sum_probs=161.2
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEE-Ee---C
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAV-TQ---S 222 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~---~ 222 (352)
...++++.+.|.+|+|+.||. .|.+||+|++-.. ++...+.+++|+.+|++|+ |+|||.+++.. .. +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 445788899999999999984 2489999988633 6777889999999999997 99999999943 21 1
Q ss_pred ---CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 223 ---SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 223 ---~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
-.++|+||||.||.|-++++++ ..|++.++++|+.|+++|+.+||... .||||||||-+||||+.++..|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 2478999999999999999853 44999999999999999999999997 47999999999999999999999999
Q ss_pred CCcccccccCCCCc--------ccCCCCCcccccccc---CCCCCCCchhHHHHHHHHHHhhcc
Q 018682 298 GVSKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 298 g~a~~~~~~~~~~~--------~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltG 350 (352)
|.+........... -....|+.|+|||++ .+.+++.|+|||+|||+||.|+++
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~ 254 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYF 254 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHh
Confidence 98864322221111 123478999999976 577999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.22 Aligned_cols=192 Identities=26% Similarity=0.401 Sum_probs=161.8
Q ss_pred CcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
.+|++.+.||+|+||.|+. .+..||+|.+.... .......+.+|+..+++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3678888999999998862 25689999997542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999764 46899999999999999999999999 99999999999999999999999998765322
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
..........++..|+|||.+.+..++.++|||||||++||+++ |.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 206 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCC
Confidence 21111112334568999999998999999999999999999876 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=268.71 Aligned_cols=197 Identities=27% Similarity=0.470 Sum_probs=175.0
Q ss_pred ccCCCCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
......-.|.+.+.||+|.|+.|. .++..||+|.+.+........ +.+.+|+++|+.++|||||+++.+.+.+.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 344555578889999999999886 468999999999876654444 45888999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+||||+.+|.+.+|+.+.+...+..+..++.|+++|++|||+++ |+|||||++|||++.+.++||+|||++..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999999999999888999999999999999999999 999999999999999999999999999887
Q ss_pred cccCCCCcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
... .......|++.|.|||++.+..| .+.+|+||+|+++|.|+.|.
T Consensus 206 ~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs 252 (596)
T KOG0586|consen 206 DYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS 252 (596)
T ss_pred ccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence 632 33445778999999999998877 46899999999999998874
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=285.22 Aligned_cols=193 Identities=21% Similarity=0.331 Sum_probs=165.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++.......+...+.+.+|+.++++++||||+++++++.+++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 688899999999999873 478999999986655455556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
|++|++|.+++... ...+...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999988641 12456677889999999999999999 99999999999999999999999999
Q ss_pred cccccccCC-----------------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+........ .......||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCC
Confidence 976521110 0011245899999999999999999999999999999999996
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=257.49 Aligned_cols=184 Identities=27% Similarity=0.414 Sum_probs=157.3
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||+|+||.||. +|+.||+|.+.............+..|++++++++||||+++++.+..+..++++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 68999998873 4789999998754443333344566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCC
Q 018682 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (352)
Q Consensus 238 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 315 (352)
.+++.... .++...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 98886533 4788888999999999999999999 9999999999999999999999999987654321 223346
Q ss_pred CCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~ 191 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCC
Confidence 788999999999888999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=243.76 Aligned_cols=195 Identities=23% Similarity=0.383 Sum_probs=163.0
Q ss_pred CCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----
Q 018682 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS----- 222 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 222 (352)
...+|++.+.+|.|+|..|+ .++..||+|++.-. ..+..+..++|++..++++|||+++++++...+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 45589999999999999887 46789999998644 355667788999999999999999998876543
Q ss_pred CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 223 SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
...|++++|+..|+|.+.++. ...+++.++++|+.++++||++||+..| ++.||||||.|||+++.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEecc
Confidence 349999999999999999874 2358999999999999999999999985 69999999999999999999999999
Q ss_pred CcccccccCCCC--------cccCCCCCccccccccCCC---CCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRP--------LTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltG~ 351 (352)
.+......-... .....+|..|+|||.+.-. ..+.++|||||||+||+|++|.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~ 238 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGE 238 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcC
Confidence 987654221111 1334578999999998644 5578999999999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=269.57 Aligned_cols=185 Identities=28% Similarity=0.421 Sum_probs=156.1
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 163 ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
||+|+||.||. +++.||+|++................|..++... .||+|+++++.+.....+|++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999999873 4789999998755443333344455677777655 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998653322 1222345
Q ss_pred CCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~ 194 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW 194 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCC
Confidence 688999999998654 5789999999999999999986
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=267.53 Aligned_cols=190 Identities=31% Similarity=0.466 Sum_probs=159.0
Q ss_pred cccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCc
Q 018682 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 224 (352)
+|++.+.||+|+||.||. .+..||+|+++... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 688889999999999863 24589999987543 223346788899999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-----------------------------------------------------------
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 245 (352)
.+++|||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 246 ----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3677888899999999999999999 999999999999999999999999998765432211
Q ss_pred C-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 310 P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 310 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
. .....++..|+|||.+.+..++.++|||||||++|||+++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~ 312 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 312 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhc
Confidence 1 1122345679999999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=252.56 Aligned_cols=194 Identities=31% Similarity=0.527 Sum_probs=166.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+|...+.||+|++|.+|. ++++|++|.+....... ......+.+|+.++++++||||+++++++..+..++++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 578889999999998873 57899999886543222 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
+||+++++|.+++...+.++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCc--ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 111 23456778999999999889999999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=256.35 Aligned_cols=190 Identities=27% Similarity=0.405 Sum_probs=164.2
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+.||+|+||.||. +++.||+|.+.............+.+|+.++++++|++|+++++.+.+++.++++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999998873 5789999998766554444455677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999988643 24889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.+..++.++|+||+||++|+|++|.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 222346789999999999889999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=267.30 Aligned_cols=191 Identities=29% Similarity=0.487 Sum_probs=160.0
Q ss_pred cccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCc
Q 018682 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 224 (352)
+|+..+.||+|+||.||. ++..||+|++.... ..+....+.+|+.+++.+ +||||+++++++...+.
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 688889999999998873 12479999997543 334456788999999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc------------------------------------------------------------
Q 018682 225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------ 244 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~------------------------------------------------------------ 244 (352)
++++|||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC-ccc
Q 018682 245 ----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTC 313 (352)
Q Consensus 245 ----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~-~~~ 313 (352)
.+++..++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 13677888999999999999999999 9999999999999999999999999987654322111 112
Q ss_pred CCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
..++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~ 312 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 234567999999988899999999999999999997 64
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=256.57 Aligned_cols=189 Identities=29% Similarity=0.483 Sum_probs=168.1
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.+| .+++.+|+|.+.............+.+|++++++++||||+++++++..++.++++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 57888999999999886 2578999999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998775433
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 195 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY 195 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 22345778899999998888899999999999999999986
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=255.62 Aligned_cols=190 Identities=24% Similarity=0.371 Sum_probs=164.3
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+.||+|+||.||. +++.||+|.+.............+.+|+.++++++|++|+++++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999998874 5789999998765544444445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999999888643 35899999999999999999999999 999999999999999999999999998654322 1
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 223346789999999998889999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=272.32 Aligned_cols=198 Identities=23% Similarity=0.345 Sum_probs=166.4
Q ss_pred cCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-
Q 018682 150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223 (352)
Q Consensus 150 i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 223 (352)
+.....+|++.+.||+|+||.||. +|+.||+|++..... .......+.+|+.++..++|++|+++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 334456899999999999998873 578999999876544 3444566888999999999999999988775432
Q ss_pred -------ceEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCE
Q 018682 224 -------PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (352)
Q Consensus 224 -------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~v 292 (352)
.++++|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 368999999999999998642 35889999999999999999999999 9999999999999999999
Q ss_pred EEEccCCcccccccC-CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 293 KVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 293 kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999987654321 11223456889999999999999999999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=256.79 Aligned_cols=190 Identities=29% Similarity=0.511 Sum_probs=155.6
Q ss_pred cccCceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCceeeeeEEEE-----e
Q 018682 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-----Q 221 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~ 221 (352)
+|++.+.||+|+||.||. .++.||+|.+....... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 688889999999998873 35789999887543322 1223455677777665 6999999999885 2
Q ss_pred CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
...++++|||+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 6999988753 34889999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+...... .......+++.|+|||.+.+..++.++|||||||++|||++|.+
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCC
Confidence 8765432 22233557889999999988899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=268.09 Aligned_cols=185 Identities=25% Similarity=0.390 Sum_probs=161.2
Q ss_pred CcccCceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 155 LDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
.+|.+.+.||+|+||.||. .+..|++|.+... ....+|+.++++++||||+++++++......|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4799999999999999873 2467999987643 234579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
+||++. ++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999994 689999977778999999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... .....+|+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 284 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence 221 22356899999999999999999999999999999999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=261.67 Aligned_cols=191 Identities=29% Similarity=0.441 Sum_probs=170.5
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|..-+.||+|+||.|+ .+|+-+|.|.+.++.+....--....+|-.+|.+++.++||.+-..|+..+.+|+|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 57788899999999775 5789999999887766544444556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
.|.||+|.-++-+-+ .+++..+..++.+|+.||++||+.+ ||.||+||+|||+|+.|.++|+|+|+|..+.. .
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--g 340 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE--G 340 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC--C
Confidence 999999988886644 5999999999999999999999999 99999999999999999999999999987754 4
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.....||.+|||||++.+..|+...|+|||||+||||+.|.
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~ 383 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGH 383 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHccc
Confidence 4555568999999999999999999999999999999999985
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=262.77 Aligned_cols=188 Identities=28% Similarity=0.392 Sum_probs=158.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
.+|+..+.||+|+||.|+. .|..||+|.+..... .......+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4789999999999998873 578999999875532 3344566778999999999999999999986543
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|++|||+++ +|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999965 67666643 4788999999999999999999999 999999999999999999999999998754
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 219 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGS 219 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCC
Confidence 321 1223356788999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=249.57 Aligned_cols=189 Identities=33% Similarity=0.573 Sum_probs=159.5
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..+.||+|+||.||. .+..+|+|.+...... ...+.+|+.+++.++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 467788999999998873 3458999987644322 24678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999998753 45889999999999999999999999 9999999999999999999999999887654322222
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 222334567999999988889999999999999999999 53
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=248.01 Aligned_cols=186 Identities=25% Similarity=0.403 Sum_probs=158.5
Q ss_pred ceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccC
Q 018682 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 160 ~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
.+.||+|.|+.|. .+|.+||||++.+. .......+.+|++++.+++ |+||++++++|+++..+|+|||-+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4579999998774 78999999999755 3445567788999999995 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC---EEEEccCCcccccccCCC-
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKEDR- 309 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---vkL~Dfg~a~~~~~~~~~- 309 (352)
||+|...+.+...+++.++.++.++|+.||.+||.+| |.|||+||+|||-..... +||+||.+..-+....+.
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999888999999999999999999999999 999999999999876554 899999876543222111
Q ss_pred -----CcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 -----PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 -----~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~ 351 (352)
....+.|+..|||||+.. ...|+.+.|.||||+|+|-||.|=
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 123567889999999763 347899999999999999999983
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=254.12 Aligned_cols=190 Identities=31% Similarity=0.567 Sum_probs=164.1
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+.||+|+||.||. +++.||+|.+....... .......+|+.++++++||||+++++++.++...+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 56789999999999983 56789999997654322 2223345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+++++|.+++.....++..++..++.|+++||.+||+++ ++|+||||+||+++.++.++|+|||.+.... ......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999997778999999999999999999999999 9999999999999999999999999987541 122233
Q ss_pred ccCCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhccC
Q 018682 312 TCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltG~ 351 (352)
....++..|+|||++. +..++.++|+||||+++|+|++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~ 196 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGK 196 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc
Confidence 4456788999999998 788899999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=263.30 Aligned_cols=187 Identities=25% Similarity=0.405 Sum_probs=156.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|+||.||. +++.||+|++.... .......+.+|+.+++.++|+||+++++++..++.++++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3677888999999999873 47899999986432 3444567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|... ...++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 223 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D 223 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence 99999998653 23567778889999999999999999 9999999999999999999999999987654321 1
Q ss_pred CcccCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.. ...+.++|||||||++|||++|.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~ 270 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence 2233568899999998743 23456899999999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=252.16 Aligned_cols=192 Identities=28% Similarity=0.406 Sum_probs=175.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|...+.||+|+||.|. ..|+.+|+|++++..+-..+.+..-..|-++|+..+||.+..+..+|...+.+|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 67778899999999886 4688999999999988888888888889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|..||.|.-.+.+...+++.....+...|+.||.|||+++ ||.||||.+|+|++++|.+||+|||+++.--... ..
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-DT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccc-ce
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999987543322 23
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
...+.|||.|+|||++....|+..+|+|.+||++|||+.|.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGR 365 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGR 365 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhcc
Confidence 34578999999999999999999999999999999999885
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=250.36 Aligned_cols=193 Identities=24% Similarity=0.463 Sum_probs=166.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.|| .+++.||+|.+.............+.+|+.+++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 68888999999999886 2678999998876544556666778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|.+++.. ...++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988853 334788999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 204 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCC
Confidence 21 1123457788999999988889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=267.33 Aligned_cols=200 Identities=27% Similarity=0.518 Sum_probs=169.5
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCc-ccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 220 (352)
..+.++...-......||+|+|-.||. .|..||-=.++. +....++..+.|..|+.+|+.|+||||+++|++|.
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 445666666666677999999999884 455666332222 12345666788999999999999999999999998
Q ss_pred eCCc--eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEcc
Q 018682 221 QSSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADF 297 (352)
Q Consensus 221 ~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Df 297 (352)
+... +-+|+|.+..|+|..|+++.+..+...++.|++||+.||.|||++.| ||+|||||.+||+|+. -|.|||+|+
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecch
Confidence 7655 88999999999999999999999999999999999999999999986 7999999999999984 589999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|+|...... ...+..|||.|||||++. ..|+..+||||||++++||.|+.
T Consensus 191 GLAtl~r~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~e 240 (632)
T KOG0584|consen 191 GLATLLRKS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSE 240 (632)
T ss_pred hHHHHhhcc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhcc
Confidence 999876543 233478999999999987 58999999999999999999985
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=268.16 Aligned_cols=187 Identities=28% Similarity=0.492 Sum_probs=164.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
-|...+.||.|+||.||+ +...||||++.-.--+..+.-+.+..|+..|++++|||++.+.+.|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 578889999999999985 467899999976655555666778889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|| -|+-.+++.- .+++.+.++..|+.+.+.||.|||+.+ .||||||..|||+++.|.|||+|||.+....
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA----- 177 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC-----
Confidence 99 5688888764 356889999999999999999999999 9999999999999999999999999987654
Q ss_pred CcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~ 351 (352)
+..+++|||+|||||++. .+.|+-++||||||++..||...+
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERk 222 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 222 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcC
Confidence 334588999999999875 468999999999999999987654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=251.75 Aligned_cols=188 Identities=27% Similarity=0.414 Sum_probs=167.7
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
-|.+..+||+|+||.|+ ..|+.+|+|.+..+ ...+++..|+.+|++++.|++|++|+.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 48888999999999886 57999999988643 235678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||..|++++.+.. ++++++.++..+++..+.||+|||... -+|||||..|||++.+|..||+|||.+-.+...-.
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 9999999999874 466999999999999999999999988 89999999999999999999999999977653222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|||||++..-.|+.++||||||+...||..|++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCC
Confidence 2345779999999999999999999999999999999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=266.51 Aligned_cols=192 Identities=26% Similarity=0.367 Sum_probs=175.6
Q ss_pred cccCceeecccEEEEEE---EcCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
++++..-||-|+||+|. .+++. +|+|++++..+-+....+.+..|-++|..++.|+||++|..|.+++++|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 55666678999999774 45555 89999999888888888889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
-|-||.|+..+..++.+....+..++..+++|++|||++| ||.|||||+|.+++.+|.+||.|||+|+.+... ..
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK 575 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999987653 33
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.-.+.|||.|.|||++.+...+..+|.||||+++|||++|++
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 345789999999999999999999999999999999999985
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=251.45 Aligned_cols=191 Identities=31% Similarity=0.512 Sum_probs=161.3
Q ss_pred cccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|+..+.||+|+||.||.. ...|++|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 5778889999999988731 2579999887442 344556789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC
Q 018682 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 289 (352)
+++|||+++++|.+++... ..++...+..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999999999764 34778889999999999999999999 9999999999999999
Q ss_pred CCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 290 ~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|||++ |.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~ 224 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCC
Confidence 9999999999876432221 11122345678999999988889999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=247.80 Aligned_cols=194 Identities=29% Similarity=0.494 Sum_probs=163.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 226 (352)
+|+..+.||+|+||.+|. ++..|++|.+.... .......+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 678889999999998873 57899999875432 12234457788999999999999999999988764 4688
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
++|||+++++|.+++.+...++...+..++.|++.+|.+||+++ ++|+||||+||+++.++.++|+|||.+......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999988777899999999999999999999999 999999999999999999999999998754321
Q ss_pred CC--CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 207 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCC
Confidence 11 11223457788999999988888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=247.83 Aligned_cols=188 Identities=30% Similarity=0.487 Sum_probs=159.7
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..+.||+|++|.||. ++..||+|.+...... .+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 577889999999998863 4578999998754322 35688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++.... .++...+..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997644 5889999999999999999999999 999999999999999999999999998776422111
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
.......+..|+|||.+.+..++.++|+||||+++|+|+|+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~ 200 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhc
Confidence 11111223579999999988999999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.27 Aligned_cols=189 Identities=33% Similarity=0.553 Sum_probs=159.4
Q ss_pred cccCceeecccEEEEEEE---c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW---R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..+.||+|+||.+|. . +..+|+|.+...... ...+.+|+.++++++||||+++++++.....++++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 577888999999998863 2 346999988754332 25688899999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 35899999999999999999999999 9999999999999999999999999987654322111
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 112234567999999988889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=248.98 Aligned_cols=189 Identities=25% Similarity=0.409 Sum_probs=162.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++.... ......+++|+.++++++||||+++++++..++.++++||
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 688999999999998873 57889999986442 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 9999999999987778999999999999999999999999 9999999999999999999999999987653221 11
Q ss_pred cccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||.+. ...++.++|+||+||++|+|++|+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~ 206 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ 206 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCC
Confidence 22345778899999874 345788999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=250.04 Aligned_cols=192 Identities=27% Similarity=0.465 Sum_probs=159.3
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3688889999999998873 24579999886432 23344568899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
.+++|||+++++|.+++.+.. .++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999987532 2467788889999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|||++++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 218 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCC
Confidence 9999987553322111 11223467899999999888999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=267.46 Aligned_cols=185 Identities=25% Similarity=0.406 Sum_probs=151.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------- 222 (352)
.+|+..+.||+|+||.||. +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4799999999999999873 57899999885431 1235699999999999999999887532
Q ss_pred -CceEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEc
Q 018682 223 -SPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 296 (352)
Q Consensus 223 -~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~D 296 (352)
..++++|||++ ++|.+++. ....++...+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 24679999996 47777664 3456899999999999999999999999 99999999999999665 699999
Q ss_pred cCCcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 297 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99998654322 2223567889999998765 468999999999999999999964
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=252.79 Aligned_cols=188 Identities=29% Similarity=0.461 Sum_probs=164.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.|+. ++..+++|.+.... ..+....+.+|++++++++||||+++++.+..++.++++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 588899999999998873 57789999886542 34455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999999888889999999999999999999998 47 999999999999999999999999988654322
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 122345788999999998888999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=249.27 Aligned_cols=190 Identities=28% Similarity=0.486 Sum_probs=159.4
Q ss_pred cccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--Cc
Q 018682 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 224 (352)
.|+..+.||+|+||.|+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 348889999999998852 46789999987542 233446788899999999999999999987653 45
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
++++|||+++++|.+++... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 89999999999999999764 4899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..... ......++..|+|||.+.+..++.++||||||+++|+|+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 32211 112233456799999998888999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=261.34 Aligned_cols=193 Identities=28% Similarity=0.444 Sum_probs=160.1
Q ss_pred CCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 222 (352)
..+|++.+.||+|+||.||.. +..||+|++.... .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 337888899999999998731 2369999997542 3344567889999999996 99999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 244 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------- 244 (352)
+.+|+||||+++|+|.+++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe
Q 018682 245 --------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (352)
Q Consensus 245 --------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill 286 (352)
..++...+..++.|++.||.|||+.+ |+|+||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 13667778899999999999999999 9999999999999
Q ss_pred CCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 287 ~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999998765432211 1122345678999999988889999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=249.99 Aligned_cols=190 Identities=25% Similarity=0.416 Sum_probs=164.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.+|. +++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+.++++||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 788889999999998873 57899999986442 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++...+.+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... ...
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998765422 112
Q ss_pred cccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....++..|+|||.+. ...++.++|+|||||++|+|++|++
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~ 207 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 23346788999999874 4568889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=247.08 Aligned_cols=188 Identities=31% Similarity=0.539 Sum_probs=158.2
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|++.+.||+|+||.||. .+..+|+|.+...... ...+.+|+.++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 577888999999998873 3457999988654332 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999753 45889999999999999999999999 9999999999999999999999999987653221111
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
.....++..|+|||.+.+..++.++|+||||+++|+|+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 1112234579999999988999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=260.66 Aligned_cols=188 Identities=27% Similarity=0.372 Sum_probs=158.6
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------C
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 223 (352)
.+|+..+.||+|+||.|+ ..++.||+|++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 479999999999999886 2578899999876532 333445677899999999999999999987543 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+||||++ ++|.+++.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 5799999995 578777754 3788899999999999999999999 999999999999999999999999999765
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... .......+++.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 222 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCC
Confidence 322 1223356788999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=247.76 Aligned_cols=189 Identities=31% Similarity=0.514 Sum_probs=160.8
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..++||+|++|.||. ++..|++|.+.... ...+.+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 677888999999998873 45789999876432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++... ..++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999753 44788889999999999999999999 999999999999999999999999999765432222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
......++..|+|||.+.+..++.++|+|||||++|+|+| |.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 202 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCC
Confidence 2222334667999999988889999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=250.26 Aligned_cols=192 Identities=32% Similarity=0.494 Sum_probs=162.1
Q ss_pred CcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|.+.+.||+|+||.||.. +..||+|.+.... ..+..+.+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 36788899999999988731 3679999987542 33455788999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 290 (352)
.+++|||+++++|.+++...+ .+++.++..++.|++.|+.+||+++ ++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 999999999999999997542 3678888999999999999999999 99999999999999999
Q ss_pred CEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 291 ~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~ 222 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCC
Confidence 999999999875432211 11122234678999999999999999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=247.42 Aligned_cols=187 Identities=32% Similarity=0.538 Sum_probs=159.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|...+.||+|+||.++. .+..|++|.+... ......+.+|+.+++.++||+|+++++++..+..++++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 477778999999998763 4788999998643 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997543 4788999999999999999999999 99999999999999999999999999876543322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
........+..|+|||.+.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 200 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 22122233567999999988899999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=259.74 Aligned_cols=188 Identities=26% Similarity=0.374 Sum_probs=158.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------C
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 223 (352)
.+|+..+.||+|+||.|+. .++.||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4799999999999999873 578999999876532 334456677899999999999999999988644 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
..|++|||+++ ++.+++.. .++...+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999964 77777654 4788999999999999999999999 999999999999999999999999998764
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 215 (355)
T cd07874 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_pred CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 322 1223356788999999999989999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=249.15 Aligned_cols=191 Identities=30% Similarity=0.502 Sum_probs=161.1
Q ss_pred CcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|.+.+.||+|+||.||.. +..+++|.+... .......+.+|+.++++++||+|+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 36888899999999988742 346899988643 34445678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 291 (352)
++++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999997543 3889999999999999999999999 999999999999999999
Q ss_pred EEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 292 LKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 292 vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
++|+|||++......... ......++..|+|||.+.+..++.++|+|||||++|+|++ |.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~ 220 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999998765322111 1112334668999999998889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=251.86 Aligned_cols=193 Identities=27% Similarity=0.401 Sum_probs=164.8
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+|+.+| ..++.|++|.+.............+.+|+.+++.++||||+++++.+..++.++++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999887 2467899998876544334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC--
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-- 308 (352)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999998764211000
Q ss_pred ------------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 ------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......++..|+|||.+.+..++.++|+|||||++|||++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~ 213 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCC
Confidence 0011234677899999998888999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=265.06 Aligned_cols=185 Identities=24% Similarity=0.337 Sum_probs=158.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
...|.+.+.||+|+||.||. .++.||+|.... ..+.+|+.++++++||||+++++++..++..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 44799999999999999984 467899995431 2356799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||++ .++|..++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999 46888888654 45899999999999999999999999 9999999999999999999999999997654322
Q ss_pred CCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence 211 12345899999999999999999999999999999998865
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=247.08 Aligned_cols=192 Identities=27% Similarity=0.443 Sum_probs=159.0
Q ss_pred CcccCceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-CCc
Q 018682 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 224 (352)
..|+....||+|+||.||.. ...+|+|+++.......-.. ...+|+..++.++|||++.+..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~-SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISM-SACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCH-HHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 36888999999999999853 34799999987643322222 34569999999999999999998877 788
Q ss_pred eEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC----CCEEEE
Q 018682 225 MMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVA 295 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~vkL~ 295 (352)
+++++||.+. +|+..++- ...++...++.|+.||+.|+.|||++= |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999965 99988862 235899999999999999999999997 9999999999999977 899999
Q ss_pred ccCCcccccccCCC--CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 296 DFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 296 Dfg~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
|||+++.+.++-.. .....+-|..|+|||.+.+. .|+++.|+||.|||+.||+|-.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~ 237 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLE 237 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccC
Confidence 99999988754321 12234568899999998765 7899999999999999999854
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=244.82 Aligned_cols=191 Identities=28% Similarity=0.440 Sum_probs=165.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.+|. ++..|++|.+...... ......+.+|+.+++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477788999999998763 5789999998754333 4455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999764 45889999999999999999999999 99999999999999999999999999876543222
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 198 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence 122345678899999999888999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=245.78 Aligned_cols=193 Identities=33% Similarity=0.557 Sum_probs=165.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH------HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD------DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
+|.+.+.||.|++|.+|. +++.+|+|.+........ +..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367778999999998873 568899998875543321 234568899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
.+++|||+++++|.+++...+.++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999988878899999999999999999999999 9999999999999999999999999987664
Q ss_pred ccCC-----CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKED-----RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~ 209 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCC
Confidence 2111 1112234678899999998888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=254.10 Aligned_cols=190 Identities=28% Similarity=0.496 Sum_probs=159.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|...+.||+|+||.||. ++..||+|.+...... .....+.+|+.++++++||||+++++++..++..+++||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 588899999999999874 5678999998754322 122356789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++ +|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 9964 8888876543 4788999999999999999999999 9999999999999999999999999987643322 1
Q ss_pred CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||.+.+ ..++.++|||||||++|+|+||.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 2223456789999998865 467899999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=267.15 Aligned_cols=188 Identities=20% Similarity=0.269 Sum_probs=154.3
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC------CceeeeeEEEEe
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH------PNVVQFLGAVTQ 221 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~ 221 (352)
...+|++.+.||+|+||.||. .++.||||++... .........|+.+++.++| +++++++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 345799999999999999974 4778999998632 1222345567777776644 458888888876
Q ss_pred C-CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCC---------
Q 018682 222 S-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG--------- 290 (352)
Q Consensus 222 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~--------- 290 (352)
+ ..+|++||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 4 4689999988 78999999888889999999999999999999998 48 99999999999998765
Q ss_pred -------CEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 291 -------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 291 -------~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+||+|||.+.... .......+|+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred ccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 49999999875432 22234568999999999999999999999999999999999963
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=251.37 Aligned_cols=190 Identities=31% Similarity=0.499 Sum_probs=154.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCceeeeeEEEEeC-----
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQS----- 222 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~----- 222 (352)
+|++.+.||+|+||.||. +++.||+|.+........ ....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 478889999999998873 578899998875432221 112345577766655 799999999988642
Q ss_pred CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
..++++|||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 45899999996 5898888764 34899999999999999999999999 999999999999999999999999998
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
....... ......++..|+|||++.+..++.++|||||||++|+|++|.+
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCc
Confidence 7654321 2223456888999999988899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=246.03 Aligned_cols=194 Identities=26% Similarity=0.501 Sum_probs=166.0
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+|+..+.||+|+||.||. +++.+|+|.+...... .......+.+|+.++++++|+||+++++++.+.+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477888999999998873 6788999988754322 223345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC-
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE- 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~- 307 (352)
+||+++++|.+++.+...++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999988777899999999999999999999999 9999999999999999999999999887643211
Q ss_pred ----CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 ----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
........++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 206 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 111223457888999999998889999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=243.75 Aligned_cols=184 Identities=32% Similarity=0.512 Sum_probs=155.3
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 235 (352)
+.||+|+||.||. +++.+|+|.+.... ..+....+.+|+.++++++||||+++++++......+++|||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3689999998873 67889999886432 3445567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc-cc
Q 018682 236 DLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TC 313 (352)
Q Consensus 236 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~-~~ 313 (352)
+|.+++...+ .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+........... ..
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9999997644 5889999999999999999999999 99999999999999999999999999875432111110 11
Q ss_pred CCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
...+..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~ 191 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 122456999999988889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=249.49 Aligned_cols=188 Identities=38% Similarity=0.699 Sum_probs=156.6
Q ss_pred CceeecccEEEEEE---Ec------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 159 NSVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 159 ~~~~ig~G~~~~v~---~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
..+.||.|.||.|+ +. +..|+||.+... ...+..+.+.+|++.+++++||||+++++++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 45789999999887 34 678999999643 34555788999999999999999999999999888899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 230 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||+++|+|.+++... ..+++.++..|+.|++.||.|||+++ ++|+||+++||+++.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999886 56899999999999999999999999 9999999999999999999999999987762211
Q ss_pred C-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 D-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. ...........|+|||.+....++.++||||||+++|||++++
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~ 202 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLG 202 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1 1112233556899999998888999999999999999999954
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=245.13 Aligned_cols=192 Identities=26% Similarity=0.486 Sum_probs=166.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.+|. +|+.|++|.++.....+......+.+|+.++++++|++++++++.+..++..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 688889999999998872 588999999876545555556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|.+++.. ...++..++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998864 234789999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~ 203 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCC
Confidence 21 122345678899999998888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=246.97 Aligned_cols=192 Identities=30% Similarity=0.543 Sum_probs=160.3
Q ss_pred CCcccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--C
Q 018682 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 222 (352)
+..|++.+.||+|+||.||. .+..|++|.+... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 34688889999999998874 4678999998643 34445678899999999999999999998754 3
Q ss_pred CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
..++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 4689999999999999999764 45889999999999999999999999 9999999999999999999999999988
Q ss_pred cccccCCCC--cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......... .....++..|+|||++.+..++.++|+|||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 208 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcC
Confidence 654322211 11122345699999998888999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=253.68 Aligned_cols=184 Identities=26% Similarity=0.443 Sum_probs=149.3
Q ss_pred ceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCceEEEEe
Q 018682 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (352)
Q Consensus 160 ~~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 230 (352)
.++||+|+||.||. .++.||+|.+..... ...+.+|+.++++++||||+++++++.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 35899999999873 346899998865432 1346789999999999999999998864 456899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe----CCCCCEEEEcc
Q 018682 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (352)
Q Consensus 231 ~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~vkL~Df 297 (352)
|+. ++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+|||+ +..+.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 984 5888887532 24788999999999999999999999 9999999999999 45678999999
Q ss_pred CCcccccccCC--CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 298 g~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
|++........ .......+|+.|+|||++.+ ..++.++||||+||++|+|++|++
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99976543211 12233567889999999876 458899999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=257.78 Aligned_cols=196 Identities=23% Similarity=0.344 Sum_probs=165.0
Q ss_pred CCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCce
Q 018682 151 DPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 225 (352)
.-....|++.+.||+|+...||. +.+.||+|++.... .+.....-|++|+..|.+|+ |.+|++++++-..++.+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 33455899999999999998873 45789999887654 35677888999999999995 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
|+|||+= ..+|..+++++.. .+...+..++.|++.|+.++|..| |||.||||.|+|+-+ |.+||+|||+|..+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9999965 6799999988765 333577789999999999999999 999999999999975 789999999998877
Q ss_pred ccCCC-CcccCCCCCccccccccCCC-----------CCCCchhHHHHHHHHHHhhccCC
Q 018682 305 VKEDR-PLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 305 ~~~~~-~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~elltG~~ 352 (352)
..... ...+..||+.||+||.+... ..++++||||||||||+|++|+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgkt 570 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKT 570 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCC
Confidence 54432 23457899999999988543 25679999999999999999974
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=247.95 Aligned_cols=192 Identities=27% Similarity=0.520 Sum_probs=162.2
Q ss_pred CcccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--C
Q 018682 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 223 (352)
.-|++.+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3578889999999998862 36789999986442 344556789999999999999999999998775 5
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
..+++|||+++++|.+++.+.. .+++.++..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 6899999999999999997643 5889999999999999999999999 99999999999999999999999999876
Q ss_pred ccccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....... ......++..|+|||.+.+..++.++|||||||++|+|+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~ 209 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCC
Confidence 5432211 112344566799999998888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=247.29 Aligned_cols=191 Identities=28% Similarity=0.472 Sum_probs=159.9
Q ss_pred cccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
+|+..+.||+|+||.||. .+..+++|.+... ........+.+|+.+++.++||||+++++++......|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 567778999999998874 3468999998743 23445567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC
Q 018682 227 IVTEYLPKGDLRAFLKRK-----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 289 (352)
++|||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 999999999999998532 23678888999999999999999999 9999999999999999
Q ss_pred CCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 290 ~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|||++ |.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~ 224 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL 224 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 9999999999876532221 11122334567999999988889999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=243.47 Aligned_cols=191 Identities=23% Similarity=0.411 Sum_probs=165.3
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||.|+||.++ .++..+++|.+...... ......+.+|+.++++++|+||+++++++.+.+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 47888999999999665 35789999998655433 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++... ..++..++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999999764 45889999999999999999999999 99999999999999999999999999876544332
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCC
Confidence 223345788999999998888899999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=251.83 Aligned_cols=194 Identities=26% Similarity=0.427 Sum_probs=166.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.+|. ++..||+|.+...........+.+..|+.+++.++||+|+++++.+..+...|++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 578889999999998873 478999999987655444456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998754 45889999999999999999999999 99999999999999999999999998865432211
Q ss_pred C----------------------------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 R----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
. ......++..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 1 0112346788999999998889999999999999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=244.61 Aligned_cols=191 Identities=33% Similarity=0.509 Sum_probs=162.4
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|+..+.||+|+||.||. +...||+|.+.... .......+..|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 588889999999998873 13479999887543 34455678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+|||+++++|.+++... +.++...+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 45899999999999999999999999 999999999999999999999999999876422
Q ss_pred CCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 307 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 307 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
... ......++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~ 206 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE 206 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCC
Confidence 211 1112234567999999998899999999999999999997 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=250.27 Aligned_cols=199 Identities=30% Similarity=0.516 Sum_probs=163.3
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCc
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 211 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 211 (352)
.+.|++.. .+|.+.+.||+|+||.||.. ...+|+|.+.... .......+..|+.+++.+ +|||
T Consensus 10 ~~~~~~~~--~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 10 DPRWEVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CCcceeeh--HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCC
Confidence 34455443 37899999999999988732 2469999987542 233456688899999999 7999
Q ss_pred eeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 018682 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (352)
Q Consensus 212 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~iv 275 (352)
|+++++++..++..|++|||+++++|.+++.... .++..++..++.|++.||.|||+++ ++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~ 162 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI 162 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999999997642 3778899999999999999999999 99
Q ss_pred ecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 276 H~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|+||||+||+++.++.++|+|||.+.......... .....+++.|+|||.+.+..++.++|+|||||++|+|+++
T Consensus 163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999987654321111 1112234679999999888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=247.34 Aligned_cols=192 Identities=24% Similarity=0.481 Sum_probs=166.0
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|++|.|| .++..+++|.+......+......+.+|+.+++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 57788899999999886 3688999998876544455556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 345789999999999999999999999 999999999999999999999999988765432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~ 203 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCC
Confidence 21 122345778899999998888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=258.42 Aligned_cols=184 Identities=27% Similarity=0.447 Sum_probs=162.1
Q ss_pred ceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 160 ~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
.+.||+|.||.|| .+|+.||||++.+..+..... ..+++|+.+|+++.||.||.+-..|+..+.+++|||-+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 5789999999998 579999999999887765444 78999999999999999999999999999999999999 5
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---CCEEEEccCCcccccccCCC
Q 018682 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 235 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|++.+.+- +.+++++...+.++.||+.||.|||-++ |+|+||||+|||+... .++||||||+|+.+....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 56666553 4567999999999999999999999999 9999999999999754 469999999999987543
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
...+..||+.|+|||++.+..|+..-|+||.|||+|--++|
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG 762 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 762 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc
Confidence 33457899999999999999999999999999999987776
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=257.85 Aligned_cols=182 Identities=26% Similarity=0.402 Sum_probs=156.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|.+.+.||+|+||.||. .+..||+|+.... ....|+.++++++||||+++++++......+++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4699999999999999873 4568999975433 2346899999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|++. ++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 9995 688888765 456899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||++.+..++.++|||||||++|||++++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcC
Confidence 1122345789999999999989999999999999999999864
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=244.15 Aligned_cols=195 Identities=31% Similarity=0.541 Sum_probs=164.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--Cce
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 225 (352)
.+|+..+.||+|+||.+|. ++..|++|.+...... .......+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999998873 5789999988654322 223456788999999999999999999988753 568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
++++||+++++|.+++...+.++......++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988777899999999999999999999999 99999999999999999999999999876532
Q ss_pred cC--CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ........++..|+|||.+.+..++.++|+||+||++|+|++|+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~ 207 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCC
Confidence 11 111223457788999999988889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=270.09 Aligned_cols=193 Identities=18% Similarity=0.287 Sum_probs=153.2
Q ss_pred CcccCceeecccEEEEEEEc------CeEEEEE--------------EcCcccCCCHHHHHHHHHHHHHHhcCCCCceee
Q 018682 155 LDFTNSVEITKGTFILAFWR------GIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~------~~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (352)
.+|++.+.||+|+||.||.. +...+.| .+.+...........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 37999999999999998831 1111111 111111122334456889999999999999999
Q ss_pred eeEEEEeCCceEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC
Q 018682 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (352)
Q Consensus 215 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 289 (352)
+++++...+..|+++|++ +++|..++... ......++..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999999999999999998 45777776532 12345677789999999999999999 9999999999999999
Q ss_pred CCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 290 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999876543322223356899999999999999999999999999999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=245.14 Aligned_cols=188 Identities=33% Similarity=0.512 Sum_probs=157.6
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|++.+.||+|+||.||. .+..||+|++...... ...+.+|+.+++.++||||+++++.+. ....+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 588889999999998863 3357999998754332 246788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999753 34788999999999999999999999 999999999999999999999999998765433322
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||...+..++.++|+||||+++|+|+||+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g 200 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 200 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 222334566799999998888999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=247.96 Aligned_cols=191 Identities=28% Similarity=0.413 Sum_probs=169.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||.|+|+.+|. ++..||+|.+...........+.+.+|++++++++||||+++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 478889999999987762 478999999987655555566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.....+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 9999999999988777999999999999999999999999 9999999999999999999999999987654322 2
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~ 196 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCC
Confidence 22345678899999998888999999999999999999986
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=253.71 Aligned_cols=191 Identities=31% Similarity=0.499 Sum_probs=158.6
Q ss_pred cccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe-CC
Q 018682 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SS 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~ 223 (352)
+|++.+.||.|+||.||.. ++.||+|++.... .....+.+..|+.+++++ +||||+++++++.. +.
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 6888899999999999842 3689999987543 233456678899999999 79999999998764 45
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------- 244 (352)
.++++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-CCcccCCCCCccc
Q 018682 245 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYV 321 (352)
Q Consensus 245 --~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~ 321 (352)
..++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..+..... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788889999999999999999999 99999999999999999999999999976533221 1112234566799
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 322 APEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 322 aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
|||++.+..++.++|||||||++|||++ |.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~ 273 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999997 64
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=251.34 Aligned_cols=192 Identities=26% Similarity=0.477 Sum_probs=159.5
Q ss_pred CCcccCceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
..+|+..+.||+|+||.||. ++. .||+|.+... ......+.+.+|+.+++.++||||+++++++..+ .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34688999999999998873 233 4899998643 2344556788999999999999999999998764 5
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++++||+++|+|.+++.... .++...+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 789999999999999998743 4788899999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCc-ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 304 TVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 304 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
........ .....+..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~ 209 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 209 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 43222111 11223567999999999899999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=242.85 Aligned_cols=185 Identities=27% Similarity=0.418 Sum_probs=156.2
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 162 ~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+||+|+||.||. ++..+|+|++.... ......+.+..|+.+++.++||||+++++++. ....+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999998873 46789999987543 23445677899999999999999999999875 4567999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC--cc
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 312 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~--~~ 312 (352)
++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999988777999999999999999999999999 9999999999999999999999999987654332211 11
Q ss_pred cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...++..|+|||.+....++.++|+|||||++|||++ |.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~ 196 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQ 196 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 1223568999999988888999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=243.26 Aligned_cols=190 Identities=31% Similarity=0.477 Sum_probs=164.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||.|+||.++. ++..+++|.+.... ....+.+.+|+.++++++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 3688889999999998862 46789999987542 234577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999999999775 67999999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCccccccccCCC---CCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||.+... .++.++|+||||+++|+|+||+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~ 201 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC
Confidence 12234567789999998776 7889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=256.87 Aligned_cols=187 Identities=28% Similarity=0.436 Sum_probs=157.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------C
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 223 (352)
.+|+..+.||+|+||.||. ++..||+|.+..... .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 3688999999999998873 467899999875432 223345577899999999999999999887543 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
..|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999988 7899888764 45899999999999999999999999 999999999999999999999999998765
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 213 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCC
Confidence 432 223457889999999876 56889999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=245.47 Aligned_cols=184 Identities=27% Similarity=0.441 Sum_probs=159.6
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.|| .+++.||+|.+.... .......+.+|+.++++++||||+++++.+..++..+++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 46778899999999887 357899999886542 34455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999999755 24688888999999999999999999 999999999999999999999999998765322 1
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 190 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCC
Confidence 22345788999999999888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=248.02 Aligned_cols=191 Identities=30% Similarity=0.456 Sum_probs=162.9
Q ss_pred CcccCceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcee
Q 018682 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~---------------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 213 (352)
.+|++.+.||+|+||.|+. .+..||+|.+.... .......+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3688889999999998874 23568999987543 234567788999999999999999
Q ss_pred eeeEEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 018682 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (352)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~ 282 (352)
++++++..+...+++||++++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 99999999999999999999999999997755 6889999999999999999999999 999999999
Q ss_pred CeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 283 NILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 283 Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|+++
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 999999999999999998764332211 12233456789999999888899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=265.44 Aligned_cols=189 Identities=25% Similarity=0.402 Sum_probs=163.0
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|.+...||.|+||.||. .+...|.|++. ..+++..+.+..|+.||..++||+|+++++.|..++.+|++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 56677899999999984 23345667664 34677888999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|.||-...++-.- ..+++.++..++.|++.||.|||+++ |||||||..|||++-+|.++|+|||.+..... ....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999998887653 45999999999999999999999999 99999999999999999999999998865432 2334
Q ss_pred cccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
..++.|||+|||||+.. ..+|+.++||||||++|.||.-+.+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 45688999999999874 4589999999999999999987653
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=275.22 Aligned_cols=194 Identities=21% Similarity=0.373 Sum_probs=159.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 227 (352)
.+|.+.+.||+|+||.||. .+..+|+|.+..... .......+..|+.++++++||||++++++|... ..+|+
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4799999999999999983 467899999876543 334456788999999999999999999988653 56899
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceecCCCCCCeEeCCC----------
Q 018682 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDDS---------- 289 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~Dikp~Nill~~~---------- 289 (352)
||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.++ .+|+||||||+|||++..
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999875 2468999999999999999999998431 139999999999999642
Q ss_pred -------CCEEEEccCCcccccccCCCCcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccC
Q 018682 290 -------GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 290 -------~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~ 351 (352)
+.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||||||||+|+||.
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 348999999987654321 2233468999999999854 45789999999999999999986
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=245.49 Aligned_cols=193 Identities=29% Similarity=0.561 Sum_probs=165.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|+..+.||+|+||.+|. ++..||+|.+...... .....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999998873 6789999998754321 12345778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~~~~~ 306 (352)
++||+++++|.+++.+.+++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988788999999999999999999999999 99999999999998776 5999999998766533
Q ss_pred CCC---CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 205 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCC
Confidence 211 112235678899999998888999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=251.17 Aligned_cols=190 Identities=18% Similarity=0.330 Sum_probs=155.4
Q ss_pred Cceeeccc--EEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 159 NSVEITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 159 ~~~~ig~G--~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
..+.||+| +|+.|+ .+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 34689999 556665 3578899999875533 344556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+++.||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999653 34889999999999999999999999 999999999999999999999999865433211110
Q ss_pred ------CcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 ------PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ------~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~~ 352 (352)
......++..|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 208 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 208 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 0112245677999999876 468899999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=246.95 Aligned_cols=190 Identities=32% Similarity=0.496 Sum_probs=160.0
Q ss_pred cccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|...+.||+|+||.+|. ++..+++|.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 577788999999998873 2346889988643 334446788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC
Q 018682 226 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 289 (352)
+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999997542 3788899999999999999999999 9999999999999999
Q ss_pred CCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 290 ~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|+| |.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 223 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999875433221 11122345678999999998899999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=242.94 Aligned_cols=191 Identities=28% Similarity=0.463 Sum_probs=163.9
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||.|+||.++ .++..+++|.+.... .....+.+..|+.+++.++||||+++++.+..++.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 47788999999999886 357899999886432 23345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++... ..++...+..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999988653 34789999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||++.+..++.++|+||||+++|+|++|.+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 198 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKH 198 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccC
Confidence 1223457888999999998889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.00 Aligned_cols=191 Identities=30% Similarity=0.484 Sum_probs=160.3
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|...++||+|+||.||. ++..+++|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3567788999999998874 2557899987643 34455678999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 289 (352)
.+++|||+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 999999999999999987643 3788899999999999999999999 9999999999999999
Q ss_pred CCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 290 GNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 290 ~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+.++|+|||++......... ......+++.|+|||.+.+..++.++|+|||||++|+|++ |.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 222 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCC
Confidence 99999999998754322111 1112234578999999998899999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=247.15 Aligned_cols=191 Identities=28% Similarity=0.463 Sum_probs=159.7
Q ss_pred CcccCceeecccEEEEEEEc-------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeee
Q 018682 155 LDFTNSVEITKGTFILAFWR-------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~-------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 215 (352)
.+|.+.+.||+|+||.||.. ...||+|.+.... .......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 36888899999999998731 1258999987542 34455678999999999999999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018682 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (352)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N 283 (352)
++++...+..+++|||+++++|.+++.... .++...+..++.|++.||.|||+++ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999986532 2577888899999999999999999 9999999999
Q ss_pred eEeCCCCCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 284 ILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 284 ill~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|+++
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 9999999999999999875432211 111223346689999999888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=243.73 Aligned_cols=185 Identities=27% Similarity=0.409 Sum_probs=162.2
Q ss_pred ecccEEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~---~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||.|+||.+| . +++.+++|.+...........+.+.+|+.+++.++||||+++++.+.++..+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 5788888775 3 3789999999866555555567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCC
Q 018682 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (352)
Q Consensus 238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~ 317 (352)
.+++.+...++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 999988777899999999999999999999999 9999999999999999999999999987765432 12234567
Q ss_pred CccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
..|++||.+.+..++.++|+||||+++|+|++|.+
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 190 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCC
Confidence 88999999988889999999999999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=241.22 Aligned_cols=192 Identities=27% Similarity=0.431 Sum_probs=162.5
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-CCceEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 229 (352)
+|++.+.||+|++|.++ .+++.|++|.+..... .....+.+.+|+.++++++|||++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 47888999999999886 2467899999865433 33445668889999999999999999988764 44689999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 230 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||+++++|.+++... ..+++.++..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999998763 34899999999999999999999999 9999999999999999999999999987664322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
. ......+++.|+|||++.+..++.++|+||||+++++|++|+.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 2 2233457888999999999889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=248.30 Aligned_cols=192 Identities=29% Similarity=0.525 Sum_probs=160.9
Q ss_pred CCcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEE
Q 018682 154 ELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 220 (352)
..+|.+.+.||+|+||.||.. +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 457888899999999988722 3479999887442 234456788999999999 7999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Ni 284 (352)
.....+++|||+++++|.+++.... .++..++..++.|++.||.|||++| ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997632 3677788899999999999999999 99999999999
Q ss_pred EeCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 285 LRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 285 ll~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
+++.++.++|+|||.+.......... .....++..|+|||++.+..++.++||||||+++|+|+++
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999987664332221 1223345679999999888899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=242.82 Aligned_cols=195 Identities=31% Similarity=0.541 Sum_probs=164.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--Cce
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 225 (352)
.+|.+.+.||+|+||.+|. ++..|++|.+.... .........+.+|+.++++++||||+++++.+.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3688899999999998863 57899999875332 12334556788999999999999999999988764 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
++++||+++++|.+++...+.++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 899999999999999988777899999999999999999999999 99999999999999999999999999876532
Q ss_pred cC--CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ........++..|+|||.+.+..++.++|+|||||++|+|++|++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 207 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 11 111123457888999999988888999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=245.29 Aligned_cols=190 Identities=27% Similarity=0.427 Sum_probs=162.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|++.+.||.|+||.||. ++..+++|.+... .......+.+|+.+++.++||||+++++.+..++.++++||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 588899999999998873 4789999998643 45556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|..++.+ ...+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 9999999888754 455899999999999999999999999 9999999999999999999999999876543221 1
Q ss_pred CcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||++. ...++.++|+|||||++|+|++|..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCC
Confidence 122345678899999884 3457889999999999999999963
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=274.67 Aligned_cols=191 Identities=35% Similarity=0.574 Sum_probs=163.2
Q ss_pred cccCceeecccEEEEEEE------cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~------~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+.+..+.||+|.||.||. .| ..||+|.+.+ ..+......|.+|..+|+.++|||||++++.+.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455667899999999983 23 3588888864 45677788999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 226 MIVTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
++++|||++|+|..|+++. ..++..+.+.++.||++|+.||++++ +|||||...|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999865 34889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccC-CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|+.+...+....... .-...|||||.+..+.++.|+|||||||++||+||-+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 9985433221111111 2235799999999999999999999999999999954
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=247.06 Aligned_cols=191 Identities=23% Similarity=0.428 Sum_probs=164.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|++|.+|. +++.|++|.+...... ....+.+|+.+++.+.||||+++++.+..+...|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 35889999999999998873 5789999988754322 246688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|.+++.. ..++..++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999999865 35789999999999999999999999 99999999999999999999999998876443221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||.+.+..++.++|+|||||++|+|++|.+
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~ 214 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 1223457789999999988888999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=242.65 Aligned_cols=191 Identities=33% Similarity=0.523 Sum_probs=161.0
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|++.+.||+|+||.||. .+..+|+|.+.... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 577889999999998873 13379999987542 24445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+|||+++++|.+++... +.++..++..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999764 45799999999999999999999999 999999999999999999999999998766433
Q ss_pred CCCCcc--cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 307 EDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 307 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...... ....+..|+|||.+.+..++.++|+||||+++|++++ |.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCC
Confidence 221111 1222457999999998889999999999999999886 65
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=246.18 Aligned_cols=193 Identities=23% Similarity=0.445 Sum_probs=166.1
Q ss_pred CCCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
....+|+..+.||.|++|.+| .+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 344579999999999999887 3678999998864432 23456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+++||+++++|.+++... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999999988754 5899999999999999999999999 999999999999999999999999988765432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|.+
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~ 213 (296)
T cd06655 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (296)
T ss_pred cc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 22 1223457788999999988889999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=249.80 Aligned_cols=189 Identities=34% Similarity=0.550 Sum_probs=156.1
Q ss_pred cccCceeecccEEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 227 (352)
+|++.+.||+|+||.||. ++. .+++|.+... ........+.+|+.++.++ +||||+++++++..++.+|+
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 677888999999998873 233 4577776532 2344556788899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC
Q 018682 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 291 (352)
+|||+++++|.+++.... .++..++..++.|++.||+|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 4678899999999999999999999 999999999999999999
Q ss_pred EEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 292 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|||+| |.
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 221 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 221 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCC
Confidence 9999999986422111 1111223567999999988889999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=247.02 Aligned_cols=192 Identities=29% Similarity=0.459 Sum_probs=161.9
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCC
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 223 (352)
.+|...+.||+|+||.|+. .+..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3688889999999998863 23479999887542 234456788999999999 7999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
..+++|||+.+++|.+++.... .++..++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997643 2789999999999999999999999 9999999999999999999999999987
Q ss_pred cccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 302 LLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 302 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
........ ......++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 65432211 1112334678999999988889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=239.26 Aligned_cols=183 Identities=34% Similarity=0.551 Sum_probs=155.4
Q ss_pred eecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 162 ~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
.||+|+||.||. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..+++|||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 689999998873 56789999987543 344445688999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCC
Q 018682 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (352)
Q Consensus 238 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 316 (352)
.+++... ..+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++................
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9998754 45789999999999999999999999 9999999999999999999999999986543222111122234
Q ss_pred CCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
+..|+|||++.+..++.++|+||||+++|+|++
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 567999999988889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=243.99 Aligned_cols=191 Identities=28% Similarity=0.486 Sum_probs=159.9
Q ss_pred cccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|++.+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 677889999999998872 23679999986442 233445688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEE
Q 018682 226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~ 295 (352)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986532 2577888999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 296 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 296 Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
|||+++....... .......++..|+|||.+.+..++.++|+|||||++|||++ |+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 9999876543221 11122345678999999988889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=245.57 Aligned_cols=184 Identities=28% Similarity=0.429 Sum_probs=158.3
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||+|+||.||. +|+.|++|.+.............+..|+.++++++||+|+++++.+...+.+|++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68899998873 5789999998765433333445667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCC
Q 018682 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (352)
Q Consensus 238 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 315 (352)
.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99997655 6899999999999999999999999 99999999999999999999999998876543 22223345
Q ss_pred CCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++..|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~ 191 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCC
Confidence 677899999998888999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=257.47 Aligned_cols=194 Identities=25% Similarity=0.383 Sum_probs=168.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
-|...+-||-|.||.|.. +...||.|.+.+...-....+...+.|..||....++-||++|..|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 477788999999998753 445789998887666566666778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|++||++-.++-+-+.+.+..+..++.++..|+++.|..| +|||||||+|||||.+|.+||+|||++.-+....+..
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999999999998899999999999999999999999999 9999999999999999999999999975432110000
Q ss_pred -----------------------------------------cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 311 -----------------------------------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 311 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
..+.+||+.|+|||++....|+..+|+||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 023458999999999999999999999999999999999
Q ss_pred cCC
Q 018682 350 YNQ 352 (352)
Q Consensus 350 G~~ 352 (352)
|..
T Consensus 867 g~~ 869 (1034)
T KOG0608|consen 867 GQP 869 (1034)
T ss_pred CCC
Confidence 963
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=240.12 Aligned_cols=185 Identities=37% Similarity=0.651 Sum_probs=161.6
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+|+..+.||+|+||.|| ..|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......+++|||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 67778899999999886 5789999999875422 4567888999999999999999999999899999999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 233 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998765 5899999999999999999999999 99999999999999999999999999876532221
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
....+..|+|||.+....++.++|+||||+++|+|++ |.
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~ 197 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCC
Confidence 2234567999999988889999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=243.66 Aligned_cols=189 Identities=30% Similarity=0.447 Sum_probs=160.4
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|++.+.||+|+||.+|. ++..+++|.+... .......+.+|+.+++.++||||+++++.+..++..++++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 56778899999998873 4678899988643 344556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++++|..++.+ ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999999988764 456899999999999999999999999 9999999999999999999999999986543221 12
Q ss_pred cccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....+++.|+|||++. +..++.++|+|||||++|+|++|++
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~ 206 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCC
Confidence 23345788999999874 3467789999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=246.48 Aligned_cols=190 Identities=26% Similarity=0.467 Sum_probs=159.1
Q ss_pred cccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|.+.+.||+|+||.||.. +..||+|.+.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4677889999999988742 4689999997542 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC
Q 018682 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 289 (352)
++++||+.+++|.+++... ..++...+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 9999999999999998532 23778888999999999999999999 9999999999999999
Q ss_pred CCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 290 GNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 290 ~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+++
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 222 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 99999999998765322211 11223456789999999888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=242.03 Aligned_cols=190 Identities=33% Similarity=0.498 Sum_probs=160.9
Q ss_pred CcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.+|++.+.||.|+||.||. .+..+++|.+...... ...+.+|+.++++++||||+++++++..+...+++||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4688889999999998873 3467999998754332 3568889999999999999999999999899999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++.... .++...+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997643 5889999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
........+..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~ 202 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 11112223567999999998889999999999999999998 43
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=263.24 Aligned_cols=189 Identities=29% Similarity=0.462 Sum_probs=160.9
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------c
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~ 224 (352)
-+...+.||+|+||.|| ..|+.||||.++... .....+..-+|+++|++++|||||++++.-+... .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34556789999999998 358899999998654 3334566778999999999999999998765433 4
Q ss_pred eEEEEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC--CCCC--EEEEcc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGN--LKVADF 297 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~--vkL~Df 297 (352)
-.++||||.||+|...+++. ..+++.+++.+..+++.||.|||++| |+||||||.||++- .+|+ -||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 67999999999999999754 34999999999999999999999999 99999999999975 3343 799999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
|.|+.+.. .....+..||..|.+||++.. ..|+..+|.|||||++|++.||.
T Consensus 169 G~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 169 GAARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE 221 (732)
T ss_pred cccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence 99998754 336677899999999999984 78899999999999999999996
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=246.70 Aligned_cols=192 Identities=23% Similarity=0.425 Sum_probs=165.4
Q ss_pred CCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
...+|+..+.||+|+||.+| .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 34589999999999999887 3578999999865432 233567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
+|||+++++|.+++.+ ..++..++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999999875 35789999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|.+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 12223457788999999998889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=244.46 Aligned_cols=184 Identities=24% Similarity=0.366 Sum_probs=152.5
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc---CCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK---IRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 162 ~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
.||+|+||.||. +++.+|+|.+.............+.+|..+++. ..||+|+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 379999998872 478999998876544333222333445444443 479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCccc
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 313 (352)
+++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccC
Confidence 9999999988888999999999999999999999999 999999999999999999999999998654322 1223
Q ss_pred CCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhccC
Q 018682 314 QDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 314 ~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltG~ 351 (352)
..++..|+|||.+. +..++.++|+||+||++|+|++|.
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 193 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence 45788999999886 456889999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=243.67 Aligned_cols=192 Identities=27% Similarity=0.444 Sum_probs=158.2
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
-+|++.+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3688889999999999884 13479999886442 23334457889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 225 MMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
.+++|||+++++|.+++... ...+...+..++.|++.||.|||+++ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753 22456778889999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||+++......... .....++..|+|||.+.+..++.++|+|||||++|||++++
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~ 218 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 218 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCC
Confidence 9999987543322111 11223456799999998888999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.30 Aligned_cols=190 Identities=29% Similarity=0.523 Sum_probs=158.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.||. ++..||+|.+..... .......+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 477888999999998874 578999999865432 22233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|++ ++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 996 6888888643 45889999999999999999999999 9999999999999999999999999987553321
Q ss_pred CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||++.+. .++.++|+|||||++|+|+||+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 199 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence 122233457889999987654 5788999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=243.02 Aligned_cols=185 Identities=27% Similarity=0.458 Sum_probs=149.5
Q ss_pred eecccEEEEEEE----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 162 EITKGTFILAFW----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 162 ~ig~G~~~~v~~----~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
.||+|+||.|+. + ...+++|.+.... .......+.+|+..++.++||||+++++.+.....++++|||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 689999998873 2 3468888776432 344456788899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-
Q 018682 235 GDLRAFLKRKGA-----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (352)
Q Consensus 235 ~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~- 308 (352)
++|.+++..... .++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 356777889999999999999999 99999999999999999999999999865332211
Q ss_pred CCcccCCCCCccccccccCC-------CCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltG~ 351 (352)
.......++..|+|||++.. ..++.++|||||||++|||++++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA 206 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC
Confidence 11122334567999998642 35678999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=243.10 Aligned_cols=192 Identities=30% Similarity=0.479 Sum_probs=162.6
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|+..+.||+|+||.||. ....+++|.+... ........+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 4688889999999998873 2357999988643 233355678999999999999999999999999899
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEE
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~ 295 (352)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 999999999999999998655 6899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|||++...............++..|+|||.+.+..++.++||||||+++|+|++++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99998654332222222334566799999998888899999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=245.35 Aligned_cols=193 Identities=24% Similarity=0.362 Sum_probs=163.3
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 225 (352)
+|++.+.||.|+||.+|. +|..||+|.+...... .....+.+.+|+.+++++ +|++|+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999998872 6788999998754322 222345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
++++||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999999988878999999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCCcccCCCCCccccccccCCC--CCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltG~ 351 (352)
..........++..|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~ 205 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA 205 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCC
Confidence 322222334578889999998653 4678899999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=245.86 Aligned_cols=190 Identities=29% Similarity=0.465 Sum_probs=159.2
Q ss_pred cccCceeecccEEEEEEEc---------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceee
Q 018682 156 DFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~---------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (352)
+|++.+.||+|+||.||.. +..+|+|.+.... .......+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 5888999999999999842 3468999987542 3444567889999999999999999
Q ss_pred eeEEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018682 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (352)
Q Consensus 215 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N 283 (352)
+++++..++..+++|||+++++|.+++.... .++..++..++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999987642 2566789999999999999999999 9999999999
Q ss_pred eEeCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 284 ILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 284 ill~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|+++.++.++|+|||++.......... ......+..|++||...+..++.++|+|||||++|||+++
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 999999999999999987653322111 1112335679999998888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=241.33 Aligned_cols=185 Identities=34% Similarity=0.583 Sum_probs=160.2
Q ss_pred eeecccEEEEEEE---c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 161 VEITKGTFILAFW---R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 161 ~~ig~G~~~~v~~---~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+.||+|+||.++. . +..|++|.+...... ...+.+.+|+.+++.++|++|+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3689999998862 2 778999999765432 24678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 233 PKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 233 ~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
++++|.+++... ..+++.++..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999875 67899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 304 TVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 304 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
..... .......++..|+|||.+....++.++|+||||+++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 203 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhc
Confidence 54321 112234467789999999888899999999999999999995
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=245.48 Aligned_cols=192 Identities=29% Similarity=0.483 Sum_probs=165.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.++. +++.|++|.+..... .....+.+.+|++++++++|+||+++++.+..++..+++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 578889999999998763 477999998875432 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|++++.+..+..+...++..++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9988777777766667899999999999999999999999 9999999999999999999999999987765443323
Q ss_pred cccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||++.+. .++.++|+||||+++|+|++|.
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 199 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 3345667889999999887 8889999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=246.99 Aligned_cols=191 Identities=29% Similarity=0.518 Sum_probs=159.4
Q ss_pred CcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 221 (352)
.+|.+.+.||+|+||.||.. ...+|+|.+.... .......+..|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 47888899999999988742 3469999887542 234456788899999999 69999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 285 (352)
++.++++|||+++++|.+++... ..++..++..++.|++.||.|||++| ++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 99999999999999999999753 23788889999999999999999999 999999999999
Q ss_pred eCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 286 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 286 l~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
++.++.+||+|||.++......... .....++..|+|||.+.+..++.++||||||+++|+|+++
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 9999999999999987654322111 1122234579999999888899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=239.34 Aligned_cols=184 Identities=26% Similarity=0.440 Sum_probs=152.7
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 162 ~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
.||+|+||.|+. .+..||+|++.... .....+.+.+|+.++++++||||+++++++. ....+++|||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 489999998873 24569999987542 3444567889999999999999999999875 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC--c
Q 018682 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--L 311 (352)
Q Consensus 235 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~--~ 311 (352)
++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......... .
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999875 446899999999999999999999999 9999999999999999999999999987554322211 1
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
....++..|+|||.+....++.++|+|||||++|+|++ |.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 196 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ 196 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCC
Confidence 11223567999999988889999999999999999996 54
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=248.43 Aligned_cols=190 Identities=25% Similarity=0.497 Sum_probs=159.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.+|. +|..|++|.+..... .......+.+|+.++++++||||+++++++.+.+.+++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 477889999999998873 578999999875432 22223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|++ ++|.+++.. .+.+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~ 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence 996 588887764 456899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||.+.+. .++.++|+|||||++|+|+||+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 22234567889999988664 4688999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=241.30 Aligned_cols=187 Identities=34% Similarity=0.510 Sum_probs=157.2
Q ss_pred cccCceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|++.+.||+|+||.|| ..+..+|+|.+...... .+.+.+|+.++++++||+++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 57888999999999887 24568999998765432 245889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999998753 34889999999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
......++..|+|||.+.+..++.++|+||||+++|+|+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 22223345679999999888899999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=244.65 Aligned_cols=191 Identities=26% Similarity=0.428 Sum_probs=162.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.+|. +|+.||+|.+..... .....+.+.+|+.++++++|||++++++++......+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 578888999999998873 578999998865432 12223457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|..++.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999888888877667999999999999999999999999 99999999999999999999999999877644321 2
Q ss_pred cccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 223456788999998865 45788999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=239.04 Aligned_cols=185 Identities=29% Similarity=0.489 Sum_probs=155.3
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 161 ~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+.||+|+||.|+. .+..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 4699999998862 1268999998766433 34567888999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcc
Q 018682 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (352)
Q Consensus 233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~ 312 (352)
++++|.+++.....+++..+..++.|++.+|.|||..+ ++|+||||+||+++.++.++|+|||.+............
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999999988778999999999999999999999999 999999999999999999999999998765433221111
Q ss_pred --cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 313 --CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 313 --~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCC
Confidence 1122457999999988889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=240.24 Aligned_cols=192 Identities=29% Similarity=0.480 Sum_probs=165.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+|+..+.||+|++|.+|. ++..|++|.+..... ..++..+.+.+|+.+++.++||||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 467778999999998873 578999998865432 2344567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
+||+++++|.+++.+...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999988777899999999999999999999999 9999999999999999999999999887654332
Q ss_pred CCcccCCCCCccccccccCCCC-CCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltG~~ 352 (352)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~ 200 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 223345778899999987766 8899999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=243.70 Aligned_cols=191 Identities=30% Similarity=0.487 Sum_probs=163.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||.|+||.++. +|..|++|++...... ......+.+|+.++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 478889999999998873 5789999998765432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+ +++|.+++.. ...+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 9999999865 345899999999999999999999999 999999999999999999999999998776544333
Q ss_pred CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 33445678899999988654 4688999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.61 Aligned_cols=190 Identities=31% Similarity=0.499 Sum_probs=162.5
Q ss_pred CCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
..+|+..+.||.|+||.||. .+..+++|.+.... ......+..|+.+++.++||||+++++++.....++++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 34688899999999998873 46789999987542 333456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 230 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||+++++|.+++... ..++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999753 34789999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
.. .....++..|+|||.+.+..++.++|+||||+++|+|+++
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~ 200 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 11 1223346679999999888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=246.17 Aligned_cols=192 Identities=30% Similarity=0.518 Sum_probs=160.2
Q ss_pred CcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCC
Q 018682 155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 223 (352)
.+|+..+.||+|+||.|+.. ...+|+|.+.... .......+.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 36778889999999988732 2579999987542 233456688999999999 7999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~ 287 (352)
.++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999999642 34788899999999999999999999 99999999999999
Q ss_pred CCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 288 DSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 288 ~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.++.++|+|||.+.......... .....++..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence 99999999999987654322111 111234567999999988889999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=240.61 Aligned_cols=188 Identities=30% Similarity=0.503 Sum_probs=158.3
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|++.++||+|+||.||. +++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..+++|||
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 577788999999998873 5788999998755432 246788999999999999999999874 4678999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++... ..++..++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998653 34788999999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
......++..|+|||++....++.++|+||||+++|+|++ |.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence 2222334568999999988889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=240.14 Aligned_cols=192 Identities=26% Similarity=0.464 Sum_probs=166.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+|+.++. +++.|++|.+...... +...+.+..|+.+++.++|+||+++++.+...+.+++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 478889999999998863 5789999998765433 4566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999988777889999999999999999999999 9999999999999999999999999987654332211
Q ss_pred c---ccCCCCCccccccccCCCC---CCCchhHHHHHHHHHHhhccC
Q 018682 311 L---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~---~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltG~ 351 (352)
. ....++..|+|||++.+.. ++.++|+||||+++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~ 203 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCC
Confidence 1 1245678899999998766 788999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=248.27 Aligned_cols=183 Identities=26% Similarity=0.448 Sum_probs=148.2
Q ss_pred eeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCceEEEEec
Q 018682 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEY 231 (352)
Q Consensus 161 ~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 231 (352)
.+||+|+||.||. .+..||+|.+..... ...+.+|+.+++.++||||+++++++.. +..++++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 5899999999873 236799998865432 1346789999999999999999998854 4578999999
Q ss_pred cCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe----CCCCCEEEEccC
Q 018682 232 LPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFG 298 (352)
Q Consensus 232 ~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~vkL~Dfg 298 (352)
++ ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 85 5888777521 24788889999999999999999999 9999999999999 456789999999
Q ss_pred CcccccccCC--CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 299 VSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 299 ~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
+++....... .......+|+.|+|||++.+ ..++.++|||||||++|||+||++
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~ 214 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCC
Confidence 9976543221 11233457889999999876 457899999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=239.92 Aligned_cols=184 Identities=33% Similarity=0.608 Sum_probs=156.4
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE-eCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 231 (352)
+|+..+.||+|+||.+| ..|..+++|.+.... ..+.+.+|+.++++++|++++++++++. .+...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 67788899999998776 578899999886432 2356889999999999999999998764 45678999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999997643 3788999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.....+..|+|||++.+..++.++|+|||||++|+|++ |+
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~ 197 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 12334567999999998889999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=242.12 Aligned_cols=190 Identities=29% Similarity=0.484 Sum_probs=164.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||.|+||.+|. ++..||+|.+.... .......+.+|+.+++++.||+|+++++.+.++...+++||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 577888999999998863 47899999886442 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.. ++++..++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 9999999999875 46889999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....++..|+|||.+.+..++.++|+|||||++|+|+||++
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence 223456778999999988889999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=242.61 Aligned_cols=190 Identities=30% Similarity=0.449 Sum_probs=165.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||.|++|.+|. ++..|++|.+.... .......+.+|+.+++.++||||+++++++.++..+++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 577888999999998873 57899999987542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 99999999999865 6899999999999999999999999 99999999999999999999999999877654321 2
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....++..|+|||.+.+..++.++|+||||+++|+|+||..
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 223456778999999998889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=241.61 Aligned_cols=189 Identities=24% Similarity=0.467 Sum_probs=157.9
Q ss_pred CcccCceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
.+|+..+.||+|+||.||. +|. +||+|.+.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 4688889999999998873 333 58999986542 34445678899999999999999999998875 457
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
++++||+++|+|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999764 45899999999999999999999999 9999999999999999999999999987764
Q ss_pred ccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 305 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
...... .....+++.|+|||...+..++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t 206 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 322111 111234567999999988889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=238.59 Aligned_cols=187 Identities=32% Similarity=0.572 Sum_probs=159.2
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..+.||.|+||.+|. .+..+++|.+...... ...+.+|++++++++||+++++++++......+++|||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 577788999999998873 3778999998755432 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++++|.+++... +.+++..+..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999998764 45889999999999999999999999 9999999999999999999999999987553322111
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
......+..|+|||.+.+..++.++|+||||+++|||++
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~ 196 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHc
Confidence 122234568999999988889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=241.47 Aligned_cols=194 Identities=31% Similarity=0.489 Sum_probs=163.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
+|...+.||.|+||.||. +|+.+|+|.+...... .....+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 677888999999998873 5789999988643211 1122356788999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++++|||+++++|.+++.+.+.++...+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988778999999999999999999999999 999999999999999999999999998764
Q ss_pred cccCCC-CcccCCCCCccccccccCCCC--CCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltG~~ 352 (352)
...... ......++..|+|||.+.... ++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 210 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence 322111 122345678899999987654 7889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=247.08 Aligned_cols=190 Identities=25% Similarity=0.489 Sum_probs=158.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||.|+||.||. ++..||+|.+...... .....+.+|+.+++.++||||+++++++..++..+++||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 688899999999998873 4788999988654322 122356789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|++ ++|.+++... ..++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 996 5898888754 45889999999999999999999999 9999999999999999999999999987643322 1
Q ss_pred CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||.+.+ ..++.++|||||||++|+|+||.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 2223446788999998765 457889999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=249.10 Aligned_cols=193 Identities=30% Similarity=0.441 Sum_probs=172.2
Q ss_pred cccCceeecccEEEEEEEc-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|.....||+|+||.|... ...+|||++++..+-..+.++--..|-++|... +-|.++++...|...+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 6777889999999988643 346999999998877766667677788888877 5778999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+.||+|-..+++-+.+.+..+..++..|+-||-+||++| |+.||||.+|||++.+|.+||+|||+++.--. ...
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~~~ 505 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-DGV 505 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc-CCc
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999875332 344
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......|||.|+|||++...+|+..+|+||+||+||||+.|++
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQp 548 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 548 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCC
Confidence 4556789999999999999999999999999999999999974
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=241.00 Aligned_cols=191 Identities=27% Similarity=0.451 Sum_probs=157.0
Q ss_pred ccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc----
Q 018682 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 224 (352)
|++.+.||+|+||.|+. .+..||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56778999999998873 136799999875433 34445678999999999999999999998865544
Q ss_pred --eEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 225 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 225 --~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
.++++||+++++|..++... ..++...+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence 79999999999999988532 24788999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 297 FGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 297 fg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||+++......... ......+..|+|||.+.+..++.++|||||||++|||++++
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCC
Confidence 99987654332211 11123456799999998888999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=243.13 Aligned_cols=190 Identities=31% Similarity=0.537 Sum_probs=158.5
Q ss_pred cccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|+..+.||+|+||.||.. ...+++|.+.... .......+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4677889999999988741 2468888886543 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 018682 226 MIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp 281 (352)
++++||+.+++|.+++... ..++...+..++.|++.||.|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 9999999999999998642 23678888999999999999999999 99999999
Q ss_pred CCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-c
Q 018682 282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-Y 350 (352)
Q Consensus 282 ~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G 350 (352)
+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence 9999999999999999998765332211 1122234568999999988889999999999999999998 5
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=241.40 Aligned_cols=190 Identities=29% Similarity=0.443 Sum_probs=157.3
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|++.+.||+|+||.||. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3688889999999998862 34679999886432 33444568889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC---CEEE
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 294 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~vkL 294 (352)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999997643 4788999999999999999999999 99999999999998755 5999
Q ss_pred EccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 9999987653221111 111223457999999988889999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=240.31 Aligned_cols=191 Identities=32% Similarity=0.527 Sum_probs=160.0
Q ss_pred cccCceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
.|.+.+.||+|+||.+|. ++ ..||+|.+.... .......+..|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 467788999999998873 12 369999987542 35556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+|||+++++|.+++... +.++..++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999998764 45889999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCc-c-cCC--CCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 307 EDRPL-T-CQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 307 ~~~~~-~-~~~--~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
..... . ... .+..|+|||.+.+..++.++|+|||||++|||++ |.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~ 209 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 209 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCC
Confidence 22111 1 111 1347999999998899999999999999999886 64
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=245.80 Aligned_cols=192 Identities=26% Similarity=0.429 Sum_probs=163.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.||. .++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..++++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 577889999999998863 47899999987543322 344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|..+......+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999999888776666899999999999999999999999 9999999999999999999999999987654332 22
Q ss_pred cccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|.+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence 223456788999998865 356789999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=241.14 Aligned_cols=190 Identities=25% Similarity=0.457 Sum_probs=156.7
Q ss_pred cccCceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
+|++.+.||+|+||.||. +++ ++++|.+... ........+..|+..++.+.||||+++++++. ....+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 677788999999998873 343 5788887532 22344567788888999999999999999875 45678
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+++||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999999764 45899999999999999999999999 99999999999999999999999999976543
Q ss_pred cCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 306 KEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 306 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.... ......++..|+|||.+.+..++.++|+|||||++|||++ |.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~ 209 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA 209 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCC
Confidence 2211 1122345678999999988889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=238.44 Aligned_cols=192 Identities=24% Similarity=0.477 Sum_probs=164.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.++. +|+.|++|.+...... ......+.+|+.++++++||||+++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 478889999999998774 6789999998754333 3344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++.... .+++.++..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999987543 4788999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||++.+..++.++|+|||||++++|++|+.
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 199 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCC
Confidence 1122446788999999988888999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=243.23 Aligned_cols=190 Identities=27% Similarity=0.413 Sum_probs=162.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||.|+||.||. ++..+|+|.+... .....+.+..|+.++++++||||+++++.+..+..+|++||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 588889999999998862 4788999998643 44555778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999998764 45899999999999999999999999 99999999999999999999999998765432211
Q ss_pred CcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||.+. ...++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 222345788899999874 3457789999999999999999963
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=245.10 Aligned_cols=191 Identities=31% Similarity=0.520 Sum_probs=161.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+|+..+.||.|++|.+|. +++.|++|.+...... .......+..|+.++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999998873 4789999999765433 122345567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||+ +++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 889999998765 6899999999999999999999999 9999999999999999999999999997765432
Q ss_pred CCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 2 2222345678999998854 46788999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=238.66 Aligned_cols=187 Identities=33% Similarity=0.500 Sum_probs=155.8
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|.+.+.||+|++|.+|. .+..+++|.+..... ..+.+.+|+.+++.++||+++++++++. .+..+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 477888999999998873 235799998865432 2246788999999999999999998875 4568999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
+++++|.+++.... .++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997643 3788899999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
......++..|+|||...+..++.++|+||||+++|+|+||
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~ 199 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhC
Confidence 22223456679999999888899999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=237.97 Aligned_cols=189 Identities=29% Similarity=0.472 Sum_probs=158.4
Q ss_pred CcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
-+|...+.||+|+||.||. .+..+++|.+... ....+.+.+|+.++++++|+||+++++.+.. ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3678888999999998873 4567999988643 2234678889999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++.+. ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999763 34678888999999999999999999 99999999999999999999999999876543222
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.......++..|+|||++....++.++|+|||||++|+++| |.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 201 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCC
Confidence 22222334567999999988889999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=238.63 Aligned_cols=191 Identities=31% Similarity=0.523 Sum_probs=160.5
Q ss_pred cccCceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|+..+.||+|+||.+|. .+ ..+++|.+.... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 677889999999998872 22 369999886542 33445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+|||+++++|.+++... +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 56899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcc--cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 307 EDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 307 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...... ....+..|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCC
Confidence 221111 1122457999999988889999999999999999997 64
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=247.43 Aligned_cols=198 Identities=31% Similarity=0.548 Sum_probs=162.7
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCce
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 212 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 212 (352)
|.|++.. .+|++.+.||+|+||.||.. +..||+|.+... ......+.+.+|+.+++++ +||||
T Consensus 5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 5555543 46888999999999988732 236899988743 2344557788999999999 79999
Q ss_pred eeeeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 018682 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (352)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 276 (352)
+++++++..++.+++++||+++++|.+++.+.. .++..++..++.|++.||.|||+++ ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999999999999999999999997532 3677888899999999999999999 999
Q ss_pred cCCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 277 ~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+++
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 999999999999999999999998765432211 11222334679999999998999999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=252.87 Aligned_cols=189 Identities=31% Similarity=0.482 Sum_probs=160.9
Q ss_pred cccCceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
...+.++||+|.||.+. ..+..||+|+++... .......|..|+++|.+++||||++++++|..++.+++++||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 46667899999999875 245899999998764 344567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
++.|+|.+|+.+... +.......|+.||++|++||.+.+ +|||||.+.|+|++.++++||+|||+++.+-..+..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999987632 345566779999999999999999 999999999999999999999999999865433221
Q ss_pred Cc-ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 310 PL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 310 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
.. ....-..+|||||.+..+.++.++|+|++|+++||+++
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~ 734 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFM 734 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHH
Confidence 11 11233578999999999999999999999999999975
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=239.87 Aligned_cols=190 Identities=28% Similarity=0.459 Sum_probs=154.6
Q ss_pred cCceeecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------Cc
Q 018682 158 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (352)
Q Consensus 158 ~~~~~ig~G~~~~v~~-----~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 224 (352)
.+.+.||+|+||.||. .+ ..+|+|.+.... ......+.+..|+.+++.++||||+++++.+... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999998873 22 269999887653 2445567788999999999999999999976432 24
Q ss_pred eEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 225 MMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
.+++|||+++++|.+++.. ...++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 7899999999999988742 233788999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++......... ......+++.|+|||.+.+..++.++|+|||||++|+|++++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 98765432211 112233566799999999989999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=243.22 Aligned_cols=191 Identities=25% Similarity=0.469 Sum_probs=157.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|+||.||. +|..|++|.+....... ....+.+|+.+++.++|+||+++++++..++..|++|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4788999999999998873 47899999986543221 2234678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+. +++.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 677766654 345788888999999999999999999 99999999999999999999999999875433221
Q ss_pred CCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 22233467889999998653 57889999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=243.69 Aligned_cols=189 Identities=35% Similarity=0.537 Sum_probs=155.9
Q ss_pred cccCceeecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 227 (352)
+|++.+.||+|+||.|+. ++ ..+++|.++.. ......+.+.+|+.+++++ +||||+++++++...+.+++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578888999999998873 23 24788887632 2334456788899999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC
Q 018682 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 291 (352)
++||+++++|.+++.... .++...+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999997532 3778899999999999999999999 999999999999999999
Q ss_pred EEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 292 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~ 216 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG 216 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9999999986432111 1111223456999999988889999999999999999997 54
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=251.71 Aligned_cols=196 Identities=30% Similarity=0.478 Sum_probs=160.3
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeee
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQF 215 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~ 215 (352)
.|+++.. +|.+.+.||+|+||.||. .+..||+|++.... .....+.+.+|+.++.++. ||||+++
T Consensus 31 ~~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 31 AWEMPRD--NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred cceecHH--HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 3444433 566778999999999873 13579999997543 2333456889999999997 9999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHhcC--------------------------------------------------
Q 018682 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------------------------------------- 245 (352)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------- 245 (352)
++++..++..++||||+++|+|.+++.+..
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999999986431
Q ss_pred ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 018682 246 ------------------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (352)
Q Consensus 246 ------------------------------------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 277 (352)
.++...+..++.|++.||.|||+.+ ++||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcc
Confidence 2456677889999999999999998 9999
Q ss_pred CCCCCCeEeCCCCCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 278 Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
||||+|||++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|||++
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999999999999876432211 11122345678999999988889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=258.77 Aligned_cols=185 Identities=34% Similarity=0.559 Sum_probs=159.3
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 235 (352)
-.+|+|+||.||- +...+|||.+.... ....+-+..|+..-++++|.|||++++.+.+++.+-+.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 3789999999983 34578999886542 233466888999999999999999999999999999999999999
Q ss_pred CHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEccCCcccccccCCCCc
Q 018682 236 DLRAFLKR-KGAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 236 ~L~~~l~~-~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+|++++.. .+++ ++...-.+.+||++||.|||.+. |||||||-+|+|++ -.|.+||+|||-++.+..... ..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~T 733 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CT 733 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-cc
Confidence 99999975 4666 68888889999999999999999 99999999999997 568899999999987764322 22
Q ss_pred ccCCCCCccccccccCCC--CCCCchhHHHHHHHHHHhhccCC
Q 018682 312 TCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltG~~ 352 (352)
..+.||..|||||++..+ .|..++|||||||++.||.||++
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrP 776 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRP 776 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCC
Confidence 356799999999999765 67889999999999999999985
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=237.65 Aligned_cols=190 Identities=35% Similarity=0.613 Sum_probs=161.2
Q ss_pred ccCceeecccEEEEEEE---c------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 157 FTNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~---~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+++.+.||.|+||.++. . +..||+|.+.... ..+..+.+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 35667899999998762 2 2789999996543 23355678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+|||+++++|.+++..... +++.++..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999999976544 899999999999999999999999 99999999999999999999999999876654
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..........+++.|+|||.+.+..++.++|+||||+++|+|++++
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCC
Confidence 3222211223567899999998888999999999999999999843
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=241.07 Aligned_cols=184 Identities=24% Similarity=0.372 Sum_probs=152.2
Q ss_pred eecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHH---HHHhcCCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL---ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 162 ~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
.||+|+||.|| .+++.||+|.+.............+..|. ..++...||+|+++++.+...+.++++|||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 37999999887 25789999998765443222222233343 34455679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCccc
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 313 (352)
+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence 9999999988778999999999999999999999999 9999999999999999999999999987553221 123
Q ss_pred CCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 314 QDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 314 ~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
..++..|+|||.+.+. .++.++|+||+|+++|+|++|.
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~ 193 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCC
Confidence 4578899999998754 6889999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=238.98 Aligned_cols=186 Identities=28% Similarity=0.400 Sum_probs=150.3
Q ss_pred eeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 161 ~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
+.||+|+||.||. .+..+++|.+.... .......+.+|+.++++++||||+++++.+.+...++++|||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 3689999998873 23579999887543 23334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 234 KGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 234 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
+++|.+++.... ..+...+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999987532 3456677889999999999999999 99999999999999999999999999865432211
Q ss_pred C-CcccCCCCCccccccccCCC-------CCCCchhHHHHHHHHHHhhc-cC
Q 018682 309 R-PLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 309 ~-~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~ellt-G~ 351 (352)
. ......++..|+|||++.+. .++.++|+||||+++|||++ |.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~ 207 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence 1 11223456789999988642 35789999999999999996 75
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=237.54 Aligned_cols=179 Identities=22% Similarity=0.396 Sum_probs=149.3
Q ss_pred eeecccEEEEEEEc-----------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 161 VEITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 161 ~~ig~G~~~~v~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
+.||+|+||.||.. ...|++|.+... .......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36899999988732 225889987643 2334457888999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC-------EEEE
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVA 295 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-------vkL~ 295 (352)
..+++|||+++++|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. ++++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999999988753 45899999999999999999999999 999999999999987664 8999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhcc
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltG 350 (352)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+++
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 99988654321 1234677899999886 46788999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=238.20 Aligned_cols=185 Identities=32% Similarity=0.520 Sum_probs=157.4
Q ss_pred eeecccEEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 161 VEITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 161 ~~ig~G~~~~v~~------~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+.||+|++|.||. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 3689999998872 12 36999999876543 556788999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-
Q 018682 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (352)
Q Consensus 233 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~- 309 (352)
++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999997754 5889999999999999999999999 999999999999999999999999998776432211
Q ss_pred -CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 310 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
......++..|+|||.+.+..++.++|+|||||++|+|++ |.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~ 198 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE 198 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCC
Confidence 1112345678999999998889999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=237.98 Aligned_cols=190 Identities=31% Similarity=0.498 Sum_probs=166.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|.+.+.||.|++|.++. ++..|++|++..... ......+.+|+..++.++||||+++++++...+..+++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 577889999999998763 488999999876532 2456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++.....+++..+..++.|++.++.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999887789999999999999999999999 99 999999999999999999999999998766443222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. ....++..|+|||.+....++.++|+||||+++|+|+||.
T Consensus 157 ~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 157 C-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred c-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 1 2345678899999999888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=243.30 Aligned_cols=190 Identities=25% Similarity=0.420 Sum_probs=164.9
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.++. +|..||+|++.... .......+.+|+.+++.++||||+++++.+.....++++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3688889999999998873 47889999886432 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++...+.++...+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999999887789999999999999999999997 46 9999999999999999999999999876543221
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....++..|+|||++.+..++.++|+|||||++|+|+||..
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~ 200 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCC
Confidence 123457889999999988889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=237.52 Aligned_cols=188 Identities=27% Similarity=0.431 Sum_probs=163.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||.|+||.++. ++..+++|.+.... ..+.+.+|+.++++++||||+++++.+..+..+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 4688889999999997762 36889999886432 1568899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999999975 445899999999999999999999999 99999999999999999999999999877654321
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~ 196 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCC
Confidence 222344678899999998888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=241.55 Aligned_cols=190 Identities=32% Similarity=0.512 Sum_probs=159.4
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|+..+.||+|+||.++. .+..||+|.+.... .......+.+|+.++++++||||+++++++..+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3688889999999998874 35789999987542 34445678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~ 282 (352)
.+++|||+++++|.+++.... .++..++..++.|++.||.|||+++ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999997432 3677888999999999999999999 999999999
Q ss_pred CeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 283 NILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 283 Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence 999999999999999998754322111 1112234567999999988899999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=239.26 Aligned_cols=177 Identities=24% Similarity=0.391 Sum_probs=146.9
Q ss_pred eecccEEEEEEEc-----------------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCce
Q 018682 162 EITKGTFILAFWR-----------------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212 (352)
Q Consensus 162 ~ig~G~~~~v~~~-----------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 212 (352)
.||+|+||.||.. ...|++|.+... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 5899999988832 135889988643 23344567889999999999999
Q ss_pred eeeeEEEEeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-
Q 018682 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290 (352)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~- 290 (352)
+++++++..+...++||||+++++|..++.. .+.+++..+..++.|++.||+|||+++ |+||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999999865 456899999999999999999999999 99999999999998644
Q ss_pred ------CEEEEccCCcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhc
Q 018682 291 ------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 291 ------~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt 349 (352)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+|||||++|||++
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 3899999987543221 12345678999998865 568899999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=242.94 Aligned_cols=188 Identities=28% Similarity=0.494 Sum_probs=160.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.+|. .+..||+|.+.... .......+.+|+.++++++||||+++++.+..++.++++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 578889999999998862 47899999886432 34445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|..++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999998763 368999999999999999999997 47 999999999999999999999999998765322
Q ss_pred CCCCcccCCCCCccccccccCCC------CCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltG~ 351 (352)
. .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 204 (286)
T cd06622 157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204 (286)
T ss_pred c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCC
Confidence 1 1223467789999998554 3478999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=247.70 Aligned_cols=189 Identities=31% Similarity=0.497 Sum_probs=155.6
Q ss_pred cccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC-C
Q 018682 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~ 223 (352)
+|++.+.||+|+||.||. .++.||+|++.... .......+.+|+.++.++ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 688899999999999873 35789999997543 233456788899999999 689999999987654 5
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------- 244 (352)
.++++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCC
Q 018682 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQD 315 (352)
Q Consensus 245 --------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~ 315 (352)
..++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12567778889999999999999999 999999999999999999999999998764322111 111223
Q ss_pred CCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 276 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 4567999999988889999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=219.14 Aligned_cols=188 Identities=26% Similarity=0.491 Sum_probs=160.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|..-++||+|+||.|+. ++..||+|.+......+. .-....+|+-+++.++|.|||++++....++.+.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 566778999999999984 467899999986643322 22445679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||. .+|..|... ++.+..+.+..++.|+++||.++|+++ ++|||+||+|+||+.+|.+||+|||+++.+..+..
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 994 589988876 456899999999999999999999999 99999999999999999999999999988765432
Q ss_pred CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhc
Q 018682 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt 349 (352)
-+....-|..|++|.++.+. -|++..|+||.|||+.|+..
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelan 197 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhh
Confidence 23344568899999998764 67889999999999999865
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=242.89 Aligned_cols=189 Identities=29% Similarity=0.485 Sum_probs=162.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|+||.||. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 466778899999998873 46789999886442 23445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 9999999998865 45889999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||.+.+..++.++|+|||||++|||++|.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~ 198 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCC
Confidence 22345678899999999888999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=235.89 Aligned_cols=190 Identities=26% Similarity=0.497 Sum_probs=163.1
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.+| .++..+|+|.+...... ......+.+|+.++++++||||+++++.+..++..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 47888999999999887 36789999998765443 3445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999764 34789999999999999999999999 99999999999998654 57999999987664322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~ 198 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLK 198 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCC
Confidence 122245678899999999888899999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=237.87 Aligned_cols=178 Identities=25% Similarity=0.420 Sum_probs=149.7
Q ss_pred eeecccEEEEEEE---c--C----------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 161 VEITKGTFILAFW---R--G----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 161 ~~ig~G~~~~v~~---~--~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+.||+|+||.||. . + ..+++|.+..... . ...+.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---h-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 3689999998862 1 2 2478887654321 1 5678899999999999999999999888 778
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-------CEEEEcc
Q 018682 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADF 297 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-------~vkL~Df 297 (352)
+++|||+++++|.+++.... .++...+..++.|++.||.|||+++ |+|+||||+||+++.++ .++|+||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999999998765 6899999999999999999999999 99999999999999887 7999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCC--CCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltG~ 351 (352)
|++..... .....++..|+|||++... .++.++|+||||+++|+|++|+
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 99876543 1123455679999998776 7889999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=236.52 Aligned_cols=186 Identities=32% Similarity=0.527 Sum_probs=152.1
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE-eCCceEEEEec
Q 018682 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (352)
Q Consensus 161 ~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 231 (352)
+.||+|+||.||. .+..+|+|.+... ......+.+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 3689999998872 2357999987532 23445677888999999999999999999765 45568999999
Q ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-
Q 018682 232 LPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~- 309 (352)
+.+++|.+++.... ..+...+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999997643 4677788889999999999999999 999999999999999999999999998754322111
Q ss_pred --CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 --PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 --~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||.+.+..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC
Confidence 111233466899999998888999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=235.18 Aligned_cols=185 Identities=32% Similarity=0.511 Sum_probs=155.3
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCC
Q 018682 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (352)
Q Consensus 161 ~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 236 (352)
+.||.|+||.+|. .++.|++|.+..... ......+.+|+.++++++||+|+++++++......+++|||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 3689999987762 378999998876533 2445678999999999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc-ccC
Q 018682 237 LRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQ 314 (352)
Q Consensus 237 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~-~~~ 314 (352)
|.+++... ..++...+..++.|++.+|.|||+++ ++||||||+||+++.++.++|+|||.+........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99999653 45788999999999999999999999 99999999999999999999999999875432111111 112
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
..+..|+|||.+.+..++.++|+||||+++|+|+||
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~ 191 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhc
Confidence 234569999999888899999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=237.52 Aligned_cols=191 Identities=30% Similarity=0.484 Sum_probs=164.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||.|+||.+|. ++..+++|++....... ..+.+.+|+.+++.++|+||+++++.+......++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 588889999999998862 56789999987543322 55778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
++++++|.+++... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999764 34889999999999999999999999 9999999999999999999999999987665433
Q ss_pred CC---CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 308 DR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.. ......++..|+|||++... .++.++|+|||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence 22 11234577889999998776 7889999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=238.21 Aligned_cols=191 Identities=28% Similarity=0.494 Sum_probs=160.0
Q ss_pred CcccCceeecccEEEEEEEc-----C----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 155 LDFTNSVEITKGTFILAFWR-----G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~-----~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
.+|+..+.||+|+||.+|.. | ..+|+|...... .......+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 46788899999999988742 2 268999886553 34455678899999999999999999999887 789
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999764 45899999999999999999999999 9999999999999999999999999997664
Q ss_pred ccCCCCc-ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 305 VKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 305 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
....... ....++..|+|||.+....++.++|+||||+++||+++ |.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~ 209 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA 209 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCC
Confidence 3221111 11223467999999988889999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=241.99 Aligned_cols=190 Identities=26% Similarity=0.483 Sum_probs=158.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|++|.||. +++.||+|.+....... ....+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 3688889999999998873 57899999987543221 1234567999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 83 EYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred ecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9997 4999988764 45789999999999999999999999 99999999999999999999999999865432211
Q ss_pred CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.+ ..++.++|+||+|+++|+|++|.
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence 1122335678999998865 45788999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=236.13 Aligned_cols=183 Identities=34% Similarity=0.591 Sum_probs=155.9
Q ss_pred cccCceeecccEEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+|++.+.||+|+||.++. .+..||+|.+.... ....+.+|+.+++.++|||++++++++..+ ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 578889999999998874 67889999886432 235688899999999999999999998764 479999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 233 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
++++|.+++.... .++...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999997643 4788899999999999999999999 9999999999999999999999999987543211
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 195 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence 11223467999999988899999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=238.19 Aligned_cols=194 Identities=27% Similarity=0.417 Sum_probs=161.4
Q ss_pred CCCcccCceeecccEEEEEEE----c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-C
Q 018682 153 HELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-S 222 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~----~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 222 (352)
...+|+..+.||+|+||.||. . +..|++|.+... ........+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 445788889999999998862 2 578999988643 245556778899999999999999999998765 4
Q ss_pred CceEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
...++++||+++++|.+++... ..++..++..++.|++.||.|||+++ ++|+||||+||+++.++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999998753 34789999999999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++||+++ |+
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 9999987653322111 112334667999999988889999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=241.01 Aligned_cols=189 Identities=32% Similarity=0.505 Sum_probs=164.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||.|+||.++. +++.+++|.+.... .......+.+|+.++++++||||+++++.+..++..++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 467778999999998863 47889999887553 23455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++... ..+++..+..++.|++.+|.|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999999875 678999999999999999999999 88 99999999999999999999999998866532211
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
. ...++..|+|||.+.+..++.++|+||||+++|+|++|++
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 197 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRF 197 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 1 1556788999999988899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=236.61 Aligned_cols=184 Identities=28% Similarity=0.407 Sum_probs=154.9
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-hcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.||.|+||.+|. +|+.||+|.+.............+..|..++ ...+|||++++++.+..++.+|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999998873 5789999998754333333333445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccC
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 314 (352)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 999999988778999999999999999999999999 99999999999999999999999998875432 1223
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.++..|+|||.+.+..++.++|+||||+++|+|++|.+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 191 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCC
Confidence 46788999999988888999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=236.58 Aligned_cols=191 Identities=25% Similarity=0.452 Sum_probs=158.5
Q ss_pred CcccCceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
.+|+..+.||+|+||.||.. ...|++|...... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 35778899999999988731 2368999886442 24455678999999999999999999998875 5678
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
++|||+++++|.+++.+.. .++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999998644 4899999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
..........++..|+|||.+....++.++|+||||+++|+|++ |.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 206 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGV 206 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCC
Confidence 32211222233467999999988889999999999999999986 64
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=238.81 Aligned_cols=191 Identities=26% Similarity=0.402 Sum_probs=158.3
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC-----
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----- 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----- 222 (352)
.-.|+..+.||+|+||.||. .++.||+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 34678888999999998873 46789999986432 1234678899999998 699999999998753
Q ss_pred -CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 223 -SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 223 -~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
..+|++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4589999999999999998863 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+....... .......++..|+|||++. ...++.++|+|||||++|+|++|+.
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 87653221 2223355788899999885 3357889999999999999999973
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=236.64 Aligned_cols=193 Identities=26% Similarity=0.429 Sum_probs=176.1
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|...+.||+|+|..|. .+.+.+|+|+++++.+.+++.++..+.|-.+..+. +||.+|-+...|..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 378889999999998664 56789999999999999888899999999999887 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
.||++||+|--.++++..++++.+..+...|+-||.|||++| |+.||||.+|+|++..|.+||+|+|+++..-.+.+
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999999999888888888999999999999999999999999 99999999999999999999999999876444333
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....+.|||.|.|||++++..|...+|+|+|||+++||+.|.
T Consensus 407 -~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagr 448 (593)
T KOG0695|consen 407 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 448 (593)
T ss_pred -ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCC
Confidence 334578999999999999999999999999999999999885
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=239.23 Aligned_cols=192 Identities=29% Similarity=0.525 Sum_probs=161.7
Q ss_pred CcccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CC
Q 018682 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 223 (352)
..|+..+.||+|+||.||. .+..+|+|.+...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 4577788999999998873 2578999998755332 345678999999999999999999999877 55
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
..+++|||+++++|.+++.... .++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 7899999999999999997654 5899999999999999999999999 99999999999999999999999999887
Q ss_pred ccccCCCCc--ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......... ....++..|+|||.+.+..++.++|+||||+++|||+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~ 209 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYG 209 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccC
Confidence 653222111 1223455699999998888999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=244.69 Aligned_cols=188 Identities=23% Similarity=0.391 Sum_probs=160.3
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|.....||+|+||.++ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 44455689999999876 2578999999864322 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|..++.. ..+++..+..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 173 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK 173 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence 9999999998765 45899999999999999999999999 9999999999999999999999999886543322 12
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 214 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 22345788999999999888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=219.66 Aligned_cols=189 Identities=25% Similarity=0.481 Sum_probs=153.9
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.......||+|+||.+. .+|+..|+|.+.... .++ ...++.+|+.+..+. .+|++|++|+....+..+|+.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34455689999999763 689999999998654 333 345566788876655 7999999999999999999999
Q ss_pred eccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 230 EYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 230 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|.+ ..+|..+-. ..+.+++..+-+|+..++.||.|||++- .++|||+||+|||++.+|++|+||||++-.+..
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999 568876653 4566899999999999999999999974 499999999999999999999999999977654
Q ss_pred cCCCCcccCCCCCccccccccCC----CCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltG~ 351 (352)
+-... ...|-..|||||.+.. ..|+.++||||||+.+.||.++.
T Consensus 202 SiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr 249 (282)
T KOG0984|consen 202 SIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILR 249 (282)
T ss_pred hhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcc
Confidence 33222 2345567999998743 47899999999999999998864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=234.62 Aligned_cols=190 Identities=31% Similarity=0.550 Sum_probs=157.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
++.....||+|+||.||. ++..|++|.+... .....+.+.+|+.+++.++|+||+++++++..++..++++|
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 444556899999998873 4568999988644 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|.+++... ..+ +...+..++.|++.||.|||+++ |+|+||||+||+++. ++.++|+|||.+......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999764 445 77888889999999999999999 999999999999986 678999999998765322
Q ss_pred CCCCcccCCCCCccccccccCCC--CCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltG~~ 352 (352)
. .......+++.|+|||++... .++.++|+||||+++|+|++|.+
T Consensus 163 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~ 209 (268)
T cd06624 163 N-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209 (268)
T ss_pred C-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCC
Confidence 2 122234578899999998654 37889999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=241.16 Aligned_cols=193 Identities=26% Similarity=0.498 Sum_probs=168.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|...+.||+|+||.+|. +|..|++|++...........+.+.+|..++++++ ||||+++++++..++..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 578888999999998873 68899999998755555555677889999999998 999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~- 308 (352)
|++++++|.+++.+.+.+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998878999999999999999999999999 99999999999999999999999999876543221
Q ss_pred ------------------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 ------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......++..|+|||......++.++|+||||++++++++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 1122345678899999998888899999999999999999986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=239.97 Aligned_cols=189 Identities=29% Similarity=0.476 Sum_probs=161.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
..|...+.||+|+||.+|. +++.||+|.+........+..+.+.+|+.+++.++||||+++++++.+++..++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3588889999999998873 57899999987554445556677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+. +++.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 577777654 456899999999999999999999999 999999999999999999999999988654322
Q ss_pred CCcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~~ 352 (352)
....++..|+|||++. ...++.++||||||+++|+|+||.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~ 212 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCC
Confidence 2235677899999874 4567889999999999999999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=247.34 Aligned_cols=188 Identities=27% Similarity=0.379 Sum_probs=159.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------C
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 223 (352)
.+|+..+.||+|+||.|+. +|+.||+|.+..... .......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4688999999999998863 678999999865432 333445677899999999999999999988644 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
..|++|||+. ++|.+++... ++...+..++.|++.||.|||++| |+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 4799999995 5888887654 889999999999999999999999 999999999999999999999999999765
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ......++..|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 214 (353)
T cd07850 169 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214 (353)
T ss_pred CCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCC
Confidence 4321 122345678899999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=243.28 Aligned_cols=187 Identities=25% Similarity=0.437 Sum_probs=159.7
Q ss_pred ccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|.....||.|+||.++ .++..||+|.+... .....+.+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3445679999999887 25788999988543 234456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+++++|.+++.. +.++..++..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 999999998864 45889999999999999999999999 99999999999999999999999999875432221 12
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....++..|+|||.+.+..++.++|+||||+++|||++|+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~ 215 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 2345788899999998888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=236.00 Aligned_cols=185 Identities=24% Similarity=0.382 Sum_probs=147.7
Q ss_pred eecccEEEEEEE----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 162 EITKGTFILAFW----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 162 ~ig~G~~~~v~~----~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
.||+|+||.||. ++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+......|++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999998873 22 245677665432 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-C
Q 018682 235 GDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (352)
Q Consensus 235 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-~ 309 (352)
++|.+++.+. ...+...+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999753 23566677889999999999999999 99999999999999999999999998754221111 1
Q ss_pred CcccCCCCCccccccccCC-------CCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.. ..++.++||||||+++|||++++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 1123446788999998743 24577899999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=237.90 Aligned_cols=187 Identities=33% Similarity=0.493 Sum_probs=160.9
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||.|+||.+|. +|+.+++|.+.............+.+|+.++++++||||+++++.+..+...|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 57888887762 4889999998766544445667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-------CC
Q 018682 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-------RP 310 (352)
Q Consensus 238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-------~~ 310 (352)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999988778999999999999999999999999 99999999999999999999999998875433211 12
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....++..|+|||.......+.++|+||||+++|+|++|..
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 223446778999999988888999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=236.32 Aligned_cols=188 Identities=30% Similarity=0.504 Sum_probs=162.1
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+.||.|+||.||. ++..||+|.+.... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 67788999999998872 56789999876432 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+++++|.+++.. ..++...+..++.|++.++.+||+++ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999999999875 45889999999999999999999999 9999999999999999999999999987654321 112
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....++..|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 198 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 2345678899999998888899999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=239.66 Aligned_cols=190 Identities=24% Similarity=0.448 Sum_probs=163.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|.+.+.||+|+||.+|. ++..|++|.+... .....+.+.+|+.+++.++||||+++++.+...+..|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4788899999999998873 5688999988543 2233466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.+. .++..++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999999998764 4788999999999999999999999 99999999999999999999999998865543222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||.+.+..++.++|+||||+++|+|++|.+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~ 213 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2223457788999999988888999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=236.07 Aligned_cols=183 Identities=34% Similarity=0.568 Sum_probs=150.8
Q ss_pred eecccEEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccC
Q 018682 162 EITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 162 ~ig~G~~~~v~~-----~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
.||+|+||.|+. ++. .+++|.+... ......+.+.+|+.+++++ +||||+++++++...+..+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 589999998863 232 5788888643 2344456788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 234 ~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
+++|.+++.... .++..++..++.|++.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997532 3678899999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
|++....... .......+..|+|||++....++.++|+|||||++|||++ |.
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9875322111 1111223567999999988889999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=237.09 Aligned_cols=188 Identities=24% Similarity=0.437 Sum_probs=161.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|...+.||.|++|.++. ++..+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 466677999999998862 4678999987533 33344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.. ..++...+..++.|++.||.+||+++ ++||||+|+||+++.++.++|+|||.+........ .
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999999999887 56899999999999999999999999 99999999999999999999999998765433211 1
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~ 212 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCC
Confidence 22345788899999998888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=242.25 Aligned_cols=192 Identities=26% Similarity=0.439 Sum_probs=157.4
Q ss_pred cccCceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceE
Q 018682 156 DFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 226 (352)
+|.+.+.||+|+||.+|. .+..||+|.+.............+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477888999999998872 5789999999874422333345677899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC----CCCEEEEcc
Q 018682 227 IVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADF 297 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~----~~~vkL~Df 297 (352)
+||||+++ ++.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 777766432 25789999999999999999999999 999999999999999 899999999
Q ss_pred CCcccccccCC--CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
|++........ .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcC
Confidence 99876543222 11123356788999998765 45788999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=230.61 Aligned_cols=191 Identities=29% Similarity=0.531 Sum_probs=167.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.+|. .++.|++|.+...... ......+.+|++++++++||+++++++++.+++..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 477889999999998874 5789999999866443 3455789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.....+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999988788999999999999999999999999 999999999999999999999999998776543321
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~ 196 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCC
Confidence 22345678899999998888899999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=233.68 Aligned_cols=191 Identities=25% Similarity=0.450 Sum_probs=162.4
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCceEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 228 (352)
+|++.+.||.|+||.+| .++..+++|.+..... .....+.+..|+.+++.++||||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 47788899999999887 3578899999875543 34455678899999999999999999998764 3458999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
|||+++++|.+++.. ..++++..+..++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999999875 356889999999999999999999 777 99999999999999999999999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 157 AKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207 (265)
T ss_pred cccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence 8876543221 22345788999999998888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=239.78 Aligned_cols=190 Identities=30% Similarity=0.470 Sum_probs=159.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 228 (352)
+|+..+.||.|+||.||. +++.+++|.+...... ......+.+|+.++++++||||+++++++... +..|++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 688889999999998873 4788999998755332 22234567799999999999999999998877 889999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
+||++ ++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 59998887644 4899999999999999999999999 9999999999999999999999999987665432
Q ss_pred CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 122234467889999988654 4688999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=239.40 Aligned_cols=193 Identities=25% Similarity=0.368 Sum_probs=162.5
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 225 (352)
+|+..+.||+|+||.+|. ++..||+|.+...... .....+.+.+|+.+++++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999998873 4578999988754322 223345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
++||||+++++|.+++.....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999999987777899999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCCcccCCCCCccccccccCCCC--CCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltG~ 351 (352)
..........++..|+|||.+.+.. .+.++|+||||+++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~ 205 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA 205 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCC
Confidence 3222222345788999999987654 688999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=275.28 Aligned_cols=198 Identities=25% Similarity=0.409 Sum_probs=169.3
Q ss_pred CCCCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
.....+++....||.|.||.|| .+|.-.|+|.++..... ......+.+|..++..++|||+|++|++=.+....
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 4455678888899999999998 46888999988654332 34456678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+|.||||++|+|.+.+......++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|+.|||.|..+.+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999999988776777777789999999999999999 99999999999999999999999999987754
Q ss_pred cCC---CCcccCCCCCccccccccCCC---CCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KED---RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltG~~ 352 (352)
... .......||+.|||||++.+. ....++|||||||+..||.||+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 421 122456799999999999754 45668999999999999999973
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=237.37 Aligned_cols=191 Identities=29% Similarity=0.390 Sum_probs=157.4
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEE-----e
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----Q 221 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~ 221 (352)
...+|++.+.||+|+||.+|. +++.+++|++.... .....+..|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 445788999999999998873 57899999876432 1224677899999999 6999999999874 3
Q ss_pred CCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
+..++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence 4568999999999999988753 245788889999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltG~ 351 (352)
|++....... .......+++.|+|||++.. ..++.++|+|||||++|+|++|.
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~ 226 (286)
T cd06638 169 GVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226 (286)
T ss_pred CceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCC
Confidence 9987654322 12233457889999998753 45788999999999999999986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=236.03 Aligned_cols=190 Identities=28% Similarity=0.499 Sum_probs=161.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l 227 (352)
.|+..+.||.|+||.+|. ++..|++|.+.... .......+.+|+.++++++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 467788999999998873 57899999986542 2334466888999999986 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
+|||+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999998764 6899999999999999999999999 9999999999999999999999999987665432
Q ss_pred CCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 200 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence 22233457888999998865 456889999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=230.09 Aligned_cols=188 Identities=30% Similarity=0.503 Sum_probs=164.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.+|. ++..+++|++..... .....+.+|+.++++++||+++++++.+..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 467788999999998763 478899999975532 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++... ..+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999999775 56899999999999999999999998 99999999999999999999999999876654321
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~ 194 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence 23345778899999998888899999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=235.79 Aligned_cols=180 Identities=21% Similarity=0.336 Sum_probs=150.2
Q ss_pred eeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 161 VEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 161 ~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+.||+|+||.||.. ..++++|.+... .....+.+..|+.+++.++||||+++++++..+...+++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 36899999988732 234788877533 233446788899999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC--------EEEEccCC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGV 299 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------vkL~Dfg~ 299 (352)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. ++++|||.
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999997654 4789999999999999999999999 999999999999987765 69999998
Q ss_pred cccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
+..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+
T Consensus 155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 202 (258)
T cd05078 155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG 202 (258)
T ss_pred ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCC
Confidence 765432 122456778999999876 45788999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=235.51 Aligned_cols=188 Identities=27% Similarity=0.471 Sum_probs=153.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|++.+.||+|+||.||. +|..||+|.+..... .... ..+..|+.. ++.++||||+++++++..++.+|++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 578889999999998874 588999999876532 2222 334445554 66778999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 230 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
||++ ++|.+++.. ...+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 688877754 23588999999999999999999997 7 9999999999999999999999999987653
Q ss_pred ccCCCCcccCCCCCccccccccCC----CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltG~ 351 (352)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (283)
T cd06617 156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204 (283)
T ss_pred ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCC
Confidence 221 1122356788999998865 45688999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=235.62 Aligned_cols=191 Identities=25% Similarity=0.449 Sum_probs=165.0
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
....|+..+.||.|++|.+|. .+..+++|.+..... ....+.+|+.+++.++|+|++++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 344688888999999998763 478899999865422 44678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
++||+++++|.+++.... .++...+..++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999999998876 7999999999999999999999999 999999999999999999999999987654432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~ 213 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence 21 122334677899999998888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=238.56 Aligned_cols=189 Identities=25% Similarity=0.488 Sum_probs=156.3
Q ss_pred CcccCceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
.+|+..+.||+|+||.||. +|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3677888999999998874 233 57999886442 234445688899999999999999999988654 56
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
++++||+++|+|.+++.... .++...+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 79999999999999987654 5888999999999999999999999 9999999999999999999999999997654
Q ss_pred ccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 305 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
..... ......++..|+|||.+.+..++.++||||||+++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 32211 1112234568999999988899999999999999999997
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=236.22 Aligned_cols=190 Identities=32% Similarity=0.496 Sum_probs=160.4
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceEEEE
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 229 (352)
|++.+.||.|+||.+|. +++.+|+|.+.... ........+.+|+.++++++|||++++++++... +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 56778999999998873 46899999998654 2333445678899999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||++ ++|.+++... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9996 4898888765 46899999999999999999999999 99999999999999999999999999877654432
Q ss_pred CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.......++..|+|||.+.+ ..++.++|+||||+++|+|+||+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~ 199 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCC
Confidence 22333445778999997764 46788999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=237.27 Aligned_cols=190 Identities=27% Similarity=0.526 Sum_probs=158.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||.|++|.+|. +|+.|++|.+..... .......+.+|++++++++||||+++++++.+++..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 477889999999998863 578999998875432 22233568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 995 6898888653 45889999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||.+.+. .++.++|+||||+++|+|+||+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 198 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 122233457789999988664 4588999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=235.78 Aligned_cols=190 Identities=28% Similarity=0.579 Sum_probs=158.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||.|++|.+|. +|..||+|.+..... ......+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 478889999999998873 578899999875432 2223556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9975 888888654 34899999999999999999999999 9999999999999999999999999987553321
Q ss_pred CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
. ......++..|++||++.+. .++.++|+|||||++|+|++|.+
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 1 12233457889999988654 56889999999999999999963
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=249.82 Aligned_cols=198 Identities=24% Similarity=0.398 Sum_probs=169.2
Q ss_pred CcccCCCCC-cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHH-----HHHHHHHHHhcCC---CCce
Q 018682 147 EYEIDPHEL-DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVR-----AFRDELALLQKIR---HPNV 212 (352)
Q Consensus 147 ~~~i~~~~~-~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~~i 212 (352)
.++...... +|+..+.+|.|+||.|. .+...|++|.+.++++-.+.+++ .+-.|+++|..++ |+||
T Consensus 552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 444444443 79999999999999885 34678999999887765443332 2456999999997 9999
Q ss_pred eeeeEEEEeCCceEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC
Q 018682 213 VQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (352)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 291 (352)
++++++|++++.+|++||-. +|.+|.+++..++.+++.++..|++|++.|+++||++| |||||||-+|+.++.+|-
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF 708 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence 99999999999999999976 56799999999999999999999999999999999999 999999999999999999
Q ss_pred EEEEccCCcccccccCCCCcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhcc
Q 018682 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 292 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG 350 (352)
+||+|||.+.... ..+...+.||..|.|||++.+.+| ...-|||+||++||.+++.
T Consensus 709 ~klidfgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyk 765 (772)
T KOG1152|consen 709 VKLIDFGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYK 765 (772)
T ss_pred EEEeeccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEec
Confidence 9999999987643 345566789999999999999877 4568999999999987653
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=234.64 Aligned_cols=188 Identities=29% Similarity=0.453 Sum_probs=159.1
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 228 (352)
+|...+.||.|++|.+| .+++.+|+|.+.... .......+.+|++++++++||||+++++++.+. +.++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 57778899999999886 257889999887542 234456788999999999999999999988654 468999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
|||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999888753 344788999999999999999999999 9999999999999999999999999986543
Q ss_pred ccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ....++..|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 2211 1234677899999999889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=229.72 Aligned_cols=192 Identities=30% Similarity=0.522 Sum_probs=167.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 228 (352)
+|...+.||+|++|.+|. ++..|++|.+...... +...+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 467788999999998873 4889999998765432 45567889999999999999999999999988 889999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
+||+++++|.+++.+...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999999988778999999999999999999999999 99999999999999999999999999877654332
Q ss_pred C-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 R-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. ......++..|+|||.+....++.++|+||||+++|+|++|.
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 1 123345778899999998888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=237.09 Aligned_cols=188 Identities=28% Similarity=0.471 Sum_probs=159.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|...+.||+|+||.++. ++..+|+|.+........+....+.+|+.+++.++|||++++++++.++...+++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 388888999999998863 578899999876544455556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+.+ +|.+++.. ..++++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 9964 77777654 456899999999999999999999999 999999999999999999999999987654321
Q ss_pred CcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~~ 352 (352)
....+++.|+|||.+. ...++.++|+|||||++|+|++|+.
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~ 222 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 2245678899999873 4567889999999999999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=235.13 Aligned_cols=194 Identities=30% Similarity=0.411 Sum_probs=159.3
Q ss_pred cCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC-
Q 018682 150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS- 222 (352)
Q Consensus 150 i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 222 (352)
+.....+|.+.+.||+|+||.+|. +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 334456799999999999998873 57899999886432 2235677899999998 799999999998754
Q ss_pred ----CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 223 ----SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 223 ----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
+..+++|||+++++|.++++. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 358999999999999998863 345889999999999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCCCCcccCCCCCccccccccCCC-----CCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltG~ 351 (352)
+|||++......... .....++..|+|||.+... .++.++|+|||||++|+|++|.
T Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~ 230 (291)
T cd06639 170 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230 (291)
T ss_pred eecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCC
Confidence 999998765432211 1224567889999987543 3678999999999999999996
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=232.85 Aligned_cols=179 Identities=22% Similarity=0.395 Sum_probs=150.0
Q ss_pred ccCcee--ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 157 FTNSVE--ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 157 ~~~~~~--ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
|.+.+. +|+|+||.|+. ++..+++|.+........ |+.....+ +||||+++++.+..++.+++|
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 344444 59999998863 577899999875432211 22222222 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~~~~~~ 307 (352)
|||+++++|.+++.....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 999999999999988778999999999999999999999999 99999999999999988 9999999988765322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....++..|+|||++.+..++.++|+||||+++|+|++|+
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 203 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence 2245788999999999889999999999999999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=234.51 Aligned_cols=185 Identities=29% Similarity=0.485 Sum_probs=153.2
Q ss_pred eecccEEEEEEEc-----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 162 ~ig~G~~~~v~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.||+|+||.||.. +..+++|.+.... .......+.+|+.+++.++||||+++++++..++..+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 6899999988731 2578999886442 23345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-----CEEEEccC
Q 018682 231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG 298 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~vkL~Dfg 298 (352)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999998642 23678889999999999999999999 99999999999999877 89999999
Q ss_pred CcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 299 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
++......... .......+..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~ 211 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCC
Confidence 98755322111 1112234678999999998899999999999999999998 54
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-33 Score=232.45 Aligned_cols=189 Identities=30% Similarity=0.434 Sum_probs=154.8
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+.+....||.|+||.|. ..|+..|||.+..... +..++++..|.....+ -+.|+||++|+....++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 56667799999999886 4789999999986543 4555677778776554 47999999999999999999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 230 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
|++ ..+|..+.+ ++..+++...-.|..-.+.||.||-..- .|+|||+||+|||++..|.+||||||++-.+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 568766553 3456888888888888999999998864 39999999999999999999999999987765
Q ss_pred ccCCCCcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~ 351 (352)
.+- ..+...|-..|||||.+.. ..|+.++|+||||++|||+.||+
T Consensus 220 ~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 220 DSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN 266 (361)
T ss_pred HHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence 332 2233456677999998853 36899999999999999999997
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=239.30 Aligned_cols=192 Identities=33% Similarity=0.524 Sum_probs=157.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 227 (352)
.+|++.+.||.|+||.+|. +|..||+|.+....... .....+.+|+.++++++|+||+++++++... +.+++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3688899999999998873 47899999986543222 1123456799999999999999999998765 46899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+|||++ ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999996 5888888753 56899999999999999999999999 999999999999999999999999998766432
Q ss_pred CCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
. .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence 2 12222334678999998865 467899999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=234.73 Aligned_cols=188 Identities=30% Similarity=0.481 Sum_probs=157.1
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCceeeeeEEEEeCC----ceE
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~ 226 (352)
..+..+.||+|.||.|+ ..++.||||++. ....+.+.+|-++++.. +|+||+++++.-+... .++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 56667799999999998 578999999985 34457788898888864 7999999998876544 799
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
+|++|.+.|+|.+|++.+ .+++....+++..+++||+|||+-. +.+|+|||||+.|||+..+++..|+|||+|
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999875 4899999999999999999999754 347999999999999999999999999999
Q ss_pred ccccccCCC-CcccCCCCCccccccccCCC-CCC-----CchhHHHHHHHHHHhhcc
Q 018682 301 KLLTVKEDR-PLTCQDTSCRYVAPEVFKNE-EYD-----TKVDVFSFALILQEVKFY 350 (352)
Q Consensus 301 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~-----~~~DiwslG~il~elltG 350 (352)
..+...... .....+||.+|||||++.+. .+. .+.||||+|.+||||++.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 877643322 22346799999999998764 122 368999999999999863
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=232.48 Aligned_cols=190 Identities=31% Similarity=0.463 Sum_probs=154.6
Q ss_pred ccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-----
Q 018682 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 223 (352)
|.+.+.||+|+||.||. ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 55677899999998872 357899999976543 3445567889999999999999999999886532
Q ss_pred -ceEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 224 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 224 -~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
..++++||+.+++|.+++... ..++...+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence 247889999999998887432 13688889999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 297 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
||++......... ......+++.|++||.+....++.++|||||||++|+|+++
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence 9998765432211 11222345679999999888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=234.42 Aligned_cols=192 Identities=26% Similarity=0.403 Sum_probs=158.4
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe-----
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----- 221 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----- 221 (352)
..-.|+..+.||.|+||.+|. .++.+|+|.+... ......+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 345788889999999998873 5788999987543 22345678899999998 69999999999853
Q ss_pred -CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 222 -SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 222 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
...+|++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 45689999999999999998753 34788888899999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
++........ ......+++.|+|||.+. ...++.++|+|||||++|+|++|.+
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~ 224 (282)
T cd06636 167 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224 (282)
T ss_pred chhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCC
Confidence 9876542221 223345788899999875 3467889999999999999999973
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=235.31 Aligned_cols=190 Identities=28% Similarity=0.502 Sum_probs=155.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|++|.+|. +|+.|++|.+..... .....+.+.+|+.++++++||||+++++++..+...|+|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 588889999999998863 578899998865432 22334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Dfg~a~~~~~~~ 307 (352)
|++ ++|.+++..... ++...+..++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 588888765443 467888899999999999999999 999999999999985 4579999999987653321
Q ss_pred CCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||.+.+ ..++.++|+||||+++|+|+||.
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~ 201 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 12223456788999998865 45788999999999999999996
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=234.95 Aligned_cols=189 Identities=30% Similarity=0.551 Sum_probs=158.9
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+.||.|++|.+|. +|..|++|++...... ......+.+|+.+++.++||+++++++++.+++..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 56778999999998873 6889999998755322 22234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
++ ++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 94 69999987765 6899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++.+. .++.++|+||||+++|+|++|+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 197 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence 12223457789999987654 5788999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=243.83 Aligned_cols=192 Identities=24% Similarity=0.429 Sum_probs=160.1
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCce
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 225 (352)
.+|++.+.||.|++|.++ .+|..||+|++..... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478888999999999886 3588999999875432 22334567789999999999999999988763 3468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+++|||+. ++|.+++.....++...+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 699999987777999999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCC---cccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRP---LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~ 209 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCC
Confidence 22211 122457788999998765 46789999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=232.74 Aligned_cols=191 Identities=29% Similarity=0.413 Sum_probs=159.1
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCC----
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS---- 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~---- 223 (352)
.-+|+..+.||.|++|.+|. +++.+++|++.... ...+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45788999999999998763 56789999886442 2345788999999999 6999999999997654
Q ss_pred --ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 224 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
.++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999998865 346899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHhhccCC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltG~~ 352 (352)
|++....... .......++..|+|||++.. ..++.++|+||||+++|+|++|..
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 216 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCC
Confidence 9987654322 12233457888999998753 346788999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=237.53 Aligned_cols=192 Identities=18% Similarity=0.312 Sum_probs=158.1
Q ss_pred ccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
+.+.+.+|.|+++.++ .++..||+|++..... ..+..+.+.+|+.+++.++||||+++++++..++..+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 4455566666776554 4688999999876532 34456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC--
Q 018682 234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (352)
Q Consensus 234 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-- 309 (352)
+++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999763 34888999999999999999999999 999999999999999999999999988654322111
Q ss_pred ----CcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 ----PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~~ 352 (352)
......++..|+|||++.. ..++.++|+||+||++|+|++|.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 1122345678999999866 357889999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=229.63 Aligned_cols=185 Identities=31% Similarity=0.478 Sum_probs=162.5
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||.|+||.+|. +++.+++|.+.............+..|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68899987762 4789999998876655555667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCC
Q 018682 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (352)
Q Consensus 238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~ 317 (352)
.+++.....+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 999988777999999999999999999999999 9999999999999999999999999987654322 122334567
Q ss_pred CccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..|+|||.+.+...+.++|+||||+++|+|++|.
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 190 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 7899999998888899999999999999999986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=235.11 Aligned_cols=190 Identities=28% Similarity=0.461 Sum_probs=155.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCc-----
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP----- 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~----- 224 (352)
+|+..+.||+|+||.||. +++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 578889999999998873 578999998865432 2222346778999999995 6999999999887665
Q ss_pred eEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEccC
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG 298 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Dfg 298 (352)
.|++|||+++ +|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 888887642 34789999999999999999999999 999999999999998 8899999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
++....... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 209 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCC
Confidence 987654321 12222345778999998765 45789999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=236.33 Aligned_cols=192 Identities=27% Similarity=0.424 Sum_probs=155.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
-+|+..+.||+|+||.||. +++.||+|.+....... .....+.+|+.++++++||+|+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 3788999999999998873 57899999886543222 12234567999999999999999999887654
Q ss_pred --ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 224 --PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 224 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
..+++|||+. ++|.+++.... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999995 58888776543 5899999999999999999999999 999999999999999999999999998
Q ss_pred ccccccCCC---CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 301 KLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 301 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
......... ......++..|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~ 221 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRS 221 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCC
Confidence 765432221 11223457789999988664 4688999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=240.68 Aligned_cols=190 Identities=28% Similarity=0.499 Sum_probs=156.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----Cc
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 224 (352)
.+|++.+.||+|+||.||. +|+.||+|.+... ........+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3788999999999998873 5789999998642 2233445677899999999999999999887644 34
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
.++++||+. ++|.+++.. ..+++..+..++.|++.||.+||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588887754 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCCC--cccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~ 207 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 322111 122456888999998654 56889999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=234.77 Aligned_cols=187 Identities=31% Similarity=0.529 Sum_probs=153.1
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh--cCCCCceeeeeEEEEeCC----ce
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ--KIRHPNVVQFLGAVTQSS----PM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~~iv~~~~~~~~~~----~~ 225 (352)
.+.+..+.||+|.||.|+ |+|..||||++.... . +...+|.++++ .|+|+||+.++++-..+. ++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----E-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----h-hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 367788899999999875 999999999996431 2 23444555555 569999999998876543 58
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-----~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
|+|++|.+.|||+||+.+ ..++....++++..+++||.+||. +|+..|.|||||+.|||+.+++...|+|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999999999998 468999999999999999999993 45556999999999999999999999999999
Q ss_pred ccccccC---CCCcccCCCCCccccccccCCC----CC--CCchhHHHHHHHHHHhh
Q 018682 301 KLLTVKE---DRPLTCQDTSCRYVAPEVFKNE----EY--DTKVDVFSFALILQEVK 348 (352)
Q Consensus 301 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~----~~--~~~~DiwslG~il~ell 348 (352)
....... +......+||.+|||||++... -+ -..+||||||+++||+.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 7665432 3344567899999999998653 12 23699999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=228.55 Aligned_cols=191 Identities=26% Similarity=0.490 Sum_probs=165.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|...+.||.|+||.++ .++..+++|.+..... .......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 47788899999999876 2478999999876543 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|.+++... ..++...+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999764 56899999999999999999999999 999999999999999999999999998765443
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. .......+++.|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~ 200 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK 200 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCC
Confidence 2 1122345778899999998888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=233.22 Aligned_cols=194 Identities=15% Similarity=0.169 Sum_probs=146.6
Q ss_pred CcccCceeecccEEEEEEEc--------CeEEEEEEcCcccCCC--HHH------HHHHHHHHHHHhcCCCCceeeeeEE
Q 018682 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISD--DDR------VRAFRDELALLQKIRHPNVVQFLGA 218 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~--------~~~vavK~~~~~~~~~--~~~------~~~~~~E~~~l~~l~h~~iv~~~~~ 218 (352)
.+|.+.+.||+|+||.||.. +..+++|+........ +.. ......+...+..+.|++++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 47999999999999999731 3456777543222110 000 0112233445566789999999987
Q ss_pred EEeCC----ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 219 VTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 219 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
+.... ..++++|++ ..++.+.+......++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence 65543 346788877 4577777776555778888999999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCC------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 295 ADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+|||+++.+..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999976542211 11123468999999999999999999999999999999999863
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=234.64 Aligned_cols=189 Identities=32% Similarity=0.468 Sum_probs=155.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|+..+.||+|+||.||. +++.||+|.+..... ......+.+|+.++.++. ||||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 456677899999998873 578999999875432 244567888999999996 999999999999999999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 230 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
||+. +++.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9985 46555432 235689999999999999999999985 7 999999999999999999999999998765
Q ss_pred cccCCCCcccCCCCCccccccccCCC---CCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltG~~ 352 (352)
.... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 208 (288)
T cd06616 159 VDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208 (288)
T ss_pred ccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence 4322 11223567889999998765 68899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=234.68 Aligned_cols=187 Identities=22% Similarity=0.404 Sum_probs=159.4
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+....||+|+||.+|. ++..||+|.+... .......+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 44446799999998862 5789999987533 233456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~ 173 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 173 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccc
Confidence 999999998754 45889999999999999999999999 9999999999999999999999999886654322 122
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 3345778899999998888899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=240.96 Aligned_cols=191 Identities=27% Similarity=0.443 Sum_probs=160.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----Cc
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 224 (352)
.+|.+.+.||+|+||.+|. ++..||+|.+...... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3688999999999998873 5789999998754322 22344567899999999999999999987644 34
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
.|+++||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999995 799999988788999999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 206 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCC
Confidence 332 12223456788999998764 46889999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=233.79 Aligned_cols=186 Identities=28% Similarity=0.475 Sum_probs=158.0
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|...+.||+|+||.+|. ++..|++|.+.............+.+|+.+++.++|||++++++++.+....|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999998874 5789999998765554555566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+. +++.+++.. ..+++..++..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 577777754 456899999999999999999999999 99999999999999999999999998764321
Q ss_pred cccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||++. ...++.++|+|||||++|+|++|.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~ 217 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 12345778899999974 456888999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=229.51 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=151.2
Q ss_pred cccCc-eeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe----CCc
Q 018682 156 DFTNS-VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSP 224 (352)
Q Consensus 156 ~~~~~-~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~ 224 (352)
+|++. ..||-|-.|.|. .+++++|+|++... ...++|++.--+. .|||||.++++|+. .+.
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45443 467888887663 57889999988533 3456777765554 59999999998864 345
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg~ 299 (352)
+.+|||.++||.|...++.++. +++.++..|++||+.|+.|||+.+ |.||||||+|+|.+. +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 8899999999999999987765 999999999999999999999999 999999999999984 44699999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|+.-... ........|++|.|||++....|+...|+||+||++|-|+.|=
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGy 260 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCC
Confidence 9875432 2334566799999999999999999999999999999999873
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=230.20 Aligned_cols=192 Identities=23% Similarity=0.452 Sum_probs=160.1
Q ss_pred cccCceeecccEEEEEEE------cCeEEEEEEcCcccC-------CCHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI-------SDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ 221 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~------~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~ 221 (352)
.|++.+.||+|+||.+|. .+..+|+|.+..... ........+.+|+.++++ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 477888999999998862 357899998754321 223345567788888875 799999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
++..+++|||+++++|.+++.. ...++...++.++.|++.+|.+||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3458899999999999999999996 66 99999999999999999999999
Q ss_pred cCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 297 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|.+
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~ 211 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCC
Confidence 99987654332 2233557788999999998889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=230.37 Aligned_cols=191 Identities=25% Similarity=0.471 Sum_probs=161.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|...+.||+|+||.+|. +|..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+..+...++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 477889999999998872 57889999987643322 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC-EEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999987643 3788999999999999999999999 999999999999998764 6999999887654322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~ 199 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 2 122345788899999998888999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=240.13 Aligned_cols=191 Identities=31% Similarity=0.488 Sum_probs=163.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-----ce
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 225 (352)
+|++.+.||.|++|.++. .+..|++|.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 478889999999998862 47899999987543 22344567888999999999999999999988765 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|++|||++ ++|.+++.+...+++..+..++.|++.||.+||++| ++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999996 589999988778999999999999999999999999 99999999999999999999999999887654
Q ss_pred cCC--CCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 306 KED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~ 204 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCC
Confidence 321 122334567889999999887 7899999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=229.04 Aligned_cols=189 Identities=29% Similarity=0.490 Sum_probs=163.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||.|+|+.++. ++..+++|.+...... ......+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 477888999999988763 5778999998765433 3445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999866 345889999999999999999999999 999999999999999999999999998766443
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 198 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 222245678899999999888999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=260.75 Aligned_cols=190 Identities=33% Similarity=0.536 Sum_probs=157.0
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--------
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------- 221 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 221 (352)
.+|+..+.||+|+||.|+ .+|+.||||++.... +......+.+|+..+.+|+|||||++|..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 378888999999999887 589999999998764 45566778889999999999999999832200
Q ss_pred --------------------------------------------------------------------------------
Q 018682 222 -------------------------------------------------------------------------------- 221 (352)
Q Consensus 222 -------------------------------------------------------------------------------- 221 (352)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CceEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 018682 222 -----------------------S--------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHEN 269 (352)
Q Consensus 222 -----------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~LH~~ 269 (352)
+ ..+||-||||+..++.+++..+... .....+++++||++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 1267899999987888888776544 4788899999999999999999
Q ss_pred CCCCceecCCCCCCeEeCCCCCEEEEccCCccccc-----------------ccCCCCcccCCCCCccccccccCCCC--
Q 018682 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVAPEVFKNEE-- 330 (352)
Q Consensus 270 ~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~-- 330 (352)
| ||||||||.||+++.++.|||+|||++.... .......+...||.-|+|||++.+..
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 9 9999999999999999999999999997721 01111235567899999999997654
Q ss_pred -CCCchhHHHHHHHHHHhhc
Q 018682 331 -YDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 331 -~~~~~DiwslG~il~ellt 349 (352)
|+.|+||||||+|++||+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc
Confidence 9999999999999999985
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=222.15 Aligned_cols=189 Identities=29% Similarity=0.480 Sum_probs=155.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+......||.|+-|.|. ..|...|||.+... .+.+..+.+...+.++.+. .+|+||+++++|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 44556689999999775 45789999998754 4566667777788877666 4999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|.+ ...+..++++ ++++++..+-++...++.||.||.+++ .|+|||+||+|||++..|++||||||++-.+...
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 998 4466666654 456888888889999999999999876 4999999999999999999999999999776533
Q ss_pred CCcccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~ 351 (352)
...+...|-+.|||||.+.- ..|+.++|+||||+.++||.||.
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~ 291 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQ 291 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhccc
Confidence 23333456678999998853 47899999999999999999996
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=229.80 Aligned_cols=186 Identities=25% Similarity=0.397 Sum_probs=152.2
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeC--CceEEE
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMIV 228 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 228 (352)
|++.+.||+|+||.+|. ++..||+|.++.... ..... ....|+.+++++. |||++++++++.++ +.++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 56778999999998763 578999999875432 22222 2346888888885 99999999999987 889999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||++ ++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99996 588777765 346899999999999999999999999 999999999999999 999999999987654322
Q ss_pred CCCcccCCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltG~ 351 (352)
. .....++..|+|||.+. +..++.++|+|||||++|||++|.
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~ 196 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCC
Confidence 2 12244678899999764 456788999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=235.10 Aligned_cols=192 Identities=29% Similarity=0.463 Sum_probs=157.2
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
.+|++.+.||.|+||.||. +|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 4688889999999998873 5789999998754321 122345678999999999999999999887654
Q ss_pred ----ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 224 ----PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 224 ----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
.+++++||+++ ++..++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999975 777777653 45899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.+...............++..|+|||.+.+ ..++.++|||||||++|+|++|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 987665433222222345678999998764 35688999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=237.12 Aligned_cols=187 Identities=29% Similarity=0.463 Sum_probs=155.9
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------C
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 223 (352)
.+|++.+.||+|+||.++ .++..||+|++..... .....+.+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 478899999999999876 3578999999875422 233345677899999999999999999988643 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
..+++++++ +++|.+++... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 478888887 78998888654 5899999999999999999999999 999999999999999999999999998754
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 171 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 171 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred cc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 32 1223456788999998766 56788999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=246.59 Aligned_cols=191 Identities=27% Similarity=0.513 Sum_probs=163.4
Q ss_pred cccCceeecccEEEEEE---Ec-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAF---WR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+.+..++||+|.||.|. |+ ...||||++....... ....|++|+.+|.+|+|||++++|+...+ ..+.+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 45667799999999886 42 2479999998765432 56889999999999999999999999887 78899
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|||+++.|+|.+.+.+ ...+.......|+.||+.|+.||.+++ +|||||-..|+|+-....|||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999876 334778888899999999999999999 99999999999999988999999999988765
Q ss_pred cCCCCcc--cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KEDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.++.... ...-...|+|||.++...++.++|+|++||+||||||+++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGE 313 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGE 313 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCC
Confidence 5433221 1222456999999999999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=251.90 Aligned_cols=196 Identities=34% Similarity=0.560 Sum_probs=169.8
Q ss_pred ccCCCCCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q 018682 149 EIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 220 (352)
||++. ...+.+.||.|.||.|+. +...||||.++... .+.....|..|+.||-+++||||+++.++..
T Consensus 625 EId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 44444 455677999999999973 34679999998653 4666778999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
..+.+.||+|||++|+|..|++.+ +.++..+...+++.|+.|+.||-..+ +|||||...|||++.+-.+|++|||+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999999865 56999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcccCCC--CCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.+.......++...| ..+|.|||.+....++..+|+||+|++|||.++.+
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 99876554344444433 46799999999999999999999999999988743
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=236.92 Aligned_cols=193 Identities=27% Similarity=0.399 Sum_probs=157.8
Q ss_pred ccc-CceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHH-----------HHHHHHHHHHHHhcCCCCceeeeeEE
Q 018682 156 DFT-NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGA 218 (352)
Q Consensus 156 ~~~-~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~ 218 (352)
+|. +.+.||.|+||.||. .++.||+|.+......... ....+.+|+.++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 456799999998873 5789999998654322210 01246789999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
+..++..+++|||+. ++|.+++.....++......++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 999999999999996 699999988777999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccC-------------CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 299 VSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 299 ~a~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
.+....... ........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 987654111 1111223457789999988764 46889999999999999999863
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=235.12 Aligned_cols=186 Identities=27% Similarity=0.300 Sum_probs=157.1
Q ss_pred CCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CC----ceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HP----NVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~~~~~~~~~ 222 (352)
.-+|.+...+|+|+||.|. .++..||||+++.- ....++-+-|+++++++. .| -++++.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4489999999999999875 24678999998632 333455677999999993 22 378889999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC------------
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------ 288 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~------------ 288 (352)
++.|+|+|.+ |-++.+++.+++ +++...+..++.|+++++.+||+.+ ++|.||||+|||+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999988 779999998765 4889999999999999999999999 999999999999742
Q ss_pred --------CCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 289 --------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 289 --------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+..|+++|||.|..... .....+.|..|+|||++.+-+++.++||||+||||+||.||.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 23589999999987432 335567889999999999999999999999999999999984
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=240.00 Aligned_cols=186 Identities=28% Similarity=0.501 Sum_probs=158.3
Q ss_pred cCceeecccEEEEEEE-------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 158 TNSVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 158 ~~~~~ig~G~~~~v~~-------~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+..+.||.|.||.||. .| ..||||.-+.+. .++..+.|.+|..+|+.++||||++++|.+.+ ...|+|
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3456899999998872 22 358999877543 45557889999999999999999999999976 578999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||+++-|.|..|++.++ .++......++.||+.||.|||+.+ +|||||...|||+.....|||+|||+++.+....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999998764 4888999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
-.......-...|||||-+.-..++.++|+|.|||.+||++.
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~ 587 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILS 587 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHH
Confidence 222222223456999999999999999999999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=235.70 Aligned_cols=187 Identities=22% Similarity=0.411 Sum_probs=152.1
Q ss_pred eeeccc--EEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 161 VEITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 161 ~~ig~G--~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
..||+| +|+.|| ..|+.||+|++..... ..+..+.+++|+.+++.++||||++++++|..++..++++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 777775 2688999999875533 34556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC-
Q 018682 234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP- 310 (352)
Q Consensus 234 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~- 310 (352)
+++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999998764 34788999999999999999999999 9999999999999999999999998543322111100
Q ss_pred -----cccCCCCCccccccccCCC--CCCCchhHHHHHHHHHHhhccC
Q 018682 311 -----LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 -----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 0112245679999998764 4788999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=235.88 Aligned_cols=191 Identities=24% Similarity=0.389 Sum_probs=155.9
Q ss_pred cccCceeecccEEEEEEE-----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC----C
Q 018682 156 DFTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----S 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----~ 223 (352)
+|+..+.||+|+||.+|. . +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 477888999999998862 3 6689999886432 2233345677899999999 599999999875432 4
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+++++|++. ++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 5789999985 699999987778999999999999999999999999 999999999999999999999999998765
Q ss_pred cccCCC---CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDR---PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
...... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~ 207 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 432211 1123457889999998765 46889999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-33 Score=228.82 Aligned_cols=192 Identities=27% Similarity=0.454 Sum_probs=156.0
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--------C
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------S 222 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~ 222 (352)
.|....+||+|+||.|+ ..|+.||+|++..+.....-...+ .+|+.+|..++|+|++.+++.|.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpita-lreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHH-HHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 57777899999999776 467889999775433222222233 459999999999999998887643 2
Q ss_pred CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
..+|+||.+|+. +|.-++... ..++..++.++++++..||.|+|+.. |+|||+||.|+||+.++.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 359999999965 888888665 45999999999999999999999999 9999999999999999999999999997
Q ss_pred cccccCC---CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 302 LLTVKED---RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 302 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+..... ..++..+-|..|++||.+.+ ..|+++.|||..|||+.||+||.+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 6653322 12344566899999998766 478999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=231.18 Aligned_cols=189 Identities=29% Similarity=0.509 Sum_probs=160.7
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|...+.||.|++|.+|. +++.+++|.+...... +.....+.+|+.++++++||+|+++++++..+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56678999999998863 5788999998765433 23446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++ +|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 965 888877663 56899999999999999999999999 9999999999999999999999999987665432 22
Q ss_pred cccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 196 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 2334567789999998776 7889999999999999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=236.42 Aligned_cols=187 Identities=27% Similarity=0.440 Sum_probs=157.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
.+|++.+.||+|+||.|+. +|..||+|.+.... ........+.+|+.+++.++||||+++++.+..+.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 3688999999999998863 57899999986542 23334456788999999999999999999987654
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++++|||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 7799888864 46899999999999999999999999 999999999999999999999999998764
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 169 DSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred ccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 322 122356788999998875 45788999999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=229.14 Aligned_cols=188 Identities=31% Similarity=0.523 Sum_probs=155.9
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCceeeeeEEEEeCCc----
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP---- 224 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~---- 224 (352)
|++.+.||+|+||.+|. ++..||+|.+...... ......+.+|+.+++++ +|||++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 56778999999998862 4789999999755432 22234566787777666 59999999999988776
Q ss_pred -eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 225 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
++++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999996 58988887643 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....... .....++..|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~ 203 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCC
Confidence 7543321 12234678899999999888999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.50 Aligned_cols=191 Identities=28% Similarity=0.469 Sum_probs=157.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC--CceE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 226 (352)
.+|++.+.||+|+||.+|. ++..+|+|.+..... .......+.+|+.+++++ +||||+++++++... ..+|
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3688889999999998862 478999998865422 233345677899999999 999999999988654 3589
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
++|||+. ++|..++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999996 5999988765 6788888899999999999999999 999999999999999999999999998765433
Q ss_pred CCC----CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDR----PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~ 210 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC
Confidence 221 2223457888999998754 46788999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=233.13 Aligned_cols=188 Identities=29% Similarity=0.473 Sum_probs=158.8
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|+||.+| .++..+++|.+.............+.+|+.+++.++|+|++++++++..+...+++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 47788899999999887 2567899998865444445555678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+. +++.+++.. ...++..++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 588777653 445889999999999999999999999 999999999999999999999999988764322
Q ss_pred CcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~~ 352 (352)
....+++.|+|||.+. ...++.++|||||||++|+|++|.+
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 212 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCC
Confidence 2235678899999874 3467889999999999999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=224.39 Aligned_cols=171 Identities=22% Similarity=0.271 Sum_probs=144.2
Q ss_pred cEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCHHHH
Q 018682 166 GTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240 (352)
Q Consensus 166 G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 240 (352)
|.|+.|+ .+++.||+|.+.... .+..|...+....||||+++++++......+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 6666665 367899999987542 123344555556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCcc
Q 018682 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320 (352)
Q Consensus 241 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y 320 (352)
+.+...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 987777999999999999999999999999 999999999999999999999999987654322 1123345679
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 321 VAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 321 ~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~ 179 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGK 179 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCc
Confidence 9999998888899999999999999999985
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=230.49 Aligned_cols=189 Identities=30% Similarity=0.554 Sum_probs=160.3
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|+..+.||+|.+|.+|. +++.+++|.+.... ......+.+..|+.++++++||+++++++++.+.+..++++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 45667899999998873 57899999998654 2233345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
++ ++|.+++.+. ..++...+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 96 5999999876 56899999999999999999999999 99999999999999999999999999876543322 2
Q ss_pred cccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
......+..|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 196 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence 2223456779999998766 7889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=232.92 Aligned_cols=189 Identities=29% Similarity=0.465 Sum_probs=157.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-CCceEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMI 227 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 227 (352)
..+|++.+.||.|+||.++. ++..||+|.+..... .....+.+..|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 44799999999999998873 578899998865432 22334567789999999999999999999875 457899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
++||+ +++|.+++.. ..++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99998 6689888864 35788888899999999999999999 999999999999999999999999998754321
Q ss_pred CCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 122346778999998765 568899999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=228.74 Aligned_cols=192 Identities=28% Similarity=0.493 Sum_probs=161.1
Q ss_pred CCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-----
Q 018682 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 223 (352)
..+.+-.+-||.|.||.|+ .+|+.|++|++..- +..--..+.+.+|+++|..++|.|++..++...-..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 3456667899999999887 46899999988633 333333456778999999999999998887665332
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+++|.+ ..+|.+.+-....++.+.++.+..||++||.|||+.+ |+||||||.|+|++.+..+||+|||+++..
T Consensus 131 EiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 131 ELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 478899998 5699999988888999999999999999999999999 999999999999999999999999999887
Q ss_pred cccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhcc
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG 350 (352)
...+....+...-|.+|+|||++.+. .|+...||||.|||+.||+..
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR 254 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQR 254 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence 66655555555668899999999875 688999999999999999753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=238.26 Aligned_cols=196 Identities=32% Similarity=0.587 Sum_probs=166.4
Q ss_pred CcccCCCCCcccCceeecccEEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~---~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 221 (352)
.||.+.. +++-..+||.|.||.|| |. .-.||||.++.+.. .+++|..|..+|+.++|||+|+++++|..
T Consensus 261 kWEmeRt--dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 261 KWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred hhhccch--heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 4555443 45556799999999887 43 46799999986533 35789999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
+..+|||+|||..|+|.+|+.+... ++.-..+.++.||.+|++||..++ +|||||...|+|+.++..||++|||+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999987643 666777889999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.+.........-......|.|||-+....++.|+|||+|||+|||+.|.+
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcC
Confidence 9988755433333333456799999999999999999999999999998864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=233.04 Aligned_cols=193 Identities=30% Similarity=0.466 Sum_probs=154.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 222 (352)
..+|++.+.||+|+||.+|. +++.+++|.+......+. ....+.+|+.+++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 34799999999999998873 578899998865433221 123467899999999999999999887543
Q ss_pred --CceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 223 --SPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 223 --~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
..+++++||+.+ ++...+.. ...+++.++..++.|+++||.|||+++ ++|+||||+||++++++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999954 67776654 346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCC----------CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDR----------PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
+......... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~ 224 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCC
Confidence 8765432211 1122345778999998765 35788999999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=232.41 Aligned_cols=197 Identities=26% Similarity=0.398 Sum_probs=162.9
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHH----HHHHHHHHHHhcCCCCceeeeeEEEE-eCCc
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVT-QSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 224 (352)
.+|-....||+|+|..|| ...+-||+|+-.......++.. +...+|..+-+.|.||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 367788899999998776 3467799998766554433333 34567999999999999999999996 4567
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC---CCCCEEEEccCCcc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSK 301 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~vkL~Dfg~a~ 301 (352)
+|-|+|||+|.+|.-|++....+++.++..|+.||+.||.||-+.. .||||-||||.|||+. ..|.+||+|||+++
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999999999999888999999999999999999999987 4799999999999986 35679999999999
Q ss_pred cccccCCCC------cccCCCCCccccccccCC----CCCCCchhHHHHHHHHHHhhccCC
Q 018682 302 LLTVKEDRP------LTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 302 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltG~~ 352 (352)
.+....... ..-..||.+|++||.+.- ...+.++||||+|||+|+.++|..
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 886443221 133568999999998743 356889999999999999999863
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=226.95 Aligned_cols=190 Identities=31% Similarity=0.469 Sum_probs=153.8
Q ss_pred CcccCceeecccEEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|++.+.||+|+||.++ + +++.||+|.+..... ......+..|+.++.+. .||||+++++++.++...|++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 468888999999999886 3 388999999875432 22334555677666666 599999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|||+. +++.+++.. ...+++..+..++.|++.||.|||+ .+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99984 577777765 4568899999999999999999997 47 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCccccccccCCCC----CCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltG~~ 352 (352)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|++
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 21 12234677899999987553 7889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=239.65 Aligned_cols=181 Identities=28% Similarity=0.435 Sum_probs=153.1
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|.....+|.|+|+.+. .+++..++|++.+... ...+|+.++... +||||+++.+.+.+....|+||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 57777789999998775 4678899999976622 234577666655 6999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe-CCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill-~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|.+.|+-+.+-+....... .++..|+.+|+.|+.|||++| +|||||||+|||+ +..+.++|+|||.++..+..
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999998888777665555 777889999999999999999 9999999999999 58899999999998876543
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....-|..|.|||++...+|+..+||||||++||+||+|.
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~ 510 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGR 510 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCC
Confidence 22234577899999999999999999999999999999995
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=225.99 Aligned_cols=187 Identities=26% Similarity=0.468 Sum_probs=156.2
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEe
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 230 (352)
|++.+.||+|++|.||. .+..|++|.+...... . ......+|+..+++++ ||||+++++.+.+++..+++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 56778999999998862 4678999998755332 1 1223456899999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+ +++|.+++.... .+++.++..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 789999887654 6899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCcccCCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|+|||++. ...++.++|+||||+++++|++|+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 122345678899999874 445788999999999999999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=232.90 Aligned_cols=186 Identities=27% Similarity=0.449 Sum_probs=153.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
.+|...+.||+|+||.++. +|..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3788889999999998862 578999999875432 2223356788999999999999999999987543
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+++++||+. .+|..+.. ..++...+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999995 47777653 35889999999999999999999999 999999999999999999999999998754
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+
T Consensus 168 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 168 DA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred CC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence 32 1122346778999998866 46788999999999999999986
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=234.26 Aligned_cols=190 Identities=25% Similarity=0.428 Sum_probs=154.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------- 222 (352)
.+|...+.||.|+||.||. +|..|++|.+..... ...+.+.+|+.++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5799999999999998873 478999998865432 3346678899999999999999999776543
Q ss_pred -------CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEE
Q 018682 223 -------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKV 294 (352)
Q Consensus 223 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL 294 (352)
...|++|||++ ++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||||+||+++. ++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 589888864 45899999999999999999999999 999999999999984 557899
Q ss_pred EccCCcccccccCCC--CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 295 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
+|||.+......... ......++..|+|||.+.. ..++.++|||||||++|+|++|.+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 217 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCC
Confidence 999998765322111 1122346778999997654 567889999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=241.15 Aligned_cols=189 Identities=28% Similarity=0.398 Sum_probs=161.2
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe-----CCc
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-----SSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-----~~~ 224 (352)
-|.+.+.||.|.||.|| .+++..|+|+....... .++++.|.++++.. .|||++.+|++|.. ++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 46777899999999887 47889999998765332 35677899999988 59999999999864 467
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
+|+|||||.+|+..++++.- ..+.+..+..|++.++.|+.+||.+. ++|||||-.|||++.++.|||+|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 99999999999999999753 45888999999999999999999999 99999999999999999999999999988
Q ss_pred ccccCCCCcccCCCCCccccccccCCC-----CCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltG~~ 352 (352)
+.... .......||+.|||||++... .|+.++|+||||++..||--|.+
T Consensus 173 ldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 173 LDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred eeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 76543 334457899999999998643 56789999999999999988764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=233.12 Aligned_cols=188 Identities=30% Similarity=0.453 Sum_probs=157.9
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc-----
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 224 (352)
.+|+..+.||+|++|.+|. ++..||+|.+..... .......+.+|+.++++++||||+++++++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 3688999999999998873 478999998875432 23344567789999999999999999988876554
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 6799998876 45899999999999999999999999 999999999999999999999999998765
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~ 214 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 322 223456778999998765 367889999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=221.44 Aligned_cols=191 Identities=29% Similarity=0.478 Sum_probs=154.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+|.+.+.||+|+||.+|. .+..+++|.++..... .......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 477889999999998873 2344566655432221 112233466799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+||+++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 345899999999999999999999999 999999999999975 569999999987654
Q ss_pred ccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 3221 222345678899999998888899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=240.97 Aligned_cols=198 Identities=33% Similarity=0.543 Sum_probs=166.3
Q ss_pred CcccCCCCCcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcee
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV 213 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 213 (352)
.|+++...+.+. +.+|.|.||.|+.. ...||||.++..... ...+.+..|+++|+.+ +||||+
T Consensus 290 ~~e~~~~~l~~~--~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLG--KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhcccc--ceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchh
Confidence 677777666444 49999999988621 457999999876543 5667899999999998 599999
Q ss_pred eeeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 018682 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (352)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 277 (352)
.+++++...+.+++++||++.|+|.++++... .++..+.+.++.||+.|++||++.. +|||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998765 3888999999999999999999998 9999
Q ss_pred CCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCC--CCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 278 Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||-..|||++.+..+||+|||+++..............+ ...|||||.+....|+.++||||+|++|||++|-+
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence 999999999999999999999998654333222111111 34599999999999999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=253.96 Aligned_cols=181 Identities=24% Similarity=0.395 Sum_probs=149.5
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.+.....||+|+||.|| .++..||+|.+...... ...|++.+++++||||+++++++.+.+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45667789999999887 35789999988643221 1346888999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.++++. +++..+..++.|++.||+|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999964 7889999999999999999994422239999999999999998887775 655433211
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....+++.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~ 876 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCC
Confidence 112356789999999999999999999999999999999963
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=205.57 Aligned_cols=182 Identities=21% Similarity=0.469 Sum_probs=154.1
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeC--CceEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l 227 (352)
+|++.+++|+|.|+.|+ .+..++++|++++- ..+.+.+|+.+|+.+. ||||+++++...+. ....+
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 79999999999998776 46789999999743 3467899999999997 99999999988754 45789
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-CCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~vkL~Dfg~a~~~~~~ 306 (352)
++||+.+.+...+. +.++...+..++.+++.||.|||+.| |.|||+||.|++|+.. -.++|+|+|+|.+....
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999887776654 34888999999999999999999999 9999999999999954 46999999999887643
Q ss_pred CCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
........+..|..||.+-. ..|+..-|+|||||++..|++.+
T Consensus 187 --~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 187 --KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred --ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 34445667788999998754 57888999999999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=206.45 Aligned_cols=190 Identities=33% Similarity=0.566 Sum_probs=162.5
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
|...+.||.|+++.+|. ++..+++|.+...... ...+.+.+|+..++.++|++++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 45677899999987762 3689999999765432 2456788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++++|.+++..... ++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999999987766 899999999999999999999998 9999999999999999999999999987765432112
Q ss_pred cccCCCCCcccccccc-CCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....++..|++||.+ ....++.++|+||||+++++|++|+
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~ 197 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGP 197 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 2234566789999998 6677888999999999999999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=228.97 Aligned_cols=195 Identities=19% Similarity=0.258 Sum_probs=143.0
Q ss_pred CCcccCceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCHH-----------HHHHHHHHH
Q 018682 154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDD-----------RVRAFRDEL 201 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~---------------------~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~ 201 (352)
.-+|.+.++||+|+||.||. .++.||||.+........+ ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 44799999999999999983 2467999998643211000 011233467
Q ss_pred HHHhcCCCCce-----eeeeEEEEe--------CCceEEEEeccCCCCHHHHHHhcC-----------------------
Q 018682 202 ALLQKIRHPNV-----VQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG----------------------- 245 (352)
Q Consensus 202 ~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~----------------------- 245 (352)
.++.+++|.++ ++++++|.. .+..|+|+||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766543 566666643 356899999999999999886421
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCcccccc
Q 018682 246 -ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324 (352)
Q Consensus 246 -~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE 324 (352)
.+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++................++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1345677889999999999999999 999999999999999999999999998765432222222233478999999
Q ss_pred ccCCCCC----------------------CCchhHHHHHHHHHHhhccC
Q 018682 325 VFKNEEY----------------------DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 325 ~~~~~~~----------------------~~~~DiwslG~il~elltG~ 351 (352)
.+..... ..+.|+||+||++|+|++|.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~ 429 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPE 429 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCC
Confidence 8754321 12479999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=213.91 Aligned_cols=189 Identities=28% Similarity=0.415 Sum_probs=156.1
Q ss_pred CCcccCceeecccEEEEE--E--EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------C
Q 018682 154 ELDFTNSVEITKGTFILA--F--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v--~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 223 (352)
..+|...+-+|.|.-..+ + ..+++||+|+...+..... ..+...+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~-~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQT-HAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCceEEecchhhccCceehhhhcCccccCc-cchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 446777777777765222 2 3688999999887744333 334456799999999999999999998643 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+|||++ ..+|..++.- .+.-..+..+..|++.|+.|||+.| |+||||||+||++..+..+||.|||+++..
T Consensus 95 e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 589999999 5699888873 3778888999999999999999999 999999999999999999999999999764
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... ...+....+..|+|||++.+..+...+||||+||++.||++|+
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~ 214 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGT 214 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhce
Confidence 432 3445677788999999999988999999999999999999985
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=232.20 Aligned_cols=194 Identities=26% Similarity=0.485 Sum_probs=164.4
Q ss_pred CCCcccCceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 153 HELDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
.+.+....+.||+|.||.||.. ..+||+|++... ...+...++..|+.+|.+++|||++++++++..+.
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 3446777889999999999832 358999998754 34555678899999999999999999999998765
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
+.||++|++.|+|.+|++.. ..+-....+.|..||++||.|||.++ ++||||-+.|+|+.....+|+.|||+++.
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 88999999999999999754 45888999999999999999999999 99999999999999999999999999988
Q ss_pred ccccCCCCcc-cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+......... ...-.+.|||-|.+....|+.++||||+||++||++|-++
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 7654433222 1223557999999999999999999999999999999553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=225.48 Aligned_cols=187 Identities=26% Similarity=0.353 Sum_probs=158.2
Q ss_pred CCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC------CCceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 222 (352)
+.+|.+....|+|-|+.|. ..|+.||||++.... -..+.-..|+++|++|. --|+++++..|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3478888888999999876 357899999997543 33345567999999995 23899999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccC
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFG 298 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg 298 (352)
+++|+|+|.+ ..+|.+++++.+. +....+..|++|++-||..|-.-| |+|.||||+|||+++.- .+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999988 5699999998654 888999999999999999999998 99999999999999654 58999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.|....... .+++.-+..|+|||++.+-+|+...|+||+||+||||.||+
T Consensus 583 SA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGk 632 (752)
T KOG0670|consen 583 SASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGK 632 (752)
T ss_pred ccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccc
Confidence 998765432 33344566899999999999999999999999999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=232.75 Aligned_cols=189 Identities=22% Similarity=0.310 Sum_probs=133.5
Q ss_pred CCCcccCceeecccEEEEEEE-----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEE-----
Q 018682 153 HELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----- 218 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~----- 218 (352)
...+|...+.||+|+||.||. + +..||+|.+...... +....| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 344789999999999999984 3 689999987643211 111111 1111122222222211
Q ss_pred -EEeCCceEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 018682 219 -VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (352)
Q Consensus 219 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 277 (352)
...+..+++++||+.+++|.+++..... .....+..++.|++.||.|||+++ |+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 2355679999999999999999875421 112345678999999999999999 9999
Q ss_pred CCCCCCeEeCC-CCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCC----------------------CCCCc
Q 018682 278 DLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----------------------EYDTK 334 (352)
Q Consensus 278 Dikp~Nill~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~ 334 (352)
||||+|||++. ++.+||+|||++..+............+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 57899999999986654333333446678999999965322 23345
Q ss_pred hhHHHHHHHHHHhhccC
Q 018682 335 VDVFSFALILQEVKFYN 351 (352)
Q Consensus 335 ~DiwslG~il~elltG~ 351 (352)
+|||||||++|||+++.
T Consensus 360 ~DVwSlGviL~el~~~~ 376 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPN 376 (566)
T ss_pred cccHHHHHHHHHHHhCc
Confidence 69999999999999863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=202.60 Aligned_cols=179 Identities=37% Similarity=0.578 Sum_probs=154.0
Q ss_pred cEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCHHHHHHh
Q 018682 166 GTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243 (352)
Q Consensus 166 G~~~~v~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 243 (352)
|....+.+ +|..+++|++........ .+.+.+|+..+++++|++++++++.+......++++|++++++|.+++..
T Consensus 3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 3 GKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred eEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 44444554 468999999976543221 57889999999999999999999999999999999999999999999987
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCccccc
Q 018682 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323 (352)
Q Consensus 244 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aP 323 (352)
...++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 666899999999999999999999999 9999999999999999999999999987765432 22234567789999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 324 EVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 324 E~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|.+....++.++|+||||+++++|++|.
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~ 183 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGK 183 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9998888899999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=232.27 Aligned_cols=186 Identities=28% Similarity=0.397 Sum_probs=151.6
Q ss_pred cccCceeecccEEEEE----EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILA----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
-|...+.+|.|+-|.+ .+.|++||||.+.... .....+|+..|+.- .||||+++|+.-.++...|++.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3555567888877644 3678999999986543 24567899999988 59999999999888999999999
Q ss_pred ccCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---C--CCEEEEccCCcc
Q 018682 231 YLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---S--GNLKVADFGVSK 301 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~--~~vkL~Dfg~a~ 301 (352)
.| ..+|.++++.... ......+....|+++||++||+.+ ||||||||+||||+. + .+++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 6799999987411 111334668899999999999999 999999999999986 3 368999999999
Q ss_pred cccccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.+...... ......||-+|+|||++....-+..+|||||||++|+.++||
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG 711 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGG 711 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCC
Confidence 88654322 234567899999999999888888999999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=229.68 Aligned_cols=184 Identities=25% Similarity=0.388 Sum_probs=157.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|.+.+.||+|+||.||. .++.||+|++.............+..|+.+++.++||||+++++.+.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4788899999999998873 47899999998665555666678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++...... .
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~-~ 159 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE-L 159 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc-c
Confidence 99999999999988778899999999999999999999999 9999999999999999999999999998754332 2
Q ss_pred CcccCCCCCccccccccCCC-CCCCchhHHHHHH
Q 018682 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFAL 342 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~ 342 (352)
......+++.|++||..... +-...+++|++|.
T Consensus 160 ~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~ 193 (669)
T cd05610 160 NMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGF 193 (669)
T ss_pred cccccccCccccCccccccCCCCceeeeeeecCc
Confidence 23345678899999965433 3345678888884
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=197.68 Aligned_cols=199 Identities=20% Similarity=0.352 Sum_probs=156.2
Q ss_pred cccCCCcccCCCCC--cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcee
Q 018682 142 AREVPEYEIDPHEL--DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVV 213 (352)
Q Consensus 142 ~~~~~~~~i~~~~~--~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv 213 (352)
.-.++..+++..++ .|++.+.+|.|-||... ...+.+++|.+..+.. ....|.+|+..--.|. |.||+
T Consensus 9 ih~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi 84 (378)
T KOG1345|consen 9 IHLIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHII 84 (378)
T ss_pred ccccccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhh
Confidence 34466667665554 79999999999999765 3467899999876543 3567888888766664 88999
Q ss_pred eeeEE-EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC--CCC
Q 018682 214 QFLGA-VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSG 290 (352)
Q Consensus 214 ~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~ 290 (352)
.-|+. |+..+.+++++||++.|+|..-+...+ +-+...+.++.|+++|+.|||+++ +||||||.+||||- +..
T Consensus 85 ~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~ 160 (378)
T KOG1345|consen 85 DTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFY 160 (378)
T ss_pred HHHHHHhhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCcc
Confidence 87764 677788899999999999988776543 778888899999999999999999 99999999999985 334
Q ss_pred CEEEEccCCcccccccCCCCcccCCCCCccccccccCCC-----CCCCchhHHHHHHHHHHhhccCC
Q 018682 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 291 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltG~~ 352 (352)
++||||||.++..... ......+..|.+||..... ..++.+|+|.||+++|.++||+.
T Consensus 161 rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~ 223 (378)
T KOG1345|consen 161 RVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF 223 (378)
T ss_pred EEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence 7999999998764321 1222345679999976432 45778999999999999999973
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-25 Score=187.02 Aligned_cols=179 Identities=38% Similarity=0.648 Sum_probs=151.8
Q ss_pred ecccEEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 163 ITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 163 ig~G~~~~v~---~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
||.|.+|.+| .. +.++++|++....... ..+.+.+|+..++.++|++|+++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 5778887665 33 7899999997653321 346788999999999999999999999998999999999998999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEccCCcccccccCCCCcccCC
Q 018682 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQD 315 (352)
Q Consensus 238 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 315 (352)
.+++... ..++...+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 9999875 46899999999999999999999999 999999999999999 89999999999876543321 122344
Q ss_pred CCCccccccccCCC-CCCCchhHHHHHHHHHHh
Q 018682 316 TSCRYVAPEVFKNE-EYDTKVDVFSFALILQEV 347 (352)
Q Consensus 316 ~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el 347 (352)
+...|++||..... .++.++|+||+|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 67789999998877 778899999999999986
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=220.82 Aligned_cols=185 Identities=28% Similarity=0.469 Sum_probs=162.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|....++|+|+||.||. .+...|+|+++... .+...-+++|+-+++..+||||+.+++.+.....+|++||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 677778999999999884 57789999998653 3345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
||.+|+|.+.-.-.+++++.++...++..++++.|||+.| -+|||||-.||++++.|.+|+.|||.+..+...-. .
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~-K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-K 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh-h
Confidence 9999999998888889999999999999999999999999 89999999999999999999999999877654332 3
Q ss_pred cccCCCCCcccccccc---CCCCCCCchhHHHHHHHHHHh
Q 018682 311 LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEV 347 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~el 347 (352)
..++.||++|||||+- +.+.|...+|||++|+...|+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 3457899999999975 456889999999999988776
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=196.37 Aligned_cols=127 Identities=28% Similarity=0.372 Sum_probs=106.0
Q ss_pred CCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----C---CceeeeeEEEE
Q 018682 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----H---PNVVQFLGAVT 220 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~~~~~~~ 220 (352)
..+|.+.++||.|-|.+|+ ...+-||+|+.+.. +...+....|+.+|++++ | .+||++++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 3589999999999998886 35778999998743 333456678999999983 2 37999999998
Q ss_pred eC----CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC
Q 018682 221 QS----SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (352)
Q Consensus 221 ~~----~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~ 287 (352)
.. .++|+|+|++ |.+|..+|... ..++...+++|++||+.||.|||+.- .|||.||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 64 4699999999 88999999864 44999999999999999999999975 499999999999964
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=196.53 Aligned_cols=165 Identities=21% Similarity=0.217 Sum_probs=125.7
Q ss_pred cCCCCCcccCceeecccEEEEEEE------cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCceee-eeEEEE
Q 018682 150 IDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FLGAVT 220 (352)
Q Consensus 150 i~~~~~~~~~~~~ig~G~~~~v~~------~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~ 220 (352)
..+...+|+..+.||+|+||.||. +++.||+|++..... ........+.+|+.+|++++|+++++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 344555799999999999999982 366789998753321 13344567899999999999999885 443
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCeEeCCCCCEEEEccCC
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~vkL~Dfg~ 299 (352)
.+..|++|||++|++|... .. .. ...++.|++++|.|||++| |+|||| ||+|||++.++.++|+|||+
T Consensus 90 -~~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred -cCCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 2457999999999999632 11 11 1467889999999999999 999999 99999999999999999999
Q ss_pred cccccccCCCCc-------ccCCCCCccccccccCC
Q 018682 300 SKLLTVKEDRPL-------TCQDTSCRYVAPEVFKN 328 (352)
Q Consensus 300 a~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~ 328 (352)
|+.+........ ....+++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 987654321111 23456778999998854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=182.68 Aligned_cols=190 Identities=18% Similarity=0.269 Sum_probs=162.2
Q ss_pred CCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceE
Q 018682 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 226 (352)
....|.+.++||+|+||..+ .++.+||||.-..+.. ..+++.|....+.| ..++|+..|.+..+..+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34589999999999999876 5789999997654432 24688899999988 4899999999888888889
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-----CEEEEccCCc
Q 018682 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVS 300 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~vkL~Dfg~a 300 (352)
+|+|++ |-+|.|++.-++ .++..++..++.|++.-++++|++. +|.|||||+|+||...+ .+.++|||++
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999998 889988887654 4999999999999999999999999 99999999999998655 3899999999
Q ss_pred ccccccCCCCc------ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 301 KLLTVKEDRPL------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 301 ~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+.+..+..+.. .+..||.+||+-.-..+.+.+.+.|+-|||-++..+|-|.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCC
Confidence 98865544332 4567999999999999999999999999999888888774
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=191.75 Aligned_cols=186 Identities=21% Similarity=0.352 Sum_probs=153.5
Q ss_pred CcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCce
Q 018682 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 225 (352)
..|....+||.|+|+.|+. ....||+|.+.... .+ ..+.+|+++|..+. +.||+++.+.+..++..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--Cc---hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3678889999999998872 46789999887543 22 35788999999995 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Dfg~a~~~~ 304 (352)
.+|+||++.....++... ++..++..+++.++.||.++|.+| ||||||||+|+|++. .+.-.|+|||++....
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999988865 678999999999999999999999 999999999999995 4568899999987211
Q ss_pred ccC------C-------------------------------------CCcccCCCCCccccccccCC-CCCCCchhHHHH
Q 018682 305 VKE------D-------------------------------------RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSF 340 (352)
Q Consensus 305 ~~~------~-------------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl 340 (352)
... . .......||++|+|||++.. +..++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 00013458999999998864 466889999999
Q ss_pred HHHHHHhhccC
Q 018682 341 ALILQEVKFYN 351 (352)
Q Consensus 341 G~il~elltG~ 351 (352)
|+|+..++++.
T Consensus 265 GVI~Lslls~~ 275 (418)
T KOG1167|consen 265 GVILLSLLSRR 275 (418)
T ss_pred cceeehhhccc
Confidence 99999998864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-25 Score=220.34 Aligned_cols=141 Identities=17% Similarity=0.218 Sum_probs=108.2
Q ss_pred CCC-CceeeeeEEE-------EeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 018682 207 IRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (352)
Q Consensus 207 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 277 (352)
++| +||+.++++| .....++.++|++ +++|.+++... ..++..++..++.||++||.|||++| |+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 344 5777777777 2334678889987 67999999753 45899999999999999999999999 9999
Q ss_pred CCCCCCeEeCCCC-------------------CEEEEccCCcccccccCC---------------CCcccCCCCCccccc
Q 018682 278 DLEPSNILRDDSG-------------------NLKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVAP 323 (352)
Q Consensus 278 Dikp~Nill~~~~-------------------~vkL~Dfg~a~~~~~~~~---------------~~~~~~~~~~~y~aP 323 (352)
||||+|||++..+ .+|++|||+++....... .......+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 455666666543211000 000113468889999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 324 EVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 324 E~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|++.+..++.++|||||||+||||++|.
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 9999999999999999999999999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=179.07 Aligned_cols=168 Identities=10% Similarity=0.169 Sum_probs=131.2
Q ss_pred CcccCceeecccEEEEEEE---cCeEEEEEEcCcccCCCHHHHHH------HHHHHHHHhcCCCCceeeeeEEEEeC---
Q 018682 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS--- 222 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~---~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~--- 222 (352)
-+|...+.+|.|+||.|+. ++..+|+|.+.+.....+..... +++|+..+.++.||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 3788999999999998873 46689999998776655544444 57899999999999999998886643
Q ss_pred -----CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 223 -----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 223 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
+..+++|||++|.+|.++.. ++. ....+++.++..+|+.| ++|||+||+||+++.++ ++|+||
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEEC
Confidence 35889999999999988732 333 24568999999999999 99999999999999988 999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHh
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 347 (352)
|.......... . ..+.....++.++|+||||+.+..+
T Consensus 179 g~~~~~~e~~a--~-----------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 179 SGKRCTAQRKA--K-----------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCcccccchhh--H-----------HHHHHHhHhcccccccceeEeehHH
Confidence 98765421110 0 1134445567789999999987654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=186.23 Aligned_cols=189 Identities=23% Similarity=0.307 Sum_probs=153.7
Q ss_pred cccCceeecccEEEEEEEc------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC----CCceeeeeEEE-EeCCc
Q 018682 156 DFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~~iv~~~~~~-~~~~~ 224 (352)
+|.+.+.||+|+||.||.. ...+|+|.......... ..+..|..++..+. .++++.+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999998831 24689987765422211 15677888888886 36899999998 47778
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-----CCEEEEcc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF 297 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-----~~vkL~Df 297 (352)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.| ++||||||+|+++... ..+.|+||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999988 88999988654 46999999999999999999999999 9999999999999865 35999999
Q ss_pred CCcc--cccccCC---C---C-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSK--LLTVKED---R---P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~--~~~~~~~---~---~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|+++ ....... . . .....||..|+++....+...+++.|+||++.++.+|+.|.
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 9998 3222111 1 1 12345899999999999999999999999999999999883
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=170.74 Aligned_cols=186 Identities=19% Similarity=0.214 Sum_probs=153.6
Q ss_pred cccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|...++||+|+||..| ..|..||+|.-+...-. .++..|..+.+.++ ...|+.+..++.+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 78999999999999777 47899999987755433 35777999999996 568888888888888899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccCCcccccc
Q 018682 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (352)
Q Consensus 230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg~a~~~~~ 305 (352)
+.. |.+|.++++-+ ..++..+++-++-|++.-++|+|.++ ++||||||+|+|..- ...+.|+|||+|+.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 88998888643 34899999999999999999999999 999999999999873 34699999999987643
Q ss_pred cCCCC------cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 306 KEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 306 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
..... .....||.+|.+-....+...+.+.|+-|+|.+|..+.-|
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG 217 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRG 217 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecC
Confidence 32221 1345689999998888888889999999999887766554
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=162.26 Aligned_cols=105 Identities=35% Similarity=0.393 Sum_probs=78.4
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
+.+|.+|..||||||+||..|+.|+|+.|+.+ |+|+|++++.|.||||+|+.+|..+|+++|+++|+.++.+|..|.||
T Consensus 63 v~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtp 142 (226)
T KOG4412|consen 63 VKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTP 142 (226)
T ss_pred CCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCch
Confidence 44555677777777777777777777777776 77777777777777777777777777777777777777777777777
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
||-|+..|+.+++++|+..++.+..+
T Consensus 143 lHRAAavGklkvie~Li~~~a~~n~q 168 (226)
T KOG4412|consen 143 LHRAAAVGKLKVIEYLISQGAPLNTQ 168 (226)
T ss_pred hHHHHhccchhhHHHHHhcCCCCCcc
Confidence 77777777777777777777655333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=176.11 Aligned_cols=192 Identities=30% Similarity=0.476 Sum_probs=163.1
Q ss_pred ccCceeecccEEEEEEEc--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-ceeeeeEEEEeCCceEEEEeccC
Q 018682 157 FTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
|...+.||.|+|+.++.. -..+++|.+.............+.+|...++.+.|+ +++++++.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 667789999999877632 267899999877655544567788999999999988 79999999977777899999999
Q ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccCCcccccccCCC
Q 018682 234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 234 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~~~~~~~~ 309 (352)
++++.+++.... .++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999998887664 6899999999999999999999999 99999999999999988 6999999998755443322
Q ss_pred -----CcccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccC
Q 018682 310 -----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 -----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~ 351 (352)
......++..|++||.+.+ ..++...|+||+|++++++++|.
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 2355678999999999987 57888999999999999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=177.04 Aligned_cols=191 Identities=25% Similarity=0.370 Sum_probs=152.6
Q ss_pred cccCceeecccEEEEEEE---c-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-Cc
Q 018682 156 DFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 224 (352)
+++..-.+.+|+||.+|. . .+.|-+|.++.. .++-....+..|.-.+..+.|||+..+.+.+.++ ..
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 455566788999998873 2 245667766543 2455567788899999999999999999988654 45
Q ss_pred eEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
.++++.+..-|+|..|+... ..++..+...++.|+..|++|||+++ |||.||...|.+|++.-++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence 78888999889999999721 22667778889999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCc-ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 297 fg~a~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
=.+++.+-..+-... ........||+||.+....|+..+|+|||||+||||+|-+
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence 999886654322111 1223456799999999999999999999999999999844
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=167.34 Aligned_cols=138 Identities=20% Similarity=0.229 Sum_probs=105.8
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCHHH-----------------------HHHHHHHHHHHhcCCCCcee
Q 018682 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDR-----------------------VRAFRDELALLQKIRHPNVV 213 (352)
Q Consensus 161 ~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~~iv 213 (352)
..||+|++|.||. +|++||+|+++......... ......|+.++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999873 58899999997653221110 12234599999999887764
Q ss_pred eeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCCeEeCCCCCE
Q 018682 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNL 292 (352)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dikp~Nill~~~~~v 292 (352)
....... ...++||||++++++.........++...+..++.|++.+|.++ |+.| |+||||||+||+++ ++.+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 4333222 22389999998877766544456789999999999999999999 6888 99999999999998 4789
Q ss_pred EEEccCCccccc
Q 018682 293 KVADFGVSKLLT 304 (352)
Q Consensus 293 kL~Dfg~a~~~~ 304 (352)
+|+|||+|....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=157.05 Aligned_cols=107 Identities=28% Similarity=0.388 Sum_probs=102.4
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
+.|.|..+..|.|+||+||..|+.|++++|+++|+.++.+|..|.||||.||..|.++++++|+..|+.+|.+|..|.||
T Consensus 96 ~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~Tp 175 (226)
T KOG4412|consen 96 GADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTP 175 (226)
T ss_pred CCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccH
Confidence 68889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
||.|...++.++...|..+|+++....
T Consensus 176 L~~al~e~~~d~a~lLV~~gAd~~~ed 202 (226)
T KOG4412|consen 176 LHHALAEGHPDVAVLLVRAGADTDRED 202 (226)
T ss_pred HHHHHhccCchHHHHHHHhccceeecc
Confidence 999998999999999999999875544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=159.30 Aligned_cols=180 Identities=14% Similarity=0.071 Sum_probs=130.0
Q ss_pred cCceeecccEEEEEEEc---CeEEEEEEcCcccCCCHHH-HHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEecc
Q 018682 158 TNSVEITKGTFILAFWR---GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 158 ~~~~~ig~G~~~~v~~~---~~~vavK~~~~~~~~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
.+...|++|+||.|++. +.+++.+.+.......... ...+++|+++|+++. ++++++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 35578999999999864 5567766665432211111 124789999999995 5789999886 3469999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCeEeCCCCCEEEEccCCcccccccCCC--
Q 018682 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (352)
Q Consensus 233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-- 309 (352)
.|.+|.+.... . ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99998754321 1 1357789999999999999 999999 799999999999999999999854432210
Q ss_pred --C--------cccCCCCCccccccccCCC-CCC-CchhHHHHHHHHHHhhccC
Q 018682 310 --P--------LTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 --~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwslG~il~elltG~ 351 (352)
. ......++.|++|+...-- ..+ ...++++.|+-+|.++|++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~ 204 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR 204 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence 0 0112245667777643221 223 5779999999999999985
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=159.45 Aligned_cols=139 Identities=19% Similarity=0.163 Sum_probs=107.5
Q ss_pred ceeecccEEEEEEE----cCeEEEEEEcCcccCCCH-----------------------HHHHHHHHHHHHHhcCCCCce
Q 018682 160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-----------------------DRVRAFRDELALLQKIRHPNV 212 (352)
Q Consensus 160 ~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~~i 212 (352)
...||+|++|.||. +|+.||+|++........ .....+..|...+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999998873 589999999886532100 012234679999999999987
Q ss_pred eeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCC
Q 018682 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 291 (352)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~ 291 (352)
.....+... ..++||||++|+++.........++..+...++.|++.++.++|+ .| |+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 554443333 248999999887554433334567888999999999999999999 88 99999999999999 789
Q ss_pred EEEEccCCccccc
Q 018682 292 LKVADFGVSKLLT 304 (352)
Q Consensus 292 vkL~Dfg~a~~~~ 304 (352)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=157.51 Aligned_cols=101 Identities=26% Similarity=0.366 Sum_probs=88.7
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCccc
Q 018682 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (352)
Q Consensus 235 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 313 (352)
|+|.+++... ..+++.+++.++.|++.||.|||+++ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 45999999999999999999999875 999999999999999 99987654321
Q ss_pred CCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
..+++.|+|||++.+..++.++|||||||++|||+||..
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 102 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYEL 102 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 247899999999999999999999999999999999963
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=158.95 Aligned_cols=137 Identities=18% Similarity=0.301 Sum_probs=105.0
Q ss_pred cccCceeecccEEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-----CCCceeeeeEEEEeCC---c
Q 018682 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---P 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~ 224 (352)
++...+.||+|+|+.||. ++. .+||++.... ....+.+.+|+.+++.+ .||||++++++++++. .
T Consensus 3 ~L~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred ecCCcceecCCCceEEEECCCCcC-eEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 355677999999999984 222 3677775432 22346789999999999 5799999999999874 3
Q ss_pred -eEEEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecCCCCCCeEeCCC----CCEEEEc
Q 018682 225 -MMIVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD 296 (352)
Q Consensus 225 -~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~Dikp~Nill~~~----~~vkL~D 296 (352)
+.+|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+|||++.. +.++|+|
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 3378999 5579999999764 45555 35677888777 9999999 9999999999999743 3799999
Q ss_pred -cCCccc
Q 018682 297 -FGVSKL 302 (352)
Q Consensus 297 -fg~a~~ 302 (352)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-22 Score=190.64 Aligned_cols=191 Identities=26% Similarity=0.387 Sum_probs=148.7
Q ss_pred cCceeecccEEEEEEE-----cCeEEEEEEcCc---ccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGE---EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 158 ~~~~~ig~G~~~~v~~-----~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
...+.+|.|.+|.++. .....+.|.+.. ...........+..|+-+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3456889999884432 122233333221 11222222333667888888899999988877776666666669
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|||++ +|..++...+.++..++-.+++|++.|+.|+|+.| +.|||+|++|++++.+|.+||+|||.+..+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 99999998778999999999999999999999999 999999999999999999999999998766544332
Q ss_pred ---CcccCCCCCccccccccCCCCCCCc-hhHHHHHHHHHHhhccCC
Q 018682 310 ---PLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ---~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~elltG~~ 352 (352)
......|+..|+|||.+.+..|+++ .||||.|+++..|.+|.+
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 2344668889999999999999875 899999999999999853
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=184.72 Aligned_cols=194 Identities=22% Similarity=0.305 Sum_probs=153.7
Q ss_pred ccCCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCceeeeeEEEEe
Q 018682 149 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQ 221 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~ 221 (352)
++......|.+.+.||+|+||.||+ +|+.||||+-++....+ |.-=.+++.+|+ -+.|..+.....-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3344455799999999999999995 58999999988765432 111223344444 2344455555555
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-------CCEEE
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-------GNLKV 294 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-------~~vkL 294 (352)
.+.-++|+||.+.|+|.++++..+.+++..+..++.|++..+++||..+ |||+||||+|+|+... --++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 6667899999999999999998888999999999999999999999999 9999999999998632 24899
Q ss_pred EccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||.|..+..-.+. ......+|-.+-++|+..+.+++..+|.|.|+.+++-||+|+
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 999998766533333 334456778899999999999999999999999999999996
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=150.25 Aligned_cols=108 Identities=19% Similarity=0.158 Sum_probs=97.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHH---HHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVE---GIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~---~~~~Ll~~ga~~n~~d-~~g~t~lh~A~~~~~~~~~~~Ll~-~ga~~~~~~ 103 (352)
++.+.+.++..|+||||+||..|+.+ ++++|+++|+++|.+| ..|+||||+|+..|+.+++++|+. .|++++.+|
T Consensus 46 ~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d 125 (166)
T PHA02743 46 DGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAIN 125 (166)
T ss_pred cchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcC
Confidence 45666777889999999999998865 4899999999999998 489999999999999999999995 799999999
Q ss_pred CCCCChhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 104 ~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
..|.||||+|+..++.+++++|+.+++++....
T Consensus 126 ~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 158 (166)
T PHA02743 126 YQHETAYHIAYKMRDRRMMEILRANGAVCDDPL 158 (166)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999999999875544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-21 Score=181.52 Aligned_cols=178 Identities=23% Similarity=0.319 Sum_probs=152.4
Q ss_pred ecccEEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccC
Q 018682 163 ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 163 ig~G~~~~v~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
+|.|.||.|+ ..|.-+|+|..++......... ....|..++...+ ||.++++...|..+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 5788888775 4567899998887665544333 5567888888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCccc
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 313 (352)
|+.|...+.....+.......+...++-+++++|+.+ +++||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 9999888877777788888889999999999999999 999999999999999999999999999875432221
Q ss_pred CCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.||..|||||++. .....+|.||+|++++||+||-
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCC
Confidence 6789999999998 5678899999999999999984
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=169.77 Aligned_cols=115 Identities=28% Similarity=0.304 Sum_probs=106.4
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d-~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+.+.+..|.+|.|+||+||.+++.+++|+|+++|||||+.+ .-|-||||+||++|+..+|.+|+++|||++.+|..|.+
T Consensus 68 g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~ 147 (600)
T KOG0509|consen 68 GESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLT 147 (600)
T ss_pred CcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCc
Confidence 78888888899999999999999999999999999999999 55899999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCccccccccc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 144 (352)
|+|+|+.+++.-++.+|+.+++++........++.-
T Consensus 148 ~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpLm 183 (600)
T KOG0509|consen 148 PLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPLM 183 (600)
T ss_pred HHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHHH
Confidence 999999999999999999999988766655555543
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-19 Score=145.03 Aligned_cols=128 Identities=16% Similarity=0.174 Sum_probs=105.1
Q ss_pred CCCcccccccccccCCchhhhhh------hhcCCCCCCCccCCchHHHHHHhcCC----HHHHHHHHHcCCCCCCCCC-C
Q 018682 4 KVPVRTTLLKQSSLAPDRERKEA------ELNGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-D 72 (352)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~------~i~~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~ga~~n~~d~-~ 72 (352)
+..++|++-........+--+.. .-++.+.+.++..|+||||+||..|+ .+++++|+++|+++|.+|. +
T Consensus 18 ~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~ 97 (169)
T PHA02741 18 NSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLE 97 (169)
T ss_pred ccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCC
Confidence 34456666555544443321110 11356677888899999999999999 5899999999999999985 8
Q ss_pred CCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCC
Q 018682 73 NRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 73 g~t~lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
|+||||+|+..++.+++++|++ .|++++.+|..|.||||+|...++.+++++|.+.++.
T Consensus 98 g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 98 GDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred CCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence 9999999999999999999998 5999999999999999999999999999999997654
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.9e-19 Score=154.11 Aligned_cols=98 Identities=27% Similarity=0.279 Sum_probs=80.1
Q ss_pred CCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
+.+|.+|+||||+||..|+.++++.|+++|+++|.+| |+||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 24 ~~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~A 101 (284)
T PHA02791 24 FKADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYA 101 (284)
T ss_pred CCCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 4567778888888888888888888888888887664 67888888888888888888888888888888888888888
Q ss_pred hccCcHHHHHHHHHcCCCCC
Q 018682 114 IYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~~~ 133 (352)
+..|+.+++++|+.+++++.
T Consensus 102 a~~g~~eivk~Ll~~gadin 121 (284)
T PHA02791 102 VDSGNMQTVKLFVKKNWRLM 121 (284)
T ss_pred HHcCCHHHHHHHHHCCCCcC
Confidence 88888888888888887763
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=145.78 Aligned_cols=130 Identities=18% Similarity=0.128 Sum_probs=103.3
Q ss_pred CCCCcccccccccccCCchh---hhhhh--hcCCCCCCCccCCchHHHHHHhcCCH---HHHHHHHHcCCCCCCCCC-CC
Q 018682 3 TKVPVRTTLLKQSSLAPDRE---RKEAE--LNGLDDDGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRDI-DN 73 (352)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~---~~~~~--i~~~~~~~~~~~g~t~l~~a~~~~~~---~~~~~Ll~~ga~~n~~d~-~g 73 (352)
++..++||+-.....-.... ..+.. .++...+..|.+|.||||+||..|+. +++++|+++|+++|.+|. +|
T Consensus 13 ~d~~g~tpLh~A~~~g~~~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g 92 (154)
T PHA02736 13 PDIEGENILHYLCRNGGVTDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFG 92 (154)
T ss_pred cCCCCCCHHHHHHHhCCHHHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCC
Confidence 44567788754444332211 11111 11122234577899999999999986 568999999999999984 89
Q ss_pred CcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 74 RTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 74 ~t~lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
+||||+|+..|+.+++++|++ .|++++.+|..|.||||+|+..++.+++++|+..+++.
T Consensus 93 ~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~~~~~~~i~~~Ll~~ga~~ 152 (154)
T PHA02736 93 NTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQC 152 (154)
T ss_pred CcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 999999999999999999998 49999999999999999999999999999999999875
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=146.15 Aligned_cols=107 Identities=22% Similarity=0.251 Sum_probs=63.5
Q ss_pred cCCCCCCCc-cCCchHHHHHHhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--cCCHHHHHHHHHCCCCCCCC
Q 018682 29 NGLDDDGEE-IKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPK 102 (352)
Q Consensus 29 ~~~~~~~~~-~~g~t~l~~a~~~---~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~--~~~~~~~~~Ll~~ga~~~~~ 102 (352)
+|.|.+..+ ..|.||||+|+.. ++.+++++|+++|+|+|.+|.+|.||||+|+. .++.+++++|+++|++++.+
T Consensus 75 ~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~ 154 (209)
T PHA02859 75 NGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNK 154 (209)
T ss_pred CCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 455555554 2566666665542 34666666666666666666666666666554 34566666666666666666
Q ss_pred CCCCCChhHH-hhccCcHHHHHHHHHcCCCCCCC
Q 018682 103 DRWGSTPLGD-AIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 103 ~~~g~t~l~~-a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
|..|.||||. |...++.+++++|++.|+++...
T Consensus 155 d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~ 188 (209)
T PHA02859 155 DFDNNNILYSYILFHSDKKIFDFLTSLGIDINET 188 (209)
T ss_pred cCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCC
Confidence 6666666663 34455666666666666655433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-18 Score=145.53 Aligned_cols=135 Identities=23% Similarity=0.365 Sum_probs=112.4
Q ss_pred eeecccEEEEEE---EcCeEEEEEEcCcccCCCHH-----HHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 161 ~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+.||+|++|.|| +.|..+++|.........++ ....+.+|+.++..+.|++++....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 478999999886 56889999987654433222 1245778999999999999887777777778889999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
+|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|+||+++ ++.++|+|||.+...
T Consensus 82 ~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999987543 2 77889999999999999999 99999999999999 788999999988753
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=126.19 Aligned_cols=87 Identities=44% Similarity=0.583 Sum_probs=81.7
Q ss_pred HHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHH
Q 018682 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123 (352)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~ 123 (352)
||+||..|+.++++.|++.+++++. |.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7999999999999999999999987 999999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCC
Q 018682 124 LLEKHGAKPLM 134 (352)
Q Consensus 124 ~L~~~~~~~~~ 134 (352)
+|+++|+++..
T Consensus 77 ~Ll~~g~~~~~ 87 (89)
T PF12796_consen 77 LLLEHGADVNI 87 (89)
T ss_dssp HHHHTTT-TTS
T ss_pred HHHHcCCCCCC
Confidence 99999988743
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=152.14 Aligned_cols=126 Identities=21% Similarity=0.100 Sum_probs=104.2
Q ss_pred CCCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 018682 3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (352)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~ 82 (352)
++..++||+-.........--.----+|.+.+.. +|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus 26 ~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~--d~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~ 103 (284)
T PHA02791 26 ADVHGHSALYYAIADNNVRLVCTLLNAGALKNLL--ENEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVD 103 (284)
T ss_pred CCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCC--CCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Confidence 4456777776665544332211111245555544 47899999999999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCCCCCC-ChhHHhhccCcHHHHHHHHHcCC
Q 018682 83 QGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKNHEVIKLLEKHGA 130 (352)
Q Consensus 83 ~~~~~~~~~Ll~~ga~~~~~~~~g~-t~l~~a~~~~~~~~~~~L~~~~~ 130 (352)
.|+.+++++|+++|++++.++..|. ||||+|+..|+.+++++|++.+.
T Consensus 104 ~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~ 152 (284)
T PHA02791 104 SGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIP 152 (284)
T ss_pred cCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCC
Confidence 9999999999999999999998885 89999999999999999998754
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=160.11 Aligned_cols=114 Identities=32% Similarity=0.397 Sum_probs=99.7
Q ss_pred cCCCCCCCc-cCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~-~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
.|.|+|... ..+.||||+||.+|++.+|.+|+++|||++.+|.+|.||||+||+.|+.-+|-+|+.+|+++|.+|..|+
T Consensus 100 ~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~gr 179 (600)
T KOG0509|consen 100 HGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGR 179 (600)
T ss_pred cCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCC
Confidence 444555554 5788999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCCCCCc-cccccc
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP-MHVKHA 142 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~~~~~-~~~~~~ 142 (352)
||||+|+++|....+..|+..++.+.... .++.++
T Consensus 180 TpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~Tp 215 (600)
T KOG0509|consen 180 TPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTP 215 (600)
T ss_pred CHHHHHHHhcccHHHHHHHHhcccccccccccCCch
Confidence 99999999998887888888888775544 333333
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=163.88 Aligned_cols=106 Identities=31% Similarity=0.444 Sum_probs=99.8
Q ss_pred cCCCCCCCccC-CchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~-g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
+|+|.+..+.. |.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 156 ~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~ 235 (477)
T PHA02878 156 YGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGN 235 (477)
T ss_pred cCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 67888888888 99999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ChhHHhhcc-CcHHHHHHHHHcCCCCCC
Q 018682 108 TPLGDAIYY-KNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 108 t~l~~a~~~-~~~~~~~~L~~~~~~~~~ 134 (352)
||||+|+.. ++.+++++|+++|+++..
T Consensus 236 TpLh~A~~~~~~~~iv~~Ll~~gadvn~ 263 (477)
T PHA02878 236 TPLHISVGYCKDYDILKLLLEHGVDVNA 263 (477)
T ss_pred CHHHHHHHhcCCHHHHHHHHHcCCCCCc
Confidence 999999975 689999999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-18 Score=142.87 Aligned_cols=131 Identities=25% Similarity=0.356 Sum_probs=105.9
Q ss_pred eecccEEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 162 EITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 162 ~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
.||+|++|.|| ++|.++++|.........+ .....+.+|+.+++.++++++.....++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999887 6788999998665433222 123567789999999988876655555566677899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988765321 78899999999999999 99999999999999 789999999988764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=140.13 Aligned_cols=105 Identities=20% Similarity=0.179 Sum_probs=92.5
Q ss_pred CCCCccCCchHHHHHHhcCCHHHHHHHHH------cCCCCCCCCCCCCcHHHHHHHcCC----HHHHHHHHHCCCCCCCC
Q 018682 33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK 102 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~------~ga~~n~~d~~g~t~lh~A~~~~~----~~~~~~Ll~~ga~~~~~ 102 (352)
.+.++..|+||||+||..|+.++++.|+. .|+++|.+|..|+||||+|+..|+ .+++++|+++|++++.+
T Consensus 14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~ 93 (169)
T PHA02741 14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ 93 (169)
T ss_pred hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence 34566788899999999999999999854 368999999999999999999998 58999999999999999
Q ss_pred CC-CCCChhHHhhccCcHHHHHHHHH-cCCCCCCCcc
Q 018682 103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPM 137 (352)
Q Consensus 103 ~~-~g~t~l~~a~~~~~~~~~~~L~~-~~~~~~~~~~ 137 (352)
+. .|.||||+|+..++.+++++|+. .++++.....
T Consensus 94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~ 130 (169)
T PHA02741 94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNA 130 (169)
T ss_pred CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCC
Confidence 85 99999999999999999999997 4777654433
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=133.84 Aligned_cols=85 Identities=27% Similarity=0.210 Sum_probs=51.3
Q ss_pred CCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 018682 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 112 (352)
.|.+|.+|+||||-|+.+|+.++|+.|+..|||++++...||||||-||..++.+++-+|+++|+|+|+......||||+
T Consensus 90 vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpLhl 169 (228)
T KOG0512|consen 90 VNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPLHL 169 (228)
T ss_pred ccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhhHH
Confidence 34555555666666666666666666666666666666666666666666666666666666666666666555666666
Q ss_pred hhccC
Q 018682 113 AIYYK 117 (352)
Q Consensus 113 a~~~~ 117 (352)
|+...
T Consensus 170 aa~~r 174 (228)
T KOG0512|consen 170 AAGNR 174 (228)
T ss_pred hhccc
Confidence 65544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-19 Score=174.84 Aligned_cols=190 Identities=20% Similarity=0.274 Sum_probs=143.0
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
++...+.+|++.|-.+. .+...|++|++.+.... +-....+...|++ ...+++||++++.-+-..++..|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 56777899999996543 34445999988654311 1122223333455 6677999999998887888888999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
.. -+|+|.+..++.+..-+.+.|+.|++.||..+|..| |+|||||.+||||+.-..+.|+||..-+..-.+.+.+.
T Consensus 103 vk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 84 599999998888889999999999999999999999 99999999999999999999999976543322222221
Q ss_pred -------ccCCCCCccccccccCC----------CC-CCCchhHHHHHHHHHHhhccC
Q 018682 312 -------TCQDTSCRYVAPEVFKN----------EE-YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 -------~~~~~~~~y~aPE~~~~----------~~-~~~~~DiwslG~il~elltG~ 351 (352)
++...+ -|.|||.+.. .+ .+++.||||+||+++||++-+
T Consensus 179 df~fFFDTSrRRt-CYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg 235 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRT-CYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEG 235 (1431)
T ss_pred cceEEEecCCcee-eecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcC
Confidence 111122 4999997643 12 577899999999999999854
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-18 Score=160.03 Aligned_cols=107 Identities=33% Similarity=0.495 Sum_probs=101.6
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
.|.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..|..|.|
T Consensus 113 ~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~t 192 (434)
T PHA02874 113 CGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGES 192 (434)
T ss_pred CcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 56778888889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
|||+|+..|+.+++++|++.++++...
T Consensus 193 pL~~A~~~g~~~iv~~Ll~~g~~i~~~ 219 (434)
T PHA02874 193 PLHNAAEYGDYACIKLLIDHGNHIMNK 219 (434)
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCcCC
Confidence 999999999999999999999886443
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=142.45 Aligned_cols=103 Identities=26% Similarity=0.286 Sum_probs=91.1
Q ss_pred CCCCccCCchHHHHHHhcC--CHHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCC
Q 018682 33 DDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDI-DNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWG 106 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~ga~~n~~d~-~g~t~lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g 106 (352)
.+..+..|.||||+|+..+ +.+++++|+++|+|+|.++. .|+||||+|+.. ++.+++++|+++|+++|.+|..|
T Consensus 44 ~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G 123 (209)
T PHA02859 44 VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDG 123 (209)
T ss_pred hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCC
Confidence 4456778999999999854 89999999999999999974 799999998864 47999999999999999999999
Q ss_pred CChhHHhhc--cCcHHHHHHHHHcCCCCCCC
Q 018682 107 STPLGDAIY--YKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 107 ~t~l~~a~~--~~~~~~~~~L~~~~~~~~~~ 135 (352)
.||||+|+. .++.+++++|++.|+++...
T Consensus 124 ~TpLh~a~~~~~~~~~iv~~Li~~gadin~~ 154 (209)
T PHA02859 124 KNLLHMYMCNFNVRINVIKLLIDSGVSFLNK 154 (209)
T ss_pred CCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 999999875 46899999999999987543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.1e-18 Score=145.86 Aligned_cols=142 Identities=20% Similarity=0.129 Sum_probs=108.0
Q ss_pred cccCceeecccEEEEEE------EcCeEEEEEEcCcccCCC-------------------H--HHHHHHHHHHHHHhcCC
Q 018682 156 DFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISD-------------------D--DRVRAFRDELALLQKIR 208 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~------~~~~~vavK~~~~~~~~~-------------------~--~~~~~~~~E~~~l~~l~ 208 (352)
-|.+.+.||+|++|.|| .+|+.||+|++....... . .....+..|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46677899999999875 257899999987543210 0 01234578999999997
Q ss_pred CC--ceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe
Q 018682 209 HP--NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (352)
Q Consensus 209 h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill 286 (352)
+. .++++++. ...++||||+++.+|..+......+...++..++.|++.++.+||+.| .++|+||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEE
Confidence 53 34444442 235899999999888776544445666677889999999999999987 39999999999999
Q ss_pred CCCCCEEEEccCCccccc
Q 018682 287 DDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 287 ~~~~~vkL~Dfg~a~~~~ 304 (352)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 7899999999887544
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.1e-18 Score=148.09 Aligned_cols=87 Identities=22% Similarity=0.256 Sum_probs=52.8
Q ss_pred CCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccC
Q 018682 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d-~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~ 117 (352)
.|.||||+||..++.+++++|+++|||+|.++ ..|.||||+|+..++.+++++|+++|++++.+|..|.||+|+|+..+
T Consensus 69 ~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdin~kd~~G~TpL~~A~~~~ 148 (300)
T PHA02884 69 SKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADINIQTNDMVTPIELALMIC 148 (300)
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHhC
Confidence 56666666666666666666666666666543 34666666666666666666666666666666666666666666555
Q ss_pred cHHHHHHH
Q 018682 118 NHEVIKLL 125 (352)
Q Consensus 118 ~~~~~~~L 125 (352)
+.+++.++
T Consensus 149 ~~~~~~~~ 156 (300)
T PHA02884 149 NNFLAFMI 156 (300)
T ss_pred ChhHHHHh
Confidence 55554444
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=157.26 Aligned_cols=100 Identities=24% Similarity=0.231 Sum_probs=86.7
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhc
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~ 115 (352)
.+.+|.||||+||..|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 98 ~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~ 177 (413)
T PHA02875 98 FYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMA 177 (413)
T ss_pred ccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 34578888999999899999999999999998888889999999999999999999999999888888889999999988
Q ss_pred cCcHHHHHHHHHcCCCCCCC
Q 018682 116 YKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 116 ~~~~~~~~~L~~~~~~~~~~ 135 (352)
.|+.+++++|++.|+++...
T Consensus 178 ~g~~eiv~~Ll~~ga~~n~~ 197 (413)
T PHA02875 178 KGDIAICKMLLDSGANIDYF 197 (413)
T ss_pred cCCHHHHHHHHhCCCCCCcC
Confidence 88888999998888887543
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.9e-18 Score=157.45 Aligned_cols=106 Identities=25% Similarity=0.325 Sum_probs=100.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC-
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS- 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~- 107 (352)
+|.|.+..+.+|.||||+||..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..|.
T Consensus 124 ~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~~ 203 (413)
T PHA02875 124 RGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGCV 203 (413)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCc
Confidence 6888888999999999999999999999999999999999999999999999999999999999999999999998875
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
||+|+|+..++.+++++|+++|+++..
T Consensus 204 t~l~~A~~~~~~~iv~~Ll~~gad~n~ 230 (413)
T PHA02875 204 AALCYAIENNKIDIVRLFIKRGADCNI 230 (413)
T ss_pred hHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence 789999999999999999999999743
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=159.73 Aligned_cols=137 Identities=23% Similarity=0.223 Sum_probs=110.7
Q ss_pred cccCceeecccEEEEEEE---cCeEEEEEEcCcccCCC-----HHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~---~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
.|...+.||+|+||.||. .+..+++|+........ ....+.+.+|+.+++.++|++++....++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 446678999999999985 45566666543322221 1223568899999999999999888777777778899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+|||+++++|.+++. ....++.|++.+|.+||+.+ ++||||||+||++ .++.++|+|||+++...
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 999999999999875 34678899999999999999 9999999999999 57789999999997654
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=157.38 Aligned_cols=106 Identities=22% Similarity=0.262 Sum_probs=95.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCCCCCC-CCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDP-KDRW 105 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~--~~~~~~~Ll~~ga~~~~-~~~~ 105 (352)
+|.|+|.++.+|+||||+||..|+.+++++|+++|||+|.+|.+|+||||+|+..+ ..+++++|+++|++++. .|..
T Consensus 61 ~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~ 140 (446)
T PHA02946 61 RGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEE 140 (446)
T ss_pred CcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCC
Confidence 78888899999999999999999999999999999999999999999999999866 48899999999999995 6889
Q ss_pred CCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 106 g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
|.|||+ |+..++.+++++|++.|+++...
T Consensus 141 g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~ 169 (446)
T PHA02946 141 GCGPLL-ACTDPSERVFKKIMSIGFEARIV 169 (446)
T ss_pred CCcHHH-HHHCCChHHHHHHHhcccccccc
Confidence 999997 55668899999999999877433
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=168.79 Aligned_cols=109 Identities=28% Similarity=0.286 Sum_probs=98.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHH---------------------------
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA--------------------------- 81 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~--------------------------- 81 (352)
+|.|.|..|.+|+||||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+
T Consensus 547 ~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~~~L 626 (823)
T PLN03192 547 AKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDLL 626 (823)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCchHH
Confidence 78889999999999999999999999999999999999999999999988655
Q ss_pred ----HcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCcc
Q 018682 82 ----CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (352)
Q Consensus 82 ----~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~ 137 (352)
..|+.++++.|+++|+++|.+|..|.||||+|+..|+.+++++|+++|+++.....
T Consensus 627 ~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~ 686 (823)
T PLN03192 627 CTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANT 686 (823)
T ss_pred HHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCC
Confidence 45556667778899999999999999999999999999999999999999865543
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-18 Score=153.49 Aligned_cols=104 Identities=29% Similarity=0.395 Sum_probs=96.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
.|++.|..+....|||--||..|+.+++++|+++|||++..|..|.|+||+||++|+.+|+++|++.|||+|.++..|+|
T Consensus 106 ~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNT 185 (615)
T KOG0508|consen 106 RGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNT 185 (615)
T ss_pred hcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCch
Confidence 45666777777889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
+||.|++.|+.+++++|+.+++.+
T Consensus 186 ALH~caEsG~vdivq~Ll~~ga~i 209 (615)
T KOG0508|consen 186 ALHDCAESGSVDIVQLLLKHGAKI 209 (615)
T ss_pred HHHhhhhcccHHHHHHHHhCCcee
Confidence 999999999999999999988765
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-18 Score=137.78 Aligned_cols=108 Identities=20% Similarity=0.200 Sum_probs=93.2
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH---HHHHHHCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV---VSLLLERGADVDP 101 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~----~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~---~~~Ll~~ga~~~~ 101 (352)
|+.|.+..+.++.++||.||..|+. +++++|++.|+++|.+|.+|+||||+|+..|+.+. +++|+++|+++|.
T Consensus 9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~ 88 (166)
T PHA02743 9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINA 88 (166)
T ss_pred cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCC
Confidence 4555656666777889999999998 66677889999999999999999999999988654 8999999999999
Q ss_pred CC-CCCCChhHHhhccCcHHHHHHHHH-cCCCCCCCc
Q 018682 102 KD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAP 136 (352)
Q Consensus 102 ~~-~~g~t~l~~a~~~~~~~~~~~L~~-~~~~~~~~~ 136 (352)
+| ..|.||||+|+..++.+++++|+. .++++....
T Consensus 89 ~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d 125 (166)
T PHA02743 89 RELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAIN 125 (166)
T ss_pred CCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcC
Confidence 98 589999999999999999999995 788875443
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=157.67 Aligned_cols=112 Identities=24% Similarity=0.249 Sum_probs=101.5
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-CCHHHHHHHHHCCCCCCCCCC-CC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDR-WG 106 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~-~~~~~~~~Ll~~ga~~~~~~~-~g 106 (352)
+|.|.+..+..|.||||+|+..|+.++++.|++.|+++|.+|..|+||||+|+.. ++.+++++|+++|++++.++. .|
T Consensus 190 ~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g 269 (477)
T PHA02878 190 YGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILG 269 (477)
T ss_pred CCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 6788888899999999999999999999999999999999999999999999976 799999999999999999986 89
Q ss_pred CChhHHhhccCcHHHHHHHHHcCCCCCCCccccccc
Q 018682 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (352)
Q Consensus 107 ~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (352)
.||||+| .++.+++++|+++|+++......+.++
T Consensus 270 ~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp 303 (477)
T PHA02878 270 LTALHSS--IKSERKLKLLLEYGADINSLNSYKLTP 303 (477)
T ss_pred CCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 9999999 567899999999999986655544444
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=158.07 Aligned_cols=108 Identities=30% Similarity=0.353 Sum_probs=95.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC-CHHHHHHHHHCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDR 104 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~-~~~~~~~Ll~~ga~~~~~~~ 104 (352)
+|.|.+..+..|.||||+|+..+ +.++++.|+++|+|+|.+|..|+||||+|+..| ..+++++|+++|++++.+|.
T Consensus 36 ~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~ 115 (471)
T PHA03095 36 AGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDK 115 (471)
T ss_pred cCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCC
Confidence 57777788888999999999988 899999999999999999999999999999999 59999999999999999999
Q ss_pred CCCChhHHhh--ccCcHHHHHHHHHcCCCCCCCc
Q 018682 105 WGSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 105 ~g~t~l~~a~--~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
.|.||||+|+ ..++.+++++|++.|+++....
T Consensus 116 ~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d 149 (471)
T PHA03095 116 VGRTPLHVYLSGFNINPKVIRLLLRKGADVNALD 149 (471)
T ss_pred CCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccC
Confidence 9999999998 5567889999999998875443
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=159.17 Aligned_cols=105 Identities=26% Similarity=0.317 Sum_probs=97.1
Q ss_pred cCCCCCCCccCCchHHHHHHhc-----CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC---CHHHHHHHHHCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVD 100 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~-----~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~---~~~~~~~Ll~~ga~~~ 100 (352)
+|+|.|..+..|.||||.|+.+ +..+++++|+++|||+|.+|.+|+||||+|+..+ +.+++++|+++||+++
T Consensus 60 ~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn 139 (489)
T PHA02798 60 LGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTT 139 (489)
T ss_pred CCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCcc
Confidence 7889999999999999998764 6789999999999999999999999999999875 7899999999999999
Q ss_pred CCCCCCCChhHHhhccCc---HHHHHHHHHcCCCCC
Q 018682 101 PKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPL 133 (352)
Q Consensus 101 ~~~~~g~t~l~~a~~~~~---~~~~~~L~~~~~~~~ 133 (352)
.+|..|.||||+|+..++ .+++++|++.|+++.
T Consensus 140 ~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin 175 (489)
T PHA02798 140 LLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDIN 175 (489)
T ss_pred ccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcc
Confidence 999999999999999887 899999999999874
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=144.03 Aligned_cols=104 Identities=18% Similarity=0.082 Sum_probs=90.2
Q ss_pred CccCCch-HHHHHHhcCCHHHHHHHHHcCCCCCCCC----CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC-CCCCCCh
Q 018682 36 EEIKPEF-RLMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPK-DRWGSTP 109 (352)
Q Consensus 36 ~~~~g~t-~l~~a~~~~~~~~~~~Ll~~ga~~n~~d----~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~-~~~g~t~ 109 (352)
+|..|.| +||.|+..|+.+++++|+++|||+|.++ ..|.||||+|+..++.+++++|+++||++|.+ +..|.||
T Consensus 28 ~d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~Tp 107 (300)
T PHA02884 28 KNKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITP 107 (300)
T ss_pred cCcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCH
Confidence 3444544 4566777899999999999999999984 58999999999999999999999999999986 4689999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCcccc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~ 139 (352)
||+|+..++.+++++|+..|+++......+
T Consensus 108 Lh~Aa~~~~~eivklLL~~GAdin~kd~~G 137 (300)
T PHA02884 108 LYISVLHGCLKCLEILLSYGADINIQTNDM 137 (300)
T ss_pred HHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 999999999999999999999986544333
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=158.28 Aligned_cols=104 Identities=23% Similarity=0.270 Sum_probs=85.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCH--HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDV--EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~--~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 106 (352)
.|.|++.++..|+||||+||..|+. .+++.|++.|+++|.+|.+|+||||+|+..|+.+++++|+++||+++.+|..|
T Consensus 211 ~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g 290 (471)
T PHA03095 211 AGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDG 290 (471)
T ss_pred cCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC
Confidence 5777777888888888888887764 57777888888888888888888888888888888888888888888888888
Q ss_pred CChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 107 ~t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
.||||+|+..++.++++.|+..++++
T Consensus 291 ~tpl~~A~~~~~~~~v~~LL~~~~~~ 316 (471)
T PHA03095 291 NTPLSLMVRNNNGRAVRAALAKNPSA 316 (471)
T ss_pred CCHHHHHHHhCCHHHHHHHHHhCCCH
Confidence 88888888888888888888877665
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=160.68 Aligned_cols=107 Identities=21% Similarity=0.212 Sum_probs=90.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCC--HHHHHHHHHcCCCCCCCCCCCCcHHHHH--------------------------
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA-------------------------- 80 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~--~~~~~~Ll~~ga~~n~~d~~g~t~lh~A-------------------------- 80 (352)
+|+|.|.++..|+||||+|+..|+ .+++++|+++|||+|.+|..|+||||.|
T Consensus 201 ~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~ 280 (764)
T PHA02716 201 NGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKN 280 (764)
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhcccccccc
Confidence 788888888899999999999885 5899999999999999999999999865
Q ss_pred -----------HHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhc--cCcHHHHHHHHHcCCCCCCC
Q 018682 81 -----------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 81 -----------~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~--~~~~~~~~~L~~~~~~~~~~ 135 (352)
+..|+.+++++|+++|++++.+|..|+||||+|+. .++.+++++|++.|+++...
T Consensus 281 ~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~k 348 (764)
T PHA02716 281 IPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEP 348 (764)
T ss_pred chhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccC
Confidence 34577888999999999999999999999998763 45788999999999887443
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=151.84 Aligned_cols=96 Identities=26% Similarity=0.213 Sum_probs=89.5
Q ss_pred cCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccC
Q 018682 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (352)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~ 117 (352)
..+.|++|.|+..++.+++++|+++|||+|.+|.+|.||||+|+..|+.+++++|+++||+++.+|..|.||||+|+..|
T Consensus 186 ~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g 265 (437)
T PHA02795 186 IIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRG 265 (437)
T ss_pred hhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcC
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred c--------HHHHHHHHHcCCCCC
Q 018682 118 N--------HEVIKLLEKHGAKPL 133 (352)
Q Consensus 118 ~--------~~~~~~L~~~~~~~~ 133 (352)
+ .+++++|+++++++.
T Consensus 266 ~~~~~~~~~~eIvelLL~~gadI~ 289 (437)
T PHA02795 266 SVIARRETHLKILEILLREPLSID 289 (437)
T ss_pred CcccccccHHHHHHHHHhCCCCCC
Confidence 4 689999999888753
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-17 Score=153.10 Aligned_cols=87 Identities=29% Similarity=0.341 Sum_probs=74.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+.++..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.++..|.|
T Consensus 146 ~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~T 225 (434)
T PHA02874 146 YGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFT 225 (434)
T ss_pred CCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCCC
Confidence 67888888899999999999999999999999999999999999999999999999999999999998776555544444
Q ss_pred hhHHhhc
Q 018682 109 PLGDAIY 115 (352)
Q Consensus 109 ~l~~a~~ 115 (352)
|||+|+.
T Consensus 226 pL~~A~~ 232 (434)
T PHA02874 226 PLHNAII 232 (434)
T ss_pred HHHHHHH
Confidence 4444433
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.4e-18 Score=167.20 Aligned_cols=105 Identities=35% Similarity=0.375 Sum_probs=101.7
Q ss_pred hcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 28 i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
-+|++.+.++..|.||||.||..|++.+|++|+++|||+|++|+.|+||||.||..|+.+|+++|+++||++|..|.+|.
T Consensus 528 ~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~ 607 (1143)
T KOG4177|consen 528 EHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGF 607 (1143)
T ss_pred hcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCc
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
|||++|...|..++++.|...+.++
T Consensus 608 TpL~iA~~lg~~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 608 TPLHIAVRLGYLSVVKLLKVVTATP 632 (1143)
T ss_pred chhHHHHHhcccchhhHHHhccCcc
Confidence 9999999999999999999999883
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=128.24 Aligned_cols=93 Identities=35% Similarity=0.433 Sum_probs=88.1
Q ss_pred chHHHHHHhcCCHHHHHHHHHcCCC-CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcH
Q 018682 41 EFRLMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119 (352)
Q Consensus 41 ~t~l~~a~~~~~~~~~~~Ll~~ga~-~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~ 119 (352)
.-.+.+|+..+....|+.||+..|+ ||.+|.+|+||||.|+++|+.+|+..|+..||+++.+...|+||||-|+.+.+.
T Consensus 64 ~rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~ 143 (228)
T KOG0512|consen 64 IRLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNF 143 (228)
T ss_pred HHHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccch
Confidence 4457889999999999999998876 999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCC
Q 018682 120 EVIKLLEKHGAKPL 133 (352)
Q Consensus 120 ~~~~~L~~~~~~~~ 133 (352)
+++-.|+++|+|+-
T Consensus 144 ~va~~LLqhgaDVn 157 (228)
T KOG0512|consen 144 EVAGRLLQHGADVN 157 (228)
T ss_pred hHHHHHHhccCccc
Confidence 99999999999973
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.6e-18 Score=147.03 Aligned_cols=190 Identities=18% Similarity=0.291 Sum_probs=123.1
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC----------CceeeeeEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----------PNVVQFLGA 218 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~ 218 (352)
...+...+.||.|+++.|+. +|+++|+|++...........+++++|.-....+.+ -.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 34567788999999998873 579999998877664444566778777765555322 122222222
Q ss_pred EE---------eC---C-----ceEEEEeccCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 018682 219 VT---------QS---S-----PMMIVTEYLPKGDLRAFLKR---KGA----LKPSTAVRFALDIARGMNYLHENKPVPI 274 (352)
Q Consensus 219 ~~---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~----~~~~~~~~i~~qi~~~l~~LH~~~~~~i 274 (352)
.. .. . ..+++|+-+ .++|.+++.. ... +.......+..|+++.+++||+.| +
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 21 11 1 246788877 5688887642 222 122333456689999999999999 9
Q ss_pred eecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCC--------CCCCCchhHHHHHHHHHH
Q 018682 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQE 346 (352)
Q Consensus 275 vH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 346 (352)
+|+||+|+|++++.+|.++|+||+....... .......+..|.+||.... -.++.+.|.|+||+++|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999987654322 1111334567999997643 256788999999999999
Q ss_pred hhccC
Q 018682 347 VKFYN 351 (352)
Q Consensus 347 lltG~ 351 (352)
|+.|.
T Consensus 243 lWC~~ 247 (288)
T PF14531_consen 243 LWCGR 247 (288)
T ss_dssp HHHSS
T ss_pred HHHcc
Confidence 98874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-16 Score=137.97 Aligned_cols=140 Identities=19% Similarity=0.206 Sum_probs=107.5
Q ss_pred cccCceeecccEEEEEEEcCeEEEEEEcCcccC----------CCHHHHHHHHHHHHHHhcCCCCce--eeeeEEEEeCC
Q 018682 156 DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSS 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~ 223 (352)
.+.+.+..|+|+++.|+..+..++||.+..... .+......+.+|+.++..+.|++| ++.+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 344556788889999998999999998854221 112334567889999999988775 66776644332
Q ss_pred c----eEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 224 P----MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 224 ~----~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
. .++|||+++| .+|.+++... .++... +.|++.+|.+||+.| |+|+||||+|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 2599999987 6899888653 455443 568999999999999 9999999999999998899999999
Q ss_pred Ccccc
Q 018682 299 VSKLL 303 (352)
Q Consensus 299 ~a~~~ 303 (352)
.+...
T Consensus 188 ~~~~~ 192 (239)
T PRK01723 188 RGELR 192 (239)
T ss_pred CcccC
Confidence 88763
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=155.19 Aligned_cols=110 Identities=36% Similarity=0.511 Sum_probs=82.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCC------CcHHHHHHHcCC--HHHHHHHHHCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------RTALHVAACQGF--TEVVSLLLERGADVD 100 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g------~t~lh~A~~~~~--~~~~~~Ll~~ga~~~ 100 (352)
+|.|.+..+..|.||||+|+..|+.+++++|+++|++++..+..| .||||+|+..|+ .+++++|+++|++++
T Consensus 165 ~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din 244 (480)
T PHA03100 165 KGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPIN 244 (480)
T ss_pred CCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCC
Confidence 456666666677777777777777777777777777777777777 777777777777 777788888888888
Q ss_pred CCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCccc
Q 018682 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (352)
Q Consensus 101 ~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~ 138 (352)
.+|..|.||||+|+..++.+++++|++.|+++......
T Consensus 245 ~~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~~ 282 (480)
T PHA03100 245 IKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKY 282 (480)
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCC
Confidence 88888888888888888888888888888776544433
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-17 Score=133.05 Aligned_cols=103 Identities=27% Similarity=0.300 Sum_probs=96.9
Q ss_pred CCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
|.-|..|-|||+||+..|++++|++|++.|||++..-+...|+|.+|++.|..+||++|+.++.|+|.-|.+|.|||-||
T Consensus 154 N~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyA 233 (296)
T KOG0502|consen 154 NACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYA 233 (296)
T ss_pred cCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeee
Confidence 45566788889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCcHHHHHHHHHcCCCCCCCc
Q 018682 114 IYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
++-++-++++.|++.|+++.+..
T Consensus 234 vrgnhvkcve~Ll~sGAd~t~e~ 256 (296)
T KOG0502|consen 234 VRGNHVKCVESLLNSGADVTQED 256 (296)
T ss_pred ecCChHHHHHHHHhcCCCccccc
Confidence 99999999999999999985544
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-17 Score=154.47 Aligned_cols=104 Identities=34% Similarity=0.477 Sum_probs=99.6
Q ss_pred cCCCCCCCccCC------chHHHHHHhcCC--HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCC
Q 018682 29 NGLDDDGEEIKP------EFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100 (352)
Q Consensus 29 ~~~~~~~~~~~g------~t~l~~a~~~~~--~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~ 100 (352)
+|.|.+..+..| .||||+|+..++ .++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++
T Consensus 198 ~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n 277 (480)
T PHA03100 198 NGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPN 277 (480)
T ss_pred cCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCC
Confidence 677777777778 899999999999 999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 101 ~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
.+|..|.||+++|+..++.+++++|+++|+++
T Consensus 278 ~~d~~g~tpl~~A~~~~~~~iv~~Ll~~g~~i 309 (480)
T PHA03100 278 LVNKYGDTPLHIAILNNNKEIFKLLLNNGPSI 309 (480)
T ss_pred ccCCCCCcHHHHHHHhCCHHHHHHHHhcCCCH
Confidence 99999999999999999999999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=136.49 Aligned_cols=136 Identities=21% Similarity=0.111 Sum_probs=103.0
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCH-------------------HHHHHHHHHHHHHhcCCCC--
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHP-- 210 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~-- 210 (352)
-|...+.||+|+||.||. +|+.||+|++........ ........|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 366678899999998872 588999998764321100 0112356788899888776
Q ss_pred ceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC
Q 018682 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (352)
Q Consensus 211 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 290 (352)
.++..++ ....+++|||++|++|...... .....++.+++.++.++|+.+ ++|+||||+||+++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence 4444443 2456899999999998765421 334568889999999999999 99999999999999999
Q ss_pred CEEEEccCCccccc
Q 018682 291 NLKVADFGVSKLLT 304 (352)
Q Consensus 291 ~vkL~Dfg~a~~~~ 304 (352)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.4e-17 Score=153.64 Aligned_cols=143 Identities=27% Similarity=0.213 Sum_probs=110.2
Q ss_pred CCCCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHH-cC-CCCCCCCCCCCcHHHH
Q 018682 2 ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHV 79 (352)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~-~g-a~~n~~d~~g~t~lh~ 79 (352)
+-++-+-||+-+..+--..+--..-.-.|+|++.++.++.||||.||..|++.+++.|++ .| ..+|..|-.|.||||+
T Consensus 268 ~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHl 347 (929)
T KOG0510|consen 268 DEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHL 347 (929)
T ss_pred cccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhh
Confidence 445556666655544333333222333667777777788888999999999999999998 54 4688899999999999
Q ss_pred HHHcCCHHHHHHHHHCCCCCC---CCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCccccccccc
Q 018682 80 AACQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (352)
Q Consensus 80 A~~~~~~~~~~~Ll~~ga~~~---~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 144 (352)
|+..|+..++++|++.||+.. ..|.+|.||||.|+.+|+..++++|+.+|+++........++..
T Consensus 348 aa~~gH~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~SA~~ 415 (929)
T KOG0510|consen 348 AAKSGHDRVVQLLLNKGALFLNMSEADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKSAFD 415 (929)
T ss_pred hhhcCHHHHHHHHHhcChhhhcccccccCCchhhhHHHHhccHHHHHHHHHcCCceeecccccccccc
Confidence 999999999999999999987 56899999999999999999999999999998554444444433
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=155.54 Aligned_cols=139 Identities=22% Similarity=0.187 Sum_probs=108.0
Q ss_pred CCCcccccccccccCCc-hh-hhhhhhcCCCCCCCccCCchHHHHH----------------------------------
Q 018682 4 KVPVRTTLLKQSSLAPD-RE-RKEAELNGLDDDGEEIKPEFRLMFL---------------------------------- 47 (352)
Q Consensus 4 ~~~~~~~~~~~~~~~~~-~~-~~~~~i~~~~~~~~~~~g~t~l~~a---------------------------------- 47 (352)
+..+.||+-........ .+ -+----+|+|+|.++..|+||||+|
T Consensus 209 D~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~ 288 (764)
T PHA02716 209 NNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSY 288 (764)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHH
Confidence 34567777554433221 11 1111236888888999999999975
Q ss_pred ---HhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--cCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhc-------
Q 018682 48 ---ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY------- 115 (352)
Q Consensus 48 ---~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~--~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~------- 115 (352)
|..|+.++++.|+++|+++|.+|.+|+||||+|+. .++.+++++|+++|++++.+|..|.||||+|+.
T Consensus 289 i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TPLH~A~~~lav~~~ 368 (764)
T PHA02716 289 ITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVLHTYLSMLSVVNI 368 (764)
T ss_pred HHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCHHHHHHHhhhhhcc
Confidence 44578899999999999999999999999999874 468999999999999999999999999999864
Q ss_pred -------cCcHHHHHHHHHcCCCCCCCccccccc
Q 018682 116 -------YKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (352)
Q Consensus 116 -------~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (352)
.++.+++++|+++|+++......+.++
T Consensus 369 ld~~~~~~~~~eVVklLL~~GADIn~kn~~G~TP 402 (764)
T PHA02716 369 LDPETDNDIRLDVIQCLISLGADITAVNCLGYTP 402 (764)
T ss_pred ccccccccChHHHHHHHHHCCCCCCCcCCCCCCh
Confidence 367899999999999985544433333
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=158.75 Aligned_cols=115 Identities=28% Similarity=0.303 Sum_probs=100.0
Q ss_pred hcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC-HHHHHHHHHCCCCCCCCCCCC
Q 018682 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDRWG 106 (352)
Q Consensus 28 i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~-~~~~~~Ll~~ga~~~~~~~~g 106 (352)
-.|.|.+..+..|.||||+|+..|+.++++.|+++|+++|..+..|.||||+|+..++ ..++++|+++|+++|.+|..|
T Consensus 363 ~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G 442 (682)
T PHA02876 363 ELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDL 442 (682)
T ss_pred HcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCC
Confidence 3677888888899999999999999999999999999999999999999999998665 567899999999999999999
Q ss_pred CChhHHhhccC-cHHHHHHHHHcCCCCCCCccccccc
Q 018682 107 STPLGDAIYYK-NHEVIKLLEKHGAKPLMAPMHVKHA 142 (352)
Q Consensus 107 ~t~l~~a~~~~-~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (352)
.||||+|+..+ +.+++++|++.|+++......+.++
T Consensus 443 ~TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp 479 (682)
T PHA02876 443 STPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP 479 (682)
T ss_pred ChHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 99999999876 6799999999999986554444333
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.5e-17 Score=144.34 Aligned_cols=113 Identities=30% Similarity=0.316 Sum_probs=104.3
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 110 (352)
+.-|+.+.+|-+||+-|+..|+.++|+.|+++||+||.......|||-.||..|+.+++++|+++|||++..|..|.|-|
T Consensus 75 V~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcL 154 (615)
T KOG0508|consen 75 VRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCL 154 (615)
T ss_pred EEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeE
Confidence 34467788999999999999999999999999999999998899999999999999999999999999999999999999
Q ss_pred HHhhccCcHHHHHHHHHcCCCCCCCcccccccc
Q 018682 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (352)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~ 143 (352)
|+|++.|+.+++++|++.|+|+......++++.
T Consensus 155 mIa~ykGh~~I~qyLle~gADvn~ks~kGNTAL 187 (615)
T KOG0508|consen 155 MIACYKGHVDIAQYLLEQGADVNAKSYKGNTAL 187 (615)
T ss_pred EeeeccCchHHHHHHHHhCCCcchhcccCchHH
Confidence 999999999999999999999876666555553
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.1e-17 Score=140.16 Aligned_cols=112 Identities=28% Similarity=0.318 Sum_probs=85.8
Q ss_pred CCCccCCchHHHHHHhcCCHHHHHHHHHcC-CCCCCCCCC--------------------------------------CC
Q 018682 34 DGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDID--------------------------------------NR 74 (352)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g-a~~n~~d~~--------------------------------------g~ 74 (352)
|.-|.+|+|+||||+.+.|.++|+.||+.| +|||.+|.. |.
T Consensus 262 NlaDsNGNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mgnVNaKAsQ~gQ 341 (452)
T KOG0514|consen 262 NLADSNGNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMGDVNAKASQHGQ 341 (452)
T ss_pred hhhcCCCCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhccCcchhhhhhcc
Confidence 344455666677777777777777777665 456555444 55
Q ss_pred cHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHc-CCCCCCCcccccccccC
Q 018682 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMAPMHVKHAREV 145 (352)
Q Consensus 75 t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~-~~~~~~~~~~~~~~~~~ 145 (352)
|+|++|+.+|..++|+.||..|||+|.+|.+|.|+|++|++.|++|++++|+.. +|++.....+.+++..+
T Consensus 342 TALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~I 413 (452)
T KOG0514|consen 342 TALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSI 413 (452)
T ss_pred hhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhh
Confidence 566668889999999999999999999999999999999999999999998875 57776666666555443
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=149.66 Aligned_cols=106 Identities=18% Similarity=0.158 Sum_probs=89.0
Q ss_pred cCCCCCCCccCCchHHHHHHhcCC----HHHHHHHHHcCC--CCCCCCCCCCcHHHH---HHHcC---------CHHHHH
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG---------FTEVVS 90 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~ga--~~n~~d~~g~t~lh~---A~~~~---------~~~~~~ 90 (352)
+|+|.|.+ ..|.||||+|+..++ .+++++|+++|+ |+|.+|.+|+||||. |...+ ..++++
T Consensus 368 ~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk 446 (672)
T PHA02730 368 NGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFD 446 (672)
T ss_pred CCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHH
Confidence 67777765 689999999888775 899999999987 689999999999984 33332 235689
Q ss_pred HHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 91 ~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
+|+++||++|.+|..|.||||+|+..++.+++++|+.+|+++...
T Consensus 447 ~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~ 491 (672)
T PHA02730 447 ILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTT 491 (672)
T ss_pred HHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999999999999999999999987443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.4e-17 Score=156.29 Aligned_cols=162 Identities=30% Similarity=0.450 Sum_probs=118.5
Q ss_pred CcccCCCCCcccCceeecccEEEEEEEc-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 221 (352)
.+...+.+.+|...+.|..|+||.||.- .+++|+| +.+... -+++ ++.....|.+|
T Consensus 75 as~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn---ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 75 ASRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN---ILTFAGNPFVV-------- 135 (1205)
T ss_pred ccccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc---cccccCCccee--------
Confidence 3456678889999999999999988853 4567773 322211 1121 44444555555
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
|+-...++.-+.++... +.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+++
T Consensus 136 -------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 -------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred -------------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhh
Confidence 44444555545555433 77899999999 9999999999999999999999999987
Q ss_pred cccccCCC--------------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDR--------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..-..... ...-..+|+.|+|||++....|...+|+|++|+|+||++.|.
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgc 255 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 255 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheee
Confidence 54211110 112346899999999999999999999999999999998774
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-17 Score=151.49 Aligned_cols=120 Identities=32% Similarity=0.508 Sum_probs=104.0
Q ss_pred ceEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
.+|+.|++|...+|.+|+..+. ..+......++.|+..+++| ++ .+|+|+||.||++..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5889999999999999997543 25677888999999999999 77 899999999999999999999999998
Q ss_pred ccccccC-----CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc
Q 018682 301 KLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 301 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 349 (352)
....... ....+...+|..||+||.+.+..|+.++||||||+||+||++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7665443 223344668999999999999999999999999999999986
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.4e-16 Score=145.49 Aligned_cols=106 Identities=19% Similarity=0.274 Sum_probs=74.0
Q ss_pred cCCCCCCCccCCchHHHHHHhcC--CHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNF-RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~ga~~n~-~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~ 105 (352)
+|+|+|.++.+|.||||+|+..+ ..+++++|+++|+++|. .|.+|.|||| ||..++.+++++|+++|++++.+|..
T Consensus 94 ~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~ 172 (446)
T PHA02946 94 HGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKF 172 (446)
T ss_pred CcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCC
Confidence 56677777777777788777654 36777777777777774 4667777776 55567777777777777777777777
Q ss_pred CCChhHHhhccC--cHHHHHHHHHcCCCCCCC
Q 018682 106 GSTPLGDAIYYK--NHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 106 g~t~l~~a~~~~--~~~~~~~L~~~~~~~~~~ 135 (352)
|.||||+|+..+ ..+++++|++.|+++...
T Consensus 173 G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~ 204 (446)
T PHA02946 173 GKNHIHRHLMSDNPKASTISWMMKLGISPSKP 204 (446)
T ss_pred CCCHHHHHHHhcCCCHHHHHHHHHcCCCCccc
Confidence 777777766543 346677777777766443
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.4e-16 Score=151.73 Aligned_cols=105 Identities=21% Similarity=0.192 Sum_probs=92.2
Q ss_pred cCCCCCCCccCCchHHHHHHhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC---------------------
Q 018682 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--------------------- 84 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~--------------------- 84 (352)
++.+.+.+|.+|+||||+||.. |+.++++.|+++|+|+|.+|..|+||||+|+..|
T Consensus 21 ~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~ 100 (661)
T PHA02917 21 DRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNI 100 (661)
T ss_pred ccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCC
Confidence 6677777788999999997665 8899999999999999999999999999888644
Q ss_pred --------------CHHHHHHHHHCCCCCCCCCCCCCChhHHh--hccCcHHHHHHHHHcCCCCC
Q 018682 85 --------------FTEVVSLLLERGADVDPKDRWGSTPLGDA--IYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 85 --------------~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a--~~~~~~~~~~~L~~~~~~~~ 133 (352)
+.+++++|+++|||+|.+|..|.||||.+ ...++.+++++|+++|+++.
T Consensus 101 ~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn 165 (661)
T PHA02917 101 NDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVL 165 (661)
T ss_pred CCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCcc
Confidence 45788999999999999999999999954 45789999999999999874
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.8e-16 Score=148.36 Aligned_cols=106 Identities=25% Similarity=0.334 Sum_probs=96.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC---HHHHHHHHHCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVDPK 102 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~---~~~~~~Ll~~ga~~~~~ 102 (352)
+|+|.|.++.+|+||||+|+..+ +.+++++|+++|||+|.+|.+|+||||+|+..++ .+++++|+++|++++..
T Consensus 98 ~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 98 NGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred CCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 78888999999999999999875 7899999999999999999999999999999988 99999999999999988
Q ss_pred C-CCCCChhHHhhcc----CcHHHHHHHHHcCCCCCC
Q 018682 103 D-RWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 103 ~-~~g~t~l~~a~~~----~~~~~~~~L~~~~~~~~~ 134 (352)
+ ..|.||+|.+... ++.+++++|+++|+++..
T Consensus 178 ~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~~ 214 (489)
T PHA02798 178 NNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIINK 214 (489)
T ss_pred cCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCccc
Confidence 5 5789999988654 478999999999998754
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-16 Score=136.51 Aligned_cols=97 Identities=35% Similarity=0.423 Sum_probs=90.1
Q ss_pred CCCCCcc-CCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCCCCCCCh
Q 018682 32 DDDGEEI-KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTP 109 (352)
Q Consensus 32 ~~~~~~~-~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~t~ 109 (352)
|+|.+-. .|+|+|+.|+.+|++++|+.||..|||||.+|.+|-|+|+.||.+|+.+|+++||.. ++|+...|.+|.|+
T Consensus 331 nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTA 410 (452)
T KOG0514|consen 331 DVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTA 410 (452)
T ss_pred CcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchh
Confidence 4444444 799999999999999999999999999999999999999999999999999999986 89999999999999
Q ss_pred hHHhhccCcHHHHHHHHHc
Q 018682 110 LGDAIYYKNHEVIKLLEKH 128 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~ 128 (352)
|.+|...|+.|+..+|..+
T Consensus 411 l~IAleagh~eIa~mlYa~ 429 (452)
T KOG0514|consen 411 LSIALEAGHREIAVMLYAH 429 (452)
T ss_pred hhhHHhcCchHHHHHHHHH
Confidence 9999999999999888765
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-16 Score=148.32 Aligned_cols=104 Identities=21% Similarity=0.278 Sum_probs=52.4
Q ss_pred cCCCCCCCccCCchHHHHHHhc---CCHHHHHHHHHcCCCC-CCCCCCCCcHHHHHHHc--CCHHHHHHHHHCCCCCCC-
Q 018682 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP- 101 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~ga~~-n~~d~~g~t~lh~A~~~--~~~~~~~~Ll~~ga~~~~- 101 (352)
+|+|.|.++..|.||||.|+.. ++.+++++|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|++++.
T Consensus 97 ~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~ 176 (494)
T PHA02989 97 FGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEK 176 (494)
T ss_pred CCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 4445555555555555544432 3455555555555555 45555555555554432 345555555555555554
Q ss_pred CCCCCCChhHHhhcc----CcHHHHHHHHHcCCCC
Q 018682 102 KDRWGSTPLGDAIYY----KNHEVIKLLEKHGAKP 132 (352)
Q Consensus 102 ~~~~g~t~l~~a~~~----~~~~~~~~L~~~~~~~ 132 (352)
.+..|.||||+|+.. ++.+++++|++.|+++
T Consensus 177 ~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~v 211 (494)
T PHA02989 177 TSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNI 211 (494)
T ss_pred ccccCCChHHHHHhcccccccHHHHHHHHhCCCCc
Confidence 344555555554433 2445555555555544
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=7e-16 Score=150.96 Aligned_cols=105 Identities=30% Similarity=0.253 Sum_probs=95.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcC-----------------------CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANER-----------------------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~-----------------------~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~ 85 (352)
+|.+.+..+.+|+||||.||+.+ ..++++.|+++|||+|.+|..|+||||+|+..++
T Consensus 385 ~ga~~~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~ 464 (661)
T PHA02917 385 EGGDAVNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNK 464 (661)
T ss_pred cCCCccccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCC
Confidence 57777777778999999988543 3578899999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCChhHHhhc-cCcHHHHHHHHHcCCCCC
Q 018682 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIY-YKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 86 ~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~-~~~~~~~~~L~~~~~~~~ 133 (352)
.+++++|+++|++++.+|..|.||||+|+. .++.+++++|+.+++++.
T Consensus 465 ~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 465 QSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred HHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 999999999999999999999999999996 678999999999998763
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.7e-16 Score=112.91 Aligned_cols=64 Identities=42% Similarity=0.587 Sum_probs=59.8
Q ss_pred CchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 018682 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (352)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (352)
|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+.+|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 8899999999999999999999999999999999999999999999999999999999999876
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.4e-16 Score=147.44 Aligned_cols=109 Identities=19% Similarity=0.234 Sum_probs=84.1
Q ss_pred cCCCC-CCCccCCchHHHHHHhc--CCHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHcC----CHHHHHHHHHCCCCCC
Q 018682 29 NGLDD-DGEEIKPEFRLMFLANE--RDVEGIKELLDSGIDVNF-RDIDNRTALHVAACQG----FTEVVSLLLERGADVD 100 (352)
Q Consensus 29 ~~~~~-~~~~~~g~t~l~~a~~~--~~~~~~~~Ll~~ga~~n~-~d~~g~t~lh~A~~~~----~~~~~~~Ll~~ga~~~ 100 (352)
+|+|. +.++..|+||||+|+.. ++.+++++|+++|+|+|. .|..|.||||+|+..+ +.+++++|+++|++++
T Consensus 133 ~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn 212 (494)
T PHA02989 133 KGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEKTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIE 212 (494)
T ss_pred CCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccccccCCChHHHHHhcccccccHHHHHHHHhCCCCcc
Confidence 56777 67778888889887653 578888888888888887 5677888888887654 7788888888877665
Q ss_pred CC--------------------------------------CCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCcc
Q 018682 101 PK--------------------------------------DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (352)
Q Consensus 101 ~~--------------------------------------~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~ 137 (352)
.+ |..|.||||+|+..++.+++++|++.|+++.....
T Consensus 213 ~~~~~~~t~l~~~~~~~~~~~~~~~~il~~l~~~advn~~d~~G~TpL~~Aa~~~~~~~v~~LL~~Gadin~~d~ 287 (494)
T PHA02989 213 TNNNGSESVLESFLDNNKILSKKEFKVLNFILKYIKINKKDKKGFNPLLISAKVDNYEAFNYLLKLGDDIYNVSK 287 (494)
T ss_pred ccCCccccHHHHHHHhchhhcccchHHHHHHHhCCCCCCCCCCCCCHHHHHHHhcCHHHHHHHHHcCCCccccCC
Confidence 43 44588888888888888888888888888754443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.4e-16 Score=128.01 Aligned_cols=135 Identities=23% Similarity=0.221 Sum_probs=93.9
Q ss_pred ceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHH---------------------HHHHHHHHhcCCCC--ce
Q 018682 160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NV 212 (352)
Q Consensus 160 ~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~i 212 (352)
.+.||+|+||.||. +|++||+|++............. ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999998874 58899999887543221111111 13566666666433 24
Q ss_pred eeeeEEEEeCCceEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCC
Q 018682 213 VQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG 290 (352)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~ 290 (352)
++.++. ...+++|||++++.+.. .+.... . ..++..++.+++.++.++|+ .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 454443 24589999998844321 111111 1 16677899999999999999 88 99999999999999 88
Q ss_pred CEEEEccCCccccc
Q 018682 291 NLKVADFGVSKLLT 304 (352)
Q Consensus 291 ~vkL~Dfg~a~~~~ 304 (352)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-16 Score=104.23 Aligned_cols=55 Identities=53% Similarity=0.668 Sum_probs=29.8
Q ss_pred HHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 59 Ll~~g-a~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
||++| +++|.+|..|.||||+||.+|+.+++++|++.|++++.+|..|+||+|+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 56777 88888888888888888888888888888888888888888888888876
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=150.79 Aligned_cols=130 Identities=30% Similarity=0.282 Sum_probs=102.2
Q ss_pred CcccccccccccCCchh-hhhhhhcCCCCCCCccCCchHHHHHHhcC-CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018682 6 PVRTTLLKQSSLAPDRE-RKEAELNGLDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (352)
Q Consensus 6 ~~~~~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~g~t~l~~a~~~~-~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~ 83 (352)
.+.||+-.......... ..-..-.|.|.+..+.+|+||||+|+..| +.++++.|++.|+++|.+|..|+||||+|+..
T Consensus 272 ~g~TpLh~Aa~~~~~~~iv~lLl~~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~ 351 (682)
T PHA02876 272 CKNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTL 351 (682)
T ss_pred CCCCHHHHHHhCCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHh
Confidence 45566655444333211 11122367777888888999999999988 58999999999999999999999999999885
Q ss_pred -CCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 84 -GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 84 -~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
++.+++++|+++|++++.+|..|.||||+|+..++.+++++|+++|+++...
T Consensus 352 ~~~~~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~ 404 (682)
T PHA02876 352 DRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEAL 404 (682)
T ss_pred CCcHHHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccc
Confidence 4788889999999999999999999999999999999999999998887443
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=146.71 Aligned_cols=102 Identities=16% Similarity=0.180 Sum_probs=88.6
Q ss_pred CCC-CCccCCchHHHHHHhcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCCC--CCCCC
Q 018682 32 DDD-GEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGAD--VDPKD 103 (352)
Q Consensus 32 ~~~-~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~--~~~~~~~Ll~~ga~--~~~~~ 103 (352)
+.| .+|.+|+||||+|+..| +.+++++|+++|||+|++|..|+||||+|+..+ +.+++++|+++|++ ++..+
T Consensus 32 ~in~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~ 111 (672)
T PHA02730 32 NLSKHIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTS 111 (672)
T ss_pred chhhhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccccc
Confidence 444 67778999999999987 599999999999999999999999999999976 79999999999654 57778
Q ss_pred CCCCChhHHhhc--cCcHHHHHHHHH-cCCCCC
Q 018682 104 RWGSTPLGDAIY--YKNHEVIKLLEK-HGAKPL 133 (352)
Q Consensus 104 ~~g~t~l~~a~~--~~~~~~~~~L~~-~~~~~~ 133 (352)
.-+.+|++.++. .++.+++++|+. .++++.
T Consensus 112 ~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~ 144 (672)
T PHA02730 112 NINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPS 144 (672)
T ss_pred ccCCchHHHHHHhcCCcHHHHHHHHHhcCCChh
Confidence 778999998877 888999999996 556653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.2e-16 Score=135.02 Aligned_cols=138 Identities=22% Similarity=0.287 Sum_probs=105.0
Q ss_pred CCCceeeeeEEEEe---------------------------CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 018682 208 RHPNVVQFLGAVTQ---------------------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260 (352)
Q Consensus 208 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~ 260 (352)
+|||||+++.+|.+ ...+|+||..+ ..+|..|+..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999988753 23589999988 469999997654 56777778899999
Q ss_pred HHHHHHHhCCCCCceecCCCCCCeEeCCC--C--CEEEEccCCcccccccCCC-----CcccCCCCCccccccccCCCC-
Q 018682 261 RGMNYLHENKPVPIIHRDLEPSNILRDDS--G--NLKVADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEE- 330 (352)
Q Consensus 261 ~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~--~vkL~Dfg~a~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~- 330 (352)
+|+.|||.+| |.|||+|++|||+.-+ + .+.++|||++-.-.+..-+ ..-...|....||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 9999999999998633 3 4789999987543221111 112345677789999986432
Q ss_pred ----C-CCchhHHHHHHHHHHhhcc
Q 018682 331 ----Y-DTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 331 ----~-~~~~DiwslG~il~elltG 350 (352)
. -.++|.|+.|.+.||+|+-
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~ 453 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGR 453 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhcc
Confidence 1 1379999999999999863
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=138.81 Aligned_cols=108 Identities=18% Similarity=0.066 Sum_probs=90.0
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC------CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD------IDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d------~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~ 102 (352)
+|+|.+.+ ++.||||.|+..++.+++++|+++|++.+... ..|.||+|.|+..++.+++++|+++||++|.+
T Consensus 140 ~GADIn~~--~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~k 217 (437)
T PHA02795 140 HGAVIYKI--ECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQL 217 (437)
T ss_pred CCCCCCCC--CCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcC
Confidence 66666653 44788999888889999999998887533222 34788999999999999999999999999999
Q ss_pred CCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCccc
Q 018682 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (352)
Q Consensus 103 ~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~ 138 (352)
|..|.||||+|+..|+.+++++|+++|+++......
T Consensus 218 D~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~ 253 (437)
T PHA02795 218 DAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSN 253 (437)
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCC
Confidence 999999999999999999999999999998554433
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.8e-16 Score=126.11 Aligned_cols=103 Identities=25% Similarity=0.331 Sum_probs=82.6
Q ss_pred CCCCCccCCchHHHHHHhcCCHHHHHHHHHcCC--C-----CCCCCCCCCcHHHHHHHcCCHH---HHHHHHHCCCCCCC
Q 018682 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGI--D-----VNFRDIDNRTALHVAACQGFTE---VVSLLLERGADVDP 101 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga--~-----~n~~d~~g~t~lh~A~~~~~~~---~~~~Ll~~ga~~~~ 101 (352)
..+..+.+|.||||+||..|+. +++++..++ + ++.+|.+|+||||+|+..|+.+ ++++|+++|++++.
T Consensus 9 ~~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~ 86 (154)
T PHA02736 9 FASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADING 86 (154)
T ss_pred HHHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccc
Confidence 3445667899999999999984 344433322 2 3456889999999999999874 68899999999999
Q ss_pred CC-CCCCChhHHhhccCcHHHHHHHHHc-CCCCCCCc
Q 018682 102 KD-RWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMAP 136 (352)
Q Consensus 102 ~~-~~g~t~l~~a~~~~~~~~~~~L~~~-~~~~~~~~ 136 (352)
+| ..|.||||+|+..++.+++++|+.. ++++....
T Consensus 87 ~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~ 123 (154)
T PHA02736 87 KERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILN 123 (154)
T ss_pred cCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCcccc
Confidence 98 5999999999999999999999974 77764433
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=144.24 Aligned_cols=100 Identities=29% Similarity=0.346 Sum_probs=92.9
Q ss_pred CCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CC-CCCCCCCCCCCChhH
Q 018682 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RG-ADVDPKDRWGSTPLG 111 (352)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~-~g-a~~~~~~~~g~t~l~ 111 (352)
+.+|.+|.||||+||..|+.++++.|+..||++|.++.++.||||.||.+|+.+.++-|++ .| ...|..|..|.||||
T Consensus 267 ~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLH 346 (929)
T KOG0510|consen 267 NDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLH 346 (929)
T ss_pred hcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchh
Confidence 3566788899999999999999999999999999999999999999999999999999999 43 557889999999999
Q ss_pred HhhccCcHHHHHHHHHcCCCCC
Q 018682 112 DAIYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~~~~~ 133 (352)
+|+..|+.++++.|++.|+...
T Consensus 347 laa~~gH~~v~qlLl~~GA~~~ 368 (929)
T KOG0510|consen 347 LAAKSGHDRVVQLLLNKGALFL 368 (929)
T ss_pred hhhhcCHHHHHHHHHhcChhhh
Confidence 9999999999999999998765
|
|
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=99.92 Aligned_cols=54 Identities=39% Similarity=0.524 Sum_probs=45.1
Q ss_pred CchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH
Q 018682 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (352)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll 93 (352)
|+||||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 689999999999999999999999999999999999999999999999999986
|
... |
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.1e-16 Score=106.90 Aligned_cols=75 Identities=23% Similarity=0.260 Sum_probs=50.3
Q ss_pred cCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 018682 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (352)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 112 (352)
..|+||||+||-.|+.+++++|+..||+++.+|++|-|||.-|++.|+.++|++|++.||+-..+..+|.+.+..
T Consensus 32 ~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~~~~ea 106 (117)
T KOG4214|consen 32 YGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGTALIEA 106 (117)
T ss_pred hCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCchhHHhh
Confidence 356666777666666667776666666766666667777766666667777777776666666666666655543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-15 Score=118.63 Aligned_cols=132 Identities=19% Similarity=0.182 Sum_probs=107.0
Q ss_pred CceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CceeeeeEEEEeCCceEEEEeccC
Q 018682 159 NSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 159 ~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
+.+.||+|.++.+| ..+..+++|....... ...+..|+..++.+++ .++++++.++...+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 34678999998776 3456899999865432 3568889999999976 589999988888788999999998
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
+..+..+ +......++.++++++..+|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777644 4566677889999999999985322399999999999999988999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-16 Score=152.99 Aligned_cols=194 Identities=27% Similarity=0.412 Sum_probs=157.2
Q ss_pred CCcccCceeecccEEEEEE------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceE
Q 018682 154 ELDFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 226 (352)
...|...+.||+|+|+.+. .....+|.|.+.... ...........|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5577788889999998664 223457777666543 23444456667888888887 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCCCCCCeEeCCCC-CEEEEccCCccc
Q 018682 227 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKL 302 (352)
Q Consensus 227 lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~ 302 (352)
+.+++..++++.+.+ .... ..+...+..++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .+++.|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999998888 4443 4677788889999999999999 888 99999999999999999 999999999987
Q ss_pred ccc--cCCCCcccCCC-CCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
+.. ..........| ++.|+|||...+. ...+..|+||+|+++.-+++|.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~ 227 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGE 227 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCC
Confidence 765 22233344556 8999999998884 4467899999999999999986
|
|
| >cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.8e-14 Score=110.26 Aligned_cols=97 Identities=45% Similarity=0.606 Sum_probs=90.9
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhc
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~ 115 (352)
++.+|.||||+|+..++.++++.|++.|++.+.++..|.||||.|+..++.+++++|++.|++++..+..|.||+|+|+.
T Consensus 3 ~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~ 82 (126)
T cd00204 3 RDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAAR 82 (126)
T ss_pred cCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcHHHHHHHHHcCCCC
Q 018682 116 YKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 116 ~~~~~~~~~L~~~~~~~ 132 (352)
.++.+++++|...+.+.
T Consensus 83 ~~~~~~~~~L~~~~~~~ 99 (126)
T cd00204 83 NGNLDVVKLLLKHGADV 99 (126)
T ss_pred cCcHHHHHHHHHcCCCC
Confidence 99999999999987443
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. |
| >PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=142.63 Aligned_cols=87 Identities=44% Similarity=0.555 Sum_probs=84.8
Q ss_pred hHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHH
Q 018682 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (352)
Q Consensus 42 t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~ 121 (352)
+.|+.||..|+.++++.|+++|+|+|.+|.+|+||||+||.+|+.+++++|+++|++++.+|..|.||||+|+..++.++
T Consensus 84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i 163 (664)
T PTZ00322 84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV 163 (664)
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence 45889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHc
Q 018682 122 IKLLEKH 128 (352)
Q Consensus 122 ~~~L~~~ 128 (352)
+++|+.+
T Consensus 164 v~~Ll~~ 170 (664)
T PTZ00322 164 VQLLSRH 170 (664)
T ss_pred HHHHHhC
Confidence 9999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.3e-15 Score=139.38 Aligned_cols=145 Identities=30% Similarity=0.512 Sum_probs=118.1
Q ss_pred HhcCCCCceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 018682 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (352)
Q Consensus 204 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~ 282 (352)
|+.+.|.|+.++++.+.++..++.|.+||..|+|.+.+... -.++......++++++.||.|+|... + -.|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccc
Confidence 46788999999999999999999999999999999999873 34777777789999999999999875 2 299999999
Q ss_pred CeEeCCCCCEEEEccCCccccccc-CCCCcccCCCCCccccccccCCC-------CCCCchhHHHHHHHHHHhhcc
Q 018682 283 NILRDDSGNLKVADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 283 Nill~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~elltG 350 (352)
|.+++....+||+|||+....... ............-|.|||.+... ..+.+.|+||+|++++|+++.
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999998765321 11111122234569999998763 146679999999999999874
|
|
| >KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4e-15 Score=134.87 Aligned_cols=57 Identities=40% Similarity=0.514 Sum_probs=40.6
Q ss_pred HHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 80 A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|+.+|..+++++|+.+|.+++.+|.+|+||||.|+.+|..+++++|+++++++....
T Consensus 205 Aaa~Gy~e~~~lLl~ag~~~~~~D~dgWtPlHAAA~Wg~~~~~elL~~~ga~~d~~t 261 (527)
T KOG0505|consen 205 AAANGYTEVAALLLQAGYSVNIKDYDGWTPLHAAAHWGQEDACELLVEHGADMDAKT 261 (527)
T ss_pred HHhhhHHHHHHHHHHhccCcccccccCCCcccHHHHhhhHhHHHHHHHhhcccchhh
Confidence 444444456777777777777777778888888888888888888888777764443
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.2e-15 Score=146.58 Aligned_cols=113 Identities=35% Similarity=0.431 Sum_probs=99.4
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 110 (352)
...+.....|-|+||.|+..+...+++.++++|++++.++.+|+||||.||.+|+.++|++|+++|||++.+++.|+|||
T Consensus 498 ~~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPL 577 (1143)
T KOG4177|consen 498 ANDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPL 577 (1143)
T ss_pred CccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChh
Confidence 44455556777788888888888888888889999999999999999999999999999999999999999999999999
Q ss_pred HHhhccCcHHHHHHHHHcCCCCCCCcccccccc
Q 018682 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (352)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~ 143 (352)
|.|+..|+.+++.+|+++|+++.-......++.
T Consensus 578 H~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL 610 (1143)
T KOG4177|consen 578 HQAAQQGHNDIAELLLKHGASVNAADLDGFTPL 610 (1143)
T ss_pred hHHHHcChHHHHHHHHHcCCCCCcccccCcchh
Confidence 999999999999999999999866655554443
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.3e-15 Score=102.48 Aligned_cols=90 Identities=29% Similarity=0.517 Sum_probs=85.2
Q ss_pred HHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHH
Q 018682 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (352)
Q Consensus 43 ~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~ 122 (352)
-+.|+..+|.++-|+..+..|.|||.. ..|+||||+||-.|..+++++|+..||+++.+|+.|-|||--|++.|+.+++
T Consensus 5 ~~~W~vkNG~~DeVk~~v~~g~nVn~~-~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cV 83 (117)
T KOG4214|consen 5 SVAWNVKNGEIDEVKQSVNEGLNVNEI-YGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCV 83 (117)
T ss_pred hHhhhhccCcHHHHHHHHHccccHHHH-hCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHH
Confidence 478999999999999999999999866 4899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCC
Q 018682 123 KLLEKHGAKPL 133 (352)
Q Consensus 123 ~~L~~~~~~~~ 133 (352)
++|++.|++-.
T Consensus 84 klLL~~GAdrt 94 (117)
T KOG4214|consen 84 KLLLQNGADRT 94 (117)
T ss_pred HHHHHcCcccc
Confidence 99999999854
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=146.60 Aligned_cols=95 Identities=28% Similarity=0.472 Sum_probs=87.2
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhc
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~ 115 (352)
.++.+.++||.||..|+.++++.|++.|+|+|.+|.+|+||||+||.+|+.+++++|+++|+++|.+|..|.||||+|+.
T Consensus 521 ~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~ 600 (823)
T PLN03192 521 DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS 600 (823)
T ss_pred CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHH
Confidence 34467789999999999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred cCcHHHHHHHHHcCC
Q 018682 116 YKNHEVIKLLEKHGA 130 (352)
Q Consensus 116 ~~~~~~~~~L~~~~~ 130 (352)
.|+.+++++|...++
T Consensus 601 ~g~~~iv~~L~~~~~ 615 (823)
T PLN03192 601 AKHHKIFRILYHFAS 615 (823)
T ss_pred hCCHHHHHHHHhcCc
Confidence 888888777766554
|
|
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.9e-15 Score=138.67 Aligned_cols=104 Identities=17% Similarity=0.128 Sum_probs=82.9
Q ss_pred cCCCCCCCccCC--chHHHHHHhcCCH---HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 018682 29 NGLDDDGEEIKP--EFRLMFLANERDV---EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (352)
Q Consensus 29 ~~~~~~~~~~~g--~t~l~~a~~~~~~---~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (352)
+|+|.+.++.+| .||||.|+..... +++++|+++|||+|.+|..|+||||+|+..++.+++++|+++||+++.+|
T Consensus 361 ~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~kD 440 (631)
T PHA02792 361 NGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINITT 440 (631)
T ss_pred cCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence 566666666654 5889987776654 45788889999999999999999999999999999999999999999999
Q ss_pred CCCCChhHHhhc---cC-------cHHHHHHHHHcCCCC
Q 018682 104 RWGSTPLGDAIY---YK-------NHEVIKLLEKHGAKP 132 (352)
Q Consensus 104 ~~g~t~l~~a~~---~~-------~~~~~~~L~~~~~~~ 132 (352)
..|.||+++|.. .+ ..++++.|++++.++
T Consensus 441 ~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i 479 (631)
T PHA02792 441 KYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI 479 (631)
T ss_pred CCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence 999999999865 22 245677787777554
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.6e-15 Score=97.09 Aligned_cols=50 Identities=30% Similarity=0.351 Sum_probs=33.2
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHH
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA 80 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A 80 (352)
.|.+..|..|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|
T Consensus 7 ~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 7 ADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp --TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 67788899999999999999999999999999999999999999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 352 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-32 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-26 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-25 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-25 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-24 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-24 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-24 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-20 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-17 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-16 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-15 | ||
| 4hqd_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 5e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-14 | ||
| 4gpm_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-13 | ||
| 4gmr_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-13 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 2e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 1n0q_A | 93 | 3ank: A Designed Ankyrin Repeat Protein With Three | 3e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-13 | ||
| 4hb5_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 8e-13 | ||
| 4dui_A | 169 | Darpin D1 Binding To Tubulin Beta Chain (not In Com | 8e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 4drx_E | 169 | Gtp-Tubulin In Complex With A Darpin Length = 169 | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-12 | ||
| 4atz_D | 154 | Ad5 Knob In Complex With A Designed Ankyrin Repeat | 2e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-12 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-12 | ||
| 1mj0_A | 166 | Sank E3_5: An Artificial Ankyrin Repeat Protein Len | 6e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 2xeh_A | 157 | Structural Determinants For Improved Thermal Stabil | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 2xee_A | 157 | Structural Determinants For Improved Thermal Stabil | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-11 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 3e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 2qyj_A | 166 | Crystal Structure Of A Designed Full Consensus Anky | 3e-11 | ||
| 3zu7_B | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-11 | ||
| 3q9u_C | 158 | In Silico And In Vitro Co-Evolution Of A High Affin | 5e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-11 | ||
| 2bkg_A | 166 | Crystal Structure Of E3_19 An Designed Ankyrin Repe | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 1svx_A | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-11 | ||
| 4f6r_D | 169 | Tubulin:stathmin-Like Domain Complex Length = 169 | 9e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 2e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3utm_A | 351 | Crystal Structure Of A Mouse Tankyrase-Axin Complex | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-10 | ||
| 2p2c_P | 169 | Inhibition Of Caspase-2 By A Designed Ankyrin Repea | 6e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-10 | ||
| 2v4h_C | 136 | Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13 | 6e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-10 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 9e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 3zuv_B | 136 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3twr_A | 165 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 2e-09 | ||
| 3twq_A | 175 | Crystal Structure Of Arc4 From Human Tankyrase 2 (A | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 3twu_A | 167 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-09 | ||
| 3noc_D | 169 | Designed Ankyrin Repeat Protein (Darpin) Binders To | 3e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-09 | ||
| 2j8s_D | 169 | Drug Export Pathway Of Multidrug Exporter Acrb Reve | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2v5q_C | 167 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 3nog_D | 169 | Designed Ankyrin Repeat Protein (Darpin) Binders To | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 2y1l_E | 169 | Caspase-8 In Complex With Darpin-8.4 Length = 169 | 7e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-09 | ||
| 2bkk_B | 169 | Crystal Structure Of Aminoglycoside Phosphotransfer | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 2xen_A | 91 | Structural Determinants For Improved Thermal Stabil | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 1k1b_A | 241 | Crystal Structure Of The Ankyrin Repeat Domain Of B | 2e-08 | ||
| 3hg0_D | 136 | Crystal Structure Of A Darpin In Complex With Orf49 | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 4grg_A | 135 | Crystal Structure Of Ige Complexed With E2_79, An A | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-08 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169 | Back alignment and structure |
|
| >pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166 | Back alignment and structure |
|
| >pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136 | Back alignment and structure |
|
| >pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165 | Back alignment and structure |
|
| >pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167 | Back alignment and structure |
|
| >pdb|3NOG|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BKK|B Chain B, Crystal Structure Of Aminoglycoside Phosphotransferase Aph (3')-Iiia In Complex With The Inhibitor Ar_3a Length = 169 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XEN|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module Length = 91 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1K1B|A Chain A, Crystal Structure Of The Ankyrin Repeat Domain Of Bcl-3: A Unique Member Of The Ikappab Protein Family Length = 241 | Back alignment and structure |
|
| >pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4GRG|A Chain A, Crystal Structure Of Ige Complexed With E2_79, An Anti-Ige Inhibitor Length = 135 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-76
Identities = 83/225 (36%), Positives = 127/225 (56%), Gaps = 15/225 (6%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
P ++ + A + + +I +L+ +I G+F A W G VAVK L E+
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQ 71
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
+ RV F E+A+++++RHPN+V F+GAVTQ + IVTEYL +G L L + GA
Sbjct: 72 DFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 247 ---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L + A D+A+GMNYLH P PI+HR+L+ N+L D +KV DFG+S+
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSR-- 187
Query: 304 TVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+K L+ + + ++APEV ++E + K DV+SF +IL E
Sbjct: 188 -LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-75
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ ID E++ + +G F A WR VA+K++ + +AF EL
Sbjct: 2 LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-----ESESERKAFIVELRQ 54
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIA 260
L ++ HPN+V+ GA P+ +V EY G L L + + A+ + L +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+G+ YLH +P +IHRDL+P N+L G LK+ DFG + + +T S
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAA 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEV 347
++APEVF+ Y K DVFS+ +IL EV
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEV 196
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-72
Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALL 204
EID EL I G F AFW G +VAVK + D + R E L
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
++HPN++ G + + +V E+ G L L K + P V +A+ IARGMN
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSG--------NLKVADFGVSKLLTVKEDRPLTCQDT 316
YLH+ VPIIHRDL+ SNIL LK+ DFG+++
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAG 176
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ ++APEV + + DV+S+ ++L E+
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-68
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFW--RGIQVAVKKLGEEVISDD----DRVRAF 197
+ +E+++ +I KG F VA+K L + ++ + F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFA 256
+ E+ ++ + HPN+V+ G + P +V E++P GDL L + +K S +R
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVSKLLTVKEDRPL 311
LDIA G+ Y+ P PI+HRDL NI KVADFG+S+ +
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSV 183
Query: 312 TCQDTSCRYVAPEVF--KNEEYDTKVDVFSFALILQEV 347
+ + +++APE + E Y K D +SFA+IL +
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-67
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
ID +L+F ++ + W+G + VK L S + R F +E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 204 LQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDI 259
L+ HPNV+ LGA + ++T ++P G L L + S AV+FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
ARGM +LH +P I L +++ D+ +++ V +
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAPA 173
Query: 320 YVAPEVFKNEEYDT---KVDVFSFALILQE 346
+VAPE + + DT D++SFA++L E
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-66
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
E++I +L+ I KG F W G +VA++ + E ++D+++AF+ E+
Sbjct: 27 EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
++ RH NVV F+GA + I+T L + + K L + + A +I +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV----KEDRPLTCQDTSC 318
M YLH I+H+DL+ N+ D+ G + + DFG+ + V + + L Q+
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 319 RYVAPEVFKNEE---------YDTKVDVFSFALILQE 346
++APE+ + + DVF+ I E
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-66
Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 27/222 (12%)
Query: 145 VPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRD 199
+P P +L + KG F I R G + +K+L D++ R F
Sbjct: 2 MPHRIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLK 56
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALD 258
E+ +++ + HPNV++F+G + + + +TEY+ G LR +K S V FA D
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
IA GM YLH IIHRDL N L ++ N+ VADFG+++L+ ++ +P +
Sbjct: 117 IASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 317 -----------SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ ++APE+ YD KVDVFSF ++L E+
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-64
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L +++AF++E+ +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
M+YLH IIHRDL+ +NI + +K+ DFG++ + Q + S ++
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 322 APEVFKNEE---YDTKVDVFSFALILQE 346
APEV + ++ Y + DV++F ++L E
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYE 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-59
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++ +I KG + + WRG +VAVK + ++ E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 204 LQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + ++T+Y G L +LK L + ++ A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
G+ +LH I HRDL+ NIL +G +AD G++ +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 315 DTSC---RYVAPEV------FKNEEYDTKVDVFSFALILQEV 347
+T RY+ PEV + + D++SF LIL EV
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-57
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
+ KG + W+G VAVK R EL +RH N++ F+ +
Sbjct: 16 VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIASD 71
Query: 220 TQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV--- 272
S + ++T Y G L +L+ L + +R L IA G+ +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 273 --PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK 327
I HRDL+ NIL +G +AD G++ + + ++ + RY+APEV
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 328 NE------EYDTKVDVFSFALILQEV 347
+ +VD+++F L+L EV
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEV 216
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 4e-55
Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 28/222 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ I KG F WRG +VAVK R E+
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQ 89
Query: 204 LQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + +V++Y G L +L R + ++ AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 148
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
A G+ +LH I HRDL+ NIL +G +AD G++ D
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 315 DTSC---RYVAPEVFKNE------EYDTKVDVFSFALILQEV 347
+ RY+APEV + E + D+++ L+ E+
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 27/222 (12%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
L +G F A VAVK + D + E+
Sbjct: 17 ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVY 70
Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
L ++H N++QF+GA + + + ++T + KG L FLK + + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129
Query: 259 IARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
+ARG+ YLHE+ P I HRD++ N+L ++ +ADFG++ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 312 TCQDT-SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEV 347
T + RY+APEV + ++D+++ L+L E+
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-51
Identities = 58/234 (24%), Positives = 90/234 (38%), Gaps = 39/234 (16%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E +D L I +G + VAVK S +R + F +E
Sbjct: 4 AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVF-----SFANR-QNFINE 55
Query: 201 LA--LLQKIRHPNVVQFLGA-----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
+ + H N+ +F+ ++V EY P G L +L ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 254 RFALDIARGMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
R A + RG+ YLH P I HRDL N+L + G ++DFG+S LT
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 308 DRPLTCQDTSC-------RYVAPEVFKN-------EEYDTKVDVFSFALILQEV 347
+D + RY+APEV + E +VD+++ LI E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-48
Identities = 59/240 (24%), Positives = 114/240 (47%), Gaps = 16/240 (6%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
+ + + + A P + ++E++ ++ + ++ G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEG 239
Query: 172 FWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
W+ + VAVK L E+ + ++ F E A++++I+HPN+VQ LG T+ P I+T
Sbjct: 240 VWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 230 EYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
E++ G+L +L+ + + + A I+ M YL + IHR+L N L
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVG 352
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ +KVADFG+S+L+T ++ APE ++ K DV++F ++L E+
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-47
Identities = 67/233 (28%), Positives = 100/233 (42%), Gaps = 22/233 (9%)
Query: 127 KHGAKPLMAPMHVKHAREVP--EYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVA 179
+PL V R VP ++ ++ +L +I +G F R VA
Sbjct: 86 LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVA 143
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
VK E + D F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 144 VKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 240 FLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
FL+ L+ T ++ D A GM YL IHRDL N L + LK++DFG
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG 258
Query: 299 VSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+S+ D ++ APE Y ++ DV+SF ++L E
Sbjct: 259 MSREE---ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-46
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 200
++E++ ++ + ++ G + W+ + VAVK L E+ + ++ F E
Sbjct: 6 DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALD 258
A++++I+HPN+VQ LG T+ P I+TE++ G+L +L+ + + + A
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ APE ++ K DV++F ++L E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 68/209 (32%), Positives = 112/209 (53%), Gaps = 20/209 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
++ IDP EL F EI G F L +W +VA+K + E +S++D F +E
Sbjct: 2 KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ K+ HP +VQ G + +P+ +VTE++ G L +L+ ++G T + LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
GM YL E +IHRDL N L ++ +KV+DFG+++ + D T +
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPV 169
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ +PEVF Y +K DV+SF +++ EV
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEV 198
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
+ ++ EL I KG F +L +RG +VAVK + + + F E +
Sbjct: 14 SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----FLAEAS 66
Query: 203 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ + L ++F+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---PLTCQDT 316
M YL N +HRDL N+L + KV+DFG++K + +D P+
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV----- 178
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ APE + +++ TK DV+SF ++L E+
Sbjct: 179 --KWTAPEALREKKFSTKSDVWSFGILLWEI 207
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-45
Identities = 69/227 (30%), Positives = 116/227 (51%), Gaps = 26/227 (11%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
K + + + + ++ EL I KG F +L +RG +VAVK
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK----- 222
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLKRKG 245
I +D +AF E +++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ +G
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 246 --ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L ++F+LD+ M YL N +HRDL N+L + KV+DFG++K
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 304 TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ +D P+ ++ APE + +++ TK DV+SF ++L E+
Sbjct: 340 SSTQDTGKLPV-------KWTAPEALREKKFSTKSDVWSFGILLWEI 379
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EIDP +L F E+ G F WRG VA+K + E +S+D+ F +E
Sbjct: 18 SWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAK 71
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ + H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
M YL + +HRDL N L +D G +KV+DFG+S+ + D T S
Sbjct: 132 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPV 185
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
R+ PEV ++ +K D+++F +++ E+
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 23/252 (9%)
Query: 114 IYYKNH--EVIKLLEKHGAKPLMAPMHVKHAREVPEY-------EIDPHELDFTNSV--- 161
+++ +H + L G P H E P EI+ + +
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 162 ---EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ G + R + VA+K L + + R F E +++ + HPN+++ G
Sbjct: 61 DSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
VT+ MIVTEY+ G L FL+ G V + GM YL + +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKV 335
DL N+L D + KV+DFG+S++L D T R+ APE + +
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 336 DVFSFALILQEV 347
DV+SF +++ EV
Sbjct: 236 DVWSFGVVMWEV 247
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-44
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALL 204
E+ E+ E+ G F L W+G VAVK + E +S+D+ F E +
Sbjct: 4 ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +V+F G ++ P+ IVTEY+ G L +L+ L+PS + D+ GM
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRY 320
+L ++ IHRDL N L D +KV+DFG+++ + D + ++
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKW 171
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEV 347
APEVF +Y +K DV++F +++ EV
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEV 198
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 8e-44
Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 18/239 (7%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
YY H L +EI L ++ +G F +
Sbjct: 148 YYSKHA--DGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMG 203
Query: 172 FWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
W G +VA+K L +S + F E +++K+RH +VQ V++ P+ IVTE
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258
Query: 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
Y+ KG L FLK + L+ V A IA GM Y+ +HRDL +NIL +
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGE 315
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ KVADFG+++L+ E ++ APE + K DV+SF ++L E+
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-44
Identities = 60/248 (24%), Positives = 114/248 (45%), Gaps = 24/248 (9%)
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---IL 170
++ +H + A R+ + + L F ++ KG F +
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSAFEDRD--PTQFEERHLKFLQ--QLGKGNFGSVEM 59
Query: 171 AFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223
+ VAVKKL S ++ +R F E+ +L+ ++H N+V++ G +
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116
Query: 224 -PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ ++ EYLP G LR +L++ K + +++ I +GM YL + IHRDL
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLAT 173
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL ++ +K+ DFG++K+L ++ + ++ + APE ++ DV+S
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233
Query: 340 FALILQEV 347
F ++L E+
Sbjct: 234 FGVVLYEL 241
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W G +VA+K L +S + F E
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEV 347
APE + K DV+SF ++L E+
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTEL 457
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ + L F ++ KG F + + VAVKKL S ++ +R F
Sbjct: 4 PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDF 58
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
E+ +L+ ++H N+V++ G + + ++ EYLP G LR +L++ K + ++
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
+ I +GM YL + IHRDL NIL ++ +K+ DFG++K+L ++ +
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ + APE ++ DV+SF ++L E+
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-43
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ L + + ++ KG F L + VAVK+L S D+ R F
Sbjct: 17 PTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDF 71
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVR 254
+ E+ +L+ + +V++ G + +V EYLP G LR FL + + L S +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
++ I +GM YL + +HRDL NIL + ++K+ADFG++KLL + +D
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ + APE + + + DV+SF ++L E+
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ G +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK L + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-- 317
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ ED T ++ +
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKF 172
Query: 318 -CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ APE + K DV+SF ++L E+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-42
Identities = 56/218 (25%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRV 194
EV + L ++ +G F L + G QVAVK L E S + +
Sbjct: 12 EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKR-KGALKPST 251
+ E+ +L+ + H N+V++ G T+ + + ++ E+LP G L+ +L + K +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
+++A+ I +GM+YL + +HRDL N+L + +K+ DFG++K + ++
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+D+ + APE ++ DV+SF + L E+
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVRAFR 198
I +L ++ G+F W + VAVK L +V+S + + F
Sbjct: 12 TCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 257
E+ + + H N+++ G V PM +VTE P G L L+ +G T R+A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
+A GM YL + IHRDL N+L +K+ DFG+ + L +D + +
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 317 -SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ APE K + D + F + L E+
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-42
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
EI P + I G F + + VA+K L ++ R F
Sbjct: 38 TTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQR-VDF 93
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E ++ + H N+++ G +++ PMMI+TEY+ G L FL+ + G V
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 317 SC--RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
R+ APE ++ + DV+SF +++ EV
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 149 EIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+D + V E+ G L + I VA+K L + + R F E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIAR 261
++ + HPN+++ G VT+S P+MIVTEY+ G L +FL K V IA
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 319
GM YL + +HRDL NIL + + KV+DFG+ ++L + T + R
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ +PE ++ + DV+S+ ++L EV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEV 243
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRD 199
E +D L + E+ G F +++ VAVK L E +D
Sbjct: 10 EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E ++Q++ +P +V+ +G M+V E G L +L++ +K + +
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---------P 310
+ GM YL E+ +HRDL N+L K++DFG+SK L E+ P
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ ++ APE ++ +K DV+SF +++ E
Sbjct: 184 V-------KWYAPECINYYKFSSKSDVWSFGVLMWEA 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 23/234 (9%)
Query: 127 KHGAKPLM-------APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG- 175
K G L + E +EI L ++ G F +A +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKH 212
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + +S + F E +++ ++H +V+ VT+ P+ I+TE++ KG
Sbjct: 213 TKVAVKTMKPGSMSVEA----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKG 267
Query: 236 DLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
L FLK + F+ IA GM ++ + IHRDL +NIL S K
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 324
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ADFG+++++ E ++ APE + K DV+SF ++L E+
Sbjct: 325 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 22/229 (9%)
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGE 185
++ ++ + + V I P L + I +G F I AVK L
Sbjct: 4 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-KR 243
I+D V F E +++ HPNV+ LG +S ++V Y+ GDLR F+
Sbjct: 64 --ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
+ F L +A+GM YL K +HRDL N + D+ +KVADFG+++
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD- 177
Query: 304 TVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ + + + + +++A E + +++ TK DV+SF ++L E+
Sbjct: 178 -MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
L ++ +G F L + VAVK L + + ++
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82
Query: 200 ELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
E+ +L+ + H +++++ G + + + +V EY+P G LR +L + ++ + + FA
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQD 315
I GM YLH IHRDL N+L D+ +K+ DFG++K + + R D
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ + APE K ++ DV+SF + L E+
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 22/247 (8%)
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAF 172
E + + ++ ++ + + V I P L + I +G F
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109
Query: 173 WRG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMM 226
I AVK L I+D V F E +++ HPNV+ LG +S +
Sbjct: 110 LLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167
Query: 227 IVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V Y+ GDLR F+ + F L +A+GM +L K +HRDL N +
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCM 224
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSF 340
D+ +KVADFG+++ + + + + + +++A E + +++ TK DV+SF
Sbjct: 225 LDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282
Query: 341 ALILQEV 347
++L E+
Sbjct: 283 GVLLWEL 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-41
Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ +EI +G+F ++VA +L + ++ +R + F++E +
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEM 78
Query: 204 LQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
L+ ++HPN+V+F + V +++VTE + G L+ +LKR +K + I
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+G+ +LH P PIIHRDL+ NI +G++K+ D G++ L + T
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPE 195
Query: 319 RYVAPEVFKNEEYDTKVDVFSF 340
++APE+++ E+YD VDV++F
Sbjct: 196 -FMAPEMYE-EKYDESVDVYAF 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 50/193 (25%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTK 334
N+L ++K+ DFG++KLL +E P+ +++A E + Y +
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-------KWMALESILHRIYTHQ 199
Query: 335 VDVFSFALILQEV 347
DV+S+ + + E+
Sbjct: 200 SDVWSYGVTVWEL 212
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
EV + I + + I KG F + IQ A+K L I++ +V
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVE 67
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
AF E L++ + HPNV+ +G + + ++ Y+ GDL F++ + +
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
F L +ARGM YL E K +HRDL N + D+S +KVADFG+++ + + +
Sbjct: 128 SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSV 182
Query: 314 QDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
Q ++ A E + + TK DV+SF ++L E+
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-------- 309
++ GM YL E +HRDL N+L + K++DFG+SK L +
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
PL ++ APE ++ ++ DV+S+ + + E
Sbjct: 175 WPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEA 206
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 48/214 (22%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 144 EVPEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAF 197
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL+ RK +L ++ + +A
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
++ + YL + +HRD+ N+L + +K+ DFG+S+ + ED
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASK 176
Query: 317 S---CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++APE + + DV+ F + + E+
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-40
Identities = 58/244 (23%), Positives = 103/244 (42%), Gaps = 32/244 (13%)
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQV 178
H + L+ + ++ + ID + L + +G F + + ++V
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEYLP 233
AVK + + S + F E A ++ HPNV++ LG + S M++ ++
Sbjct: 66 AVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 234 KGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
GDL +L + T ++F +DIA GM YL +HRDL N +
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALI 343
D + VADFG+SK + Q +++A E + Y +K DV++F +
Sbjct: 182 DDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 344 LQEV 347
+ E+
Sbjct: 239 MWEI 242
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-40
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
P+Y I ++ + E+ +G + I VAVK ++ D F
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +++ + HP++V+ +G + + P I+ E P G+L +L+R K +LK T V ++L
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS- 317
I + M YL +HRD+ NIL +K+ DFG+S+ + ED +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTR 175
Query: 318 --CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++++PE + T DV+ FA+ + E+
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEI 207
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-40
Identities = 47/198 (23%), Positives = 77/198 (38%), Gaps = 13/198 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F + G++ + G AVK+ DR R + + + +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN 269
V+ A + + + TE L+ + GA L + + D + +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++H D++P+NI G K+ DFG+ L + RY+APE+
Sbjct: 177 G---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGD-PRYMAPELL-QG 230
Query: 330 EYDTKVDVFSFALILQEV 347
Y T DVFS L + EV
Sbjct: 231 SYGTAADVFSLGLTILEV 248
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-40
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EL + G F W I V +K + ++ S +A D
Sbjct: 9 IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
+ + + H ++V+ LG S + +VT+YLP G L ++ +GAL P + + +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTS 317
IA+GM YL E+ ++HR+L N+L ++VADFGV+ LL + + T
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++A E +Y + DV+S+ + + E+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWEL 210
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 45/174 (25%), Positives = 92/174 (52%), Gaps = 7/174 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 49 GRQYVIKEINISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 235 GDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL + + + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
++ DFG++++L + C T Y++PE+ +N+ Y+ K D+++ +L E
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPYNNKSDIWALGCVLYE 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-40
Identities = 70/243 (28%), Positives = 112/243 (46%), Gaps = 47/243 (19%)
Query: 138 HVKHAREVPEY----EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEE 186
H H + P+ +D +++ F + I +G F + A + + A+K++ E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 187 VISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK- 244
S DD R F EL +L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 64 A-SKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 245 ---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L + FA D+ARGM+YL + + IHRDL NIL ++
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178
Query: 290 GNLKVADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
K+ADFG+S+ V + P+ R++A E Y T DV+S+ ++L
Sbjct: 179 YVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 345 QEV 347
E+
Sbjct: 232 WEI 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 51/239 (21%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
FG+++ + VK + P+ +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
++ + I + + KG F A + ++VAVK L ++I+ D
Sbjct: 14 KLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-E 70
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLKR------ 243
F E A +++ HP+V + +G +S M++ ++ GDL AFL
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L T VRF +DIA GM YL IHRDL N + + + VADFG+S
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS--- 184
Query: 304 TVKEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
R + D +++A E + Y DV++F + + E+
Sbjct: 185 -----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-39
Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
G + K+L +++ ++ E+ LL++++HPN+V++ + ++ + IV EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 233 PKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVP--IIHRDLEPSNILR 286
GDL + + + + L +R + + H ++HRDL+P+N+
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
D N+K+ DFG++++L T T Y++PE Y+ K D++S +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFVGTPY-YMSPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-39
Identities = 49/190 (25%), Positives = 95/190 (50%), Gaps = 17/190 (8%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKVDV 337
N+L ++K+ DFG++KLL +E +++A E + Y + DV
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 338 FSFALILQEV 347
+S+ + + E+
Sbjct: 203 WSYGVTVWEL 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 43/233 (18%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ +VAVK L + D
Sbjct: 39 EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL ++ + +H N+V LGA T P++++TEY GDL FL+RK
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+ F+ +A+GM +L IHRD+ N+L + K+ DFG++
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 301 KLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ + VK + L +++APE + Y + DV+S+ ++L E+
Sbjct: 212 RDIMNDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 58/245 (23%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
P++E L + +G F + A + VAVK L E + +R
Sbjct: 16 PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELR 71
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------- 244
E +L+++ HP+V++ GA +Q P++++ EY G LR FL+
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
AL + FA I++GM YL E K ++HRDL NIL +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD----TSC-----RYVAPEVFKNEEYDTKVDVFSFAL 342
+K++DFG+S R + +D S +++A E + Y T+ DV+SF +
Sbjct: 189 MKISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 ILQEV 347
+L E+
Sbjct: 241 LLWEI 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 51/270 (18%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
++ + I E + ++A + E P +E+ L + +G F +LA
Sbjct: 31 HHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAFGQVVLA 88
Query: 172 FWRGI---------QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221
G+ +VAVK L + ++ D E+ +++ I +H N++ LGA TQ
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLKSDA-TEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNY 265
P+ ++ EY KG+LR +L+ + L V A +ARGM Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTS 317
L K IHRDL N+L + +K+ADFG+++ + + P+
Sbjct: 207 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV------ 257
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++APE + Y + DV+SF ++L E+
Sbjct: 258 -KWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 50/234 (21%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+E+ ++ + E+ +G+F +G+ +VA+K + E S +R
Sbjct: 18 DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER-I 73
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------G 245
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
S ++ A +IA GM YL+ NK +HRDL N + + +K+ DFG++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT----- 185
Query: 306 KEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEV 347
R + D Y +PE K+ + T DV+SF ++L E+
Sbjct: 186 ---RDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 47/224 (20%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRG---------IQVAVKKLGEEVISDDDRVR 195
++I +L F + +GTF R +V +K L + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
+F + +++ K+ H ++V G ++V E++ G L +LK+ K + +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNIL--------RDDSGNLKVADFGVSKLLTVK 306
A +A M++L EN +IH ++ NIL + +K++D G+S + K
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 307 E--DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEV 347
+ + +V PE +N + + D +SF L E+
Sbjct: 175 DILQERI-------PWVPPECIENPKNLNLATDKWSFGTTLWEI 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 69/270 (25%), Positives = 110/270 (40%), Gaps = 64/270 (23%)
Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---- 176
LL++ P+ M + ++ E + +++ +I +G F A G+
Sbjct: 18 LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYE 75
Query: 177 ---QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK L EE S D + F+ E AL+ + +PN+V+ LG PM ++ EY+
Sbjct: 76 PFTMVAVKMLKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 234 KGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHEN 269
GDL FL+ L + + A +A GM YL E
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV-------- 321
K +HRDL N L ++ +K+ADFG+S R + D Y
Sbjct: 194 K---FVHRDLATRNCLVGENMVVKIADFGLS--------RNIYSADY---YKADGNDAIP 239
Query: 322 ----APEVFKNEEYDTKVDVFSFALILQEV 347
PE Y T+ DV+++ ++L E+
Sbjct: 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 46/194 (23%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G F A G+ VA+KK+ + D E+ LL+++ HPNV+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPV 272
+ + + + IV E GDL +K + T ++ + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
++HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGYN 214
Query: 333 TKVDVFSFALILQE 346
K D++S +L E
Sbjct: 215 FKSDIWSLGCLLYE 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 63/245 (25%), Positives = 100/245 (40%), Gaps = 58/245 (23%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A GI QVAVK L E+ +D
Sbjct: 38 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + FA +A+GM +L +HRDL N+L
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 210
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD-----TSC----RYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG++ R + + +++APE Y K DV+S+ +
Sbjct: 211 VKICDFGLA--------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 343 ILQEV 347
+L E+
Sbjct: 263 LLWEI 267
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 67/245 (27%), Positives = 104/245 (42%), Gaps = 51/245 (20%)
Query: 141 HAREVPEY-------EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKL 183
H E P+Y I ++ E+ +G F LA + VAVK L
Sbjct: 22 HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL FL+
Sbjct: 80 KEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136
Query: 244 ---------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
G L + A +A GM YL +HRDL N L
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193
Query: 289 SGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG+S+ + V L R++ PE ++ T+ DV+SF +
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTML-----PIRWMPPESILYRKFTTESDVWSFGV 248
Query: 343 ILQEV 347
+L E+
Sbjct: 249 VLWEI 253
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 51/254 (20%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QV 178
P++A + E P++E +L + +G F ++A GI V
Sbjct: 13 DPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ ++ D E+ +++ I +H N++ LGA TQ P+ ++ EY KG+L
Sbjct: 71 AVKMLKDDA-TEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 238 RAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
R +L+ + + V +ARGM YL K IHRDL
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185
Query: 282 SNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDT 333
N+L ++ +K+ADFG+++ + + P+ +++APE + Y
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTH 238
Query: 334 KVDVFSFALILQEV 347
+ DV+SF +++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 48/216 (22%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL-------TVKEDRPL 311
++ + YL + +HRD+ N+L + +K+ DFG+S+ + K P+
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++APE + + DV+ F + + E+
Sbjct: 557 -------KWMAPESINFRRFTSASDVWMFGVCMWEI 585
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-38
Identities = 64/237 (27%), Positives = 96/237 (40%), Gaps = 57/237 (24%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
I ++ E+ +G F LA + VAVK L + + R + F+
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---------------- 242
E LL ++H ++V+F G P+++V EY+ GDL FL+
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
KG L S + A IA GM YL +HRDL N L + +K+ DFG+S
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-- 180
Query: 303 LTVKEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEV 347
R + D Y PE ++ T+ DV+SF +IL E+
Sbjct: 181 ------RDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 44/231 (19%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
EI + F E+ + F G VA+K L ++ R FR
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--------------- 243
E L +++HPNVV LG VT+ P+ ++ Y GDL FL
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 244 -KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
K AL+P V IA GM YL + ++H+DL N+L D N+K++D G+ +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ + + L R++APE ++ D++S+ ++L EV
Sbjct: 178 VYAADYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 24 LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-LD 79
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALKP 249
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLL--- 303
+ A DIA G YL EN IHRD+ N L G K+ DFG+++ +
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 304 --TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
K P+ +++ PE F + +K D +SF ++L E+
Sbjct: 197 SYYRKGGCAMLPV-------KWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 63/255 (24%), Positives = 115/255 (45%), Gaps = 51/255 (20%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------Q 177
P++A + E P++E +L + +G F ++A GI
Sbjct: 58 DTPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVT 115
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L ++ + + + E+ +++ I +H N++ LGA TQ P+ ++ EY KG+
Sbjct: 116 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 237 LRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
LR +L+ + + V +ARGM YL K IHRDL
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230
Query: 281 PSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYD 332
N+L ++ +K+ADFG+++ + + P+ +++APE + Y
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYT 283
Query: 333 TKVDVFSFALILQEV 347
+ DV+SF +++ E+
Sbjct: 284 HQSDVWSFGVLMWEI 298
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 31/198 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------------VTQS 222
A+K++ + R + R E+ L K+ HP +V++ A +
Sbjct: 30 DCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ I + K +L+ ++ + ++ S + L IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----------CRYVAPEVFKN 328
+PSNI +KV DFG+ + E+ Y++PE
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
Query: 329 EEYDTKVDVFSFALILQE 346
Y KVD+FS LIL E
Sbjct: 205 NSYSHKVDIFSLGLILFE 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 147 EYEIDPHEL-DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+ +D DF I G F A R G +K++ + +A R E
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAER-E 54
Query: 201 LALLQKIRHPNVVQFLGA----------------VTQSSPMMIVTEYLPKGDLRAFLKRK 244
+ L K+ H N+V + G +++ + I E+ KG L +++++
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 245 GA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
L A+ I +G++Y+H K +I+RDL+PSNI D+ +K+ DFG+
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 303 LTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
L R S RY++PE +++Y +VD+++ LIL E
Sbjct: 172 LKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 61/231 (26%), Positives = 92/231 (39%), Gaps = 44/231 (19%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 64 DLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-L 119
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALK 248
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 305
+ A DIA G YL EN IHRD+ N L G K+ DFG++
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA----- 231
Query: 306 KEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
R + +++ PE F + +K D +SF ++L E+
Sbjct: 232 ---RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 142 AREVPEYEIDPHEL-DFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVR 195
A+E+PE +DP + + KG F I A K + + ++ +
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
E+++ + + H +VV F G + + +V E + L KR+ AL A +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
I G YLH N+ +IHRDL+ N+ ++ +K+ DFG++ + +R +
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER----KK 173
Query: 316 TSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
C Y+APEV + + +VDV+S I+
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 44/175 (25%), Positives = 84/175 (48%), Gaps = 12/175 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + R E+ + +RHPN+++ G ++ + ++ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G + L++ + ++A ++Y H + +IHRD++P N+L +G LK+
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 150
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
ADFG S P + + C Y+ PE+ + +D KVD++S ++ E
Sbjct: 151 ADFGWSVHA------PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 199
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 48/220 (21%), Positives = 82/220 (37%), Gaps = 37/220 (16%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I G F R G A+K+ + + D A R+ A +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL 266
+VV++ A + M+I EY G L + K + L + RG+ Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNL-------------------KVADFGVSKLLTVKE 307
H ++H D++PSNI + K+ D G ++
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185
Query: 308 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQE 346
P + R++A EV + N + K D+F+ AL +
Sbjct: 186 -SPQVEEGD-SRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 67/237 (28%), Positives = 103/237 (43%), Gaps = 50/237 (21%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
++E L + +G F I A GI VAVK L E + RA
Sbjct: 21 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76
Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKR----------- 243
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 244 -----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193
Query: 299 VSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++ + K D PL +++APE + Y + DV+SF ++L E+
Sbjct: 194 LARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 10/173 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
A K + + ++ + E+++ + + H +VV F G + + +V E +
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L KR+ AL A + I G YLH N+ +IHRDL+ N+ ++ +K+
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
DFG++ + +R + C Y+APEV + + +VDV+S I+
Sbjct: 183 GDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 48/219 (21%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 328 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 384
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-------- 309
++ GM YL E +HR+L N+L + K++DFG+SK L +
Sbjct: 444 QVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
PL ++ APE ++ ++ DV+S+ + + E
Sbjct: 501 WPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEA 532
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 12/175 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + + R E+ + +RHPN+++ + ++ E+ P+
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L L++ G + F ++A ++Y HE K +IHRD++P N+L G LK+
Sbjct: 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI 155
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
ADFG S P + T C Y+ PE+ + + +D KVD++ ++ E
Sbjct: 156 ADFGWSVH------APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 20/190 (10%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ KGT+ +++A+K E+ D + +E+AL + ++H N+VQ+L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAV--RFALDIARGMNYLHENKPVP 273
G+ +++ + I E +P G L A L+ K G LK + + I G+ YLH+N+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 274 IIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-- 330
I+HRD++ N+L + SG LK++DFG SK L T T Y+APE+
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-YMAPEIIDKGPRG 201
Query: 331 YDTKVDVFSF 340
Y D++S
Sbjct: 202 YGKAADIWSL 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 40/222 (18%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G F + A A+KK+ +++ E+ LL + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILS-EVMLLASLNHQ 62
Query: 211 NVVQFLGA-------------VTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFA 256
VV++ A V + S + I EY G L + + + R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD- 315
I ++Y+H IIHRDL+P NI D+S N+K+ DFG++K + D
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 316 ---------TSC---RYVAPEVFKNE-EYDTKVDVFSFALIL 344
++ YVA EV Y+ K+D++S +I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-36
Identities = 52/204 (25%), Positives = 82/204 (40%), Gaps = 21/204 (10%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+YE T+ + +G+F + G Q AVKK+ EV + E
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------E 100
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
L + P +V GAV + + I E L G L +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLTCQDTSCR 319
G+ YLH + I+H D++ N+L G+ + DFG + L
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 320 ----YVAPEVFKNEEYDTKVDVFS 339
++APEV + D KVD++S
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWS 241
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K + + ++ + FR E+ +++ + HPN+V+ + + ++ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G++ +L G +K A I + Y H+ + I+HRDL+ N+L D N+K+
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
ADFG S L D C Y APE+F+ ++YD +VDV+S +IL
Sbjct: 156 ADFGFSNE--FTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 3e-35
Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 25/185 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL------GAVTQSSPMMIV 228
G QVA+K+ + +S +R R E+ +++K+ HPNVV + + ++
Sbjct: 39 GEQVAIKQC-RQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 229 TEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
EY GDLR +L + LK DI+ + YLHEN+ IIHRDL+P NI+
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153
Query: 286 RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFS 339
K+ D G +K L + T +Y+APE+ + ++Y VD +S
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWS 208
Query: 340 FALIL 344
F +
Sbjct: 209 FGTLA 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 44/190 (23%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 335 VDVFSFALIL 344
VD++S +
Sbjct: 204 VDLWSIGVTF 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 44/190 (23%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 335 VDVFSFALIL 344
VD++S +
Sbjct: 204 VDLWSIGVTF 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 46/174 (26%), Positives = 90/174 (51%), Gaps = 11/174 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++VA+K + ++ + V+ ++E+ + +++HP++++ S+ + +V E
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G++ +LK R + A F I GM YLH + I+HRDL SN+L + N+K
Sbjct: 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+ADFG++ L + ++ T C Y++PE+ + + DV+S +
Sbjct: 153 IADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMF 202
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 55/174 (31%), Positives = 91/174 (52%), Gaps = 12/174 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VAVK L + I D V + E+ L+ RHP++++ ++ + +V EY+
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L ++ + G ++ A R I ++Y H + ++HRDL+P N+L D N K+
Sbjct: 96 GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
ADFG+S ++ + L TSC Y APEV Y +VD++S +IL
Sbjct: 153 ADFGLSNMM--SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 33 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 91 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 146
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 147 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 339 SFALIL 344
S IL
Sbjct: 205 SLGCIL 210
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 166 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 339 SFALIL 344
S IL
Sbjct: 224 SLGCIL 229
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 80 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 193
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 194 KLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 339 SFALIL 344
S IL
Sbjct: 252 SLGCIL 257
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 38/184 (20%), Positives = 71/184 (38%), Gaps = 25/184 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----IVTE 230
G A+K++ + + + E + + HPN+++ + + ++
Sbjct: 54 GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
+ +G L ++R L + L I RG+ +H HRDL+P+NIL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTC--------QDTSCRYVAPEVFKNEEY---DTKV 335
D G + D G + + Q + Y APE+F + + D +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 336 DVFS 339
DV+S
Sbjct: 228 DVWS 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
PM K + I + L T + GTF + G +VAVK L + I
Sbjct: 1 GPMAEKQKHDGRVK-IGHYILGDT----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D V R E+ L+ RHP++++ ++ S + +V EY+ G+L ++ + G L
Sbjct: 56 SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
+ R I G++Y H + ++HRDL+P N+L D N K+ADFG+S ++ +
Sbjct: 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGE 170
Query: 310 PLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
L TSC Y APEV Y +VD++S +IL
Sbjct: 171 FL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 38/210 (18%)
Query: 165 KGTF---ILAFWRGIQVAVKKL--------------GEEVISDDDRVRAFRDELALLQKI 207
+G F IL A+KK + IS + F++EL ++ I
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR------ 261
++ + G +T + I+ EY+ + F + L + + + +
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 262 --GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
+Y+H K I HRD++PSNIL D +G +K++DFG S+ + D+ + S
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIK---GSRG 212
Query: 319 --RYVAPEVFKNEE--YDTKVDVFSFALIL 344
++ PE F NE KVD++S + L
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-32
Identities = 54/174 (31%), Positives = 94/174 (54%), Gaps = 13/174 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VA+K + +++ D E++ L+ +RHP++++ +T + +++V EY
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L ++ K + RF I + Y H +K I+HRDL+P N+L DD+ N+K+
Sbjct: 93 GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
ADFG+S ++ + L TSC Y APEV + Y +VDV+S ++L
Sbjct: 150 ADFGLSNIM--TDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA++ K + D E+ +L+K+ HP +++ + IV
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 276 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 341 ALIL 344
+IL
Sbjct: 331 GVIL 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 41/181 (22%), Positives = 72/181 (39%), Gaps = 17/181 (9%)
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
+ + +S + A ++ + N V L + + I + K +L+
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 240 FLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
++ R+ +L+ + + IA + +LH ++HRDL+PSNI +KV D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 207
Query: 297 FGVSKLLTVKEDRPLTCQDTSCR-----------YVAPEVFKNEEYDTKVDVFSFALILQ 345
FG+ + E+ Y++PE Y KVD+FS LIL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 346 E 346
E
Sbjct: 268 E 268
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 29/187 (15%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G +VA+K+ + + + F E+ L RHP++V +G + + M+++ +Y+
Sbjct: 63 GAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 233 PKGDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
G+L+ L + + ARG++YLH IIHRD++ NIL D+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSF 340
+ K+ DFG+SK T + T S Y+ PE F K DV+SF
Sbjct: 175 NFVPKITDFGISKKGTELD-------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 341 ALILQEV 347
++L EV
Sbjct: 228 GVVLFEV 234
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA+K K + D E+ +L+K+ HP +++ + IV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 94 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 150
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 151 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 341 ALIL 344
+IL
Sbjct: 206 GVIL 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 18/180 (10%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+V VK K+ E+ +D ++ E+A+L ++ H N+++ L +V
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
Query: 230 E-YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + DL AF+ R L A + + YL IIHRD++ NI+ +
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAE 165
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
+K+ DFG + ++ + T C Y APEV Y +++++S + L
Sbjct: 166 DFTIKLIDFGSAAY--LERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 29/195 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--------M 225
G + A+K+L + +++++ RA E+ ++K+ HPN+VQF A +
Sbjct: 53 GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 226 MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
+++TE + K +G L T ++ R + ++H KP PIIHRDL+ N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVEN 168
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----------TSCRYVAPEVF---KNE 329
+L + G +K+ DFG + ++ D + Q T+ Y PE+ N
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 330 EYDTKVDVFSFALIL 344
K D+++ IL
Sbjct: 229 PIGEKQDIWALGCIL 243
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A K + E I R + R EL +L + P +V F GA + I E++
Sbjct: 58 GLVMARKLIHLE-IKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L LK+ G + + ++ + +G+ YL E I+HRD++PSNIL + G +K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEV 347
DFGVS L D+ Y++PE + Y + D++S L L E+
Sbjct: 174 CDFGVSGQLI----------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 175 GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVKKL V + + F E+ ++ K +H N+V+ LG + + +V Y+P
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 234 KGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G L L P + A A G+N+LHEN IHRD++ +NIL D++
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR------YVAPEVFKNEEYDT-----KVDVFS 339
K++DFG+++ + R Y+AP E K D++S
Sbjct: 171 TAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAP------EALRGEITPKSDIYS 219
Query: 340 FALILQE 346
F ++L E
Sbjct: 220 FGVVLLE 226
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 20/155 (12%)
Query: 200 ELALLQKIRHPNVVQF---LGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRF 255
E+A+L+K+ HPNVV+ L + + +V E + +G + + L A +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKPLSEDQARFY 142
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
D+ +G+ YLH K IIHRD++PSN+L + G++K+ADFGVS D L+
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLS--- 195
Query: 316 TSC---RYVAPEVFKNE--EYD-TKVDVFSFALIL 344
+ ++APE + +DV++ + L
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 22/182 (12%)
Query: 175 GIQVAVKKLGEEVISD----DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIV 228
+ VA+K + ++ ISD + R E+ LL+K+ V++ L + +++
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126
Query: 229 TEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
E P DL F+ +GAL+ A F + + + H ++HRD++ NIL D
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183
Query: 288 -DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFAL 342
+ G LK+ DFG LL D Y PE + Y V+S +
Sbjct: 184 LNRGELKLIDFGSGALLK---DTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 343 IL 344
+L
Sbjct: 238 LL 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ A K + + +S D + E + +K++HPN+V+ ++ + S +V + +
Sbjct: 31 GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + + A I + Y H N I+HR+L+P N+L +
Sbjct: 90 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ADFG++ V + Y++PEV K + Y VD+++ +IL
Sbjct: 147 VKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 9e-30
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 23/194 (11%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F L R G A+K + + D + +E+A+L+KI+H N+V
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++ +V + + G+L + +G A + + YLHEN I+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
RDL+P N+L +++ + + DFG+SK+ ++ ++ T+C YVAPEV +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMS---TACGTPGYVAPEVLAQKP 183
Query: 331 YDTKVDVFSFALIL 344
Y VD +S +I
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 134 MAPMHVKHA-REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV 187
MA V+ + + DP EL FT +I KG+F F VA+K + E
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE- 58
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+D + + E+ +L + P V ++ G+ + + + I+ EYL G L+
Sbjct: 59 -EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 248 KPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
+ A R L +G++YLH K IHRD++ +N+L + G +K+ADFGV+ LT
Sbjct: 118 ETQIATILREIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
+ + T T ++APEV K YD+K D++S
Sbjct: 172 TQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSL 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
P+ + + Y+ +I G F L + VAVK +
Sbjct: 9 GPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAA- 58
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D+ V+ R E+ + +RHPN+V+F + + + I+ EY G+L + G
Sbjct: 59 IDENVQ--R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307
A F + G++Y H + I HRDL+ N L D S LK+ DFG SK
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VL 170
Query: 308 DRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
++ Y+APEV +EYD DV+S + L
Sbjct: 171 HSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 9/173 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+K + E + SD + E +++ P+VV + + + D
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L A L+R+G L P AV I ++ H HRD++P NIL + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
FG++ T D LT + Y+APE F + D+++ +L E
Sbjct: 178 FGIASATT---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 9/173 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + ++ ++ F E+ ++ H N+V + + +V EY+
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L +++ G L TA+ F I G+ + H+ + I+HRD++P NIL D + LK+ D
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
FG++K L+ + LT + + +Y +PE K E D D++S ++L E
Sbjct: 155 FGIAKALS---ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 22/184 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVK+L EE + F+ E+ ++ H N+++ G + ++V Y+
Sbjct: 54 GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 235 GDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G + + L+ + +P R AL ARG+ YLH++ IIHRD++ +NIL D+
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSFAL 342
V DFG++KL+ K DT + ++APE + K DVF + +
Sbjct: 172 EAVVGDFGLAKLMDYK--------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223
Query: 343 ILQE 346
+L E
Sbjct: 224 MLLE 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 20/177 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ +L++++HPN+V L + + +V EY +
Sbjct: 31 VAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L R P V+ + +N+ H++ IHRD++P NIL +K+ D
Sbjct: 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCD 145
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQE 346
FG ++LLT V +PE+ + +Y VDV++ + E
Sbjct: 146 FGFARLLTG-PSDYYDD------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAE 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKK 182
P MA M + F+++ ++ + G F + G++ A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ + +S D + E + +K++HPN+V+ ++ + S +V + + G+L +
Sbjct: 62 INTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGV 299
+ + A I + Y H N I+HR+L+P N+L + +K+ADFG+
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 300 SKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+ V + Y++PEV K + Y VD+++ +IL
Sbjct: 178 AIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 43/181 (23%), Positives = 76/181 (41%), Gaps = 18/181 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTE 230
+ AVK L ++ + + E+ LL+++RH NV+Q + + + V E
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88
Query: 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
Y G + A + + G+ YLH I+H+D++P N+L
Sbjct: 89 YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145
Query: 290 GNLKVADFGVSKLL-TVKEDRPLTCQDTSC---RYVAPEVFKNEE-YD-TKVDVFSFALI 343
G LK++ GV++ L D TS + PE+ + + KVD++S +
Sbjct: 146 GTLKISALGVAEALHPFAADDTC---RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202
Query: 344 L 344
L
Sbjct: 203 L 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 50/184 (27%), Positives = 73/184 (39%), Gaps = 24/184 (13%)
Query: 175 GIQVAVKKLG----EEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAVTQSSPMM 226
+QVA+K + D V E+ALL K+ HP V++ L M
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114
Query: 227 IVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V E LP DL ++ KG L + F + + + H ++HRD++ NIL
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENIL 171
Query: 286 RD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSF 340
D G K+ DFG LL D P Y PE +Y V+S
Sbjct: 172 IDLRRGCAKLIDFGSGALL---HDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSL 225
Query: 341 ALIL 344
++L
Sbjct: 226 GILL 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 43/176 (24%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
I+ A KK+ + + D DR + E+ +++ + HPN+++ ++ + +V E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + K + S A R D+ + Y H+ + HRDL+P N L
Sbjct: 91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSP 147
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
LK+ DFG++ K + + T YV+P+V + Y + D +S +++
Sbjct: 148 LKLIDFGLAAR--FKPGKMMR---TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 48/173 (27%), Positives = 91/173 (52%), Gaps = 12/173 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V E+ +
Sbjct: 30 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ + G L P F + +G+ + H ++HRDL+P N+L + +G LK+
Sbjct: 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
A+FG+++ + R + + + Y P+V F + Y T +D++S I E
Sbjct: 143 ANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 53/173 (30%), Positives = 99/173 (57%), Gaps = 12/173 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + ++D+ + A R E++LL+++ HPN+V + + + +V E++ K
Sbjct: 48 VALKRIRLD--AEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ L K L+ S + + RG+ + H+++ I+HRDL+P N+L + G LK+
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
ADFG+++ + R T + + Y AP+V +++Y T VD++S I E
Sbjct: 161 ADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 23/185 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228
G + AVK ++ A R E +L+++ HP+++ + + SS M +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+ + KG+L +L K AL + +++LH N I+HRDL+P NIL DD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVFS 339
+ ++++DFG S ++ L C Y+APE+ K Y +VD+++
Sbjct: 236 NMQIRLSDFGFSCH--LEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 340 FALIL 344
+IL
Sbjct: 291 CGVIL 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 60/174 (34%), Positives = 93/174 (53%), Gaps = 11/174 (6%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK+ D A R E+ LLQ++ HPN++ L A S + +V +++
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL +K L PS + L +G+ YLH++ I+HRDL+P+N+L D++G LK
Sbjct: 97 -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
+ADFG++K +R T Q + Y APE+ F Y VD+++ IL E
Sbjct: 153 LADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 205
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 16/176 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+S +++ + Y+APEV + YD K DV+S +IL
Sbjct: 163 IKIIDFGLSTC--FQQNTKMK---DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 47/195 (24%), Positives = 94/195 (48%), Gaps = 14/195 (7%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + +T +I +G + G +VA++++ + + +E+ +++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+ ++PN+V +L + + +V EYL G L + + A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH N+ +IHRD++ NIL G++K+ DFG +T ++ + T T ++APEV
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEV 187
Query: 326 FKNEEYDTKVDVFSF 340
+ Y KVD++S
Sbjct: 188 VTRKAYGPKVDIWSL 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 52/173 (30%), Positives = 98/173 (56%), Gaps = 12/173 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+KK+ E +D+ + R E+++L++++H N+V+ + +++V E+L +
Sbjct: 29 FALKKIRLE--KEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ L +G L+ TA F L + G+ Y H+ + ++HRDL+P N+L + G LK+
Sbjct: 85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKI 141
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
ADFG+++ + R T + + Y AP+V +++Y T +D++S I E
Sbjct: 142 ADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 142 AREVPEYEIDPHELDFTNSV-----EITKGTF---ILAFWR--GIQVAVKKLGEEVISDD 191
A VP+Y ID D + E+ +G + A+K V+
Sbjct: 35 ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKT 89
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
+ R E+ +L ++ HPN+++ + + +V E + G+L + KG
Sbjct: 90 VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKED 308
A I + YLHEN I+HRDL+P N+L LK+ADFG+SK+ V+
Sbjct: 150 AADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQ 204
Query: 309 RPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+ T C Y APE+ + Y +VD++S +I
Sbjct: 205 VLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 16/179 (8%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ H NV+ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
++K+ DFG++ + ++ + +VAPE+ E + D++S +I
Sbjct: 152 NIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 22/182 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G + A K +L E+ +L++IRHPN++ + ++++
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL K +L A +F I G++YLH + I H DL+P NI+
Sbjct: 88 ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDK 144
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 342
+ +K+ DFG++ + + +VAPE+ E + D++S +
Sbjct: 145 NVPNPRIKLIDFGIAHKI--EAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 343 IL 344
I
Sbjct: 200 IT 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 8/171 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ LL+++RH N+V L + +V E++ +
Sbjct: 53 VAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 238 RAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L+ L ++ I G+ + H + IIHRD++P NIL SG +K+ D
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
FG ++ L + + Y APE+ + +Y VDV++ ++ E
Sbjct: 168 FGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTE 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVR-AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227
+ AVK G + +R A E+ +L+K+ HPN++Q ++ +
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
V + + KG+L +L K L + + + LH+ I+HRDL+P NIL D
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVF 338
D N+K+ DFG S + L C Y+APE+ + Y +VD++
Sbjct: 159 DDMNIKLTDFGFSCQ--LDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 339 SFALIL 344
S +I+
Sbjct: 214 STGVIM 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 43/180 (23%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ +K + ++ + E+ +L+ + HPN+++ M IV E
Sbjct: 47 GLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RD 287
G+L + R AL + + Y H ++H+DL+P NIL
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTS 161
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+++L K D T + Y+APEVFK + K D++S +++
Sbjct: 162 PHSPIKIIDFGLAEL--FKSDEHST---NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ AVK I D + + LL+ +HPN++ + +VTE +
Sbjct: 47 NMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSG 290
G+L + R+ A I + + YLH ++HRDL+PSNIL +
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
++++ DFG +K L E+ L T C +VAPEV + + YD D++S ++L
Sbjct: 158 SIRICDFGFAKQLR-AENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 16/179 (8%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G+Q A K + E+++L++I+HPNV+ + ++++
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVS--REDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL K +L A F I G+ YLH + I H DL+P NI+
Sbjct: 94 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 150
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG++ + + +VAPE+ E + D++S +I
Sbjct: 151 NVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
Y+ + ++L+ E+ GT + G +AVK++ + ++ R D
Sbjct: 19 RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLD 75
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+L+ P +VQ G ++ + I E + + + +G + + + I +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-Y 320
+ YL E +IHRD++PSNIL D+ G +K+ DFG+S L + + + C Y
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAY 190
Query: 321 VAPEVFKNEE-----YDTKVDVFSFALILQEV 347
+APE + YD + DV+S + L E+
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 15/174 (8%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++LL+ ++H N+V + + +V EYL K
Sbjct: 30 VALKEIRLEHEEGAP----CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL+ +L G + F + RG+ Y H K ++HRDL+P N+L ++ G LK
Sbjct: 85 -DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
+ADFG+++ ++ + + + Y P++ + +Y T++D++ I E
Sbjct: 141 LADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYE 193
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 25/185 (13%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G Q AVK K + ++ E ++ ++HP++V+ L + + +V
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 230 EYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
E++ DL + ++ A + I + Y H+N IIHRD++P +L
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162
Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFS 339
+++S +K+ FGV+ L + ++APEV K E Y VDV+
Sbjct: 163 LASKENSAPVKLGGFGVAIQLG-ESGLVAG---GRVGTPHFMAPEVVKREPYGKPVDVWG 218
Query: 340 FALIL 344
+IL
Sbjct: 219 CGVIL 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 14/195 (7%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L + V+I +G+ + G QVAVK + + R +E+ +++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH +IHRD++ +IL G +K++DFG ++ + + T ++APEV
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEV 212
Query: 326 FKNEEYDTKVDVFSF 340
Y T+VD++S
Sbjct: 213 ISRSLYATEVDIWSL 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 9/173 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G + AVK + + + + E+ LL+++ HPN+++ +V E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + A R + G+ Y+H+NK I+HRDL+P N+L + N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+++ DFG+S + + + + + Y+APEV YD K DV+S +IL
Sbjct: 168 IRIIDFGLSTH--FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVIL 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-27
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 11/177 (6%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL--GAVTQSSPMM--IVTEYL 232
VAVK L ++ D FR E + HP +V G + + IV EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
LR + +G + P A+ D + +N+ H+N IIHRD++P+NI+ + +
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155
Query: 293 KVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
KV DFG+++ + +T + +Y++PE + + D + DV+S +L E
Sbjct: 156 KVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 45/177 (25%), Positives = 90/177 (50%), Gaps = 16/177 (9%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ E +++ V A R E++LL++++H N+++ + + + ++ EY
Sbjct: 62 VAIKRIRLE--HEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSG 290
DL+ ++ + + F + G+N+ H + +HRDL+P N+L ++
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
LK+ DFG+++ + R T + + Y PE+ + Y T VD++S A I E
Sbjct: 175 VLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAE 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 39/194 (20%), Positives = 86/194 (44%), Gaps = 19/194 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ KG F G + A + + +S D + E + + ++HPN+V+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++++ ++ + + G+L + + + A I + + H+ ++H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
R+L+P N+L + +K+ADFG++ + E + Y++PEV + +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWF---GFAGTPGYLSPEVLRKDP 189
Query: 331 YDTKVDVFSFALIL 344
Y VD+++ +IL
Sbjct: 190 YGKPVDLWACGVIL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 43/179 (24%), Positives = 81/179 (45%), Gaps = 16/179 (8%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ HPN++ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVC--REEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
++K+ DFG++ +++ + +VAPE+ E + D++S +I
Sbjct: 152 NIPIPHIKLIDFGLAHE--IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
P E+ F ++ +G++ + G VA+K + + ++ E++++Q
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ P+VV++ G+ +++ + IV EY G + ++ R L +G+
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + IHRD++ NIL + G+ K+ADFGV+ LT + T T ++APE
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPE 195
Query: 325 VFKNEEYDTKVDVFS 339
V + Y+ D++S
Sbjct: 196 VIQEIGYNCVADIWS 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 33/234 (14%), Positives = 78/234 (33%), Gaps = 35/234 (14%)
Query: 138 HVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEV 187
+ + E+++ + + + +G F A + +K
Sbjct: 50 KLPAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA- 246
+ + L+ ++F A + ++V E G L +
Sbjct: 108 PWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164
Query: 247 ----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----------RDDSGN 291
+ + FA+ + + +H+ + IIH D++P N + D S
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 292 LKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
L + D G S + + + T + + + E+ N+ ++ ++D F A +
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 41/228 (17%), Positives = 81/228 (35%), Gaps = 26/228 (11%)
Query: 134 MAPMHVKHAREVPEYEI----DPHELDFTNSVEITKGTFILAF-WRGIQ------VAVKK 182
MA H H + + + I KG L V V++
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ E S++ V + EL + + HPN+V + + + +VT ++ G + +
Sbjct: 60 INLEACSNEM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 243 --RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+ + + ++Y+H +HR ++ S+IL G + ++ +
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 301 KLLTVKEDRPLTCQDTSCRYV------APEVFK--NEEYDTKVDVFSF 340
+ R D V +PEV + + YD K D++S
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 25/204 (12%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G + + +VA+K++ E + E+ + + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA-LDIA-------RG 262
N+V + + + +V + L G + +K A + IA G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TS 317
+ YLH+N IHRD++ NIL + G++++ADFGVS L D T
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 318 CRYVAPEVFK-NEEYDTKVDVFSF 340
C ++APEV + YD K D++SF
Sbjct: 191 C-WMAPEVMEQVRGYDFKADIWSF 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
AVK +IS + E+ L+ HPN+V+ +V E L
Sbjct: 36 NQAFAVK-----IISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
G+L +K+K + A + ++++H+ ++HRDL+P N+L +D+
Sbjct: 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNL 146
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG ++L +++PL T C Y APE+ YD D++S +IL
Sbjct: 147 EIKIIDFGFARLKPP-DNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-26
Identities = 48/179 (26%), Positives = 92/179 (51%), Gaps = 20/179 (11%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++L+++++H N+V+ + + + +V E++
Sbjct: 33 VALKEVKLDSEEGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 235 GDLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
DL+ ++ L+ + F + +G+ + HENK I+HRDL+P N+L +
Sbjct: 88 -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINK 143
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
G LK+ DFG+++ + + + + Y AP+V + Y T +D++S IL E
Sbjct: 144 RGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 18/174 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
G + A K L + D R E+A+L+ + P V+ +S ++++ EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
Query: 234 KGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
G++ + + + +R I G+ YLH+N I+H DL+P NIL
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFS 339
G++K+ DFG+S+ + L Y+APE+ + T D+++
Sbjct: 170 LGDIKIVDFGMSRKI--GHACELR---EIMGTPEYLAPEILNYDPITTATDMWN 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 148 YEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+ +L+ E+ +G + + G +AVK++ V + ++ R D
Sbjct: 2 MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDI 58
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDI 259
++ + P V F GA+ + + I E + + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+ + +LH +IHRD++PSN+L + G +K+ DFG+S L + D C+
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 320 -YVAPEVFKNEE----YDTKVDVFSFALILQEV 347
Y+APE E Y K D++S + + E+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 44/173 (25%), Positives = 87/173 (50%), Gaps = 10/173 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ A+K + + +S + +E+A+L+ + HPN+++ +V E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + A + G+ YLH++ I+HRDL+P N+L ++
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+S + + + + + + Y+APEV + ++YD K DV+S +IL
Sbjct: 178 IKIVDFGLSAV--FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVIL 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 47/193 (24%), Positives = 77/193 (39%), Gaps = 25/193 (12%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + + VAVK++ E S DR E+ LL++ HPNV+++
Sbjct: 38 GTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
I E L+ ++++K A + G+ +LH I+HRDL+P
Sbjct: 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPH 147
Query: 283 NILRDDSGN-----LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK---NEEY 331
NIL ++DFG+ K L + + ++APE+ E
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 332 DTKVDVFSFALIL 344
VD+FS +
Sbjct: 207 TYTVDIFSAGCVF 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 50/173 (28%), Positives = 88/173 (50%), Gaps = 10/173 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+S +++ + + + Y+APEV + YD K DV+S +IL
Sbjct: 163 IKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ +L EI +G + ++ G +AVK++ V + ++ + D
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLD 72
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-----AVRFA 256
+++ P +VQF GA+ + I E + F K ++ +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
L + +N+L EN IIHRD++PSNIL D SGN+K+ DFG+S L D +D
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 317 SCR-YVAPEVFKNEE----YDTKVDVFSFALILQEV 347
CR Y+APE YD + DV+S + L E+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 34/175 (19%), Positives = 77/175 (44%), Gaps = 15/175 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G K + D V+ +E++++ ++ HP ++ A M+++ E+L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
G+L F + + + + G+ ++HE+ I+H D++P NI+ +
Sbjct: 133 GEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKA 187
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
++K+ DFG++ L D + + + APE+ E D+++ ++
Sbjct: 188 SSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 34/175 (19%), Positives = 70/175 (40%), Gaps = 16/175 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + + E+++L RH N++ + ++++ E++
Sbjct: 30 KKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
D+ F L V + + + +LH + I H D+ P NI+ S
Sbjct: 86 LDI--FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRS 140
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ +FG ++ L K T+ Y APEV +++ T D++S ++
Sbjct: 141 STIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 42/211 (19%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + ++G VAVK++ D E+ LL + HPNV+++ + T
Sbjct: 29 GTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ I E +L+ ++ K K + IA G+ +LH K IIH
Sbjct: 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138
Query: 277 RDLEPSNIL-------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RY 320
RDL+P NIL ++ + ++DFG+ K L + T + +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 321 VAPEVFKNEE-------YDTKVDVFSFALIL 344
APE+ + +D+FS +
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K + SD + VR E+ + +RHP +V A + M+++ E++
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
G+L F + AV + + +G+ ++HEN +H DL+P NI+ S
Sbjct: 239 GEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRS 293
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
LK+ DFG++ L + + + + APEV + + D++S ++
Sbjct: 294 NELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 55/261 (21%), Positives = 109/261 (41%), Gaps = 26/261 (9%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP---EYEID 151
R + K+ W + L + + K+ L A P + A++ Y +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
E + G F G+++A K + + D + V+ +E++++ +
Sbjct: 93 KTE-------ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQ 142
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNY 265
+ H N++Q A + +++V EY+ G+L + L + F I G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 266 LHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
+H+ I+H DL+P NIL D+ +K+ DFG+++ K L + ++AP
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAP 257
Query: 324 EVFKNEEYDTKVDVFSFALIL 344
EV + D++S +I
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 38/231 (16%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITK-----GTF---ILAFWR--GIQVAVKKLGE 185
H EV +P + T+ +++K G + F R G + A+K L
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFL 241
D +A ++ Q P++V L ++I+ E + G+L + +
Sbjct: 63 -----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 242 KRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVAD 296
+ +G + A DI + +LH + I HRD++P N+L ++ LK+ D
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
FG +K L T C YVAPEV E+YD D++S +I+
Sbjct: 175 FGFAKET---TQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 40/172 (23%), Positives = 82/172 (47%), Gaps = 10/172 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + I +++V E ++ ++ HP V+ + Y G+L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++++ G+ + RF +I + YLH IIHRDL+P NIL ++ ++++ DF
Sbjct: 119 KYIRKIGSFDETCT-RFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 174
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
G +K+L+ + + + +YV+PE+ + D+++ I+ +
Sbjct: 175 GTAKVLSPESKQARAN--SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 41/238 (17%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGI----------QVAV 180
PL P V + E+ +TN I G+F G+ +VA+
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSF------GVVFQAKLVESDEVAI 69
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPK 234
KK + D R R EL +++ ++HPNVV + +V EY+P+
Sbjct: 70 KK-----VLQDKR-FKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DS 289
+ R + K K + + + R + Y+H I HRD++P N+L D S
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPS 178
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
G LK+ DFG +K+L P S Y APE+ F Y T +D++S ++ E
Sbjct: 179 GVLKLIDFGSAKILI--AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 47/183 (25%), Positives = 88/183 (48%), Gaps = 19/183 (10%)
Query: 175 GIQVAVK----------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+ A+K + ++ + + +E++LL+ + HPN+++
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+VTE+ G+L + + A I G+ YLH++ I+HRD++P NI
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177
Query: 285 L---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
L ++ N+K+ DFG+S +D L + + Y+APEV K ++Y+ K DV+S
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCG 234
Query: 342 LIL 344
+I+
Sbjct: 235 VIM 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 47/222 (21%), Positives = 74/222 (33%), Gaps = 58/222 (26%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
A+K K+ + D +R++ E+ L++K+ HPN+ + + +V
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 230 EYLPKGDLRAFLKRKGALKPST-------------------------------------- 251
E G L L
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 252 --AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
I ++YLH I HRD++P N L + S +K+ DFG+SK
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 308 DRPLTCQDTSC---RYVAPEVFK--NEEYDTKVDVFSFALIL 344
+ T +VAPEV NE Y K D +S ++L
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++DP+E+ + E+ G F + G A K + ++ + + E+ +
Sbjct: 14 DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEI 69
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARG 262
L HP +V+ LGA + I+ E+ P G + A + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV- 321
+N+LH + IIHRDL+ N+L G++++ADFGVS + + ++
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-------FIG 179
Query: 322 -----APEV-----FKNEEYDTKVDVFSF 340
APEV K+ YD K D++S
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSL 208
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 3e-24
Identities = 29/89 (32%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + D+ ++ LL +G D N +D T LH A G +VV LLL+ A V+
Sbjct: 14 LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+PL DA + +++KLL +GA
Sbjct: 74 YQNDSPLHDAAKNGHVDIVKLLLSYGASR 102
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 94.8 bits (237), Expect = 5e-24
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ LL VN N + LH AA G ++V LLL GA + + +G P+
Sbjct: 59 VELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDD 118
Query: 116 YKNHEVIKLLEKHGA 130
++ L EK+ +
Sbjct: 119 ESMKSLLLLPEKNES 133
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 2e-20
Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 1/68 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GID + T LH+A+ +G V LL+ G+D + KD G TPL +A + + +V+
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59
Query: 123 KLLEKHGA 130
+LL +H A
Sbjct: 60 ELLLQHKA 67
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 49.3 bits (119), Expect = 1e-07
Identities = 7/43 (16%), Positives = 15/43 (34%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
+K LL G N +I + + ++ L + +
Sbjct: 92 VKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESS 134
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 38.6 bits (91), Expect = 6e-04
Identities = 9/37 (24%), Positives = 16/37 (43%), Gaps = 1/37 (2%)
Query: 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G D + G T L A + ++ L ++G+ P
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDP 36
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 96.3 bits (241), Expect = 3e-24
Identities = 21/87 (24%), Positives = 37/87 (42%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ LA + ++ + ++ +N D + T L AA G VV LL+ GAD
Sbjct: 7 VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + L A +++K+L G
Sbjct: 67 KGRESALSLACSKGYTDIVKMLLDCGV 93
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 92.8 bits (232), Expect = 5e-23
Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ L E L ++ + +K LLD G+DVN D + T L A
Sbjct: 60 ADPQLLGKGRE--SA---LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ V +LLE GAD + G + A+ V +++E H K
Sbjct: 115 VKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLK 160
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 1e-22
Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E +N D++G P LM+ A + ++ LL +G D +AL +A +
Sbjct: 25 QENVINHTDEEGF--TP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSK 79
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T++V +LL+ G DV+ D G TPL A++ + + +K+L + GA
Sbjct: 80 GYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGA 126
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 75.1 bits (186), Expect = 2e-16
Identities = 17/61 (27%), Positives = 30/61 (49%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
N ++H A QG ++ +E+ ++ D G TPL A + V++ L ++GA
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 66.3 bits (163), Expect = 2e-13
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 5/79 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ + V+ +K LL+SG D ++ +A G+
Sbjct: 93 VDVNEYDWNGG--TP---LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDR 104
V ++ + +
Sbjct: 148 RSVQQVIESHLLKLLQNIK 166
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 25/184 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G VA+KK + D R R EL +++K+ H N+V+ S +V
Sbjct: 79 GELVAIKK-----VLQDKR-FKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 229 TEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+Y+P+ + R + + K L + + R + Y+H I HRD++P N+
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 187
Query: 285 LRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 342
L D D+ LK+ DFG +K L P S Y APE+ F +Y + +DV+S
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245
Query: 343 ILQE 346
+L E
Sbjct: 246 VLAE 249
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 94.4 bits (236), Expect = 4e-24
Identities = 30/89 (33%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
M+ D++ +K+ + G DVN R LH AA G E++ LL +GAD++ D
Sbjct: 11 FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ TPL A+Y + +KLL GA
Sbjct: 71 KHHITPLLSAVYEGHVSCVKLLLSKGADK 99
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 1e-17
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K ++N + G KP L + A+ +E ++ LL G D+N D + T L A +
Sbjct: 29 KGEDVNRTLEGGR--KP---LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
G V LLL +GAD K G T +++
Sbjct: 84 GHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 71.3 bits (176), Expect = 1e-15
Identities = 14/59 (23%), Positives = 21/59 (35%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
A G + V + +G DV+ G PL A E+++ L GA
Sbjct: 6 MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGA 64
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 5e-24
Identities = 25/89 (28%), Positives = 39/89 (43%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A ++ L+ G VN D+ + LH A G V +LL+ GA V+
Sbjct: 63 MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL +A + + + LL +HGA
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASV 151
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-20
Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 7/105 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ P L + +K+LL+SG DVN + + LH
Sbjct: 181 GNIDHKISHLG--TP---LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTAS 234
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+ LL++ GAD K+ G P+ ++ LE+ GA
Sbjct: 235 EELACLLMDFGADTQAKNAEGKRPVELVP-PESPLAQLFLEREGA 278
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 3e-20
Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ L+ G +++ + T L++A V LLE GADV+ + + +PL +
Sbjct: 173 VNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVR 231
Query: 116 YKNHEVIKLLEKHGAKP 132
+ E+ LL GA
Sbjct: 232 TASEELACLLMDFGADT 248
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 3e-19
Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+N + D P L + +K LL G VN D T L A G
Sbjct: 83 WAVNIITADHV--SP---LHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGS 137
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V+LLL+ GA V P+ ++P+ +A + E + L +G
Sbjct: 138 WDCVNLLLQHGASVQPESD-LASPIHEAARRGHVECVNSLIAYGGNI 183
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-18
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++NG+ D P L + + LL G V + D + +H AA +G
Sbjct: 116 AQVNGVTADWH--TP---LFNACVSGSWDCVNLLLQHGASVQ-PESDLASPIHEAARRGH 169
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E V+ L+ G ++D K TPL A + +K L + GA
Sbjct: 170 VECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADV 216
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-17
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
RD GI+ LL + + + + + + +H AA G + L+ +G V+ +
Sbjct: 38 GPRDFPGIR-LLSNPLMGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVS 94
Query: 109 PLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A + +K+L KHGA+
Sbjct: 95 PLHEACLGGHLSCVKILLKHGAQV 118
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 56.7 bits (138), Expect = 2e-09
Identities = 12/80 (15%), Positives = 22/80 (27%), Gaps = 12/80 (15%)
Query: 56 IKELLDSGIDVNFRD-----IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
L+ G + D +D G LL D +P+
Sbjct: 11 SSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGI-----RLLSNPLMGDAVS--DWSPM 63
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
+A + + ++ L G
Sbjct: 64 HEAAIHGHQLSLRNLISQGW 83
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 7/45 (15%), Positives = 17/45 (37%), Gaps = 1/45 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L+D G D ++ + + + + + + L GA +
Sbjct: 238 ACLLMDFGADTQAKNAEGKRPVELVPPESPLAQL-FLEREGASLP 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 14/168 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + + VR EL ++Q + HP +V + M +V + L GDLR
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L++ K T F ++ ++YL + IIHRD++P NIL D+ G++ + DF
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
++ + + + +T T Y+APE+F + + Y VD +S
Sbjct: 161 IAAM--LPRETQIT---TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 14/175 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL- 237
A KKL ++ + + E +L K+ +V A + + +V + GD+
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 238 ---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ + A+ + I G+ +LH+ II+RDL+P N+L DD GN+++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
+D G++ L + + ++APE+ EEYD VD F+ + L E
Sbjct: 331 SDLGLAVELKAGQTKT----KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 44/185 (23%), Positives = 80/185 (43%), Gaps = 21/185 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
+ AVK + ++ RV E+ +L + + H NV++ + + +V E +
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
G + + + ++ A D+A +++LH I HRDL+P NIL +
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQD---TSC---RYVAPEVFK-----NEEYDTKVDVFS 339
+K+ DF + + + D T C Y+APEV + YD + D++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 340 FALIL 344
+IL
Sbjct: 212 LGVIL 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 29/183 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 87 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 195
Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFA 341
+ + LK+ DFG +K LT T C YVAPEV E+YD D++S
Sbjct: 196 SKRPNAILKLTDFGFAKE--TTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 342 LIL 344
+I+
Sbjct: 251 VIM 253
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-23
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N +++G P L + ++ LL G D R + T +AA G
Sbjct: 29 ANVNFQEEEGGWT-P---LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGS 84
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+++ L L +GADV+ D +G T +A Y + +K L K GA
Sbjct: 85 VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGA 129
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 5e-22
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A + +++KL GA
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGA 96
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 3e-21
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 10/112 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE----LLDSGIDVNFRDIDNRTALHVAA 81
A++N D+ G L+ D ++ LLD G DVN R +T L +A
Sbjct: 173 ADVNACDNMGR--NA---LIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-18
Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 16/116 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ +G P + A V+ +K L G DVN D TA AA G
Sbjct: 63 ADPVLRKKNGA--TP---FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGK 117
Query: 86 TEVVSLLLERGADVDPKD----------RWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
+ + L +RGA+V+ + + G+T L DA + EV+K LL++ GA
Sbjct: 118 VKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGA 173
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 1e-15
Identities = 37/120 (30%), Positives = 49/120 (40%), Gaps = 20/120 (16%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN----------RT 75
A++N D G M A V+ +K L G +VN R T
Sbjct: 96 ADVNECDFYGF--TA---FMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGAT 150
Query: 76 ALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLLEKHGA 130
AL AA +G EV+ +LL E GADV+ D G L A+ + + LL HGA
Sbjct: 151 ALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGA 210
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 1e-15
Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKH 128
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +H
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 5e-13
Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ P L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGK--TP---LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-23
Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MM 226
VA+K + + R E+ALL+++ HPNVV+ + S +
Sbjct: 37 VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95
Query: 227 IVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V E++ + DLR +L + L T RG+++LH N I+HRDL+P NI
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
L G +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 152 LVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209
Query: 345 QE 346
E
Sbjct: 210 AE 211
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 98.3 bits (246), Expect = 2e-23
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A+ + ++ L+ A + E + LL ++ + D T LH+AA
Sbjct: 15 AKAVLTGEYKKDE-----LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYN 69
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V LLL+ GADV KD+ G PL +A Y ++EV +LL KHGA
Sbjct: 70 RVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGA 115
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 7e-23
Identities = 35/89 (39%), Positives = 42/89 (47%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V ++ LL G DV+ +D LH A G EV LLL+ GA V+ D
Sbjct: 62 LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A EV LL HGA P
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHGADP 150
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 8e-22
Identities = 25/77 (32%), Positives = 41/77 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G +VN ++ D T LHVAA + +V+ +L + GA ++ D G T L A
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAAL 289
Query: 116 YKNHEVIKLLEKHGAKP 132
+ + +LL +G+ P
Sbjct: 290 AGHLQTCRLLLSYGSDP 306
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 6e-21
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+++ D G P L + E + LL G VN D+ T LH AA +
Sbjct: 82 ADVHAKDKGGL--VP---LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNR 136
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
EV SLLL GAD + G + + A + E + K + L A
Sbjct: 137 VEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHS-LLQA 185
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 8e-21
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVD 100
L+ A E D+ +K+ L I + + TALH A +V LLL +GA+V+
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241
Query: 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
K++ TPL A +++V+++L KHGAK
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHGAKM 273
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 5e-19
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+L D + L AA G ++++LL + D STPL A
Sbjct: 7 ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAA 66
Query: 115 YYKNHEVIKLLEKHGA 130
Y +++LL +HGA
Sbjct: 67 GYNRVRIVQLLLQHGA 82
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 8e-18
Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 5/77 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ L G +N D +TALH AA G + LLL G+D G T
Sbjct: 263 MEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMG-- 320
Query: 116 YKNHEVIKLLEKHGAKP 132
+E ++ +
Sbjct: 321 ---NEAVQQILSESTPM 334
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 1e-13
Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 29/131 (22%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA----- 80
A +N +D P L A++ VE LL G D + ++A+ +A
Sbjct: 115 ACVNAMDLWQF--TP---LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPEL 169
Query: 81 ----------------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA---IYYKNHEV 121
A + V L + + T L A ++ K +V
Sbjct: 170 RERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQV 229
Query: 122 IKLLEKHGAKP 132
+LL + GA
Sbjct: 230 AELLLRKGANV 240
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 10/83 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N LD G+ L A ++ + LL G D + + TA +
Sbjct: 271 AKMNALDSLGQTA-----LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN---- 321
Query: 86 TEVVSLLLERGADVDPKDRWGST 108
E V +L + D
Sbjct: 322 -EAVQQILSESTPMRTSDVDYRL 343
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 2e-05
Identities = 9/60 (15%), Positives = 17/60 (28%), Gaps = 14/60 (23%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGA 130
++AL L + A + L +A N +++ LL
Sbjct: 3 FGKSALD-------------LADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNV 49
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 23/200 (11%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + VA+KK+ +++ + E+ LQ
Sbjct: 51 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVA 322
LH + +IHRD++ NIL + G +K+ DFG + ++ P ++A
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY--------WMA 218
Query: 323 PEV---FKNEEYDTKVDVFS 339
PEV +YD KVDV+S
Sbjct: 219 PEVILAMDEGQYDGKVDVWS 238
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 92.4 bits (231), Expect = 2e-23
Identities = 38/87 (43%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E +K+LL G DVN R D T LH+AA G E+V LLL +GADV+ +
Sbjct: 13 LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A +HE++KLL+ GA
Sbjct: 73 KDGNTPEHLAKKNGHHEIVKLLDAKGA 99
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 3e-18
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G D T LH AA G E V LL +GADV+ + + G+TPL A + E++
Sbjct: 1 GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58
Query: 123 KLLEKHGA 130
KLL GA
Sbjct: 59 KLLLAKGA 66
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 74.0 bits (183), Expect = 1e-16
Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 5/85 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N DG P L A E +K LL G DVN R D T H+A G
Sbjct: 33 ADVNARSKDGN--TP---LHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGH 87
Query: 86 TEVVSLLLERGADVDPKDRWGSTPL 110
E+V LL +GADV+ + S
Sbjct: 88 HEIVKLLDAKGADVNARSWGSSHHH 112
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 95.2 bits (238), Expect = 3e-23
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 116 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 170
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
E +LL+ A+ D D P A +H++++LL+++ +H
Sbjct: 171 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS-PQLH 222
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 1e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 96 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFA 182
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 6e-20
Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 29 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 88
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G+TPL A +++ L A
Sbjct: 89 MHDGTTPLILAARLAVEGMLEDLINSHADV 118
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 85.5 bits (213), Expect = 1e-19
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 7 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 67 SADAQGVFQILIRNRAT 83
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 83.2 bits (207), Expect = 6e-19
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 49 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 103
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 104 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 149
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 50.9 bits (123), Expect = 1e-07
Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 84 GFTEVVSLLLERGADV-DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
V+S + +GA + + DR G T L A Y + K L + A
Sbjct: 2 DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASA 49
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 4e-23
Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + L + E L + + + LL+ +D+N D + T L A
Sbjct: 60 ADPHILAKERE--SA---LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V LL RGAD+ + G TP+ A+ +V +++E H K
Sbjct: 115 VKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKL 161
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 4e-22
Identities = 27/87 (31%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++E ++ LL+ G D + + +AL +A+ G+T++V LLLER D++ D
Sbjct: 40 LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A+ + + ++ L GA
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGA 126
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 1e-21
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA + +++ +KE L G + VN D T L A+ G E V LLE GAD
Sbjct: 6 IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ + L A +++ LL +
Sbjct: 66 AKERESALSLASTGGYTDIVGLLLERDVDI 95
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 1e-16
Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ V+ ++ LL G D+ T + +A G+
Sbjct: 93 VDINIYDWNGG--TP---LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDRWGSTP 109
+V ++ + + + P
Sbjct: 148 RKVQQVIENHILKLFQSNLVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 5e-14
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ ++H A QG + + L +G + V+ D G TPL A + E ++ L + GA
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 98.3 bits (246), Expect = 4e-23
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
G + G P L + + +K LL G N ++ T LH+AA G
Sbjct: 5 ISGGGGGESGL--TP---LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGH 59
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TEV LL+ A V+ K + TPL A + ++KLL ++ A P
Sbjct: 60 TEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP 106
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 1e-22
Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N G P L A E E + LL + N + T LH+ A +G
Sbjct: 236 GSANAESVQGV--TP---LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGH 290
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V +L++ G VD R G TPL A +Y N +++K L +H A
Sbjct: 291 VPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADV 337
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+A N + G P L +A E V L+ G+ V+ T LHVA+
Sbjct: 267 KQANGNLGNKSGL--TP---LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHY 321
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ ADV+ K + G +PL A + +++ LL K+GA P
Sbjct: 322 GNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASP 370
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N G P L A E VE + LL+ T LHVAA G
Sbjct: 104 ANPNLATTAGH--TP---LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGK 158
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLER A + + G TPL A+++ N +++KLL G P
Sbjct: 159 VRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSP 205
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
++A N +G P L + +++ +K LL G + + T LH+AA Q
Sbjct: 168 RDAHPNAAGKNGL--TP---LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQ 222
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
EV LL+ G + + G TPL A + E++ LL A
Sbjct: 223 NQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANG 271
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 4e-22
Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 5/110 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+ +A++N D + P L A +K LL++ + N T LH+AA
Sbjct: 68 QNKAKVNAKAKDDQT--P---LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAR 122
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G E V LLE+ A + G TPL A Y V +LL + A P
Sbjct: 123 EGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHP 172
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 4e-22
Identities = 31/109 (28%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
KEA + G P L A V + LL+ N + T LHVA
Sbjct: 135 KEASQACMTKKGF--TP---LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHH 189
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL RG G TPL A EV + L ++G
Sbjct: 190 NNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSA 238
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ A N + E P L A E K LL + VN + D++T LH AA
Sbjct: 36 RGASPNVSNVKVE--TP---LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 90
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G T +V LLLE A+ + G TPL A + E + L + A
Sbjct: 91 GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ 139
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 8e-22
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ G P L ++ +++ +K LL DVN + + LH AA QG
Sbjct: 302 VMVDATTRMGY--TP---LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH 356
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
T++V+LLL+ GA + G+TPL A V +L+ +
Sbjct: 357 TDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE 402
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ +G P L A + VE + LL G N + T LH+AA +G
Sbjct: 203 GSPHSPAWNGY--TP---LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGH 257
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+V+LLL + A+ + ++ G TPL + V +L KHG
Sbjct: 258 AEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMV 304
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 1e-19
Identities = 24/70 (34%), Positives = 32/70 (45%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GI T LHVA+ G +V LL+RGA + + TPL A + EV
Sbjct: 4 GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63
Query: 123 KLLEKHGAKP 132
K L ++ AK
Sbjct: 64 KYLLQNKAKV 73
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 2e-05
Identities = 11/38 (28%), Positives = 16/38 (42%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G G TPL A + + ++K L + GA P
Sbjct: 3 PGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASP 40
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 5e-23
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 17/141 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ DDG + + D E + LL+ G D+N+ ++D TALH A
Sbjct: 32 KKTKVKFDDGAV------FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDN 85
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLMA 135
++V L+E GA+++ D G PL A ++ + L GA PL
Sbjct: 86 VDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDI 145
Query: 136 PMHVKHAREVPEYEIDPHELD 156
E+ + E++ +D
Sbjct: 146 AEEEAM-EELLQNEVNRQGVD 165
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 5e-21
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 56 IKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ L+S I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A
Sbjct: 181 ARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA 240
Query: 115 YYKNHEVIKLLEKHGAKP 132
++ E ++L ++
Sbjct: 241 HWGKEEACRILVENLCDM 258
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 3e-20
Identities = 22/76 (28%), Positives = 35/76 (46%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K L+ + DVN +D D T LH AA G E +L+E D++ ++ G T A
Sbjct: 215 LKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE 274
Query: 116 YKNHEVIKLLEKHGAK 131
+ +L +K
Sbjct: 275 DILGYLEELQKKQNLL 290
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 2e-16
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ + + D+ A G TE V LLERGAD++ + G T L A
Sbjct: 22 TDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQA 80
Query: 114 IYYKNHEVIKLLEKHGA 130
N +++K L ++GA
Sbjct: 81 CIDDNVDMVKFLVENGA 97
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 4e-13
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 11/105 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ +G+ P L E E ++ ++ +D A
Sbjct: 130 AHVGAVNSEGD--TP---LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIML 178
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ L + + G T L A EV+KLL +
Sbjct: 179 RDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARY 223
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 64.4 bits (158), Expect = 6e-12
Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 1/67 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + G + + + K G+ L A + E + L
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFL-AACSSGDTEEVLRL 59
Query: 126 EKHGAKP 132
+ GA
Sbjct: 60 LERGADI 66
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 51.3 bits (124), Expect = 2e-07
Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 5/78 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D DG P L A+ E + L+++ D+ + +TA VA
Sbjct: 223 YDVNIKDYDGWT--P---LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDIL 277
Query: 86 TEVVSLLLERGADVDPKD 103
+ L ++ K
Sbjct: 278 GYLEELQKKQNLLHSEKR 295
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 95.2 bits (238), Expect = 6e-23
Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 148 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 202
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E +LL+ A+ D D P A +H++++LL+
Sbjct: 203 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 1e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 188 NREETPLFLAAREGSYETAKVLLDHFA 214
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 6e-20
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 81 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 135
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 136 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 181
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-19
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 61 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 120
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+TPL A +++ L A
Sbjct: 121 MHDGTTPLILAARLAVEGMLEDLINSHA 148
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 2e-18
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 39 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 99 SADAQGVFQILIRNRAT 115
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 72.1 bits (178), Expect = 8e-15
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 14/83 (16%)
Query: 64 IDVNFRDIDNRTALHVAACQGFT-------------EVVSLLLERGADV-DPKDRWGSTP 109
+DVN R D T L +A+C G V+S + +GA + + DR G T
Sbjct: 1 MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y + K L + A
Sbjct: 61 LHLAARYSRSDAAKRLLEASADA 83
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 55.9 bits (136), Expect = 3e-09
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ E P L A E E K LLD + + D +R +A +
Sbjct: 181 ANKDMQNNREE--TP---LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMH 235
Query: 86 TEVVSLLLERGADVDPK 102
++V LL
Sbjct: 236 HDIVRLLDLEHHHHHHH 252
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-23
Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 21/181 (11%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MMI 227
VA+K++ + + ++ + R E+A+L+ + HPNVV+ T S + +
Sbjct: 40 VALKRVRVQ--TGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
V E++ + DL +L + + T + RG+++LH ++ ++HRDL+P NIL
Sbjct: 97 VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 152
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
SG +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 153 VTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 346 E 346
E
Sbjct: 211 E 211
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-23
Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 2/108 (1%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
RK P L+ A ++E +++ + D + + + TALH A C
Sbjct: 6 RKAGSPRKARRARLN--PLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAIC 63
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V L+ GA+V+ D G TPL A + + L +HGA
Sbjct: 64 GANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGA 111
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-18
Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 8/109 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +++G L + + L+ +G +VN D T LH AA
Sbjct: 45 NDPSQPNEEGI--TA---LHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCND 99
Query: 86 TEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKN--HEVIKLLEKHGAK 131
T + L++ GA + G+T Y+ + L
Sbjct: 100 TVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQS 148
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 1/67 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L D + + AL + F + +S V +D T A
Sbjct: 139 ATYLADVEQSMGLMNSGAVYALWDYS-AEFGDELSFREGESVTVLRRDGPEETDWWWAAL 197
Query: 116 YKNHEVI 122
+ +
Sbjct: 198 HGQEGYV 204
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 11/88 (12%), Positives = 21/88 (23%), Gaps = 7/88 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
E + ++ ++ + + + + V RD T AA
Sbjct: 145 VEQSMGLMNSGAVY------ALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALH 198
Query: 84 GFTEVV-SLLLERGADVDPKDRWGSTPL 110
G V V P+
Sbjct: 199 GQEGYVPRNYFGLFPRVKPQRSKVKHHH 226
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 3/47 (6%)
Query: 89 VSLLLERGADVDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +L + R L DA EV++ K P
Sbjct: 1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDP 47
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 90.1 bits (225), Expect = 8e-23
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 19 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 74.7 bits (185), Expect = 4e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 53.1 bits (129), Expect = 2e-09
Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
A++N D +G P L A +E +K LL++G DVN +D + RT LH+AA
Sbjct: 24 AGADVNAKDKNGR--TP---LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 84 GFTEVVSLLLERGA 97
G EVV LLLE GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 9e-23
Identities = 19/204 (9%), Positives = 38/204 (18%), Gaps = 41/204 (20%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT----- 229
A+K + + + ++ + + P V
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 230 --------------------EYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARG 262
DL +G + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
L ++H P N+ G L + D K Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVPVTYAP 259
Query: 323 PEVFKNEE--YDTKVDVFSFALIL 344
E + ++ + L +
Sbjct: 260 REFLNASTATFTHALNAWQLGLSI 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 13/173 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ I +E +L+K+ VV A + +V + GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+ G + AV +A +I G+ LH + I++RDL+P NIL DD G+++++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
G++ V E + + Y+APEV KNE Y D ++ +L E
Sbjct: 330 LGLAV--HVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 1e-22
Identities = 32/87 (36%), Positives = 48/87 (55%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + LL +G+ + R +RT LH+AA +G +V +LL+ GADV+ KD
Sbjct: 38 LHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKD 97
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
T L A + + EV++LL K+GA
Sbjct: 98 MLKMTALHWATEHNHQEVVELLIKYGA 124
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 7e-21
Identities = 28/83 (33%), Positives = 44/83 (53%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A+E ++ LL G DVN +D+ TALH A EVV LL++ GADV +
Sbjct: 71 LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++ T +I N ++ ++L+
Sbjct: 131 KFCKTAFDISIDNGNEDLAEILQ 153
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 1e-20
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G D + LH+AA G +LL G D +
Sbjct: 6 LLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ TPL A + ++++L KHGA
Sbjct: 65 KVDRTPLHMAASEGHANIVEVLLKHGA 91
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 70.5 bits (174), Expect = 6e-15
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GA D G++PL A Y + ++L + G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV 58
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 1e-22
Identities = 20/85 (23%), Positives = 33/85 (38%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+++LL D+N + LH A G +V L+ GA V +++G P+ A
Sbjct: 88 VQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKA 147
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVK 140
+ + EK G P
Sbjct: 148 PLRELLRERAEKMGQNLNRIPYKDT 172
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 1e-21
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ E +LN DD G P L + E ++ L+ G +N + + T LH+AA
Sbjct: 26 DNTENDLNQGDDHGF--SP---LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAA 80
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ AD++ + G+ PL A ++ +V + L +GA
Sbjct: 81 SHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALV 131
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 7e-14
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + +G V L L+ D++ D G +PL A V+++L
Sbjct: 2 SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 93.6 bits (234), Expect = 2e-22
Identities = 30/88 (34%), Positives = 43/88 (48%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V+ L+ +G +++ D RT L AA E V L++ GA VDPKD
Sbjct: 15 LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
GST L A ++EV++ L +G
Sbjct: 75 AEGSTCLHLAAKKGHYEVVQYLLSNGQM 102
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 89.0 bits (222), Expect = 7e-21
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL + D++ +I + LH+AA + + V L L R +DV K++ G TPL A
Sbjct: 160 AEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASL 219
Query: 116 YKNHEVIKLLEKHGA 130
+ K
Sbjct: 220 NSQVWSALQMSKALQ 234
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 9e-21
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL G D+N RD + LH AA G ++ +LL D+ + G +PL A
Sbjct: 127 VKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186
Query: 116 YKNHEVIKLLEKHGA 130
++ + L +
Sbjct: 187 ENRYDCVVLFLSRDS 201
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 2e-20
Identities = 20/67 (29%), Positives = 34/67 (50%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
++ + R+ LH AA G ++ +L++ GA++D TPL +A + E +K
Sbjct: 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVK 61
Query: 124 LLEKHGA 130
L K GA
Sbjct: 62 YLIKAGA 68
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 2e-20
Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A ++ D +G L A + E ++ LL +G +DVN +D T + A
Sbjct: 68 ALVDPKDAEGS--TC---LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYK 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL +G+D++ +D + L A + ++ ++L
Sbjct: 123 HVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDL 170
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 54.0 bits (131), Expect = 1e-08
Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ +L+ ++ G+ P L A E + + L DV ++ + T L A+
Sbjct: 166 AKCDLHAVNIHGD--SP---LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLN 220
Query: 84 GFTEVVSLLLERGAD 98
+ + D
Sbjct: 221 SQVWSALQMSKALQD 235
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 2e-22
Identities = 26/77 (33%), Positives = 39/77 (50%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
E + LL G + + +D +H AA GF + + LLE ADV+ +D G+ PL A
Sbjct: 51 EIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLA 110
Query: 114 IYYKNHEVIKLLEKHGA 130
+ V++ L KH A
Sbjct: 111 AKEGHLRVVEFLVKHTA 127
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 7e-21
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D+E + LL + ++VN ++ RTAL V G E+ LL RGA+ D KD
Sbjct: 9 LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
R G + DA + ++ L + A
Sbjct: 68 RTGFAVIHDAARAGFLDTLQTLLEFQA 94
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 8e-21
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D G + A ++ ++ LL+ DVN D + LH+AA +G
Sbjct: 61 ANPDLKDRTGF--AV---IHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGH 115
Query: 86 TEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
VV L++ A +V ++ G T A Y +EV+ L++ +GA
Sbjct: 116 LRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 70.5 bits (174), Expect = 7e-15
Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
L AA +G E ++ LL+ +V+ ++ +G T L N E+ + L GA
Sbjct: 4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGAN 62
Query: 132 P 132
P
Sbjct: 63 P 63
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-22
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGD--TA---LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-22
Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQG 84
+L + DG P L +D E ++ L D+G D+N + RT LH+A
Sbjct: 149 LQLEAENYDGH--TP---LHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQ 203
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V+ LLL+ GAD + G TPLG A+ N + +LL HGA
Sbjct: 204 AASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPE 251
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 1/115 (0%)
Query: 19 PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH 78
R+ + L D + + + E D + + + D T LH
Sbjct: 104 HPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLH 163
Query: 79 VAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VA E+V LL + GAD++ + G TPL A+ + V++LL K GA P
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADP 218
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ LL +G D R RT L A + + LL GA +P +
Sbjct: 208 LELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGS 267
Query: 116 YKNHEVIKLLEKHG 129
+ + +++
Sbjct: 268 DSDSDNRDEGDEYD 281
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 14/101 (13%), Positives = 24/101 (23%), Gaps = 14/101 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + +++L +G V + TALH+A +LL+
Sbjct: 49 LHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDA 108
Query: 104 RWGSTPLGDAIYYKN--------------HEVIKLLEKHGA 130
+E E
Sbjct: 109 SDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRL 149
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 10/171 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + A + V EY G+L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I + YLH +++RD++ N++ D G++K+ DFG
Sbjct: 94 FHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
+ K T C Y+APEV ++ +Y VD + +++ E
Sbjct: 151 LCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 178 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSP--------MMI 227
VA+KK+ E ++ + A R E+ +LQ ++H NVV + + + +
Sbjct: 45 VALKKVLME--NEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101
Query: 228 VTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
V ++ DL L S R + G+ Y+H NK I+HRD++ +N+L
Sbjct: 102 VFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 157
Query: 287 DDSGNLKVADFGVSKLLTV---KEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 342
G LK+ADFG+++ ++ + T + + Y PE+ +Y +D++
Sbjct: 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 217
Query: 343 ILQE 346
I+ E
Sbjct: 218 IMAE 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I +E L+L+ P +V A + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL L + G + +A +I G+ ++H +++RDL+P+NIL D+ G+++++
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334
Query: 296 DFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF-KNEEYDTKVDVFSFALILQE 346
D G++ + +P S Y+APEV K YD+ D FS +L +
Sbjct: 335 DLGLACD--FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 2e-22
Identities = 35/89 (39%), Positives = 46/89 (51%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L F A V ++ LL G DV+ +D LH A G EV LL++ GA V+ D
Sbjct: 46 LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVAD 105
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A +E+ KLL +HGA P
Sbjct: 106 LWKFTPLHEAAAKGKYEICKLLLQHGADP 134
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 85.1 bits (212), Expect = 4e-20
Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L+ G VN D+ T LH AA +G E+ LLL+ GAD K+R G+TPL D + +
Sbjct: 94 LVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL-DLVKDGD 152
Query: 119 HEVIKLLEKHGA 130
++ LL A
Sbjct: 153 TDIQDLLRGDAA 164
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 84.4 bits (210), Expect = 7e-20
Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ A DVE +K+L ++ + T LH AA VV LL+ GADV K
Sbjct: 12 LLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAK 71
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D+ G PL +A Y ++EV +LL KHGA
Sbjct: 72 DKGGLVPLHNACSYGHYEVAELLVKHGA 99
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 4e-14
Identities = 20/69 (28%), Positives = 26/69 (37%), Gaps = 4/69 (5%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEV 121
G N + L AA G E V L + + STPL A Y V
Sbjct: 1 GAMGN---SEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57
Query: 122 IKLLEKHGA 130
++ L +HGA
Sbjct: 58 VEYLLQHGA 66
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 47.0 bits (113), Expect = 1e-06
Identities = 13/42 (30%), Positives = 18/42 (42%), Gaps = 1/42 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
K LL G D ++ D T L + G T++ LL A
Sbjct: 124 CKLLLQHGADPTKKNRDGNTPLDLVK-DGDTDIQDLLRGDAA 164
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 9/171 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I ++YLH K +++RDL+ N++ D G++K+ DFG
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
+ K T C Y+APEV ++ +Y VD + +++ E
Sbjct: 295 LCKEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 3e-22
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L A DV+ ++ LL + + + +TAL V G T + LL++GA + +
Sbjct: 6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D G++P+ DA + +K+L +HGA
Sbjct: 65 DTSGTSPVHDAARTGFLDTLKVLVEHGA 92
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 89.0 bits (222), Expect = 1e-21
Identities = 23/73 (31%), Positives = 36/73 (49%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
ELL G N +D + +H AA GF + + +L+E GADV+ D G+ P+ A+
Sbjct: 51 ALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQ 110
Query: 116 YKNHEVIKLLEKH 128
+ V+ L
Sbjct: 111 EGHTAVVSFLAAE 123
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 84.8 bits (211), Expect = 4e-20
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D G P + A ++ +K L++ G DVN D +H+A +G
Sbjct: 59 ASPNVQDTSGT--SP---VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGH 113
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
T VVS L +D+ +D G TPL A+ +++ +L+ H
Sbjct: 114 TAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 3e-12
Identities = 17/60 (28%), Positives = 24/60 (40%), Gaps = 4/60 (6%)
Query: 75 TALHVAACQGFTEVV-SLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGAKP 132
L AA +G + V LL D +R+G T L ++ + L K GA P
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMF--GSTAIALELLKQGASP 61
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQG 84
+++ +D++G L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 68 RDVDAVDENGR--TA---LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYV 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 123 RPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 169
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 49 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADI 137
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 115 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 174
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + ++ EV +++EK G
Sbjct: 175 ---VINVLEGQVFEYAEVDEIVEKRGK 198
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-10
Identities = 9/69 (13%), Positives = 17/69 (24%), Gaps = 4/69 (5%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
I + + + G + ADV + TP A + + +
Sbjct: 6 IIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALS 62
Query: 124 LLEKHGAKP 132
L
Sbjct: 63 QL-LEDRDV 70
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 12/106 (11%), Positives = 27/106 (25%), Gaps = 16/106 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++ D+ G L + G + + + +
Sbjct: 135 ADIEVEDERGL--TA---LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEY 186
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EV ++ +RG G + + + H A+
Sbjct: 187 AEVDEIVEKRGK--------GKDVEYLVRWKDGGDCEWVKGVHVAE 224
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 4/48 (8%), Positives = 14/48 (29%), Gaps = 2/48 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
++ + + ++ + + + A+ KD L
Sbjct: 189 VDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD--YEDGL 234
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-22
Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 18/120 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANE------RDVEGIKELLDSGIDVNFRDIDNRTALHV 79
A++ +G L E K L+ G D+ + +
Sbjct: 66 ADIKSRTKEGT--TL---FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFK 120
Query: 80 AACQGFTEVVS-------LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
F + + + G + KD+WG T L + +K++E + K
Sbjct: 121 NIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-15
Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 9/96 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN---RTALHVAACQGFTEVVSLLLERGADVD 100
+ A E EL + G + + + L + ++ L+ +GAD+
Sbjct: 10 VSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIK 69
Query: 101 PKDRWGSTPLGDAIYYKNH------EVIKLLEKHGA 130
+ + G+T + E+ K+ + GA
Sbjct: 70 SRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-11
Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 12/85 (14%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-------LLDSGIDVNFRDIDNRTALH 78
A++ L + + V+ + SG+ + +D TAL
Sbjct: 105 ADITALYKPYK--IV---VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALE 159
Query: 79 VAACQGFTEVVSLLLERGADVDPKD 103
+ ++ + + K+
Sbjct: 160 FVKRCQKPIALKMMEDYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-08
Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
+ + AA G E L E+G + K L + +++ L
Sbjct: 4 MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63
Query: 128 HGA 130
GA
Sbjct: 64 KGA 66
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 3e-22
Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++ + L
Sbjct: 120 EQGHRDIARYLHAATG 135
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 1e-21
Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ L + L A VE +++LL++G D N + R + V G
Sbjct: 3 PGIHMLGGSSD--AG---LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGS 56
Query: 86 TEVVSLLLERGADVDPKDRWGST-PLGDAIYYKNHEVIKLLEKHGA 130
+V LLL GA+ + D T P+ DA + + +L + GA
Sbjct: 57 AQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGA 102
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 84.4 bits (210), Expect = 3e-20
Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EV 121
++ + L AA +G E V LLE GAD + +R+G P+ + +V
Sbjct: 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM--GSAQV 59
Query: 122 IKLLEKHGAKP 132
+LL HGA+P
Sbjct: 60 AELLLLHGAEP 70
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 3e-11
Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 4/73 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ D R + +A QG
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGH 123
Query: 86 TEVVSLLLERGAD 98
++ L D
Sbjct: 124 RDIARYLHAATGD 136
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 3e-22
Identities = 33/87 (37%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN D T LH+AA G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E++++L K+GA
Sbjct: 78 HAGMTPLRLAALFGHLEIVEVLLKNGA 104
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 90.1 bits (225), Expect = 6e-22
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D G P L A +E ++ LL +G DVN D T L +AA G
Sbjct: 38 ADVNAEDASGW--TP---LHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+V +LL+ GADV+ D G TPL A + + E++++L K+GA
Sbjct: 93 LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGA 137
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 89.0 bits (222), Expect = 2e-21
Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D G P L A +E ++ LL +G DVN D++ T LH+AA G
Sbjct: 71 ADVNAVDHAGM--TP---LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGH 125
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+V +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 126 LEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 73.9 bits (183), Expect = 4e-16
Identities = 22/61 (36%), Positives = 34/61 (55%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
D L AA G + V +L+ GADV+ +D G TPL A + + E++++L K+G
Sbjct: 11 GSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNG 70
Query: 130 A 130
A
Sbjct: 71 A 71
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 3e-22
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ AN+RD + +KE+L V+ D + T L++A E+ L++RGAD++ +
Sbjct: 9 LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ +P A E++ + KH
Sbjct: 69 NSISDSPYLYAGAQGRTEILAYMLKHAT 96
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 81.3 bits (202), Expect = 2e-18
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 44 LMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAAC-----QGFTEVVSLLLERGA 97
L+ A + ++ +K LL+ G D++F++ TAL A Q + ++V LL+E GA
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169
Query: 98 DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
D KD G T + A E+ K+L ++
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKILAQY 200
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 4e-17
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)
Query: 56 IKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPLGDA 113
+ +L D+N + AL AA +G + V LLLE G D+D ++ +G T L +A
Sbjct: 88 LAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEA 147
Query: 114 IYY----KNH-EVIKLLEKHGA 130
+ + + +++KLL ++GA
Sbjct: 148 VGLREGNQLYQDIVKLLMENGA 169
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 76.3 bits (189), Expect = 1e-16
Identities = 17/62 (27%), Positives = 28/62 (45%)
Query: 69 RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + L A + +V +L + VD D G+TPL A++ + E+ K L
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 4e-22
Identities = 32/87 (36%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN +D T L++A G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E+ ++L KHGA
Sbjct: 78 AIGFTPLHLAAFIGHLEIAEVLLKHGA 104
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 85.1 bits (212), Expect = 2e-20
Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D+ G P L +E ++ LL +G DVN D T LH+AA G
Sbjct: 38 ADVNAKDEYGL--TP---LYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+ +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 93 LEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKL 135
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 72.0 bits (178), Expect = 1e-15
Identities = 23/59 (38%), Positives = 35/59 (59%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GADV+ KD +G TPL A + + E++++L K+GA
Sbjct: 13 DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGA 71
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 33/190 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKG 235
A+K++ IS A R E+ALL++++HPNV+ + + + +Y
Sbjct: 51 YALKQIEGTGISMS----ACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104
Query: 236 DLRAFLK---------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
DL +K + L I G++YLH N ++HRDL+P+NIL
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161
Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-----YVAPEV-FKNEEYDTKVD 336
+ G +K+AD G ++L +PL D Y APE+ Y +D
Sbjct: 162 MGEGPERGRVKIADMGFARLFNS-PLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAID 218
Query: 337 VFSFALILQE 346
+++ I E
Sbjct: 219 IWAIGCIFAE 228
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 5e-22
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 48 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 107 MRGGLTALHMAAGYVRPEVVEALVELGADI 136
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-21
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 26 AELNGLDDDGEEIKPEFR--LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAAC 82
+++ +D++G R L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 67 RDVDAVDENG-------RTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 120 YVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 168
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 9e-12
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 17/85 (20%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKH 128
VI +LE
Sbjct: 174 -----------------VINVLEGQ 181
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 8e-11
Identities = 9/69 (13%), Positives = 18/69 (26%), Gaps = 4/69 (5%)
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ I + + + G + ADV + TP A + +
Sbjct: 3 NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQA 59
Query: 122 IKLLEKHGA 130
+ L
Sbjct: 60 LSQL-LEDR 67
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 6e-22
Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 19/105 (18%)
Query: 47 LANERDVEG-------------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
+A D +G + G +++ + +T LH+A
Sbjct: 1 MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60
Query: 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VV LL+ GA DR G T A +++ ++ L A
Sbjct: 61 VVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPG 105
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 3e-21
Identities = 22/87 (25%), Positives = 39/87 (44%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD K+
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A + ++++ A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 3e-20
Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 1/78 (1%)
Query: 56 IKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ LL+ G D++ DI + R+ L A +V LLL+ GA+V+ + GS+ L A
Sbjct: 132 VQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191
Query: 115 YYKNHEVIKLLEKHGAKP 132
+++ L + GA
Sbjct: 192 GRGLLPLVRTLVRSGADS 209
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 84.4 bits (210), Expect = 3e-19
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
EL+ ++ + P L ++ L+ +G D +TA H+A
Sbjct: 37 RELDIYNNLRQ--TP---LHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRS 91
Query: 86 TEVVSLLLERGA----DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LL+ A D++ ++ G T L A+ + E ++LL + GA
Sbjct: 92 PTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGA 140
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 84.4 bits (210), Expect = 3e-19
Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG----IDVNFRDIDNRTALHVAA 81
A LD G+ R ++ LLDS +D+ R+ D TALHVA
Sbjct: 70 ASPMALDRHGQ--TA---AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAV 124
Query: 82 CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGA 130
E V LLLERGAD+D D G +PL A+ + +++LL +HGA
Sbjct: 125 NTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 174
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 6e-22
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
++ E +EL+++G DV D +N T LH AA ++V + +GA VD
Sbjct: 13 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72
Query: 104 R-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
STPL A + ++ L K+GA P
Sbjct: 73 GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 6e-21
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ D + LL + VN D TALH A G T V+SLLLE GA+VD ++ G
Sbjct: 154 HSVDP--TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGE 211
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAK 131
+ L A KN +I L++
Sbjct: 212 SALDLAKQRKNVWMINHLQEARQA 235
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 9e-20
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ +L+ G D + D + + +H+AA G T +V+ L+ +G DVD D+ G TPL A Y
Sbjct: 92 VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151
Query: 116 YKNH-EVIKLLEKHGA 130
+ + +LL
Sbjct: 152 RTHSVDPTRLLLTFNV 167
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 1e-19
Identities = 28/134 (20%), Positives = 49/134 (36%), Gaps = 16/134 (11%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQG 84
++ D + L + A ++ +K + G V+ D N T LH A QG
Sbjct: 33 YDVRQPDKENV--TL---LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQG 87
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLM 134
+V L++ GAD D G + + A + + ++ L G PLM
Sbjct: 88 HLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLM 147
Query: 135 APMHVKHAREVPEY 148
+ H+ +
Sbjct: 148 WAAYRTHSVDPTRL 161
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 84.0 bits (209), Expect = 4e-19
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + +D +G + A + L+ G DV+ D + T L AA +
Sbjct: 100 ADPSLIDGEGC--SC---IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTH 154
Query: 86 T-EVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + LLL V+ D++ +T L A+ N VI LL + GA
Sbjct: 155 SVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 4e-17
Identities = 16/65 (24%), Positives = 24/65 (36%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + A G E L+E G DV D+ T L A +++K
Sbjct: 2 MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61
Query: 126 EKHGA 130
GA
Sbjct: 62 ISKGA 66
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 57.4 bits (140), Expect = 7e-10
Identities = 12/60 (20%), Positives = 27/60 (45%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + I LL++G +V+ ++I +AL +A + +++ L E +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 6e-22
Identities = 40/75 (53%), Positives = 51/75 (68%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 18 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 77
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 78 NGHLEVVKLLLEAGA 92
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 8e-22
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 52 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 111
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 112 GHLEVVKLLLEAGA 125
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 75.1 bits (186), Expect = 7e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 54.3 bits (132), Expect = 2e-09
Identities = 24/42 (57%), Positives = 30/42 (71%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
+K LL++G DVN +D + RT LH+AA G EVV LLLE GA
Sbjct: 84 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 8e-22
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + +V + LL++G N + N LH AA T++V +LL G D D
Sbjct: 35 SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T L A+ N + +KL K
Sbjct: 93 DKGNTALYYAVDSGNMQTVKLFVKKNW 119
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 9e-21
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
N + +K L S D D+ +A + A +V LL GA + +
Sbjct: 7 INTWKSKQLKSFL-SSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NE 63
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
PL A ++ +++K+L G
Sbjct: 64 FPLHQAATLEDTKIVKILLFSGLDD 88
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-20
Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D + +K LL SG+D + D TAL+ A G + V L +++ +
Sbjct: 66 LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125
Query: 104 RWG-STPLGDAIYYKNHEVIKLLEKHGA 130
+ G T A+ + ++
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIP 153
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 7e-18
Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
L G + DV + L F + +H+ G
Sbjct: 119 WRLMFYGKTGWKT-S---FYHAVMLNDVSIVSYFLSEI-PSTFDLAILLSCIHITIKNGH 173
Query: 86 TEVVSLLLERGADVDPKDRWGSTP-LGDAIYYKNHEVIKLLEKHGA 130
+++ LLL+ + + P + AI K+ E+++ L K+
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDI 219
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 8/81 (9%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111
V+ + LLD N + + +A E++ L + ++ +
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANL 226
Query: 112 DAIYYKNHEVIKLLEKHGAKP 132
+ + + E+ K++ + +
Sbjct: 227 ENVLLDDAEIAKMIIEKHVEY 247
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 8e-11
Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 13/97 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N + + + +D+E ++ L I++ +A
Sbjct: 185 TSTNTNNSLLFIPD----IKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDD 233
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
E+ +++E+ + + K E+I
Sbjct: 234 AEIAKMIIEKHVEYKSDSYTKDLDI--VKNNKLDEII 268
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++ +E +LQ + P +V+ + +S + +V EY+ G++
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L+R G A +A I YLH +I+RDL+P N+L D G ++V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
+ K + T T C +APE+ ++ Y+ VD
Sbjct: 187 FA-----KRVKGRT--WTLCGTPEALAPEIILSKGYNKAVD 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 11/172 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E L + P + Q + V EY+ GDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
G+ K T C Y+APE+ + Y VD ++F ++L E
Sbjct: 487 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + IV
Sbjct: 50 ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
LK+ DFG+++ T +T + Y APEV Y VD++S I+ E
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + F + GT+ + G A+K + +V D++ + E+ +L+
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEE--EIKQEINMLK 75
Query: 206 KI-RHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFA 256
K H N+ + GA + +P + +V E+ G + +K + LK
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+I RG+++LH++K +IHRD++ N+L ++ +K+ DFGVS L R T T
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 317 SCRYVAPEVFKNEE-----YDTKVDVFS 339
++APEV +E YD K D++S
Sbjct: 193 PY-WMAPEVIACDENPDATYDFKSDLWS 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 26/134 (19%), Positives = 51/134 (38%), Gaps = 11/134 (8%)
Query: 172 FWRGI------QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
FW+ + QVA+ + + + DD ++ L +I P V + L V +
Sbjct: 47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
++V E++ G L+ + P A+R +A + H + PS +
Sbjct: 107 LVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVR 161
Query: 286 RDDSGNLKVADFGV 299
G++ +A
Sbjct: 162 VSIDGDVVLAYPAT 175
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 28/87 (32%), Positives = 46/87 (52%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + E + + ++ ++ D + + + TALH A C G TE+V L++ G +V+ D
Sbjct: 41 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A N +V K L + GA
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGA 127
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +D+G I L E +K L+ G++VN D D T LH AA
Sbjct: 61 DDPSLPNDEG--ITA---LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNN 115
Query: 86 TEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+V L+E GA V D + + + + + L K
Sbjct: 116 VQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 165
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-18
Identities = 16/77 (20%), Positives = 33/77 (42%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ E + G+ V F L ++ +G ++V ++ D + G T L +A
Sbjct: 19 KTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNA 77
Query: 114 IYYKNHEVIKLLEKHGA 130
+ + E++K L + G
Sbjct: 78 VCAGHTEIVKFLVQFGV 94
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 8/63 (12%), Positives = 19/63 (30%), Gaps = 1/63 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
+I + +L + S + G V L D+ ++++ +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60
Query: 130 AKP 132
P
Sbjct: 61 DDP 63
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 13/124 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN---FRDIDNRTALHVAAC 82
+N D DG P L A+ +V+ K L++SG V + D+
Sbjct: 94 VNVNAADSDGW--TP---LHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEME 148
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142
+G+T+ L + ++ L Y+ +L K G M +H +
Sbjct: 149 EGYTQCSQFLYGVQEKMGIMNKGVIYAL---WDYEPQNDDELPMKEGDC--MTIIHREDE 203
Query: 143 REVP 146
E+
Sbjct: 204 DEIE 207
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP- 101
L+ A E DV+ + +LL G +V+ R TALH+AA E +L+E ++
Sbjct: 7 LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66
Query: 102 ----KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G T L A+ +N +++ L GA
Sbjct: 67 PMTSELYEGQTALHIAVINQNVNLVRALLARGA 99
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 28/105 (26%), Positives = 40/105 (38%), Gaps = 17/105 (16%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-------------RTALHVAACQGFTEVVS 90
L ++V ++ LL G V+ R + L AAC G E+V
Sbjct: 79 LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEV----IKLLEKHGAK 131
LL+E GAD+ +D G+T L I N LL +
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG 183
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 23/123 (18%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA 80
E++ GE L A ++E L+++ ++ + +TALH+A
Sbjct: 28 CEVHQRGAMGETA-----LHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA 82
Query: 81 ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEK 127
+V LL RGA V + +G PL A + E+++LL +
Sbjct: 83 VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIE 142
Query: 128 HGA 130
HGA
Sbjct: 143 HGA 145
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 22/97 (22%), Positives = 33/97 (34%), Gaps = 10/97 (10%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS----LLLERGADV 99
L F A E ++ L++ G D+ +D T LH+ Q LLL
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184
Query: 100 DPK------DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
K + G TP A N + + L +
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRK 221
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-13
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 1/67 (1%)
Query: 75 TALHVAACQGFTEVVS-LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
+ L +AA + + +S LL G +V + G T L A Y N E +L + + +
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELV 64
Query: 134 MAPMHVK 140
PM +
Sbjct: 65 FEPMTSE 71
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 2e-21
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 46 FLANERDVEG---------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90
FL N RD I +L+++ + +DI+ TAL A +
Sbjct: 26 FLRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAE 85
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL +G++V+ KD G TPL +I + E+ L +HGA
Sbjct: 86 KLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGA 125
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 3e-21
Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++LL G +VN +D +T L + G++E+ LLE GA+V+ ++
Sbjct: 72 LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A Y E++K L + GA
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGA 158
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 2e-20
Identities = 30/87 (34%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
LM+ E LL+ G +VN R+++ T L VA+ G +E+V LLE GAD+ +D
Sbjct: 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T A + EVIK+ +
Sbjct: 165 LTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (124), Expect = 5e-08
Identities = 9/64 (14%), Positives = 19/64 (29%), Gaps = 6/64 (9%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ D + + + + + L +D + TPL A I L
Sbjct: 2 SHMDKNGEIVEKIKDEKSINQNLDFLRNY------RDSYNRTPLMVACMLGMENAIDKLV 55
Query: 127 KHGA 130
++
Sbjct: 56 ENFD 59
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQG 84
+NGLD G L + + + ++ L I++N ++ TALH AA +G
Sbjct: 97 VGVNGLDKAGS--TA---LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKG 151
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ ++V LLL +GA D ++ A ++K + A
Sbjct: 152 YADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVR 199
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-18
Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E ++ + D + ++ + L V + LH AA +
Sbjct: 34 EEGDIIYITDMSDT-----NWWKGTSK-----GRTGLIPSNYVAEQAESIDNPLHEAAKR 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
G + L+ V+ D+ GST L A + + ++++ L +
Sbjct: 84 GNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNI 131
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 11/89 (12%), Positives = 24/89 (26%), Gaps = 5/89 (5%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + EL D+ + + T +G T ++ V +
Sbjct: 16 VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A N ++ +
Sbjct: 71 ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 9/58 (15%), Positives = 20/58 (34%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ LL G + R+I+ + A +A ++ A + D+
Sbjct: 156 VQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDS 213
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 7/66 (10%), Positives = 12/66 (18%), Gaps = 5/66 (7%)
Query: 74 RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL-----EKH 128
+ + A L D+ T +I +
Sbjct: 13 QVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAES 72
Query: 129 GAKPLM 134
PL
Sbjct: 73 IDNPLH 78
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 3e-21
Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D +D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ +V + L
Sbjct: 120 ELGHRDVARYLRAAAG 135
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-20
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A VE ++ LL++G + N + R + V G V LLL GA+ + D
Sbjct: 16 LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74
Query: 104 RWGST-PLGDAIYYKNHEVIKLLEKHGAKP 132
T P+ DA + + +L + GA+
Sbjct: 75 PATLTRPVHDAAREGFLDTLVVLHRAGARL 104
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 9e-17
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 5/74 (6%)
Query: 60 LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
++ + + L AA +G E V LLE GA+ + + +G P+ +
Sbjct: 1 MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMM--GS 56
Query: 120 -EVIKLLEKHGAKP 132
V +LL HGA+P
Sbjct: 57 ARVAELLLLHGAEP 70
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 1e-13
Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 9/96 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ RD R + +A G
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+V L GS ++
Sbjct: 124 RDVARYLRAAAGGTR-----GSNHARIDAAEGPSDI 154
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 145 VPEYEIDPHELD-FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
E E+D F +GTF L + G+ VA+KK+ D R
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNR 65
Query: 199 D--ELALLQKIRHPNVVQFLGAVTQSSP-------MMIVTEYLPKGDL----RAFLKRKG 245
+ + L + HPN+VQ + +V EY+P L R + +R+
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 304
A P F + R + LH V + HRD++P N+L + G LK+ DFG +K L+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 305 VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
P S Y APE+ F N+ Y T VD++S I E
Sbjct: 184 --PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 4e-21
Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 13/161 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +E++ +V DE +L + HP +++ G + + ++ +Y+ G+L
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L++ A +A ++ + YLH II+RDL+P NIL D +G++K+ DFG
Sbjct: 95 SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
+ K +T T C Y+APEV + Y+ +D
Sbjct: 152 FA-----KYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSID 185
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 30/185 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T +S + +V
Sbjct: 49 GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL+ + K + +G+ Y+H ++HRDL+P N+ ++
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
LK+ DFG+++ D +T YV APEV Y+ VD++S
Sbjct: 162 DCELKILDFGLAR----HADAEMT------GYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 342 LILQE 346
I+ E
Sbjct: 212 CIMAE 216
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 35/195 (17%)
Query: 174 RGIQVAVKKLGEEVISDDDRV---------RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
GI VA+K++ V R R E+ LL HPN++
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 225 MM-----IVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+VTE + DL + ++ + P F I G++ LHE ++HRD
Sbjct: 104 PAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEY 331
L P NIL D+ ++ + DF +++ D T YV APE+ + + +
Sbjct: 160 LHPGNILLADNNDITICDFNLAR--EDTADANKT------HYVTHRWYRAPELVMQFKGF 211
Query: 332 DTKVDVFSFALILQE 346
VD++S ++ E
Sbjct: 212 TKLVDMWSAGCVMAE 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-21
Identities = 50/162 (30%), Positives = 85/162 (52%), Gaps = 11/162 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 98 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
G+ K D T T C Y+APE+ + E+Y VD
Sbjct: 155 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVD 192
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E +L + P + Q + V EY+ GDL
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
G+ K T C Y+APE+ + Y VD
Sbjct: 166 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVD 203
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-21
Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++V+ DD V E +L HP + + V EYL GDL
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++ S A +A +I G+ +LH I++RDL+ NIL D G++K+ADF
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
G+ K + + + +T C Y+APE+ ++Y+ VD +SF ++L E
Sbjct: 163 GMCKENMLGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 9e-21
Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 1/91 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L + + ++ L+ G DVN ++ N RTALH+A ++VSLLL+ GADV+
Sbjct: 121 LHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRV 180
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
G +P + + + L + + L
Sbjct: 181 TYQGYSPYQLTWGRPSTRIQQQLGQLTLENL 211
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 3e-20
Identities = 21/87 (24%), Positives = 38/87 (43%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+E I+++ +NF++ +T LH+A E+ LL G D + +D G+TP
Sbjct: 22 ALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTP 81
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136
L A + +L + P +
Sbjct: 82 LHLACEQGCLASVGVLTQSCTTPHLHS 108
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-18
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 12/114 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHV 79
+ D G P L + + + L S + + + T LH+
Sbjct: 69 CDPELRDFRGN--TP---LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL 123
Query: 80 AACQGFTEVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
A+ G+ +V LL+ GADV+ ++ G T L A+ +N +++ LL K GA
Sbjct: 124 ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV 177
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-13
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 70 DIDNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
D + LH+A EV+ + A ++ ++ TPL A+ E+ + L
Sbjct: 5 TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64
Query: 126 EKHGAKP 132
G P
Sbjct: 65 LGAGCDP 71
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-12
Identities = 9/66 (13%), Positives = 17/66 (25%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G DVN + + + T + L + +
Sbjct: 167 VSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTE 226
Query: 116 YKNHEV 121
+ E
Sbjct: 227 SEFTEF 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 27/184 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + +V
Sbjct: 87 DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEVFKNEEYDTKVDVFSFAL 342
LK+ DFG+++ T +T YV APEV Y VD++S
Sbjct: 200 DCTLKILDFGLAR--TAGTSFMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 343 ILQE 346
I+ E
Sbjct: 252 IMGE 255
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 17/179 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + + V FR+E +L + Q A + + +V EY GDL
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L + G P+ RF +I ++ +H +HRD++P NIL D G++++ADF
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-------YDTKVDVFSFALILQE 346
G L + Y++PE+ + Y + D ++ + E
Sbjct: 207 GSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 11/162 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A++ + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
G+ K D T C Y+APE+ + E+Y VD
Sbjct: 198 GMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVD 235
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 55 GIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
G + D ++ D +N +HVAA +G T+ V L+E G ++R+G T L A
Sbjct: 1 GPGSMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLA 60
Query: 114 IYYKNHEVIKLLEKHGAK 131
+ + K L G
Sbjct: 61 CKFGCVDTAKYLASVGEV 78
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 5/111 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A + + ++ L+++G+ ++ TALH+A G + L G
Sbjct: 24 IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV---KHAREVPEYEID 151
G P+ A+ +++ L + + P + REV E
Sbjct: 84 --GQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSH 132
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 24/125 (19%), Positives = 47/125 (37%), Gaps = 10/125 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-----GIDVNFRDIDNRTALHVA 80
A D E P LM R+ E + ++D+ + +++ + + LH A
Sbjct: 164 ASPTAKDKADE--TP---LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWA 218
Query: 81 ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
+ +V +E G DV+ +D + PL ++ + K L + L+
Sbjct: 219 ILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYH 278
Query: 141 HAREV 145
+ V
Sbjct: 279 NGTTV 283
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 8e-19
Identities = 14/86 (16%), Positives = 23/86 (26%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L +G V + + AA EV+ LL E+ +V G
Sbjct: 264 LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTG 323
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V ++ A
Sbjct: 324 AGGAVKRKKKAAPAVKRMKLAPSAPV 349
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 1e-17
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-----GADVDPKDRWGSTPL 110
IK L+ G +D + T L A E + L+++ +D ++ G++ L
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
AI +V + G
Sbjct: 216 HWAILINWEDVAMRFVEMGIDV 237
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 7/75 (9%)
Query: 63 GIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
I + + +TALH G + E++ +L++ GA KD+ TPL A+ ++N E
Sbjct: 128 EIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNRE 187
Query: 121 VIKLL-----EKHGA 130
+ L+ K
Sbjct: 188 ALDLMMDTVPSKSSL 202
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 2/100 (2%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL+++ + NG + + + A+ E ++ L + +V
Sbjct: 263 LLQKT--DVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSL 320
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ V + L A V + R +
Sbjct: 321 NTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSS 360
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 7e-09
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 14/91 (15%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + + L++ + + + EV K
Sbjct: 88 IHLAVMANKTDLVVALVEGAKE------RGQMPESLLNECDEREVN------EIGSHVKH 135
Query: 104 RWGSTPLGDAIYY-KNH-EVIKLLEKHGAKP 132
G T L + + E+IK+L + GA P
Sbjct: 136 CKGQTALHWCVGLGPEYLEMIKILVQLGASP 166
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 4e-04
Identities = 6/43 (13%), Positives = 13/43 (30%)
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
S+ + D + A + ++ L + G P
Sbjct: 4 SMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSP 46
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 37/204 (18%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+A+L ++ H +VV+ L V +V
Sbjct: 78 KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E D + + L ++ G+ Y+H I+HRDL+P+N L +
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------------YV------AP 323
++KV DFG+++ + E+ + +V AP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252
Query: 324 EV-FKNEEYDTKVDVFSFALILQE 346
E+ E Y +DV+S I E
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAE 276
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 2e-20
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 4/93 (4%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV--- 99
L E + ++ELL S + +D D R LH + E+ S LL + +V
Sbjct: 6 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D D G TP A N EV+K L KP
Sbjct: 66 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKP 98
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-19
Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 58 ELL---DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ L D+N T LH+A + + EV L+E GA V KD++ PL A
Sbjct: 89 KSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAA 148
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++I+LL G
Sbjct: 149 SVGSLKLIELLCGLGK 164
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 1e-19
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+LN + + G L ++ E + L+++G V +D N+ LH AA G
Sbjct: 98 PDLNKITNQGV--TC---LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS 152
Query: 86 TEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLL-EKHGAKP 132
+++ LL G + V+ +D+ G TPL A+ + + LL EK+GA+
Sbjct: 153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEY 201
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 82.1 bits (204), Expect = 2e-18
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI---DNRTALHVAAC 82
+ L D DG P L + + + E LL +VN D T H+A
Sbjct: 27 SLLLQKDQDGR--IP---LHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACS 81
Query: 83 QGFTEVVSLLLER--GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G EVV L +R D++ G T L A+ K EV + L ++GA
Sbjct: 82 VGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGA 131
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 4e-15
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 10/105 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQG 84
A + D + P L A+ ++ I+ L G VN++D T L A +G
Sbjct: 131 ASVRIKDKFNQ--IP---LHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEG 185
Query: 85 FTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ LL+E+ GA+ D D G+ N +V K +
Sbjct: 186 HGDAAVLLVEKYGAEYDLVDNKGAKAE---DVALNEQVKKFFLNN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-14
Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LH A + F +V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKME 60
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L HP + Q + V E++ GDL
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
G+ K T T C Y+APE+ + Y VD
Sbjct: 169 GMCKEGICNGVT--T--ATFCGTPDYIAPEILQEMLYGPAVD 206
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-20
Identities = 28/75 (37%), Positives = 37/75 (49%), Gaps = 3/75 (4%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L+ G + D L AA G + V +L+ GADV KD+ GSTPL A
Sbjct: 10 SSGLVPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAAR 66
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 67 NGHLEVVKLLLEAGA 81
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-19
Identities = 30/83 (36%), Positives = 48/83 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DV +D + T LH+AA G EVV LLLE GADV +D
Sbjct: 28 LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++G T +I N ++ ++L+
Sbjct: 88 KFGKTAFDISIDNGNEDLAEILQ 110
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-09
Identities = 9/51 (17%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ S L+ RG+ + L +A + +++L +GA
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGA 48
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 37/180 (20%), Positives = 67/180 (37%), Gaps = 29/180 (16%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVTEY 231
V +K L D + E L ++ HP++VQ V + IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
+ L+ L + A+ + L+I ++YLH +++ DL+P NI+ +
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQ- 219
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
LK+ D G + + + APE+ + D+++ L
Sbjct: 220 LKLIDLGAVSRIN----------SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-20
Identities = 44/183 (24%), Positives = 67/183 (36%), Gaps = 11/183 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA ++ +KE + + D D+RTALH A G TE+V LL+ G V+ K
Sbjct: 10 ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL------MAPMHV---KHAREVPEYEIDPH 153
D G +PL A E++K L GA P+H K+ E+ ++
Sbjct: 70 DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ A +G V L S + + L L
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188
Query: 214 QFL 216
+FL
Sbjct: 189 KFL 191
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 2e-15
Identities = 11/60 (18%), Positives = 23/60 (38%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ N ++A E+ +L + D+ T L A + E+++ L + G
Sbjct: 5 VSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGV 64
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N ++ +G L + A++ E LL+ G + + +D + TA+H AA +G
Sbjct: 97 AHVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGN 151
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
++V +LL A + +D G+TPL A + E K L GA
Sbjct: 152 LKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGAS 197
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-14
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D + A + +++ + LL N +D + T LH+A +
Sbjct: 130 ANPDAKDHYDATA-----MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEER 184
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E L+ +GA + +++ TPL A +I G +
Sbjct: 185 VEEAKFLVTQGASIYIENKEEKTPLQVA--KGGLGLILKRLAEGEEA 229
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 7/75 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D +G L +E VE K L+ G + + + +T L VA G
Sbjct: 163 ASTNIQDTEGNTP-----LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GG 215
Query: 86 TEVVSLLLERGADVD 100
++ L G +
Sbjct: 216 LGLILKRLAEGEEAS 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ +RH NV+ L T + +V
Sbjct: 50 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
LK+ DFG+++ + D +T YV APEV Y VD++S
Sbjct: 164 DCELKILDFGLAR----QADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 342 LILQE 346
I+ E
Sbjct: 214 CIMAE 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 23/110 (20%), Positives = 53/110 (48%), Gaps = 4/110 (3%)
Query: 26 AELNGLDDDGEEIKPEFR---LMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAA 81
A+++ ++ + L + A ++ +K L+ + G + + +D D +T + +AA
Sbjct: 262 AKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAA 321
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+G EVV L+++GA V+ D T A +H ++ + ++ +
Sbjct: 322 QEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 18/72 (25%), Positives = 33/72 (45%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
KE + +G DVN D D T L +A +V+ L++ GAD ++ + L A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206
Query: 114 IYYKNHEVIKLL 125
++ ++ +
Sbjct: 207 AANRDFGMMVYM 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 11/124 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D D P LM R + L+ +G D + R+ALH AA
Sbjct: 157 ADVNAMDCDEN--TP---LMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRD 211
Query: 86 TEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKNHEVI---KLLEKHGAKPLMAPMHV 139
++ +L D++ DR G T L + + + + KLL + GAK
Sbjct: 212 FGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAAR 271
Query: 140 KHAR 143
K +
Sbjct: 272 KDSE 275
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 9/87 (10%)
Query: 53 VEGIKELLDSGIDVNFR--------DIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKD 103
V K L++ G V++ RTALH AA +V L+ E+G++ D +D
Sbjct: 251 VASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQD 310
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TP+ A EV+ L + GA
Sbjct: 311 EDGKTPIMLAAQEGRIEVVMYLIQQGA 337
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 9/83 (10%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------ERGADVDPKDRWGS 107
+ + +++ NRT LH A E L+ GADV+ D +
Sbjct: 109 TEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDEN 167
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
TPL A+ + ++ L K GA
Sbjct: 168 TPLMLAVLARRRRLVAYLMKAGA 190
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 7/111 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + N L + + + + ++ LH A
Sbjct: 50 IKRQRNELQHYSL-----YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA-A 103
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
G + + ++ R T L + E + L H AK +
Sbjct: 104 GSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECI 153
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 9/116 (7%), Positives = 26/116 (22%), Gaps = 5/116 (4%)
Query: 19 PDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR 74
+R RK +N + EE + +++ + N +
Sbjct: 3 GNRTRKRRMINASVWMPPMENEEKNRKNHQSITSSQHSLLEASYDGYIKRQRNELQHYSL 62
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G + + L ++ + + + +
Sbjct: 63 YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEAAG-SYAITEPITRESV 117
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 5/75 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + D+DG+ P +M A E +E + L+ G V D + TA +A
Sbjct: 304 SNKDKQDEDGK--TP---IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNH 358
Query: 86 TEVVSLLLERGADVD 100
+V + + +
Sbjct: 359 HNIVDIFDRCRPERE 373
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 6/72 (8%), Positives = 18/72 (25%), Gaps = 9/72 (12%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ + ++ +L A+ G+ + + + P N
Sbjct: 25 EKNRKNHQSITSSQHSLLEASYDGYIKRQ---------RNELQHYSLYPNPQGYGNGNDF 75
Query: 121 VIKLLEKHGAKP 132
+ + P
Sbjct: 76 LGDFNHTNLQIP 87
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 32/199 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+ +L +++ +++ + + IV
Sbjct: 51 EKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E DL+ K L ++ G N++HE+ IIHRDL+P+N L +
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------------YV------APEV-FK 327
++KV DFG+++ + ++D + +V APE+
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 328 NEEYDTKVDVFSFALILQE 346
E Y +D++S I E
Sbjct: 226 QENYTKSIDIWSTGCIFAE 244
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 9e-20
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 56 AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L ++ + ++A +++LH II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
+SK E + + C Y+APEV + D
Sbjct: 172 LSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSAD 208
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 67/238 (28%), Positives = 103/238 (43%), Gaps = 41/238 (17%)
Query: 134 MAPMHVKHAREVPEY---EIDPHELDFTNSVEITK-------GTFILAFWR--GIQVAVK 181
MA H H++E P + E++ + + G+ AF G++VAVK
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPKG 235
KL S R +R EL LL+ ++H NV+ L T + + +VT +
Sbjct: 61 KLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL +K + L I RG+ Y+H IIHRDL+PSN+ ++ LK+
Sbjct: 119 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 174
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQE 346
DFG++ R + T YV APE+ Y+ VD++S I+ E
Sbjct: 175 DFGLA--------RHTADEMTG--YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+ A +A +IA + YLH I++RDL+P NIL D G++ + DF
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
G+ K T T C Y+APEV + YD VD
Sbjct: 184 GLCKENIEHNST--T--STFCGTPEYLAPEVLHKQPYDRTVD 221
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 40/177 (22%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + FR+E +L + A + + +V +Y GDL
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L + P RF ++ ++ +H+ +HRD++P NIL D +G++++ADF
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-----YDTKVDVFSFALILQE 346
G L + Y++PE+ + E Y + D +S + + E
Sbjct: 220 GSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 11/162 (6%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++ + + E +L++++HP +V + A + ++ EYL G+L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+G TA + +I+ + +LH+ II+RDL+P NI+ + G++K+ DF
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 336
G+ K T C Y+APE+ ++ VD
Sbjct: 166 GLCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVD 203
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + F +E ++ P VVQ A + +V EY+P GDL
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L + A + ++ ++ +H IHRD++P N+L D SG+LK+ADFG
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVD 336
+ + DT+ Y++PEV K++ Y + D
Sbjct: 214 TCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 24/188 (12%)
Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IV 228
G VA+KK+ E +R R E+ +L+ +H N++ S I+
Sbjct: 36 GEIVAIKKI--EPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + DL + + L F R + LH + +IHRDL+PSN+L +
Sbjct: 93 QELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINS 147
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YV------APEV-FKNEEYDTKVDVF 338
+ +LKV DFG+++++ +V APEV + +Y +DV+
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 339 SFALILQE 346
S IL E
Sbjct: 208 SCGCILAE 215
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 43/216 (19%), Positives = 81/216 (37%), Gaps = 57/216 (26%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-------- 226
G + A+KK + D R R EL +++ + H N+++ + +
Sbjct: 32 GKRFALKK-----VLQDPR-YKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84
Query: 227 ------------------------------IVTEYLPKGDL----RAFLKRKGALKPSTA 252
++ EY+P L ++F++ ++ +
Sbjct: 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 311
+ + R + ++H I HRD++P N+L + LK+ DFG +K L P
Sbjct: 144 SIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI--PSEPS 198
Query: 312 TCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQE 346
S Y APE+ EY +D++S + E
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 31/188 (16%)
Query: 175 GIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----I 227
++VA+KK+ E R R E+ +L + RH N++ + + I
Sbjct: 52 KVRVAIKKISPFEHQT---YCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
V + + DL L + L F I RG+ Y+H ++HRDL+PSN+L +
Sbjct: 108 VQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 288 DSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEV-FKNEEYDTKVDVF 338
+ +LK+ DFG++++ D LT YV APE+ ++ Y +D++
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIW 216
Query: 339 SFALILQE 346
S IL E
Sbjct: 217 SVGCILAE 224
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 36/180 (20%), Positives = 78/180 (43%), Gaps = 19/180 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI--VTEY 231
+V VK + + + R E+ +L+ +R PN++ V V E+
Sbjct: 61 NEKVVVKI-----LKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSG 290
+ D + + L + +I + ++Y H I+HRD++P N++ D +
Sbjct: 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 168
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKF 349
L++ D+G+++ + + S + PE+ + + YD +D++S +L + F
Sbjct: 169 KLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-18
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 175 GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----- 226
+VA+KK I D A R E+ +++++ H N+V+ + S +
Sbjct: 36 DKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89
Query: 227 ---------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
IV EY+ DL L +G L A F + RG+ Y+H ++HR
Sbjct: 90 SLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144
Query: 278 DLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNE 329
DL+P+N+ + LK+ DFG+++ + + + +P +
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSE--GLVTKWYRSPRLLLSPN 200
Query: 330 EYDTKVDVFSFALILQE 346
Y +D+++ I E
Sbjct: 201 NYTKAIDMWAAGCIFAE 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 41/180 (22%), Positives = 69/180 (38%), Gaps = 44/180 (24%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 43 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 151
Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ + LK+ DFG A E E+YD D++S +I+
Sbjct: 152 SKRPNAILKLTDFG----------------------FAKETTG-EKYDKSCDMWSLGVIM 188
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 25/214 (11%), Positives = 60/214 (28%), Gaps = 52/214 (24%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-------------------------H 209
G V + ++ ++E+ L+ +R
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 210 PNVVQFLGAVTQSSPMMIVTEY-LPKGD-------LRAFLKRKGALKPSTAVRFALDIAR 261
+++ + Y + + L + +L ++ L + R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
+ LH ++H L P +I+ D G + + F V++ + S +
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL----VRDGARVVS-SVSRGFE 269
Query: 322 APEVFKNEE-----------YDTKVDVFSFALIL 344
PE+ D ++ L++
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 24/208 (11%), Positives = 57/208 (27%), Gaps = 41/208 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------------------HPNV 212
G V + ++ ++E+ L+ +R P
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 213 VQFLGAVTQSSPMMIVTEYLPK-----------GDLRAFLKRKGALKPSTAVRFALDIAR 261
+ + M +++ + L + +L ++ L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
+ LH ++H L P +I+ D G + + F P+
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279
Query: 322 APEVFKNEEYDTK-----VDVFSFALIL 344
A + ++ D ++ L +
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAI 307
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 34/198 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM----IVT 229
G VAVKK+ + + D R FR E+ +L ++ H N+V L + + +V
Sbjct: 34 GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLR--ADNDRDVYLVF 90
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+Y+ DL A + R L+P + + + YLH ++HRD++PSNIL +
Sbjct: 91 DYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------YV------APEV-FKN 328
++KVADFG+S+ + YV APE+ +
Sbjct: 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205
Query: 329 EEYDTKVDVFSFALILQE 346
+Y +D++S IL E
Sbjct: 206 TKYTKGIDMWSLGCILGE 223
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 21/127 (16%), Positives = 35/127 (27%), Gaps = 2/127 (1%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL +R K+ + + F ++ + LL S V
Sbjct: 66 LLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQ 125
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGDAIYYKNHEVIKLLEKH 128
+N A +AA G V++ L E A + V+ L +
Sbjct: 126 AENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCEL 185
Query: 129 GAKPLMA 135
A
Sbjct: 186 APTEATA 192
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 17/87 (19%), Positives = 24/87 (27%), Gaps = 5/87 (5%)
Query: 57 KELLDSGIDVNFRDI--DNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGD 112
L + I +N A +AA G V++ L E
Sbjct: 145 NRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRW 204
Query: 113 AIYYKNH-EVIKLLEKHGAKPLMAPMH 138
A + H VI L A +H
Sbjct: 205 AAVGRGHHNVINFLLDCPVMLAYAEIH 231
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 15/118 (12%), Positives = 33/118 (27%), Gaps = 14/118 (11%)
Query: 24 KEAELNGLDD--DGEEIKPEFRLMFLANERDVEGIKELL---------DSGIDVNFRDID 72
K + +G+ D E F ++ R+ E + + + + D
Sbjct: 259 KLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGD 318
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
L +A G +LLL + + ++ + +H
Sbjct: 319 ANELLRLALRLGNQGACALLLSIPSVLALTKA---NNYYINETGGRLDLRAVALEHHH 373
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 12/91 (13%)
Query: 56 IKELLDSGIDVNFRDI--DNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+ L + I +N A AA G V++ LL+ + +
Sbjct: 179 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFE---- 234
Query: 113 AIYYKNHEVIKLLEKHGA--KPLMAPMHVKH 141
Y V + +H K + + +
Sbjct: 235 ---YGEKYVNPFIARHVNRLKEMHDAFKLSN 262
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGD 236
A+K L ++ R E +L+ IR P +V A + + ++ +Y+ G+
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L L ++ + +I + +LH+ II+RD++ NIL D +G++ + D
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 202
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE--YDTKVD 336
FG+SK V ++ C Y+AP++ + + +D VD
Sbjct: 203 FGLSK-EFVADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAVD 244
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 21/125 (16%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 14 QSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNF-R 69
Q L P+ + L + + + E + ++ + ++ + + ++ +++N
Sbjct: 68 QRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPV 127
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLL 125
D T LH E+V L++ G++ D G + L A+ N+ LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187
Query: 126 EKHGA 130
+
Sbjct: 188 DYLYP 192
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 18/87 (20%), Positives = 33/87 (37%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+ E+ + +E + +N +D + T L++AA
Sbjct: 234 KKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARL 293
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPL 110
G +V LL+ GAD ++ G P+
Sbjct: 294 GNISIVDALLDYGADPFIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 19/145 (13%), Positives = 46/145 (31%), Gaps = 22/145 (15%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-------FTEVVSLLLERG 96
L +L + ++E +K L+ G + + D + L A F ++ L
Sbjct: 135 LHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYL---Y 191
Query: 97 ADVDPKDRWGSTPL------------GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144
+ +D T L A Y ++ + K +P+ + + K ++
Sbjct: 192 PCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKP 251
Query: 145 VPEYEIDPHELDFTNSVEITKGTFI 169
+ + ++ +
Sbjct: 252 NDKNGERKDSILENLDLKWIIANML 276
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 4/83 (4%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAA----CQGFTEVVSLLLERGADVDPKDRWGSTP 109
+ ++ + + + E + L ++ +D G T
Sbjct: 227 ILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTC 286
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A N ++ L +GA P
Sbjct: 287 LNIAARLGNISIVDALLDYGADP 309
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 16/121 (13%), Positives = 30/121 (24%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLA---NERDVEGIKELLDSGI-DVNFRDIDNRTALHVAA 81
+ D+ GE L+ N D + LLD + D NRT LH
Sbjct: 155 SNRLYGDNMGE--SC---LVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHII 209
Query: 82 CQGFTE------------VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
++ ++++ + + + I
Sbjct: 210 ITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLK 269
Query: 130 A 130
Sbjct: 270 W 270
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 41/211 (19%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR---------- 208
G F LA VA+K ++ D A DE+ LLQ++
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 209 -HPNVVQFLGAVTQSSPMM----IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIAR 261
++++ L P +V E L +L A +K+ P V+ + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLTVKEDRPLTCQD 315
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+ Y +PEV + D++S A ++ E
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 27/93 (29%), Positives = 44/93 (47%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
AN+ + + ++ +G ++ + D TALH AA + + LLL+ A V + G
Sbjct: 201 ANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGE 260
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
T L A + E +LLE+ A P+HV
Sbjct: 261 TALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQGF---TEVVSLLLERGADV 99
RD+ + E +G D LH+A +V +++ G +
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D K G+T L A Y + +KLL K A
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG+++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ K D L +++APE + Y + DV+SF ++L E+
Sbjct: 243 IYKDPDYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 35/110 (31%), Positives = 49/110 (44%), Gaps = 16/110 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
++E L + +G F I A GI VAVK L E + RA
Sbjct: 16 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 71
Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKGDLRAFLKRK 244
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A LN + + I + L R + +K+ + +TALH+A +
Sbjct: 61 AMLNLHNGQNDTIA-----LLLDVARKTDSLKQFV--NASYTDSYYKGQTALHIAIERRN 113
Query: 86 TEVVSLLLERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+V+LL+E GADV +G PL A ++K L ++ +
Sbjct: 114 MTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173
Query: 132 P 132
P
Sbjct: 174 P 174
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 25/112 (22%), Positives = 38/112 (33%), Gaps = 22/112 (19%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + +K LL + D++ RD T LH T + +
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211
Query: 92 LLERGADVDP-------KDRWGSTPLGDAIYYKNHEVIKLL---EKHGAKPL 133
+L GA + P +R G TPL A V+ + E H +
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECR 263
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 8/64 (12%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
+L + + T L +AA G V++ +L+R A ++
Sbjct: 217 AKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHH 269
Query: 117 KNHE 120
+H
Sbjct: 270 -HHH 272
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 11/88 (12%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-------RGADVDPKDR-WGSTPLGDA- 113
+ +R ++ A Q + + LL R D + KD G T L A
Sbjct: 3 SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62
Query: 114 --IYYKNHEVIKLLEKHGAKPLMAPMHV 139
++ ++ I LL K V
Sbjct: 63 LNLHNGQNDTIALLLDVARKTDSLKQFV 90
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 31/199 (15%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH------PNV 212
KG+F + A+ VA+K ++ ++ R R +E+ +L+ +R NV
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP--STAVR-FALDIARGMNYLHEN 269
+ L T + + + E L +L +K K + VR FA I + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 270 KPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
+ IIH DL+P NIL + +KV DFG S E + + S Y APEV
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFYRAPEVIL 272
Query: 328 NEEYDTKVDVFSFALILQE 346
Y +D++S IL E
Sbjct: 273 GARYGMPIDMWSLGCILAE 291
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 37/142 (26%)
Query: 21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------- 73
+ A+ G L +R ++ +K L+++G DV+ R
Sbjct: 76 KPLVNAQCTDEFYQGH--SA---LHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQG 130
Query: 74 ------RTALHVAACQGFTEVVSLLLERG---ADVDPKDRWGSTPL-------------- 110
L +AAC +VV+ LLE A ++ D G+T L
Sbjct: 131 TCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENS 190
Query: 111 --GDAIYYKNHEVIKLLEKHGA 130
+Y ++ L
Sbjct: 191 ALVIHMYDGLLQMGARLCPTVQ 212
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 15/91 (16%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-------------WGSTP 109
+ALH+A + + V LL+E GADV + +G P
Sbjct: 80 NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
L A K +V+ L ++ +P A +
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQP--ASLEAT 168
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 1/76 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ + +AL + G ++ + L + + G TPL A E+ + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240
Query: 126 EKHGAKPLMAPMHVKH 141
+ A H H
Sbjct: 241 LQREFSG-AAAHHHHH 255
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 22/110 (20%)
Query: 43 RLMFLANERDVEGIKELLDS--------GIDVNFRDIDNRTALHVAAC---QGFTEVVSL 91
RL + + E + LL+ +T L A G +
Sbjct: 5 RLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMP 64
Query: 92 LLERG-----------ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL+ A + G + L AI ++ + +KLL ++GA
Sbjct: 65 LLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGA 114
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 9/48 (18%), Positives = 18/48 (37%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
++ L + + T L +AA +G E+ +L+R
Sbjct: 201 LQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 13/71 (18%), Positives = 20/71 (28%), Gaps = 11/71 (15%)
Query: 73 NRTALHVAACQGFTEVVSLLLE--------RGADVDPKDRWGSTPLGDAIY--YKNH-EV 121
+R L +G E ++ LLE + G T L A+
Sbjct: 2 DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61
Query: 122 IKLLEKHGAKP 132
I L +
Sbjct: 62 IMPLLQIDKDS 72
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 22/184 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMM 226
VA+K +I + + E+ LL+ + +V + +
Sbjct: 78 EQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 227 IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V E L +L L+ R FA + + +L + + IIH DL+P NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENI 190
Query: 285 L--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
L +K+ DFG S + + + S Y +PEV YD +D++S
Sbjct: 191 LLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 343 ILQE 346
IL E
Sbjct: 247 ILVE 250
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-14
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 26/114 (22%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN--------------RTALHVAACQGFTEVV 89
L R ++ L++ G DV+ + L +AAC +V
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 90 SLLLERG---ADVDPKDRWGSTPLGDAIYYKNH---------EVIKLLEKHGAK 131
L E G AD+ +D G+T L + ++ ++ LL AK
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAK 210
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 25/113 (22%)
Query: 45 MFLANERDVEGIKELLDSG---------IDVNFRDIDNR--TALHVAACQGFTEVVSLLL 93
+ + + I LLD I+ FRD+ R TALH+A + V LL+
Sbjct: 54 LLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLV 113
Query: 94 ERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+GADV + R +G PL A ++ L ++G K
Sbjct: 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 22/105 (20%)
Query: 48 ANERDVEGIKE----LLDSGIDVNFRDIDN----RTALHVAA---CQGFTEVVSLLLERG 96
+ +G++ LL + + +T L A G + + +LL+
Sbjct: 13 VSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIA 72
Query: 97 ADVDP-----------KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T L AI + ++LL + GA
Sbjct: 73 EKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGA 117
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 19/107 (17%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + L ++G D+ +D T LH T++ L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203
Query: 92 LLERGADVDPK-------DRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
LL + A + P + G +PL A + + + +
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIA 250
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 14/70 (20%), Positives = 23/70 (32%), Gaps = 11/70 (15%)
Query: 73 NRTALHVAA----CQGFTEVVSLLLERGADVDPKDRW----GSTPLGDA---IYYKNHEV 121
NR L G ++S LL + ++ G T L A + ++
Sbjct: 5 NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64
Query: 122 IKLLEKHGAK 131
I +L K
Sbjct: 65 IPILLDIAEK 74
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 8/59 (13%), Positives = 17/59 (28%), Gaps = 7/59 (11%)
Query: 49 NERDVEGIKELLDSGIDVN-------FRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
+ + LL + + D + L +AA G + ++ R
Sbjct: 194 TKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA 252
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 20/93 (21%), Positives = 40/93 (43%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ + + L+ + +++ + TALH E + LLL A ++ + G
Sbjct: 180 VDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGE 239
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
TPL A K+ +LL + + + +HV+
Sbjct: 240 TPLDIAKRLKHEHCEELLTQALSGRFNSHVHVE 272
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQG---FTEVVSLLLERGADV 99
RD+ G+ + G+D+ + TALH+A +V L++ ++
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D + GST L N E +KLL + A
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 26/99 (26%), Positives = 38/99 (38%), Gaps = 9/99 (9%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVA---ACQGFTEVVSLLL 93
RL RD+ + E +G D LH+A A Q +V ++
Sbjct: 135 RLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFII 194
Query: 94 ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G +D K G+T L A Y + +KLL K A
Sbjct: 195 QNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 233
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 49/220 (22%), Positives = 85/220 (38%), Gaps = 51/220 (23%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRH-----PNVV 213
GTF +L AVK V+ + + + + E +L+KI++ N+V
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKP 271
++ G M ++ E L L + R ++ + ++I + +NYL +
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157
Query: 272 VPIIHRDLEPSNIL-------------------------RDDSGNLKVADFGVSKLLTVK 306
+ H DL+P NIL R S +K+ DFG +
Sbjct: 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TF 211
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+ + +Y APEV N +D D++SF +L E
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 1e-10
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 3/101 (2%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ + P L+ + + LL +G +VN D R LH A G
Sbjct: 224 ADVNWVNGGQDNATP---LIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGH 280
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
T + L L+RGAD+ +D G PL A+ N +++ LL
Sbjct: 281 TGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR 321
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 3e-10
Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 48 ANERDVEGIKELLDSGIDVNFR--DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105
+ + + + L G DVN+ DN T L A LL+ GA+V+ D
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSA 267
Query: 106 GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G PL A + + L K GA
Sbjct: 268 GRGPLHHATILGHTGLACLFLKRGADL 294
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 52/198 (26%), Positives = 76/198 (38%), Gaps = 41/198 (20%)
Query: 177 QVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVT 229
QVA+K +I + + R A R E+ +L+KI+ V M I
Sbjct: 47 QVALK-----IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 230 EYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L K + FLK P VR A + + +LHEN+ + H DL+P NIL
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFV 157
Query: 286 -----------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
+ +++VADFG + + T + Y PEV
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTTIVATRHYRPPEVILE 213
Query: 329 EEYDTKVDVFSFALILQE 346
+ DV+S IL E
Sbjct: 214 LGWAQPCDVWSIGCILFE 231
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 48/193 (24%), Positives = 72/193 (37%), Gaps = 33/193 (17%)
Query: 178 VAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVTE 230
VAVK ++ + DR A R E+ +L+ + VQ L + IV E
Sbjct: 43 VAVK-----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97
Query: 231 YLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
L F+K G L +R A I + +N+LH NK + H DL+P NIL
Sbjct: 98 LLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQ 153
Query: 289 SGNLKVADFGVSKLLTVKEDRPL-------TC--QDTSCRYV------APEVFKNEEYDT 333
S + + + + + + + V APEV +
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQ 213
Query: 334 KVDVFSFALILQE 346
DV+S IL E
Sbjct: 214 PCDVWSIGCILIE 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 49/246 (19%), Positives = 79/246 (32%), Gaps = 76/246 (30%)
Query: 164 TKGTFILA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPN---VV 213
T L+ VA+K V S + DE+ LL+ +R PN VV
Sbjct: 49 HFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 214 QFLGAVTQSSP----MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLH 267
Q L S + +V E L L ++ + L + + +G++YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 268 ENKPVPIIHRDLEPSNIL------------------------------------------ 285
IIH D++P NIL
Sbjct: 164 TK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 286 -------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
+ +K+AD G + + T + +Y + EV Y+T D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 339 SFALIL 344
S A +
Sbjct: 278 STACMA 283
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 27/133 (20%), Positives = 54/133 (40%), Gaps = 16/133 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K E + + E + + ++ + + ++V + L
Sbjct: 32 NEEVAIKL---E--NVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86
Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
DL F RK +LK T + A + + ++H +HRD++P N L
Sbjct: 87 PSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRR 141
Query: 289 SGNLKVADFGVSK 301
+ + + DFG++K
Sbjct: 142 ANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 21/77 (27%), Positives = 41/77 (53%), Gaps = 6/77 (7%)
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
+V E L DL+ + G K ST ++ + + + Y+HEN+ +H D++ +N+L
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184
Query: 286 -RDDSGNLKVADFGVSK 301
+ + +AD+G+S
Sbjct: 185 GYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 18/135 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
VA+K + R E +++ + Q +V E L
Sbjct: 34 NEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88
Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
DL R +LK T + A+ + M Y+H +I+RD++P N L R +
Sbjct: 89 PSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN 143
Query: 290 GNLKVA---DFGVSK 301
+V DF ++K
Sbjct: 144 KTQQVIHIIDFALAK 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 6e-05
Identities = 32/249 (12%), Positives = 70/249 (28%), Gaps = 72/249 (28%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+ + D + + L ++ E + +++ ++N ALH
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK-VKLENEYALH---------- 446
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEY 148
+++ D P Y+ +H H H+K+
Sbjct: 447 -RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG------H---------HLKNIEHPERM 490
Query: 149 EIDPHE-LDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
+ LDF F L +++ D A L LQ++
Sbjct: 491 TLFRMVFLDF-------------RF----------LEQKIRHDSTAWNASGSILNTLQQL 527
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL----KPSTAVRFALDIARGM 263
+ + + + P + + FL + K + +R AL
Sbjct: 528 K-----FYKPYICDNDPKY--ERLV--NAILDFLPKIEENLICSKYTDLLRIAL------ 572
Query: 264 NYLHENKPV 272
+ E++ +
Sbjct: 573 --MAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 3e-04
Identities = 37/362 (10%), Positives = 96/362 (26%), Gaps = 125/362 (34%)
Query: 19 PDRER---KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT 75
D + + E++ + + + RL + + E +++ ++ + +N+
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY------- 91
Query: 76 ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
F L+ + + T + Y + + + + + A
Sbjct: 92 --------KF------LMSPIKT-EQRQPSMMTRM----YIEQRDRL-----YNDNQVFA 127
Query: 136 PMHVKHAREVPE-----YEIDPHELDFTNSVEIT----KGTFILAFWRGIQVAVKKLGEE 186
+V + + E+ P + + G+ G + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKN-------VLIDGVLGS-------GKTW----VALD 169
Query: 187 VISDDDRVRAF---------------RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
V L +LQK+ + + SS + +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH- 228
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DS 289
++A L+R L ++KP L +L + ++
Sbjct: 229 ----SIQAELRR----------------------LLKSKPYE---NCLL---VLLNVQNA 256
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS-------FAL 342
+ LLT + + +T +++ + D +
Sbjct: 257 KAWNAFNLSCKILLTTR-FKQVT------DFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 343 IL 344
L
Sbjct: 310 YL 311
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 8/69 (11%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL 292
DL F RK +LK T + A + + Y+H IHRD++P N L +
Sbjct: 93 DLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147
Query: 293 KVADFGVSK 301
+ DFG++K
Sbjct: 148 YIIDFGLAK 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 7e-05
Identities = 29/202 (14%), Positives = 52/202 (25%), Gaps = 52/202 (25%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDD-----RVRAFRDELAL 203
+I +G F VA+K + E + E+ +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 204 LQKI---------RHPNVVQFLGA--VTQSSP---------------------------- 224
+++ R + V S P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 225 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
+ IV E+ G DL + +TA + + + + HRDL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGN 192
Query: 284 ILRDDSGNLKVADFGVSKLLTV 305
+L + K+ K T+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 12/82 (14%)
Query: 227 IVTEYLPK--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V + L DL RK ++K T A + + +HE +++RD++P N
Sbjct: 83 LVIDLLGPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNF 137
Query: 285 L-----RDDSGNLKVADFGVSK 301
L ++ + V DFG+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 6/68 (8%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
+ L + ++ A + + +LHEN+ +H ++ NI +D +
Sbjct: 146 SALDVSPKH-VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201
Query: 294 VADFGVSK 301
+A +G +
Sbjct: 202 LAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 14/68 (20%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
+ ++ + K T ++ +L I + Y+HE++ +H D++ SN+L + +
Sbjct: 140 KIYEANAKRFSRK--TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY 194
Query: 294 VADFGVSK 301
+ D+G++
Sbjct: 195 LVDYGLAY 202
|
| >3agd_A Salt-tolerant glutaminase; glutaminase super family, hydrolase; 2.20A {Micrococcus luteus} PDB: 3age_A* 3if5_A 3ih8_A 3ih9_A 3iha_A* 3ihb_A 2dfw_A Length = 456 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 5e-04
Identities = 6/85 (7%), Positives = 17/85 (20%), Gaps = 2/85 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ F E ++ + +L A + +
Sbjct: 335 IRFGGAEAVLDALTDLRTGAEKPGTGWDAAVYPRWQEAAADRAALSAATGGGAVHEAAAA 394
Query: 104 RWGSTPLGD--AIYYKNHEVIKLLE 126
G + V ++ +
Sbjct: 395 AARDENDGPIRTVVLNLARVDRIDD 419
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.93 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.91 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.89 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.89 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.88 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.87 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.87 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.87 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.87 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.87 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.87 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.87 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.87 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.87 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.87 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.86 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.86 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.86 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.86 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.86 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.86 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.85 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.85 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.85 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.85 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.85 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.85 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.85 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.85 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.85 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.85 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.85 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.84 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.84 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.84 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.84 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.84 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.84 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.83 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.83 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.83 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.83 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.83 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.83 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.83 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.83 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.82 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.82 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.82 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.82 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.82 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.82 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.82 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.82 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.82 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.82 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.82 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.82 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.82 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.82 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.82 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.81 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.81 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.81 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.81 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.81 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.81 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.81 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.81 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.8 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.8 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.8 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.8 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.8 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.8 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.8 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.79 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.79 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.79 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.79 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.79 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.79 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.79 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.79 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.79 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.79 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.78 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.78 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.78 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.78 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.78 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.78 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.77 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.77 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.77 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.76 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.76 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.75 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.74 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.73 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.72 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.72 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.72 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.71 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.71 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.68 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.68 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.65 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.55 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.5 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.49 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.01 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.53 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.27 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.93 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.71 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 80.18 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=363.54 Aligned_cols=194 Identities=22% Similarity=0.419 Sum_probs=174.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++.+.........+.+.+|+++|++++||||++++++|.+++.+|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 699999999999999984 588999999976543333345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-C
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-~ 309 (352)
||+||+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|||||++.+..|+.++|||||||++|||+||..
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 3345689999999999999999999999999999999999963
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=359.59 Aligned_cols=192 Identities=23% Similarity=0.471 Sum_probs=165.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||||++..... .....+.+++|+.+|++++|||||+++++|.+++.+|+|||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 799999999999999884 588999999987654 34556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+||+|.+++...+ .+++.+++.|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999999997543 4789999999999999999999999 99999999999999999999999999987643211
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|||||++.+..|+.++|||||||++|||+||..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~ 223 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 1234569999999999999999999999999999999999963
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=345.62 Aligned_cols=191 Identities=29% Similarity=0.506 Sum_probs=157.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++.+...........+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 799999999999999984 588999999987666555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+ +|+|.+++.+.+.+++.++..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NF 167 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--Cc
Confidence 99 6799999998889999999999999999999999999 999999999999999999999999999865432 22
Q ss_pred cccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~~ 352 (352)
.....||+.|+|||++.+..+ +.++|||||||++|+|+||..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~ 210 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC
Confidence 334679999999999998876 579999999999999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=354.62 Aligned_cols=189 Identities=22% Similarity=0.373 Sum_probs=169.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..++||+|+||.||. +|+.||||++....... .+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 588999999999999984 58899999997554333 3457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
||+||+|.+++.+ +.+++.++..|+.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 9999999999976 46999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....||+.|||||++.+..|+.++|||||||++|||++|..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 345689999999999999999999999999999999999963
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=350.74 Aligned_cols=188 Identities=27% Similarity=0.370 Sum_probs=164.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
.-.|+..++||+|+||.||. +|+.||||+++..... .+|+.++++++|||||++++++.+++.+|+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678888999999999983 5889999999765432 4699999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~~~~~~ 307 (352)
||||+||+|.+++++.+.+++.++..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+....
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999998888999999999999999999999999 99999999999999987 59999999998765332
Q ss_pred CC----CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DR----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ......||+.|||||++.+.+|+.++|||||||++|||+||..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 11 1223569999999999999999999999999999999999963
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=339.65 Aligned_cols=190 Identities=28% Similarity=0.552 Sum_probs=165.4
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCceEE
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI 227 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 227 (352)
|+..++||+|+||.||. ++..||+|++..... .....+.+.+|+.++++++|||||+++++|.+ ++.+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 46677899999999984 478999999976644 44556789999999999999999999999875 345899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Dfg~a~~~~~~ 306 (352)
|||||++|+|.+++.+.+.+++..+..|+.||+.||.|||++++ +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 99999999999999988889999999999999999999999873 499999999999998 478999999999975432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|||||++.+ .|+.++|||||||++|||+||..
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 23345679999999999875 69999999999999999999963
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=351.68 Aligned_cols=192 Identities=26% Similarity=0.365 Sum_probs=163.8
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|++.+.||+|+||.||. .++.||+|++.+....... ...+.+|+.+|++++||||+++++++.+++.+|+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 699999999999999983 3678999998765432211 2357789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||||+||+|.+++.+.+.+++.++..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999999889999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|||||++.+..|+.++|||||||++|||+||..
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 224 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence 23345679999999999999999999999999999999999963
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=356.46 Aligned_cols=190 Identities=22% Similarity=0.368 Sum_probs=169.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
..|+..+.||+|+||.||. +|+.||||++....... .+.+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 3599999999999999984 58899999997553332 356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|||+||+|.+++.. +.+++.++..|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.+.... .
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 99999999999976 45999999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|||||++.+..|+.++|||||||++|||++|..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 3345679999999999999999999999999999999999963
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=344.21 Aligned_cols=190 Identities=30% Similarity=0.496 Sum_probs=165.1
Q ss_pred cccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|...+.||+|+||.||. ++..||||+++.. .....+.|.+|+.+|++++|||||++++++.+++.+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 678889999999999873 3678999999743 455667899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCE
Q 018682 226 MIVTEYLPKGDLRAFLKRK-------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~v 292 (352)
|+|||||++|+|.+++.+. ..+++.++..|+.|+++||.|||+++ |+||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999763 35899999999999999999999999 9999999999999999999
Q ss_pred EEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 293 KVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 293 kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
||+|||+|+......... .....||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~ 228 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999998654332221 122457899999999999999999999999999999999 54
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=339.23 Aligned_cols=200 Identities=29% Similarity=0.458 Sum_probs=166.4
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
..|+|+..++ +..++||+|+||.||. ....||||+++... ...+..+.|.+|+.++++++|||||++++++. ++
T Consensus 29 ~~Wei~~~~l--~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~ 104 (307)
T 3omv_A 29 YYWEIEASEV--MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD 104 (307)
T ss_dssp CCCBCCTTSC--CEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred cCcEEcHHHe--EEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence 4578877654 5567999999999984 34579999997543 35566788999999999999999999999875 46
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
.+|+|||||++|+|.+++... ..+++.++..|+.|++.||.|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 789999999999999999764 56999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccC-CCCcccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKE-DRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~~ 352 (352)
..... ........||+.|||||++.+ .+|+.++|||||||++|||+||.+
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~ 235 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCC
Confidence 64322 223345679999999999853 468999999999999999999963
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=341.61 Aligned_cols=190 Identities=31% Similarity=0.488 Sum_probs=160.5
Q ss_pred cccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|...++||+|+||.||. +++.||||+++.. .....+.|.+|+.+|++++|||||++++++.+++.+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 577788999999999984 3678999999743 456667899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC
Q 018682 226 MIVTEYLPKGDLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 290 (352)
|+|||||++|+|.+++.+. +++++.++..|+.|++.||.|||+++ |+||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 9999999999999999753 35899999999999999999999999 99999999999999999
Q ss_pred CEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 291 NLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 291 ~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~ 258 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCC
Confidence 9999999999876433222 2234568999999999999999999999999999999999 54
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=335.16 Aligned_cols=190 Identities=27% Similarity=0.454 Sum_probs=155.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC-------
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 223 (352)
+|++.+.||+|+||.||. +|+.||||++... ..+...+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 588899999999999983 4889999998644 24555678899999999999999999999987654
Q ss_pred -----ceEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEE
Q 018682 224 -----PMMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (352)
Q Consensus 224 -----~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~ 295 (352)
.+|++||||++|+|.+++..... .+...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999987654 345668889999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccCCC-----------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 296 DFGVSKLLTVKEDR-----------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 296 Dfg~a~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+++
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~P 226 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHSC
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHccC
Confidence 99999876543221 11234699999999999999999999999999999999973
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=338.51 Aligned_cols=197 Identities=29% Similarity=0.467 Sum_probs=167.1
Q ss_pred cccCCCCCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeE
Q 018682 148 YEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (352)
Q Consensus 148 ~~i~~~~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 217 (352)
.+++..+ ++..++||+|+||.||. +++.||||+++... .....+.|++|+.++++++|||||++++
T Consensus 21 ~ei~~~~--~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 21 KEISLSA--VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp CBCCGGG--EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHHH--CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 3444443 45567999999999983 35789999997543 3334567999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 018682 218 AVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (352)
Q Consensus 218 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp 281 (352)
++.+++.+++|||||++|+|.+++... ..+++.++..|+.|+++||+|||+++ ||||||||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~ 173 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLAT 173 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccc
Confidence 999999999999999999999999643 34889999999999999999999999 99999999
Q ss_pred CCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 282 ~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |.
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~ 245 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCC
Confidence 9999999999999999999876543322 2334568999999999999999999999999999999999 54
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=327.38 Aligned_cols=191 Identities=28% Similarity=0.445 Sum_probs=155.2
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC----ceEEE
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 228 (352)
+|...+.||+|+||.|| ++|+.||||++.... ......+.|+..+.+++||||+++++++.+++ .+|+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 57788999999999887 789999999986432 12222345666677889999999999998764 57999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
|||+++|+|.++++.. .+++..+..++.|++.||.|||++. ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999865 5899999999999999999999871 112999999999999999999999999999876
Q ss_pred cccCCC---CcccCCCCCccccccccCCC------CCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltG~ 351 (352)
...... ......||+.|||||++.+. .++.++|||||||++|||+||.
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~ 215 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTB
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCC
Confidence 543321 12235689999999998764 4677999999999999999984
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=332.36 Aligned_cols=198 Identities=30% Similarity=0.477 Sum_probs=168.1
Q ss_pred CcccCCCCCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-Cceeee
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~ 215 (352)
.||++.. +|++.+.||+|+||.||.. ++.||+|.+.... .....+.+.+|+.+|++++| ||||++
T Consensus 58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4667654 6778889999999999842 3579999997543 44556789999999999965 899999
Q ss_pred eEEEEeC-CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018682 216 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (352)
Q Consensus 216 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D 278 (352)
+++|.+. +.+++|||||++|+|.+++++. ..+++.++..++.||++||.|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9998764 5789999999999999999753 33789999999999999999999999 99999
Q ss_pred CCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 279 ikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
|||+|||++.++.+||+|||+|+........ ......+|+.|||||++.+..|+.++|||||||++|||+| |.
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 9999999999999999999999876543322 2233557899999999999999999999999999999998 54
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=333.19 Aligned_cols=192 Identities=26% Similarity=0.425 Sum_probs=165.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe------CCc
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 224 (352)
+|++.+.||+|+||.||. +|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 699999999999999984 589999999976533 44455678899999999999999999998764 357
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+|+|||||+ |+|.+++.+.+.+++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999995 689999988888999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccC---CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 305 VKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 305 ~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
... ........||+.|+|||++.+. .++.++||||+||++|||++|.+
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~ 261 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCC
Confidence 321 2233457899999999998775 56899999999999999999963
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=349.42 Aligned_cols=192 Identities=25% Similarity=0.371 Sum_probs=167.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
-+|++.+.||+|+||.||. +|+.||+|++.+..+. ........+.++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 3799999999999999984 5889999999754322 2222333344577778889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+||||++||+|.+++.+.+.+++..+..|+.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999999999889999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|||||++.. ..|+.++|||||||++|||++|..
T Consensus 346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~ 389 (689)
T 3v5w_A 346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389 (689)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 2334679999999999964 579999999999999999999963
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=320.25 Aligned_cols=186 Identities=21% Similarity=0.297 Sum_probs=158.7
Q ss_pred CcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCce
Q 018682 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 225 (352)
-+|++.+.||+|+||.||. .++.||+|.+.... . ...+.+|+++|+.+ +||||++++++|.+++.+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3699999999999999984 25789999886542 2 24577899999988 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-CCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~vkL~Dfg~a~~~~ 304 (352)
|+||||+++++|.++++ .+++.++..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999984 4899999999999999999999999 9999999999999876 799999999997653
Q ss_pred ccCC---------------------------CCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKED---------------------------RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.... .......||+.|+|||++.+. .++.++||||+||++|||+||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 2211 112345699999999998775 5899999999999999999996
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=334.96 Aligned_cols=189 Identities=22% Similarity=0.398 Sum_probs=168.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.|+. +|+.||+|++... .....+.+++|+.+|+.++||||++++++|.+++.+|++||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 799999999999999983 5889999998654 34445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC--CCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~vkL~Dfg~a~~~~~~~ 307 (352)
||+||+|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999864 456999999999999999999999999 9999999999999854 78999999999876532
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|||||++.+..|+.++|||||||++|||++|..
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~ 354 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 23345679999999999999999999999999999999999963
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.54 Aligned_cols=194 Identities=25% Similarity=0.421 Sum_probs=169.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. .+..||+|.+...........+.+.+|+.++++++||||+++++++..++.+|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 3799999999999999983 47899999987666666777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++...+++++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999876544333
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.+..++.++||||||+++|+|+||.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 209 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 334456899999999999999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.33 Aligned_cols=192 Identities=28% Similarity=0.423 Sum_probs=169.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.|+. +|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 788999999999999984 588999999975432222234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cc
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999987643222 22
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 202 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCC
Confidence 33456899999999999999999999999999999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=306.77 Aligned_cols=194 Identities=26% Similarity=0.439 Sum_probs=171.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|+..+.||+|+||.|+. +++.||+|++.+.........+.+..|..+++++ +||||+++++++.+.+.+|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 3789999999999999984 4789999999877666665666788999999887 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999999999998888999999999999999999999999 999999999999999999999999999753322 2
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~ 251 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 23345678999999999999999999999999999999999963
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=299.40 Aligned_cols=193 Identities=26% Similarity=0.441 Sum_probs=174.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|+..+.||+|+||.|+. +++.||+|++...........+.+.+|..+++++ +||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 3789999999999999984 4889999999887777777778899999999987 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 999999999999988888999999999999999999999999 9999999999999999999999999997643222
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 207 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCC
Confidence 2234467899999999999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=296.86 Aligned_cols=193 Identities=28% Similarity=0.493 Sum_probs=172.1
Q ss_pred CCCcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
..-+|++.+.||+|+||.|+ .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34479999999999999998 3688999999976544 45556778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999999988888999999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCcccCCCCCccccccccCCCCCC-CchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||++.+..++ .++|||||||++|+|++|.
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 211 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSS
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 223446789999999999888775 7899999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.82 Aligned_cols=194 Identities=27% Similarity=0.399 Sum_probs=167.2
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
-+|++.+.||+|+||.|+. +|+.||+|++.+...........+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 3799999999999999983 4789999999765433333456678899999988 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~ 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-G 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-C
Confidence 999999999999998888999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 222 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCC
Confidence 23344678999999999998899999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=297.71 Aligned_cols=190 Identities=27% Similarity=0.486 Sum_probs=169.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.|+. +|+.||+|++...........+.+.+|..+++.++||||+++++++.+...+|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 3788999999999999984 58899999987543222223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999865432
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 200 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCC
Confidence 23456899999999999999999999999999999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.92 Aligned_cols=196 Identities=22% Similarity=0.343 Sum_probs=168.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|+||.||. +++.||+|++.+...........+++|..+++.++||||++++++|.+++.+|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 44799999999999999984 4789999998653221111123478899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||+++|+|.+++.+ .+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999987 467999999999999999999999999 9999999999999999999999999997765443
Q ss_pred CCCcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
........||+.|+|||++. ...++.++|||||||++|||++|..
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence 33334467899999999986 5678999999999999999999963
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=300.04 Aligned_cols=197 Identities=29% Similarity=0.429 Sum_probs=169.8
Q ss_pred CCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCce
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 225 (352)
....+|+..+.||+|+||.||. +|+.||+|++.............+..|..+++.+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3445799999999999999883 5889999999754322122345677899999876 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999976432
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. .......||+.|+|||++.+..++.++|+|||||++|||++|..
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 216 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCC
Confidence 22 22345678999999999999999999999999999999999963
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=287.89 Aligned_cols=190 Identities=23% Similarity=0.429 Sum_probs=169.1
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|+||.||. +++.||+|++....... .+.+.+|+.++++++||||+++++++...+.+++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 44799999999999999984 57899999987554333 35678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|.+++... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999875 5899999999999999999999999 99999999999999999999999999877654322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 234457899999999999999999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=302.10 Aligned_cols=192 Identities=28% Similarity=0.451 Sum_probs=169.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3789999999999998873 47889999987543222233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+.+++|.+++.....+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++...... .
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred CcccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~ 214 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCC
Confidence 3345678999999999864 45899999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.90 Aligned_cols=196 Identities=23% Similarity=0.351 Sum_probs=168.8
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|+||.|+. +|+.||+|++.+.........+.+++|..++..++||||+++++++.+.+.+|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 44799999999999998873 5889999998653222222234578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999998754 6999999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccCCCCCccccccccC-------CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFK-------NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltG~~ 352 (352)
........||+.|+|||++. ...++.++|||||||++|||++|..
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 268 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCC
Confidence 32233467899999999987 4578999999999999999999963
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=296.52 Aligned_cols=195 Identities=25% Similarity=0.384 Sum_probs=171.1
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
....|++.+.||+|+||.||. +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 344799999999999999984 488999999876543221 124578899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC----CEEEEccCCc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~vkL~Dfg~a 300 (352)
+++||||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999988888999999999999999999999999 99999999999998777 7999999999
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred eEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 876532 22334568999999999999999999999999999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=298.62 Aligned_cols=194 Identities=29% Similarity=0.412 Sum_probs=169.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|+..+.||+|+||.||. +|+.||+|++...........+.+..|..+++.+ +||+|+++++++.+.+.+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 4799999999999999884 4678999998764322222345678899999988 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||++|++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++...... .
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G 175 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC-C
Confidence 999999999999998888999999999999999999999999 999999999999999999999999999764322 2
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 219 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCC
Confidence 23344678999999999999999999999999999999999963
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=286.98 Aligned_cols=191 Identities=35% Similarity=0.561 Sum_probs=167.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|+..+.||+|+||.||. ++..||+|++.. ......+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 3788899999999999874 478999998853 35666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999987 456899999999999999999999999 99999999999999999999999999987643322
Q ss_pred CC-------------cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RP-------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 219 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCC
Confidence 11 11456899999999999999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=308.34 Aligned_cols=196 Identities=25% Similarity=0.365 Sum_probs=167.1
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
...+|+..+.||+|+||.||. +++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 344799999999999999983 478999999865321111112347789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||||+++|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999999764 5899999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccCCCCCccccccccCCCC----CCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltG~~ 352 (352)
........||+.|+|||++.+.. ++.++|||||||++|||++|..
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 22334567999999999997655 7889999999999999999963
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=298.83 Aligned_cols=191 Identities=25% Similarity=0.395 Sum_probs=169.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|+||.||. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4799999999999998873 58899999986543222223466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999865432
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCC
Confidence 223568999999999999999999999999999999999963
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=298.03 Aligned_cols=195 Identities=28% Similarity=0.424 Sum_probs=162.6
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCceeeeeEEEEeCCceEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
..+|+..+.||+|+||.||. +++.||+|++.+...........+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 34799999999999999884 478899999987766555555667777776 567899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||||+++++|.+++.+...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999999999998888999999999999999999999999 9999999999999999999999999997643222
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 237 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 22344678999999999999999999999999999999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=300.74 Aligned_cols=192 Identities=19% Similarity=0.342 Sum_probs=169.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 788999999999999984 588999999976543 33445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC---CCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999999998888999999999999999999999999 99999999999998 46789999999997765432
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|+|++|.+
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 22234678999999999999999999999999999999999963
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=291.52 Aligned_cols=193 Identities=25% Similarity=0.396 Sum_probs=159.8
Q ss_pred CcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
.+|++.+.||+|+||.||. +|+.||+|++...... .......+.+|+.+++.++||||+++++++..++.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4799999999999999982 6789999999865432 223345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|+||||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999875432
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 218 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCC
Confidence 22 1223456899999999999989999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=293.49 Aligned_cols=191 Identities=23% Similarity=0.410 Sum_probs=170.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999984 488999999976544 44556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC---CEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 9999999999988888999999999999999999999999 99999999999998654 5999999999776532
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 228 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 22334578999999999999999999999999999999999963
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.70 Aligned_cols=194 Identities=26% Similarity=0.419 Sum_probs=165.6
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce----
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM---- 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---- 225 (352)
-+|++.+.||+|+||.|| .+++.||+|++.............+.+|+.++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 479999999999999998 35789999999887666777778899999999999999999999998876544
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
|+||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999976543
Q ss_pred cCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 216 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 3221 222345799999999999999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.05 Aligned_cols=194 Identities=40% Similarity=0.682 Sum_probs=162.3
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
.+|++.+.||+|+||.|| ++|+.||+|++..... .....+.+.+|+.++++++||||+++++++...+.+++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 478889999999999887 5789999999976543 455667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 232 LPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
+++++|.+++..... +++..+..++.|++.||.|||++++ +|+||||||+||+++.++.+||+|||++...... .
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~ 193 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-F 193 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccccc-c
Confidence 999999999987543 8999999999999999999999873 4999999999999999999999999998754332 1
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 236 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCC
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 2233456899999999999999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.72 Aligned_cols=191 Identities=29% Similarity=0.485 Sum_probs=166.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|.+.+.||+|+||.||. +++.||+|++........+....+.+|+.+++.++||||+++++++...+.+++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3789999999999999873 67899999986543222222356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+ +|+|.+++...+.+++.++..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999 7899999988888999999999999999999999999 9999999999999999999999999997654332
Q ss_pred CcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++.+..+ ++++|||||||++|+|++|.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 205 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence 2234568999999999988776 68999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.58 Aligned_cols=194 Identities=17% Similarity=0.248 Sum_probs=167.2
Q ss_pred ccCCCCCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCceeee
Q 018682 149 EIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQF 215 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~ 215 (352)
++.....+|.+.+.||+|+||.||.. ++.||+|++.... ...+..|+.+++.++ |++|+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34445568999999999999998853 6789999997542 245677888888886 9999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC--
Q 018682 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-- 288 (352)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-- 288 (352)
++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccc
Confidence 9999999999999999999999999974 456999999999999999999999999 999999999999998
Q ss_pred ---------CCCEEEEccCCcccccccC-CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 289 ---------SGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 289 ---------~~~vkL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.+||+|||++..+.... ........||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 8999999999997654221 22334466899999999999999999999999999999999997
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.28 Aligned_cols=192 Identities=29% Similarity=0.529 Sum_probs=166.7
Q ss_pred CcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 221 (352)
.+|++.+.||+|+||.||.. +..||+|++... ......+.+.+|+.+++++ +||||+++++++..
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 47889999999999999832 357999999755 2455667899999999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 285 (352)
.+.+|+||||+++++|.+++.... .++..++..++.|++.||.|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999998653 3788999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 286 RDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 286 l~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
++.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 303 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999986653322 12233456788999999999999999999999999999999 53
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=287.94 Aligned_cols=193 Identities=25% Similarity=0.401 Sum_probs=169.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
..|+..+.||+|+||.||. +|..||+|++........ ...+.+.+|+.++++++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3689999999999999984 488999999876543211 12467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC----CEEEEccCCccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL 302 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~vkL~Dfg~a~~ 302 (352)
+||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999988888999999999999999999999999 99999999999999887 799999999987
Q ss_pred ccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 215 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 64322 2234568999999999999999999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=304.37 Aligned_cols=193 Identities=27% Similarity=0.414 Sum_probs=161.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|+||.||. +|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 3689999999999999983 57899999997654444555567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+ +| |+||||||+|||++.++.+||+|||++...... .
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 303 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC-C
Confidence 999999999999888889999999999999999999998 88 999999999999999999999999998764332 2
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 346 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence 2234467899999999999999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=282.09 Aligned_cols=190 Identities=25% Similarity=0.490 Sum_probs=163.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.||. +++.||+|++..... .......+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 688999999999998873 478999999976543 33444677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++ ++.+++. ..+.+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9976 5555554 4567999999999999999999999999 999999999999999999999999999876432 22
Q ss_pred CcccCCCCCccccccccCCCC-CCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~ 199 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcC
Confidence 333456789999999987765 799999999999999999876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=278.63 Aligned_cols=204 Identities=25% Similarity=0.390 Sum_probs=178.7
Q ss_pred cCCCcccCC-CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeE
Q 018682 144 EVPEYEIDP-HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (352)
Q Consensus 144 ~~~~~~i~~-~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 217 (352)
++|+..+++ ...+|.+.+.||+|+||.||. +++.||+|++...........+.+.+|+.+++.++||||+++++
T Consensus 3 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (294)
T 2rku_A 3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82 (294)
T ss_dssp CCCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 344444433 334799999999999999884 47899999998776666777788999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 218 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
++.+++..+++|||+++++|.+++.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred eeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence 99999999999999999999999988888999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|++....... .......+++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 160 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 212 (294)
T 2rku_A 160 GLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212 (294)
T ss_dssp TTCEECCSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cCceecccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9997754322 2233456889999999999988999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=283.02 Aligned_cols=194 Identities=23% Similarity=0.298 Sum_probs=163.2
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +++.||+|++.......+...+.+.+|+.++++++||||+++++++..++.++++|
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 4799999999999998873 58899999998766656666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998776543333
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence 334456889999999999989999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=285.75 Aligned_cols=188 Identities=18% Similarity=0.319 Sum_probs=166.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. ++..||+|.+... ......+.+|+.+++.++||||+++++++.+.+.++++|
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 4789999999999999984 4889999998643 234456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC--CCCEEEEccCCccccccc
Q 018682 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~vkL~Dfg~a~~~~~~ 306 (352)
||+++++|.+++.... .+++.++..++.|++.||.|||++| |+||||||+|||++. ++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999997653 6999999999999999999999999 999999999999997 789999999999876432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 2223456889999999999988899999999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=284.57 Aligned_cols=191 Identities=27% Similarity=0.469 Sum_probs=161.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc------
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP------ 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 224 (352)
+|++.+.||+|+||.||. +|+.||+|++.... .+...+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 688899999999999883 58899999987543 33345678999999999999999999999865432
Q ss_pred ---------------------------------------------------eEEEEeccCCCCHHHHHHhcCC---CCHH
Q 018682 225 ---------------------------------------------------MMIVTEYLPKGDLRAFLKRKGA---LKPS 250 (352)
Q Consensus 225 ---------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~---~~~~ 250 (352)
++++|||+++++|.+++..... .+..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 8999999999999999987543 4556
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-----------CCcccCCCCCc
Q 018682 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-----------RPLTCQDTSCR 319 (352)
Q Consensus 251 ~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-----------~~~~~~~~~~~ 319 (352)
.+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......+|+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78899999999999999999 99999999999999999999999999987654321 12233568999
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 320 YVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 320 y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|+|||++.+..++.++|||||||++|+|++|.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~ 273 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.50 Aligned_cols=192 Identities=25% Similarity=0.371 Sum_probs=164.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
+|++.+.||+|+||.||. +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 689999999999999984 4789999998643211 111246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC---EEEEccCCcc
Q 018682 229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSK 301 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---vkL~Dfg~a~ 301 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999998877542 24899999999999999999999999 999999999999987655 9999999998
Q ss_pred cccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC 230 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCC
Confidence 765422 1223456899999999999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.38 Aligned_cols=194 Identities=26% Similarity=0.386 Sum_probs=169.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|...+.||+|+||.||. +|+.||+|++.+...........+.+|+.++++++||||+++++++.+...+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4788999999999999983 58899999997543322223456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 230 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
||++|++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999763 35899999999999999999999999 99999999999999999999999999987653
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
... ......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~ 387 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCC
Confidence 322 2233578999999999999999999999999999999999963
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.98 Aligned_cols=194 Identities=27% Similarity=0.398 Sum_probs=169.5
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|+||.||. +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 34699999999999999984 5889999998754332222345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|||++||+|.+++...+. +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999987543 899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 340 --~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~ 383 (576)
T 2acx_A 340 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383 (576)
T ss_dssp --CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSC
T ss_pred --ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 22334578999999999999899999999999999999999963
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.98 Aligned_cols=199 Identities=18% Similarity=0.321 Sum_probs=171.6
Q ss_pred cCCCCCcccCceeeccc--EEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q 018682 150 IDPHELDFTNSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (352)
Q Consensus 150 i~~~~~~~~~~~~ig~G--~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 222 (352)
+-+..-+|++.+.||+| +||.||. +|+.||+|++..... ..+..+.+.+|+.++++++||||+++++++.++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 33455589999999999 9998873 588999999976643 456677889999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccc
Confidence 9999999999999999999875 56999999999999999999999999 999999999999999999999999987
Q ss_pred ccccccC------CCCcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccCC
Q 018682 301 KLLTVKE------DRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 301 ~~~~~~~------~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~~ 352 (352)
....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 235 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 6543211 111223467889999999987 578999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=297.02 Aligned_cols=191 Identities=26% Similarity=0.396 Sum_probs=153.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----Cc
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 224 (352)
.+|++.+.||+|+||.|+. +++.||||++... .......+.+.+|+.+++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4799999999999998873 5789999998754 33555667889999999999999999999998543 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+|+||||+ +++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999998 5799999998888999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCC--------------------------CcccCCCCCcccccccc-CCCCCCCchhHHHHHHHHHHhhcc
Q 018682 305 VKEDR--------------------------PLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 305 ~~~~~--------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltG 350 (352)
..... ......+|+.|+|||++ ....++.++|||||||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 32211 12335679999999975 566799999999999999999984
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=277.27 Aligned_cols=190 Identities=31% Similarity=0.536 Sum_probs=165.8
Q ss_pred CcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.+|+..+.||+|+||.||. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..+++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3688889999999998874 6788999999865432 2468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999764 45899999999999999999999999 999999999999999999999999999865433322
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~ 205 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 3333456778999999998899999999999999999999 53
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=282.64 Aligned_cols=195 Identities=24% Similarity=0.358 Sum_probs=175.2
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
...+|.+.+.||+|+||.||. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 345799999999999999884 477999999987766667777889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
+|||+++++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999999988888999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 238 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence 2233456889999999999888999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=281.90 Aligned_cols=194 Identities=27% Similarity=0.502 Sum_probs=162.9
Q ss_pred CCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 152 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
....+|++.+.||+|+||.||. +|+.||+|++..... .......+.+|+.++++++||||+++++++.+++.+++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 3445899999999999998873 578999999975532 23334678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
||||+++ +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999975 888887764 34899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 173 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 217 (311)
T 3niz_A 173 V-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217 (311)
T ss_dssp C-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred c-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence 2 22334567899999999876 56899999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=283.38 Aligned_cols=194 Identities=30% Similarity=0.472 Sum_probs=165.2
Q ss_pred CCCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
...+|++.+.||+|+||.||. .+..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 345789999999999999873 34569999997542 45566789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++||||+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999754 56999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCc--ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 304 TVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 304 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
........ ....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 252 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 54322221 22335678999999998899999999999999999998 54
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=284.47 Aligned_cols=194 Identities=26% Similarity=0.405 Sum_probs=163.5
Q ss_pred cCCCCCcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc--
Q 018682 150 IDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-- 224 (352)
Q Consensus 150 i~~~~~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 224 (352)
+.....+|++.+.||+|+||.|| +.++.||+|++... .........|+.++++++||||+++++++.....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 33445589999999999999887 57899999998643 2233455669999999999999999999987553
Q ss_pred --eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCceecCCCCCCeEeCCCCCE
Q 018682 225 --MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------KPVPIIHRDLEPSNILRDDSGNL 292 (352)
Q Consensus 225 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~~~~ivH~Dikp~Nill~~~~~v 292 (352)
+++||||+++++|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence 69999999999999999774 489999999999999999999999 8 9999999999999999999
Q ss_pred EEEccCCcccccccCCC-CcccCCCCCccccccccCCC-----CCCCchhHHHHHHHHHHhhccC
Q 018682 293 KVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 293 kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltG~ 351 (352)
||+|||++......... ......+|+.|+|||++.+. .++.++|||||||++|||+||.
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 235 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence 99999999776543322 22335689999999998763 4566889999999999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=276.15 Aligned_cols=192 Identities=31% Similarity=0.517 Sum_probs=166.4
Q ss_pred CCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
...+|++.+.||+|+||.||. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+++..+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 345789999999999998873 3568999999765432 24688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999998754 4899999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
........+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 203 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK 203 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTC
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCC
Confidence 223333445678999999998889999999999999999999 54
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=287.98 Aligned_cols=192 Identities=28% Similarity=0.429 Sum_probs=165.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4799999999999999984 588999999865432 223356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC-C
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-D 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~-~ 308 (352)
||+++++|.+++.....+++.++..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++....... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999987777999999999999999999999999 9999999999999999999999999997654322 1
Q ss_pred CCcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 205 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCC
Confidence 22234578999999999987765 67899999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=283.62 Aligned_cols=202 Identities=29% Similarity=0.493 Sum_probs=173.0
Q ss_pred cCCCcccCCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q 018682 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (352)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 219 (352)
..+..++.....+|+..+.||+|+||.||. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345566666777999999999999999884 47899999987542 23456788999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEE
Q 018682 220 TQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (352)
Q Consensus 220 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~ 295 (352)
...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999986543 4889999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 296 DFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 296 Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 238 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCC
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCC
Confidence 99999765432222 222344788999999998889999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.65 Aligned_cols=192 Identities=31% Similarity=0.491 Sum_probs=168.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|.+.+.||+|+||.||. +|+.||+|++........+....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3789999999999998873 58899999987543222223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 213 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCC
Confidence 2334568999999999988765 67999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=286.15 Aligned_cols=203 Identities=29% Similarity=0.455 Sum_probs=173.3
Q ss_pred cCCCcccCCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q 018682 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (352)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 219 (352)
..+.-++.....+|+..+.||+|+||.||. +|+.||+|++...... .....+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 344445555666899999999999999984 5788999999765322 1123588999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCCceecCCCCCCeEeCCCCCE
Q 018682 220 TQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHEN---KPVPIIHRDLEPSNILRDDSGNL 292 (352)
Q Consensus 220 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~~~~ivH~Dikp~Nill~~~~~v 292 (352)
...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCE
Confidence 99999999999999999999998643 389999999999999999999999 8 9999999999999999999
Q ss_pred EEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 293 kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||+|||++...............+|+.|+|||++.+..++.++|||||||++|+|+||.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCC
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCC
Confidence 99999999876544444444556899999999998888999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=280.98 Aligned_cols=190 Identities=25% Similarity=0.524 Sum_probs=150.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|+||.||. +|+.||+|++..... ....+.+.+|+.++++++||||+++++++..++.+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3788999999999999984 478999999865432 222356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 230 EYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 230 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
||++ ++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 5999998753 34889999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (317)
T 2pmi_A 159 GIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206 (317)
T ss_dssp TSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 4322 22234567899999999876 46899999999999999999996
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=277.52 Aligned_cols=197 Identities=28% Similarity=0.520 Sum_probs=166.1
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 221 (352)
..|+++ ..+|+..+.||+|+||.||. ++..||+|++....... +.+.+|+.++++++||||+++++++.+
T Consensus 17 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCC--GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCC--HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 344544 34788899999999999873 45689999998654332 468889999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
.+.++++|||+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence 9999999999999999999986 456999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...............+++.|+|||++.+..++.++||||||+++|+|+| |.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~ 219 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 7664433223333456778999999998889999999999999999998 64
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=287.25 Aligned_cols=192 Identities=29% Similarity=0.400 Sum_probs=159.8
Q ss_pred CCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
.....+|++.+.||+|+||.||. +++.||+|++....... +.+.+|+.+++.++||||+++++++...+.+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34455899999999999998873 68899999997654333 4577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC--EEEEccCCcccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLL 303 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--vkL~Dfg~a~~~ 303 (352)
++||||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+|||+++..
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999999999988888999999999999999999999999 999999999999987765 999999998753
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCc-hhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~elltG~ 351 (352)
... .......+|+.|+|||++.+..++.+ +|||||||++|+|++|.
T Consensus 169 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 215 (361)
T 3uc3_A 169 VLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS
T ss_pred ccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC
Confidence 322 22234568999999999988877665 89999999999999996
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=291.70 Aligned_cols=191 Identities=25% Similarity=0.431 Sum_probs=163.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----Cc
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 224 (352)
.+|++.+.||+|+||.|+. +++.||||++... .......+.+.+|+.+++.++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3799999999999999884 4789999999754 34555667889999999999999999999999776 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999999995 699999998888999999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCC---------------------CcccCCCCCcccccccc-CCCCCCCchhHHHHHHHHHHhhcc
Q 018682 305 VKEDR---------------------PLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 305 ~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltG 350 (352)
..... ......+|+.|+|||++ ....++.++|||||||++|||++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 33211 12456789999999985 566799999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=279.70 Aligned_cols=189 Identities=23% Similarity=0.370 Sum_probs=165.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|...+.||+|+||.||. +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 466777999999999883 5889999998754332 24568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 9999999999865 45899999999999999999999999 99999999999999999999999999877654322 2
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....+|+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 234568999999999999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.61 Aligned_cols=195 Identities=25% Similarity=0.372 Sum_probs=170.5
Q ss_pred CCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
....+|++.+.||+|+||.||. +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3344799999999999999874 478999999876543221 12467889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC----CEEEEccCC
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGV 299 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~vkL~Dfg~ 299 (352)
.++++|||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999999998888999999999999999999999999 99999999999999888 799999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+....... ......+|+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 215 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCC
Confidence 98765322 223456899999999999999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=276.44 Aligned_cols=188 Identities=25% Similarity=0.332 Sum_probs=157.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh-cCCCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|+..+.||+|+||.||. +|+.||||++.......... .....|+..+. ..+||||+++++++.+++.+++||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 699999999999999984 58899999987654433333 33444555554 458999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+ +++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 67998888764 45999999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~ 252 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM 252 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC
Confidence 2234568999999999876 7899999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=278.42 Aligned_cols=192 Identities=29% Similarity=0.545 Sum_probs=162.0
Q ss_pred CCcccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--
Q 018682 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-- 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 222 (352)
..+|++.+.||+|+||.||. +++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 45799999999999999873 5789999998743 456667899999999999999999999998653
Q ss_pred CceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
..+++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 56899999999999999998754 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
........ ......++..|+|||++.+..++.++||||||+++|+|+||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence 76433221 122344667799999999889999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=286.45 Aligned_cols=191 Identities=27% Similarity=0.464 Sum_probs=154.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCC--ceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS--PMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~~l 227 (352)
+|++.+.||+|+||.|+. +|+.||+|++... .........+.+|+.+++.+. ||||+++++++..++ .+|+
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 789999999999998874 4889999998754 334555677888999999997 999999999997654 6899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999996 599999876 46899999999999999999999999 9999999999999999999999999997653211
Q ss_pred --------------------CCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 --------------------DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 --------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
........+|+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 111233568999999999876 678999999999999999999963
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=277.19 Aligned_cols=191 Identities=25% Similarity=0.446 Sum_probs=165.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. ++..||+|++.............+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 4799999999999999984 46789999986543322223466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 99999999999988888999999999999999999999999 999999999999999999999999988654322
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 204 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCC
Confidence 223456889999999999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=285.15 Aligned_cols=192 Identities=30% Similarity=0.521 Sum_probs=167.5
Q ss_pred CcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 221 (352)
.+|.+.+.||+|+||.||.. +..||+|++... ........+.+|+.+++++ +||||+++++++..
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47889999999999999842 257999999754 3455667889999999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 285 (352)
++.+++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999998753 4899999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 286 RDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 286 l~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~ 291 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 99999999999999986654322 22233456788999999999999999999999999999999 53
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=279.80 Aligned_cols=191 Identities=25% Similarity=0.414 Sum_probs=163.9
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC--ceE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 226 (352)
..+|++.+.||+|+||.||. +++.||+|++....... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 44799999999999999983 38899999987543322 2456788999999999999999999998765 789
Q ss_pred EEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe----CCCCCEEEEccCC
Q 018682 227 IVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGV 299 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~vkL~Dfg~ 299 (352)
+||||+++++|.+++..... +++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999986433 899999999999999999999999 9999999999999 7777899999999
Q ss_pred cccccccCCCCcccCCCCCccccccccC--------CCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFK--------NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltG~ 351 (352)
+....... ......+|+.|+|||++. +..++.++|||||||++|||+||.
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~ 220 (319)
T 4euu_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220 (319)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCC
Confidence 98765432 223456899999999885 567899999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=286.85 Aligned_cols=189 Identities=18% Similarity=0.365 Sum_probs=166.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. +|+.||+|++... .......+.+|+.++++++||||+++++++.+...+++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 3799999999999999984 5789999998644 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC--CCCEEEEccCCccccccc
Q 018682 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~vkL~Dfg~a~~~~~~ 306 (352)
||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++. .+.+||+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999987653 5899999999999999999999999 999999999999974 467999999999876432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 247 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCC
Confidence 2 233456899999999999999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=309.78 Aligned_cols=194 Identities=29% Similarity=0.410 Sum_probs=169.9
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|++.+.||+|+||.||. +++.||+|++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|+|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 4789999999999998883 4678999998754322223345678899999988 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|||+++++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 999999999999998888999999999999999999999999 9999999999999999999999999998643322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~ 540 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCC
Confidence 23345678999999999999999999999999999999999963
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=282.31 Aligned_cols=188 Identities=18% Similarity=0.219 Sum_probs=164.2
Q ss_pred CcccCceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|++.+.||+|+||.|| .+|+.||+|++...... +.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 378999999999999887 36889999998654322 3578899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC-----EEEEccCCccc
Q 018682 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL 302 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----vkL~Dfg~a~~ 302 (352)
|||+ +++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 99999999863 56999999999999999999999999 999999999999998887 99999999987
Q ss_pred ccccCCCC------cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
........ .....||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 64433211 23467899999999999999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=281.86 Aligned_cols=188 Identities=29% Similarity=0.487 Sum_probs=165.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|+||.||. +|+.||+|++...........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 588899999999999983 588999999976655555666788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+. |+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 996 58888775 4556999999999999999999999999 999999999999999999999999999765432
Q ss_pred CcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~~ 352 (352)
....+|+.|+|||++. ...++.++|||||||++|||++|..
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 251 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 2356899999999884 5678999999999999999999963
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=271.27 Aligned_cols=191 Identities=24% Similarity=0.410 Sum_probs=169.9
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++..++..+++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4799999999999999984 478999999976644 4555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC---EEEEccCCccccccc
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVK 306 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---vkL~Dfg~a~~~~~~ 306 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999988888999999999999999999999999 999999999999986655 999999999765432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. ......+|+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 162 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred c--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence 2 223456899999999999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=276.42 Aligned_cols=192 Identities=27% Similarity=0.537 Sum_probs=163.3
Q ss_pred CcccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--C
Q 018682 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 223 (352)
..|+..+.||+|+||.||. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3589999999999999872 57899999997543 223346788999999999999999999999876 6
Q ss_pred ceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
.++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 68999999999999999954 456999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCC--CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
...... .......+|..|+|||++.+..++.++||||||+++|+|+||.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence 654322 1223355778899999998888999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.82 Aligned_cols=182 Identities=25% Similarity=0.430 Sum_probs=144.1
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccC
Q 018682 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 160 ~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
.+.||+|+||.||. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.++...|+||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 36899999999884 4789999998643 2356778999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC---CEEEEccCCcccccccCCCC
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++...... ...
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 165 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP 165 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence 9999999999888999999999999999999999999 99999999999998766 7999999999765432 222
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 206 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence 33456789999999999999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=276.80 Aligned_cols=191 Identities=25% Similarity=0.404 Sum_probs=163.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++.... ......+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 688999999999999883 48899999987653 344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++++|.+++.....+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999987653322 2
Q ss_pred cccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+|+.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 200 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 234567889999999876 67899999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=283.56 Aligned_cols=187 Identities=27% Similarity=0.432 Sum_probs=152.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. +++.||+|++.... ..+.+.+|+.++++++||||+++++++...+.+++||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4689999999999999984 46789999987542 2356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccCCccccccc
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg~a~~~~~~ 306 (352)
||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999988888999999999999999999999999 999999999999975 789999999998765432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 247 (349)
T 2w4o_A 205 --VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF 247 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 1223456899999999999989999999999999999999996
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=274.37 Aligned_cols=192 Identities=22% Similarity=0.424 Sum_probs=154.2
Q ss_pred CCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
..+|++.+.||+|+||.||. .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34788999999999998873 2457999998753 34556678999999999999999999999874 5678
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999998654 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...........+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 215 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC
Confidence 433333334456778999999988899999999999999999997 53
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.85 Aligned_cols=195 Identities=25% Similarity=0.437 Sum_probs=148.4
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|++.+.||+|+||.||. +|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 34799999999999998873 5789999998654322222246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999875 56899999999999999999999999 9999999999999999999999999997764332
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
. ......+++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2 2223567899999999998889999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=277.87 Aligned_cols=191 Identities=28% Similarity=0.460 Sum_probs=158.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCC-----------------------HHHHHHHHHHHHHHhcC
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------------------DDRVRAFRDELALLQKI 207 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 207 (352)
+|++.+.||+|+||.||. +++.||+|++....... ....+.+.+|+.+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 789999999999999984 47899999987653221 12235688999999999
Q ss_pred CCCceeeeeEEEEe--CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 018682 208 RHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (352)
Q Consensus 208 ~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 285 (352)
+||||+++++++.+ ...+++||||+++++|.+++. ...+++.++..++.|++.||.|||+++ |+||||||+||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 99999999999987 567999999999999987654 346899999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCC---CCCchhHHHHHHHHHHhhccC
Q 018682 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 286 l~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltG~ 351 (352)
++.++.+||+|||++........ ......+|+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99999999999999987653321 223456899999999997765 367899999999999999996
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=276.32 Aligned_cols=191 Identities=29% Similarity=0.527 Sum_probs=160.4
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..+.||+|+||.||. .|+.||+|++..... .....+.+.+|+.++++++||||+++++++...+.++++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 688899999999999884 478999999875432 122235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++ +|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 975 999998764 56899999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred cccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 233467899999999876 458999999999999999999963
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=280.99 Aligned_cols=194 Identities=31% Similarity=0.470 Sum_probs=167.1
Q ss_pred CCCcccCceeecccEEEEEEE---c-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q 018682 153 HELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~---~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 222 (352)
...+|+..+.||+|+||.||. . ++.||+|++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345788999999999998873 2 2789999997543 455667899999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D 278 (352)
+.+++||||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999999999999999999863 46899999999999999999999999 99999
Q ss_pred CCCCCeEeCCCCCEEEEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 279 LEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 279 ikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
|||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|+| |.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999976543321 12233456888999999988889999999999999999999 64
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=283.52 Aligned_cols=194 Identities=29% Similarity=0.496 Sum_probs=157.9
Q ss_pred CCCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
...+|++.+.||+|+||.||. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 345899999999999999984 35679999997542 45566789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
+++||||+++++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999998754 5899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCc--ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 304 TVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 304 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
........ ....+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~ 248 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCC
Confidence 53322211 12234678999999998899999999999999999998 64
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=288.54 Aligned_cols=194 Identities=23% Similarity=0.353 Sum_probs=165.2
Q ss_pred CcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 224 (352)
.+|++.+.||+|+||.||. +++.||+|++...... .......+.+|+.+++.+ +||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4799999999999999882 6789999998754321 111224466799999999 69999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+++||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999997654
Q ss_pred ccCCCCcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~ 351 (352)
...........+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 333333334568999999999985 35788999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=275.24 Aligned_cols=191 Identities=26% Similarity=0.449 Sum_probs=167.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. ++..||+|++.............+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3789999999999999884 47889999986543222222356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998665432
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 209 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCC
Confidence 223456889999999999989999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=285.06 Aligned_cols=191 Identities=24% Similarity=0.416 Sum_probs=166.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|++.+.||+|+||.||. +++.||+|++........ .....+.+|+.++++++||||+++++++.+.+.+
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 799999999999998873 588999999876543221 1234567899999999999999999999999999
Q ss_pred EEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+++|||+.++ +|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999998666 99999998888999999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCCcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
... ......+|+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 182 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 227 (335)
T 3dls_A 182 RGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227 (335)
T ss_dssp TTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred CCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCC
Confidence 332 2234568999999999988776 78899999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=276.41 Aligned_cols=193 Identities=30% Similarity=0.513 Sum_probs=167.3
Q ss_pred CCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
..+|.+.+.||+|+||.||.. +..||+|++... ......+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 457889999999999988742 378999999754 24566678999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGA------------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di 279 (352)
..+++|||+++++|.+++..... +++.++..++.|++.||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999986543 789999999999999999999999 999999
Q ss_pred CCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 280 kp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
||+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999765433221 1223456788999999988889999999999999999999 64
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=283.40 Aligned_cols=187 Identities=22% Similarity=0.377 Sum_probs=158.1
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+...+.||+|+||.||. +|+.||+|++... .....+.+.+|+.++++++||||+++++++...+.+++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 44467899999999884 4789999998754 334556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe--CCCCCEEEEccCCcccccccCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--DDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill--~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999988654 45899999999999999999999999 9999999999999 566789999999998764322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 285 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSS
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 223356899999999999989999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=269.30 Aligned_cols=187 Identities=24% Similarity=0.408 Sum_probs=165.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. ++..||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 689999999999999884 36689999987654433 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe---CCCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++.....+++..+..++.|++.||.|||+++ |+|+||||+||++ +.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999999988888999999999999999999999999 9999999999999 788899999999997765332
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.+. ++.++||||||+++|+|++|.
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~ 204 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGY 204 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSS
T ss_pred --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCC
Confidence 23345688999999998764 899999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.88 Aligned_cols=191 Identities=26% Similarity=0.466 Sum_probs=169.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|+..+.||+|+||.||. +|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 699999999999999983 588999999876554434445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe---CCCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|+.+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 182 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence 9999999999998888999999999999999999999999 9999999999999 46788999999999765432
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 225 (484)
T 3nyv_A 183 -KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225 (484)
T ss_dssp -CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCC
Confidence 23344568999999999876 68999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=281.61 Aligned_cols=195 Identities=23% Similarity=0.388 Sum_probs=163.2
Q ss_pred CCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CceeeeeEEEEeCCc
Q 018682 151 DPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSP 224 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~ 224 (352)
.....+|++.+.||+|+||.||. +++.||+|++.... ......+.+.+|+.++++++| |||+++++++..+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34456799999999999999984 47889999987653 345566788999999999976 999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+++|||+ .+++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999995 58899999999888999999999999999999999999 99999999999997 5789999999998764
Q ss_pred ccCCC-CcccCCCCCccccccccCC-----------CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltG~ 351 (352)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 33221 2234568999999999854 67888999999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=278.04 Aligned_cols=192 Identities=29% Similarity=0.523 Sum_probs=165.4
Q ss_pred CcccCceeecccEEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 221 (352)
.+|++.+.||+|+||.||. ++..||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4788999999999999873 35689999997542 455667889999999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 285 (352)
.+.+++||||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 999999999999999999998653 3889999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 286 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 286 l~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 257 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999866533211 1223456788999999988889999999999999999999 54
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=288.64 Aligned_cols=191 Identities=32% Similarity=0.583 Sum_probs=163.3
Q ss_pred CcccCCCCCcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
.|+++. .+|+..+.||+|+||.|| +.|+.||||+++... ..+.+.+|+.++++++||||+++++++....
T Consensus 187 ~~~i~~--~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNM--KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCG--GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccCh--HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 344443 367888999999999887 578999999997543 2357889999999999999999999987665
Q ss_pred -ceEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 224 -PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 224 -~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
.+++||||+++++|.+++...+. ++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 79999999999999999987543 789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+..... .....+++.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 337 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 384 (450)
T 1k9a_A 337 KEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384 (450)
T ss_dssp EECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 754322 122356788999999999999999999999999999998 54
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=280.70 Aligned_cols=192 Identities=23% Similarity=0.455 Sum_probs=157.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 3799999999999998874 588999999976532 3334456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-----CCCCEEEEccCCccccc
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-----DSGNLKVADFGVSKLLT 304 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-----~~~~vkL~Dfg~a~~~~ 304 (352)
||++ ++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++ ..+.+||+|||++....
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9997 599999998888999999999999999999999999 99999999999995 44559999999997654
Q ss_pred ccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 322 222334578999999998774 58999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=273.05 Aligned_cols=193 Identities=24% Similarity=0.474 Sum_probs=160.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. +|+.||+|++.............+.+|+.++++++||||+++++++..++..+++|
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3799999999999999883 58899999998765666777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 230 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
||+++++|.+++.. ...++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 455899999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.. .......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~ 233 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 22 1223346788999999999989999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=273.26 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=172.0
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEEE-----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeee
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 216 (352)
+.++.++.....|...+.||+|+||.||. + +..||+|.+... ......+.+.+|+.++++++||||++++
T Consensus 11 ~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (298)
T 3pls_A 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALI 88 (298)
T ss_dssp TGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 45566777778899999999999999983 2 237999998743 3556667889999999999999999999
Q ss_pred EEEEeCCce-EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 217 GAVTQSSPM-MIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 217 ~~~~~~~~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
+++.+.+.. +++|||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp EEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEe
Confidence 999876665 999999999999999986 345889999999999999999999999 999999999999999999999
Q ss_pred EccCCcccccccC---CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 225 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRG 225 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCC
Confidence 9999997654321 11223345678899999999999999999999999999999965
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=270.52 Aligned_cols=193 Identities=32% Similarity=0.522 Sum_probs=155.2
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCC-HHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISD-DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.+|+..+.||+|+||.|| +.++.||+|++....... ....+.+++|+.+++.++||||+++++++..++..+++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 478899999999999887 578999999987643322 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC--------CCCEEEEccCCccc
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--------SGNLKVADFGVSKL 302 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~--------~~~vkL~Dfg~a~~ 302 (352)
|+++++|.+++.. ..+++..+..++.|++.||.|||+++..+|+||||||+||+++. ++.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 9999999999864 46899999999999999999999998445889999999999986 67899999999976
Q ss_pred ccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 166 WHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCC
T ss_pred ccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 54322 22356889999999999888999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=280.97 Aligned_cols=188 Identities=27% Similarity=0.436 Sum_probs=158.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
.+|+..+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4799999999999998873 58899999997653 34555677889999999999999999999997653
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999987 46899999999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 224 (367)
T 1cm8_A 179 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224 (367)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCC
Confidence 42 2234567899999999876 678999999999999999999963
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.90 Aligned_cols=185 Identities=26% Similarity=0.475 Sum_probs=161.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|+..+.||+|+||.|+. +|+.||+|++...... ..+|+.++.++ +||||+++++++.+++.+|+||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 688999999999999874 5889999999765432 34688888877 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-C---CEEEEccCCcccccc
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-G---NLKVADFGVSKLLTV 305 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~---~vkL~Dfg~a~~~~~ 305 (352)
||+++++|.+++...+.+++.++..++.|++.||.|||++| |+||||||+|||+... + .+||+|||++.....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999998888999999999999999999999999 9999999999998543 2 499999999987654
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 217 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCC
Confidence 322 233456799999999998888899999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=284.75 Aligned_cols=192 Identities=31% Similarity=0.453 Sum_probs=163.9
Q ss_pred CcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
.+|++.+.||+|+||.||. ++..||+|++... ........+.+|+.++++++||||+++++++.....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4788999999999998873 3468999999643 244555678889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC---CEEE
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 294 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~vkL 294 (352)
.++||||+++++|.+++.... .++..+++.++.|++.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999998643 4889999999999999999999999 99999999999999555 4999
Q ss_pred EccCCcccccccC-CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999997653322 122234557889999999988899999999999999999998 53
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.54 Aligned_cols=192 Identities=24% Similarity=0.457 Sum_probs=163.9
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH----------HHHHHHHHHHHHHhcCCCCceeeeeEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----------DRVRAFRDELALLQKIRHPNVVQFLGAV 219 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 219 (352)
.+|.+.+.||+|+||.||. ++..||+|++........ ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4799999999999999983 578999999876543221 2246788999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC---CEEEEc
Q 018682 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVAD 296 (352)
Q Consensus 220 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~vkL~D 296 (352)
.+...+|+||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999988888999999999999999999999999 99999999999999776 699999
Q ss_pred cCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 297 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 193 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 245 (504)
T 3q5i_A 193 FGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245 (504)
T ss_dssp CTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCC
Confidence 9999876533 22334568999999999875 68999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=291.71 Aligned_cols=189 Identities=26% Similarity=0.372 Sum_probs=158.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
.+|++.+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4799999999999999973 48899999997653 34555677889999999999999999999997553
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46999999965 57666643 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
... .......+|+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCC
Confidence 432 23344678999999999999999999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=277.21 Aligned_cols=185 Identities=27% Similarity=0.386 Sum_probs=163.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----CCceeeeeEEEEeCCc
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPNVVQFLGAVTQSSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~ 224 (352)
-+|++.+.||+|+||.||. +++.||+|++.. .....+.+..|+.+++.++ ||||+++++++...+.
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 4799999999999999983 578999999863 2444566788999999986 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC--------------
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------------- 288 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-------------- 288 (352)
+++||||+ +++|.+++.... .++...+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence 99999999 899999998754 4899999999999999999999999 999999999999975
Q ss_pred -----------CCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 289 -----------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 289 -----------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 78899999999976432 223456899999999999999999999999999999999996
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=287.82 Aligned_cols=199 Identities=31% Similarity=0.470 Sum_probs=167.2
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 220 (352)
..|+++. .+|+..+.||+|+||.||. +++.||+|.+... ...+..+.+.+|+.++++++||||+++++++.
T Consensus 107 ~~~~~~~--~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 107 DKWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp CTTBCCG--GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEch--HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3455443 3788889999999999873 5889999998754 24555567889999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
.++.+++||||+++++|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCC
Confidence 9999999999999999999997654 5899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCc-ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 300 SKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 300 a~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+........... ....+++.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 876432211111 11123567999999988889999999999999999998 53
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=273.42 Aligned_cols=198 Identities=27% Similarity=0.391 Sum_probs=164.4
Q ss_pred ccCCCCCcccCce-eecccEEEEEEEc-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q 018682 149 EIDPHELDFTNSV-EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (352)
Q Consensus 149 ~i~~~~~~~~~~~-~ig~G~~~~v~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 220 (352)
++.....+|++.+ .||+|+||.||.. +..||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3333445788877 9999999998743 57899999976532 334467789999999999999999999998
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
..+..+++|||+++++|.+++.....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 56778999999999999999998888999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 301 KLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 301 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
......... ......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 218 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 218 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCC
Confidence 776433221 1122345678999999988888999999999999999999 64
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=282.68 Aligned_cols=193 Identities=30% Similarity=0.458 Sum_probs=164.2
Q ss_pred CCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 222 (352)
..+|++.+.||+|+||.||.. ++.||+|++... ......+.+.+|+.+++++ +||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 347889999999999999842 378999999754 2445567789999999999 799999999999876
Q ss_pred Cc-eEEEEeccCCCCHHHHHHhcCC-------------------------------------------------------
Q 018682 223 SP-MMIVTEYLPKGDLRAFLKRKGA------------------------------------------------------- 246 (352)
Q Consensus 223 ~~-~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 246 (352)
+. ++++|||+++++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 54 8999999999999999986532
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccC
Q 018682 247 -----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQ 314 (352)
Q Consensus 247 -----------~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~ 314 (352)
+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 889999999999999999999999 999999999999999999999999999765432221 22334
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.+|+.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 293 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCC
Confidence 56788999999998899999999999999999998 64
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=269.60 Aligned_cols=191 Identities=25% Similarity=0.432 Sum_probs=165.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|++.+.||+|+||.||. +|+.||+|++........ ...+.+.+|+.++++++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 688899999999999884 488999999876543321 124678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC----CEEEEccCCcccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL 303 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~vkL~Dfg~a~~~ 303 (352)
+|||+++++|.+++.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999988788999999999999999999999999 99999999999999877 7999999999765
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 208 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCC
Confidence 4322 223356889999999999989999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=274.61 Aligned_cols=190 Identities=28% Similarity=0.509 Sum_probs=164.8
Q ss_pred cccCceeecccEEEEEE---E------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--Cc
Q 018682 156 DFTNSVEITKGTFILAF---W------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 224 (352)
.|++.+.||+|+||.|| + +++.||+|++... ......+.+.+|+.++++++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 45899999999999995 2 6789999999754 3455667899999999999999999999999874 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+++||||+++++|.+++.... +++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 899999999999999997654 899999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCC--CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... .......+++.|+|||++.+..++.++||||||+++|+|+||.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~ 234 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 4322 1123345778899999999888999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=291.52 Aligned_cols=190 Identities=24% Similarity=0.432 Sum_probs=161.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. ++..||+|++....... .....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 699999999999999983 57899999987654322 224568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---CCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.. +.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999999988888999999999999999999999999 9999999999999764 459999999998765332
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+|+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 194 --~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~ 235 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred --cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCC
Confidence 2334568999999999864 68999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=289.86 Aligned_cols=189 Identities=13% Similarity=0.176 Sum_probs=158.2
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH---HHhcCCCCceeeee-------EE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA---LLQKIRHPNVVQFL-------GA 218 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------~~ 218 (352)
..+|++.+.||+|+||.||. +|+.||||++...........+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45799999999999999983 48899999998655555556678999995 45555799999998 66
Q ss_pred EEeCCc-----------------eEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCCc
Q 018682 219 VTQSSP-----------------MMIVTEYLPKGDLRAFLKRKGALKP-------STAVRFALDIARGMNYLHENKPVPI 274 (352)
Q Consensus 219 ~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~LH~~~~~~i 274 (352)
+...+. .|++|||+ +|+|.+++...+.+++ ..+..++.|++.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665542 88999999 6799999987554555 777889999999999999999 9
Q ss_pred eecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCC-----------CCCCchhHHHHHHH
Q 018682 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALI 343 (352)
Q Consensus 275 vH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~i 343 (352)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986322 2234456 899999999877 89999999999999
Q ss_pred HHHhhccC
Q 018682 344 LQEVKFYN 351 (352)
Q Consensus 344 l~elltG~ 351 (352)
+|||++|.
T Consensus 303 l~elltg~ 310 (377)
T 3byv_A 303 IYWIWCAD 310 (377)
T ss_dssp HHHHHHSS
T ss_pred HHHHHHCC
Confidence 99999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=282.73 Aligned_cols=193 Identities=23% Similarity=0.385 Sum_probs=162.9
Q ss_pred CCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCceeeeeEEEEeCCceEE
Q 018682 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l 227 (352)
..+|++.+.||+|+||.||. .++.||+|++..... .....+.+.+|+.++++++ ||||+++++++..++.+|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34699999999999999984 378999999876543 4556678999999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||| +.+++|.+++.....+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 558899999998888999999999999999999999999 99999999999996 5789999999998764332
Q ss_pred CC-CcccCCCCCccccccccCC-----------CCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~ 265 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCC
Confidence 21 2234568999999999865 368889999999999999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=269.46 Aligned_cols=189 Identities=32% Similarity=0.548 Sum_probs=164.8
Q ss_pred CcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.+|+..+.||+|+||.||. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+++..+++||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3688889999999998874 5789999999865432 2568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999865 45899999999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
......+++.|+|||++.+..++.++||||||+++|+|+++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhcc
Confidence 22334567789999999888899999999999999999993
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=272.47 Aligned_cols=202 Identities=31% Similarity=0.492 Sum_probs=169.6
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeee
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 216 (352)
+..+.+.+...+|+..+.||+|+||.||.. ...+|+|.+... ......+.+.+|+.++++++||||++++
T Consensus 15 ~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 92 (298)
T 3f66_A 15 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL 92 (298)
T ss_dssp HGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeee
Confidence 345667778889999999999999999831 235899988753 3556667899999999999999999999
Q ss_pred EEEE-eCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 217 GAVT-QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 217 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
+++. .++..+++|||+++++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl 169 (298)
T 3f66_A 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKV 169 (298)
T ss_dssp EEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred eEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEE
Confidence 9864 456789999999999999999764 45889999999999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCC---CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~ 229 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 229 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 99999976543321 1122345677899999999889999999999999999999965
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.08 Aligned_cols=200 Identities=29% Similarity=0.477 Sum_probs=157.4
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 222 (352)
.+.+++. ..+|++.+.||+|+||.||. ....||+|++.... ......+.+.+|+.++++++||||++++++. ..
T Consensus 16 ~~~~ei~--~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 16 ADDWEIP--DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp --CCBCC--TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCccC--ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 3444554 33688899999999999984 45679999997653 3556667899999999999999999999954 56
Q ss_pred CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
..++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 6789999999999999999643 45899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccC-CCCcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKE-DRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~ 351 (352)
...... ........+|+.|+|||++. +..++.++||||||+++|+|++|.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence 654322 22223456899999999986 567888999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=273.66 Aligned_cols=186 Identities=24% Similarity=0.370 Sum_probs=161.7
Q ss_pred CcccCceeecccEEEEEEE-----cC-------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q 018682 155 LDFTNSVEITKGTFILAFW-----RG-------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 222 (352)
.+|+..+.||+|+||.||. ++ ..||+|++.... ....+.+.+|+.++++++||||+++++++.++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4788999999999998873 22 579999986542 23346788999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC--------EE
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LK 293 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------vk 293 (352)
+..++||||+++++|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999987654 899999999999999999999999 999999999999998887 99
Q ss_pred EEccCCcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 294 L~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
|+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 215 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG 215 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTT
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCC
Confidence 9999998654321 22346788999999987 67899999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=268.30 Aligned_cols=188 Identities=23% Similarity=0.385 Sum_probs=161.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|++.+.||+|+||.||. +++.||+|++........ ....+.+|+..+..+ +||||+++++++.+++.+++||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 688999999999999884 588999999876544333 445677899999988 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC----------------
Q 018682 230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---------------- 289 (352)
Q Consensus 230 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---------------- 289 (352)
||+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999764 56899999999999999999999999 9999999999999844
Q ss_pred ---CCEEEEccCCcccccccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 290 ---GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 290 ---~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
..++|+|||.+....... ...+|+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 479999999987754322 23588999999999775 56679999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=283.50 Aligned_cols=183 Identities=28% Similarity=0.399 Sum_probs=151.5
Q ss_pred cccCc-eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh-cCCCCceeeeeEEEEe----CCc
Q 018682 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQ----SSP 224 (352)
Q Consensus 156 ~~~~~-~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~----~~~ 224 (352)
+|.+. +.||+|+||.||. +|+.||+|++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 56665 6899999999984 4789999998532 34667888874 5589999999999876 567
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg~ 299 (352)
+|+||||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998653 4899999999999999999999999 999999999999997 78899999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+...... .......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 260 (400)
T 1nxk_A 211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCC
Confidence 9865432 2223456799999999999999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=275.70 Aligned_cols=193 Identities=30% Similarity=0.474 Sum_probs=150.0
Q ss_pred CCcccCceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
..+|++.+.||+|+||.||. ++ ..||+|++....... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34789999999999999983 22 279999997654433 3457789999999999999999999999877655
Q ss_pred ------EEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEE
Q 018682 226 ------MIVTEYLPKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (352)
Q Consensus 226 ------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vk 293 (352)
+++|||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999996532 5899999999999999999999999 99999999999999999999
Q ss_pred EEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 294 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 294 L~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|+++
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 9999999765433221 22234457789999999998999999999999999999994
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=276.97 Aligned_cols=192 Identities=26% Similarity=0.421 Sum_probs=163.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|+..+.||+|+||.||. +|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3799999999999998873 37899999986553 34555667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.++......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-c
Confidence 99999999998887778999999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred CcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCC
Confidence 22345678999999998775 7899999999999999999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=270.18 Aligned_cols=189 Identities=18% Similarity=0.228 Sum_probs=164.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.+|++.+.||+|+||.||. +|+.||+|++...... +.+.+|+.+++.+ +|++++++++++......+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 4799999999999998873 5889999988644322 3577899999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC-----EEEEccCCccc
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL 302 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----vkL~Dfg~a~~ 302 (352)
|||+ +++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 999999998754 5999999999999999999999999 999999999999987776 99999999987
Q ss_pred ccccCCC------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence 6543221 2234568999999999999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=290.11 Aligned_cols=195 Identities=29% Similarity=0.479 Sum_probs=164.5
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 222 (352)
.|++.. .+|+..+.||+|+||.||. .+..||||++..... ..+.+.+|+.++++++||||+++++++. .
T Consensus 182 ~~~i~~--~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 182 AWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp CSBCCG--GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred ceeech--HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 344443 3678889999999999873 377899999976532 2467889999999999999999999886 6
Q ss_pred CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
+.+++||||+++|+|.+++... ..++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 6799999999999999999753 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+..............+++.|+|||++....++.++|||||||++|||+| |.
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCC
Confidence 8754322122223345678999999998899999999999999999999 54
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.61 Aligned_cols=187 Identities=27% Similarity=0.431 Sum_probs=163.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|...+.||+|+||.||. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.++++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 688999999999999883 58899999987542 2233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe---CCCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+|+||||+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999999988888999999999999999999999999 9999999999999 77889999999998754322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 204 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY 204 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 223345789999999999999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=273.53 Aligned_cols=192 Identities=28% Similarity=0.475 Sum_probs=165.1
Q ss_pred CCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
..+|++.+.||+|+||.||. .+..||+|.+... ........+.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 44799999999999998873 3678999999754 24455567889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEE
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vk 293 (352)
..+++|||+++++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 999999999999999999752 34689999999999999999999999 99999999999999999999
Q ss_pred EEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 294 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 294 L~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 236 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhc
Confidence 9999998765433221 11223457889999999988899999999999999999994
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=273.21 Aligned_cols=186 Identities=30% Similarity=0.491 Sum_probs=155.1
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc--CCCCceeeeeEEEEeC----Cce
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQS----SPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~----~~~ 225 (352)
.+|++.+.||+|+||.|| ++++.||+|++.... ...+..|.+++.. ++||||+++++++... ..+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 479999999999999887 579999999986431 2344556666665 7999999999987543 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
+++|||+++++|.++++. ..+++..+..++.|++.||.||| +.+ |+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999964 46899999999999999999999 888 999999999999999999999999
Q ss_pred CCcccccccCCCC---cccCCCCCccccccccCCC------CCCCchhHHHHHHHHHHhhcc
Q 018682 298 GVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 298 g~a~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltG 350 (352)
|++.......... .....+|+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 9997654332211 2234689999999999876 445789999999999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.62 Aligned_cols=193 Identities=26% Similarity=0.457 Sum_probs=161.9
Q ss_pred CCCcccCceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 153 HELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
...+|+..+.||+|+||.||.. +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3447889999999999988741 2359999997552 45556789999999999999999999998865 56
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+++|||+++++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 79999999999999999765 44899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
............+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~ 212 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 212 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCC
Confidence 5443333344556788999999988889999999999999999998 65
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=274.12 Aligned_cols=192 Identities=31% Similarity=0.469 Sum_probs=159.9
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcC---CCCceeeeeEEEEeCC-
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSS- 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~- 223 (352)
.+|++.+.||+|+||.||. +++.||+|++....... ......+.+|+.+++.+ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 4799999999999998873 57899999986443211 11113455677777666 4999999999998765
Q ss_pred ----ceEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 224 ----PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 224 ----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
.++++|||+. ++|.+++..... +++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeC
Confidence 4899999996 699999987654 899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
|++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 165 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 217 (308)
T 3g33_A 165 GLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217 (308)
T ss_dssp SCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSC
T ss_pred ccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCC
Confidence 999765432 22344567999999999999999999999999999999999963
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=279.03 Aligned_cols=193 Identities=30% Similarity=0.458 Sum_probs=162.5
Q ss_pred CCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 222 (352)
..+|+..+.||+|+||.||. .+..||+|++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34788899999999999873 34579999997542 233456788999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di 279 (352)
+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 99999999999999999998643 2788999999999999999999999 999999
Q ss_pred CCCCeEeCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 280 kp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
||+||+++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999997664332211 123345778999999988899999999999999999998 64
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=291.87 Aligned_cols=191 Identities=27% Similarity=0.461 Sum_probs=164.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +++.||+|++........ ....+.+|+.++++++||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 3799999999999999883 588999999865432221 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC---CCCCEEEEccCCccccccc
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~vkL~Dfg~a~~~~~~ 306 (352)
||+++++|.+++.....+++..+..++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999999988888999999999999999999999999 99999999999995 4567999999999765432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 220 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCC
Confidence 22334568999999999876 58999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=280.72 Aligned_cols=189 Identities=29% Similarity=0.466 Sum_probs=168.2
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. ++..||+|++.... .....+.+.+|+.++++++||||+++++++..++.+++||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 4799999999999999884 47899999987542 4556678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++...+.+++..+..++.|++.||.|||++ + |+||||||+||+++.++.++|+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999888899999999999999999999996 8 999999999999999999999999998755322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 227 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTS
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 123356889999999999999999999999999999999996
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=282.89 Aligned_cols=202 Identities=30% Similarity=0.484 Sum_probs=161.5
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeee
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 216 (352)
...+.+.+....|...+.||+|+||.||.. +..||+|.+... ......+.+.+|+.++++++||||++++
T Consensus 79 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~ 156 (373)
T 3c1x_A 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL 156 (373)
T ss_dssp TTTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCC
T ss_pred ccccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 445667777788999999999999999831 246899998643 3445667899999999999999999999
Q ss_pred EEEE-eCCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 217 GAVT-QSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 217 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
+++. .++..++||||+++++|.+++.... .++..++..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp EEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEE
Confidence 9875 4567899999999999999998653 4889999999999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCCC---CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||+||+
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~ 293 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCc
Confidence 999999765432211 112344677899999999889999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=270.77 Aligned_cols=192 Identities=30% Similarity=0.476 Sum_probs=160.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +|+.||+|++........+..+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 3788999999999998883 58899999986543222223457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999987654322
Q ss_pred CcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..+ +.++|+||||+++|+|++|.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 208 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSS
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCC
Confidence 2233467889999999988765 57999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.13 Aligned_cols=191 Identities=28% Similarity=0.442 Sum_probs=166.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC-C----HHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCc
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~-~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 224 (352)
+|++.+.||+|+||.||. +|+.||||++...... . .+..+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 688889999999999873 4889999998754321 1 22345678999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999988878999999999999999999999999 9999999999999999999999999987765
Q ss_pred ccCCCCcccCCCCCccccccccCC------CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~elltG~ 351 (352)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 322 2334668999999998853 35788999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=292.02 Aligned_cols=189 Identities=31% Similarity=0.545 Sum_probs=164.2
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|+..+.||+|+||.||. .+..||+|.+...... .+.+.+|+.++++++||||+++++++.....+++||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3688889999999998873 3789999999765322 467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 230 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||+++++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999864 34889999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
........+++.|+|||++.+..++.++|||||||++|||+|+
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 2222334456789999999988899999999999999999993
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=273.20 Aligned_cols=191 Identities=23% Similarity=0.346 Sum_probs=158.4
Q ss_pred cccCc-eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~-~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
.|++. +.||+|+||.||. +++.||+|++...... ....+.+|+.+++++ +||||+++++++.+++.+|+|
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 56663 6799999999984 5889999998754322 235678899999885 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC---EEEEccCCcccccc
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 305 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---vkL~Dfg~a~~~~~ 305 (352)
|||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999988888999999999999999999999999 999999999999998776 99999999876542
Q ss_pred cCC------CCcccCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KED------RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltG~~ 352 (352)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 224 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCC
Confidence 211 11123458999999999865 467899999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=280.99 Aligned_cols=195 Identities=14% Similarity=0.231 Sum_probs=159.1
Q ss_pred CCCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHH--------HHHHHHHHHHhcCCCCceee
Q 018682 153 HELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQ 214 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~iv~ 214 (352)
...+|++.+.||+|+||.||.. ++.||+|++........... ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 3448999999999999999842 57899999865421100011 12334666777889999999
Q ss_pred eeEEEEeC----CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC--
Q 018682 215 FLGAVTQS----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-- 287 (352)
Q Consensus 215 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-- 287 (352)
+++++... ...|+||||+ +++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 99998765 4489999999 99999999875 56999999999999999999999999 99999999999999
Q ss_pred CCCCEEEEccCCcccccccCCC------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 288 DSGNLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 288 ~~~~vkL~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 8899999999999776433211 113345899999999999999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=264.71 Aligned_cols=195 Identities=27% Similarity=0.528 Sum_probs=167.0
Q ss_pred CCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----
Q 018682 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---- 221 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 221 (352)
......|...+.||+|+||.||. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 34445688889999999999884 467899999876544 45556788999999999999999999999875
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEccCCc
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVS 300 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Dfg~a 300 (352)
...+++||||+++++|.+++.....++...+..++.|++.||.|||++++ +|+|+||||+||+++ .++.+||+|||++
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 34589999999999999999988889999999999999999999999862 499999999999998 7889999999998
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..... .......+++.|+|||++.+ .++.++||||||+++|+|++|.
T Consensus 180 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~ 226 (290)
T 1t4h_A 180 TLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp GGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCC
Confidence 65432 22334568899999998875 5899999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=268.92 Aligned_cols=191 Identities=29% Similarity=0.454 Sum_probs=163.8
Q ss_pred ccCceeecccEEEEEEE---cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~---~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
|...+.||+|+||.||. +++.||+|++..... ...+..+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 44558999999998874 788999999875432 33445677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 233 PKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 233 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999974 345899999999999999999999999 999999999999999999999999998765432221
Q ss_pred -CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+ .++.++||||||+++|+|++|.
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~ 231 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGL 231 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCC
Confidence 1223468899999998876 5789999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=281.78 Aligned_cols=195 Identities=24% Similarity=0.370 Sum_probs=160.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
.+|++.+.||+|+||.||. ++..||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 3799999999999998873 4678999998654321 23345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 018682 228 VTEYLPKGDLRAFLKR----------------------------------------KGALKPSTAVRFALDIARGMNYLH 267 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH 267 (352)
||||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 011356778889999999999999
Q ss_pred hCCCCCceecCCCCCCeEeCCCC--CEEEEccCCcccccccCCC---CcccCCCCCccccccccCC--CCCCCchhHHHH
Q 018682 268 ENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSF 340 (352)
Q Consensus 268 ~~~~~~ivH~Dikp~Nill~~~~--~vkL~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl 340 (352)
+++ |+||||||+||+++.++ .+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||
T Consensus 186 ~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 999 99999999999998776 8999999999865432221 2344568999999999865 678999999999
Q ss_pred HHHHHHhhccCC
Q 018682 341 ALILQEVKFYNQ 352 (352)
Q Consensus 341 G~il~elltG~~ 352 (352)
||++|+|++|..
T Consensus 263 G~il~el~~g~~ 274 (345)
T 3hko_A 263 GVLLHLLLMGAV 274 (345)
T ss_dssp HHHHHHHHHSSC
T ss_pred HHHHHHHHHCCC
Confidence 999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=268.11 Aligned_cols=189 Identities=23% Similarity=0.399 Sum_probs=159.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|...+.||+|+||.||. ++..+|+|++...... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3699999999999999983 5789999998765432 22467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe---CCCCCEEEEccCCccc
Q 018682 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKL 302 (352)
Q Consensus 230 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~vkL~Dfg~a~~ 302 (352)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999998854 356999999999999999999999999 9999999999999 4567899999999976
Q ss_pred ccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..... ......+++.|+|||++.+ .++.++||||||+++|+|++|.
T Consensus 177 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~ 222 (285)
T 3is5_A 177 FKSDE--HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGC 222 (285)
T ss_dssp ------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCCcc--cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCC
Confidence 54322 2234568899999999864 6889999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=271.19 Aligned_cols=193 Identities=30% Similarity=0.437 Sum_probs=166.5
Q ss_pred CCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 222 (352)
..+|+..+.||+|+||.||. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 34788899999999999873 34789999997542 345567889999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Ni 284 (352)
+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 99999999999999999998653 3899999999999999999999999 99999999999
Q ss_pred EeCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 285 LRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 285 ll~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+++.++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|+| |.
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999998765432211 122345678999999988899999999999999999998 53
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=274.84 Aligned_cols=192 Identities=26% Similarity=0.480 Sum_probs=157.0
Q ss_pred CCcccCceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
..+|+..+.||+|+||.||. +++ +||+|.+.... .....+.+.+|+.++++++||||+++++++..+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C
Confidence 34799999999999999983 233 46888876432 233456788999999999999999999999875 4
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999999999874 56899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 304 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 217 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCC
Confidence 543322 2223445778999999999999999999999999999999 54
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=272.02 Aligned_cols=191 Identities=31% Similarity=0.511 Sum_probs=166.1
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|+||.||. .+..||+|.+.... ...+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 44788899999999998874 37899999987432 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999864 34899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.........+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~ 210 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 210 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 3333333445778999999998899999999999999999999 53
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=273.12 Aligned_cols=192 Identities=32% Similarity=0.546 Sum_probs=166.5
Q ss_pred CCcccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE--eC
Q 018682 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~ 222 (352)
..+|+..+.||+|+||.||. .+..||+|++... .....+.+.+|+.++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 44899999999999999872 5789999998754 4556677999999999999999999999887 44
Q ss_pred CceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 568999999999999999986 345999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
........ ......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~ 227 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCC
Confidence 76433221 223345778899999998888999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=276.70 Aligned_cols=189 Identities=25% Similarity=0.494 Sum_probs=154.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++..... ......+.+|+.++++++||||+++++++..++.+++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 688999999999999983 578999999865421 1112234579999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|++ ++|.+++...+ .++...+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 996 59988887654 4899999999999999999999999 9999999999999999999999999987654322 2
Q ss_pred CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 2233467899999999876 57899999999999999999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=276.92 Aligned_cols=188 Identities=27% Similarity=0.373 Sum_probs=155.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
.+|++.+.||+|+||.||. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4799999999999999873 48899999987543 34556677889999999999999999999997665
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCC-CCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 6899999996 588888863 4899999999999999999999999 999999999999999999999999999765
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 178 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 223 (371)
T 2xrw_A 178 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 432 1223456889999999999999999999999999999999996
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=276.96 Aligned_cols=196 Identities=31% Similarity=0.492 Sum_probs=158.5
Q ss_pred CCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH--HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
....+|++.+.||+|+||.||. +|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3445799999999999999984 478999999975432221 122467889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++||||+++ +|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999975 8988887643 5899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
.... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 4332 223345679999999998654 57899999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.94 Aligned_cols=191 Identities=28% Similarity=0.434 Sum_probs=166.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 688899999999998874 4889999998755432 344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-C
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-~ 309 (352)
|+++++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999987777999999999999999999999999 99999999999999999999999999876543221 1
Q ss_pred CcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+..+ +.++||||||+++|+|++|.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 205 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCC
Confidence 2234567899999999987665 67899999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.69 Aligned_cols=189 Identities=31% Similarity=0.499 Sum_probs=162.3
Q ss_pred CcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.+|++.+.||+|+||.||. .+..||+|.+...... .+.+.+|+.++++++||||+++++++. ++..+++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3788899999999998874 3678999998755322 356889999999999999999999876 456899999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999997542 5899999999999999999999999 99999999999999999999999999987654332
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 208 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 22333456778999999988889999999999999999999 53
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=271.55 Aligned_cols=194 Identities=30% Similarity=0.488 Sum_probs=160.1
Q ss_pred CCCcccCceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 153 HELDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
...+|+..+.||+|+||.||.. +..||+|.+.... .......+.+|+.++++++||||+++++++...+
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3457888899999999988741 2359999997542 4455667899999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
..++||||+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999765 56999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCC--cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 303 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 303 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 64332211 122345678999999998899999999999999999998 64
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=264.17 Aligned_cols=188 Identities=27% Similarity=0.435 Sum_probs=162.9
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC--CceEEEEe
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 230 (352)
+|+..+.||+|+||.|| ++++.||+|++..... .....+.+.+|+.++++++||||+++++++.+. +..+++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 68889999999999887 5699999999986533 455567799999999999999999999999877 77899999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+++++|.+++.... .+++..+..++.|++.||.|||++++ +++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS--- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence 999999999998765 48999999999999999999999763 499999999999999999999999988754322
Q ss_pred CCcccCCCCCccccccccCCCCCCC---chhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDT---KVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~elltG~ 351 (352)
....+|+.|+|||++.+..++. ++||||||+++|+|++|.
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 208 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCS
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 2245788999999998765554 799999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=286.60 Aligned_cols=190 Identities=26% Similarity=0.396 Sum_probs=154.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|...+.||+|+||.||. +++.||+|++...... .......+.+|+.++++++||||+++++++. .+.+
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 689999999999999984 4789999998765432 1222335789999999999999999999975 4568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC---CEEEEccCCccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKL 302 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~vkL~Dfg~a~~ 302 (352)
++||||+++++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 999999999999999988888999999999999999999999999 99999999999997554 599999999987
Q ss_pred ccccCCCCcccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~ 351 (352)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 292 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~ 341 (419)
T 3i6u_A 292 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341 (419)
T ss_dssp CC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 6432 22234568999999999853 57788999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.06 Aligned_cols=194 Identities=26% Similarity=0.415 Sum_probs=161.4
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-------
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------- 221 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 221 (352)
..+|++.+.||+|+||.||. +|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 34899999999999998873 57899999987654322 223456789999999999999999999987
Q ss_pred -CCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 222 -SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 222 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
.+.+++||||+++ +|.+.+... ..+++.++..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999975 777777653 56999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccC---CCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKE---DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
+....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 227 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 97664322 122234567999999998876 468999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=269.40 Aligned_cols=193 Identities=27% Similarity=0.435 Sum_probs=154.2
Q ss_pred CCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC--
Q 018682 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-- 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 223 (352)
..+|.+.+.||+|+||.||. .+..||+|.+..... .....+.+.+|+.++++++||||+++++++....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34788999999999998873 345899999976533 4555677899999999999999999999998755
Q ss_pred ---ceEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEE
Q 018682 224 ---PMMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (352)
Q Consensus 224 ---~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL 294 (352)
..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 35999999999999999853 345899999999999999999999999 999999999999999999999
Q ss_pred EccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 295 ADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 245 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhc
Confidence 99999976543321 122334567889999999999999999999999999999994
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=277.00 Aligned_cols=188 Identities=29% Similarity=0.460 Sum_probs=147.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------C
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 223 (352)
.+|+..+.||+|+||.||. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4799999999999998874 48899999997653 3455567788999999999999999999998654 5
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 7899998876 56999999999999999999999999 999999999999999999999999999764
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 228 (367)
T 2fst_X 183 AD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 32 1234568899999999876 678999999999999999999963
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=265.81 Aligned_cols=190 Identities=25% Similarity=0.428 Sum_probs=162.7
Q ss_pred cccCce-eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~-~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|.+.. .||+|+||.||. .+..||+|++... ......+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 555555 999999998873 4778999999754 3456677899999999999999999999999 5567999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999654 45899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 307 EDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 307 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 211 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 221 1223445788999999988889999999999999999998 64
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=269.72 Aligned_cols=182 Identities=35% Similarity=0.622 Sum_probs=153.4
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
+|++.+.||+|+||.|| +.++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 68888999999999876 57899999998633 23467889999999999999999999876 4589999999
Q ss_pred CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCCCCceecCCCCCCeEeCCCCC-EEEEccCCcccccc
Q 018682 233 PKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHE---NKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTV 305 (352)
Q Consensus 233 ~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~---~~~~~ivH~Dikp~Nill~~~~~-vkL~Dfg~a~~~~~ 305 (352)
++++|.+++..... ++...+..++.|+++||.|||+ ++ |+||||||+||+++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999986543 6889999999999999999999 67 999999999999998887 79999999876532
Q ss_pred cCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
. .....+|+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 200 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 2 22345889999999999999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=266.24 Aligned_cols=189 Identities=26% Similarity=0.415 Sum_probs=161.6
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|++.+.||+|+||.||. +|+.||+|.+..... .+.+.+|+.+++.++||||+++++++..++.++++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34799999999999998874 388999999875421 25678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 229 TEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 229 ~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999997 3556999999999999999999999999 9999999999999999999999999997654322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCC
Confidence 1223456789999999999989999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=267.33 Aligned_cols=184 Identities=29% Similarity=0.506 Sum_probs=161.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe---------
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 221 (352)
+|+..+.||+|+||.||. +++.||+|.+.... ..+.+|+.++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 688999999999998873 48899999986542 246789999999999999999998864
Q ss_pred -------CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCE
Q 018682 222 -------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (352)
Q Consensus 222 -------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~v 292 (352)
...++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 44589999999999999999754 56899999999999999999999999 9999999999999999999
Q ss_pred EEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 293 kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~ 218 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCC
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcC
Confidence 999999987765432 223356889999999999989999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=286.69 Aligned_cols=195 Identities=33% Similarity=0.502 Sum_probs=159.0
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 222 (352)
.|++.. .+|+..+.||+|+||.||. .+..||+|++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 178 ~~~i~~--~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 178 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp CSBCCG--GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccCh--hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 344433 3678889999999998873 3468999999865432 3568899999999999999999999866
Q ss_pred CceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
+.+++||||+++++|.+++.. ...++..++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence 778999999999999999964 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
+..............+++.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 379 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCC
Confidence 8765332222233446778999999988899999999999999999999 53
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.95 Aligned_cols=193 Identities=26% Similarity=0.369 Sum_probs=167.3
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC--C----HHHHHHHHHHHHHHhcCC-CCceeeeeEEEEe
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--D----DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ 221 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~--~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 221 (352)
..+|++.+.||+|+||.||. +|+.||+|++...... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 44799999999999999884 5789999998654311 1 233466788999999995 9999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
++..++||||+++++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999998888999999999999999999999999 9999999999999999999999999997
Q ss_pred cccccCCCCcccCCCCCccccccccC------CCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~elltG~ 351 (352)
...... ......+++.|+|||++. ...++.++||||||+++|+|++|.
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 764322 223456789999999884 456789999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.06 Aligned_cols=191 Identities=30% Similarity=0.484 Sum_probs=167.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
..|+..+.||+|+||.||. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++..+..+++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3589999999999998884 478999999875532 223567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.. +.++...+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 99999999999865 46899999999999999999999999 9999999999999999999999999997764332 2
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCC
Confidence 2234568899999999999899999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=264.37 Aligned_cols=191 Identities=31% Similarity=0.495 Sum_probs=160.7
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHH----HHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
..+|+..+.||+|+||.||. +++.||+|++........... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 34799999999999998873 578999999876544333222 67889999999999999999999986554
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC-----EEEEccC
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFG 298 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----vkL~Dfg 298 (352)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ .+|+||||||+||+++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 7999999999998888654 45899999999999999999999987 34999999999999988776 9999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccC--CCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~elltG~ 351 (352)
++..... ......+|+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 9875332 233456889999999984 456788999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=274.85 Aligned_cols=195 Identities=18% Similarity=0.234 Sum_probs=158.3
Q ss_pred CCCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHH--------HHHHHHHHHHHhcCCCCceeeee
Q 018682 153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVVQFL 216 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~ 216 (352)
...+|++.+.||+|+||.||. .+..+|+|++.......... ...+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 345799999999999998873 56789999987542111111 12356788999999999999999
Q ss_pred EEEEe----CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC--
Q 018682 217 GAVTQ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-- 290 (352)
Q Consensus 217 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-- 290 (352)
+++.. ....|++|||+ +++|.+++...+.+++.+++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 99988 67899999999 9999999987778999999999999999999999999 99999999999999877
Q ss_pred CEEEEccCCcccccccCCC------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 291 NLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 291 ~vkL~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.+||+|||+++.+...... ......+|+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 257 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999776432211 113456899999999999989999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=270.15 Aligned_cols=193 Identities=29% Similarity=0.547 Sum_probs=165.0
Q ss_pred CCCcccCceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 153 HELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
...+|++.+.||+|+||.||. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 344789999999999998873 5789999998753 3455678899999999999999999999887644
Q ss_pred --ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 224 --PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 224 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 789999999999999999875 45899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 301 KLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 301 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......... ......++..|+|||++.+..++.++||||||+++|+|+||.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~ 245 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTT
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcC
Confidence 876543221 122344677899999998888899999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=269.10 Aligned_cols=193 Identities=22% Similarity=0.378 Sum_probs=160.8
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCc
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSP 224 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 224 (352)
..+|++.+.||+|+||.||. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34799999999999998873 5789999988643 45566788999999999999999999999873 346
Q ss_pred eEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 225 MMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
.+++|||+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999975 456999999999999999999999999 999999999999999999999999988
Q ss_pred ccccccCCCC--------cccCCCCCccccccccCCCC---CCCchhHHHHHHHHHHhhccCC
Q 018682 301 KLLTVKEDRP--------LTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 301 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltG~~ 352 (352)
.......... .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 244 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 7643211110 01234688999999987654 6889999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.13 Aligned_cols=186 Identities=28% Similarity=0.475 Sum_probs=155.1
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCceeeeeEEEEeC----Cce
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~----~~~ 225 (352)
.+|++.+.||+|+||.|| ++++.||+|++.... ......|.+++... +||||+++++++... ..+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 379999999999999887 578999999985331 13344456666554 899999999999887 679
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
++||||+++++|.++++.. .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999765 589999999999999999999998 8 999999999999999999999999
Q ss_pred CCcccccccCCCC---cccCCCCCccccccccCCCCCCCc------hhHHHHHHHHHHhhcc
Q 018682 298 GVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNEEYDTK------VDVFSFALILQEVKFY 350 (352)
Q Consensus 298 g~a~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~il~elltG 350 (352)
|++.......... .....+|+.|+|||++.+...+.. +|||||||++|||+||
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9997654332221 124568999999999988766665 9999999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=275.37 Aligned_cols=187 Identities=24% Similarity=0.415 Sum_probs=155.1
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS----- 222 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 222 (352)
...+|+..+.||+|+||.||. +|+.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 445899999999999999984 578999998865422 224699999999999999999998543
Q ss_pred ---------------------------------CceEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 018682 223 ---------------------------------SPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNY 265 (352)
Q Consensus 223 ---------------------------------~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~ 265 (352)
..+++||||++ ++|.+.+. ....+++..+..++.|++.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34889999997 47766664 35679999999999999999999
Q ss_pred HHhCCCCCceecCCCCCCeEeC-CCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHH
Q 018682 266 LHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALI 343 (352)
Q Consensus 266 LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i 343 (352)
||++| |+||||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999997 68899999999998664332 23345678999999988764 58999999999999
Q ss_pred HHHhhccCC
Q 018682 344 LQEVKFYNQ 352 (352)
Q Consensus 344 l~elltG~~ 352 (352)
+|+|++|..
T Consensus 232 l~ell~g~~ 240 (383)
T 3eb0_A 232 FGELILGKP 240 (383)
T ss_dssp HHHHHHSSC
T ss_pred HHHHHhCCC
Confidence 999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=278.35 Aligned_cols=190 Identities=13% Similarity=0.154 Sum_probs=146.8
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCceeeee-------EEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFL-------GAV 219 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~ 219 (352)
..+|+..+.||+|+||.||. +|+.||+|++...........+.+++|+.+++.+ +||||++++ +.+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34699999999999999873 5789999999877655556677788885544444 699987754 555
Q ss_pred EeCC-----------------ceEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCCce
Q 018682 220 TQSS-----------------PMMIVTEYLPKGDLRAFLKRK-GALKPSTA------VRFALDIARGMNYLHENKPVPII 275 (352)
Q Consensus 220 ~~~~-----------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~LH~~~~~~iv 275 (352)
..++ .+|+||||++ ++|.+++... ..++.... ..++.|++.||.|||+++ |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 4433 3899999998 8999999863 23444455 567799999999999999 99
Q ss_pred ecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhhccC
Q 018682 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 276 H~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltG~ 351 (352)
||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999865322 113445689999999987 68999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=272.32 Aligned_cols=192 Identities=28% Similarity=0.469 Sum_probs=164.4
Q ss_pred CCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 222 (352)
..+|+..+.||+|+||.||.. ...||+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 347888999999999999842 2479999997542 455567889999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~ 288 (352)
+.+++||||+++++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 9999999999999999999753 34789999999999999999999999 999999999999999
Q ss_pred CCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 289 SGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 289 ~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
++.+||+|||++.......... .....+++.|+|||++.+..++.++|||||||++|+|+|+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcC
Confidence 9999999999997654332211 1223456789999999888999999999999999999993
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=277.95 Aligned_cols=186 Identities=28% Similarity=0.375 Sum_probs=161.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC------CCCceeeeeEEEEeCC
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI------RHPNVVQFLGAVTQSS 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~ 223 (352)
.+|++.+.||+|+||.||. +++.||+|++... ....+.+.+|+.+++.+ .|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 4799999999999999984 4789999998643 34446677888888876 5779999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC--EEEEccCC
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGV 299 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--vkL~Dfg~ 299 (352)
.++++|||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999995 69999988654 3899999999999999999999999 999999999999999887 99999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+..... ......+|+.|+|||++.+..++.++|||||||++|||+||.+
T Consensus 249 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 249 SCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 976432 2234568999999999999999999999999999999999963
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=270.76 Aligned_cols=191 Identities=27% Similarity=0.475 Sum_probs=163.8
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----C
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 223 (352)
..+|++.+.||+|+||.||. ++..||+|++... ......+.+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34799999999999999974 5789999998743 3455567788999999999999999999999765 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
..|++|||++ ++|.+++... .+++.++..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 6899999996 5999998764 5899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCC--cccCCCCCccccccccC-CCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRP--LTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltG~ 351 (352)
....... .....+|+.|+|||++. +..++.++|||||||++|+|++|.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 5332221 23457899999999865 456899999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=265.58 Aligned_cols=186 Identities=33% Similarity=0.585 Sum_probs=155.0
Q ss_pred CCcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-CceEEEE
Q 018682 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVT 229 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 229 (352)
..+|+..+.||+|+||.|| +.|+.||+|++.... ..+.+.+|+.++++++||||+++++++... +.++++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3478999999999999887 578999999997542 245788999999999999999999987554 4789999
Q ss_pred eccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 230 EYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||+++++|.+++..... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999999976543 789999999999999999999999 999999999999999999999999998764432
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.....+++.|+|||++.+..++.++||||||+++|+|+| |.
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 212 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCC
Confidence 122356788999999988889999999999999999998 54
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=272.17 Aligned_cols=190 Identities=27% Similarity=0.403 Sum_probs=158.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|++.+.||+|+||.||. +++.||+|++...... .......+.+|+.++++++||||+++++++..+. .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 688999999999999884 4789999998765321 1223345789999999999999999999987654 8
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC---EEEEccCCccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKL 302 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---vkL~Dfg~a~~ 302 (352)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 999999999999999988788999999999999999999999999 999999999999987664 99999999976
Q ss_pred ccccCCCCcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... .......+|+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (322)
T 2ycf_A 167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216 (322)
T ss_dssp CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSS
T ss_pred cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 5422 1122345789999999863 567889999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.88 Aligned_cols=191 Identities=25% Similarity=0.413 Sum_probs=162.5
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC--ceE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 226 (352)
..+|++.+.||+|+||.||. +|+.||+|++....... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 44799999999999999984 38899999997543222 2456778999999999999999999998765 689
Q ss_pred EEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe----CCCCCEEEEccCC
Q 018682 227 IVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGV 299 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~vkL~Dfg~ 299 (352)
+||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999975432 899999999999999999999999 9999999999999 7777899999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCC--------CCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltG~ 351 (352)
+....... ......+|+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~ 220 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCC
Confidence 98764332 2233568999999998864 46778999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=271.03 Aligned_cols=190 Identities=34% Similarity=0.543 Sum_probs=159.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 226 (352)
.+|+..+.||+|+||.||. ++.. +++|.+... ......+.+.+|+.+++++ +||||+++++++.+.+.++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 3788999999999998873 4554 499988643 2334456788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC
Q 018682 227 IVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 290 (352)
++|||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999998654 6899999999999999999999999 99999999999999999
Q ss_pred CEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 291 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 239 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCC
Confidence 99999999987543221 2223456788999999988888999999999999999998 64
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=270.74 Aligned_cols=193 Identities=30% Similarity=0.473 Sum_probs=164.6
Q ss_pred CCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeC
Q 018682 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 222 (352)
..+|++.+.||+|+||.||. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 45789999999999999874 24789999997542 455567789999999999 699999999998775
Q ss_pred C-ceEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 018682 223 S-PMMIVTEYLPKGDLRAFLKRKGA----------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (352)
Q Consensus 223 ~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 285 (352)
+ .++++|||+++++|.+++..... +++..+..++.|++.||.|||+++ |+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 49999999999999999987543 789999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 286 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 286 l~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|+| |.
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999765433221 1123346788999999998899999999999999999998 54
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=264.32 Aligned_cols=191 Identities=25% Similarity=0.434 Sum_probs=150.1
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|+||.||. +|+.||+|++.... ......+.+.++...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 34789999999999999873 68899999997553 2333444556666668889999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
|||++ ++|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 488777653 45699999999999999999999998 8 999999999999999999999999999765
Q ss_pred cccCCCCcccCCCCCcccccccc----CCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ......+|+.|+|||++ .+..++.++|||||||++|+|+||.
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 210 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTS
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCC
Confidence 4322 22334688999999996 5667889999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=269.95 Aligned_cols=194 Identities=27% Similarity=0.454 Sum_probs=148.3
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
...+|++.+.||+|+||.||. +++.||+|.+..... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345788999999999998873 578999999865432 2345678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCC
Q 018682 228 VTEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~ 299 (352)
+|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999974 345899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCC----CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 300 SKLLTVKED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 300 a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
+........ .......+|+.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 224 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence 876543221 11233568899999999865 56899999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=275.65 Aligned_cols=188 Identities=14% Similarity=0.201 Sum_probs=160.9
Q ss_pred CCCCcccCceeecccEEEEEEE-------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceee----
Q 018682 152 PHELDFTNSVEITKGTFILAFW-------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ---- 214 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~---- 214 (352)
....+|++.+.||+|+||.||. .++.||+|++... +.+.+|+.++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhh
Confidence 3346899999999999999883 2788999998644 35778999999999999887
Q ss_pred -----------eeEEEEe-CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 018682 215 -----------FLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280 (352)
Q Consensus 215 -----------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dik 280 (352)
+++++.. ++..++||||+ +++|.+++... ..+++.++..++.|++.||.|||+++ |+|||||
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik 186 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVT 186 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence 6777776 67889999999 99999999875 67999999999999999999999999 9999999
Q ss_pred CCCeEeCCCC--CEEEEccCCcccccccCCC------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 281 PSNILRDDSG--NLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 281 p~Nill~~~~--~vkL~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|+|||++.++ .+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999988 8999999999776533221 113346899999999999989999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=271.07 Aligned_cols=187 Identities=28% Similarity=0.445 Sum_probs=152.2
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHH--HhcCCCCceeeeeEEEEe-----CCc
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELAL--LQKIRHPNVVQFLGAVTQ-----SSP 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~-----~~~ 224 (352)
-+|++.+.||+|+||.|| .+++.||+|++.... ...+..|..+ ++.++||||+++++.+.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 478999999999999887 578999999986432 1233444444 445899999999986543 235
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCceecCCCCCCeEeCCCCCEEEE
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------KPVPIIHRDLEPSNILRDDSGNLKVA 295 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~~~~ivH~Dikp~Nill~~~~~vkL~ 295 (352)
+++||||+++++|.+++.... .++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 789999999999999997654 58899999999999999999999 8 9999999999999999999999
Q ss_pred ccCCcccccccC-------CCCcccCCCCCccccccccCC-------CCCCCchhHHHHHHHHHHhhccC
Q 018682 296 DFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 296 Dfg~a~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltG~ 351 (352)
|||++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 999998764321 111224568999999999977 45667899999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=272.92 Aligned_cols=192 Identities=27% Similarity=0.490 Sum_probs=159.0
Q ss_pred CCcccCceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
..+|+..+.||+|+||.||. ++. +||+|.+..... ......+.+|+.++++++||||+++++++. ++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 44799999999999999984 233 488887754321 112235678999999999999999999886 567
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++||||+++++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 89999999999999999864 46899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 304 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...... ......+++.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 215 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence 543322 2234557788999999998899999999999999999999 64
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=267.71 Aligned_cols=182 Identities=22% Similarity=0.439 Sum_probs=159.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEe--CCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~l 227 (352)
+|++.+.||+|+||.||. +++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....++
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 799999999999999984 57899999987432 256889999999997 9999999999987 667899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~~~~~ 306 (352)
+|||+++++|.+++.. +++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999998853 889999999999999999999999 99999999999999777 8999999999865433
Q ss_pred CCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCC
Confidence 2 2334568889999999877 67899999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=292.01 Aligned_cols=186 Identities=27% Similarity=0.415 Sum_probs=157.4
Q ss_pred eeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 161 ~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
+.||+|+||.||. .++.||||+++.... .....+.+.+|+.++++++||||+++++++.. +.+++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 5799999999973 357899999976533 33445778999999999999999999999864 56899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC--Cc
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 311 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~--~~ 311 (352)
+++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999998888999999999999999999999999 999999999999999999999999999876433221 12
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
....+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 23345778999999999899999999999999999998 64
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=265.77 Aligned_cols=194 Identities=25% Similarity=0.383 Sum_probs=158.2
Q ss_pred cCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEe--
Q 018682 150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-- 221 (352)
Q Consensus 150 i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 221 (352)
+....-+|++.+.||+|+||.||. +|+.||+|++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334455899999999999998873 5889999998654322 25678899999998 79999999999987
Q ss_pred ----CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEE
Q 018682 222 ----SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (352)
Q Consensus 222 ----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~ 295 (352)
.+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 46799999999999999999864 45899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccC
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~ 351 (352)
|||++....... .......+++.|+|||++. +..++.++|||||||++|+|++|.
T Consensus 172 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 172 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSS
T ss_pred eCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCC
Confidence 999987654322 1223356889999999986 567889999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=289.71 Aligned_cols=194 Identities=33% Similarity=0.509 Sum_probs=163.1
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE---c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW---R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~---~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 222 (352)
.|++.. .+|+..+.||+|+||.||. . +..||||++...... .+.+.+|+.+|++++||||+++++++.+
T Consensus 261 ~~~i~~--~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 261 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp CSBCCG--GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ceecch--hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 344433 3678888999999999873 3 468999999865432 3568899999999999999999999865
Q ss_pred CceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
+.+|+||||+++++|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 679999999999999999964 245899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
+..............++..|+|||++.+..++.++|||||||++|||+|+
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 86543221122233456789999999888999999999999999999993
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=263.42 Aligned_cols=188 Identities=29% Similarity=0.489 Sum_probs=156.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe---------
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 221 (352)
+|+..+.||+|+||.||. +++.||+|++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 688899999999998873 578999999853 24456778999999999999999999998865
Q ss_pred ----CCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 222 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 222 ----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
.+.++++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 356899999999999999998644 4788999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccC-------------CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhcc
Q 018682 297 FGVSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 297 fg~a~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG 350 (352)
||++....... ........+++.|+|||++.+. .++.++|||||||++|+|+++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p 227 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence 99987654221 1122335578899999998764 689999999999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=265.59 Aligned_cols=185 Identities=28% Similarity=0.377 Sum_probs=161.7
Q ss_pred CcccCceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC------ceeeeeEEEEeC
Q 018682 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP------NVVQFLGAVTQS 222 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~ 222 (352)
.+|++.+.||+|+||.||. +++.||+|++... ....+.+.+|+.+++.++|+ +++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3799999999999998873 4789999998642 34456788899999988655 499999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC------------
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------ 288 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~------------ 288 (352)
+.+++||||+ +++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999 889999998765 5889999999999999999999999 999999999999987
Q ss_pred -------CCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 289 -------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 289 -------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 231 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence 66899999999876432 223456899999999999999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=266.03 Aligned_cols=194 Identities=29% Similarity=0.484 Sum_probs=154.5
Q ss_pred CCcccCceeecccEEEEEEEc------C--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 154 ELDFTNSVEITKGTFILAFWR------G--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~~------~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
..+|++.+.||+|+||.||.. + ..||+|++........+..+.+.+|+.++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 447999999999999987731 2 269999998765555566788999999999999999999999988654 8
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999999764 45899999999999999999999999 9999999999999999999999999997764
Q ss_pred ccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 305 VKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 305 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 222 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 33221 1223456778999999988888999999999999999999 54
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=267.71 Aligned_cols=193 Identities=25% Similarity=0.390 Sum_probs=162.2
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS----- 222 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 222 (352)
...+|++.+.||+|+||.||. +|+.||+|++... ........+.+|+.++++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 345899999999999999873 4889999998643 3455566788999999999999999999987654
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
...+++|||+. ++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999996 699999876 46899999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCC---------CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDR---------PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCC
Confidence 6432211 1123467899999998754 678999999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.93 Aligned_cols=184 Identities=24% Similarity=0.424 Sum_probs=153.6
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccCC
Q 018682 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 162 ~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 234 (352)
.||+|+||.||. .+..||||+++... .....+.+.+|+.++++++||||+++++++.. +.+++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 799999999873 35679999997653 22345678999999999999999999999876 569999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC--c
Q 018682 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--L 311 (352)
Q Consensus 235 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~--~ 311 (352)
++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......... .
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999999754 45899999999999999999999999 9999999999999999999999999998764332211 1
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
....+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 537 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 537 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 22334678999999998899999999999999999998 64
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=278.19 Aligned_cols=188 Identities=29% Similarity=0.447 Sum_probs=155.1
Q ss_pred CCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC----
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 222 (352)
+...+|+..+.||+|+||.||. +|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 4455799999999999999983 488999998865421 234699999999999999999988542
Q ss_pred --CceEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-CCEEEE
Q 018682 223 --SPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVA 295 (352)
Q Consensus 223 --~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~vkL~ 295 (352)
..+++||||+++ ++.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEec
Confidence 237799999975 6666554 3456999999999999999999999999 9999999999999965 568999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 200 DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 200 DFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp CCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 999998754322 22345689999999998764 78999999999999999999963
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=268.69 Aligned_cols=192 Identities=30% Similarity=0.453 Sum_probs=159.9
Q ss_pred CCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
..+|++.+.||+|+||.||. ++..||+|.+... ........+.+|+.++++++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34799999999999998873 3457999999643 34555667889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---CCEE
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLK 293 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~vk 293 (352)
..|++|||+++++|.+++.... .++...++.++.|++.||.|||+++ |+||||||+||+++.+ ..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999998753 3889999999999999999999999 9999999999999944 4699
Q ss_pred EEccCCcccccccCC-CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 294 VADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 294 L~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|+|+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 999999875433221 122334568899999999888999999999999999999983
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=268.98 Aligned_cols=185 Identities=29% Similarity=0.486 Sum_probs=158.5
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc--CCCCceeeeeEEEEeCC----ceE
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~ 226 (352)
+|++.+.||+|+||.|| ++|+.||+|++.... ...+.+|.++++. ++||||+++++++.... .++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 78999999999999887 579999999986431 2456778888887 78999999999998876 799
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
++|||+++++|.+++.+. .+++.+++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999764 5899999999999999999999 888 9999999999999999999999999
Q ss_pred CcccccccCCC---CcccCCCCCccccccccCCCC------CCCchhHHHHHHHHHHhhcc
Q 018682 299 VSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 299 ~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~elltG 350 (352)
++......... ......+|+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99766543221 223456899999999987752 33689999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=260.82 Aligned_cols=188 Identities=18% Similarity=0.229 Sum_probs=159.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEE-EeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 228 (352)
.+|+..+.||+|+||.||. +|+.||+|++...... +.+.+|+.+++.++|++++..+..+ ...+..+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 3799999999999998873 5889999998655432 3578899999999988766655554 566778999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC---CCCCEEEEccCCccccc
Q 018682 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLT 304 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~vkL~Dfg~a~~~~ 304 (352)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 8999999974 456999999999999999999999999 99999999999994 78899999999998765
Q ss_pred ccCCC------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 212 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 43321 123456899999999999999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=270.21 Aligned_cols=187 Identities=25% Similarity=0.448 Sum_probs=159.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce----
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM---- 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---- 225 (352)
.+|...+.||+|+||.||. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3789999999999999984 48899999997653 3455567888999999999999999999999877655
Q ss_pred --EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 226 --MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 226 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
+++|||+. ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 68888874 34899999999999999999999999 999999999999999999999999999765
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 240 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 240 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 322 233567899999999877 688999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.27 Aligned_cols=192 Identities=26% Similarity=0.479 Sum_probs=155.0
Q ss_pred CCcccCceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
..+|++.+.||+|+||.||. +++ +|++|.+..... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 45799999999999999984 343 467887754322 223467889999999999999999999998754
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++++|++.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999864 55899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 304 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 217 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCC
Confidence 433221 2223445778999999999999999999999999999999 54
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=269.69 Aligned_cols=190 Identities=24% Similarity=0.409 Sum_probs=160.9
Q ss_pred cccCc-eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEE
Q 018682 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 156 ~~~~~-~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 228 (352)
.|.+. +.||+|+||.||. +++.||+|++...... ......+.+|+.+++.+. ||||+++++++...+.+++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 45555 7899999999984 4889999998765432 233456888999999995 69999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccCCcccc
Q 018682 229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLL 303 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg~a~~~ 303 (352)
|||+++++|.+++... ..+++.++..++.|++.||.|||++| |+||||||+||+++. ++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999998543 56899999999999999999999999 999999999999997 789999999999876
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 185 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (327)
T 3lm5_A 185 GHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT 230 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence 4322 223356899999999999999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=275.88 Aligned_cols=186 Identities=26% Similarity=0.455 Sum_probs=143.5
Q ss_pred ccC-ceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCceE
Q 018682 157 FTN-SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM 226 (352)
Q Consensus 157 ~~~-~~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 226 (352)
|.+ .+.||+|+||.||. ++..||+|++...... ..+.+|+.++++++||||+++++++.. +..+|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 444 45899999999973 3578999999765332 357789999999999999999999965 66799
Q ss_pred EEEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe----CCCCCEE
Q 018682 227 IVTEYLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLK 293 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~vk 293 (352)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 5888877532 24899999999999999999999999 9999999999999 6778999
Q ss_pred EEccCCcccccccCC--CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 294 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 294 L~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
|+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 233 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence 999999987643221 22234568999999999877 45899999999999999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=275.40 Aligned_cols=191 Identities=25% Similarity=0.461 Sum_probs=165.0
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHH--------------HHHHHHHHHHHHhcCCCCceeeeeE
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDD--------------RVRAFRDELALLQKIRHPNVVQFLG 217 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~iv~~~~ 217 (352)
.+|++.+.||+|+||.|| .+|+.||+|.+......... ..+.+.+|+.++++++||||+++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 379999999999998776 47999999998754322211 1167889999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCC
Q 018682 218 AVTQSSPMMIVTEYLPKGDLRAF------LKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDD 288 (352)
Q Consensus 218 ~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~ 288 (352)
++.+.+.+++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+ +| |+|+||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999999998 655 4669999999999999999999999 88 999999999999999
Q ss_pred CCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCC-CCCC-chhHHHHHHHHHHhhccC
Q 018682 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDT-KVDVFSFALILQEVKFYN 351 (352)
Q Consensus 289 ~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~elltG~ 351 (352)
++.++|+|||++...... ......+++.|+|||++.+. .++. ++||||||+++|+|++|.
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 999999999999765432 23345688999999999887 6666 899999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=261.69 Aligned_cols=189 Identities=18% Similarity=0.232 Sum_probs=157.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEE-EeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 228 (352)
.+|+..+.||+|+||.||. +++.||+|++...... ..+.+|+.+++.++|++++..+..+ ......+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3799999999999998873 5789999986544322 3577899999999988766665555 667778999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe---CCCCCEEEEccCCccccc
Q 018682 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~vkL~Dfg~a~~~~ 304 (352)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 9999999985 456999999999999999999999999 9999999999999 788899999999998765
Q ss_pred ccCC------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 305 VKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 305 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCC
Confidence 4332 12234568999999999999999999999999999999999963
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=273.09 Aligned_cols=185 Identities=24% Similarity=0.359 Sum_probs=159.0
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--------CCceeeeeEEEE-
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--------HPNVVQFLGAVT- 220 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~- 220 (352)
-+|++.+.||+|+||.||. +++.||+|++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4799999999999999984 4789999998633 445567889999999985 788999999987
Q ss_pred ---eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCC----
Q 018682 221 ---QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSG---- 290 (352)
Q Consensus 221 ---~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~---- 290 (352)
....+++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 456799999999 56776666544 4599999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CEEEEccCCcccccccCCCCcccCCCCCccccccc
Q 018682 291 ---------------------------------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325 (352)
Q Consensus 291 ---------------------------------------------~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~ 325 (352)
.+||+|||++...... .....+|+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999875432 233568999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 326 FKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 326 ~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+.+..++.++|||||||++|+|+||.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~ 290 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGD 290 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCC
Confidence 99999999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=264.71 Aligned_cols=196 Identities=23% Similarity=0.412 Sum_probs=162.8
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCceE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM 226 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 226 (352)
..+|++.+.||+|+||.||. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 34799999999999998874 578999999976543 45566789999999999999999999998854 56799
Q ss_pred EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 227 IVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENK--PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
++|||+++++|.+++... ..+++..++.++.|++.||.|||+++ ..+|+|+||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999753 34899999999999999999999976 123999999999999999999999999998
Q ss_pred ccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
....... .......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 164 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 164 RILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp HHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred eeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 7654321 1112345788999999999889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=265.74 Aligned_cols=191 Identities=26% Similarity=0.421 Sum_probs=159.1
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++..++..+++|
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3799999999999998873 478999999875432 23467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999999875 456999999999999999999999999 9999999999999999999999999875432111
Q ss_pred CCcccCCCCCcccccccc-----CCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 309 RPLTCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.......+++.|+|||++ ....++.++||||||+++|+|++|..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 220 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence 112234678999999988 46678999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=270.88 Aligned_cols=193 Identities=26% Similarity=0.399 Sum_probs=155.7
Q ss_pred CCcccCceeecccEEEEEEE----cCeEEEEEEcCcccC--------CCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe
Q 018682 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVI--------SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 221 (352)
..+|+..+.||+|+||.||. +|..||+|++..... ......+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 34799999999999999984 488999999865432 233445778999999999999999999999854
Q ss_pred C-----CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEE
Q 018682 222 S-----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (352)
Q Consensus 222 ~-----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~ 295 (352)
. ..+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEE
Confidence 3 35899999997 5888887754 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 177 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 177 DFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 999997544322 2234567889999999876 678999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=262.28 Aligned_cols=189 Identities=29% Similarity=0.506 Sum_probs=158.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|.....||+|+||.||. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 445556899999998873 47799999986542 3344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-CCCEEEEccCCccccccc
Q 018682 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~vkL~Dfg~a~~~~~~ 306 (352)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999998652 3568888899999999999999999 999999999999987 889999999999765432
Q ss_pred CCCCcccCCCCCccccccccCCCC--CCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltG~ 351 (352)
. .......+++.|+|||++.+.. ++.++||||||+++|+|++|.
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTS
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 2 1223456889999999987643 788999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=271.97 Aligned_cols=188 Identities=31% Similarity=0.467 Sum_probs=153.8
Q ss_pred CCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc----
Q 018682 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 224 (352)
...+|+..+.||+|+||.||. .+..||+|++...... ..+|+.+++.++||||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 345799999999999999983 3556999987644221 2369999999999999999999976543
Q ss_pred --eEEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEccC
Q 018682 225 --MMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 298 (352)
Q Consensus 225 --~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Dfg 298 (352)
+++||||++++.+.... .....+++..+..++.|++.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 88999999764333322 23556999999999999999999999999 99999999999999 78999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 188 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 188 SAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp TCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 998764322 23345679999999998664 58999999999999999999963
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=266.32 Aligned_cols=199 Identities=29% Similarity=0.532 Sum_probs=152.2
Q ss_pred ccCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEe-
Q 018682 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ- 221 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~- 221 (352)
.++....+|++.+.||+|+||.||. +++.||+|++... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 3444556899999999999998873 6789999988543 4556677899999999996 9999999999843
Q ss_pred -------CCceEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC
Q 018682 222 -------SSPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (352)
Q Consensus 222 -------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 291 (352)
...++++|||+. |+|.+++.. .+.+++.+++.++.|++.||.|||++++ +|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSC
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCC
Confidence 344899999995 699888864 4569999999999999999999999862 4999999999999999999
Q ss_pred EEEEccCCcccccccCCCC-----------cccCCCCCcccccccc---CCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 292 LKVADFGVSKLLTVKEDRP-----------LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 292 vkL~Dfg~a~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+||+|||++.......... .....+|+.|+|||++ .+..++.++|||||||++|+|++|..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 9999999998765332211 1134578899999998 56678899999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=259.69 Aligned_cols=189 Identities=28% Similarity=0.470 Sum_probs=163.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +++.||+|++....... ...+.+.+|+.++++++||||+++++++...+.++++||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 789999999999998884 57899999987554322 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---CCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~vkL~Dfg~a~~~~~~~ 307 (352)
|+++++|.+++.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999999988778999999999999999999999999 9999999999999754 469999999987654322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
......+++.|+|||++.+ .++.++||||||+++|+|++|.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~ 219 (287)
T 2wei_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT 219 (287)
T ss_dssp --SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred --ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCC
Confidence 1222346788999999876 4899999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=262.88 Aligned_cols=193 Identities=23% Similarity=0.367 Sum_probs=158.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCceeeeeEEEE--eCCceE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 226 (352)
.+|++.+.||+|+||.||. ++..||+|++...... .......+.+|+.++++++||||+++++++. +...++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 3789999999999999873 5789999999754321 1223467889999999999999999999984 456799
Q ss_pred EEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 227 IVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
++|||++++ |.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999765 7777765 345899999999999999999999999 9999999999999999999999999997654
Q ss_pred ccC-CCCcccCCCCCccccccccCCCC--CCCchhHHHHHHHHHHhhccC
Q 018682 305 VKE-DRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltG~ 351 (352)
... ........+++.|+|||++.+.. ++.++||||||+++|+|++|.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 210 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC
Confidence 322 12223456889999999987643 377999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=286.43 Aligned_cols=192 Identities=22% Similarity=0.423 Sum_probs=161.0
Q ss_pred CCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
..+|+..+.||+|+||.||. .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34688899999999998873 2457999998743 34556678999999999999999999999884 5678
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
|+||||+++++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999998654 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
...........+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~ 590 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 590 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCC
Confidence 433333334456788999999988899999999999999999998 53
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.79 Aligned_cols=193 Identities=31% Similarity=0.466 Sum_probs=143.6
Q ss_pred CCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCceeeeeEEEEeCCc
Q 018682 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
+....+|+..+.||+|+||.||. +|+.||+|++.... .......+..|+. +++.++||||+++++++..++.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 33445788999999999999873 48899999997542 3334445555655 7778899999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 225 MMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
.+++|||+++ +|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999975 88887763 45689999999999999999999998 8 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCcccccccc----CCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++....... ......+|+.|+|||++ .+..++.++|||||||++|+|++|.
T Consensus 172 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (327)
T 3aln_A 172 ISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226 (327)
T ss_dssp SSCC--------------------------------CCSHHHHHHHHHHHHHHHHSC
T ss_pred Cceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCC
Confidence 997654322 22234688999999998 4567899999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=261.11 Aligned_cols=189 Identities=24% Similarity=0.443 Sum_probs=153.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE---------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--------- 220 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--------- 220 (352)
.+|++.+.||+|+||.||. +++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 4799999999999998874 3889999988643 4566678899999999999999999999874
Q ss_pred -----eCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEE
Q 018682 221 -----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKV 294 (352)
Q Consensus 221 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL 294 (352)
.....+++|||++ ++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 599999865 56899999999999999999999999 99999999999997 5678999
Q ss_pred EccCCcccccccCC--CCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 295 ADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 295 ~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCC
Confidence 99999986543211 12223446888999998765 67899999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=266.97 Aligned_cols=187 Identities=25% Similarity=0.447 Sum_probs=158.7
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc-----
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 224 (352)
.+|...+.||+|+||.||. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3789999999999999874 48899999997653 345556778899999999999999999999987654
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
+|++|||++ ++|.+++.. .+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999996 588887743 4899999999999999999999999 999999999999999999999999998764
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 222 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCC
Confidence 322 233567899999999876 678999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=264.24 Aligned_cols=193 Identities=29% Similarity=0.504 Sum_probs=160.2
Q ss_pred CCCcccCceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCceeeeeEEEE---
Q 018682 153 HELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT--- 220 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~--- 220 (352)
...+|++.+.||+|+||.||. +|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 345799999999999998873 36789999987543221 1112455677777665 8999999999987
Q ss_pred --eCCceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 221 --QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 221 --~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
....++++|||++ ++|.+++.... .+++..+..++.|++.||.|||++| |+|+||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 69999998753 3899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 297 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 99987654322 2234567899999999999899999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.94 Aligned_cols=195 Identities=24% Similarity=0.388 Sum_probs=161.7
Q ss_pred CCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCceeeeeEEEEeCCc
Q 018682 151 DPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSP 224 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~ 224 (352)
.....+|++.+.||+|+||.||. +++.||+|++..... .....+.+.+|+.++++++ ||||+++++++..++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 33445799999999999999984 478899999875533 4556678899999999997 5999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
++++|| +.+++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++. +.+||+|||++....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 558899999998888999999999999999999999999 999999999999964 889999999997664
Q ss_pred ccCCC-CcccCCCCCccccccccCC-----------CCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltG~ 351 (352)
..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 33221 1233468899999999865 46788999999999999999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=266.18 Aligned_cols=188 Identities=29% Similarity=0.426 Sum_probs=144.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc-----
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 224 (352)
-+|++.+.||+|+||.||. +|..||+|++....... ....+|+..++.++||||+++++++...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 3789999999999998873 47899999885543222 345667888888999999999999976543
Q ss_pred --eEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceecCCCCCCeEeCC-CCCEEEE
Q 018682 225 --MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDD-SGNLKVA 295 (352)
Q Consensus 225 --~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~Dikp~Nill~~-~~~vkL~ 295 (352)
++++|||+++ +|...+. ....+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999976 5544443 4556899999999999999999999 888 999999999999996 8899999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 175 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~ 230 (360)
T 3e3p_A 175 DFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230 (360)
T ss_dssp CCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999998765332 22345678999999998654 48999999999999999999963
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=274.89 Aligned_cols=188 Identities=24% Similarity=0.346 Sum_probs=150.9
Q ss_pred CCcccCceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|...+.||+|+||.|+ ++|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+...+|++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4478999999999999754 4688999999875432 2356799999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-----CCCEEEEccCCccc
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKL 302 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~vkL~Dfg~a~~ 302 (352)
|||+. ++|.+++.... ..+...+..++.|++.||.|||+++ |+||||||+|||++. ...+||+|||++..
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99995 59999998654 3555667889999999999999999 999999999999953 23588999999987
Q ss_pred ccccCC--CCcccCCCCCccccccccC---CCCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKED--RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltG~ 351 (352)
...... .......||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g 226 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG 226 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCC
Confidence 653321 1223456899999999997 456788999999999999999943
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=274.72 Aligned_cols=195 Identities=25% Similarity=0.371 Sum_probs=149.0
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEE
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAV 219 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 219 (352)
+|.++.... ..|...+.||+|+||.|+ .+|+.||||++.... .+.+.+|+.+++++ +||||+++++++
T Consensus 6 ~p~~~~~l~-~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~ 78 (434)
T 2rio_A 6 IPNFEQSLK-NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSE 78 (434)
T ss_dssp --CCSCSCS-SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccchhhhhh-heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 344444332 245667889999999875 368899999886432 24567899999876 899999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---
Q 018682 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALK-------PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--- 289 (352)
Q Consensus 220 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--- 289 (352)
.+++.+|++|||++ ++|.+++....... +..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~ 154 (434)
T 2rio_A 79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRF 154 (434)
T ss_dssp ECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHH
T ss_pred ecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCccc
Confidence 99999999999995 69999998654322 2235679999999999999999 9999999999999754
Q ss_pred ----------CCEEEEccCCcccccccCCC---CcccCCCCCccccccccCC-------CCCCCchhHHHHHHHHHHhhc
Q 018682 290 ----------GNLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEVKF 349 (352)
Q Consensus 290 ----------~~vkL~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt 349 (352)
+.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+|
T Consensus 155 ~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt 234 (434)
T 2rio_A 155 TADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234 (434)
T ss_dssp HSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence 47999999999876543221 1223568999999999865 578999999999999999999
Q ss_pred c
Q 018682 350 Y 350 (352)
Q Consensus 350 G 350 (352)
|
T Consensus 235 ~ 235 (434)
T 2rio_A 235 K 235 (434)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=261.76 Aligned_cols=186 Identities=27% Similarity=0.316 Sum_probs=159.6
Q ss_pred CcccCceeecccEEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc------eeeeeEEEEeC
Q 018682 155 LDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQS 222 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~ 222 (352)
.+|++.+.||+|+||.||. + +..||+|++... ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 4799999999999999983 2 378999998632 345567888999999987655 89999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe--------------
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-------------- 286 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill-------------- 286 (352)
+.++++|||+ ++++.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 667777776543 5899999999999999999999999 9999999999999
Q ss_pred -----CCCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 287 -----DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 287 -----~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+.++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 5678899999999976432 2234568999999999999999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.94 Aligned_cols=197 Identities=26% Similarity=0.405 Sum_probs=165.6
Q ss_pred ccCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCC--CCceeeeeEE
Q 018682 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGA 218 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~~~~~ 218 (352)
+.+....+|++.+.||+|+||.||. +++.||+|++........ .....+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445556899999999999999884 588999999876543221 11134667999999996 5999999999
Q ss_pred EEeCCceEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEc
Q 018682 219 VTQSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVAD 296 (352)
Q Consensus 219 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~D 296 (352)
+...+..+++||++.+ ++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999976 899999998888999999999999999999999999 99999999999999 778999999
Q ss_pred cCCcccccccCCCCcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 297 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
||++...... ......+|+.|+|||++.+..+ +.++||||||+++|+|++|.
T Consensus 194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 9999876432 2234568999999999876665 67899999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=272.48 Aligned_cols=188 Identities=16% Similarity=0.210 Sum_probs=160.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-CceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 228 (352)
-+|++.+.||+|+||.||. +++.||||++...... ..+..|+.+++.++| +++..+..++...+..++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 3789999999999999884 3889999987654332 247789999999986 5666666677778889999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe---CCCCCEEEEccCCccccc
Q 018682 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~vkL~Dfg~a~~~~ 304 (352)
|||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 9999999985 456999999999999999999999999 9999999999999 578899999999998765
Q ss_pred ccCCC------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~ 210 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 43321 122466899999999999999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.27 Aligned_cols=183 Identities=22% Similarity=0.342 Sum_probs=157.9
Q ss_pred CcccCceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc----
Q 018682 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 224 (352)
-+|++.+.||+|+||.||. +|+.||||++... ...+....+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4799999999999999883 4789999998753 345566778999999999999999999999988766
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.|+||||+++++|.+++.. .+++.++..++.||+.||.|||++| |+||||||+|||++.+ .+||+|||++...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988765 6899999999999999999999999 9999999999999985 8999999999875
Q ss_pred cccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
... ....||+.|+|||++.+.. +.++|||||||++|+|++|.
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~ 273 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDL 273 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCC
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCC
Confidence 432 3356899999999987654 88999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=263.89 Aligned_cols=186 Identities=25% Similarity=0.320 Sum_probs=159.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CC-----ceeeeeEEEEeCC
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSS 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~ 223 (352)
.+|++.+.||+|+||.||. +++.||+|++... ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4799999999999999984 4789999999643 344566778899888874 44 4999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCCCCceecCCCCCCeEeC--CCCCEEEEcc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHE--NKPVPIIHRDLEPSNILRD--DSGNLKVADF 297 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~~~~ivH~Dikp~Nill~--~~~~vkL~Df 297 (352)
.+++||||++ ++|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 5999999865 358999999999999999999995 56 99999999999995 4678999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
|++...... .....+|+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999875432 234568899999999999999999999999999999999963
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=263.02 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=157.1
Q ss_pred CCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcC----CCCceeeeeEEE
Q 018682 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKI----RHPNVVQFLGAV 219 (352)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~iv~~~~~~ 219 (352)
....+|++.+.||+|+||.||. +++.||+|++........ .....+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3345799999999999999984 478999999976543321 1223456799999888 899999999999
Q ss_pred EeCCceEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEcc
Q 018682 220 TQSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297 (352)
Q Consensus 220 ~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Df 297 (352)
...+..+++||+ +.+++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999 789999999998888999999999999999999999999 99999999999999 7889999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCC-CchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltG~ 351 (352)
|++...... ......+++.|+|||++.+..+. .++||||||+++|+|++|.
T Consensus 185 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 185 GSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp SSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred chhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence 998876432 23345688999999998766654 5899999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.18 Aligned_cols=186 Identities=22% Similarity=0.368 Sum_probs=160.1
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----------CCceeeeeE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLG 217 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~ 217 (352)
..+|++.+.||+|+||.||. +++.||+|++... ......+.+|+.++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 34799999999999999983 5889999998643 344567888999999886 899999999
Q ss_pred EEEeCC----ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeC---
Q 018682 218 AVTQSS----PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRD--- 287 (352)
Q Consensus 218 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~--- 287 (352)
++...+ .++++||++ +++|.+++... ..+++..+..++.|++.||.|||++ + |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 998654 689999999 88999999863 4489999999999999999999998 9 99999999999995
Q ss_pred ---CCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 288 ---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 288 ---~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|+||.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 3447999999999765432 23346789999999999999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=271.70 Aligned_cols=186 Identities=15% Similarity=0.152 Sum_probs=150.6
Q ss_pred CcccCceeecccEEEEEE---EcCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCC---------CCceeeeeE
Q 018682 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIR---------HPNVVQFLG 217 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~iv~~~~ 217 (352)
.+|++.+.||+|+||.|| .+|+.||+|++...... .....+.+.+|+.+++.++ ||||+++.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 478999999999999887 57899999999765432 2223356788999988885 666666655
Q ss_pred EE-----------------Ee-------------CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018682 218 AV-----------------TQ-------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267 (352)
Q Consensus 218 ~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH 267 (352)
.+ .+ .+.+|+||||+++|++.+.+.+ ..+++..+..++.||+.||.|||
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 53 32 6789999999999976555543 55899999999999999999999
Q ss_pred -hCCCCCceecCCCCCCeEeCCCC--------------------CEEEEccCCcccccccCCCCcccCCCCCcccccccc
Q 018682 268 -ENKPVPIIHRDLEPSNILRDDSG--------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326 (352)
Q Consensus 268 -~~~~~~ivH~Dikp~Nill~~~~--------------------~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~ 326 (352)
+++ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++
T Consensus 179 ~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 179 ASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGG
T ss_pred HhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhh
Confidence 899 99999999999999887 8999999999875432 24688999999999
Q ss_pred CCCCCCCchhHHHHHHH-HHHhhccC
Q 018682 327 KNEEYDTKVDVFSFALI-LQEVKFYN 351 (352)
Q Consensus 327 ~~~~~~~~~DiwslG~i-l~elltG~ 351 (352)
.+.. +.++|||||+++ .+++++|.
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~ 274 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEY 274 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSC
T ss_pred cCCC-ccceehhhhhCCCCccccccc
Confidence 8766 889999998777 66676663
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=261.33 Aligned_cols=186 Identities=27% Similarity=0.370 Sum_probs=137.8
Q ss_pred CCCcccCce-eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----C
Q 018682 153 HELDFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (352)
Q Consensus 153 ~~~~~~~~~-~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 222 (352)
...+|.+.+ .||+|+||.||. +|+.||+|++... .. ........++.++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 344788854 699999999984 4889999998542 21 12223334567799999999999976 4
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC---CCEEEEcc
Q 018682 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADF 297 (352)
Q Consensus 223 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~vkL~Df 297 (352)
..+++||||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 45899999999999999998754 5899999999999999999999999 9999999999999864 45999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSS
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 999765432 223356789999999998888999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=265.14 Aligned_cols=199 Identities=27% Similarity=0.445 Sum_probs=160.2
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 223 (352)
..|++.. .+|++.+.||+|+||.||. .+..+|+|++...... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 26 ~~~~i~~--~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPF--EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCC--SCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCH--HHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3444443 3688889999999998873 3456999998765322 222345778999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
.++++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+||+++ ++.++|+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999998654 5899999999999999999999999 99999999999998 67999999999865
Q ss_pred ccccC----CCCcccCCCCCccccccccCC---------CCCCCchhHHHHHHHHHHhhccC
Q 018682 303 LTVKE----DRPLTCQDTSCRYVAPEVFKN---------EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 303 ~~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~il~elltG~ 351 (352)
..... ........+++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 240 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 43211 122233457889999999864 35788999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=278.45 Aligned_cols=190 Identities=30% Similarity=0.431 Sum_probs=164.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe------CC
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SS 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 223 (352)
-+|++.+.||+|+||.||. +|+.||+|++... ......+.+.+|+.++++++||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3799999999999998873 5789999998754 245566788999999999999999999998765 67
Q ss_pred ceEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC---EEEEcc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADF 297 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---vkL~Df 297 (352)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.| |+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999998744 5899999999999999999999999 999999999999997765 999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~ 220 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSC
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCC
Confidence 9998765332 223456899999999999999999999999999999999995
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.87 Aligned_cols=191 Identities=28% Similarity=0.437 Sum_probs=144.8
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEE
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 228 (352)
..+|+..+.||+|+||.||. +|+.||+|++..... .....+.+..+..+++.++||||+++++++..++.++++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 34788899999999998873 488999999875432 233344455566678888999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
|||+ ++.+..+... ...+++..+..++.|++.||.|||++ + |+|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 5667666654 45699999999999999999999995 8 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~ 351 (352)
. ......+++.|+|||++. ...++.++||||||+++|+|++|.
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC
Confidence 2 223346789999999984 457889999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=247.08 Aligned_cols=164 Identities=16% Similarity=0.155 Sum_probs=146.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +|+.||+|++........+..+.+.+|+.++++++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 4799999999999998873 38899999998876666777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||++|++|.++++.. ....++..++.|++.||.|||++| |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999543 466788899999999999999999 9999999999999999999997443
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
|++ +++.++|||||||++|+|+||.
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~ 199 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNR 199 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSE
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCC
Confidence 233 3688999999999999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-33 Score=270.11 Aligned_cols=171 Identities=15% Similarity=0.110 Sum_probs=130.3
Q ss_pred EEcCeEEEEEEcCcccCC---C----HHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEEEEeccCCCCHHHHHHh
Q 018682 172 FWRGIQVAVKKLGEEVIS---D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243 (352)
Q Consensus 172 ~~~~~~vavK~~~~~~~~---~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 243 (352)
++.|+.+++|.+...... . +...+.|++|+++|+++ .|+||+++++++++++.+||||||++|++|.+++.+
T Consensus 256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~ 335 (569)
T 4azs_A 256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA 335 (569)
T ss_dssp EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence 467889999998765322 1 23346799999999999 699999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCccccc
Q 018682 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323 (352)
Q Consensus 244 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aP 323 (352)
.++++.. .|+.||+.||+|+|++| ||||||||+|||++.++.+||+|||+|+....... ......||+.|+||
T Consensus 336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAP 408 (569)
T 4azs_A 336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVN 408 (569)
T ss_dssp TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccH
Confidence 8888765 47899999999999999 99999999999999999999999999987654322 23345689999999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 324 EVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 324 E~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|++.+. +...+|+||+|+++++|.+|
T Consensus 409 E~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 409 ELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHC------------------CCCCTT
T ss_pred HHhCCC-CCCcccccccccchhhhccc
Confidence 999764 56789999999999988765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=259.51 Aligned_cols=190 Identities=13% Similarity=0.165 Sum_probs=144.8
Q ss_pred CCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-Cce---------e----
Q 018682 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNV---------V---- 213 (352)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i---------v---- 213 (352)
...+|...+.||+|+||.||. +|+.||||++...........+.+++|+.+++.++| ++. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 344688889999999999983 488999999885544444446778999999999976 211 1
Q ss_pred --------eeeEEEEe-----CCceEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 018682 214 --------QFLGAVTQ-----SSPMMIVTEYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARGMNYLHENKPVP 273 (352)
Q Consensus 214 --------~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ 273 (352)
.+..++.. ...++++|+++ +++|.++++. ...+++..+..++.|++.||.|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111111 22467788876 6899998852 223667788889999999999999999
Q ss_pred ceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCcccccccc----------CCCCCCCchhHHHHHHH
Q 018682 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----------KNEEYDTKVDVFSFALI 343 (352)
Q Consensus 274 ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~i 343 (352)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998765432 233456 899999998 56678889999999999
Q ss_pred HHHhhccC
Q 018682 344 LQEVKFYN 351 (352)
Q Consensus 344 l~elltG~ 351 (352)
+|||+||.
T Consensus 307 l~elltg~ 314 (413)
T 3dzo_A 307 IYWIWCAD 314 (413)
T ss_dssp HHHHHHSS
T ss_pred HHHHHHCC
Confidence 99999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=239.55 Aligned_cols=163 Identities=26% Similarity=0.397 Sum_probs=141.0
Q ss_pred CcccCc-eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-hcCCCCceeeeeEEEEe----CC
Q 018682 155 LDFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQ----SS 223 (352)
Q Consensus 155 ~~~~~~-~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~ 223 (352)
.+|.+. +.||+|+||.||. +++.||+|++... ..+.+|+.++ +..+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 367776 7799999999873 5789999998532 3567788888 56689999999999987 67
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccC
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFG 298 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg 298 (352)
.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7999999999999999998754 5899999999999999999999999 999999999999998 7889999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.... +..++.++|||||||++|+|++|.
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~ 195 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGY 195 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSS
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCC
Confidence 886432 234678999999999999999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=237.28 Aligned_cols=178 Identities=20% Similarity=0.240 Sum_probs=138.4
Q ss_pred cCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHH-----HHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 158 TNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 158 ~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
...+.||+|+||.|| +.+..+++|........... ..+.+.+|+.++++++||||+++..++...+..|+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 345689999999998 46889999987665444332 2355789999999999999996666666778889999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++++|.+++.. +..++.|++++|.|||+++ |+||||||+|||++. .+||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999865 5689999999999999999 999999999999998 9999999999876543221
Q ss_pred C------cccCCCCCccccccccCC--CCCCCchhHHHHHHHHHHhh
Q 018682 310 P------LTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEVK 348 (352)
Q Consensus 310 ~------~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell 348 (352)
. .....||+.|+|||++.. ..|+..+|+||..+-..+-+
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v 532 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV 532 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 1 124568999999999976 56777889999887666554
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=184.65 Aligned_cols=128 Identities=38% Similarity=0.404 Sum_probs=87.1
Q ss_pred CcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018682 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (352)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~ 85 (352)
.++||+-.........--.-..-+|.|.+.++.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+
T Consensus 36 ~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~ 115 (169)
T 4gpm_A 36 DGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGH 115 (169)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCC
Confidence 34444444333333322222233566667777777777888888888888888888788888777778888888888888
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCC
Q 018682 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 86 ~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~ 133 (352)
.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++.
T Consensus 116 ~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GA~ie 163 (169)
T 4gpm_A 116 KEVVKLLISKGADVNTSDSDGRTPLDLAREHGNEEVVKLLEKQGGWLE 163 (169)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC-----
T ss_pred HHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcC
Confidence 888888888888887777778888888877777778888877777753
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=157.41 Aligned_cols=93 Identities=46% Similarity=0.578 Sum_probs=89.2
Q ss_pred CCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCc
Q 018682 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~ 118 (352)
+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~ 80 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCC
Q 018682 119 HEVIKLLEKHGAK 131 (352)
Q Consensus 119 ~~~~~~L~~~~~~ 131 (352)
.+++++|++.|++
T Consensus 81 ~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 81 LEVVKLLLEAGAY 93 (93)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHHcCCC
Confidence 9999999998874
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-24 Score=173.94 Aligned_cols=113 Identities=39% Similarity=0.479 Sum_probs=105.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|+|..+.+|+||||+|+..++.++++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus 26 ~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~T 105 (169)
T 4gpm_A 26 NGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRT 105 (169)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCC
Confidence 67888899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCcccccc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 141 (352)
|||+|+..|+.+++++|++.|+++........+
T Consensus 106 pLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~T 138 (169)
T 4gpm_A 106 PLHHAAENGHKEVVKLLISKGADVNTSDSDGRT 138 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCccccCCCCCC
Confidence 999999999999999999999998655444333
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-24 Score=187.84 Aligned_cols=156 Identities=18% Similarity=0.121 Sum_probs=119.6
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCH---------------HHHHHHHHHHHHHhcCCCCceeeee
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD---------------DRVRAFRDELALLQKIRHPNVVQFL 216 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~~~ 216 (352)
.|...+.||+|+||.||. +|+.||+|++........ .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 455669999999998874 588999999975432111 23567889999999998 4 5666
Q ss_pred EEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEc
Q 018682 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (352)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~D 296 (352)
+++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++| |+||||||+|||++ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65543 56799999999999987 31 2234579999999999999999 99999999999999 99999999
Q ss_pred cCCcccccccCCCCcccCCCCCccccccccCC----------CCCCCchhHHHH
Q 018682 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN----------EEYDTKVDVFSF 340 (352)
Q Consensus 297 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~Diwsl 340 (352)
||++... ..+.|||++.. ..+...+|+|.+
T Consensus 236 FG~a~~~--------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 236 FPQSVEV--------------GEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CTTCEET--------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCCCeEC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9998642 34688998753 345566677764
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=163.04 Aligned_cols=102 Identities=22% Similarity=0.273 Sum_probs=67.0
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~-g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
++.|.+..+..|+||||+||. |+.+++++|+++|+++|.+|.. |+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 34 ~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (136)
T 1d9s_A 34 AGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGR 112 (136)
T ss_dssp TTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSSS
T ss_pred cCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 455555556666666666666 6666666666666666666666 66666666666666666666666666666666666
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
||||+|+..++.+++++|+++|++
T Consensus 113 tpl~~A~~~~~~~~~~~Ll~~Gad 136 (136)
T 1d9s_A 113 LPVDLAEEQGHRDIARYLHAATGD 136 (136)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred CHHHHHHHcCCHHHHHHHHHcCCC
Confidence 666666666666666666666553
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=159.21 Aligned_cols=114 Identities=28% Similarity=0.332 Sum_probs=102.4
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
|+|+ ..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 1 G~d~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~ 79 (137)
T 3c5r_A 1 GIDP-FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSP 79 (137)
T ss_dssp ---C-CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCH
T ss_pred CCCC-CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCH
Confidence 4566 678899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCccccccccc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 144 (352)
||+|+..++.+++++|++.++++........++..
T Consensus 80 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~ 114 (137)
T 3c5r_A 80 LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVD 114 (137)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGGG
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHH
Confidence 99999999999999999999998665554444443
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=157.52 Aligned_cols=101 Identities=32% Similarity=0.436 Sum_probs=84.3
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 36 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 115 (136)
T 2jab_A 36 NGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKT 115 (136)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCCCCC
Confidence 56677777778888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred hhHHhhccCcHHHHHHHHHcC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~ 129 (352)
|||+|+..++.+++++|+++|
T Consensus 116 pl~~A~~~~~~~~~~~Ll~~G 136 (136)
T 2jab_A 116 AFDISIGNGNEDLAEILQKLN 136 (136)
T ss_dssp HHHHHHHTTCHHHHHHHHHC-
T ss_pred HHHHHHHCCCHHHHHHHHHcC
Confidence 888888888888888887754
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-22 Score=163.60 Aligned_cols=134 Identities=19% Similarity=0.191 Sum_probs=104.7
Q ss_pred cccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCc-HHHHHHHcCC
Q 018682 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGF 85 (352)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t-~lh~A~~~~~ 85 (352)
+.|++..........--+-.--+|.|.+..+..|+||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+..|+
T Consensus 12 ~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~ 90 (156)
T 1bi7_B 12 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 90 (156)
T ss_dssp STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred chHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCC
Confidence 445554444333333222223367888888899999999985 99999999999999999999999999 9999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCcccccc
Q 018682 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (352)
Q Consensus 86 ~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 141 (352)
.+++++|+++|++++.+|..|.||||+|+..++.+++++|+++|+++........+
T Consensus 91 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 146 (156)
T 1bi7_B 91 LDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARID 146 (156)
T ss_dssp HHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSSCC------------
T ss_pred HHHHHHHHHcCCCCcccCCCCCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCc
Confidence 99999999999999999999999999999999999999999999998655443333
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=157.80 Aligned_cols=106 Identities=24% Similarity=0.228 Sum_probs=99.6
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC-CCC
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-GST 108 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~-g~t 108 (352)
+.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |.|
T Consensus 2 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t 80 (136)
T 1d9s_A 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTR 80 (136)
T ss_dssp CCCCSCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBC
T ss_pred CCCccCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCC
Confidence 35667788889999999999999999999999999999999999999999999 9999999999999999999999 999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|||+|+..++.+++++|++.++++....
T Consensus 81 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~d 108 (136)
T 1d9s_A 81 PVHDAAREGFLDTLVVLHRAGARLDVCD 108 (136)
T ss_dssp HHHHHHHHTCHHHHHHHHHTCCCCCCCS
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCccC
Confidence 9999999999999999999999875443
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=157.81 Aligned_cols=102 Identities=27% Similarity=0.305 Sum_probs=64.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.+.+..+..|+||||+|+. |+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 27 ~~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 105 (162)
T 1ihb_A 27 NNVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNL 105 (162)
T ss_dssp SCCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 345555555566666666666 6666666666666666666666666666666666666666666666666666666666
Q ss_pred hhHHhhccCcHHHHHHHHHcCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
|||+|+..++.+++++|++.+++
T Consensus 106 ~L~~A~~~~~~~~v~~Ll~~g~~ 128 (162)
T 1ihb_A 106 PLHLAAKEGHLRVVEFLVKHTAS 128 (162)
T ss_dssp HHHHHHHTTCHHHHHHHHHHSCC
T ss_pred HHHHHHHcCCHHHHHHHHHccCC
Confidence 66666666666666666666655
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=151.25 Aligned_cols=103 Identities=44% Similarity=0.559 Sum_probs=96.2
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.+.+..+..|.||||+|+..++.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 24 ~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t 103 (126)
T 1n0r_A 24 AGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRT 103 (126)
T ss_dssp HTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCCCC
Confidence 56777778888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
|+++|+..++.+++++|+++|++
T Consensus 104 ~l~~A~~~~~~~~~~~Ll~~Gad 126 (126)
T 1n0r_A 104 PLHLAARNGHLEVVKLLLEAGAY 126 (126)
T ss_dssp HHHHHHHTTCHHHHHHHHHHTCC
T ss_pred HHHHHHHcCcHHHHHHHHHcCCC
Confidence 99999999999999999998875
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-21 Score=159.89 Aligned_cols=113 Identities=22% Similarity=0.273 Sum_probs=102.2
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
+.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 29 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~ 108 (179)
T 3f6q_A 29 ENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVP 108 (179)
T ss_dssp TSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCH
Confidence 56777888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCccccccc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (352)
||+|+..++.+++++|+++|+++........++
T Consensus 109 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 141 (179)
T 3f6q_A 109 LHYACFWGQDQVAEDLVANGALVSICNKYGEMP 141 (179)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCG
T ss_pred HHHHHHcCCHHHHHHHHHCCCCcchhccCCCCc
Confidence 999999999999999999999876554444444
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=153.19 Aligned_cols=100 Identities=38% Similarity=0.483 Sum_probs=95.7
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
-+|.+|+||||+||..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 4 ~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~ 83 (115)
T 2l6b_A 4 WGSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAK 83 (115)
T ss_dssp CCSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcHHHHHHHHHcCCCCCC
Q 018682 115 YYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 115 ~~~~~~~~~~L~~~~~~~~~ 134 (352)
..++.+++++|+++|+++..
T Consensus 84 ~~~~~~~~~~Ll~~ga~~n~ 103 (115)
T 2l6b_A 84 KNGHHEIVKLLDAKGADVNA 103 (115)
T ss_dssp TTTCHHHHHHHHTTSSSHHH
T ss_pred HCCCHHHHHHHHHcCCCCCc
Confidence 99999999999999998743
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=150.92 Aligned_cols=104 Identities=29% Similarity=0.366 Sum_probs=93.0
Q ss_pred ccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhcc
Q 018682 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (352)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~ 116 (352)
+..|.||||+||..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~ 83 (123)
T 3aaa_C 4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83 (123)
T ss_dssp ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence 45688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcHHHHHHHHHcCCCCCCCccccc
Q 018682 117 KNHEVIKLLEKHGAKPLMAPMHVK 140 (352)
Q Consensus 117 ~~~~~~~~L~~~~~~~~~~~~~~~ 140 (352)
++.+++++|++.++++........
T Consensus 84 ~~~~~v~~Ll~~ga~~~~~~~~g~ 107 (123)
T 3aaa_C 84 GHVSCVKLLLSKGADKTVKGPDGL 107 (123)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCHHHHHHHHHcCCCCCCcCCCCC
Confidence 999999999999988755443333
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-21 Score=158.21 Aligned_cols=108 Identities=35% Similarity=0.426 Sum_probs=102.5
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 36 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t 115 (169)
T 2y1l_E 36 NGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHT 115 (169)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCC
Confidence 67888888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|||+|+..++.+++++|++.++++....
T Consensus 116 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 143 (169)
T 2y1l_E 116 PLHLAAMFGHLEIVEVLLKNGADVNAQD 143 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 9999999999999999999999875443
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=162.99 Aligned_cols=133 Identities=26% Similarity=0.304 Sum_probs=109.3
Q ss_pred CCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018682 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (352)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~ 83 (352)
+..++||+-.........--+----++.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 32 d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 111 (192)
T 2rfm_A 32 DSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIF 111 (192)
T ss_dssp CTTCCCHHHHHHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence 34556666544333322221112224567777888899999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 84 ~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|+.+++++|+++|++++.+|..|.||||+|+..++.+++++|++.|+++....
T Consensus 112 ~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 164 (192)
T 2rfm_A 112 GYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164 (192)
T ss_dssp TCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBC
T ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence 99999999999999999999999999999999999999999999998875443
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-21 Score=156.72 Aligned_cols=115 Identities=31% Similarity=0.370 Sum_probs=104.4
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
.+.+.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 31 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 110 (165)
T 3twr_A 31 QSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFT 110 (165)
T ss_dssp TTTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred CCCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCC
Confidence 34566677778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCcccccccc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~ 143 (352)
|||+|+..++.+++++|+++++++........++.
T Consensus 111 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l 145 (165)
T 3twr_A 111 PLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL 145 (165)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTG
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChh
Confidence 99999999999999999999998866554444443
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=157.93 Aligned_cols=108 Identities=27% Similarity=0.376 Sum_probs=100.5
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.+.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 25 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 104 (167)
T 3v31_A 25 QENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGT 104 (167)
T ss_dssp HSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCC
T ss_pred cCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCC
Confidence 46677788889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|||+|+..++.+++++|++.++++....
T Consensus 105 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 132 (167)
T 3v31_A 105 PLLYAVHGNHVKCVKMLLESGADPTIET 132 (167)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 9999999999999999999998875443
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-21 Score=154.72 Aligned_cols=106 Identities=31% Similarity=0.352 Sum_probs=97.8
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
|.+.+ .+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 25 g~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 103 (153)
T 1awc_B 25 GAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTA 103 (153)
T ss_dssp TCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCH
T ss_pred CCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 44444 57789999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
||+|+..++.+++++|++.|+++....
T Consensus 104 L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 130 (153)
T 1awc_B 104 LHWATEHNHQEVVELLIKYGADVHTQS 130 (153)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCccccC
Confidence 999999999999999999999875443
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-21 Score=170.55 Aligned_cols=102 Identities=20% Similarity=0.174 Sum_probs=96.5
Q ss_pred CCCCccCCchHHHHHHhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 33 DDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
.+..+..|+||||+||.. |+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++||+++.+|..|.||
T Consensus 162 l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tp 241 (278)
T 1dcq_A 162 LANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETP 241 (278)
T ss_dssp CSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence 455578899999999999 89999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
||+|+..|+.+++++|++++++...
T Consensus 242 L~~A~~~~~~~~v~~Ll~~ga~~~~ 266 (278)
T 1dcq_A 242 LDIAKRLKHEHCEELLTQALSGRFN 266 (278)
T ss_dssp HHHHHHTTCHHHHHHHHHHHTTCCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCC
Confidence 9999999999999999999987543
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=159.77 Aligned_cols=104 Identities=26% Similarity=0.352 Sum_probs=79.3
Q ss_pred CCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 018682 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 112 (352)
.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 29 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~ 108 (172)
T 3v30_A 29 VNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLY 108 (172)
T ss_dssp GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHH
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 45556677777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred hhccCcHHHHHHHHHcCCCCCCCc
Q 018682 113 AIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 113 a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|+..++.+++++|++.|+++....
T Consensus 109 A~~~~~~~~v~~Ll~~ga~~~~~~ 132 (172)
T 3v30_A 109 AVRGNHVKCVEALLARGADLTTEA 132 (172)
T ss_dssp HHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCHHHHHHHHHcCCCccccC
Confidence 777777777777777777765443
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-21 Score=169.94 Aligned_cols=116 Identities=28% Similarity=0.381 Sum_probs=86.4
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
+.|.+..+.+|.||||+|+..++.+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|.||
T Consensus 109 ~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~ 188 (269)
T 4b93_B 109 GANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTA 188 (269)
T ss_dssp TCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBH
T ss_pred CCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcH
Confidence 33444444445555555555555555666666677778888888899999999999999999999999999988899999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCcccccccccC
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV 145 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~~ 145 (352)
||+|+..|+.+++++|+++|+++......+.++...
T Consensus 189 Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~ 224 (269)
T 4b93_B 189 LHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVDC 224 (269)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSGGG
T ss_pred HHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHH
Confidence 999999999999999999888876555555555443
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-21 Score=153.68 Aligned_cols=97 Identities=31% Similarity=0.410 Sum_probs=94.2
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 56 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 135 (153)
T 1awc_B 56 AGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKT 135 (153)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCC
Confidence 67888888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHH
Q 018682 109 PLGDAIYYKNHEVIKLL 125 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L 125 (352)
|+++|+..|+.+++++|
T Consensus 136 ~l~~A~~~~~~~i~~~L 152 (153)
T 1awc_B 136 AFDISIDNGNEDLAEIL 152 (153)
T ss_dssp HHHHHHHTTCHHHHHHH
T ss_pred HHHHHHHcCCHHHHHHh
Confidence 99999999999999987
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-21 Score=158.14 Aligned_cols=107 Identities=21% Similarity=0.183 Sum_probs=102.4
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 61 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 140 (179)
T 3f6q_A 61 RGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEM 140 (179)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCC
Confidence 67888888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
|+++|+..++.+++++|++.++++...
T Consensus 141 pl~~A~~~~~~~~~~~L~~~g~~~~~~ 167 (179)
T 3f6q_A 141 PVDKAKAPLRELLRERAEKMGQNLNRI 167 (179)
T ss_dssp GGGGSCHHHHHHHHHHHHHTTCCCSCB
T ss_pred cHHHHHHHHHHHHHHHHHHhhcCcccC
Confidence 999999999999999999999987543
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.5e-21 Score=154.98 Aligned_cols=101 Identities=31% Similarity=0.328 Sum_probs=95.5
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 64 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 143 (165)
T 3twr_A 64 HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNT 143 (165)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 67888889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGA 130 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~ 130 (352)
|+++|.. ++.+++++|.+.|+
T Consensus 144 ~l~~a~~-~~~~i~~~L~~~gA 164 (165)
T 3twr_A 144 PLDLVKD-GDTDIQDLLRGDAA 164 (165)
T ss_dssp TGGGSCT-TCHHHHHHHHTC--
T ss_pred hhHhHhc-CChHHHHHHhhccc
Confidence 9999877 89999999998764
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=167.51 Aligned_cols=131 Identities=24% Similarity=0.277 Sum_probs=88.3
Q ss_pred CCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018682 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (352)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~ 83 (352)
+..+.||+-..............--+|.+.+ .++.|.||||.||..|+.++++.|+++|+++|.+|..|+||||+|+..
T Consensus 2 ~~~g~t~L~~a~~~~~~~~~~~ll~~g~~~~-~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~ 80 (239)
T 1ycs_B 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVK-FNPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCA 80 (239)
T ss_dssp ------------------------------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHH
T ss_pred CccccccCchhhhhhhHHHHHHHhccCCCcc-cCchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHc
Confidence 3456666655444433333222223455555 347889999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 84 ~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 81 g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~ 132 (239)
T 1ycs_B 81 GHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAM 132 (239)
T ss_dssp TCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccee
Confidence 9999999999999999999999999999999999999999999999887543
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-21 Score=156.03 Aligned_cols=132 Identities=23% Similarity=0.193 Sum_probs=110.6
Q ss_pred CCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018682 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (352)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~ 84 (352)
..+.||+-.........--+----+|.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 34 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 113 (172)
T 3v30_A 34 ERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGN 113 (172)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence 34555555443333222212222367888888899999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 85 ~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
+.+++++|+++|++++.+|..|.||||+|+..++.+++++|++++++.....
T Consensus 114 ~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~ 165 (172)
T 3v30_A 114 HVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKLFQSN 165 (172)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHSCC-
T ss_pred CHHHHHHHHHcCCCccccCCCCCCHHHHHHHhCcHHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999999999999999988765443
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.85 E-value=7.4e-21 Score=152.66 Aligned_cols=105 Identities=24% Similarity=0.260 Sum_probs=83.1
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
+.+.+..+..|+||||+ |..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 26 ~~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 104 (156)
T 1bd8_A 26 LVHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALP 104 (156)
T ss_dssp CCCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred CcCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcH
Confidence 34666777778888888 77888888888888888888888888888888888888888888888888888888888888
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
||+|+..|+.+++++|++. +++....
T Consensus 105 L~~A~~~~~~~~v~~Ll~~-~~~~~~~ 130 (156)
T 1bd8_A 105 IHLAVQEGHTAVVSFLAAE-SDLHRRD 130 (156)
T ss_dssp HHHHHHHTCHHHHHHHHTT-SCTTCCC
T ss_pred HHHHHHhChHHHHHHHHhc-cCCCCcC
Confidence 8888888888888888877 6654443
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.8e-21 Score=154.85 Aligned_cols=101 Identities=34% Similarity=0.477 Sum_probs=97.0
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 69 ~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 148 (169)
T 2y1l_E 69 NGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKT 148 (169)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 67888888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~ 129 (352)
|+++|+..++.+++++|++.|
T Consensus 149 ~l~~A~~~~~~~~~~~L~~~G 169 (169)
T 2y1l_E 149 AFDISIDNGNEDLAEILQKLN 169 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHTC-
T ss_pred HHHHHHHhCCHHHHHHHHHcC
Confidence 999999999999999998865
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.85 E-value=5.1e-21 Score=150.17 Aligned_cols=101 Identities=32% Similarity=0.401 Sum_probs=94.5
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhc
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~ 115 (352)
....|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 10 ~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~ 89 (136)
T 2jab_A 10 HGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF 89 (136)
T ss_dssp --CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred ccccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence 44578999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcHHHHHHHHHcCCCCCCCc
Q 018682 116 YKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 116 ~~~~~~~~~L~~~~~~~~~~~ 136 (352)
.++.+++++|+++++++....
T Consensus 90 ~~~~~~v~~Ll~~g~~~~~~~ 110 (136)
T 2jab_A 90 IGHLEIAEVLLKHGADVNAQD 110 (136)
T ss_dssp HTCHHHHHHHHHTTCCTTCCC
T ss_pred cCCHHHHHHHHHcCCCCcCcC
Confidence 999999999999998875443
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=149.64 Aligned_cols=92 Identities=27% Similarity=0.234 Sum_probs=85.5
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 29 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 108 (123)
T 3aaa_C 29 KGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLT 108 (123)
T ss_dssp TTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 67788888889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHH
Q 018682 109 PLGDAIYYKNHE 120 (352)
Q Consensus 109 ~l~~a~~~~~~~ 120 (352)
|+|+|...+..+
T Consensus 109 ~l~~A~~~~~~~ 120 (123)
T 3aaa_C 109 AFEATDNQAIKA 120 (123)
T ss_dssp HHHHCCCHHHHH
T ss_pred HHHHhCCHHHHH
Confidence 999995444333
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-21 Score=144.61 Aligned_cols=91 Identities=33% Similarity=0.463 Sum_probs=86.0
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
..+.+|.|+||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 19 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~ 98 (110)
T 2zgd_A 19 HMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISI 98 (110)
T ss_dssp ---CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHH
Confidence 45668889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcHHHHHHH
Q 018682 115 YYKNHEVIKLL 125 (352)
Q Consensus 115 ~~~~~~~~~~L 125 (352)
..++.+++++|
T Consensus 99 ~~~~~~~~~~L 109 (110)
T 2zgd_A 99 DNGNEDLAEIL 109 (110)
T ss_dssp HHTCHHHHHHH
T ss_pred HcCCHHHHHHh
Confidence 99999999987
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.5e-21 Score=153.26 Aligned_cols=126 Identities=25% Similarity=0.271 Sum_probs=106.8
Q ss_pred CCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018682 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (352)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~ 84 (352)
..++||+-.... ....--+----+|.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|
T Consensus 36 ~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 114 (162)
T 1ihb_A 36 GFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEG 114 (162)
T ss_dssp TTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred ccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcC
Confidence 345666655443 2221111222267888889999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCC-CCCCCCCCCChhHHhhccCcHHHHHHHHHcCCC
Q 018682 85 FTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 85 ~~~~~~~Ll~~ga~-~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
+.+++++|+++|++ ++.+|..|.||||+|+..++.+++++|+++|++
T Consensus 115 ~~~~v~~Ll~~g~~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~GAd 162 (162)
T 1ihb_A 115 HLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGAG 162 (162)
T ss_dssp CHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred CHHHHHHHHHccCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence 99999999999998 699999999999999999999999999999975
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-21 Score=152.97 Aligned_cols=126 Identities=23% Similarity=0.161 Sum_probs=103.0
Q ss_pred CCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018682 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (352)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~ 83 (352)
+..+.|++-.........--+-..-+|.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 7 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 86 (137)
T 3c5r_A 7 NHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKN 86 (137)
T ss_dssp CTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHT
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHc
Confidence 34455665544433332222222236788888899999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcC
Q 018682 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 84 ~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~ 129 (352)
|+.+++++|+++|++++.+|..|.||+++|+..+..+++++|.+..
T Consensus 87 ~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~l~~l~~~~ 132 (137)
T 3c5r_A 87 GHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNE 132 (137)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCCGGGGCCCHHHHHHHSCC----
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhccHHHHHhhccccc
Confidence 9999999999999999999999999999999999888888776654
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=166.23 Aligned_cols=115 Identities=30% Similarity=0.332 Sum_probs=100.9
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~-g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+.+.+..+..|.||||+||..|+.+++++|+++|+++|.++.. |+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 148 ~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t 227 (282)
T 1oy3_D 148 RLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRT 227 (282)
T ss_dssp GGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred hhcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCC
Confidence 4556778889999999999999999999999999999999865 999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCccccccccc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 144 (352)
|||+|+..++.+++++|+++|+++........++..
T Consensus 228 pL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~ 263 (282)
T 1oy3_D 228 PLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCS 263 (282)
T ss_dssp HHHHHHTSSCHHHHHHHHHTTCCCCCCC--------
T ss_pred HHHHHHHcCCcHHHHHHHHcCCCcCcCCCccccccc
Confidence 999999999999999999999998766555555544
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=164.03 Aligned_cols=108 Identities=18% Similarity=0.086 Sum_probs=99.3
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~ 107 (352)
+|.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.++ ..|.
T Consensus 43 ~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~ 122 (229)
T 2vge_A 43 EMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGA 122 (229)
T ss_dssp HSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCC
Confidence 577888888899999999999999999999999999999999999999999999999999999999999999987 6999
Q ss_pred ChhHHh--hccCcHHHHHHHHHcCCCCCCCc
Q 018682 108 TPLGDA--IYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 108 t~l~~a--~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
||||+| +..++.+++++|++.|+++....
T Consensus 123 tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~ 153 (229)
T 2vge_A 123 TAFEKCDPYREGYADCATYLADVEQSMGLMN 153 (229)
T ss_dssp CTGGGCCTTSTTHHHHHHHHHHHHHHTTTSG
T ss_pred CHHHHHHHHhcChHHHHHHHHHcCCCccccc
Confidence 999999 89999999999999998875543
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=151.04 Aligned_cols=122 Identities=24% Similarity=0.277 Sum_probs=104.8
Q ss_pred CCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018682 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (352)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~ 84 (352)
..+.||+-. .......--+-.--+|.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 34 ~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 112 (156)
T 1bd8_A 34 RFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEG 112 (156)
T ss_dssp TTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHT
T ss_pred CCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhC
Confidence 346666655 3322222222222367888899999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHc
Q 018682 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128 (352)
Q Consensus 85 ~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~ 128 (352)
+.+++++|+++ ++++.+|..|.||+|+|+..++.+++++|+++
T Consensus 113 ~~~~v~~Ll~~-~~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~ 155 (156)
T 1bd8_A 113 HTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp CHHHHHHHHTT-SCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred hHHHHHHHHhc-cCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhh
Confidence 99999999999 99999999999999999999999999999874
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=157.43 Aligned_cols=124 Identities=27% Similarity=0.251 Sum_probs=105.6
Q ss_pred CcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018682 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (352)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~ 85 (352)
.+.||+-.........--+----+|.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus 67 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~ 146 (192)
T 2rfm_A 67 EGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGR 146 (192)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTC
T ss_pred cCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCC
Confidence 45555554443332222111222577888888999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcC
Q 018682 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 86 ~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~ 129 (352)
.+++++|+++|++++.+|..|.||+++|+..++.+++++|++.+
T Consensus 147 ~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~~ 190 (192)
T 2rfm_A 147 SEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVR 190 (192)
T ss_dssp HHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCcHHHHHHHHhcc
Confidence 99999999999999999999999999999999999999998864
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.84 E-value=8.6e-21 Score=154.14 Aligned_cols=127 Identities=25% Similarity=0.190 Sum_probs=107.9
Q ss_pred CcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018682 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (352)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~ 85 (352)
.+.||+-.........--+-..-+|.+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus 35 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~ 114 (167)
T 3v31_A 35 EGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNH 114 (167)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCC
Confidence 45555554443332222111222578888888999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 86 ~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
.+++++|+++|++++.+|..|.||+++|+..|+.+++++|++++.+.
T Consensus 115 ~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~ 161 (167)
T 3v31_A 115 VKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKL 161 (167)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999987654
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-20 Score=157.85 Aligned_cols=114 Identities=25% Similarity=0.226 Sum_probs=102.0
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCCCCCh
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTP 109 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~t~ 109 (352)
.+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++| ++++.+|..|.||
T Consensus 98 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~ 177 (228)
T 2dzn_A 98 PDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTP 177 (228)
T ss_dssp CCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCH
T ss_pred cccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCH
Confidence 677788888999999999999999999999999999999999999999999999999999999999 9999999999999
Q ss_pred hHHhhccCcHHHHHHHH-HcCCCCCCCccccccccc
Q 018682 110 LGDAIYYKNHEVIKLLE-KHGAKPLMAPMHVKHARE 144 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~-~~~~~~~~~~~~~~~~~~ 144 (352)
||+|+..++.+++++|+ +.|+++........++..
T Consensus 178 L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l~ 213 (228)
T 2dzn_A 178 LFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAED 213 (228)
T ss_dssp HHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGGG
T ss_pred HHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHHH
Confidence 99999999999999999 889988665555555443
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=3.2e-20 Score=143.00 Aligned_cols=98 Identities=44% Similarity=0.535 Sum_probs=93.8
Q ss_pred CCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCc
Q 018682 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~ 118 (352)
+|+||||+||..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~ 80 (126)
T 1n0r_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (126)
T ss_dssp CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCc
Q 018682 119 HEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 119 ~~~~~~L~~~~~~~~~~~ 136 (352)
.+++++|++.++++....
T Consensus 81 ~~~~~~Ll~~g~~~~~~~ 98 (126)
T 1n0r_A 81 LEVVKLLLEAGADVNAKD 98 (126)
T ss_dssp HHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHHHHcCCCCcccC
Confidence 999999999998875443
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=164.88 Aligned_cols=108 Identities=31% Similarity=0.335 Sum_probs=103.2
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|+|.|..+.+|+||||+||..|+.+++++|++.|++++.++.+|.||+|+|+..++.+++++|+++|++++.+|..|.|
T Consensus 75 ~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~T 154 (269)
T 4b93_B 75 SGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNT 154 (269)
T ss_dssp CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred CCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCCCCCCC
Confidence 67888889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|||+|+..|+.+++++|++.|+++....
T Consensus 155 pL~~A~~~g~~~~v~~Ll~~gadvn~~~ 182 (269)
T 4b93_B 155 PLIYACSGGHHELVALLLQHGASINASN 182 (269)
T ss_dssp HHHHHHHTTCGGGHHHHHHTTCCTTCBC
T ss_pred HHHHHHHCCCHHHHHHHHHCCCCCCccc
Confidence 9999999999999999999999875443
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.6e-21 Score=157.77 Aligned_cols=110 Identities=19% Similarity=0.162 Sum_probs=89.6
Q ss_pred CCCCc-cCCchHHHHHHhcCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC------HHHHHHHHHCCCCCCC
Q 018682 33 DDGEE-IKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGF------TEVVSLLLERGADVDP 101 (352)
Q Consensus 33 ~~~~~-~~g~t~l~~a~~~~~~----~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~------~~~~~~Ll~~ga~~~~ 101 (352)
.+..+ ..|+||||+|+..++. +++++|+++|||+|.+|..|+||||+|+..++ .+++++|+++||++|.
T Consensus 30 ~~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~ 109 (186)
T 3t8k_A 30 YEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITA 109 (186)
T ss_dssp SSCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSS
T ss_pred cccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCc
Confidence 33444 6789999999998875 58999999999999999999999999998886 5789999999999999
Q ss_pred CCCCCC-ChhHHhhccC-----cHHHHHHHHH-cCCCCCCCccccccc
Q 018682 102 KDRWGS-TPLGDAIYYK-----NHEVIKLLEK-HGAKPLMAPMHVKHA 142 (352)
Q Consensus 102 ~~~~g~-t~l~~a~~~~-----~~~~~~~L~~-~~~~~~~~~~~~~~~ 142 (352)
+|..|. ||||+|+..+ ..+++++|++ +|+++......+.++
T Consensus 110 ~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp 157 (186)
T 3t8k_A 110 LYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA 157 (186)
T ss_dssp CBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred cCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence 999999 9999998844 3568889998 888876555444443
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=168.01 Aligned_cols=110 Identities=26% Similarity=0.292 Sum_probs=101.5
Q ss_pred cCCCCCC------CccCCchHHHHHHhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCC
Q 018682 29 NGLDDDG------EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99 (352)
Q Consensus 29 ~~~~~~~------~~~~g~t~l~~a~~~---~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~ 99 (352)
++.|.+. .+..|+||||+||.. |+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++||++
T Consensus 173 ~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~ 252 (301)
T 2b0o_E 173 NGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252 (301)
T ss_dssp TTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCC
T ss_pred cCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 5666666 688999999999997 8999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCccc
Q 018682 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (352)
Q Consensus 100 ~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~ 138 (352)
+.+|..|.||||+|+..++.+++++|++.+++....+.+
T Consensus 253 ~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~~g~tpLh 291 (301)
T 2b0o_E 253 GTVNEAGETALDIARKKHHKECEELLEQAQAGTFAFPLH 291 (301)
T ss_dssp SCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHTTSSCCC
T ss_pred CCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCChhH
Confidence 999999999999999999999999999998876555443
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.9e-20 Score=156.22 Aligned_cols=103 Identities=28% Similarity=0.224 Sum_probs=68.1
Q ss_pred CCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 018682 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~ 111 (352)
+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 84 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~ 163 (223)
T 2f8y_A 84 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLF 163 (223)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHH
T ss_pred CcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHH
Confidence 45555556666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred HhhccCcHHHHHHHHHcCCCCCC
Q 018682 112 DAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
+|+..++.+++++|+++++++..
T Consensus 164 ~A~~~~~~~~v~~Ll~~ga~~~~ 186 (223)
T 2f8y_A 164 LAAREGSYETAKVLLDHFANRDI 186 (223)
T ss_dssp HHHHHTCHHHHHHHHHTTCCTTC
T ss_pred HHHHcCCHHHHHHHHHcCCCCcc
Confidence 66666666666666666666543
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.4e-20 Score=156.85 Aligned_cols=103 Identities=28% Similarity=0.271 Sum_probs=51.6
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
|.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 96 g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 175 (231)
T 3aji_A 96 GAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTP 175 (231)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccCCCCCCH
Confidence 34444444444455555555555555555555555555555455555555555555555555555555555555555555
Q ss_pred hHHhhccCcHHHHHHHHHcCCCC
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
||+|+..++.+++++|++.|+++
T Consensus 176 L~~A~~~~~~~~v~~Ll~~ga~~ 198 (231)
T 3aji_A 176 LHLACDEERVEEAKFLVTQGASI 198 (231)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCS
T ss_pred HHHHHHCCCHHHHHHHHHCCCCC
Confidence 55555555555555555554444
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-20 Score=161.23 Aligned_cols=105 Identities=28% Similarity=0.219 Sum_probs=79.0
Q ss_pred CCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 018682 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~ 111 (352)
+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 116 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~ 195 (253)
T 1yyh_A 116 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLF 195 (253)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred CccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHH
Confidence 55666667777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred HhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 112 DAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
+|+..++.+++++|+++|+++....
T Consensus 196 ~A~~~~~~~~v~~Ll~~ga~~~~~d 220 (253)
T 1yyh_A 196 LAAREGSYETAKVLLDHFANRDITD 220 (253)
T ss_dssp HHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHCCCHHHHHHHHHcCCCccccc
Confidence 7777777777777777777764433
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.3e-21 Score=157.90 Aligned_cols=101 Identities=18% Similarity=0.163 Sum_probs=93.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcCC------HHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHcC-----CHHHHHHHHH-C
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERD------VEGIKELLDSGIDVNFRDIDNR-TALHVAACQG-----FTEVVSLLLE-R 95 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~------~~~~~~Ll~~ga~~n~~d~~g~-t~lh~A~~~~-----~~~~~~~Ll~-~ 95 (352)
+|+|+|.++.+|+||||+|+..++ .+++++|+++|||+|.+|..|+ ||||+|+..+ +.+++++|++ +
T Consensus 64 ~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~ 143 (186)
T 3t8k_A 64 KGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQS 143 (186)
T ss_dssp TTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTST
T ss_pred CCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhc
Confidence 788889999999999999999887 6899999999999999999999 9999999954 4579999999 9
Q ss_pred CCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcC
Q 018682 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 96 ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~ 129 (352)
|++++.+|..|.||||+|+..++.+++++|..+.
T Consensus 144 gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~ 177 (186)
T 3t8k_A 144 GLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYI 177 (186)
T ss_dssp TCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHH
T ss_pred CCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHH
Confidence 9999999999999999999999999999998754
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=159.60 Aligned_cols=107 Identities=22% Similarity=0.106 Sum_probs=100.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC-
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS- 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~- 107 (352)
+|.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.++..|.
T Consensus 59 ~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~~ 138 (239)
T 1ycs_B 59 EVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQ 138 (239)
T ss_dssp TTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCCc
Confidence 6778888899999999999999999999999999999999999999999999999999999999999999999998877
Q ss_pred ChhHHh--hccCcHHHHHHHHHcCCCCCCC
Q 018682 108 TPLGDA--IYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 108 t~l~~a--~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
||+|+| +..|+.+++++|+..++++...
T Consensus 139 t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~ 168 (239)
T 1ycs_B 139 TAADKCEEMEEGYTQCSQFLYGVQEKMGIM 168 (239)
T ss_dssp CHHHHCCSSSTTCCCHHHHHHHHHHHTTTT
T ss_pred chHHHHHHhhhccHHHHHHHHHhhhccccc
Confidence 999999 7789999999999999887544
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.82 E-value=6.1e-20 Score=157.72 Aligned_cols=100 Identities=25% Similarity=0.245 Sum_probs=72.2
Q ss_pred CCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 018682 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (352)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~-~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 112 (352)
+..+..|.||||+||..|+.+++++|+++|+++|.+|. .|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 111 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~ 190 (236)
T 1ikn_D 111 KATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQL 190 (236)
T ss_dssp GCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGG
T ss_pred hccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHHH
Confidence 44555677777777777777777777777777777776 67777777777777777777777777777777777777777
Q ss_pred hhccCcHHHHHHHHHcCCCCC
Q 018682 113 AIYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 113 a~~~~~~~~~~~L~~~~~~~~ 133 (352)
|+..++.+++++|+++|+++.
T Consensus 191 A~~~~~~~~~~~Ll~~ga~~~ 211 (236)
T 1ikn_D 191 TWGRPSTRIQQQLGQLTLENL 211 (236)
T ss_dssp CTTSSCHHHHHHHHTTSCGGG
T ss_pred HHccCchHHHHHHHHcchhhh
Confidence 777777777777777777653
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.7e-20 Score=157.37 Aligned_cols=106 Identities=26% Similarity=0.351 Sum_probs=92.1
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCC-----CCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~-----n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 104 (352)
+.|.+..+..|+||||+||..|+.+++++|+++|+++ +.+|..|+||||+|+..|+.+++++|+++|++++.++.
T Consensus 27 g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 106 (232)
T 2rfa_A 27 GCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARAT 106 (232)
T ss_dssp CSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCC
T ss_pred CCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccC
Confidence 7778888888899999999999999999999988876 77788899999999999999999999999999888765
Q ss_pred -------------CCCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 105 -------------WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 105 -------------~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
.|.||||+|+..|+.+++++|+++|+++...
T Consensus 107 ~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 150 (232)
T 2rfa_A 107 GSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQ 150 (232)
T ss_dssp SGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred CcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 7899999999999999999999988876443
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.6e-20 Score=162.53 Aligned_cols=101 Identities=31% Similarity=0.323 Sum_probs=83.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~ 107 (352)
+|.+.+..+..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|++ .|++++.+|..|.
T Consensus 172 ~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~ 251 (276)
T 4hbd_A 172 LGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGS 251 (276)
T ss_dssp HSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSC
T ss_pred cCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCC
Confidence 445556666778888888888888888888888888888888888888888888888888888888 7888888888888
Q ss_pred ChhHHhhccCcHHHHHHHHHcC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~ 129 (352)
||||+|+..|+.+++++|+++.
T Consensus 252 TpL~~A~~~g~~~iv~~Ll~~~ 273 (276)
T 4hbd_A 252 TALMVALDAGQSEIASMLYSRM 273 (276)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHC
T ss_pred CHHHHHHHcCCHHHHHHHHhcc
Confidence 8888888888888888887754
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-19 Score=154.88 Aligned_cols=129 Identities=26% Similarity=0.244 Sum_probs=107.7
Q ss_pred CCcccccccccccCCchh-----hhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCC--------
Q 018682 5 VPVRTTLLKQSSLAPDRE-----RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-------- 71 (352)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~-----~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~-------- 71 (352)
..+.||+-.........- +.++++...+.+..+..|.||||+||..|+.+++++|+++|+++|.++.
T Consensus 35 ~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~ 114 (232)
T 2rfa_A 35 AMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRP 114 (232)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecc
Confidence 345566554433322221 3445554455577788999999999999999999999999999999876
Q ss_pred -----CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHH----HHHHHcCCCCC
Q 018682 72 -----DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI----KLLEKHGAKPL 133 (352)
Q Consensus 72 -----~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~----~~L~~~~~~~~ 133 (352)
.|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++.+++ ++|++.++++.
T Consensus 115 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~ 185 (232)
T 2rfa_A 115 HNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH 185 (232)
T ss_dssp TCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCS
T ss_pred cccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchh
Confidence 799999999999999999999999999999999999999999999999988 99999998764
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=159.86 Aligned_cols=106 Identities=24% Similarity=0.318 Sum_probs=80.3
Q ss_pred ccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCCCCCCChhHHhhc
Q 018682 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIY 115 (352)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~t~l~~a~~ 115 (352)
+..|.||||+||..|+.++++.|++.|+++|.+|..|+||||+||..|+.+++++|+++ |++++.+|..|.||||+|+.
T Consensus 70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~ 149 (222)
T 3ehr_A 70 AESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAW 149 (222)
T ss_dssp EEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHH
T ss_pred ccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHH
Confidence 44567778888888888888888888888887777788888888888888888888877 78888888888888888888
Q ss_pred cCcHHHHHHHHHcCCCCCCCccccccc
Q 018682 116 YKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (352)
Q Consensus 116 ~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (352)
.|+.+++++|++.|+++........++
T Consensus 150 ~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 176 (222)
T 3ehr_A 150 KGYADIVQLLLAKGARTDLRNIEKKLA 176 (222)
T ss_dssp HTCHHHHHHHHHHTCCSCCCCTTSCCH
T ss_pred cCCHHHHHHHHHcCCCCccccCCCCCH
Confidence 788888888888777765544444333
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-19 Score=155.60 Aligned_cols=101 Identities=26% Similarity=0.323 Sum_probs=96.0
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
..+..|.||||+||..|+.++++.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 16 ~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~ 95 (229)
T 2vge_A 16 RARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAA 95 (229)
T ss_dssp CTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred ccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 45567889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcHHHHHHHHHcCCCCCCC
Q 018682 115 YYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 115 ~~~~~~~~~~L~~~~~~~~~~ 135 (352)
..|+.+++++|++.|+++...
T Consensus 96 ~~g~~~~v~~Ll~~ga~~~~~ 116 (229)
T 2vge_A 96 SCNDTVICMALVQHGAAIFAT 116 (229)
T ss_dssp HTTCHHHHHHHHTTTCCTTCC
T ss_pred HcCCHHHHHHHHHcCCCcccc
Confidence 999999999999999987544
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.4e-20 Score=151.90 Aligned_cols=102 Identities=33% Similarity=0.326 Sum_probs=94.6
Q ss_pred ccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCCCChhHHhhc
Q 018682 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIY 115 (352)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~t~l~~a~~ 115 (352)
+..|+||||+||..|+.++++.|++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+| ..|.||||+|+.
T Consensus 41 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~ 119 (183)
T 3deo_A 41 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119 (183)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHh
Confidence 4588999999999999999999999 99999999999999999999999999999999999999998 899999999999
Q ss_pred cCcHHHHHHHHHcCCCCCCCcccc
Q 018682 116 YKNHEVIKLLEKHGAKPLMAPMHV 139 (352)
Q Consensus 116 ~~~~~~~~~L~~~~~~~~~~~~~~ 139 (352)
.++.+++++|+++|+++.......
T Consensus 120 ~~~~~~v~~Ll~~ga~~~~~d~~g 143 (183)
T 3deo_A 120 YVRPEVVEALVELGADIEVEDERG 143 (183)
T ss_dssp TTCHHHHHHHHHHTCCTTCCCTTS
T ss_pred cCcHHHHHHHHHcCCCCcCCCCCC
Confidence 999999999999999875544333
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-19 Score=153.50 Aligned_cols=131 Identities=21% Similarity=0.140 Sum_probs=81.8
Q ss_pred CCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCC-CCCCCCCCCCcHHHHHHHc
Q 018682 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQ 83 (352)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga-~~n~~d~~g~t~lh~A~~~ 83 (352)
..+.||+-.........--+----+|.+.+..+..|+||||+|+..|+.+++++|+++++ +++.+|..|+||||+|+..
T Consensus 23 ~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~ 102 (223)
T 2f8y_A 23 RTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARL 102 (223)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHH
T ss_pred CCCCchHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHh
Confidence 344555544433333222111222455666666666677777777777777777776665 6666666777777777777
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 84 ~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
|+.+++++|+++|++++.+|..|.||||+|+..++.+++++|++.++++...
T Consensus 103 ~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 154 (223)
T 2f8y_A 103 AVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQ 154 (223)
T ss_dssp TCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence 7777777777777777777777777777777777777777777766665433
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-19 Score=155.67 Aligned_cols=111 Identities=24% Similarity=0.347 Sum_probs=91.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCC------CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~------~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~ 102 (352)
+|.|.+..+..|.||||+||..|+.+++++|+++|++ ++..|..|+||||+|+..|+.+++++|+++|++++.+
T Consensus 67 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 146 (236)
T 1ikn_D 67 AGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQ 146 (236)
T ss_dssp CCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCC
Confidence 5677777788888888888888888888888888775 5677778888888888888888888888888888888
Q ss_pred CC-CCCChhHHhhccCcHHHHHHHHHcCCCCCCCcccc
Q 018682 103 DR-WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (352)
Q Consensus 103 ~~-~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~ 139 (352)
+. .|.||||+|+..++.+++++|+++|+++.......
T Consensus 147 ~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 184 (236)
T 1ikn_D 147 EPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQG 184 (236)
T ss_dssp CTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTC
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCC
Confidence 87 88888888888888888888888888875444333
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=149.78 Aligned_cols=102 Identities=25% Similarity=0.250 Sum_probs=93.6
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC-hhHHh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST-PLGDA 113 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t-~l~~a 113 (352)
..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+ .|+.+++++|+++|++++.+|..|.| |||+|
T Consensus 7 ~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A 85 (156)
T 1bi7_B 7 SSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDA 85 (156)
T ss_dssp ---CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHH
T ss_pred CCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 45567899999999999999999999999999999999999999985 99999999999999999999999999 99999
Q ss_pred hccCcHHHHHHHHHcCCCCCCCcc
Q 018682 114 IYYKNHEVIKLLEKHGAKPLMAPM 137 (352)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~~~~~~~ 137 (352)
+..|+.+++++|+++|+++.....
T Consensus 86 ~~~~~~~~v~~Ll~~ga~~~~~d~ 109 (156)
T 1bi7_B 86 AREGFLDTLVVLHRAGARLDVRDA 109 (156)
T ss_dssp HHHTCHHHHHHHHHHTCCSSCCCT
T ss_pred HHCCCHHHHHHHHHcCCCCcccCC
Confidence 999999999999999998755443
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-19 Score=154.36 Aligned_cols=98 Identities=32% Similarity=0.440 Sum_probs=53.4
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 35 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 114 (231)
T 3aji_A 35 RTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAA 114 (231)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred cCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHH
Confidence 33444555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccCcHHHHHHHHHcCCCC
Q 018682 115 YYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 115 ~~~~~~~~~~L~~~~~~~ 132 (352)
..++.+++++|++.++++
T Consensus 115 ~~~~~~~~~~Ll~~g~~~ 132 (231)
T 3aji_A 115 SKNRHEIAVMLLEGGANP 132 (231)
T ss_dssp HTTCHHHHHHHHHTTCCT
T ss_pred HcCCHHHHHHHHHcCCCC
Confidence 555555555555555544
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=163.12 Aligned_cols=95 Identities=25% Similarity=0.226 Sum_probs=72.7
Q ss_pred CCchHHHHHHhcCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHHcCC---------HHHHHHHHHCCCCCC------
Q 018682 39 KPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF---------TEVVSLLLERGADVD------ 100 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~---~ga~~n~~d~~g~t~lh~A~~~~~---------~~~~~~Ll~~ga~~~------ 100 (352)
.|.||||+||..|+.+++++|++ +|+++|.+|.+|+||||+|+..|+ .+++++|+++|++++
T Consensus 147 ~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~ 226 (273)
T 2pnn_A 147 FGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLE 226 (273)
T ss_dssp SCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGG
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccc
Confidence 67788888888888888888887 778888888888888888887776 677788888877776
Q ss_pred -CCCCCCCChhHHhhccCcHHHHHHHHHcCC-CCC
Q 018682 101 -PKDRWGSTPLGDAIYYKNHEVIKLLEKHGA-KPL 133 (352)
Q Consensus 101 -~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~-~~~ 133 (352)
.+|..|.||||+|+..|+.+++++|+++|+ ++.
T Consensus 227 ~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~dp~ 261 (273)
T 2pnn_A 227 EITNRKGLTPLALAASSGKIGVLAYILQREIHEPE 261 (273)
T ss_dssp GCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC---
T ss_pred cccCCCCCCHHHHHHHhChHHHHHHHHHCCCCCch
Confidence 377778888888888888888888888777 543
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.82 E-value=9.5e-20 Score=158.33 Aligned_cols=101 Identities=23% Similarity=0.273 Sum_probs=96.2
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 146 ~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 225 (253)
T 1yyh_A 146 SHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRL 225 (253)
T ss_dssp TTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccCCCC
Confidence 67888888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~ 129 (352)
|+++|+..|+.+++++|....
T Consensus 226 pl~~A~~~g~~~i~~~l~~~~ 246 (253)
T 1yyh_A 226 PRDIAQERMHHDIVRLLDLEH 246 (253)
T ss_dssp HHHHHHHTTCHHHHHHHHC--
T ss_pred HHHHHHHcCCHHHHHHHHHHh
Confidence 999999999999999998754
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=2.3e-19 Score=159.46 Aligned_cols=118 Identities=28% Similarity=0.278 Sum_probs=89.5
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCC-------------------------------------
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI------------------------------------- 71 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~------------------------------------- 71 (352)
+|.|.+..+..|+||||+|+..|+.+++++|+++|++++.+|.
T Consensus 95 ~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~ll~~~~~~~~~~~~~~~ 174 (299)
T 1s70_B 95 NGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEE 174 (299)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHhcchHHHHHHHHhhcCCCchhhhhhhh
Confidence 5667777777788888888888888888888888887776653
Q ss_pred -----------------------CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHc
Q 018682 72 -----------------------DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128 (352)
Q Consensus 72 -----------------------~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~ 128 (352)
.|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.
T Consensus 175 ~~~~~~~~~~l~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ 254 (299)
T 1s70_B 175 RIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVEN 254 (299)
T ss_dssp HHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHT
T ss_pred hHHHHHHHHHHhccCcchhhhcCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHhcCCHHHHHHHHHc
Confidence 356777777888888888888888888888888888888888888888888888888
Q ss_pred CCCCCCCcccccccccCC
Q 018682 129 GAKPLMAPMHVKHAREVP 146 (352)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~ 146 (352)
|+++......+.++....
T Consensus 255 gad~~~~d~~g~t~l~~A 272 (299)
T 1s70_B 255 LCDMEAVNKVGQTAFDVA 272 (299)
T ss_dssp TCCTTCCCTTSCCTTTSC
T ss_pred CCCCCCcCCCCCCHHHHH
Confidence 887765555555554443
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-19 Score=154.72 Aligned_cols=112 Identities=24% Similarity=0.255 Sum_probs=97.2
Q ss_pred CCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 018682 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d-~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 110 (352)
+.+..+..|.||||+|+..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 108 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L 187 (241)
T 1k1a_A 108 DLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSAL 187 (241)
T ss_dssp CTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHH
T ss_pred cccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 667777888999999999999999999999999999888 7799999999999999999999999999999999999999
Q ss_pred HHhhccCcHHHHHHHHHcCCCCCCCcccccccc
Q 018682 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (352)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~ 143 (352)
|+|+..++.+++++|+++|+++........++.
T Consensus 188 ~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 220 (241)
T 1k1a_A 188 HSASGRGLLPLVRTLVRSGADSSLKNCHNDTPL 220 (241)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTT
T ss_pred HHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHH
Confidence 999999999999999999988765554444443
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.3e-20 Score=156.21 Aligned_cols=106 Identities=22% Similarity=0.275 Sum_probs=92.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
+|.|.+..+..|+||||+||..|+.+++++|+++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 95 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 174 (222)
T 3ehr_A 95 NRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEKK 174 (222)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTSC
T ss_pred CCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCC
Confidence 7788888999999999999999999999999998 999999999999999999999999999999999999999999999
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
|||++|+..+..++++.|...++....
T Consensus 175 t~l~~A~~~~~~~~l~~l~~~~~~~~~ 201 (222)
T 3ehr_A 175 LAFDMATNAACASLLKKKQGTDAVRTL 201 (222)
T ss_dssp CHHHHCCSHHHHHHHC-----------
T ss_pred CHHHHhcchhHHHHHHHHhccchhhhc
Confidence 999999999999999999998887543
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.8e-20 Score=150.35 Aligned_cols=90 Identities=33% Similarity=0.357 Sum_probs=85.3
Q ss_pred hhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 018682 27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105 (352)
Q Consensus 27 ~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d-~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~ 105 (352)
.+.+.|.+..+..|+||||+||..|+.+++++|+++|+++|.+| .+|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 63 Ll~~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~ 142 (183)
T 3deo_A 63 LLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDER 142 (183)
T ss_dssp HTTTSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTT
T ss_pred HHhcCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCC
Confidence 34588889999999999999999999999999999999999999 88999999999999999999999999999999999
Q ss_pred CCChhHHhhcc
Q 018682 106 GSTPLGDAIYY 116 (352)
Q Consensus 106 g~t~l~~a~~~ 116 (352)
|.||||+|+..
T Consensus 143 g~tpl~~A~~~ 153 (183)
T 3deo_A 143 GLTALELAREI 153 (183)
T ss_dssp SCCHHHHHHHH
T ss_pred CCCHHHHHHHh
Confidence 99999999875
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.7e-19 Score=153.55 Aligned_cols=106 Identities=22% Similarity=0.326 Sum_probs=77.1
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 110 (352)
.+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 102 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L 181 (237)
T 3b7b_A 102 MDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPL 181 (237)
T ss_dssp CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCCHH
T ss_pred CCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 55566666677777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred HHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 111 GDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|+|+..++.+++++|+++|+++....
T Consensus 182 ~~A~~~~~~~~v~~Ll~~gad~~~~d 207 (237)
T 3b7b_A 182 HIAARENRYDCVVLFLSRDSDVTLKN 207 (237)
T ss_dssp HHHHHTTCHHHHHHHHTTTCCTTCCC
T ss_pred HHHHHhCCHhHHHHHHHcCCCCCccC
Confidence 77777777777777777777664433
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.7e-19 Score=148.78 Aligned_cols=103 Identities=24% Similarity=0.337 Sum_probs=95.9
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH-HCCCCCCCCCCCCCCh
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTP 109 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll-~~ga~~~~~~~~g~t~ 109 (352)
.+.+..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+ ..+++++.+|..|.||
T Consensus 30 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~ 109 (201)
T 3hra_A 30 YQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNA 109 (201)
T ss_dssp CCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCS
T ss_pred CCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcH
Confidence 477788889999999999999999999999999999999999999999999999999999999 5688999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcC-CCCC
Q 018682 110 LGDAIYYKNHEVIKLLEKHG-AKPL 133 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~-~~~~ 133 (352)
||+|+..++.+++++|++.+ +++.
T Consensus 110 L~~A~~~~~~~~v~~Ll~~g~~~~~ 134 (201)
T 3hra_A 110 LIPAAEKGHIDNVKLLLEDGREDID 134 (201)
T ss_dssp HHHHHHTTCHHHHHHHHHHCCCCTT
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCcC
Confidence 99999999999999999998 6553
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-19 Score=162.42 Aligned_cols=109 Identities=32% Similarity=0.402 Sum_probs=102.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
.+.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 47 ~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t 126 (351)
T 3utm_A 47 LNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFT 126 (351)
T ss_dssp TTTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred cCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence 46777788889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCcc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~ 137 (352)
|||+|+..++.+++++|+++++++.....
T Consensus 127 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 155 (351)
T 3utm_A 127 PLHEAASKNRVEVCSLLLSHGADPTLVNC 155 (351)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCccccC
Confidence 99999999999999999999998755443
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=164.51 Aligned_cols=103 Identities=28% Similarity=0.367 Sum_probs=94.9
Q ss_pred cCCCCCCCc--cCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 018682 29 NGLDDDGEE--IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (352)
Q Consensus 29 ~~~~~~~~~--~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 106 (352)
+|.|.|..+ ..|.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 222 ~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d~~G 301 (368)
T 3jue_A 222 HGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEG 301 (368)
T ss_dssp TTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred cCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcCCCC
Confidence 677777777 789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CChhHHhhccCcHHHHHHHHHcCCC
Q 018682 107 STPLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 107 ~t~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
.||||+|+..++.+++++|+..+..
T Consensus 302 ~TpL~~A~~~g~~~iv~lLl~~~~~ 326 (368)
T 3jue_A 302 RDPLTIAMETANADIVTLLRLAKMR 326 (368)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred CCHHHHHHHCCCHHHHHHHHHcCCC
Confidence 9999999999999999999987643
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.80 E-value=7.4e-20 Score=159.19 Aligned_cols=96 Identities=27% Similarity=0.370 Sum_probs=63.0
Q ss_pred ccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCC-------------CCcHHHHHHHcCCHHHHHHHHH---CCCCCC
Q 018682 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-------------NRTALHVAACQGFTEVVSLLLE---RGADVD 100 (352)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~-------------g~t~lh~A~~~~~~~~~~~Ll~---~ga~~~ 100 (352)
+..|.||||+||..|+.+++++|+++|+++|.+|.. |+||||+|+..|+.+++++|++ +|++++
T Consensus 87 d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n 166 (256)
T 2etb_A 87 FYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLE 166 (256)
T ss_dssp TTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTT
T ss_pred cccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcC
Confidence 345666666666666666666666666666666654 6666666666666666666666 666666
Q ss_pred CCCCCCCChhHHhhc--cCcHH-------HHHHHHHcCCCC
Q 018682 101 PKDRWGSTPLGDAIY--YKNHE-------VIKLLEKHGAKP 132 (352)
Q Consensus 101 ~~~~~g~t~l~~a~~--~~~~~-------~~~~L~~~~~~~ 132 (352)
.+|..|.||||+|+. .++.+ ++++|+++|+++
T Consensus 167 ~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~ 207 (256)
T 2etb_A 167 ATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARL 207 (256)
T ss_dssp CCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCc
Confidence 666666666666665 55555 666666666555
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=156.96 Aligned_cols=104 Identities=21% Similarity=0.152 Sum_probs=82.2
Q ss_pred CcccccccccccCCchhhhhhhhcCCCCCCCccC-------------CchHHHHHHhcCCHHHHHHHHH---cCCCCCCC
Q 018682 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------------PEFRLMFLANERDVEGIKELLD---SGIDVNFR 69 (352)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-------------g~t~l~~a~~~~~~~~~~~Ll~---~ga~~n~~ 69 (352)
.+.||+-.........--+----+|.|.+..+.. |.||||+||..|+.+++++|++ +|+|+|.+
T Consensus 89 ~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~ 168 (256)
T 2etb_A 89 QGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEAT 168 (256)
T ss_dssp TTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCC
T ss_pred cCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCcc
Confidence 4556655443333222211111246666666654 9999999999999999999999 99999999
Q ss_pred CCCCCcHHHHHHH--cCCHH-------HHHHHHHCCCCC-------CCCCCCCCCh
Q 018682 70 DIDNRTALHVAAC--QGFTE-------VVSLLLERGADV-------DPKDRWGSTP 109 (352)
Q Consensus 70 d~~g~t~lh~A~~--~~~~~-------~~~~Ll~~ga~~-------~~~~~~g~t~ 109 (352)
|.+|+||||+|+. .++.+ ++++|+++|+++ +.+|..|.||
T Consensus 169 d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~d~~g~tp 224 (256)
T 2etb_A 169 DSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTP 224 (256)
T ss_dssp CTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHSTTCCGGGCCCTTSCCH
T ss_pred CCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCcccccccccccCCCCCCH
Confidence 9999999999999 88888 999999999999 8999999887
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-20 Score=159.33 Aligned_cols=136 Identities=21% Similarity=0.184 Sum_probs=103.1
Q ss_pred cccCceeecccEEEEEE---E--cCeE--EEEEEcCcccCCC---------------------HHHHHHHHHHHHHHhcC
Q 018682 156 DFTNSVEITKGTFILAF---W--RGIQ--VAVKKLGEEVISD---------------------DDRVRAFRDELALLQKI 207 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~--~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l 207 (352)
-|.+.+.||+|+||.|| . +|+. ||||++....... ......+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 35677899999999887 2 6888 9999876542111 11123678899999999
Q ss_pred CCCce--eeeeEEEEeCCceEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCC
Q 018682 208 RHPNV--VQFLGAVTQSSPMMIVTEYLPK-G----DLRAFLKRKGALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDL 279 (352)
Q Consensus 208 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Di 279 (352)
.|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.| |+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 88754 444432 356899999942 3 77766432 235567789999999999999 898 999999
Q ss_pred CCCCeEeCCCCCEEEEccCCcccc
Q 018682 280 EPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 280 kp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999764
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=156.59 Aligned_cols=102 Identities=33% Similarity=0.325 Sum_probs=94.5
Q ss_pred cCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCCCChhHHhhcc
Q 018682 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYY 116 (352)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~t~l~~a~~~ 116 (352)
..|.||||+||..|+.++++.|++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.++ ..|.||||+|+..
T Consensus 43 ~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~ 121 (244)
T 3ui2_A 43 SEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGY 121 (244)
T ss_dssp HHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHT
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHc
Confidence 478999999999999999999999 99999999999999999999999999999999999999998 8899999999999
Q ss_pred CcHHHHHHHHHcCCCCCCCccccc
Q 018682 117 KNHEVIKLLEKHGAKPLMAPMHVK 140 (352)
Q Consensus 117 ~~~~~~~~L~~~~~~~~~~~~~~~ 140 (352)
|+.+++++|+++|+++........
T Consensus 122 g~~~~v~~Ll~~ga~~~~~d~~g~ 145 (244)
T 3ui2_A 122 VRPEVVEALVELGADIEVEDERGL 145 (244)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred CCHHHHHHHHHCCCCCCCCCCCCC
Confidence 999999999999998755444333
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.1e-19 Score=147.92 Aligned_cols=109 Identities=26% Similarity=0.349 Sum_probs=100.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWG 106 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll-~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g 106 (352)
+|.|.+..+..|.||||+|+..|+.+++++|+ ..++++|.+|..|+||||+|+..|+.+++++|+++| ++++.+|..|
T Consensus 61 ~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g 140 (201)
T 3hra_A 61 RGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFG 140 (201)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCCTTS
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCCCCC
Confidence 67888888899999999999999999999999 567899999999999999999999999999999998 9999999999
Q ss_pred CChhHHhhccCc-----HHHHHHHHHcCCCCCCCcc
Q 018682 107 STPLGDAIYYKN-----HEVIKLLEKHGAKPLMAPM 137 (352)
Q Consensus 107 ~t~l~~a~~~~~-----~~~~~~L~~~~~~~~~~~~ 137 (352)
.||||+|+..++ .+++++|++.|+++.....
T Consensus 141 ~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~ 176 (201)
T 3hra_A 141 YTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDN 176 (201)
T ss_dssp CCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCT
T ss_pred CCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCC
Confidence 999999999887 8999999999998755443
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-20 Score=161.47 Aligned_cols=100 Identities=23% Similarity=0.245 Sum_probs=66.4
Q ss_pred CCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC--------------CCCCcHHHHHHHcCCHHHHHHHHH---C
Q 018682 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--------------IDNRTALHVAACQGFTEVVSLLLE---R 95 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d--------------~~g~t~lh~A~~~~~~~~~~~Ll~---~ 95 (352)
.+..+..|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|++ +
T Consensus 86 ~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ 165 (260)
T 3jxi_A 86 FRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHK 165 (260)
T ss_dssp BCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSC
T ss_pred ccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhcccc
Confidence 34444566666777777777777777777777776666 456777777777777777777776 6
Q ss_pred CCCCCCCCCCCCChhHHhhccCc---------HHHHHHHHHcCCCC
Q 018682 96 GADVDPKDRWGSTPLGDAIYYKN---------HEVIKLLEKHGAKP 132 (352)
Q Consensus 96 ga~~~~~~~~g~t~l~~a~~~~~---------~~~~~~L~~~~~~~ 132 (352)
|++++.+|..|.||||+|+..++ .+++++|++.|+++
T Consensus 166 ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~ 211 (260)
T 3jxi_A 166 QADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKL 211 (260)
T ss_dssp CCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCccc
Confidence 67777777677777777765554 46666666666654
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-19 Score=155.21 Aligned_cols=105 Identities=32% Similarity=0.343 Sum_probs=96.1
Q ss_pred hhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 018682 27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105 (352)
Q Consensus 27 ~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d-~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~ 105 (352)
.+.+.|.|..+..|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 64 Ll~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~ 143 (244)
T 3ui2_A 64 LLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDER 143 (244)
T ss_dssp TTTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHcCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Confidence 34578889999999999999999999999999999999999999 78999999999999999999999999999999999
Q ss_pred CCChhHHhh----------------ccCcHHHHHHHHHcCCC
Q 018682 106 GSTPLGDAI----------------YYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 106 g~t~l~~a~----------------~~~~~~~~~~L~~~~~~ 131 (352)
|.||||+|+ ..|+.+++++|.+...+
T Consensus 144 g~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~~ 185 (244)
T 3ui2_A 144 GLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFE 185 (244)
T ss_dssp CCCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHEE
T ss_pred CCcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhccc
Confidence 999999987 55778889998886543
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-19 Score=167.02 Aligned_cols=111 Identities=27% Similarity=0.322 Sum_probs=96.6
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus 267 ~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g~t 346 (437)
T 1n11_A 267 KQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYS 346 (437)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCCCCC
Confidence 56777778888889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCcccc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~ 139 (352)
|||+|+..|+.+++++|++.|+++.......
T Consensus 347 ~L~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g 377 (437)
T 1n11_A 347 PLHQAAQQGHTDIVTLLLKNGASPNEVSSDG 377 (437)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCSCCCCSSS
T ss_pred HHHHHHHCChHHHHHHHHHCcCCCCCCCCCC
Confidence 9999999999999999999988875544333
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=157.12 Aligned_cols=96 Identities=19% Similarity=0.186 Sum_probs=80.2
Q ss_pred cCCCCCCCc--------------cCCchHHHHHHhcCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHHcCC------
Q 018682 29 NGLDDDGEE--------------IKPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF------ 85 (352)
Q Consensus 29 ~~~~~~~~~--------------~~g~t~l~~a~~~~~~~~~~~Ll~---~ga~~n~~d~~g~t~lh~A~~~~~------ 85 (352)
+|.|.+..+ ..|.||||+||..|+.+++++|++ +|+++|.+|..|+||||+|+..++
T Consensus 115 ~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~ 194 (260)
T 3jxi_A 115 KGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENT 194 (260)
T ss_dssp TTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHH
T ss_pred CCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHH
Confidence 566666666 689999999999999999999999 899999999999999999998887
Q ss_pred ---HHHHHHHHHCCCCC-------CCCCCCCCChhHHhhccCcH--------HHHHHHHHcCCCC
Q 018682 86 ---TEVVSLLLERGADV-------DPKDRWGSTPLGDAIYYKNH--------EVIKLLEKHGAKP 132 (352)
Q Consensus 86 ---~~~~~~Ll~~ga~~-------~~~~~~g~t~l~~a~~~~~~--------~~~~~L~~~~~~~ 132 (352)
.+++++|+++|+++ +.+|..|.|| -. +++++|++++.++
T Consensus 195 ~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tp--------L~~A~~~g~~~~v~~Ll~~g~~~ 251 (260)
T 3jxi_A 195 KFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSP--------LMMAAKTGKIGIFQHIIRREIAD 251 (260)
T ss_dssp HHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCH--------HHHHHHTTCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCcccccccchhhcccCCCCCH--------HHHHHHcCCHHHHHHHHHhCCCc
Confidence 79999999999998 6688888776 21 3466777766554
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.7e-19 Score=150.09 Aligned_cols=97 Identities=27% Similarity=0.301 Sum_probs=73.2
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcC--CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSG--IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g--a~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
.+..|.||||+|+..|+.+++++|+++| +++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 68 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A 147 (228)
T 2dzn_A 68 PDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRA 147 (228)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHH
Confidence 5567777777777777777777777777 77777777777777777777777777777777777777777777777777
Q ss_pred hccCcHHHHHHHHHcC-CCC
Q 018682 114 IYYKNHEVIKLLEKHG-AKP 132 (352)
Q Consensus 114 ~~~~~~~~~~~L~~~~-~~~ 132 (352)
+..|+.+++++|++.+ +++
T Consensus 148 ~~~~~~~~v~~Ll~~g~~~~ 167 (228)
T 2dzn_A 148 ASVGSLKLIELLCGLGKSAV 167 (228)
T ss_dssp HHTTCHHHHHHHHTTTCCCS
T ss_pred HHcCCHHHHHHHHhcCcccc
Confidence 7777777777777776 554
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.1e-19 Score=156.06 Aligned_cols=101 Identities=26% Similarity=0.277 Sum_probs=90.1
Q ss_pred CCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 018682 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 112 (352)
.+..+..|+||||+||..|+.++++.|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 52 ~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~ 131 (285)
T 3d9h_A 52 LMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFN 131 (285)
T ss_dssp TCSSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHH
T ss_pred ccCCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHH
Confidence 35677788888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhccCcHHHHHHHHHcCCCCC
Q 018682 113 AIYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 113 a~~~~~~~~~~~L~~~~~~~~ 133 (352)
|+..|+.+++++|++.++++.
T Consensus 132 A~~~~~~~~v~~Ll~~g~~~~ 152 (285)
T 3d9h_A 132 ACVSGSWDCVNLLLQHGASVQ 152 (285)
T ss_dssp HHHHTCHHHHHHHHHTTCCSS
T ss_pred HHHcCHHHHHHHHHHCCCCCC
Confidence 999999999999999888764
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=157.04 Aligned_cols=107 Identities=26% Similarity=0.219 Sum_probs=82.6
Q ss_pred CCCCCccCCchHHHHHH-----hcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 018682 32 DDDGEEIKPEFRLMFLA-----NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~-----~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 106 (352)
+.+..+..|.||||+|+ ..++.++++.|++.|++++..|..|+||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus 137 ~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G 216 (276)
T 4hbd_A 137 KVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDG 216 (276)
T ss_dssp CTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred cCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Confidence 44555555555555555 3455555555555555666666678899999999999999999999999999999999
Q ss_pred CChhHHhhccCcHHHHHHHHH-cCCCCCCCccc
Q 018682 107 STPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMH 138 (352)
Q Consensus 107 ~t~l~~a~~~~~~~~~~~L~~-~~~~~~~~~~~ 138 (352)
.||||+|+..|+.+++++|++ .|+++......
T Consensus 217 ~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~ 249 (276)
T 4hbd_A 217 STALMCACEHGHKEIAGLLLAVPSCDISLTDRD 249 (276)
T ss_dssp CCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTT
T ss_pred CCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCC
Confidence 999999999999999999999 78887554433
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-19 Score=156.06 Aligned_cols=68 Identities=37% Similarity=0.503 Sum_probs=38.5
Q ss_pred CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCC-CCCChhHHhhccCcHHHHHHHHHcCCCCC
Q 018682 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 66 ~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~-~g~t~l~~a~~~~~~~~~~~L~~~~~~~~ 133 (352)
+|.+|..|+||||+|+..|+.+++++|+++|++++.++. .|.||||+|+..|+.+++++|++.|+++.
T Consensus 151 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~ 219 (282)
T 1oy3_D 151 LEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPT 219 (282)
T ss_dssp TTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTT
T ss_pred CCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCc
Confidence 444455555555555555555555555555555555553 25566666655555555665555555543
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=160.05 Aligned_cols=102 Identities=25% Similarity=0.260 Sum_probs=90.8
Q ss_pred CCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 018682 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~ 111 (352)
+.+..|.+|+||||+||..|+.+++++|+++|+++|.+| |+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 23 ~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~ 100 (285)
T 3kea_A 23 DTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALY 100 (285)
T ss_dssp TTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred CCCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHH
Confidence 677888889999999999999999999999999998884 899999999999999999999999999999999999999
Q ss_pred HhhccCcHHHHHHHHHcCCCCCCC
Q 018682 112 DAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
+|+..|+.+++++|+++|+++...
T Consensus 101 ~A~~~g~~~~v~~Ll~~ga~~~~~ 124 (285)
T 3kea_A 101 YAVDSGNMQTVKLFVKKNWRLMFY 124 (285)
T ss_dssp HHHHTTCHHHHHHHHHHCGGGGGC
T ss_pred HHHHcCCHHHHHHHHhcCCCCCcc
Confidence 999999999999999998887543
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=158.89 Aligned_cols=127 Identities=20% Similarity=0.092 Sum_probs=105.5
Q ss_pred CCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018682 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (352)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~ 83 (352)
+..+.||+-.........--+----+|.|.+.. +|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 28 d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~--~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~ 105 (285)
T 3kea_A 28 DVHGHSASYYAIADNNVRLVCTLLNAGALKNLL--ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDS 105 (285)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCC--TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCC--CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Confidence 445666665554433332211122245555555 489999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCC-CChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 84 GFTEVVSLLLERGADVDPKDRWG-STPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 84 ~~~~~~~~Ll~~ga~~~~~~~~g-~t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
|+.+++++|+++|++++.+|..| .||||+|+..|+.+++++|++.+++.
T Consensus 106 g~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~~~~~v~~Ll~~g~~~ 155 (285)
T 3kea_A 106 GNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST 155 (285)
T ss_dssp TCHHHHHHHHHHCGGGGGCSSSGGGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred CCHHHHHHHHhcCCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence 99999999999999999999999 89999999999999999999998764
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=5.2e-19 Score=159.64 Aligned_cols=115 Identities=19% Similarity=0.155 Sum_probs=94.0
Q ss_pred cCCCCCC-CccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC----------------------
Q 018682 29 NGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---------------------- 85 (352)
Q Consensus 29 ~~~~~~~-~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~---------------------- 85 (352)
.|.|.|. .+.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+
T Consensus 119 ~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d 198 (327)
T 1sw6_A 119 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED 198 (327)
T ss_dssp SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred cCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCC
Confidence 5788888 89999999999999999999999999999999999999999999998654
Q ss_pred -------------------HHHHHHHHHCCC---------------------------------------------CCCC
Q 018682 86 -------------------TEVVSLLLERGA---------------------------------------------DVDP 101 (352)
Q Consensus 86 -------------------~~~~~~Ll~~ga---------------------------------------------~~~~ 101 (352)
.+++++|++.++ +++.
T Consensus 199 ~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n~ 278 (327)
T 1sw6_A 199 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA 278 (327)
T ss_dssp TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred CCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCCC
Confidence 344555554422 5778
Q ss_pred CCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCcccccccc
Q 018682 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (352)
Q Consensus 102 ~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~ 143 (352)
+|..|.||||+|+..|+.+++++|+++|+++........++.
T Consensus 279 ~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL 320 (327)
T 1sw6_A 279 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 320 (327)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHH
Confidence 888889999999999999999999999988765554444443
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=163.51 Aligned_cols=104 Identities=19% Similarity=0.190 Sum_probs=89.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCC-----CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID-----VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~-----~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (352)
+|.|.+..+..|+||||+||..|+.+++++|+++|++ +|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 162 ~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d 241 (364)
T 3ljn_A 162 LGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMED 241 (364)
T ss_dssp HTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCC
T ss_pred cCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence 5677777888888888888888888888888888888 88888888888888888888888888888888888888
Q ss_pred CCCCChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 104 ~~g~t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
..|.||||+|+..|+.+++++|+++++++
T Consensus 242 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~ 270 (364)
T 3ljn_A 242 NEHTVPLYLSVRAAMVLLTKELLQKTDVF 270 (364)
T ss_dssp TTSCCHHHHHHHTCCHHHHHHHHHHSCHH
T ss_pred CCCCCHHHHHHHhChHHHHHHHHHcCCch
Confidence 88888888888888888888888887664
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=159.79 Aligned_cols=101 Identities=27% Similarity=0.354 Sum_probs=75.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
+|.|.|.++..|+||||+||..|+.++++.|++. |+++|.+|.+|+||||+|+..|+.+++++|+++||++|.+
T Consensus 228 ~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~----- 302 (337)
T 4g8k_A 228 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG----- 302 (337)
T ss_dssp TTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC-----
T ss_pred CCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC-----
Confidence 5666777777777778888888888888777764 6777777777888888888888888888888778777654
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
+|||+|+..++.+++++|+++|+++..
T Consensus 303 ~~L~~A~~~~~~~iv~~Ll~~GA~~d~ 329 (337)
T 4g8k_A 303 DLVMTARRNYDHSLVKVLLSHGAKEDF 329 (337)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCC--
T ss_pred CHHHHHHHcCCHHHHHHHHHCcCCCCC
Confidence 477888777777788888887777643
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.9e-19 Score=155.32 Aligned_cols=105 Identities=25% Similarity=0.198 Sum_probs=98.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+ .|.|
T Consensus 81 ~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g~t 159 (285)
T 3d9h_A 81 QGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLAS 159 (285)
T ss_dssp TTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TTSC
T ss_pred CCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CCCC
Confidence 678888899999999999999999999999999999999999999999999999999999999999999998755 4999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
|||+|+..|+.+++++|++.++++..
T Consensus 160 ~L~~A~~~g~~~~v~~Ll~~g~~~~~ 185 (285)
T 3d9h_A 160 PIHEAARRGHVECVNSLIAYGGNIDH 185 (285)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence 99999999999999999999887643
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=148.48 Aligned_cols=104 Identities=35% Similarity=0.429 Sum_probs=69.4
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~ 107 (352)
+|.+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++| ++++..+..|.
T Consensus 33 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~ 112 (237)
T 3b7b_A 33 AGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGW 112 (237)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSC
T ss_pred cCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCC
Confidence 45555556666666666666666666666666666666666666666666666666666666666666 66666666666
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
||||+|+..++.+++++|++.++++
T Consensus 113 t~L~~A~~~~~~~~~~~Ll~~g~~~ 137 (237)
T 3b7b_A 113 TPMIWATEYKHVDLVKLLLSKGSDI 137 (237)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCT
T ss_pred CHHHHHHHcCCHHHHHHHHHCCCCC
Confidence 6666666666666666666666554
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=165.47 Aligned_cols=104 Identities=32% Similarity=0.320 Sum_probs=61.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..|..|.|
T Consensus 36 ~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t 115 (437)
T 1n11_A 36 RGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHT 115 (437)
T ss_dssp TTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhCCCCCCCCCCCCCc
Confidence 34555555555556666666666666666666666666666656666666666666666666666666666666666666
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
|||+|+..|+.++++.|++.+++.
T Consensus 116 ~L~~A~~~g~~~~v~~Ll~~~~~~ 139 (437)
T 1n11_A 116 PLHIAAREGHVETVLALLEKEASQ 139 (437)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCS
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCC
Confidence 666666666666666665555543
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-18 Score=151.84 Aligned_cols=106 Identities=28% Similarity=0.263 Sum_probs=98.3
Q ss_pred CCCCCCCccCCchHHHHHHhcCC----HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCC
Q 018682 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDR 104 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~ 104 (352)
+.+.+..+..|+||||+|+..++ .+++++|+++|+++|.+|..|+||||+|+..|+.+++++|++ .|++++.+|.
T Consensus 172 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~~~ 251 (285)
T 1wdy_A 172 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDS 251 (285)
T ss_dssp CCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCT
T ss_pred CCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCccccCC
Confidence 78888888899999999999999 899999999999999999999999999999999999999999 7999999999
Q ss_pred CCCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 105 ~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
.|.||||+|+..++.+++++|+++|+++...
T Consensus 252 ~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~ 282 (285)
T 1wdy_A 252 DGKTALLLAVELKLKKIAELLCKRGASTDCG 282 (285)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHSSCSCCS
T ss_pred CCCcHHHHHHHcCcHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999999987543
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=161.70 Aligned_cols=105 Identities=20% Similarity=0.161 Sum_probs=98.4
Q ss_pred CCCCCccCCchHHHHHHhcC--CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCC-----CCCCCC
Q 018682 32 DDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-----VDPKDR 104 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~-----~~~~~~ 104 (352)
+.+..+..|.||||+||..| +.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++ ++.+|.
T Consensus 130 ~~~~~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~ 209 (364)
T 3ljn_A 130 GSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANK 209 (364)
T ss_dssp TTEEEEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCT
T ss_pred ccccCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCC
Confidence 34447889999999999999 99999999999999999999999999999999999999999999999 999999
Q ss_pred CCCChhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 105 ~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
.|.||||+|+..|+.+++++|+++|+++....
T Consensus 210 ~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d 241 (364)
T 3ljn_A 210 QGNSHLHWAILINWEDVAMRFVEMGIDVNMED 241 (364)
T ss_dssp TCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999999875443
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-19 Score=154.94 Aligned_cols=98 Identities=23% Similarity=0.285 Sum_probs=92.7
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCC--------------CCCcHHHHHHHcCCHHHHHHHHH---CCCC
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI--------------DNRTALHVAACQGFTEVVSLLLE---RGAD 98 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~--------------~g~t~lh~A~~~~~~~~~~~Ll~---~ga~ 98 (352)
.+..|.||||+||..|+.+++++|+++|+++|.+|. .|+||||+|+..|+.+++++|++ +|++
T Consensus 97 ~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad 176 (273)
T 2pnn_A 97 SYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPAD 176 (273)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCC
T ss_pred ccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCC
Confidence 566899999999999999999999999999999997 79999999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHhhccCc---------HHHHHHHHHcCCCCC
Q 018682 99 VDPKDRWGSTPLGDAIYYKN---------HEVIKLLEKHGAKPL 133 (352)
Q Consensus 99 ~~~~~~~g~t~l~~a~~~~~---------~~~~~~L~~~~~~~~ 133 (352)
++.+|..|.||||+|+..++ .+++++|++.|+++.
T Consensus 177 ~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n 220 (273)
T 2pnn_A 177 ISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLH 220 (273)
T ss_dssp TTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred ceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcc
Confidence 99999999999999999887 789999999988764
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=154.37 Aligned_cols=102 Identities=25% Similarity=0.369 Sum_probs=95.6
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
..+..|.||||.||..|+.++++.|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 35 ~~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~ 114 (299)
T 1s70_B 35 KVKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAA 114 (299)
T ss_dssp CCEECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccccCCccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHH
Confidence 34557899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcHHHHHHHHHcCCCCCCCc
Q 018682 115 YYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 115 ~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
..|+.+++++|+++++++....
T Consensus 115 ~~g~~~~v~~Ll~~g~~~~~~~ 136 (299)
T 1s70_B 115 SCGYLDIAEYLISQGAHVGAVN 136 (299)
T ss_dssp HHTCHHHHHHHHHTTCCTTCCC
T ss_pred HcCCHHHHHHHHhCCCCCCCcC
Confidence 9999999999999998875443
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.1e-18 Score=146.37 Aligned_cols=132 Identities=19% Similarity=0.102 Sum_probs=94.9
Q ss_pred CCCCcccccccccccCCchhhh-hhh---hcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHH
Q 018682 3 TKVPVRTTLLKQSSLAPDRERK-EAE---LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH 78 (352)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~-~~~---i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh 78 (352)
++..+.|++-.........--+ -.+ -.+.+.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|+||||
T Consensus 5 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~ 84 (241)
T 1k1a_A 5 ADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAH 84 (241)
T ss_dssp --CTTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred cCCCCCcHHHHHHHcCCHHHHHHHHHHHHhcCCCCCcccccCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHH
Confidence 3445566665544443332211 011 145666777777888888888888888888888888888888888888888
Q ss_pred HHHHcCCHHHHHHHHHCCC----CCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 79 VAACQGFTEVVSLLLERGA----DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 79 ~A~~~~~~~~~~~Ll~~ga----~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
+|+..|+.+++++|+++|+ +++..|..|.||||+|+..++.+++++|++.++++..
T Consensus 85 ~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~ 144 (241)
T 1k1a_A 85 LACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDA 144 (241)
T ss_dssp HHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred HHHHcCCHHHHHHHHHcCCCccccccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCccc
Confidence 8888888888888888876 7777888888888888888888888888888777643
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-18 Score=150.26 Aligned_cols=106 Identities=26% Similarity=0.308 Sum_probs=99.0
Q ss_pred cCCCCCCC-ccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 29 NGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~-~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
++.+.+.. +..|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 27 ~g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 106 (285)
T 1wdy_A 27 GGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGF 106 (285)
T ss_dssp TTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTCC
T ss_pred cCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCcccC
Confidence 45666666 67899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
||||+|+..++.+++++|++.++++..
T Consensus 107 t~L~~A~~~~~~~~~~~Ll~~g~~~~~ 133 (285)
T 1wdy_A 107 TAFMEAAVYGKVKALKFLYKRGANVNL 133 (285)
T ss_dssp BHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred CHHHHHHHhCCHHHHHHHHHhCCCccc
Confidence 999999999999999999999988643
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=158.79 Aligned_cols=97 Identities=24% Similarity=0.317 Sum_probs=91.6
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g-a~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
..+..|.||||+||..|+.+++++|+++| +++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|||++|
T Consensus 274 ~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~~A 353 (373)
T 2fo1_E 274 SEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA 353 (373)
T ss_dssp SSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHH
T ss_pred cccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHHHH
Confidence 36678999999999999999999999876 99999999999999999999999999999999999999999999999999
Q ss_pred hccCcHHHHHHHHHcCCC
Q 018682 114 IYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~ 131 (352)
+..|+.+++++|++++++
T Consensus 354 ~~~g~~~iv~~Ll~~~a~ 371 (373)
T 2fo1_E 354 QANNHHNIVDIFDRCRPE 371 (373)
T ss_dssp HHTTCHHHHHHHHTTC--
T ss_pred HHcCCHHHHHHHHhcCcc
Confidence 999999999999998765
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.2e-18 Score=152.49 Aligned_cols=112 Identities=25% Similarity=0.289 Sum_probs=100.5
Q ss_pred CCCCccCCchHHHHHHhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 33 DDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
....+..|.||||+|+.. ++.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 204 ~~~~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t~ 283 (351)
T 3utm_A 204 NFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTA 283 (351)
T ss_dssp TCCCTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cccCCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 334567899999999998 66899999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCccccccccc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 144 (352)
||+|+..|+.+++++|+++|+++........++..
T Consensus 284 L~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~tal~ 318 (351)
T 3utm_A 284 LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQ 318 (351)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred HHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCChhh
Confidence 99999999999999999999998666555544433
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-17 Score=142.16 Aligned_cols=130 Identities=21% Similarity=0.164 Sum_probs=108.0
Q ss_pred CcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHcC
Q 018682 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQG 84 (352)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~-~g~t~lh~A~~~~ 84 (352)
.+.|++..........--+..--+|.|.+..+..|.||||+|+..|+.+++++|+++|++++..+. .|+||||+|+..|
T Consensus 8 ~~~~~l~~A~~~g~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~ 87 (240)
T 3eu9_A 8 YSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQG 87 (240)
T ss_dssp GGGCCHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHT
T ss_pred ccchHHHHHHHcCChHHHHHHHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcC
Confidence 344555444444433332223336788888888999999999999999999999999999987664 4999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCC
Q 018682 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (352)
Q Consensus 85 ~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~ 135 (352)
+.+++++|+++|++++.+|..|.||||+|+..++.+++++|++.++++...
T Consensus 88 ~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~ 138 (240)
T 3eu9_A 88 HLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMM 138 (240)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCcccc
Confidence 999999999999999999999999999999999999999999998886443
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=8.4e-18 Score=154.51 Aligned_cols=106 Identities=25% Similarity=0.263 Sum_probs=101.0
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC---CCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG---ADVDPKDRW 105 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~g---a~~~~~~~~ 105 (352)
+|.|.|..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++| ++++..|..
T Consensus 155 ~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~ 234 (373)
T 2fo1_E 155 AGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRN 234 (373)
T ss_dssp TCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTT
T ss_pred cCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHhcCccccChhhcCCC
Confidence 67888889999999999999999999999999999999999999999999999999999999999998 899999999
Q ss_pred CCChhHHhhccC---cHHHHHHHHHcCCCCCC
Q 018682 106 GSTPLGDAIYYK---NHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 106 g~t~l~~a~~~~---~~~~~~~L~~~~~~~~~ 134 (352)
|.||||+|+..+ +.+++++|++.++++..
T Consensus 235 g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~ 266 (373)
T 2fo1_E 235 GMTALMIVAHNEGRDQVASAKLLVEKGAKVDY 266 (373)
T ss_dssp SCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSC
T ss_pred CCCHHHHHHHhCCcchHHHHHHHHHCCCCccc
Confidence 999999999988 89999999999988754
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=151.23 Aligned_cols=105 Identities=25% Similarity=0.272 Sum_probs=95.3
Q ss_pred CCccCCchHHHHHHhc-CCHHHHHHHHHcCCCCCCCC--CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 018682 35 GEEIKPEFRLMFLANE-RDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~-~~~~~~~~Ll~~ga~~n~~d--~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~ 111 (352)
.....+.|+||.|+.. ++.++++.|+++|+|+|..| ..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||
T Consensus 194 l~~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh 273 (368)
T 3jue_A 194 LGSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLH 273 (368)
T ss_dssp ---CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred cccCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHH
Confidence 3445678999999999 99999999999999999998 88999999999999999999999999999999999999999
Q ss_pred HhhccCcHHHHHHHHHcCCCCCCCcccc
Q 018682 112 DAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (352)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~~~~~~~~~~~ 139 (352)
+|+..|+.+++++|+++|+++.......
T Consensus 274 ~A~~~g~~~~v~~LL~~Gad~~~~d~~G 301 (368)
T 3jue_A 274 HATILGHTGLACLFLKRGADLGARDSEG 301 (368)
T ss_dssp HHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HHHHcCcHHHHHHHHHCcCCCCCcCCCC
Confidence 9999999999999999999875544333
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-17 Score=149.45 Aligned_cols=105 Identities=29% Similarity=0.263 Sum_probs=89.2
Q ss_pred cCCCCCCCccCCchHHHHHHhcCC----HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKD 103 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~-ga~~~~~~ 103 (352)
.|.|.+..+..|.|+||.++..+. .+++++|+++|+|+|.+|.+|+||||+|+..|+.++++.|+.. |++++.+|
T Consensus 191 ~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d 270 (337)
T 4g8k_A 191 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 270 (337)
T ss_dssp SCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBC
T ss_pred cCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcC
Confidence 367777777788888887666443 3577888888889999999999999999999999999999985 89999999
Q ss_pred CCCCChhHHhhccCcHHHHHHHHHcCCCCC
Q 018682 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 104 ~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~ 133 (352)
..|.||||+|+..|+.+++++|+++|+++.
T Consensus 271 ~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n 300 (337)
T 4g8k_A 271 SDGKTALLLAVELKLKKIAELLCKRGASTD 300 (337)
T ss_dssp TTSCBHHHHHHHTTCHHHHHHHHTTSCSST
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence 999999999999999999999999998874
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-17 Score=120.35 Aligned_cols=70 Identities=41% Similarity=0.546 Sum_probs=67.3
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~ 98 (352)
+|.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++||+
T Consensus 24 ~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 24 AGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY 93 (93)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred cCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 6788888899999999999999999999999999999999999999999999999999999999999985
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.9e-17 Score=139.89 Aligned_cols=103 Identities=26% Similarity=0.221 Sum_probs=56.8
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC-HHHHHHHHHCCCCCCCCCC-CCC
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WGS 107 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~-~~~~~~Ll~~ga~~~~~~~-~g~ 107 (352)
|.+.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++ .+++++|++.|++++..+. .|.
T Consensus 99 g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g~ 178 (240)
T 3eu9_A 99 GADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKN 178 (240)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTCC
T ss_pred CCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCCC
Confidence 44444455555555555555555555555555555555555555555555554443 4555555555555555554 555
Q ss_pred ChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
||||+|+..++.+++++|+++|+++
T Consensus 179 t~L~~A~~~~~~~~v~~Ll~~g~~~ 203 (240)
T 3eu9_A 179 TALHWAVLAGNTTVISLLLEAGANV 203 (240)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHTCCT
T ss_pred cHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 5555555555555666665555554
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.2e-18 Score=128.75 Aligned_cols=108 Identities=29% Similarity=0.283 Sum_probs=88.0
Q ss_pred CCCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 018682 3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (352)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~ 82 (352)
++..++|++-.........--...--++.+.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus 5 ~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~ 84 (115)
T 2l6b_A 5 GSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKK 84 (115)
T ss_dssp CSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHT
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence 34556666655544333333222333677888888999999999999999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 018682 83 QGFTEVVSLLLERGADVDPKDRWGSTPL 110 (352)
Q Consensus 83 ~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 110 (352)
.|+.+++++|+++|+++|.++..|.+|-
T Consensus 85 ~~~~~~~~~Ll~~ga~~n~~~~~~~~~~ 112 (115)
T 2l6b_A 85 NGHHEIVKLLDAKGADVNARSWGSSHHH 112 (115)
T ss_dssp TTCHHHHHHHHTTSSSHHHHSCCCC---
T ss_pred CCCHHHHHHHHHcCCCCCcCCccccccc
Confidence 9999999999999999999999999874
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.9e-16 Score=141.00 Aligned_cols=100 Identities=24% Similarity=0.257 Sum_probs=92.3
Q ss_pred CCchHHHHHHhcCCHHHHHHHHHcCCCCCC------CCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 39 KPEFRLMFLANERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~------~d~~g~t~lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
.+.++||.|+..|+.+.++.|++.|+|+|. .|..|+||||+|+.. |+.+++++|+++|+++|.+|..|.||
T Consensus 150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp 229 (301)
T 2b0o_E 150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA 229 (301)
T ss_dssp -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 356789999999999999999999999998 689999999999997 89999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCccc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~~~ 138 (352)
||+|+..|+.+++++|+++|+++......
T Consensus 230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~ 258 (301)
T 2b0o_E 230 LHYAALYNQPDCLKLLLKGRALVGTVNEA 258 (301)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCCSCCCTT
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 99999999999999999999997554433
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.9e-16 Score=150.90 Aligned_cols=100 Identities=25% Similarity=0.261 Sum_probs=92.4
Q ss_pred CchHHHHHHhcCCHHHHHHHHHcCCCCCCC------CCCCCcHHHHHHH---cCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 018682 40 PEFRLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAAC---QGFTEVVSLLLERGADVDPKDRWGSTPL 110 (352)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~------d~~g~t~lh~A~~---~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 110 (352)
..+.||.|+..|+.+.++.|+++|+|+|.+ |..|+||||+|+. .|+.+++++|+++|+++|.+|..|.|||
T Consensus 132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL 211 (497)
T 3lvq_E 132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL 211 (497)
T ss_dssp CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence 347899999999999999999999999988 8899999999976 9999999999999999999999999999
Q ss_pred HHhhccCcHHHHHHHHHcCCCCCCCcccc
Q 018682 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (352)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~~~~~~~~~~~ 139 (352)
|+|+..|+.+++++|+++|+++......+
T Consensus 212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g 240 (497)
T 3lvq_E 212 HYAALYNQPDCLKLLLKGRALVGTVNEAG 240 (497)
T ss_dssp HHHTTTTCHHHHHHHHHTCCCCSCCCTTC
T ss_pred HHHHHcCCHHHHHHHHHcCCCCCCcCCCC
Confidence 99999999999999999999986554433
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.66 E-value=4.6e-16 Score=136.93 Aligned_cols=102 Identities=25% Similarity=0.273 Sum_probs=92.2
Q ss_pred CCchHHHHHHhcCCHHHHHHHHHcCCCCC------CCCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 39 KPEFRLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n------~~d~~g~t~lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
...++|+.|+..|+.+.++.+++.|++++ ..|..|+||||+|+.. |+.+++++|+++|+++|.+|..|.||
T Consensus 129 ~~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~Tp 208 (278)
T 1dcq_A 129 AKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTA 208 (278)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCH
T ss_pred hhhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCH
Confidence 45678999999999999999999999954 4588999999999999 89999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCCCCCccccc
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~ 140 (352)
||+|+..|+.+++++|+++|+++......+.
T Consensus 209 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~ 239 (278)
T 1dcq_A 209 LHYCCLTDNAECLKLLLRGKASIEIANESGE 239 (278)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCccCCCC
Confidence 9999999999999999999999865544333
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=9.7e-17 Score=145.79 Aligned_cols=136 Identities=17% Similarity=0.112 Sum_probs=97.3
Q ss_pred ccCceeecccEEEEEEE----cCeEEEEEEcCcccCC--------------C-HHH----HHHHHHHHHHHhcCCCCcee
Q 018682 157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS--------------D-DDR----VRAFRDELALLQKIRHPNVV 213 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~--------------~-~~~----~~~~~~E~~~l~~l~h~~iv 213 (352)
|.+...||.|+++.||. +|+.||||+++..... . ... .-....|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78889999999999984 5889999987643211 0 000 11124577778877555443
Q ss_pred eeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC--
Q 018682 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-- 291 (352)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-- 291 (352)
...-+.. ...++||||++|.+|.++. .......++.|++.+|.+||+.| ||||||||.|||++.++.
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcc
Confidence 2221111 2348999999998886542 22234567899999999999999 999999999999997763
Q ss_pred --------EEEEccCCcccc
Q 018682 292 --------LKVADFGVSKLL 303 (352)
Q Consensus 292 --------vkL~Dfg~a~~~ 303 (352)
+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 899999977554
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=144.00 Aligned_cols=87 Identities=23% Similarity=0.122 Sum_probs=77.7
Q ss_pred CCCCCCccCCchHHHHHHh----cCCHHHHHHHHHcCC------------------------------------------
Q 018682 31 LDDDGEEIKPEFRLMFLAN----ERDVEGIKELLDSGI------------------------------------------ 64 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~----~~~~~~~~~Ll~~ga------------------------------------------ 64 (352)
.+.+..+..|+||||+||. .|+.+++++|++.++
T Consensus 192 ~~~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~L 271 (327)
T 1sw6_A 192 PCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWI 271 (327)
T ss_dssp GGGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHH
T ss_pred ccccCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHH
Confidence 3456777789999999999 899999999998743
Q ss_pred ---CCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccC
Q 018682 65 ---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (352)
Q Consensus 65 ---~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~ 117 (352)
++|.+|.+|+||||+|+..|+.+++++|+++||+++.+|..|.||||+|+..|
T Consensus 272 l~~~~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~g 327 (327)
T 1sw6_A 272 IANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAGLE 327 (327)
T ss_dssp HHHTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC--
T ss_pred HHhCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcC
Confidence 68889999999999999999999999999999999999999999999998764
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=1.5e-16 Score=145.59 Aligned_cols=90 Identities=16% Similarity=0.070 Sum_probs=51.0
Q ss_pred CCchHHHHHHhcCCHHHHHHHHHcCCCC---CCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCC--CCCCCCChhHHh
Q 018682 39 KPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP--KDRWGSTPLGDA 113 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~ga~~---n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~--~~~~g~t~l~~a 113 (352)
.|.||||+||..|+.+++++|+++|+|+ +..+.+ +||||+||..|+.+++++|+++|++++. .|..|.||||+|
T Consensus 127 ~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~A 205 (376)
T 2aja_A 127 ENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWA 205 (376)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHH
Confidence 4555666666666666666666666541 111112 5666666666666666666666665554 555556666666
Q ss_pred h-ccCcHHHHHHHHHcC
Q 018682 114 I-YYKNHEVIKLLEKHG 129 (352)
Q Consensus 114 ~-~~~~~~~~~~L~~~~ 129 (352)
+ ..|+.+++++|++.+
T Consensus 206 a~~~G~~eiv~~Ll~~g 222 (376)
T 2aja_A 206 AVGRGHHNVINFLLDCP 222 (376)
T ss_dssp HSTTCCHHHHHHHTTSH
T ss_pred HHHCCCHHHHHHHHhCC
Confidence 6 666666666665543
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4.3e-14 Score=106.12 Aligned_cols=64 Identities=27% Similarity=0.368 Sum_probs=61.3
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHH
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLL 92 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~L 92 (352)
++.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|
T Consensus 46 ~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L 109 (110)
T 2zgd_A 46 NGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNEDLAEIL 109 (110)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHH
T ss_pred cCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHHHcCCHHHHHHh
Confidence 6778888889999999999999999999999999999999999999999999999999999987
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=2.8e-15 Score=137.17 Aligned_cols=96 Identities=17% Similarity=0.027 Sum_probs=78.7
Q ss_pred ccCCchHHHHHHhcCCHHHHHHHHHcCCCC---CCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCC---CCCCCCCCChh
Q 018682 37 EIKPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPL 110 (352)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~---n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~---~~~~~~g~t~l 110 (352)
+.+++||||+||..|+.+++++|+++|+.. +..|..|+||||+||..|+.+++++|+++|+++ +..+.. .|||
T Consensus 89 g~~~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpL 167 (376)
T 2aja_A 89 GIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAF 167 (376)
T ss_dssp TCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHH
T ss_pred CCCcCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHH
Confidence 345679999999999999999999999832 234557899999999999999999999999862 222223 8999
Q ss_pred HHhhccCcHHHHHHHHHcCCCCC
Q 018682 111 GDAIYYKNHEVIKLLEKHGAKPL 133 (352)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~~~~~ 133 (352)
|+|+..|+.+++++|+++|+++.
T Consensus 168 h~Aa~~G~~eiv~~Ll~~ga~~~ 190 (376)
T 2aja_A 168 RLAAENGHLHVLNRLCELAPTEA 190 (376)
T ss_dssp HHHHHTTCHHHHHHHHHSCGGGH
T ss_pred HHHHHCCCHHHHHHHHHcCCccc
Confidence 99999999999999999998853
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=5e-12 Score=109.97 Aligned_cols=138 Identities=12% Similarity=0.024 Sum_probs=101.2
Q ss_pred ccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEecc
Q 018682 157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
|+....++.|+...|| ..+..+++|......... ...+.+|+.+++.+. +..++++++++...+..|++||++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 5455555555544444 457899999987532111 134788999999884 677889999999888999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 018682 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------------------------------------------ 270 (352)
Q Consensus 233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------ 270 (352)
+|.+|.+.+. +......++.++..+|..||+..
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999987531 22233467889999999999811
Q ss_pred --------------CCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 271 --------------PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 271 --------------~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
+..++|+|++|.||+++.+..+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 12389999999999998755567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.2e-10 Score=104.37 Aligned_cols=140 Identities=14% Similarity=0.197 Sum_probs=99.2
Q ss_pred ceeecccEEEEEE---EcCeEEEEEEcC--cccCCCHHHHHHHHHHHHHHhcCC--CCceeeeeEEEEeC---CceEEEE
Q 018682 160 SVEITKGTFILAF---WRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS---SPMMIVT 229 (352)
Q Consensus 160 ~~~ig~G~~~~v~---~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~ 229 (352)
.+.++.|.+..+| ..+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3466777655444 456789999876 32211 12346788999999986 45578888888766 4489999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK--------------------------------------- 270 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------- 270 (352)
||++|..+.+. ....++..+...++.++...|..||+..
T Consensus 121 e~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99998777431 1123678888889999999999999731
Q ss_pred ----------------CCCceecCCCCCCeEeCCCCC--EEEEccCCcccc
Q 018682 271 ----------------PVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLL 303 (352)
Q Consensus 271 ----------------~~~ivH~Dikp~Nill~~~~~--vkL~Dfg~a~~~ 303 (352)
+..++|+|++|.||+++.++. +.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 134999999999999997753 689999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=3.9e-10 Score=97.60 Aligned_cols=115 Identities=21% Similarity=0.184 Sum_probs=84.1
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc--eeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHH
Q 018682 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252 (352)
Q Consensus 175 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 252 (352)
|..+++|...... ...+..|+.+++.+.+.+ +++++++...++..+++|||++|.+|. . ...+.
T Consensus 44 g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~~--- 109 (264)
T 1nd4_A 44 RPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLAP--- 109 (264)
T ss_dssp SCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T---SCCCH---
T ss_pred CCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c---CcCCH---
Confidence 5679999976541 134678999998885433 567888888878899999999998884 1 11222
Q ss_pred HHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCceec
Q 018682 253 VRFALDIARGMNYLHENK-------------------------------------------------------PVPIIHR 277 (352)
Q Consensus 253 ~~i~~qi~~~l~~LH~~~-------------------------------------------------------~~~ivH~ 277 (352)
..++.++...|..||+.. +..++|+
T Consensus 110 ~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Hg 189 (264)
T 1nd4_A 110 AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHG 189 (264)
T ss_dssp HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECS
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECC
Confidence 245677777788888643 1129999
Q ss_pred CCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 278 DLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 278 Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
|++|.||+++.++.+.|+||+.+...
T Consensus 190 Dl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 190 DACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp SCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CCCCCcEEEECCcEEEEEcchhcccC
Confidence 99999999987655679999987653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=5.1e-10 Score=99.44 Aligned_cols=182 Identities=18% Similarity=0.140 Sum_probs=119.2
Q ss_pred eeecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCc--eeeeeEEEEeCC---ceEEEEeccCC
Q 018682 161 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN--VVQFLGAVTQSS---PMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~~ 234 (352)
+.++.|....+|.-+..+++|+... ......+.+|..+++.+ .+.. +++++....... .-|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 3588888888887778899998653 23456788999999887 3333 445554443333 34889999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 018682 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-------------------------------------------- 270 (352)
Q Consensus 235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------------- 270 (352)
.++..... ..++..+...++.++...+..||+..
T Consensus 101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 88865433 23678888888889999888888621
Q ss_pred -----------CCCceecCCCCCCeEeCC--CCCEEEEccCCcccccccCCCCcccCCCCCccccccccC----C-CCC-
Q 018682 271 -----------PVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK----N-EEY- 331 (352)
Q Consensus 271 -----------~~~ivH~Dikp~Nill~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~- 331 (352)
+..++|+|++|.||+++. ...+.|+||+.+.......+....... . .-..|+... . +..
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~-~-~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED-D-EEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT-T-TSCCHHHHHHHHHHHTCSC
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh-c-cccCHHHHHHHHHHcCCCC
Confidence 124799999999999998 455789999987653221110000000 0 001222111 0 011
Q ss_pred --------CCchhHHHHHHHHHHhhccC
Q 018682 332 --------DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 332 --------~~~~DiwslG~il~elltG~ 351 (352)
....+.|+++.++|.+.+|.
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~ 284 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGY 284 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 11268999999999999985
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=3e-07 Score=81.55 Aligned_cols=136 Identities=19% Similarity=0.162 Sum_probs=94.2
Q ss_pred eeecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC---ceeeeeEEEE-eCCceEEEEeccCCCC
Q 018682 161 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVT-QSSPMMIVTEYLPKGD 236 (352)
Q Consensus 161 ~~ig~G~~~~v~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~~ 236 (352)
+.++.|....+|.-|..+++|+.. .......+..|..+|+.+.+. .+++.+.+.. ..+..+++||+++|.+
T Consensus 25 ~~l~~G~~n~v~~vg~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILVNGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEETTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEECCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 456777776777668889999853 234456788999999998642 3667776664 3456789999999988
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 018682 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENK---------------------------------------------- 270 (352)
Q Consensus 237 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------------- 270 (352)
+....- ..++..+...++.++...|..||+..
T Consensus 100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 866321 12445555555555555555555432
Q ss_pred -----------CCCceecCCCCCCeEeCC---CCCE-EEEccCCcccc
Q 018682 271 -----------PVPIIHRDLEPSNILRDD---SGNL-KVADFGVSKLL 303 (352)
Q Consensus 271 -----------~~~ivH~Dikp~Nill~~---~~~v-kL~Dfg~a~~~ 303 (352)
+..++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 223699999999999997 4554 79999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.4e-06 Score=75.54 Aligned_cols=119 Identities=14% Similarity=0.156 Sum_probs=87.1
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHH
Q 018682 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253 (352)
Q Consensus 175 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 253 (352)
+..+++|+.... ....+..|...|+.+. +--+++++.++.+.+..|+|||+++|.++.+..... .....
T Consensus 50 ~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~ 119 (272)
T 4gkh_A 50 APELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGE 119 (272)
T ss_dssp CCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHH
T ss_pred CeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHH
Confidence 567999976432 3456788999998874 334778899999889999999999998887765432 22233
Q ss_pred HHHHHHHHHHHHHHhCC-------------------------------------------------------CCCceecC
Q 018682 254 RFALDIARGMNYLHENK-------------------------------------------------------PVPIIHRD 278 (352)
Q Consensus 254 ~i~~qi~~~l~~LH~~~-------------------------------------------------------~~~ivH~D 278 (352)
.+..++...|..||+.. +..++|+|
T Consensus 120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD 199 (272)
T 4gkh_A 120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD 199 (272)
T ss_dssp HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence 45566666677777431 12378999
Q ss_pred CCCCCeEeCCCCCEEEEccCCcccc
Q 018682 279 LEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 279 ikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
+.+.||+++.++.+-|+||+.+...
T Consensus 200 l~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 200 FSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCCeEEEECCeEEEEEECcccccC
Confidence 9999999998766779999987653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=3.2e-06 Score=76.49 Aligned_cols=75 Identities=7% Similarity=0.034 Sum_probs=48.0
Q ss_pred ceee-cccEEEEEE---Ec--------CeEEEEEEcCccc---CCCHHHHHHHHHHHHHHhcCC-C--CceeeeeEEEEe
Q 018682 160 SVEI-TKGTFILAF---WR--------GIQVAVKKLGEEV---ISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQ 221 (352)
Q Consensus 160 ~~~i-g~G~~~~v~---~~--------~~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~ 221 (352)
.+.| +.|....+| .. +..+++|+..... ... ...+.+|+.+++.+. + -.+++++.+..+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456 666555444 22 6789999876532 101 124677888888774 2 357778877765
Q ss_pred C---CceEEEEeccCCCCH
Q 018682 222 S---SPMMIVTEYLPKGDL 237 (352)
Q Consensus 222 ~---~~~~lv~e~~~~~~L 237 (352)
. +..|++||+++|.++
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 4 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00016 Score=64.55 Aligned_cols=30 Identities=20% Similarity=0.347 Sum_probs=26.9
Q ss_pred CceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 273 ~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 499999999999998788899999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=2.8e-05 Score=71.34 Aligned_cols=73 Identities=18% Similarity=0.135 Sum_probs=43.2
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccC-CCH---HHHHHHHHHHHHHhcCCC--C-ceeeeeEEEEeCCceEEE
Q 018682 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVI-SDD---DRVRAFRDELALLQKIRH--P-NVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 161 ~~ig~G~~~~v~~-----~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~iv~~~~~~~~~~~~~lv 228 (352)
+.+|.|..+.+|. .++.+++|....... ..+ .....+..|..+++.+.. | .+++++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 4678887776652 357899997653211 000 012345678888887732 3 44566643 34556899
Q ss_pred EeccCCC
Q 018682 229 TEYLPKG 235 (352)
Q Consensus 229 ~e~~~~~ 235 (352)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=2.3e-05 Score=72.63 Aligned_cols=77 Identities=14% Similarity=0.046 Sum_probs=45.7
Q ss_pred CceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcccCCCCCccccccccCCCCC---CCchhHHHHHHHHHHhhc
Q 018682 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY---DTKVDVFSFALILQEVKF 349 (352)
Q Consensus 273 ~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~ellt 349 (352)
.++|+|++|.|||++.++ +.++||+.+......-+.......-...|++|+......- ....++.++...+|+.++
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 499999999999998776 9999999886543211111100000123566665532111 123455577777777765
Q ss_pred c
Q 018682 350 Y 350 (352)
Q Consensus 350 G 350 (352)
+
T Consensus 312 ~ 312 (420)
T 2pyw_A 312 K 312 (420)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00025 Score=62.70 Aligned_cols=72 Identities=19% Similarity=0.105 Sum_probs=52.6
Q ss_pred ceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCceeeeeEEEEeCCceEEEEeccC
Q 018682 160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 160 ~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
.+.|+.|....+| .++..+++|+.... ....+..|...|+.+. ...+++++.+....+..+++||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567777554333 35678999987532 1356788999888873 3568889988887888999999998
Q ss_pred CCCH
Q 018682 234 KGDL 237 (352)
Q Consensus 234 ~~~L 237 (352)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0014 Score=58.44 Aligned_cols=32 Identities=31% Similarity=0.444 Sum_probs=27.2
Q ss_pred CCceecCCCCCCeEeCCC----CCEEEEccCCcccc
Q 018682 272 VPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 303 (352)
Q Consensus 272 ~~ivH~Dikp~Nill~~~----~~vkL~Dfg~a~~~ 303 (352)
..++|+|+++.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 359999999999999874 67999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=57.44 Aligned_cols=71 Identities=15% Similarity=0.156 Sum_probs=40.7
Q ss_pred ceeecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCce-eeeeEEEEeCCceEEEEecc-CCCCH
Q 018682 160 SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYL-PKGDL 237 (352)
Q Consensus 160 ~~~ig~G~~~~v~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~~L 237 (352)
.+.|+.|....+|.- ..+++|+....... .-...+|+.+++.+...++ ++++..+ ...-++++||+ +|.++
T Consensus 23 i~~l~gG~tN~~~~~-~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 567777766555544 67899988643111 0112457777777642222 5666543 33357899999 66444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0052 Score=53.43 Aligned_cols=73 Identities=18% Similarity=0.111 Sum_probs=47.5
Q ss_pred ccCceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-C--CceeeeeEEEEeCCceEEEE
Q 018682 157 FTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv~ 229 (352)
....+.+|.|..+.+| .+|+.|++|+........ ...+..|+..|+.+. . -.+++++.+. .-+++|
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 3445678877766665 368999999876443222 235778999998874 2 2355555542 237899
Q ss_pred eccCCCC
Q 018682 230 EYLPKGD 236 (352)
Q Consensus 230 e~~~~~~ 236 (352)
|+++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0081 Score=53.13 Aligned_cols=29 Identities=21% Similarity=0.174 Sum_probs=24.8
Q ss_pred CceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 273 ~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++|+|+++.||+++ + .+.++||+.+...
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 488999999999999 4 8999999876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.003 Score=57.28 Aligned_cols=120 Identities=21% Similarity=0.279 Sum_probs=71.2
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccCCCCHH--------------H
Q 018682 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLR--------------A 239 (352)
Q Consensus 175 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~--------------~ 239 (352)
+..+++|+..... .. ...+.+|..+++.+. +.-.+++++.+.+ .+||||++|.+|. +
T Consensus 82 ~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~ 153 (379)
T 3feg_A 82 PREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT 153 (379)
T ss_dssp CSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred CCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence 4689999874321 11 234567999988874 3334667766543 3999999875442 1
Q ss_pred HHH---hc-----CCCC--HHHHHHHHHHHHH-------------------HHHHH----HhC-CCCCceecCCCCCCeE
Q 018682 240 FLK---RK-----GALK--PSTAVRFALDIAR-------------------GMNYL----HEN-KPVPIIHRDLEPSNIL 285 (352)
Q Consensus 240 ~l~---~~-----~~~~--~~~~~~i~~qi~~-------------------~l~~L----H~~-~~~~ivH~Dikp~Nil 285 (352)
.+. .- .... ..++.++..++-. .+..| ... .+..++|+|+.+.||+
T Consensus 154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil 233 (379)
T 3feg_A 154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL 233 (379)
T ss_dssp HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence 111 11 0111 2344445544321 12332 221 2345899999999999
Q ss_pred eCCC----CCEEEEccCCccc
Q 018682 286 RDDS----GNLKVADFGVSKL 302 (352)
Q Consensus 286 l~~~----~~vkL~Dfg~a~~ 302 (352)
++.+ +.+.++||..+..
T Consensus 234 ~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 234 LLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EESCC---CCEEECCCTTCEE
T ss_pred EcCCCCccCcEEEEecccCCc
Confidence 9876 6899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.01 Score=52.29 Aligned_cols=30 Identities=23% Similarity=0.173 Sum_probs=25.5
Q ss_pred CceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 273 ~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
.++|+|+++.||+++.+..+.++||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 489999999999998765567999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.34 E-value=0.019 Score=47.26 Aligned_cols=99 Identities=14% Similarity=0.107 Sum_probs=64.2
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcc
Q 018682 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (352)
Q Consensus 235 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~ 312 (352)
.+|.++++. ..++++++++.++.|.+.+|..+-. ..+ ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc-----------
Confidence 479999875 4579999999999999999887622 221 1222457899999999987653 1110
Q ss_pred cCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+.|||... ...+.+.=|||||+++|.-+-.+
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1123467888764 34456789999999999876543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0042 Score=57.42 Aligned_cols=53 Identities=11% Similarity=0.118 Sum_probs=33.4
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccCCCC
Q 018682 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (352)
Q Consensus 175 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 236 (352)
+..+++|+.... .. ...+..|..+++.+. +.-.+++++.+.. .+++||++|.+
T Consensus 105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 468999988532 11 124456888888874 3233667765532 38999997643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.026 Score=52.47 Aligned_cols=69 Identities=12% Similarity=0.046 Sum_probs=39.4
Q ss_pred eeecccEEEEEE---EcC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCce-eeeeEEEEeCCceEEEEeccCC
Q 018682 161 VEITKGTFILAF---WRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYLPK 234 (352)
Q Consensus 161 ~~ig~G~~~~v~---~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 234 (352)
+.|+.|-.-.+| ..+ ..+++|+.......- . ...+|..+++.+...++ +++++.+. + .+|+||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---I-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---S-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---c-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 456656443333 444 789999875432110 0 11468888888864434 56777663 2 359999987
Q ss_pred CCH
Q 018682 235 GDL 237 (352)
Q Consensus 235 ~~L 237 (352)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.41 E-value=0.51 Score=38.84 Aligned_cols=83 Identities=11% Similarity=0.038 Sum_probs=59.2
Q ss_pred CCCceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceecCCCCCCeEe
Q 018682 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN-YLHENKPVPIIHRDLEPSNILR 286 (352)
Q Consensus 208 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~Dikp~Nill 286 (352)
.||++ -...-.+++.+.+.++.-+++.=...++ ..+..+.++++.+|+.... ++++ -+|--++|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEE
Confidence 47877 3344466677777777553332233333 3688999999999887766 4443 5788999999999
Q ss_pred CCCCCEEEEccCCc
Q 018682 287 DDSGNLKVADFGVS 300 (352)
Q Consensus 287 ~~~~~vkL~Dfg~a 300 (352)
+.++.+++.-.|+-
T Consensus 118 ~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 118 NRALEPFFLHVGVK 131 (219)
T ss_dssp CTTCCEEESCCEET
T ss_pred eCCCcEEEEEcCCc
Confidence 99999999888754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.89 E-value=0.19 Score=44.56 Aligned_cols=32 Identities=19% Similarity=0.376 Sum_probs=27.7
Q ss_pred CCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 272 ~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35999999999999998788999999877653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.80 E-value=0.11 Score=46.58 Aligned_cols=30 Identities=30% Similarity=0.557 Sum_probs=24.5
Q ss_pred CCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 272 ~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
..++|+|+++.|||++.+. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3489999999999998654 89999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.18 E-value=0.43 Score=39.11 Aligned_cols=83 Identities=12% Similarity=0.141 Sum_probs=59.5
Q ss_pred CCCceeeeeEEEEeCCceEEEEeccC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEe
Q 018682 208 RHPNVVQFLGAVTQSSPMMIVTEYLP-KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (352)
Q Consensus 208 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill 286 (352)
.||+++.. ..-.+++.+.+.++.-+ +-++.. ++ ..+....++++.+|+....++++ =+|--++|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 47888865 45556666666666543 223332 22 36889999999999888755543 3788999999999
Q ss_pred CCCCCEEEEccCCc
Q 018682 287 DDSGNLKVADFGVS 300 (352)
Q Consensus 287 ~~~~~vkL~Dfg~a 300 (352)
+.++.+++.-.|+.
T Consensus 113 ~~~~~p~i~~RGik 126 (215)
T 4ann_A 113 TRDGLPIAKTRGLQ 126 (215)
T ss_dssp CTTSCEEESCCEET
T ss_pred cCCCCEEEEEccCc
Confidence 99999999877753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.71 E-value=0.41 Score=43.49 Aligned_cols=31 Identities=29% Similarity=0.373 Sum_probs=25.4
Q ss_pred CceecCCCCCCeEe------CCCCCEEEEccCCcccc
Q 018682 273 PIIHRDLEPSNILR------DDSGNLKVADFGVSKLL 303 (352)
Q Consensus 273 ~ivH~Dikp~Nill------~~~~~vkL~Dfg~a~~~ 303 (352)
.++|+|+.+.|||+ +....+.++||..|...
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 36799999999999 44567999999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=80.18 E-value=0.57 Score=42.95 Aligned_cols=31 Identities=26% Similarity=0.564 Sum_probs=26.6
Q ss_pred CCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 271 ~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 345899999999999 7778899999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 352 | ||||
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-24 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 6e-23 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-16 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-15 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 4e-14 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 6e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-12 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 8e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-21 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-20 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-14 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 9e-10 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-08 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-07 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-17 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 9e-12 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 7e-10 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-06 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 0.001 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-15 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 9e-15 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 4e-11 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 4e-10 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 2e-07 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-14 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-11 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-09 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-06 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-05 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 2e-13 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 5e-12 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 2e-10 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 2e-08 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 3e-13 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 4e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 8e-07 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 5e-13 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 7e-11 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 3e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 5e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 2e-04 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 8e-13 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-12 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-11 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-08 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 6e-04 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 3e-12 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 3e-09 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 1e-05 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 0.001 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 3e-12 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 6e-06 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 7e-11 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 4e-09 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-10 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 5e-10 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-09 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-08 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-06 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 3e-08 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 9e-07 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 6e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 8e-08 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 1e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 4e-05 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 1e-07 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 7e-05 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 5e-05 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 0.003 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 3e-04 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 0.002 |
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-47
Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ ++ EL I KG F +L +RG +VAVK I +D +AF E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIAR 261
++RH N+VQ LG + + + IVTEY+ KG L +L+ +G L ++F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
M YL N +HRDL N+L + KV+DFG++K + + ++
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT 167
Query: 322 APEVFKNEEYDTKVDVFSFALILQEV 347
APE + +++ TK DV+SF ++L E+
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEI 193
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 3e-46
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF E+ G + G+ +A K + E EL +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+V F GA + I E++ G L LK+ G + + ++ + +G+ YL E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
I+HRD++PSNIL + G +K+ DFGVS L D + Y++PE +
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 331 YDTKVDVFSFALILQEV 347
Y + D++S L L E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-46
Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ ++ DF + KG F LA + +A+K L + + R E+
Sbjct: 2 QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+ +RHPN+++ G ++ + ++ EY P G + L++ + ++A
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
++Y H + +IHRD++P N+L +G LK+ADFG S T + Y+
Sbjct: 118 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYL 171
Query: 322 APEVFKNEEYDTKVDVFSFALILQE 346
PE+ + +D KVD++S ++ E
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYE 196
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-45
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L + +AF++E+ +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL-QAFKNEVGV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
M+YLH IIHRDL+ +NI + +K+ DFG++ + + Q + S ++
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 322 APEVFKNEE---YDTKVDVFSFALILQEV 347
APEV + ++ Y + DV++F ++L E+
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYEL 202
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-43
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS--TAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK +K + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ E +
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ APE + K DV+SF ++L E+
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEI 203
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 1e-43
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L F++ EI G+F A VA+KK+ +++ + E+
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQK+RHPN +Q+ G + +V EY K L+ +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ DFG + ++ P + ++A
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMA 179
Query: 323 PEVF---KNEEYDTKVDVFSFALILQE 346
PEV +YD KVDV+S + E
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIE 206
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-43
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WR VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL +HRDL N L +D G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
V ++ +K D+++F +++ E+
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEI 194
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 2e-43
Identities = 46/205 (22%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G++ + G + K+L +++ ++ + E+ LL++++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 211 NVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMN 264
N+V++ + ++ + IV EY GDL + + + + L +R + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 265 YLHENKPV--PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
H ++HRDL+P+N+ D N+K+ DFG++++L T Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT-PYYMS 182
Query: 323 PEVFKNEEYDTKVDVFSFALILQEV 347
PE Y+ K D++S +L E+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYEL 207
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-43
Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F EI G F L +W +VA+K + E +S++D F +E ++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMN 264
K+ HP +VQ G + +P+ +V E++ G L +L+ + L T + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL E +IHRDL N L ++ +KV+DFG+++ + + T ++ +PE
Sbjct: 116 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 325 VFKNEEYDTKVDVFSFALILQEV 347
VF Y +K DV+SF +++ EV
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEV 195
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-42
Identities = 57/195 (29%), Positives = 104/195 (53%), Gaps = 16/195 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
EI +G+F ++VA +L + ++ +R R F++E +L+ ++HPN+V+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFY 74
Query: 217 GA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+ V +++VTE + G L+ +LKR +K + I +G+ +LH P
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 273 PIIHRDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
PIIHRDL+ NI +G++K+ D G++ L K + ++APE+++ +Y
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEE-KY 189
Query: 332 DTKVDVFSFALILQE 346
D VDV++F + + E
Sbjct: 190 DESVDVYAFGMCMLE 204
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-41
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+++P + + E+ G F A + + A K + + ++ + + E+ +
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L HPN+V+ L A + + I+ E+ G + A + + + L S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+NYLH+NK IIHRDL+ NIL G++K+ADFGVS T + + + ++A
Sbjct: 123 LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMA 178
Query: 323 PEVF-----KNEEYDTKVDVFSFALILQE 346
PEV K+ YD K DV+S + L E
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIE 207
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-41
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P D+ + +G + LA R VAVK + + D + E+ + +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM 59
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ H NVV+F G + + + EY G+L ++ + A RF + G+ YL
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEV 325
H I HRD++P N+L D+ NLK++DFG++ + +R L + YVAPE+
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 326 FKNEEYDT-KVDVFSFALILQE 346
K E+ VDV+S ++L
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTA 198
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 44/198 (22%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G+F +LA + A+K L + I +++V E ++ ++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V+ + Y G+L ++++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK- 127
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE 329
IIHRDL+P NIL ++ ++++ DFG +K+L+ + + YV+PE+ +
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 330 EYDTKVDVFSFALILQEV 347
D+++ I+ ++
Sbjct: 186 SACKSSDLWALGCIIYQL 203
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-40
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W +VA+K L +S + F E
Sbjct: 11 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQE 346
APE + K DV+SF ++L E
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTE 206
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-40
Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRD 199
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E ++ ++ +P +V+ +G V Q+ +M+V E G L FL ++ + S
Sbjct: 59 EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDT 316
++ GM YL E +HRDL N+L + K++DFG+SK L + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ APE ++ ++ DV+S+ + + E
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-40
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 42/237 (17%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-------IQVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A G IQVAVK L E+ +D
Sbjct: 30 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + FA +A+GM +L +HRDL N+L
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202
Query: 292 LKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+K+ DFG+++ + + + +++APE Y K DV+S+ ++L E+
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 9e-40
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
++E++ ++ + ++ G + W+ + VAVK L E D V F
Sbjct: 8 NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFA 256
E A++++I+HPN+VQ LG T+ P I+TE++ G+L +L + + + A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
++ APE ++ K DV++F ++L E+
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+D L + E+ G F +++ VAVK L E +D E
Sbjct: 3 LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
++Q++ +P +V+ +G + ++ M+V E G L +L++ +K + ++ G
Sbjct: 61 VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRY 320
M YL E+ +HRDL N+L K++DFG+SK L E+ ++
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEV 347
APE ++ +K DV+SF +++ E
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEA 203
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 2e-39
Identities = 43/191 (22%), Positives = 91/191 (47%), Gaps = 13/191 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G A G +VA++++ + + +E+ ++++ ++PN+V +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EYL G L + + + + +LH N+ +IH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RD++ NIL G++K+ DFG +T ++ + + + ++APEV + Y KVD
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 337 VFSFALILQEV 347
++S ++ E+
Sbjct: 199 IWSLGIMAIEM 209
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (352), Expect = 4e-39
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISD 190
P+ +KH + Y+I E+ G F R G A K + SD
Sbjct: 16 PVEIKHDHVLDHYDIHE---------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKP 249
+ R E+ + +RHP +V A + M+++ E++ G+L + +
Sbjct: 67 KET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
AV + + +G+ ++HEN +H DL+P NI+ S LK+ DFG++ L K+
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+T + APEV + + D++S ++
Sbjct: 181 SVKVTTGT--AEFAAPEVAEGKPVGYYTDMWSVGVLSYI 217
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-39
Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 7/185 (3%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+G + + + VAVK L +V+S + + F E+ + + H N+++ G V + P
Sbjct: 26 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84
Query: 225 MMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
M +VTE P G L K +G T R+A+ +A GM YL IHRDL N
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFA 341
+L +K+ DFG+ + L +D + + + APE K + D + F
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 342 LILQE 346
+ L E
Sbjct: 202 VTLWE 206
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-38
Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFR 198
+YEI ++ I +G F + + VA+K + + D F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFL 56
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
++ + YL + +HRD+ N+L + +K+ DFG+S+ + +
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+++APE + + DV+ F + + E+
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEI 202
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-38
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 162 EITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
I KG F WRG +VAVK S ++R E+ +RH N++ F+ A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV-- 272
+ + + +V++Y G L +L R + ++ AL A G+ +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 273 ---PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
I HRDL+ NIL +G +AD G++ D + RY+APEV
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 327 ------KNEEYDTKVDVFSFALILQEV 347
K+ E + D+++ L+ E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-38
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRH 209
DF + KG+F LA ++ A+K L ++V+ DD V E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
P + + V EYL GDL ++ S A +A +I G+ +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I++RDL+ NIL D G++K+ADFG+ K + + + T T Y+APE+ +
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT-PDYIAPEILLGQ 178
Query: 330 EYDTKVDVFSFALILQE 346
+Y+ VD +SF ++L E
Sbjct: 179 KYNHSVDWWSFGVLLYE 195
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-38
Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 37/232 (15%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A + VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
FG+++ + + + +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 7e-38
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDE 200
EID + I G F + I VA+K L + + R F E
Sbjct: 22 EIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE 77
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDI 259
+++ + HPNV+ G VT+S+P+MI+TE++ G L +FL++ G V I
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
A GM YL + +HRDL NIL + + KV+DFG+S+ L P
Sbjct: 138 AAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 319 ---RYVAPEVFKNEEYDTKVDVFSFALILQEV 347
R+ APE + ++ + DV+S+ +++ EV
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEV 226
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 136 bits (343), Expect = 1e-37
Identities = 35/193 (18%), Positives = 82/193 (42%), Gaps = 16/193 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ G F + G K + D ++E++++ ++ HP ++
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 92
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
A M+++ E+L G+L + + + + + + G+ ++HE+ I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149
Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
H D++P NI+ + ++K+ DFG++ L D + + + APE+ E
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 334 KVDVFSFALILQE 346
D+++ ++
Sbjct: 208 YTDMWAIGVLGYV 220
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 2e-37
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 15/194 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F ILA + VA+K + ++ + + + + +E+A+L KI+HPN+V
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ ++ + + G+L + KG A R + + YLH+ I+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVH 130
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
RDL+P N+L D+ + ++DFG+SK+ L+ + YVAPEV + Y
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 334 KVDVFSFALILQEV 347
VD +S +I +
Sbjct: 189 AVDCWSIGVIAYIL 202
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 4e-36
Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 42/239 (17%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF----------ILAFWRGIQVAVKKLGEEVISDDDR 193
++ E + +++ +I +G F +L + VAVK L EE + D
Sbjct: 4 KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADM 59
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------- 245
F+ E AL+ + +PN+V+ LG PM ++ EY+ GDL FL+
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L + + A +A GM YL E K +HRDL N L ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+K+ADFG+S+ + + D R++ PE Y T+ DV+++ ++L E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-35
Identities = 37/193 (19%), Positives = 78/193 (40%), Gaps = 17/193 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G F K + + D+V + E+++L RH N++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVL-VKKEISILNIARHRNILHLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++++ E++ D+ + L V + + + +LH + I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
H D+ P NI+ S +K+ +FG ++ L K T+ Y APEV +++ T
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 334 KVDVFSFALILQE 346
D++S ++
Sbjct: 183 ATDMWSLGTLVYV 195
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-35
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EI P + I G F + + VA+K L + + F
Sbjct: 3 EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALD 258
E ++ + H N+++ G +++ PMMI+TEY+ G + ++ G V
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
R+ APE ++ + DV+SF +++ EV
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-35
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTF---ILAFW-----RGIQVAVKKLGEEVISDDDRV 194
+ V I P L + I +G F + I AVK L I+D V
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEV 72
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLK-RKGALKPSTA 252
F E +++ HPNV+ LG +S ++V Y+ GDLR F++
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
+ F L +A+GM +L K +HRDL N + D+ +KVADFG+++ + KE +
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 313 CQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQE 346
+ + +++A E + +++ TK DV+SF ++L E
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 126 bits (316), Expect = 1e-34
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 14/197 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G LA VAVK L ++ D FR E + HP +V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 217 GAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+P IV EY+ LR + +G + P A+ D + +N+ H+N
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-- 131
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEE 330
IIHRD++P+NI+ + +KV DFG+++ + + + +Y++PE + +
Sbjct: 132 -IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 331 YDTKVDVFSFALILQEV 347
D + DV+S +L EV
Sbjct: 191 VDARSDVYSLGCVLYEV 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 127 bits (320), Expect = 2e-34
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF+ I +G F G A+K L ++ I +E L+L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P +V A + + + + GDL L + G + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF- 326
+++RDL+P+NIL D+ G+++++D G++ + + Y+APEV
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPEVLQ 178
Query: 327 KNEEYDTKVDVFSFALILQE 346
K YD+ D FS +L +
Sbjct: 179 KGVAYDSSADWFSLGCMLFK 198
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 3e-34
Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F L R G A+K L +E++ +V DE +L + HP +++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + + ++ +Y+ G+L + L++ A +A ++ + YLH II+
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIY 127
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P NIL D +G++K+ DFG +K + + Y+APEV + Y+ +D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 337 VFSFALILQE 346
+SF +++ E
Sbjct: 184 WWSFGILIYE 193
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-34
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRDEL 201
+D +++ F + I +G F + A + + A+K++ + + D R F EL
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61
Query: 202 ALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------------- 244
+L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 245 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
L + FA D+ARGM+YL + IHRDL NIL ++ K+ADFG+S+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-- 176
Query: 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ T R++A E Y T DV+S+ ++L E+
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 124 bits (313), Expect = 4e-34
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 23/203 (11%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-H 209
+ +G + + AVK + + A E+ +L+K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN++Q ++ +V + + KG+L +L K L + + + LH+
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I+HRDL+P NIL DD N+K+ DFG S L L + Y+APE+ +
Sbjct: 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIECS 184
Query: 330 E------YDTKVDVFSFALILQE 346
Y +VD++S +I+
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYT 207
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-34
Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 37/232 (15%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR---------GIQVAVKKLGEEVISDDDR 193
P +E+ L + +G F +LA +VAVK L + D
Sbjct: 6 PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61
Query: 194 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L V A +ARGM YL IHRDL N+L + +K+AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178
Query: 297 FGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
FG+++ + + T +++APE + Y + DV+SF ++L E+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-33
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 17/197 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDR---VRAFRDELALLQKIRHPNVV 213
E+ G F + G+Q A K + + R E+++L++I+HPNV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
+ ++++ E + G+L FL K +L A F I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---Q 133
Query: 274 IIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I H DL+P NI+ D +K+ DFG++ + + +VAPE+ E
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 330 EYDTKVDVFSFALILQE 346
+ D++S +I
Sbjct: 192 PLGLEADMWSIGVITYI 208
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-33
Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 156 DFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
+F + G F W I VA+K+L E + + DE ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ +P+V + LG S+ +I L + K + + + + IA+GMNYL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEV 325
+ + ++HRDL N+L ++K+ DFG++KLL +E +++A E
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 326 FKNEEYDTKVDVFSFALILQEV 347
+ Y + DV+S+ + + E+
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWEL 206
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-33
Identities = 54/222 (24%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+E+ ++ + E+ +G+F +G+ +VA+K + E +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------A 246
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
S ++ A +IA GM YL+ N +HRDL N + + +K+ DFG+++ +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 307 ED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
+ R R+++PE K+ + T DV+SF ++L E+
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-33
Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 10/191 (5%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
+ +G F A + VA+KK+ G + D R E+ LLQ++ HPN++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
L A S + +V +++ L PS + L +G+ YLH++ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 122
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
HRDL+P+N+L D++G LK+ADFG++K T +F Y V
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 336 DVFSFALILQE 346
D+++ IL E
Sbjct: 183 DMWAVGCILAE 193
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-31
Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ G + F + + A+K L D +A R+ + + P++V+ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 218 A----VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKP 271
++IV E L G+L + ++ +G A A I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 272 VPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
I HRD++P N+L + LK+ DFG +K T LT + YVAPEV
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGP 187
Query: 329 EEYDTKVDVFSFALILQEVKF 349
E+YD D++S +I+ +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLC 208
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-31
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 9/196 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + KGTF IL + G A+K L +EVI D V E +LQ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ A + V EY G+L L R+ A + +I + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
+++RD++ N++ D G++K+ DFG+ K + + + Y+APEV ++ +
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQE 346
Y VD + +++ E
Sbjct: 182 YGRAVDWWGLGVVMYE 197
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-30
Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GTF A R G +VA+KK+ E + + A R E+ +LQ ++H NVV +
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 75
Query: 217 GAVTQSSP--------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+ + +V ++ S R + G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEV 325
NK I+HRD++ +N+L G LK+ADFG+++ ++ ++ Y PE+
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 326 FKNE-EYDTKVDVFSFALILQE 346
E +Y +D++ I+ E
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAE 214
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (293), Expect = 1e-30
Identities = 47/190 (24%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F +L + G A+K L ++ + ++ +E +LQ + P +V+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +S + +V EY+ G++ + L+R G A +A I YLH +I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P N+L D G ++V DFG +K + + +APE+ ++ Y+ VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 337 VFSFALILQE 346
++ +++ E
Sbjct: 221 WWALGVLIYE 230
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-30
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 19/198 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIR--HPN 211
+ G F + VA+K + ++ ISD + E+ LL+K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 212 VVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V++ L + +++ E P DL F+ +GAL+ A F + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 271 PVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++HRD++ NIL D + G LK+ DFG LL +D T D + Y PE +
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 330 EYDTK-VDVFSFALILQE 346
Y + V+S ++L +
Sbjct: 185 RYHGRSAAVWSLGILLYD 202
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-30
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDR 193
+ ++E L + +G F I A GI VAVK L E + R
Sbjct: 4 DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ L+ H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 62 -ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L + ++ +A+GM +L K IHRDL NIL + +K+ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD 177
Query: 297 FGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEV 347
FG+++ + D +++APE + Y + DV+SF ++L E+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (283), Expect = 7e-30
Identities = 48/189 (25%), Positives = 94/189 (49%), Gaps = 8/189 (4%)
Query: 162 EITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+I +GT+ A G A+KK+ E + R E+++L++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD 67
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
+ +++V E+L + + +G L+ TA F L + G+ Y H+ + ++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
DL+P N+L + G LK+ADFG+++ + + T + +++Y T +D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 338 FSFALILQE 346
+S I E
Sbjct: 185 WSVGCIFAE 193
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 8e-30
Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P E+ +T++ I G+F A G VA+KK+ R EL +++K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFAL 257
+ H N+V+ S + +V +Y+P+ R + + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ R + Y+H I HRD++P N+ L D+ LK+ DFG +K L V+ + ++ +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICS 185
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+F +Y + +DV+S +L E
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+++ P +TN I +G + A+ ++VA+KK+ + E+
Sbjct: 4 FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58
Query: 203 LLQKIRHPNVVQFLGAV----TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+L + RH N++ + + + + +L DL LK + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--T 316
I RG+ Y+H ++HRDL+PSN+L + + +LK+ DFG++++ D +
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 317 SCRYVAPEVFKNEEYDT-KVDVFSFALIL 344
+ Y APE+ N + T +D++S IL
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-29
Identities = 46/190 (24%), Positives = 88/190 (46%), Gaps = 9/190 (4%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GT+ A R VA+K++ + + A R E+ LL++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V E+ + + F G L P F + +G+ + H ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P N+L + +G LK+A+FG+++ + T +F + Y T +D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 337 VFSFALILQE 346
++S I E
Sbjct: 185 MWSAGCIFAE 194
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (277), Expect = 7e-29
Identities = 34/200 (17%), Positives = 64/200 (32%), Gaps = 23/200 (11%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I G+F L G +VA+K + + E + + ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 217 GAV-TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++V E L F T + A + + Y+H I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125
Query: 276 HRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEVF 326
HRD++P N L + + DFG++K + RY +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 327 KNEEYDTKVDVFSFALILQE 346
E + D+ S +L
Sbjct: 186 LGIEQSRRDDLESLGYVLMY 205
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 9e-29
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I +GT+ A + G VA+KK+ + ++ A R E++LL+++ HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN 269
N+V+ L + + + +V E+L + + + + + +G+ + H +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++HRDL+P N+L + G +K+ADFG+++ R T + + Y APE+
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGC 177
Query: 330 EY-DTKVDVFSFALILQE 346
+Y T VD++S I E
Sbjct: 178 KYYSTAVDIWSLGCIFAE 195
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-27
Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 7/186 (3%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH-PNVVQFLGAVTQS 222
I G A+K L + I + R E +L+ IR P +V A
Sbjct: 42 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + ++ +Y+ G+L L ++ + +I + +LH+ II+RD++
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSF 340
NIL D +G++ + DFG+SK E + Y+AP++ + + +D VD +S
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 341 ALILQE 346
+++ E
Sbjct: 219 GVLMYE 224
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 162 EITKGTF---ILAFWR---GIQVAVKKLGEEVISDDDRVRAFR--DELALLQKIRHPNVV 213
EI +G + A G VA+K++ + + + R L L+ HPNVV
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 214 QFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLH 267
+ T S + +V E++ + K + T + RG+++LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
++ ++HRDL+P NIL SG +K+ADFG++++ + + + Y APEV
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 188
Query: 328 NEEYDTKVDVFSFALILQE 346
Y T VD++S I E
Sbjct: 189 QSSYATPVDLWSVGCIFAE 207
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 105 bits (262), Expect = 1e-26
Identities = 34/201 (16%), Positives = 64/201 (31%), Gaps = 23/201 (11%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I +G+F QVA+K SD ++R LL V +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + ++V + L T A + + +HE +++
Sbjct: 70 G--QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124
Query: 277 RDLEPSNIL-----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEV 325
RD++P N L ++ + V DFG+ K + + RY++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 326 FKNEEYDTKVDVFSFALILQE 346
E + D+ + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMY 205
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 8e-26
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 148 YEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
E+ + + G + A G +VA+KKL S+ RA+R
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEYLPKGDLRAFLKRKGALKPSTA 252
EL LL+ +RH NV+ L T + +V ++ G L + L
Sbjct: 67 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
+ +G+ Y+H IHRDL+P N+ ++ LK+ DFG+++ + D +T
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMT 176
Query: 313 CQDTSCRYVAPEVFKNEE-YDTKVDVFSFALIL 344
+ Y APEV N Y VD++S I+
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99 bits (248), Expect = 1e-24
Identities = 39/225 (17%), Positives = 91/225 (40%), Gaps = 28/225 (12%)
Query: 137 MHVKHAREVPEYEIDPHELDFTNS------VEITKGTF---ILAFWR--GIQVAVKKLGE 185
V R ++ + H +++ N ++ +G + A +V VK L
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-- 68
Query: 186 EVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLK 242
+ + + E+ +L+ +R PN++ V S +V E++ D + +
Sbjct: 69 ----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK 301
L + +I + ++Y H I+HRD++P N++ D + L++ D+G+++
Sbjct: 125 T---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
++ + + + + YD +D++S +L
Sbjct: 179 FYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 6e-23
Identities = 36/145 (24%), Positives = 57/145 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + +K LL G N ++ T LH+AA G TEV LL+ A V+ K
Sbjct: 4 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEI 163
+ TPL A + ++KLL ++ A P +A + E + E
Sbjct: 64 KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123
Query: 164 TKGTFILAFWRGIQVAVKKLGEEVI 188
++ + + VA K V
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVA 148
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.1 bits (191), Expect = 1e-16
Identities = 33/119 (27%), Positives = 53/119 (44%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G+ D L ++ +++ +K LL DVN + + LH AA QG T++
Sbjct: 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDI 345
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPE 147
V+LLL+ GA + G+TPL A V +L+ + + KH PE
Sbjct: 346 VTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPE 404
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.1 bits (178), Expect = 5e-15
Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 12/152 (7%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK--- 131
T LHVA+ G +V LL+RGA + + TPL A + EV K L ++ AK
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61
Query: 132 -------PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
PL + H + + ++ + + + +A G V L
Sbjct: 62 KAKDDQTPLHCAARIGH-TNMVKLLLE-NNANPNLATTAGHTPLHIAAREGHVETVLALL 119
Query: 185 EEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ S + L + K V + L
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELL 151
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.8 bits (172), Expect = 4e-14
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 17/217 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + +G L A + VE + LL G N + T LH+AA +
Sbjct: 187 RGGSPHSPAWNGY-----TPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQE 241
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PL 133
G E+V+LLL + A+ + ++ G TPL + V +L KHG PL
Sbjct: 242 GHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPL 301
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 193
H + + V +++ + + A +G V L + S ++
Sbjct: 302 HVASHYGNIKLVKFLLQHQADVNAKTKLGYS--PLHQAAQQGHTDIVTLLLKNGASPNEV 359
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
LA+ +++ + +V L VT + ++V++
Sbjct: 360 SSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 396
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.9 bits (162), Expect = 6e-13
Identities = 41/182 (22%), Positives = 55/182 (30%), Gaps = 12/182 (6%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V + LL+ N + T LHVA ++V LLL RG
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195
Query: 104 RWGSTPLGDAIYYKNHEVIKLL----------EKHGAKPLMAPMHVKHAREVPEYEIDPH 153
G TPL A EV + L G PL HA V
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQA 255
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ N +T L G L + + D R L + + +V
Sbjct: 256 NGNLGNKSGLT--PLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLV 313
Query: 214 QF 215
+F
Sbjct: 314 KF 315
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (160), Expect = 1e-12
Identities = 36/143 (25%), Positives = 47/143 (32%), Gaps = 38/143 (26%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
++ A N + E L A E K LL + VN + D++T LH AA
Sbjct: 21 QRGASPNVSNVKVETP-----LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAAR 75
Query: 83 QGFTEVVSLLLER---------------------------------GADVDPKDRWGSTP 109
G T +V LLLE A + G TP
Sbjct: 76 IGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y V +LL + A P
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHP 158
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.5 bits (153), Expect = 8e-12
Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 8/164 (4%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ T LHVAA G V LLLER A + + G TPL A+++ N +
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179
Query: 121 VIKLLEKHGAKPL------MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGT--FILAF 172
++KLL G P P+H+ + E + + + E +G LA
Sbjct: 180 IVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA 239
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
G V L + + + ++ L L+ + H V L
Sbjct: 240 QEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 2e-22
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 16/192 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G + AF G++VAVKKL S R +R EL LL+ ++H NV+ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 217 GAVTQSSPMMIVTEYL----PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
T + + + G + + L I RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
IIHRDL+PSN+ ++ LK+ DFG+++ +D T + Y+
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 333 TKVDVFSFALIL 344
VD++S I+
Sbjct: 198 QTVDIWSVGCIM 209
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 2e-21
Identities = 51/196 (26%), Positives = 78/196 (39%), Gaps = 20/196 (10%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I G A+ VA+KKL + RA+R EL L++ + H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLL 82
Query: 217 GAVTQSSPMM------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
T + +V E + + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSA- 138
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
IIHRDL+PSNI+ LK+ DFG+++ T +T + Y APEV
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 331 YDTKVDVFSFALILQE 346
Y VD++S I+ E
Sbjct: 195 YKENVDIWSVGCIMGE 210
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (216), Expect = 2e-20
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 2/112 (1%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ A++N D+ G + + LLD G DVN R +T L +A
Sbjct: 169 DEMGADVNACDNMGRNALIHAL-LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 3e-14
Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGKTP-----LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (135), Expect = 9e-10
Identities = 20/72 (27%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHG 129
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +HG
Sbjct: 3 VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHG 62
Query: 130 AKPLMAPMHVKH 141
A P++ +
Sbjct: 63 ADPVLRKKNGAT 74
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.0 bits (126), Expect = 1e-08
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 1/96 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
+ G+TP A + +++KL GA +
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (118), Expect = 1e-07
Identities = 24/72 (33%), Positives = 31/72 (43%), Gaps = 5/72 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----E 120
TAL AA +G EV+ +LL E GADV+ D G L A+ +
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200
Query: 121 VIKLLEKHGAKP 132
+ LL HGA
Sbjct: 201 ITHLLLDHGADV 212
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 79.0 bits (193), Expect = 2e-17
Identities = 18/65 (27%), Positives = 35/65 (53%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G + + +D D +T + +AA +G EVV L+++GA V+ D T A +H ++
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270
Query: 123 KLLEK 127
+ ++
Sbjct: 271 DIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 62.4 bits (150), Expect = 9e-12
Identities = 28/110 (25%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 41 EFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLL------ 93
E + I E + VN D NRT LH A E L+
Sbjct: 1 ESPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKE 59
Query: 94 --ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
GADV+ D +TPL A+ + ++ L K GA P + +
Sbjct: 60 CIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERS 109
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 57.1 bits (136), Expect = 7e-10
Identities = 12/51 (23%), Positives = 20/51 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
+M A E +E + L+ G V D + TA +A +V +
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 46.3 bits (108), Expect = 2e-06
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 1/71 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ RTALH AA V L+ E+G++ D +D G TP+ A EV
Sbjct: 177 AARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEV 236
Query: 122 IKLLEKHGAKP 132
+ L + GA
Sbjct: 237 VMYLIQQGASV 247
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 37.4 bits (85), Expect = 0.001
Identities = 18/88 (20%), Positives = 35/88 (39%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
KE + +G DVN D D T L +A +V+ L++ GAD ++ + L A
Sbjct: 55 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 114
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
++ ++ + ++
Sbjct: 115 AANRDFGMMVYMLNSTKLKGDIEELDRN 142
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.5 bits (179), Expect = 4e-15
Identities = 45/212 (21%), Positives = 79/212 (37%), Gaps = 37/212 (17%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ-- 214
++ G F LA VA+K + D A DE+ LLQ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 215 -------------FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIA 260
F +++V E L + L K + P + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSG------NLKVADFGVSKLLTVKEDRPLTCQ 314
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNS 189
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+ Y +PEV + D++S A ++ E
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 71.7 bits (174), Expect = 9e-15
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + E +K L+ + DVN +D D T LH AA G E +L+E D++ +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ G T + +++ LE+ K
Sbjct: 263 KVGQTAF----DVADEDILGYLEELQKK 286
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 60.5 bits (145), Expect = 4e-11
Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 9/115 (7%)
Query: 48 ANERDVEGIKELLDSGIDVNFR---------DIDNRTALHVAACQGFTEVVSLLLERGAD 98
A ++ E +K + S D+ D+ A G TE V LLERGAD
Sbjct: 6 AKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPH 153
++ + G T L A N +++K L ++GA
Sbjct: 66 INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 57.8 bits (138), Expect = 4e-10
Identities = 26/74 (35%), Positives = 39/74 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A ++
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244
Query: 119 HEVIKLLEKHGAKP 132
E ++L ++
Sbjct: 245 EEACRILVENLCDM 258
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 49.3 bits (116), Expect = 2e-07
Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 2/175 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + D E + LL+ G D+N+ ++D TALH A ++V L+E GA+++ D
Sbjct: 44 FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHAREVPEYEIDPHELDFTNSV 161
G PL A ++ + L GA E + + +
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQG 163
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ ++ A + L I+D ++ L + + V++ L
Sbjct: 164 VDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLL 218
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 71.5 bits (174), Expect = 1e-14
Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR--WGSTPL 110
++ + LL S V +N A +AA G V++ L E
Sbjct: 106 LDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAF 165
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A + V+ L +
Sbjct: 166 RLAAENGHLHVLNRLCELAPTE 187
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 61.8 bits (149), Expect = 2e-11
Identities = 13/83 (15%), Positives = 22/83 (26%), Gaps = 3/83 (3%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVDPKDRWGS 107
+ D + + I + VAA G + + LLL V
Sbjct: 68 YYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENY 127
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
A + V+ L +
Sbjct: 128 QAFRLAAENGHLHVLNRLCELAP 150
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 56.4 bits (135), Expect = 1e-09
Identities = 27/166 (16%), Positives = 48/166 (28%), Gaps = 13/166 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID--NRTALHVAA 81
+ + + + + A + + L + I N A +AA
Sbjct: 115 SDEIVKVIQAENYQA-----FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAA 169
Query: 82 CQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
G V++ L E + A+ +H VI L A +
Sbjct: 170 ENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEI- 228
Query: 139 VKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
H E E ++P N ++ F L+ G+ V K
Sbjct: 229 --HEFEYGEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSE 272
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 46.4 bits (109), Expect = 3e-06
Identities = 10/77 (12%), Positives = 20/77 (25%), Gaps = 7/77 (9%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-----GST 108
+G+ +L+ + L + + + LL +
Sbjct: 262 DGVFDLVTK--SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319
Query: 109 PLGDAIYYKNHEVIKLL 125
L A+ N LL
Sbjct: 320 LLRLALRLGNQGACALL 336
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 43.3 bits (101), Expect = 2e-05
Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)
Query: 44 LMFLANERDVEGIKELLDSG-----IDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L+ +E ++ I+ LL D L +A G +LLL
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.4 bits (163), Expect = 2e-13
Identities = 24/65 (36%), Positives = 31/65 (47%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
RT LH+A V+ LLL+ GAD + G TPLG A+ N + +LL
Sbjct: 186 KPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLR 245
Query: 127 KHGAK 131
HGA
Sbjct: 246 AHGAP 250
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.2 bits (152), Expect = 5e-12
Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ ++ LL +G D R RT L A + + LL GA +P+D
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 58.2 bits (139), Expect = 2e-10
Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGAD---VDPKDRWGSTPLGDAIYYKNHEVIK 123
+ D TALH+A + LL A +D ++ G T L A ++
Sbjct: 3 GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62
Query: 124 LLEKHGAKPLMAPMHVKH 141
L GA L+A
Sbjct: 63 KLYAAGAGVLVAERGGHT 80
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 52.0 bits (123), Expect = 2e-08
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGDTA-----LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 65.6 bits (158), Expect = 3e-13
Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+A++N D+ G+ L + A + E + LL + + +D + T L +AA
Sbjct: 111 TADADINAADNSGKTA-----LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAR 165
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+G E LL+ A+ + D P A +H++++LL+
Sbjct: 166 EGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.6 bits (114), Expect = 2e-07
Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 87 EVVSLLLERGADVDPK-DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
+V+S LL +GA+++ D+ G T L A + + K L GA +
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRT 58
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.9 bits (112), Expect = 4e-07
Identities = 26/76 (34%), Positives = 39/76 (51%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
++L+ + D+N D +TALH AA TE V++LL A+ D +D TPL A
Sbjct: 107 EDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAARE 166
Query: 117 KNHEVIKLLEKHGAKP 132
++E K L + A
Sbjct: 167 GSYEASKALLDNFANR 182
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.1 bits (110), Expect = 8e-07
Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 1/40 (2%)
Query: 54 EGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92
+ I +LL G ++N D T+LH+AA + L
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.6 bits (161), Expect = 5e-13
Identities = 16/58 (27%), Positives = 28/58 (48%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+E + +N +D + T L++AA G +V LL+ GAD ++ G P+
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.1 bits (144), Expect = 7e-11
Identities = 19/129 (14%), Positives = 45/129 (34%), Gaps = 2/129 (1%)
Query: 2 ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD 61
E K+ + L + + + + E + ++ + ++ + +
Sbjct: 34 EQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFP 93
Query: 62 -SGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ +++N D T LH E+V L++ G++ D G + L A+ N+
Sbjct: 94 NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNN 153
Query: 120 EVIKLLEKH 128
E
Sbjct: 154 YDSGTFEAL 162
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.0 bits (123), Expect = 3e-08
Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 3/77 (3%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER---GADVDPKDRWGSTPLGDAIY 115
+ + + + + + ++ L + ++ +D G T L A
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268
Query: 116 YKNHEVIKLLEKHGAKP 132
N ++ L +GA P
Sbjct: 269 LGNISIVDALLDYGADP 285
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.6 bits (122), Expect = 5e-08
Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)
Query: 6 PVRTT---LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
P+ T L +P + K ++D+ +++K E L L E L +
Sbjct: 2 PIITFTHDLTSDFLSSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNND 61
Query: 63 GIDVNFRDIDNRTALHVAACQGFT-EVVSLLLERGADVD-PKDRWGSTPLGDAIYYKNHE 120
+ N + + EV +++ P D G+TPL N E
Sbjct: 62 SSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLE 121
Query: 121 VIKLLEKHGAKP 132
++K L KHG+
Sbjct: 122 LVKHLVKHGSNR 133
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 12/57 (21%), Positives = 19/57 (33%), Gaps = 5/57 (8%)
Query: 25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
LN D +G+ L A ++ + LLD G D + + A
Sbjct: 249 ANMLNAQDSNGDTC-----LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.0 bits (157), Expect = 8e-13
Identities = 32/123 (26%), Positives = 46/123 (37%), Gaps = 34/123 (27%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG------------------ 84
+ LA +E +KE + + D D+RTALH A G
Sbjct: 7 VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66
Query: 85 ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
E+V LL +GA V+ ++ G TPL A HE+ +L + G
Sbjct: 67 DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 126
Query: 130 AKP 132
A P
Sbjct: 127 ANP 129
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.8 bits (154), Expect = 2e-12
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ +G L + A++ E LL+ G + + +D TA+H AA +G
Sbjct: 94 AQVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+++ +LL A + +D G+TPL A + E KLL GA
Sbjct: 149 LKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASI 195
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.4 bits (145), Expect = 2e-11
Identities = 24/70 (34%), Positives = 37/70 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL G VN + + T LH AA + E+ +LLE GA+ D KD + +T + A N
Sbjct: 89 LLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 119 HEVIKLLEKH 128
++I +L +
Sbjct: 149 LKMIHILLYY 158
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (120), Expect = 4e-08
Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 1/52 (1%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L +E VE K L+ G + + + +T L VA G ++ ++E
Sbjct: 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 6e-04
Identities = 8/48 (16%), Positives = 15/48 (31%), Gaps = 1/48 (2%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ + A G E+ +L + D+ T L A +
Sbjct: 3 SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHT 50
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (152), Expect = 3e-12
Identities = 21/82 (25%), Positives = 38/82 (46%)
Query: 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP 101
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD
Sbjct: 146 SPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSL 205
Query: 102 KDRWGSTPLGDAIYYKNHEVIK 123
K+ TPL A + ++++
Sbjct: 206 KNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (129), Expect = 3e-09
Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFTEVVSLLL----ERGADVDPKDRWGSTPLGDAIYYKNH 119
D T LH+A QG V L+ + G ++D + TPL A+
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLP 53
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 1e-05
Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 4/102 (3%)
Query: 44 LMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
L + ++ + L++ G +++ + +T LH+A VV LL+ GA
Sbjct: 7 LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
DR G T A +++ ++ L A + +
Sbjct: 67 MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY 108
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.001
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L N E ++ LL+ G D++ DI R+ L A +V LLL+ GA+V+ +
Sbjct: 114 LHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQ 173
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
GS+ L A +++ L + GA
Sbjct: 174 MYSGSSALHSASGRGLLPLVRTLVRSGADS 203
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 61.5 bits (148), Expect = 3e-12
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 42/140 (30%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAA---CQGFTEVVSLLL 93
L RD+ G+ + G+D+ + + TALH+A + +V L+
Sbjct: 9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLV 68
Query: 94 ERGADVDPK---------------------------------DRWGSTPLGDAIYYKNHE 120
+ ++D + + G TPL A K+
Sbjct: 69 QNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEH 128
Query: 121 VIKLLEKHGAKPLMAPMHVK 140
+LL + + + +HV+
Sbjct: 129 CEELLTQALSGRFNSHVHVE 148
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.4 bits (101), Expect = 6e-06
Identities = 15/129 (11%), Positives = 30/129 (23%), Gaps = 12/129 (9%)
Query: 72 DNRTALHV---AACQGFTEVVSLLLERGADVDPK------DRWGSTPLGDAIYYKNH--- 119
D LH A + G D+ K T L A+ +
Sbjct: 2 DTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL 61
Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
++ L ++ A + L + + + + +A
Sbjct: 62 HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121
Query: 180 VKKLGEEVI 188
+ E
Sbjct: 122 KRLKHEHCE 130
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (141), Expect = 7e-11
Identities = 19/67 (28%), Positives = 31/67 (46%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ RTALH+A ++VSLLL+ GADV+ G +P + + + L
Sbjct: 139 AQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLG 198
Query: 127 KHGAKPL 133
+ + L
Sbjct: 199 QLTLENL 205
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (127), Expect = 4e-09
Identities = 9/55 (16%), Positives = 20/55 (36%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
L + ++ + + LL G DVN + + + T + L + +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.6 bits (124), Expect = 1e-08
Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
D + LH+A EV+ + A ++ ++ TPL A+
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQP 52
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.9 bits (139), Expect = 1e-10
Identities = 29/181 (16%), Positives = 57/181 (31%), Gaps = 34/181 (18%)
Query: 174 RGIQVAVKKLGEEVISDDD---------------RVRAFRDELALLQKIRHPNVVQFLGA 218
+ + VK S +R+ R+E LQK++ V +
Sbjct: 23 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
++ E + +L + I + + I+H D
Sbjct: 83 ----EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGD 128
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L N+L + G + + DF S + + R + +D + + Y T+ D+
Sbjct: 129 LSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITYFSRTYRTEKDIN 183
Query: 339 S 339
S
Sbjct: 184 S 184
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.8 bits (135), Expect = 5e-10
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKL 124
VN++D T L A +G + LL+E+ GA+ D D G+ A+ N +V K
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221
Query: 125 LEKHGA 130
+
Sbjct: 222 FLNNVV 227
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 55.2 bits (131), Expect = 1e-09
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 1/68 (1%)
Query: 75 TALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
LH A + V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 134 MAPMHVKH 141
+
Sbjct: 62 LDDYPDDS 69
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.7 bits (122), Expect = 3e-08
Identities = 10/55 (18%), Positives = 17/55 (30%), Gaps = 4/55 (7%)
Query: 45 MFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
E + L++ G + + D A VA + +V L D
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.7 bits (109), Expect = 1e-06
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKD 103
++ E + L+++G V +D N+ LH AA G +++ LL G V+ +D
Sbjct: 110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQD 169
Query: 104 RWGSTPLGDAIYYKNHEVIK-LLEKHGAKP 132
+ G TPL A+ + + L+EK+GA+
Sbjct: 170 KQGWTPLFHALAEGHGDAAVLLVEKYGAEY 199
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.4 bits (108), Expect = 2e-06
Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 1/99 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L E + ++ELL S + +D D R LH + E+ S LL + +V+
Sbjct: 4 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 63
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
D + + +++++ +PL ++
Sbjct: 64 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKIT 102
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (118), Expect = 3e-08
Identities = 9/32 (28%), Positives = 18/32 (56%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L AA +G E ++ LL+ +V+ ++ +G
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 9e-07
Identities = 12/31 (38%), Positives = 15/31 (48%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERG 96
V R+ TA +A G EVVSL+ G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 6e-05
Identities = 9/31 (29%), Positives = 16/31 (51%)
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
V ++ G T A Y +EV+ L++ +G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 49.1 bits (115), Expect = 8e-08
Identities = 23/64 (35%), Positives = 36/64 (56%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN +D+ TALH A EVV LL++ GADV + ++ T +I N ++
Sbjct: 90 GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149
Query: 123 KLLE 126
++L+
Sbjct: 150 EILQ 153
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.5 bits (98), Expect = 1e-05
Identities = 12/64 (18%), Positives = 29/64 (45%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G D + +++ L + E ++ L+ G DV+ + +TA ++ G ++
Sbjct: 89 HGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDL 148
Query: 89 VSLL 92
+L
Sbjct: 149 AEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.0 bits (94), Expect = 4e-05
Identities = 23/153 (15%), Positives = 48/153 (31%), Gaps = 9/153 (5%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
D L AA G + V +L+ GA D G++PL A Y + ++L + G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVS 59
Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDD 191
+ + E + ++ + + A + +EV+
Sbjct: 60 RDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELL 119
Query: 192 DRVRAFRDE--------LALLQKIRHPNVVQFL 216
+ A + + ++ + L
Sbjct: 120 IKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 1e-07
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN D +H+A +G T VVS L +D+ +D G TPL A+ +++
Sbjct: 91 GADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLV 149
Query: 123 KLLEKH 128
+L+ H
Sbjct: 150 DILQGH 155
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 7e-05
Identities = 13/46 (28%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 75 TALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNH 119
L AA +G + V LL R D +R+G T L ++
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTA 49
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (93), Expect = 5e-05
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 56 IKELLDSGIDVNFRDI-DNRTA--LHVAACQGFTEVVSLLLERGADV 99
K L++SG V D +TA +G+T+ L +
Sbjct: 83 CKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.4 bits (80), Expect = 0.003
Identities = 18/124 (14%), Positives = 34/124 (27%), Gaps = 36/124 (29%)
Query: 44 LMFLANERDVEGIKELLDSGIDVN---------------------------------FRD 70
L+ + E + + ++ ++ D + D
Sbjct: 5 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 64
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDR---WGSTPLGDAIYYKNHEVIKLLEK 127
D T LH AA +V L+E GA V + + + + + L
Sbjct: 65 SDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYG 124
Query: 128 HGAK 131
K
Sbjct: 125 VQEK 128
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 3e-04
Identities = 20/114 (17%), Positives = 33/114 (28%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
L AA +G E V LLE GA+ + + +G P+ + LL
Sbjct: 5 DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCA 64
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI 188
P + E L + + +A + +V
Sbjct: 65 DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVA 118
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.7 bits (80), Expect = 0.002
Identities = 7/28 (25%), Positives = 11/28 (39%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLE 94
+ RD R + +A G +V L
Sbjct: 96 DVRDAWGRLPVDLAEELGHRDVARYLRA 123
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.89 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.87 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.85 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.85 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.84 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.82 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.81 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.81 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.8 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.78 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.78 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.77 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.76 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.76 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.76 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.76 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.75 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.75 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.74 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.74 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.72 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.71 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.69 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.69 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.69 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.68 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.68 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.68 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.68 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.68 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.67 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.67 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.66 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.62 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.6 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.59 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.57 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.65 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.22 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=339.04 Aligned_cols=190 Identities=25% Similarity=0.458 Sum_probs=170.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 689999999999999984 578999999875433333334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++|+|.+++.+.+.+++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|...... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 9999999999998888999999999999999999999999 999999999999999999999999999765432 2
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~ 201 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 201 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCC
Confidence 34467899999999999999999999999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=334.40 Aligned_cols=190 Identities=23% Similarity=0.425 Sum_probs=169.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
.+|++.+.||+|+||.||. +|+.||+|++....... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 3799999999999999984 58899999987654333 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++|+|.+++.+. .+++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.+.... .
T Consensus 97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 999999999988764 5999999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+.+++.++|||||||++|+|+||..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 3345679999999999999999999999999999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=338.02 Aligned_cols=192 Identities=28% Similarity=0.431 Sum_probs=166.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++..... .+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 699999999999999983 488999999875432 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC-CC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~-~~ 309 (352)
|+++|+|.+++...+.+++.++..++.|+++||.|||++| |+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999988778999999999999999999999999 9999999999999999999999999998765332 22
Q ss_pred CcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+..+ +.++|||||||++|||+||..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~ 204 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 204 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCC
Confidence 2345679999999999988776 567999999999999999963
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=340.51 Aligned_cols=194 Identities=22% Similarity=0.419 Sum_probs=169.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||||++...........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 599999999999999983 478999999875433233345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC-C
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~-~ 309 (352)
|+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCC
Confidence 2344679999999999999999999999999999999999963
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=341.32 Aligned_cols=193 Identities=27% Similarity=0.418 Sum_probs=172.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++.+.........+.+.+|+.+|++++||||++++++|.+++.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 688999999999999983 588999999976543333345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+++|+|.+++.+.+.+++..+..++.|++.||+|||++| |+||||||+|||++.+|.+||+|||+|+...... ..
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-cc
Confidence 9999999999999888999999999999999999999999 9999999999999999999999999998754332 23
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCC
Confidence 344678999999999999999999999999999999999963
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=340.05 Aligned_cols=189 Identities=29% Similarity=0.467 Sum_probs=168.8
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
-+|++.+.||+|+||.||. +|+.||+|+++... .+...+.+.+|+.+|++++||||++++++|.+++.+|+||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4789999999999999884 58899999987543 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
||+++|+|.+++.+.+.+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|.......
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 9999999999999888899999999999999999999974 8 9999999999999999999999999998764322
Q ss_pred CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....||+.|+|||++.+.+|+.++|||||||++|||++|.
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~ 200 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 23467999999999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-46 Score=333.21 Aligned_cols=189 Identities=28% Similarity=0.448 Sum_probs=170.3
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|+..+.||+|+||.||. +|+.||||++........+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999983 578999999987666666667789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
||++|+|..++...+++++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9999999888888788999999999999999999999999 999999999999999999999999999765432
Q ss_pred cccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~~ 352 (352)
....||+.|+|||++.+ ..|+.++|||||||++|||++|..
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~ 212 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCC
Confidence 34578999999999864 468999999999999999999963
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-46 Score=335.20 Aligned_cols=190 Identities=27% Similarity=0.489 Sum_probs=171.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 689999999999999873 488999999875433233335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|++|++|..++.....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999888999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....||+.|+|||++.+..++.++|||||||++|+|+||..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~ 199 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCC
Confidence 234679999999999999999999999999999999999963
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=324.65 Aligned_cols=199 Identities=29% Similarity=0.457 Sum_probs=164.5
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 224 (352)
+||+++. +|++.+.||+|+||.||. ....||||+++..... ....+.|++|+.++++++||||+++++++. ++.
T Consensus 2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CCBCCTT--CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred Ccccccc--cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 5677655 466778999999999984 3457999999766443 445678999999999999999999999864 467
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
+++||||+++|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 89999999999999999764 55999999999999999999999999 999999999999999999999999999776
Q ss_pred cccCC-CCcccCCCCCccccccccCC---CCCCCchhHHHHHHHHHHhhccCC
Q 018682 304 TVKED-RPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 304 ~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltG~~ 352 (352)
..... .......||+.|+|||++.+ ..++.++|||||||++|||+||.+
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~ 207 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCC
Confidence 53322 23345678999999999864 357899999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=321.15 Aligned_cols=189 Identities=28% Similarity=0.542 Sum_probs=164.0
Q ss_pred ccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe----CCceEE
Q 018682 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI 227 (352)
Q Consensus 157 ~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 227 (352)
|+..++||+|+||.||. ++..||+|.+..... .....+.+.+|+++|++++||||+++++++.+ +..+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 45667899999999984 477999999876644 44556789999999999999999999999875 345899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC-CCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~vkL~Dfg~a~~~~~~ 306 (352)
||||+++|+|.+++.+...+++.++..++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+|+....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 9999999999999998888999999999999999999999986 3499999999999997 578999999999976432
Q ss_pred CCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus 168 --~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~ 209 (270)
T d1t4ha_ 168 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209 (270)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred --CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCC
Confidence 23345679999999999876 5999999999999999999996
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-46 Score=331.04 Aligned_cols=197 Identities=31% Similarity=0.551 Sum_probs=171.6
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 220 (352)
..||+++. +|+..+.||+|+||.||. +|+.||||+++..... .+.+.+|+.+|++++||||+++++++.
T Consensus 10 ~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 45777765 577788999999998873 4789999998755332 356889999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
+++.++++|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccc
Confidence 999999999999999999999764 45899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|+..............+++.|+|||++.+..++.++|||||||++|||++|+
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~ 213 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTS
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCC
Confidence 99876544333333345788999999999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=331.24 Aligned_cols=190 Identities=29% Similarity=0.423 Sum_probs=165.2
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|++.+.||+|+||.||. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 488899999999999984 57899999986542 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
|+++|+|.+++.+ ...+++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|....... .
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 9999999999765 456999999999999999999999999 9999999999999999999999999997654321 1
Q ss_pred CcccCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++. ...|+.++|||||||++|||+||.+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCC
Confidence 123467899999999984 4578999999999999999999963
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=324.91 Aligned_cols=195 Identities=23% Similarity=0.430 Sum_probs=157.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--CCceEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 228 (352)
+|++.+.||+|+||.||. +|+.||+|++..... .+...+.+.+|++++++++||||+++++++.+ ++.+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 688999999999999983 478999999987654 45556788999999999999999999999864 4668999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~--~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
|||+++|+|.+++.+ ...+++..++.++.|++.||.|||++++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 4569999999999999999999998641 1399999999999999999999999999987
Q ss_pred ccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCC
Confidence 654322 2334678999999999999999999999999999999999963
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=323.92 Aligned_cols=189 Identities=31% Similarity=0.544 Sum_probs=156.7
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..+.||+|+||.||. +++.||||++...... .+.+.+|+.++++++||||+++++++..++.+++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 577889999999998873 5778999999765332 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999998765 45889999999999999999999999 9999999999999999999999999998765544444
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.....+|+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~ 199 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCC
Confidence 44466889999999999999999999999999999999965
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-46 Score=331.15 Aligned_cols=190 Identities=25% Similarity=0.429 Sum_probs=153.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
.|++.+.||+|+||.||. +|+.||||++....... ....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 489999999999998873 48899999997654322 23567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC---CCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~vkL~Dfg~a~~~~~~~ 307 (352)
|++||+|.+++.+.+.+++.++..++.||+.||.|||+++ |+||||||+|||+. .++.+||+|||+|+......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999998888999999999999999999999999 99999999999995 47889999999998654322
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 207 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCC
Confidence 2334678999999999999999999999999999999999963
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-46 Score=324.01 Aligned_cols=197 Identities=31% Similarity=0.505 Sum_probs=168.9
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEE---E-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAF---W-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~---~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 220 (352)
..+||++.. +|++.+.||+|+||.|| + +++.||||++...... .+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 346777654 67888899999999998 3 4678999999754332 356899999999999999999999875
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
++.+++||||+++|+|.+++... ..+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence 46789999999999999977533 35899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|+..............+|+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~ 207 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTT
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCC
Confidence 99877644433444566889999999999889999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-46 Score=335.24 Aligned_cols=190 Identities=25% Similarity=0.404 Sum_probs=171.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+...+++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 799999999999999983 588999999875433223334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
|+.+|+|..++.+.+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.....||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~ 236 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCC
Confidence 234568999999999999999999999999999999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=323.08 Aligned_cols=193 Identities=25% Similarity=0.401 Sum_probs=170.5
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
-+|++.+.||+|+||.||. +|+.||||++.+...... ...+.+.+|+.+|++++||||++++++|.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3699999999999999984 488999999876543321 23467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC----CEEEEccCCccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL 302 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~vkL~Dfg~a~~ 302 (352)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999998888999999999999999999999999 99999999999999776 499999999987
Q ss_pred ccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
..... ......+|+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCC
Confidence 65332 2334568999999999999999999999999999999999963
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-45 Score=330.23 Aligned_cols=188 Identities=23% Similarity=0.405 Sum_probs=168.0
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 799999999999999984 4889999999754 34455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC--CCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~vkL~Dfg~a~~~~~~~ 307 (352)
|+++|+|.+++. ..+.+++.++..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 999999999985 4456999999999999999999999999 999999999999964 578999999999876532
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......||+.|+|||++.+..++.++|||||||++|+|+||.
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~ 222 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSS
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCC
Confidence 3334567899999999999999999999999999999999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=318.51 Aligned_cols=194 Identities=26% Similarity=0.421 Sum_probs=166.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCc----eE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----MM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~ 226 (352)
+|++.+.||+|+||.||. +|+.||||++......+.+....+.+|+.+++.++||||+++++++..++. +|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 589999999999999984 588999999988777777777889999999999999999999999987543 89
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
+||||++|++|.+++...+.+++.++..++.|++.||.|||++| |+||||||+|||++.++.++|+|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999999998888999999999999999999999999 999999999999999999999999988765432
Q ss_pred CC--CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 307 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. .......||+.|+|||++.+..+++++|||||||++|||+||..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence 22 22344578999999999999999999999999999999999963
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.2e-45 Score=328.40 Aligned_cols=188 Identities=18% Similarity=0.369 Sum_probs=167.6
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++... .......+.+|+.+|++++||||++++++|.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 599999999999999983 5889999998754 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeC--CCCCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||+||+|.+++...+ ++++.++..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 999999998876544 5999999999999999999999999 99999999999998 5789999999999876532
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||++.+..++.++|||||||++|+|+||.
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCC
Confidence 2334567899999999999999999999999999999999996
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.6e-45 Score=329.95 Aligned_cols=191 Identities=25% Similarity=0.373 Sum_probs=164.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|++.+.||+|+||.||. +|+.||+|++.+..... .........|+.+++.++||||++++++|.+++.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 688999999999999983 58899999986543221 1122223345777888899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccC
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~ 307 (352)
||||+++|+|.+++.+...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999998888999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.. ..++.++|||||||++|||+||..
T Consensus 161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~ 204 (364)
T d1omwa3 161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204 (364)
T ss_dssp --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCC
Confidence 2234578999999999864 578999999999999999999963
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-44 Score=319.33 Aligned_cols=190 Identities=33% Similarity=0.542 Sum_probs=155.0
Q ss_pred cccCceeecccEEEEEEEc-----C---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFWR-----G---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~-----~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|+..+.||+|+||.||.. + ..||+|.+... ......+.|.+|+.+|++++||||+++++++..++.+++
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 5778899999999999731 2 35899988654 245566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
||||+++|+|.+++... +.+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999988874 45899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCc----ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 307 EDRPL----TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 307 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
..... ....+|+.|+|||++.+..++.++|||||||++|||+|+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhC
Confidence 22211 123468899999999999999999999999999999983
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=324.25 Aligned_cols=193 Identities=30% Similarity=0.451 Sum_probs=168.1
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh-cCCCCceeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ 229 (352)
+|++.+.||+|+||.||. +|+.||||++.+......+..+.+..|..++. .++||||+++++++.+++.+|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 688899999999999983 68999999997543222223345566666654 689999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC
Q 018682 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (352)
Q Consensus 230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~ 309 (352)
||+++|+|.+++.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999998655332 2
Q ss_pred CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
......||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 201 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCC
Confidence 3344678999999999999999999999999999999999963
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=317.48 Aligned_cols=186 Identities=27% Similarity=0.415 Sum_probs=158.2
Q ss_pred eeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEeccC
Q 018682 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (352)
Q Consensus 161 ~~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 233 (352)
++||+|+||.||. .++.||||+++.... ++...+.+.+|+.+|++++||||+++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 5799999999974 236799999976543 34556789999999999999999999999865 56789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCC--Cc
Q 018682 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 311 (352)
Q Consensus 234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~--~~ 311 (352)
+|+|.+++.+...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999998888999999999999999999999999 999999999999999999999999999876433221 12
Q ss_pred ccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
....+|+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCC
Confidence 33568899999999999999999999999999999998 54
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=310.25 Aligned_cols=188 Identities=28% Similarity=0.520 Sum_probs=167.2
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|+..+.||+|+||.||. +++.||||+++..... .+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 677788999999999984 5779999999765432 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
+++|+|.+++.. ...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999998764 455889999999999999999999999 9999999999999999999999999998766544444
Q ss_pred cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
.....+|+.|+|||++.+..++.++|||||||++|||+|+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~ 197 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 197 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhc
Confidence 4456789999999999999999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=313.10 Aligned_cols=196 Identities=31% Similarity=0.531 Sum_probs=161.3
Q ss_pred ccCCCCCcccCceeecccEEEEEEE---c--C----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEE
Q 018682 149 EIDPHELDFTNSVEITKGTFILAFW---R--G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (352)
Q Consensus 149 ~i~~~~~~~~~~~~ig~G~~~~v~~---~--~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 219 (352)
||++. .|+..+.||+|+||.||. . + ..||||++.... .+.....+.+|+.++++++||||+++++++
T Consensus 3 ei~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 3 EIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp BCCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence 44444 577889999999999873 2 1 479999987542 445556789999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 220 TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 220 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
.+.+.++++|||+.++++.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999999999999988654 56999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~ 210 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCC
Confidence 99876443222 122345788999999999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-43 Score=309.54 Aligned_cols=191 Identities=26% Similarity=0.377 Sum_probs=168.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCC
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS 223 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 223 (352)
+|++.+.||+|+||.||. +|+.||||++....... +...+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 688999999999999984 68899999987654332 223456788999999997 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+||||+++|+|.+++...+.+++.++..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999998889999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcccCCCCCccccccccC------CCCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~elltG~ 351 (352)
... .......||+.|+|||++. ...++.++||||+||++|+|+||.
T Consensus 161 ~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 161 DPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 542 2334467899999999885 335688999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=314.98 Aligned_cols=197 Identities=32% Similarity=0.499 Sum_probs=162.9
Q ss_pred CCCcccCCCCCcccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEE
Q 018682 145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (352)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 220 (352)
...|+|+.. +|++.+.||+|+||.||. +++.||||++...... .+.|.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 9 KDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TTCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 346777654 688899999999999873 4568999999755432 256889999999999999999999985
Q ss_pred eCCceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 221 QSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 221 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
++.+++||||+++|+|..++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 83 -~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 83 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp -SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccc
Confidence 5678999999999999988753 356999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+++..............+|+.|+|||++....++.++|||||||++|||+||+
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~ 211 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 211 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCC
Confidence 99876544444444567899999999999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=313.35 Aligned_cols=190 Identities=24% Similarity=0.421 Sum_probs=162.5
Q ss_pred cccCce-eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~-~ig~G~~~~v~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 227 (352)
+|.... +||+|+||.||. ++..||||+++.. ......+.+.+|+.+|++++||||+++++++.+ +.+|+
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 455555 499999999974 2457999999754 345667789999999999999999999999865 56899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
||||+++|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998653 56999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 307 EDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 307 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
... ......+|+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~ 210 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCC
Confidence 221 2234567889999999998899999999999999999998 54
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=311.61 Aligned_cols=196 Identities=23% Similarity=0.452 Sum_probs=157.2
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 218 (352)
+|||+.. +|+..+.||+|+||.||. .+..||+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4677654 688889999999999873 1356899988643 355666789999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEcc
Q 018682 219 VTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (352)
Q Consensus 219 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Df 297 (352)
+. ++.+|+||||+++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccc
Confidence 85 56789999999999999987654 46899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhcc
Q 018682 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFY 350 (352)
Q Consensus 298 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG 350 (352)
|+|+..............+|+.|+|||++.+..++.++|||||||++|||+|+
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~ 205 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 205 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred hhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhc
Confidence 99987655444444556688999999999999999999999999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=320.41 Aligned_cols=197 Identities=29% Similarity=0.468 Sum_probs=164.0
Q ss_pred cccCCCCCcccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeee
Q 018682 148 YEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFL 216 (352)
Q Consensus 148 ~~i~~~~~~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 216 (352)
||+++. +|++.+.||+|+||.||.. ...||+|.+.... .......+.+|+.+++++ +||||++++
T Consensus 32 wei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 32 WEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 555543 5778899999999999742 1369999887543 233446788999999988 899999999
Q ss_pred EEEEeCCceEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 018682 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVP 273 (352)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ 273 (352)
+++.+.+.+|+||||+++|+|.+++.... .+++..++.++.|++.||.|||+++
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--- 184 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--- 184 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 99999999999999999999999997542 4788999999999999999999999
Q ss_pred ceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 274 ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
|+||||||+|||++.++.+||+|||+|+......... .....+|+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 9999999999999999999999999998765433222 123456899999999999999999999999999999998 54
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=316.19 Aligned_cols=187 Identities=18% Similarity=0.316 Sum_probs=165.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|++.... .....+.+|+++|++++||||++++++|.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 689999999999999983 58899999997542 223567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC--CCEEEEccCCcccccccC
Q 018682 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~vkL~Dfg~a~~~~~~~ 307 (352)
||+|++|.+++...+ .+++.++..++.||+.||+|||++| |+||||||+|||++.+ ..+||+|||++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999999998665 6999999999999999999999999 9999999999999854 47999999999875432
Q ss_pred CCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~ 200 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCC
Confidence 2233456789999999999999999999999999999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=314.74 Aligned_cols=189 Identities=30% Similarity=0.448 Sum_probs=158.3
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH--HHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEecc
Q 018682 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (352)
Q Consensus 160 ~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 232 (352)
.+.||+|+||.||. +|+.||||++........ ...+.+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999983 588999999976543221 12346889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCcc
Q 018682 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (352)
Q Consensus 233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~~ 312 (352)
.++++..+......+++.++..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... ....
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 88887777766677999999999999999999999999 9999999999999999999999999997765432 2233
Q ss_pred cCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 313 CQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 313 ~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
...+|+.|+|||++.. ..++.++|||||||++|||+||.+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence 4568999999998865 467999999999999999999963
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=314.12 Aligned_cols=184 Identities=27% Similarity=0.391 Sum_probs=158.5
Q ss_pred cccCce-eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc-CCCCceeeeeEEEEe----CCc
Q 018682 156 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ----SSP 224 (352)
Q Consensus 156 ~~~~~~-~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~~ 224 (352)
+|.+.. .||+|+||.||. +++.||||++... ..+++|+.++.+ .+||||++++++|.+ +..
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 687764 599999999983 5789999998632 356789988654 589999999999876 456
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccCC
Q 018682 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg~ 299 (352)
+|+|||||+||+|.+++.+. ..+++.++..++.||+.||.|||++| |+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 89999999999999999874 35899999999999999999999999 999999999999985 45799999999
Q ss_pred cccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 300 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
|+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||..
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 98765432 3344678999999999999999999999999999999999963
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-43 Score=302.64 Aligned_cols=190 Identities=33% Similarity=0.612 Sum_probs=157.2
Q ss_pred cccCCCCCcccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-CC
Q 018682 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 223 (352)
Q Consensus 148 ~~i~~~~~~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 223 (352)
|+++..+ |+..+.||+|+||.|| +.|.+||||+++... ..+.+.+|++++++++||||+++++++.+ ++
T Consensus 2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 6676664 5667899999999887 789999999997542 23578899999999999999999999854 46
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence 7899999999999999986543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
..... .....+++.|+|||++.+..++.++|||||||++|||+|++
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~ 197 (262)
T d1byga_ 152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCC
Confidence 65432 22345688999999999899999999999999999999853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=309.28 Aligned_cols=199 Identities=30% Similarity=0.486 Sum_probs=158.4
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceee
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQ 214 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~ 214 (352)
..|+++.. +|+..+.||+|+||.||. +++.||+|++.... .....+.+.+|..++.++ +|+||+.
T Consensus 6 ~~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 34566543 688889999999999984 24689999987543 344556677788877776 6899999
Q ss_pred eeEEEEeC-CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 018682 215 FLGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (352)
Q Consensus 215 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 277 (352)
+++++... ..++++|||+++|+|.+++... ..+++.++..++.|+++||.|||+++ |+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 99987654 4689999999999999999753 23789999999999999999999999 9999
Q ss_pred CCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 278 Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence 99999999999999999999999876543332 233457899999999999999999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=304.47 Aligned_cols=201 Identities=30% Similarity=0.532 Sum_probs=167.1
Q ss_pred cCCCcccCCCCCcccCceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCC
Q 018682 144 EVPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP 210 (352)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~ig~G~~~~v~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 210 (352)
..|.|+++.. +|.+.+.||+|+||.||.. +..||||+++... .......+.+|...+.++ +||
T Consensus 4 ~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 4 EDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred cCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCC
Confidence 3456777665 6777899999999988731 2479999997653 445566788898988888 799
Q ss_pred ceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 018682 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPI 274 (352)
Q Consensus 211 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i 274 (352)
||+++++++.+++.+++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+++ |
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---i 156 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---C 156 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---E
Confidence 9999999999999999999999999999999754 24899999999999999999999999 9
Q ss_pred eecCCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 275 vH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+||||||+|||++.++.+||+|||++......... ......+++.|+|||.+.+..|+.++|||||||++|||++++
T Consensus 157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g 234 (299)
T d1fgka_ 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234 (299)
T ss_dssp CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence 99999999999999999999999999876544332 234456788999999999999999999999999999999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=307.70 Aligned_cols=192 Identities=26% Similarity=0.391 Sum_probs=163.5
Q ss_pred CCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHH---HHHHHHHHHHHHhcCC--CCceeeeeEEEEeCC
Q 018682 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD---RVRAFRDELALLQKIR--HPNVVQFLGAVTQSS 223 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 223 (352)
..+|++.+.||+|+||.||. +|+.||||++......... ....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 45799999999999999983 5889999998765433211 1123567999999986 899999999999999
Q ss_pred ceEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCC-CCEEEEccCCcc
Q 018682 224 PMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSK 301 (352)
Q Consensus 224 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~vkL~Dfg~a~ 301 (352)
.+++||||+.+ +++.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+|.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 99999999975 688899988888999999999999999999999999 9999999999999854 789999999997
Q ss_pred cccccCCCCcccCCCCCccccccccCCCCC-CCchhHHHHHHHHHHhhccC
Q 018682 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltG~ 351 (352)
..... ......||+.|+|||++.+..+ +.++|||||||++|||+||.
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~ 207 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCC
Confidence 65332 3344678999999999987665 56789999999999999996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-42 Score=305.04 Aligned_cols=191 Identities=32% Similarity=0.506 Sum_probs=165.8
Q ss_pred cccCceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
+|+..+.||+|+||.||.. ++.||||++.... ..+..+.+.+|+.++++++||||+++++++...+..
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 6888999999999999832 3689999987542 455567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 018682 226 MIVTEYLPKGDLRAFLKRKG------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp 281 (352)
+++|||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999996432 3788899999999999999999999 99999999
Q ss_pred CCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 282 ~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
+|||++.++.+||+|||+|+........ ......+++.|+|||++.+..++.++|||||||++|||++|+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 9999999999999999999765433322 223456788999999999999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=304.10 Aligned_cols=193 Identities=28% Similarity=0.481 Sum_probs=154.6
Q ss_pred CcccCceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceE
Q 018682 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 226 (352)
.+|++.+.||+|+||.||.. ..+||||++.+.....++..+.+.+|+.++++++||||+++++++.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 36888999999999988731 24799999987766666777889999999999999999999999965 5789
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+||||++++++.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999999999987765 356999999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCC--CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhc-cC
Q 018682 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKF-YN 351 (352)
Q Consensus 306 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-G~ 351 (352)
.... ......++..|+|||++.+..++.++|||||||++|||+| |.
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~ 212 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCC
Confidence 3322 1223456788999999999999999999999999999998 54
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=306.80 Aligned_cols=191 Identities=26% Similarity=0.500 Sum_probs=158.2
Q ss_pred CcccCceeecccEEEEEEE-----cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCce
Q 018682 155 LDFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 225 (352)
.+|++.+.||+|+||.||. +| .+||+|.+.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCe
Confidence 3699999999999999973 23 268999886442 23345678999999999999999999999976 467
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
++++|++.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8888999999998888764 56999999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 305 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
...... .....+|+.|+|||++.+..++.++|||||||++|||+|++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g 210 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 210 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCC
Confidence 433222 23345789999999999999999999999999999999954
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=304.93 Aligned_cols=190 Identities=27% Similarity=0.532 Sum_probs=158.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||+|+++.... .+...+.+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 688999999999999883 488999999975532 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCC
Q 018682 231 YLPKGDLRAFLK-R-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (352)
Q Consensus 231 ~~~~~~L~~~l~-~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~ 308 (352)
|+.+ ++.+++. . ...+++.++..++.|++.||+|||++| |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9965 4444443 3 345999999999999999999999999 9999999999999999999999999997765332
Q ss_pred CCcccCCCCCccccccccCCCC-CCCchhHHHHHHHHHHhhccC
Q 018682 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||.+.... ++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~ 200 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence 2334456899999999876655 578999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=302.52 Aligned_cols=198 Identities=30% Similarity=0.452 Sum_probs=170.6
Q ss_pred CcccCCCCCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeee
Q 018682 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (352)
Q Consensus 147 ~~~i~~~~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 215 (352)
.|++++. +|+..+.||+|+||.||. +++.||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4677665 667788999999999984 34689999997543 455566789999999999 69999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 018682 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (352)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 277 (352)
++++.+.+.++++|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999999999987543 4889999999999999999999999 9999
Q ss_pred CCCCCCeEeCCCCCEEEEccCCcccccccCCC-CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 278 Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
||||+||+++.++.+|++|||.++........ ......+|+.|+|||++.+..++.++|||||||++|||+|++
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 99999999999999999999999876543322 223356789999999999999999999999999999999965
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=302.48 Aligned_cols=190 Identities=34% Similarity=0.566 Sum_probs=159.0
Q ss_pred cccCceeecccEEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCceeeeeEEEEeCCceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 227 (352)
+|+..+.||+|+||.||. +|. .||||.+... ...+..+.+.+|+.+|+++ +||||+++++++.+++.+++
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 566778999999999873 333 5778877533 2334456789999999998 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCC
Q 018682 228 VTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 291 (352)
||||+++|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999753 45899999999999999999999999 999999999999999999
Q ss_pred EEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 292 vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
+||+|||+++........ ....+|..|+|||.+.+..++.++|||||||++|||++|++
T Consensus 166 ~kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~ 224 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224 (309)
T ss_dssp EEECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred eEEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCC
Confidence 999999999765433222 23457889999999999999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-41 Score=297.47 Aligned_cols=199 Identities=28% Similarity=0.483 Sum_probs=170.9
Q ss_pred CCcccCCCCCcccCceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeee
Q 018682 146 PEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215 (352)
Q Consensus 146 ~~~~i~~~~~~~~~~~~ig~G~~~~v~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 215 (352)
..|++++. +|+..+.||+|+||.||. .++.||||+++.. ........+.+|+.++++++||||+++
T Consensus 13 ~~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 13 DEWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CTTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 35778765 677889999999999973 2468999999754 244555678999999999999999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeE
Q 018682 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (352)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 285 (352)
++++..+...++||||+++|+|.+++... ..++...+..++.|+++||.|||+++ |+||||||+|||
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiL 165 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 165 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCcee
Confidence 99999999999999999999999988642 23688899999999999999999999 999999999999
Q ss_pred eCCCCCEEEEccCCcccccccCCCC-cccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 286 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 286 l~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||+||+
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 9999999999999998665433222 23345789999999999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=296.70 Aligned_cols=191 Identities=30% Similarity=0.503 Sum_probs=162.0
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe-CCceE
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 226 (352)
.+...+.||+|+||.||. ....||||++.. .......+.+.+|++++++++||||+++++++.. ++..+
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 333357899999999983 123699999864 3456667889999999999999999999999876 46799
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+||||+++++|.+++.... .++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999999999988544 4778889999999999999999999 99999999999999999999999999987653
Q ss_pred cCCC---CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 306 KEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 306 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
.... ......+|+.|+|||.+....++.++||||||+++|||+||+
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~ 231 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCC
Confidence 3222 122356789999999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-41 Score=299.52 Aligned_cols=191 Identities=27% Similarity=0.480 Sum_probs=162.5
Q ss_pred cccCceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEec
Q 018682 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 231 (352)
+|++.+.||+|+||.||. +|+.||||++..... .+...+.+.+|+.+|++++||||+++++++..++..+++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 788999999999999984 478999999976543 222346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCCc
Q 018682 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (352)
Q Consensus 232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~~ 311 (352)
+.++.+..+....+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+........ ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 988777777776778999999999999999999999999 99999999999999999999999999987654322 23
Q ss_pred ccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 312 TCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 312 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
....+++.|+|||.+.+ ..++.++|||||||++|||++|.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 34567889999999865 46689999999999999999996
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=297.66 Aligned_cols=188 Identities=28% Similarity=0.444 Sum_probs=154.3
Q ss_pred cccCceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC----ceEEE
Q 018682 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 228 (352)
+|...+.||+|+||.|| ++|+.||||++.... ......+.|+..+++++||||+++++++.+++ .+|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 57778899999999886 689999999986432 12222334556666789999999999998654 58999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCCCceecCCCCCCeEeCCCCCEEEEccCCc
Q 018682 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE--------NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a 300 (352)
|||+++|+|.+++++. .+++..+..++.|++.||.|+|+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999875 58999999999999999999997 46 999999999999999999999999999
Q ss_pred ccccccCCC---CcccCCCCCccccccccCCCC------CCCchhHHHHHHHHHHhhccC
Q 018682 301 KLLTVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 301 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~elltG~ 351 (352)
+........ ......||+.|+|||++.+.. ++.++|||||||++|||+||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~ 215 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTB
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCC
Confidence 876543321 223467899999999987642 567899999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=303.67 Aligned_cols=194 Identities=24% Similarity=0.364 Sum_probs=167.9
Q ss_pred cccCceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCC-CceeeeeEEEEeCCce
Q 018682 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~--------~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 225 (352)
+|++.+.||+|+||.||. +|+.||||++.+.... +....+.+.+|+.++++++| |||+++++++.+...+
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 599999999999999984 3789999998765432 12223567789999999976 8999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+++|||+.+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..+..
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999987655
Q ss_pred cCCCCcccCCCCCccccccccCCC--CCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltG~~ 352 (352)
..........+++.|+|||.+.+. .++.++|||||||+||+|+||+.
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 444444556789999999998754 46789999999999999999963
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=299.38 Aligned_cols=192 Identities=28% Similarity=0.461 Sum_probs=157.5
Q ss_pred CCcccCceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCceeeeeEEEEe---
Q 018682 154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ--- 221 (352)
Q Consensus 154 ~~~~~~~~~ig~G~~~~v~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~--- 221 (352)
+-+|++.+.||+|+||.||. .++.||||++....... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 34799999999999999973 25679999986543322 1122355677777665 79999999999863
Q ss_pred --CCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 222 --SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 222 --~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
...++++||+++++.+...... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 3468999999988776555443 345899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++...... .......||+.|+|||++.+.+|+.++|||||||++|||+||.
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~ 212 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCC
Confidence 98765432 2334567899999999999999999999999999999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=297.64 Aligned_cols=187 Identities=27% Similarity=0.438 Sum_probs=157.6
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 223 (352)
-+|++.+.||+|+||.||. +|+.||||++.... ..+...+.+.+|+.+|++++||||++++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3799999999999999984 48899999998654 35556678889999999999999999999997654
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.+|+||||+ +.+|..+.+. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|...
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 479999999 6788887765 46999999999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~ 216 (346)
T d1cm8a_ 172 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216 (346)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCc
Confidence 43 2344678999999998866 45689999999999999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=290.26 Aligned_cols=191 Identities=24% Similarity=0.453 Sum_probs=168.8
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCCceEEEEe
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 230 (352)
+|++.+.||+|+||.||. +|+.||||+++.... .+.....+.+|+.+++.++||||+++++++.+....++++|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 689999999999999984 578899999976543 34456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccccCCCC
Q 018682 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (352)
Q Consensus 231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~~~~~ 310 (352)
++.++++..++...+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+....... ..
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-cc
Confidence 9999999998888888999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred cccCCCCCccccccccCCCC-CCCchhHHHHHHHHHHhhccC
Q 018682 311 LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltG~ 351 (352)
.....+++.|+|||++.... ++.++|||||||++|||++|+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~ 199 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence 33455778899999887654 689999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=295.49 Aligned_cols=190 Identities=27% Similarity=0.459 Sum_probs=157.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeCC----ceE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMM 226 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~ 226 (352)
+|++.+.||+|+||.||. +|+.||||++... ......+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 599999999999999873 5889999998753 24555677889999999999999999999987653 234
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccccc
Q 018682 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (352)
Q Consensus 227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~~ 306 (352)
++++++.+++|.+++... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 445556689999999764 5999999999999999999999999 999999999999999999999999999766443
Q ss_pred CCC--CcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~ 351 (352)
... ......+|+.|+|||++.. ..++.++||||+||++|+|++|.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~ 210 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence 222 2344568999999999854 46788999999999999999996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-39 Score=288.38 Aligned_cols=189 Identities=19% Similarity=0.228 Sum_probs=162.3
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-CceeeeeEEEEeCCceEEE
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 228 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 228 (352)
-+|++.+.||+|+||.||. +|+.||||++...... ..+++|++.++.++| ++++.+++++..+...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 3689999999999999984 5889999988654322 346789999999975 8999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC-----CCCEEEEccCCccc
Q 018682 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKL 302 (352)
Q Consensus 229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~vkL~Dfg~a~~ 302 (352)
|||+ +++|.+++...+ .++..++..++.|++.||+|||++| |+||||||+|||++. .+.+||+|||+|+.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999 789999987654 5999999999999999999999999 999999999999974 56799999999987
Q ss_pred ccccCC------CCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 303 LTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 303 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
...... .......||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~ 211 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 211 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCC
Confidence 653321 12234568999999999999999999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=296.53 Aligned_cols=190 Identities=29% Similarity=0.435 Sum_probs=157.0
Q ss_pred CCCCCcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC---
Q 018682 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--- 222 (352)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 222 (352)
.+.+.+|+..+.||+|+||.||. +|+.||||++..... ...+|+.+|++++||||++++++|...
T Consensus 16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp CCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 44566899999999999999983 588999999875432 234699999999999999999998643
Q ss_pred ---CceEEEEeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEE
Q 018682 223 ---SPMMIVTEYLPKGDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVA 295 (352)
Q Consensus 223 ---~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~ 295 (352)
..+|+||||++++.+..+ ......+++.++..++.||+.||+|||++| |+||||||+|||++.++ .+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEEC
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEe
Confidence 247899999976543333 234556999999999999999999999999 99999999999999775 89999
Q ss_pred ccCCcccccccCCCCcccCCCCCccccccccCC-CCCCCchhHHHHHHHHHHhhccCC
Q 018682 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 296 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltG~~ 352 (352)
|||++....... ......|++.|+|||.+.+ ..++.++|||||||++|||++|..
T Consensus 166 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 166 DFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp CCTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred cccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCC
Confidence 999998764332 3334578899999998764 578999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=295.28 Aligned_cols=194 Identities=25% Similarity=0.383 Sum_probs=159.4
Q ss_pred CcccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEe--------
Q 018682 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------- 221 (352)
Q Consensus 155 ~~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 221 (352)
-+|++.+.||+|+||.||. +|+.||||++...... +.....+.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4899999999999999983 5789999998765432 2234567889999999999999999998855
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcc
Q 018682 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (352)
Q Consensus 222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~ 301 (352)
++.+|++|||++++.+..+......+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 3468999999987777666556667999999999999999999999999 9999999999999999999999999997
Q ss_pred cccccC---CCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 302 LLTVKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 302 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
...... ........+|+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCC
Confidence 665322 1222345689999999998765 78999999999999999999963
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.2e-39 Score=288.52 Aligned_cols=182 Identities=21% Similarity=0.424 Sum_probs=156.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeC--CceEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI 227 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l 227 (352)
+|++.+.||+|+||.||. +|+.||||+++... .+.+.+|+.+|++++ ||||++++++|... ..+++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 699999999999999984 58899999986432 356788999999995 99999999999854 56999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCC-CEEEEccCCccccccc
Q 018682 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (352)
Q Consensus 228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~vkL~Dfg~a~~~~~~ 306 (352)
||||+++++|..+. ..+++.++..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+|......
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999997764 45999999999999999999999999 99999999999998655 5999999999876533
Q ss_pred CCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccC
Q 018682 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~ 351 (352)
.......+|+.|+|||.+.+. .++.++||||+||++|+|++|+
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~ 227 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCC
Confidence 233445688999999997765 5799999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-39 Score=284.35 Aligned_cols=188 Identities=18% Similarity=0.219 Sum_probs=155.5
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc-eeeeeEEEEeCCceEEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVT 229 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 229 (352)
+|++.+.||+|+||.||. +|+.||||++...... ..+..|++++++++|++ |+.+..++.+++..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 599999999999999983 4889999987754322 34778999999998766 455566667778899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCC---CCCEEEEccCCcccccc
Q 018682 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (352)
Q Consensus 230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~vkL~Dfg~a~~~~~ 305 (352)
||+ ++++.+.+.. ...+++..+..++.|++.||+|||++| |+||||||+|||++. +..++|+|||+|+....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 5566666554 456999999999999999999999999 999999999999864 44699999999987654
Q ss_pred cCCC------CcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.... ......||+.|+|||++.+.+++.++|||||||++|||+||..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCC
Confidence 3221 2234578999999999999999999999999999999999963
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=288.07 Aligned_cols=188 Identities=26% Similarity=0.355 Sum_probs=152.7
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC------Cc
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 224 (352)
+|++.+.||+|+||.|+. +|+.||||++..... +......+.+|+.++++++||||++++++|... ..
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 699999999999999984 589999999976643 455667788999999999999999999999643 57
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCccccc
Q 018682 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (352)
Q Consensus 225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~ 304 (352)
+|+||||+.++.+ +.+ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.++++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence 8999999966544 444 345899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccCC
Q 018682 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~~ 352 (352)
.. .......+|+.|+|||++.+..+++++||||+||++|+|++|+.
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCC
Confidence 32 23344568899999999999999999999999999999999973
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=287.92 Aligned_cols=188 Identities=29% Similarity=0.428 Sum_probs=156.9
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCceeeeeEEEEeC-----Cce
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 225 (352)
+|++.+.||+|+||.||. +|+.||||++.... .+....+.+.+|+.+|++++||||+++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 599999999999998873 58999999998654 3455556788999999999999999999998643 334
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccCCcccccc
Q 018682 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (352)
Q Consensus 226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~~~ 305 (352)
+++++++.+++|.+++.. +.+++.++..++.||+.||.|||++| |+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 666777789999999865 46999999999999999999999999 99999999999999999999999999876432
Q ss_pred cCCCCcccCCCCCccccccccCCC-CCCCchhHHHHHHHHHHhhccCC
Q 018682 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEVKFYNQ 352 (352)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltG~~ 352 (352)
......+++.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCC
Confidence 23345678899999987665 56889999999999999999963
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=1e-32 Score=251.10 Aligned_cols=185 Identities=22% Similarity=0.357 Sum_probs=148.4
Q ss_pred cccCceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----------CCceeeeeEEE
Q 018682 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGAV 219 (352)
Q Consensus 156 ~~~~~~~ig~G~~~~v~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~ 219 (352)
+|++.+.||+|+||.||. +|+.||||++... ....+.+.+|+.+++.+. |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 599999999999999983 5899999999743 333456778998888774 57899999888
Q ss_pred EeC--CceEEEEeccCCC-CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeEeCCCCC--
Q 018682 220 TQS--SPMMIVTEYLPKG-DLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN-- 291 (352)
Q Consensus 220 ~~~--~~~~lv~e~~~~~-~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~-- 291 (352)
... ...+++++++... ....... ....+++..+..++.|++.||.|||+ .| |+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 653 4455666655443 3333333 23458899999999999999999998 77 999999999999986653
Q ss_pred ----EEEEccCCcccccccCCCCcccCCCCCccccccccCCCCCCCchhHHHHHHHHHHhhccC
Q 018682 292 ----LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEVKFYN 351 (352)
Q Consensus 292 ----vkL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltG~ 351 (352)
++++|||.+..... ......+|+.|+|||++.+..++.++|+||+||++++|++|+
T Consensus 167 ~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp TEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCC
Confidence 99999999876543 223456899999999999999999999999999999999986
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.89 E-value=1.1e-23 Score=159.40 Aligned_cols=106 Identities=30% Similarity=0.393 Sum_probs=98.6
Q ss_pred chHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHH
Q 018682 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (352)
Q Consensus 41 ~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~ 120 (352)
+|||++||..|+.++++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+
T Consensus 3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~ 82 (118)
T d1myoa_ 3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS 82 (118)
T ss_dssp HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCcccccccccCC
Q 018682 121 VIKLLEKHGAKPLMAPMHVKHAREVP 146 (352)
Q Consensus 121 ~~~~L~~~~~~~~~~~~~~~~~~~~~ 146 (352)
++++|++.|+++......+.++....
T Consensus 83 ~v~~Ll~~Gad~~~~d~~G~t~l~~a 108 (118)
T d1myoa_ 83 CVKLLLSKGADKTVKGPDGLTALEAT 108 (118)
T ss_dssp HHHHHHTTCCCSSSSSSSTCCCCCTC
T ss_pred hhhhhhcccccceeeCCCCCCHHHHH
Confidence 99999999999876666666655443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3.8e-24 Score=176.24 Aligned_cols=162 Identities=19% Similarity=0.142 Sum_probs=116.7
Q ss_pred cCceeecccEEEEEEE----cCeEEEEEEcCcccCC---------------CHHHHHHHHHHHHHHhcCCCCceeeeeEE
Q 018682 158 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (352)
Q Consensus 158 ~~~~~ig~G~~~~v~~----~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 218 (352)
.+.+.||+|+||.||. +|+.||||+++..... ..........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999983 6889999987643211 01122345668899999999999988765
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeEeCCCCCEEEEccC
Q 018682 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (352)
Q Consensus 219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~vkL~Dfg 298 (352)
. ..+++|||+++..+.+ ++......++.|++.++.|||++| |+||||||+|||++++ .++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCT
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECC
Confidence 3 2379999998765432 455666789999999999999999 9999999999999965 49999999
Q ss_pred CcccccccCCCCcccCCCCCccccc------cccCCCCCCCchhHHHHHHHH
Q 018682 299 VSKLLTVKEDRPLTCQDTSCRYVAP------EVFKNEEYDTKVDVFSFALIL 344 (352)
Q Consensus 299 ~a~~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~DiwslG~il 344 (352)
.|.....+... .|... +.+ ...|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 98764322111 11111 111 34678899999975433
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.89 E-value=4.9e-23 Score=162.94 Aligned_cols=99 Identities=20% Similarity=0.192 Sum_probs=92.3
Q ss_pred CccCCchHHHHHHhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 018682 36 EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~---~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 112 (352)
.+..|+||||+|+.. ++.+++++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||||+
T Consensus 41 ~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~ 120 (154)
T d1dcqa1 41 GHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDI 120 (154)
T ss_dssp CSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHH
Confidence 366899999999974 67899999999999999999999999999999999999999999999999999999999999
Q ss_pred hhccCcHHHHHHHHHcCCCCCC
Q 018682 113 AIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 113 a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
|+..|+.+++++|++.+.....
T Consensus 121 A~~~~~~~i~~~L~~~~~~~~~ 142 (154)
T d1dcqa1 121 AKRLKHEHCEELLTQALSGRFN 142 (154)
T ss_dssp HHHTTCHHHHHHHHHHHTTCCC
T ss_pred HHHcCCHHHHHHHHHhCCCCCC
Confidence 9999999999999998766543
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.8e-22 Score=154.29 Aligned_cols=93 Identities=30% Similarity=0.371 Sum_probs=85.9
Q ss_pred hHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHH
Q 018682 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (352)
Q Consensus 42 t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~ 121 (352)
+.||.||..|+.++++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|.+|.||||+|+.+|+.++
T Consensus 3 ~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~ 82 (130)
T d1ycsb1 3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV 82 (130)
T ss_dssp HHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCC
Q 018682 122 IKLLEKHGAKPLM 134 (352)
Q Consensus 122 ~~~L~~~~~~~~~ 134 (352)
+++|+++|+++..
T Consensus 83 v~~Ll~~ga~v~~ 95 (130)
T d1ycsb1 83 CKFLVESGAAVFA 95 (130)
T ss_dssp HHHHHHTTCCTTC
T ss_pred HHHHHHcCCCccc
Confidence 9999999988753
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=1e-22 Score=153.98 Aligned_cols=87 Identities=30% Similarity=0.271 Sum_probs=83.3
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.+|+.+++++|+++|+|++.+|..|.|
T Consensus 24 ~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~~G~t 103 (118)
T d1myoa_ 24 KGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLT 103 (118)
T ss_dssp TTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSSSTCC
T ss_pred hhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCCCCCC
Confidence 67788888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhc
Q 018682 109 PLGDAIY 115 (352)
Q Consensus 109 ~l~~a~~ 115 (352)
|||+|..
T Consensus 104 ~l~~a~~ 110 (118)
T d1myoa_ 104 ALEATDN 110 (118)
T ss_dssp CCCTCSS
T ss_pred HHHHHhH
Confidence 9999854
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.8e-21 Score=149.61 Aligned_cols=100 Identities=23% Similarity=0.110 Sum_probs=91.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCC-CCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~-~g~ 107 (352)
+|.|+|.++.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.+|+.+++++|+++|++++..+. .|.
T Consensus 23 ~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~~~~~~ 102 (130)
T d1ycsb1 23 EVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQ 102 (130)
T ss_dssp TTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCC
T ss_pred cCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCcccccCCCCC
Confidence 6788888999999999999999999999999999999999999999999999999999999999999999998874 588
Q ss_pred ChhHHh--hccCcHHHHHHHHHc
Q 018682 108 TPLGDA--IYYKNHEVIKLLEKH 128 (352)
Q Consensus 108 t~l~~a--~~~~~~~~~~~L~~~ 128 (352)
||++++ ...|+.+++++|...
T Consensus 103 ~~~~~~~a~~~g~~eiv~~L~~~ 125 (130)
T d1ycsb1 103 TAADKCEEMEEGYTQCSQFLYGV 125 (130)
T ss_dssp CHHHHCCSSSTTCCCHHHHHHHH
T ss_pred CHHHHHHHHHcChHHHHHHHHhH
Confidence 887765 567889999999874
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=1.1e-21 Score=149.89 Aligned_cols=98 Identities=22% Similarity=0.314 Sum_probs=86.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~-t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (352)
+|.|+|..+.+|.||||.| ..|+.+++++|+++|+++|.+|..|. ||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 25 ~gad~n~~~~~g~t~l~~a-~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~G~ 103 (125)
T d1bi7b_ 25 AGANPNAPNSYGRRPIQVM-MMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGR 103 (125)
T ss_dssp TTCCTTCCCSSSCCTTTSS-CTTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCC
T ss_pred cCCcccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCC
Confidence 5677778888889999866 47899999999999999999988865 699999999999999999999999999999999
Q ss_pred ChhHHhhccCcHHHHHHHHH
Q 018682 108 TPLGDAIYYKNHEVIKLLEK 127 (352)
Q Consensus 108 t~l~~a~~~~~~~~~~~L~~ 127 (352)
||||+|+..|+.+++++|+.
T Consensus 104 T~l~~A~~~g~~~~v~~Lls 123 (125)
T d1bi7b_ 104 LPVDLAEELGHRDVARYLRA 123 (125)
T ss_dssp CHHHHHHHHTCHHHHHHHSS
T ss_pred CHHHHHHHcCCHHHHHHHHh
Confidence 99999999999999998864
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.82 E-value=2.6e-20 Score=159.68 Aligned_cols=102 Identities=33% Similarity=0.410 Sum_probs=95.0
Q ss_pred CCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~-d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+.+.+.++.+|+||||+||..++.+++++|++++++.+.. +..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 148 ~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t 227 (255)
T d1oy3d_ 148 RLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRT 227 (255)
T ss_dssp GGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CcccccccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCC
Confidence 3455667788999999999999999999999999998865 567999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
|||+|+..++.+++++|+++|++
T Consensus 228 ~L~~A~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 228 PLGSALLRPNPILARLLRAHGAP 250 (255)
T ss_dssp HHHHHHTSSCHHHHHHHHHTTCC
T ss_pred HHHHHHHCCCHHHHHHHHHcCCC
Confidence 99999999999999999999996
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.1e-19 Score=152.99 Aligned_cols=114 Identities=26% Similarity=0.259 Sum_probs=106.1
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.|.+..+.+|.||||+|+..|+.+++++|+++|+|+|.+|.+|.||||+|+..++.+++++|++.|++++.+|..|.|
T Consensus 92 ~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~T 171 (223)
T d1uoha_ 92 KGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNT 171 (223)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred cCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCc
Confidence 66788889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCccccccc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (352)
|||+|+..|+.+++++|++.|+++........++
T Consensus 172 pL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tp 205 (223)
T d1uoha_ 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTP 205 (223)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred eeccccccCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999999999999999999999986655444444
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2.2e-20 Score=142.54 Aligned_cols=100 Identities=24% Similarity=0.257 Sum_probs=90.4
Q ss_pred CchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC-ChhHHhhccCc
Q 018682 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN 118 (352)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~-t~l~~a~~~~~ 118 (352)
+.++||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+ .|+.+++++|+++|++++.+|..|. ||||+|+..|+
T Consensus 3 ~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~ 81 (125)
T d1bi7b_ 3 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 81 (125)
T ss_dssp STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred ChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 457799999999999999999999999999999999999775 7999999999999999999998876 69999999999
Q ss_pred HHHHHHHHHcCCCCCCCccccc
Q 018682 119 HEVIKLLEKHGAKPLMAPMHVK 140 (352)
Q Consensus 119 ~~~~~~L~~~~~~~~~~~~~~~ 140 (352)
.+++++|++.|+++......+.
T Consensus 82 ~~~v~~Ll~~ga~~~~~d~~G~ 103 (125)
T d1bi7b_ 82 LDTLVVLHRAGARLDVRDAWGR 103 (125)
T ss_dssp HHHHHHHHHHTCCSSCCCTTCC
T ss_pred ccccccccccccccccccCCCC
Confidence 9999999999998765544333
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.2e-19 Score=141.39 Aligned_cols=99 Identities=26% Similarity=0.371 Sum_probs=72.8
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.|.+..+..|.+||+.|+..++.++++.++++|+++|.+|.+|+||||+|+..|+.+++++|+ .|++++.+|..|.|
T Consensus 57 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~T 135 (156)
T d1bd8a_ 57 QGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLT 135 (156)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCCCCC
Confidence 55666666667777777777777777777777777777777777777777777777777777666 56777777777777
Q ss_pred hhHHhhccCcHHHHHHHHHc
Q 018682 109 PLGDAIYYKNHEVIKLLEKH 128 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~ 128 (352)
|||+|+..|+.+++++|+++
T Consensus 136 pL~~A~~~g~~~iv~~Ll~h 155 (156)
T d1bd8a_ 136 PLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp HHHHHHHSCCHHHHHHHHTT
T ss_pred HHHHHHHcCCHHHHHHHHhh
Confidence 77777777777777777664
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=6e-19 Score=146.36 Aligned_cols=99 Identities=22% Similarity=0.229 Sum_probs=94.5
Q ss_pred hhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 018682 27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (352)
Q Consensus 27 ~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 106 (352)
.-.+.+.+..+..|+|||++|+..+..++++.|++.++++|.+|.+|.||||+||..|+.+++++|+++||+++.+|..|
T Consensus 110 ~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g 189 (209)
T d1ot8a_ 110 ITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMD 189 (209)
T ss_dssp HHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred hhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCC
Confidence 34677778888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CChhHHhhccCcHHHHHHH
Q 018682 107 STPLGDAIYYKNHEVIKLL 125 (352)
Q Consensus 107 ~t~l~~a~~~~~~~~~~~L 125 (352)
.||||+|+..|+.+++++|
T Consensus 190 ~Tpl~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 190 RLPRDVASERLHHDIVRLL 208 (209)
T ss_dssp CCHHHHHHHTTCHHHHHHH
T ss_pred CCHHHHHHHcCCHHHHhhc
Confidence 9999999999999999987
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=7e-19 Score=147.88 Aligned_cols=98 Identities=22% Similarity=0.234 Sum_probs=93.5
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|++..+.+|.||||+|+..++.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++||+++.+|..|+|
T Consensus 125 ~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~t 204 (223)
T d1uoha_ 125 GGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKT 204 (223)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred CCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 67888899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHH
Q 018682 109 PLGDAIYYKNHEVIKLLEK 127 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~ 127 (352)
|||+|. .|+.++++.|++
T Consensus 205 pl~~A~-~~~~~i~~~Ll~ 222 (223)
T d1uoha_ 205 PLQVAK-GGLGLILKRMVE 222 (223)
T ss_dssp HHHHCC-TTHHHHHHHHHC
T ss_pred HHHHHH-CCCHHHHhcccC
Confidence 999984 688899998875
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.77 E-value=3.1e-19 Score=152.84 Aligned_cols=95 Identities=23% Similarity=0.171 Sum_probs=89.1
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcCCC---CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~---~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 112 (352)
.+.+|.||||+||..|+.+++++|+++|++ +|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 5 i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~ 84 (255)
T d1oy3d_ 5 VTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHL 84 (255)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHH
T ss_pred CCcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhh
Confidence 456889999999999999999999999988 77888999999999999999999999999999999999999999999
Q ss_pred hhccCcHHHHHHHHHcCC
Q 018682 113 AIYYKNHEVIKLLEKHGA 130 (352)
Q Consensus 113 a~~~~~~~~~~~L~~~~~ 130 (352)
|+..++.+++++|++...
T Consensus 85 A~~~~~~~~~~~Ll~~~~ 102 (255)
T d1oy3d_ 85 ACRVRAHTCACVLLQPRP 102 (255)
T ss_dssp HTTTTCHHHHHHHSSSCC
T ss_pred hhccCchHHHHHHHhhcc
Confidence 999999999999977654
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.76 E-value=1.8e-18 Score=152.14 Aligned_cols=115 Identities=18% Similarity=0.198 Sum_probs=94.1
Q ss_pred cCCCCCCC-ccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH-------HHHHH---------
Q 018682 29 NGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT-------EVVSL--------- 91 (352)
Q Consensus 29 ~~~~~~~~-~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~-------~~~~~--------- 91 (352)
.+.|.|.. |.+|+||||+||..|+.++|++|+++|||+|.+|..|+||||.||..++. +++++
T Consensus 95 ~~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d 174 (301)
T d1sw6a_ 95 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED 174 (301)
T ss_dssp SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred cCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcc
Confidence 45677755 78999999999999999999999999999999999999999999976531 23222
Q ss_pred ---------------------------------HHHCCCC-------------------------------------CCC
Q 018682 92 ---------------------------------LLERGAD-------------------------------------VDP 101 (352)
Q Consensus 92 ---------------------------------Ll~~ga~-------------------------------------~~~ 101 (352)
++..+.. +|.
T Consensus 175 ~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~ 254 (301)
T d1sw6a_ 175 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA 254 (301)
T ss_dssp TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred cccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccC
Confidence 2222211 688
Q ss_pred CCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCcccccccc
Q 018682 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (352)
Q Consensus 102 ~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~ 143 (352)
+|..|+||||+|++.|+.+++++|++.|+++......+.++.
T Consensus 255 ~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl 296 (301)
T d1sw6a_ 255 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296 (301)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 999999999999999999999999999999877665555554
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.76 E-value=1.6e-18 Score=145.88 Aligned_cols=100 Identities=26% Similarity=0.267 Sum_probs=87.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWG 106 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g-a~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g 106 (352)
.+.+.+..+..|+||||+|+..|+.++++.|++.| .++|.+|.+|+||||+|+.+|+.+++++|++ .|++++.+|..|
T Consensus 127 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g 206 (229)
T d1ixva_ 127 NGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKG 206 (229)
T ss_dssp TTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTS
T ss_pred hcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCC
Confidence 56677778888999999999999999999999886 6789999999999999999999999999996 599999999999
Q ss_pred CChhHHhhccCcHHHHHHHHHcCCC
Q 018682 107 STPLGDAIYYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 107 ~t~l~~a~~~~~~~~~~~L~~~~~~ 131 (352)
.||||+|+ +.+++++|++.|+|
T Consensus 207 ~t~l~~A~---~~~~~~~Ll~~g~d 228 (229)
T d1ixva_ 207 AKAEDVAL---NEQVKKFFLNNVVD 228 (229)
T ss_dssp CCTGGGCS---CHHHHHHHHHHCCC
T ss_pred CCHHHHHh---hHHHHHHHHHcCCC
Confidence 99999987 35788999998886
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.76 E-value=3.5e-19 Score=154.21 Aligned_cols=91 Identities=22% Similarity=0.289 Sum_probs=84.7
Q ss_pred cCCchHHHHHHhcCCHHHHHHH--------HHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 38 IKPEFRLMFLANERDVEGIKEL--------LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~L--------l~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
.+|+||||+||..|+.++++.| ++.|||||.+|.+|+||||+|+..|+.+++++|+++||+++.+|..|.||
T Consensus 31 ~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~ 110 (277)
T d2fo1e1 31 RHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSA 110 (277)
T ss_dssp SSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCH
T ss_pred CCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccccccccccccccccccccccccc
Confidence 3699999999999999988777 56799999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHHc
Q 018682 110 LGDAIYYKNHEVIKLLEKH 128 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~ 128 (352)
+++|...++.++...+...
T Consensus 111 l~~a~~~~~~~~~~~l~~~ 129 (277)
T d2fo1e1 111 LHQAAANRDFGMMVYMLNS 129 (277)
T ss_dssp HHHHHHTTCHHHHHHHTTS
T ss_pred ccchhhhcchhhhhhhhhc
Confidence 9999999999998887653
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1e-18 Score=159.60 Aligned_cols=92 Identities=32% Similarity=0.375 Sum_probs=89.0
Q ss_pred hHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHH
Q 018682 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (352)
Q Consensus 42 t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~ 121 (352)
||||+||..|+.++|+.|+++|+|+|.+|..|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.++
T Consensus 2 TpL~~Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~~~ 81 (408)
T d1n11a_ 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNM 81 (408)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHHH
T ss_pred ChHHHHHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCC
Q 018682 122 IKLLEKHGAKPL 133 (352)
Q Consensus 122 ~~~L~~~~~~~~ 133 (352)
+++|+....+..
T Consensus 82 ~~~Ll~~~~~~~ 93 (408)
T d1n11a_ 82 VKLLLENNANPN 93 (408)
T ss_dssp HHHHHHHTCCTT
T ss_pred HHHHHHhhhccc
Confidence 999998877653
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.75 E-value=3.7e-18 Score=134.45 Aligned_cols=91 Identities=31% Similarity=0.390 Sum_probs=75.8
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
..+..+.++++.++...+.+.++.++++|++++.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 62 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~ 141 (153)
T d1awcb_ 62 ARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISI 141 (153)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccccccccccccccccccceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHH
Confidence 33344455555555566666667777788899999999999999999999999999999999999999999999999999
Q ss_pred ccCcHHHHHHH
Q 018682 115 YYKNHEVIKLL 125 (352)
Q Consensus 115 ~~~~~~~~~~L 125 (352)
.+|+.+++++|
T Consensus 142 ~~g~~eiv~lL 152 (153)
T d1awcb_ 142 DNGNEDLAEIL 152 (153)
T ss_dssp HTTCHHHHHHH
T ss_pred HcCCHHHHHhC
Confidence 99999999876
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.3e-18 Score=155.45 Aligned_cols=99 Identities=29% Similarity=0.294 Sum_probs=91.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+..+..+.||||.|+..++.++++.+++.|+++|.+|.+|.||||+|+.+|+.+++++|+++||++|.+|.+|.|
T Consensus 286 ~g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t 365 (408)
T d1n11a_ 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT 365 (408)
T ss_dssp HTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred CCCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence 47777788888899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHH
Q 018682 109 PLGDAIYYKNHEVIKLLEK 127 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~ 127 (352)
|||+|+..|+.+++++|..
T Consensus 366 ~L~~A~~~~~~~iv~~L~~ 384 (408)
T d1n11a_ 366 PLAIAKRLGYISVTDVLKV 384 (408)
T ss_dssp HHHHHHHTTCHHHHHHHHH
T ss_pred HHHHHHHcCCHHHHHHHHH
Confidence 9999999999999887754
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.74 E-value=4.6e-18 Score=133.88 Aligned_cols=101 Identities=31% Similarity=0.355 Sum_probs=76.7
Q ss_pred chHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC---------------------------------HH
Q 018682 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---------------------------------TE 87 (352)
Q Consensus 41 ~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~---------------------------------~~ 87 (352)
.||||.||..|+.++|++||++|++++ .|..|+||||+|+..++ .+
T Consensus 3 ~t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (153)
T d1awcb_ 3 GKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHAN 81 (153)
T ss_dssp HHHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHH
T ss_pred CHHHHHHHHCCCHHHHHHHHHcCCCcc-cccCCCccccccccccccccccccccccccccccccccccccccccccccce
Confidence 366666666666666666666666665 46666666666665554 45
Q ss_pred HHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHcCCCCCCCccccccc
Q 018682 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (352)
Q Consensus 88 ~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (352)
++++|+.+|++++.+|..|.||||+|+..|+.+++++|+++|+++......+.++
T Consensus 82 ~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tp 136 (153)
T d1awcb_ 82 IVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTA 136 (153)
T ss_dssp HHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred eeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCH
Confidence 7888889999999999999999999999999999999999999986554444333
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=8.2e-18 Score=133.09 Aligned_cols=106 Identities=24% Similarity=0.271 Sum_probs=97.3
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
++.|++..|..|+||||+|+ .++.++++.|+++++++|.++..|.+|++.|+..++.+++++++++|++++.+|..|.|
T Consensus 25 ~~~~~n~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t 103 (156)
T d1bd8a_ 25 ELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGAL 103 (156)
T ss_dssp TCCCTTCCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred CCCCCCccCCCCCccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCe
Confidence 57788899999999999886 48899999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCcHHHHHHHHHcCCCCCCCc
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~~~~~~~ 136 (352)
|||+|+..|+.+++++|. .++++....
T Consensus 104 ~L~~A~~~~~~~i~~~L~-~~~~~~~~d 130 (156)
T d1bd8a_ 104 PIHLAVQEGHTAVVSFLA-AESDLHRRD 130 (156)
T ss_dssp HHHHHHHHTCHHHHHHHH-TTSCTTCCC
T ss_pred eecccccccccccccccc-ccccccccC
Confidence 999999999999999887 567664433
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.72 E-value=7.7e-18 Score=146.88 Aligned_cols=87 Identities=28% Similarity=0.294 Sum_probs=81.7
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
...+....+..|.||||.|+..|+.++++.|++.|+|+|.+|.+|+||||+|+..|+.+++++|+++|||++.+|..|.|
T Consensus 188 ~~~~~~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~T 267 (291)
T d1s70b_ 188 GHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQT 267 (291)
T ss_dssp TCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cccccccccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 34455667778999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhc
Q 018682 109 PLGDAIY 115 (352)
Q Consensus 109 ~l~~a~~ 115 (352)
|||+|++
T Consensus 268 aL~~A~e 274 (291)
T d1s70b_ 268 AFDVADE 274 (291)
T ss_dssp TTTSCCS
T ss_pred HHHHHHH
Confidence 9999976
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.5e-17 Score=139.36 Aligned_cols=116 Identities=27% Similarity=0.262 Sum_probs=90.3
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH------------------
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS------------------ 90 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~------------------ 90 (352)
++.++|.++.+|+||||+||..|+.+++++|+++|+|++.+|.+|+||||+|+..++.++++
T Consensus 28 ~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 107 (221)
T d1iknd_ 28 DLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKAT 107 (221)
T ss_dssp -CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCC
T ss_pred CCCCcccCCCCCCccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 56677788888999999999999999999999999999988888888888888777665554
Q ss_pred ---------------------HHHHCCCCCCCCC-CCCCChhHHhhccCcHHHHHHHHHcCCCCCCCccccccccc
Q 018682 91 ---------------------LLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (352)
Q Consensus 91 ---------------------~Ll~~ga~~~~~~-~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 144 (352)
+|+..|++++..+ ..|.||||+|+..|+.+++++|+++|+|+......+.++..
T Consensus 108 ~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~ 183 (221)
T d1iknd_ 108 NYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQ 183 (221)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGG
T ss_pred ccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHH
Confidence 4445566666554 56889999999999999999999998887655444444433
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.69 E-value=9.4e-19 Score=156.95 Aligned_cols=98 Identities=19% Similarity=0.071 Sum_probs=85.1
Q ss_pred CCccCCchHHHHHHhcCCHHHHHH---HHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC--CCCCCh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKE---LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTP 109 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~---Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~--~~g~t~ 109 (352)
.++..|.||||+||.+|+.+++++ |++.|+++|.+|.+|+||||+||.+|+.++|++|+++|++++..+ .+|.||
T Consensus 85 ~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~ 164 (346)
T d2ajaa1 85 KKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHA 164 (346)
T ss_dssp HHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHH
T ss_pred hccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCCh
Confidence 456688999999999999877665 789999999999999999999999999999999999999998876 468999
Q ss_pred hHHhhccCcHHHHHHHHHcCCCC
Q 018682 110 LGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
||+|+..|+.+++++|++.+++.
T Consensus 165 L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 165 FRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp HHHHHHTTCHHHHHHHHHSCGGG
T ss_pred hHHHHHHhhHHHHHHHHHcCCcc
Confidence 99999999999999999988654
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=8.9e-17 Score=134.52 Aligned_cols=98 Identities=24% Similarity=0.240 Sum_probs=88.6
Q ss_pred CCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d-~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
....+|.||||.|+..++.+.+++|++.|+++|.++ .+|+||||+|+..|+.+++++|+++|+|++.+|..|.||||+|
T Consensus 106 ~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A 185 (221)
T d1iknd_ 106 ATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLT 185 (221)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGC
T ss_pred ccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHH
Confidence 344467888998888899999999999999998876 5799999999999999999999999999999999999999999
Q ss_pred hccCcHHHHHHHHHcCCCC
Q 018682 114 IYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~~ 132 (352)
+..++.+++++|.+...+.
T Consensus 186 ~~~~~~~~~~~l~~~~~~~ 204 (221)
T d1iknd_ 186 WGRPSTRIQQQLGQLTLEN 204 (221)
T ss_dssp TTSSCHHHHHHHHTTSCGG
T ss_pred HHCCCHHHHHHHHHcCCcc
Confidence 9999999999999987654
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.69 E-value=1.2e-16 Score=125.70 Aligned_cols=99 Identities=25% Similarity=0.303 Sum_probs=87.1
Q ss_pred HHHHHHhcCCHHHHHHHHHcCCCCCCC------CCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 43 RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 43 ~l~~a~~~~~~~~~~~Ll~~ga~~n~~------d~~g~t~lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
.|+.|+..+++..+..++..|+|++.. +..|+||||+|+.. ++.+++++|+++|+++|.+|..|.||||+|
T Consensus 9 ~L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A 88 (154)
T d1dcqa1 9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYC 88 (154)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHH
T ss_pred HHHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccc
Confidence 355788999999999999999998765 67899999999974 688999999999999999999999999999
Q ss_pred hccCcHHHHHHHHHcCCCCCCCcccccc
Q 018682 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (352)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 141 (352)
+..|+.+++++|+++|+++......+.+
T Consensus 89 ~~~~~~~~v~~Ll~~gad~~~~d~~g~t 116 (154)
T d1dcqa1 89 CLTDNAECLKLLLRGKASIEIANESGET 116 (154)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cccccccccccccccCccccccCCCCCC
Confidence 9999999999999999988655443333
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.4e-16 Score=125.62 Aligned_cols=101 Identities=28% Similarity=0.308 Sum_probs=73.4
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (352)
+|.|.+.+|.+|.||||+|+ .|+.+++++|+++|++++.++..|.|+|+.|+..+..+.++.|++.+.+++..|..|.+
T Consensus 23 ~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 101 (156)
T d1ihba_ 23 NNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNL 101 (156)
T ss_dssp SCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccccccccccccccccccccccc
Confidence 56666677777777777664 56777777777777777777777777777777777777777777777777777777777
Q ss_pred hhHHhhccCcHHHHHHHHHcCC
Q 018682 109 PLGDAIYYKNHEVIKLLEKHGA 130 (352)
Q Consensus 109 ~l~~a~~~~~~~~~~~L~~~~~ 130 (352)
|+++|+..++.+++++|++++.
T Consensus 102 ~l~~a~~~~~~~~~~~Ll~~~~ 123 (156)
T d1ihba_ 102 PLHLAAKEGHLRVVEFLVKHTA 123 (156)
T ss_dssp HHHHHHHTTCHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccc
Confidence 7777777777777777766654
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.2e-16 Score=124.42 Aligned_cols=125 Identities=26% Similarity=0.293 Sum_probs=106.7
Q ss_pred CCCcccccccccccCCchhhhhhhhcCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018682 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (352)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~ 83 (352)
+..+.||+-... ....+--+-.-..+.|.+..+..|.|+|+.++..++.+.++.|++.+.+++..|..|.+|||+|+..
T Consensus 31 d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~a~~~ 109 (156)
T d1ihba_ 31 NGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKE 109 (156)
T ss_dssp CTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCcccccccccc-cccccccccccccccccccccccCccccccccccccccccccccccccccccccccccccccccccc
Confidence 455778876543 2222111222236788888999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCC-CCCCCCCCCCChhHHhhccCcHHHHHHHHHcC
Q 018682 84 GFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (352)
Q Consensus 84 ~~~~~~~~Ll~~ga-~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~~ 129 (352)
++.+++++|+++|+ +++.+|..|.||||+|+..++.+++++|+++|
T Consensus 110 ~~~~~~~~Ll~~~~~~~~~~d~~g~TpL~~A~~~~~~~iv~~Ll~~G 156 (156)
T d1ihba_ 110 GHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156 (156)
T ss_dssp TCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred ccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHhcC
Confidence 99999999999876 89999999999999999999999999999876
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.68 E-value=7.2e-17 Score=139.34 Aligned_cols=97 Identities=26% Similarity=0.367 Sum_probs=90.1
Q ss_pred CCCCCCccCCchHHHHHHhcCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 018682 31 LDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (352)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll-~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 109 (352)
...+..+..|.||||+++..++.+.++.++ ..+.+++.+|..|+||||+|+..|+.+++++|+++|+|++.+|..|.||
T Consensus 178 ~~~~~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~ 257 (277)
T d2fo1e1 178 ARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTA 257 (277)
T ss_dssp GGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCH
T ss_pred ccccccccCCCCccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCH
Confidence 344566778999999999999999999866 6789999999999999999999999999999999999999999999999
Q ss_pred hHHhhccCcHHHHHHHHH
Q 018682 110 LGDAIYYKNHEVIKLLEK 127 (352)
Q Consensus 110 l~~a~~~~~~~~~~~L~~ 127 (352)
||+|+..|+.+++++|.+
T Consensus 258 L~~A~~~~~~~iv~lL~~ 275 (277)
T d2fo1e1 258 RQLAQANNHHNIVDIFDR 275 (277)
T ss_dssp HHHHHHTTCHHHHHHHHT
T ss_pred HHHHHHcCCHHHHHHHHH
Confidence 999999999999999986
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.1e-16 Score=138.78 Aligned_cols=106 Identities=27% Similarity=0.234 Sum_probs=91.1
Q ss_pred cCCCCCCCccCCchHHHHHHh----cCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLAN----ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKD 103 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~----~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~-ga~~~~~~ 103 (352)
.+.|.+..+..|.++++.+.. .+..++++.|+++|+++|.+|.+|.||||+|+..|+.+++++|++. |++++.+|
T Consensus 171 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d 250 (285)
T d1wdya_ 171 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250 (285)
T ss_dssp SCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCC
T ss_pred cCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCC
Confidence 356666677777766665433 2335688888999999999999999999999999999999999984 99999999
Q ss_pred CCCCChhHHhhccCcHHHHHHHHHcCCCCCC
Q 018682 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 104 ~~g~t~l~~a~~~~~~~~~~~L~~~~~~~~~ 134 (352)
.+|.||||+|+..++.+++++|+++|+++..
T Consensus 251 ~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~ 281 (285)
T d1wdya_ 251 SDGKTALLLAVELKLKKIAELLCKRGASTDC 281 (285)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHSSCSCC
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCc
Confidence 9999999999999999999999999999743
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=3.5e-17 Score=135.50 Aligned_cols=102 Identities=32% Similarity=0.263 Sum_probs=91.1
Q ss_pred CccCCchHHHHHHhcCCHHHHHHHHHcCCCCCC-----------------------------------------------
Q 018682 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNF----------------------------------------------- 68 (352)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~----------------------------------------------- 68 (352)
.|.+|.||||+||..|+.+++++|++.|+++|.
T Consensus 19 ~d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (209)
T d1ot8a_ 19 MDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARMHDGTTPLILAA 98 (209)
T ss_dssp HHHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTCCCHHHHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 367788999999999999999999998888763
Q ss_pred --------------------CCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccCcHHHHHHHHHc
Q 018682 69 --------------------RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128 (352)
Q Consensus 69 --------------------~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~~~~~~~~L~~~ 128 (352)
+|..|+||||+|+..+..++++.|++++++++..|..|.||||+|+..|+.+++++|+++
T Consensus 99 ~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~ 178 (209)
T d1ot8a_ 99 RLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDN 178 (209)
T ss_dssp HTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHT
T ss_pred cccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHC
Confidence 366788899999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcc
Q 018682 129 GAKPLMAPM 137 (352)
Q Consensus 129 ~~~~~~~~~ 137 (352)
|+++.....
T Consensus 179 gad~n~~d~ 187 (209)
T d1ot8a_ 179 FANREITDH 187 (209)
T ss_dssp TCCTTCCCT
T ss_pred CCCCCCcCC
Confidence 999755443
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.67 E-value=1e-16 Score=139.67 Aligned_cols=97 Identities=27% Similarity=0.396 Sum_probs=91.9
Q ss_pred cCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhhccC
Q 018682 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (352)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~~~~ 117 (352)
.++.|+||.||..|+.++|+.||++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++.+..+..+.+||++++..+
T Consensus 38 ~~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~ 117 (291)
T d1s70b_ 38 FDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCG 117 (291)
T ss_dssp ECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred CCCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeeccccccccccccccccccccccccc
Confidence 45779999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHHHcCCCCCC
Q 018682 118 NHEVIKLLEKHGAKPLM 134 (352)
Q Consensus 118 ~~~~~~~L~~~~~~~~~ 134 (352)
+.++++.|+++++....
T Consensus 118 ~~~~~~~l~~~~~~~~~ 134 (291)
T d1s70b_ 118 YLDIAEYLISQGAHVGA 134 (291)
T ss_dssp CHHHHHHHHHTTCCTTC
T ss_pred ccchhhcccccCccccc
Confidence 99999999998876543
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.8e-16 Score=131.47 Aligned_cols=93 Identities=22% Similarity=0.280 Sum_probs=86.7
Q ss_pred CCchHHHHHHhcCCHHHHHHHHH----cCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 39 KPEFRLMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~----~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
+|+||||+||..|+.++++.|++ .|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+..|.++++.|.
T Consensus 2 dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~ 81 (228)
T d1k1aa_ 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLAC 81 (228)
T ss_dssp TTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccc
Confidence 69999999999999999999874 79999999999999999999999999999999999999999999999999999
Q ss_pred ccCcHHHHHHHHHcCCC
Q 018682 115 YYKNHEVIKLLEKHGAK 131 (352)
Q Consensus 115 ~~~~~~~~~~L~~~~~~ 131 (352)
..++.++++.+......
T Consensus 82 ~~~~~~~~~~~~~~~~~ 98 (228)
T d1k1aa_ 82 EHRSPTCLRALLDSAAP 98 (228)
T ss_dssp HTTCHHHHHHHHHHSCT
T ss_pred ccccccchhhhhhcccc
Confidence 99999998887775443
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.66 E-value=8.3e-19 Score=157.32 Aligned_cols=104 Identities=15% Similarity=0.018 Sum_probs=90.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCC--CCCcHHHHHHHcCCHHHHHHHHHCCCCCC---CCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI--DNRTALHVAACQGFTEVVSLLLERGADVD---PKD 103 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~--~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~---~~~ 103 (352)
.|.+.|..+.+|+||||+||..|+.++|++|+++|+++|..|. +|+||||+||.+|+.+++++|++.|++.. ..+
T Consensus 115 ~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~~~~~ 194 (346)
T d2ajaa1 115 SDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQA 194 (346)
T ss_dssp CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHH
T ss_pred CCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCccccccccc
Confidence 6788888999999999999999999999999999999998764 59999999999999999999999998754 334
Q ss_pred CCCCChhHHhhccCcHHHHHHHHHcCCCC
Q 018682 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (352)
Q Consensus 104 ~~g~t~l~~a~~~~~~~~~~~L~~~~~~~ 132 (352)
..|.||++.|+..|+.+++++|++.|+++
T Consensus 195 ~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~ 223 (346)
T d2ajaa1 195 ENYYAFRWAAVGRGHHNVINFLLDCPVML 223 (346)
T ss_dssp HHHHHHHHHHSTTCCHHHHHHHTTSHHHH
T ss_pred CCCcchhhHHhhcCHHHHHHHHHhCCCCc
Confidence 56678888999999999999999987664
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=5.7e-16 Score=128.41 Aligned_cols=90 Identities=23% Similarity=0.290 Sum_probs=84.7
Q ss_pred CCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHh
Q 018682 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (352)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a 113 (352)
......|.++|+.|+..+...+++.++++|.+++.+|..|.||||+|+..|+.+++++|+++|||++.+|..|.||||+|
T Consensus 138 ~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A 217 (228)
T d1k1aa_ 138 AVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVA 217 (228)
T ss_dssp CCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTC
T ss_pred cccccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 34556889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCcHHHHH
Q 018682 114 IYYKNHEVIK 123 (352)
Q Consensus 114 ~~~~~~~~~~ 123 (352)
+..|+.++++
T Consensus 218 ~~~~~~divk 227 (228)
T d1k1aa_ 218 RSRRVIDILR 227 (228)
T ss_dssp SSHHHHHHHT
T ss_pred HhCCCccccC
Confidence 9999888764
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=8.4e-16 Score=133.06 Aligned_cols=76 Identities=26% Similarity=0.369 Sum_probs=71.9
Q ss_pred cCCCCCCCccCCchHHHHHHhcCCHHHHHHHHH-cCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Q 018682 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (352)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~-~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 104 (352)
+|.|.+.++..|.||||+||..|+.+++++|++ .|+|+|.+|.+|.||||+|+..|+.+++++|+++|||+|.+|.
T Consensus 208 ~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 208 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp TTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred CCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 577888889999999999999999999999998 4999999999999999999999999999999999999999874
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.59 E-value=6.9e-15 Score=123.14 Aligned_cols=113 Identities=25% Similarity=0.229 Sum_probs=99.8
Q ss_pred CCCCCccCCchHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCCCCChh
Q 018682 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPL 110 (352)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~ga~~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~t~l 110 (352)
+....+..+.|+|+.++..++.++++.|++.|.+.+.+|.+|+||||+|+..|+.+++++|++.| .+++.+|..|.|||
T Consensus 97 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpL 176 (229)
T d1ixva_ 97 DLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPL 176 (229)
T ss_dssp CTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHH
T ss_pred cccccccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCch
Confidence 45556678899999999999999999999999999999999999999999999999999999986 78899999999999
Q ss_pred HHhhccCcHHHHHHHHH-cCCCCCCCccccccccc
Q 018682 111 GDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHARE 144 (352)
Q Consensus 111 ~~a~~~~~~~~~~~L~~-~~~~~~~~~~~~~~~~~ 144 (352)
|+|+..++.+++++|++ .|+++......+.++..
T Consensus 177 h~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l~ 211 (229)
T d1ixva_ 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAED 211 (229)
T ss_dssp HHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTGG
T ss_pred hhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHHH
Confidence 99999999999999986 68988665544444433
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.57 E-value=2.8e-15 Score=131.36 Aligned_cols=49 Identities=31% Similarity=0.376 Sum_probs=47.7
Q ss_pred CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHhh
Q 018682 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (352)
Q Consensus 66 ~n~~d~~g~t~lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~a~ 114 (352)
+|.+|.+|+||||+||+.|+.+++++|+++||+++.+|..|.|||++|+
T Consensus 252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300 (301)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence 7899999999999999999999999999999999999999999999986
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=8.5e-07 Score=74.49 Aligned_cols=128 Identities=13% Similarity=0.017 Sum_probs=84.4
Q ss_pred EEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccCCCCHHHHHHhcCC
Q 018682 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246 (352)
Q Consensus 168 ~~~v~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 246 (352)
...+...+..+++|+......... ..+.+|...++.+. +--+++++.+...++..++||++++|.++.+....
T Consensus 30 v~rv~~~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--- 103 (263)
T d1j7la_ 30 VYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--- 103 (263)
T ss_dssp EEEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT---
T ss_pred EEEEEeCCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc---
Confidence 345556778899998865432221 23567888887764 33467888888888889999999999887554321
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------------
Q 018682 247 LKPSTAVRFALDIARGMNYLHENK-------------------------------------------------------- 270 (352)
Q Consensus 247 ~~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------------------------- 270 (352)
......++.++...+..||+..
T Consensus 104 --~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 181 (263)
T d1j7la_ 104 --EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE 181 (263)
T ss_dssp --CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred --cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence 1111223344444445555321
Q ss_pred CCCceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 271 ~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
+..++|+|+.|.||+++.++.+-|+||+.+...
T Consensus 182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 123789999999999997665679999987653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.3e-05 Score=66.61 Aligned_cols=123 Identities=18% Similarity=0.172 Sum_probs=72.6
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCceeeeeEEEEeCCceEEEEeccCCCCHHH------------
Q 018682 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA------------ 239 (352)
Q Consensus 174 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~------------ 239 (352)
.+..+++|....... ..+..|...++.+. .-.+++++.+..+++..+++|++++|.++.+
T Consensus 34 ~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~~~~~~~~~~l 107 (255)
T d1nd4a_ 34 GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIM 107 (255)
T ss_dssp TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSCCCHHHHHHHH
T ss_pred CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccccccHHHHHHHH
Confidence 355688898765432 23667888777663 2336778888888888999999998865422
Q ss_pred --HHHh-------cCCC--CHHHHHH-----H---------------HHHHHHHHHHHHhCC----CCCceecCCCCCCe
Q 018682 240 --FLKR-------KGAL--KPSTAVR-----F---------------ALDIARGMNYLHENK----PVPIIHRDLEPSNI 284 (352)
Q Consensus 240 --~l~~-------~~~~--~~~~~~~-----i---------------~~qi~~~l~~LH~~~----~~~ivH~Dikp~Ni 284 (352)
.+.+ ..++ ....... + .......+..+.... +..++|+|+.|.||
T Consensus 108 ~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nv 187 (255)
T d1nd4a_ 108 ADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNI 187 (255)
T ss_dssp HHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGE
T ss_pred HHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcce
Confidence 1111 0000 0000000 0 000112233333322 22379999999999
Q ss_pred EeCCCCCEEEEccCCccc
Q 018682 285 LRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 285 ll~~~~~vkL~Dfg~a~~ 302 (352)
|++.+..+-|+||+.+..
T Consensus 188 l~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 188 MVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEETTEEEEECCCTTCEE
T ss_pred EEeCCceEEEEEchhccc
Confidence 999876677999998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.65 E-value=6.2e-05 Score=66.78 Aligned_cols=30 Identities=27% Similarity=0.332 Sum_probs=25.6
Q ss_pred CceecCCCCCCeEeCCCCCEEEEccCCcccc
Q 018682 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (352)
Q Consensus 273 ~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~~ 303 (352)
.++|+|++|.|||++.+ .++++||..+...
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcccC
Confidence 48999999999999876 4899999887653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.52 E-value=0.0027 Score=54.24 Aligned_cols=123 Identities=12% Similarity=0.103 Sum_probs=67.0
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCce--eeee-----EEEEeCCceEEEEeccCCCCH-----HHHH
Q 018682 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV--VQFL-----GAVTQSSPMMIVTEYLPKGDL-----RAFL 241 (352)
Q Consensus 174 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~~L-----~~~l 241 (352)
+|..|++|+..+...+ .+++..|...+..|....+ +... ..+..++..+.++++++|..+ ..+.
T Consensus 45 dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~ 120 (325)
T d1zyla1 45 DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQME 120 (325)
T ss_dssp TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHH
T ss_pred CCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHH
Confidence 6788999998765432 2456678887777632111 1111 123456678889999876322 1111
Q ss_pred H---------h----c-----CCCC-------------------HH---HHHHHHHHHHHHHHHHH-hCCCCCceecCCC
Q 018682 242 K---------R----K-----GALK-------------------PS---TAVRFALDIARGMNYLH-ENKPVPIIHRDLE 280 (352)
Q Consensus 242 ~---------~----~-----~~~~-------------------~~---~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dik 280 (352)
. . . ..++ .. .....+.++...+.-.- +..+..++|+|+.
T Consensus 121 ~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh 200 (325)
T d1zyla1 121 AVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCH 200 (325)
T ss_dssp HHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCS
T ss_pred HHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCC
Confidence 0 0 0 0011 11 11122333333333221 2223458999999
Q ss_pred CCCeEeCCCCCEEEEccCCccc
Q 018682 281 PSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 281 p~Nill~~~~~vkL~Dfg~a~~ 302 (352)
+.|||++.+ ..++||+-+..
T Consensus 201 ~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 201 AGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp GGGEEESSS--EEECCCTTCCE
T ss_pred cccEEEeCC--ceEEechhccc
Confidence 999999743 56899997764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.67 E-value=0.0027 Score=55.89 Aligned_cols=53 Identities=13% Similarity=0.182 Sum_probs=33.8
Q ss_pred eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCceeeeeEEEEeCCceEEEEeccCCCCH
Q 018682 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (352)
Q Consensus 176 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 237 (352)
..|.+++.... ... -...+|..+++.+. +.-.+++++++.. .+|+||++|.++
T Consensus 75 ~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 75 NKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp SEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 46778776522 121 23457888888874 4445677777643 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.22 E-value=0.0098 Score=50.20 Aligned_cols=32 Identities=25% Similarity=0.242 Sum_probs=27.2
Q ss_pred CCCceecCCCCCCeEeCCCCCEEEEccCCccc
Q 018682 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (352)
Q Consensus 271 ~~~ivH~Dikp~Nill~~~~~vkL~Dfg~a~~ 302 (352)
+..++|+|+.++|++++.+...-++||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 33599999999999999887678999998754
|